Citrus Sinensis ID: 003818
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 793 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.943 | 0.899 | 0.438 | 1e-179 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.919 | 0.892 | 0.347 | 1e-110 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.954 | 0.868 | 0.318 | 1e-108 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.895 | 0.856 | 0.341 | 1e-104 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.930 | 0.898 | 0.313 | 8e-96 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.924 | 0.885 | 0.325 | 6e-93 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.847 | 0.843 | 0.324 | 2e-89 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.896 | 0.815 | 0.285 | 6e-77 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.930 | 0.866 | 0.286 | 1e-73 | |
| Q9SXB3 | 820 | G-type lectin S-receptor- | no | no | 0.901 | 0.871 | 0.294 | 1e-73 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 628 bits (1620), Expect = e-179, Method: Compositional matrix adjust.
Identities = 352/802 (43%), Positives = 483/802 (60%), Gaps = 54/802 (6%)
Query: 24 NISLGSSLTASNDNP-AASWISQSGDFAFGFRQVG-DRGFLLAIWFNEIPERTIVWSANR 81
++ +G SLTAS ++SW S SGDFAFGFR++ + GF L+IWF++I ++TIVW A
Sbjct: 31 SVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPNDGFTLSIWFDKISDKTIVWHAQA 90
Query: 82 DN----LVQRGSKVELTGDGQLILRDSSGKEIWREPPSTGAAYAAMLDTGNLVL---ASQ 134
N LV GSKV LT DG L++ D G+E+WR + D GN VL S+
Sbjct: 91 VNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALSGGSVSRGRFTDDGNFVLFRDGSE 150
Query: 135 DS-STMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYT--- 190
DS +W SF++PTDTLLP Q + G + +R TET++ GRF L+ DGNL L++
Sbjct: 151 DSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGNLQLHSLNA 210
Query: 191 TTYPFDGANAAYWSTQTSI--GSGYQVVFNQSGFIYLTARNGS--ILNAVTSNNVTAQDF 246
T + Y+ + T+ G Q+VFNQSG IY+ RN S ++ + A F
Sbjct: 211 ETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIYVLQRNNSRFVVKDRDPDFSIAAPF 270
Query: 247 YQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSF 306
Y G I PK + G L N+C A G+ ACG+N+
Sbjct: 271 YIST-----GFLLSTIIPKEARRIVG-----GCLLGLCRDNMCSPDDA-LGNMACGYNNI 319
Query: 307 CSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSC----DRAVEEMDLFEFRDMPNT 362
CSLG+++R C+CP + DP + C +F Q+C A +++L+EF + T
Sbjct: 320 CSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKT 379
Query: 363 DWPLNDYEHFTSVDEDWCREACLSDCFCAVAIF---REGECWKKRAPLSNGRIDPSVGGK 419
+WP DYE + + DE+ C+ +CLSDC CA IF R+ +CWKK+ PLS+G P
Sbjct: 380 NWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSD 439
Query: 420 ALVKVRKDYSDASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTV 479
+KVR +G+ K+ LI S LG S F+ + + R+ +K +N +
Sbjct: 440 TFIKVRNRSIADVPVTGNRAKKLDWLIIACSVLLGTSAFVIFDTSCSY--RKTKKSKNMM 497
Query: 480 ESQ----------KGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTE--NE 527
++Q E+NL+ FTY EL T F EELG GAFG VYKG L +E
Sbjct: 498 KNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSE 557
Query: 528 KPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLA 587
VAVKKL + + E+EFK E+ IG+ +HKNLV+L+GFCNEG+ +++VYE++ G+LA
Sbjct: 558 VTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLA 617
Query: 588 DFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDF 647
+FLFR+ R P+W R IA ARG+ YLHEEC QIIHCDIKPQNILLD + RISDF
Sbjct: 618 NFLFRRPR-PSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDF 676
Query: 648 GLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVD 707
GLAKLL +QT T T IRGTKGYVAPEWF+N PIT+KVDVYS+G++LLE+VCC+K ++
Sbjct: 677 GLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL- 735
Query: 708 ATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAM 767
E +IL +WAYDCFR+ +L L E+D EAM+D++ VE++V IAIWCIQE+ +RP M
Sbjct: 736 ---EDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNM 792
Query: 768 KKVTQMIEGAVDVSIPPDPASF 789
+ VTQM+EG + V PP+P+ +
Sbjct: 793 RNVTQMLEGVIQVFDPPNPSPY 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 400 bits (1028), Expect = e-110, Method: Compositional matrix adjust.
Identities = 296/851 (34%), Positives = 423/851 (49%), Gaps = 122/851 (14%)
Query: 4 LLFFLIPLLLPISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLL 63
+L F I L AA S + LGSSL + +++ S G F+ GF +V F
Sbjct: 14 ILSFFIALF---PRAASSRDILPLGSSLVVESYE-SSTLQSSDGTFSSGFYEVYTHAFTF 69
Query: 64 AIWFNEIP-----ERTIVWSANRDNLVQ-RGSKVELTGDGQLILRDSSGKEIWREPPS-- 115
++W+++ +TIVWSAN D V R S + L DG ++L D G +WR +
Sbjct: 70 SVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNF 129
Query: 116 TGAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGR 175
TG A +LDTGNLV+ +T+W+SFD PTDT LPTQ+++ T+++ T + S G
Sbjct: 130 TGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVP--TTQSRSPGN 187
Query: 176 FMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNA 235
++F +L + + Y + YW + YQ NQ Y + R G + +
Sbjct: 188 YIFRFS---DLSVLSLIYHVPQVSDIYWPDPDQ--NLYQDGRNQ----YNSTRLGMLTD- 237
Query: 236 VTSNNVTAQDFY---------------QRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSF 280
S + + DF +R +DPDG R Y S + G W +
Sbjct: 238 --SGVLASSDFADGQALVASDVGPGVKRRLTLDPDGNLRLY----SMNDSDGSWSVSMVA 291
Query: 281 LSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFV 340
++ P NI G CG N C C CPPGY +P + +GC V
Sbjct: 292 MT-QPCNI---------HGLCGPNGICHY--SPTPTCSCPPGYATRNPGNWTEGCMA-IV 338
Query: 341 PQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREG-- 398
+CDR + F +PNTD+ +D +H SV CR+ C+SDC C ++EG
Sbjct: 339 NTTCDRYDKRS--MRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTG 396
Query: 399 ECWKKRAPLSNGRIDPSVGGKAL-------VKV------RKDYSDASAGSGSNRKENSTL 445
C+ K A L +GR P+ + + V V R D D+ + N ++
Sbjct: 397 SCYPK-AYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSI 455
Query: 446 ---IYILSATLGG-----------SIFLHLLVTFI-----FFHRRNQKKQNTVESQKGMP 486
+ T GG + F + V+FI F +R + S+KG
Sbjct: 456 REPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYK 515
Query: 487 EM--NLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ 544
M N + ++Y+EL T FK ELG G G VYKGVL E+++ VAVKKL + V +G++
Sbjct: 516 AMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVL--EDDRHVAVKKL-ENVRQGKE 572
Query: 545 EFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP--NWYKR 602
F+AE+S IGR NH NLV++ GFC+EG HRLLV EYV NGSLA+ LF + +W R
Sbjct: 573 VFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGR 632
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL-KTDQTQTT 661
IA G A+GL YLH EC +IHCD+KP+NILLD F +I+DFGL KLL + TQ
Sbjct: 633 FNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNV 692
Query: 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFE-VDATEECQMILADWA 720
+ +RGT GY+APEW +LPITAKVDVYS+G++LLEL+ + E V T+E +L
Sbjct: 693 SHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLV 752
Query: 721 YDCFRERKLGLLVENDEEAMDD------------IKRVEKFVMIAIWCIQEDPSLRPAMK 768
R L +E +E++ D + + +A+ C++ED S RP M+
Sbjct: 753 ------RMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTME 806
Query: 769 KVTQMIEGAVD 779
Q + A D
Sbjct: 807 HAVQTLLSADD 817
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 392 bits (1008), Expect = e-108, Method: Compositional matrix adjust.
Identities = 266/834 (31%), Positives = 430/834 (51%), Gaps = 77/834 (9%)
Query: 6 FFLIPLLLPISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVG--DRGFLL 63
FFL+ L + +I LGS L AS N A W+S +G FA GF + DR FLL
Sbjct: 19 FFLVSL--------ATEPHIGLGSKLKASEPNRA--WVSANGTFAIGFTRFKPTDR-FLL 67
Query: 64 AIWFNEIP-ERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPST-GAAYA 121
+IWF ++P + TIVWS NR++ V + + +EL G L+L D + +W S G A
Sbjct: 68 SIWFAQLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQN-TVVWTSNTSNHGVESA 126
Query: 122 AMLDTGNLVLASQDSS---TMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMF 178
M ++GN +L + + T+W+SF P+DTLLP Q ++ ++ + + + + G +
Sbjct: 127 VMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRH--GHYSL 184
Query: 179 ELQTDGNLLLYTTTYPFD---GANAAYWSTQ--TSIGSGYQVVFNQSG---FIYLTARNG 230
++ L TY + AN +YWS +++ V + +G +Y + G
Sbjct: 185 KMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIG 244
Query: 231 SIL---NAVTSNN---------VTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAW 278
++ N V N +T +R V++ +G R Y + + + +W W
Sbjct: 245 AVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRW-DNDMNGSSQWVPEW 303
Query: 279 SFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKL-CQCPPGYTFFDPDDVMKGCKE 337
+ +S P +I +G CG N C+L ++ C C PG + K C +
Sbjct: 304 AAVSN-PCDI---------AGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSD 352
Query: 338 NF-VPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDE----DWCREACLSDCFCAV 392
N + Q C+ + F+ + T++ ++ ++ + C E CLSDC C
Sbjct: 353 NSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVA 412
Query: 393 AIF----REGECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSN---RKENSTL 445
+++ + CW ++ G DP G VK R + S S + ++ RK +
Sbjct: 413 SVYGLDDEKPYCWILKSLNFGGFRDP--GSTLFVKTRANESYPSNSNNNDSKSRKSHGLR 470
Query: 446 --IYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITG 503
+ ++ +G + + LL ++++ ++ + + FTY++L+ T
Sbjct: 471 QKVLVIPIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTN 530
Query: 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
F + LG G FG VYKG T E VAVK+L +A++ GE+EF E++ IG +H NLV+
Sbjct: 531 NFSQLLGSGGFGTVYKG--TVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVR 588
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN---WYKRMQIAFGTARGLFYLHEEC 620
L G+C+E HRLLVYEY+ NGSL ++F + N W R +IA TA+G+ Y HE+C
Sbjct: 589 LCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQC 648
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+++IIHCDIKP+NILLD F ++SDFGLAK++ + + T IRGT+GY+APEW N P
Sbjct: 649 RNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRP 708
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740
IT K DVYS+G+LLLE+V R+N ++ E WAY V+ + +
Sbjct: 709 ITVKADVYSYGMLLLEIVGGRRNLDMSYDAE-DFFYPGWAYKELTNGTSLKAVDKRLQGV 767
Query: 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD-VSIPPDPASFISSI 793
+ + V K + +A WCIQ++ S+RP+M +V +++EG D +++PP P + + I
Sbjct: 768 AEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTILELI 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 276/808 (34%), Positives = 408/808 (50%), Gaps = 98/808 (12%)
Query: 21 SSSNISLGSSLTASNDNPAASWISQSGDFAFGF-RQVGDRGFLLAIWF-NEIPERTIVWS 78
S S I LGS + AS N +W S + F+ F FL A+ F +P +WS
Sbjct: 23 SFSTIPLGSVIYASGSN--QNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWS 76
Query: 79 ANRDNLVQRGSKVELTGDGQLILRDSSGKEIW-REPPSTGAAYAAMLDTGNLVLASQDSS 137
A + RGS + L G L L + SG +W + G ++ DTG +L + S
Sbjct: 77 AG--TVDSRGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSV 133
Query: 138 TMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDG 197
+W SFD+PTDT++ +Q + G K++ SG + F+L+ GNL L T
Sbjct: 134 PVWSSFDNPTDTIVQSQNFTAG-KIL--------RSGLYSFQLERSGNLTLRWNT----- 179
Query: 198 ANAAYWSTQTSIGSGY-----QVVFNQSGFIYLTARNGSILNA---VTSNNVTAQDFYQR 249
+A YW+ + ++ +G + + N +L V S + + ++
Sbjct: 180 -SAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESN--LLGGAEIVYSGDYGDSNTFRF 236
Query: 250 AVVDPDGVFRHYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSL 309
+D DG R Y S++ G WS + + CL G CG CS
Sbjct: 237 LKLDDDGNLRIY---SSASRNSGPVNAHWSAV-----DQCLVY------GYCGNFGICSY 282
Query: 310 GDDQRKLCQCPP-GYTFFDPDDVMKGCKENFVPQSCDRAVEEMDL-----FEFRDMPNTD 363
+D +C CP + F D +D KGCK C +DL F + D PN+
Sbjct: 283 -NDTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNS- 340
Query: 364 WPLNDYEHFTSVDEDWCREACLSDCFCAVAIFRE---GECWKKR-APLSNGRIDPSVGGK 419
E F + CR CLS C ++ G CW+K G PSV
Sbjct: 341 ------ESFFAGSSP-CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPST 393
Query: 420 ALVKV-----RKDYSDASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFH--RRN 472
+ VKV A+ G +N K + ++ + A + G + L + +++ R+N
Sbjct: 394 SYVKVCGPVVANTLERATKGDDNNSKVHLWIVAV--AVIAGLLGLVAVEIGLWWCCCRKN 451
Query: 473 QK------KQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTEN 526
+ +E G P FTYKEL+ T FKE+LG G FG VY+GVLT N
Sbjct: 452 PRFGTLSSHYTLLEYASGAP----VQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--N 505
Query: 527 EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586
VAVK+L + + +GE++F+ E++ I T+H NLV+L+GFC++G HRLLVYE++ NGSL
Sbjct: 506 RTVVAVKQL-EGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSL 564
Query: 587 ADFLFR--KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI 644
+FLF ++ W R IA GTA+G+ YLHEEC+ I+HCDIKP+NIL+D F A++
Sbjct: 565 DNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKV 624
Query: 645 SDFGLAKLLK-TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703
SDFGLAKLL D +++RGT+GY+APEW NLPIT+K DVYS+G++LLELV ++N
Sbjct: 625 SDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRN 684
Query: 704 FEVDATEECQMILADWAYDCFRERKLGLLVEN--DEEAMDDIKRVEKFVMIAIWCIQEDP 761
F+V + + + WAY+ F + +++ E+ D+++V + V + WCIQE P
Sbjct: 685 FDV-SEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQP 743
Query: 762 SLRPAMKKVTQMIEGAVDVSIPPDPASF 789
RP M KV QM+EG ++ P P +
Sbjct: 744 LQRPTMGKVVQMLEGITEIKNPLCPKTI 771
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 8e-96, Method: Compositional matrix adjust.
Identities = 263/838 (31%), Positives = 409/838 (48%), Gaps = 100/838 (11%)
Query: 1 MQGLLFFLIPLLL----PISAAAQSSSNISLGSSLTASN--DNPAASWISQSGDFAFGFR 54
M+G+ ++ L+ P+ A S +I+ G + N +N S + F FGF
Sbjct: 1 MRGVFIVIVTCLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGFGFV 60
Query: 55 QVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EP 113
D L + ++WSANR + V K +G +++ G E+WR +
Sbjct: 61 TTQDSVTLFTLSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVME---GTEVWRLDN 117
Query: 114 PSTGAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSS 173
A+ + D+GNLV+ S D +++WESFD PTDTL+ Q +G K+ + + +N +
Sbjct: 118 SGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMT- 176
Query: 174 GRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFI---------- 223
+ E+++ +L + P YWS + + + + N+ G +
Sbjct: 177 --YALEIKSGDMVLSVNSLTP-----QVYWS----MANARERIINKDGGVVTSSSLLGNS 225
Query: 224 --YLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFL 281
+ + + V S+N + AV+ +GV S S G A
Sbjct: 226 WRFFDQKQVLLWQFVFSDNKDDNTTWI-AVLGNNGVI--------SFSNLGSGASAADSS 276
Query: 282 SFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFDPD---DVMKGCKEN 338
+ IPS++C CG CS K+C C G + D + CK+
Sbjct: 277 TKIPSDLCGTPEP------CGPYYVCS----GSKVCGCVSGLSRARSDCKTGITSPCKKT 326
Query: 339 ----FVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAI 394
+P A + +D F P P + D D C+E C ++C C
Sbjct: 327 KDNATLPLQLVSAGDGVDYFALGYAP----PFSK-----KTDLDSCKEFCHNNCSCLGLF 377
Query: 395 FRE--GECWKKRAPLSNGRIDPS-VGGKALVKVRKDYSDASAGSGSNRKENSTLIYILSA 451
F+ G C+ G S GG V K S S G + + Y++
Sbjct: 378 FQNSSGNCFLFDYI---GSFKTSGNGGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVII 434
Query: 452 TLGGSIFLHLLVTFIF-FHRRNQ----------KKQNTVESQKGMPEMNLQDFTYKELEV 500
+ + +L+ F H+R + ++ N +E+ GMP F YK+L+
Sbjct: 435 VVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMP----IRFAYKDLQS 490
Query: 501 ITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
T F +LG+G FG VY+G L + +AVKKL + + +G++EF+AE+S IG +H +
Sbjct: 491 ATNNFSVKLGQGGFGSVYEGTLPDGSR--LAVKKL-EGIGQGKKEFRAEVSIIGSIHHLH 547
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---NWYKRMQIAFGTARGLFYLH 617
LV+L GFC EG HRLL YE++S GSL ++FRK +W R IA GTA+GL YLH
Sbjct: 548 LVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLH 607
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
E+C ++I+HCDIKP+NILLD FNA++SDFGLAKL+ +Q+ T +RGT+GY+APEW
Sbjct: 608 EDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWIT 667
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFE-VDATEECQMILADWAYDCFRERKLGLLVEND 736
N I+ K DVYS+G++LLEL+ RKN++ + +E+C +A+ E KL +V+
Sbjct: 668 NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH--FPSFAFKKMEEGKLMDIVDGK 725
Query: 737 EEAMDDI-KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFISSI 793
+ +D +RV++ + A+WCIQED RP+M KV QM+EG V PP ++ S +
Sbjct: 726 MKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMGSRL 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 267/821 (32%), Positives = 401/821 (48%), Gaps = 88/821 (10%)
Query: 6 FFLIPLLLPISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRG-FLLA 64
FF I + S+A + + T S D +S G + GF + G F +
Sbjct: 10 FFFICFFIHGSSAVDT-----ISGDFTLSGDQTI---VSSDGTYEMGFFKPGSSSNFYIG 61
Query: 65 IWFNEIPERTIVWSANRDNLVQ-RGSKVELTGDGQLILRDSSGKE-IW----REPPSTGA 118
+W+ ++ + TI+W ANRD V + S V +G LIL D + + +W S A
Sbjct: 62 MWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSA 120
Query: 119 AYAAMLDTGNLVLASQDSS----TMWESFDDPTDTLLP--TQVMSQGTKVIARLTE---- 168
A + D GNLVL + SS +W+SFD P DT LP + + T RLT
Sbjct: 121 LEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSL 180
Query: 169 TNYSSGRFMFELQTDGNLLLYTTTYP--FDGANAAY----WSTQTSI-GSGYQVVFNQSG 221
+ S G F EL +T Y ++G+N + W+ Q+ I S ++ N
Sbjct: 181 EDPSPGLFSLELDE-------STAYKILWNGSNEYWSSGPWNPQSRIFDSVPEMRLN--- 230
Query: 222 FIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFL 281
+IY + + ++ + ++ Q R V+D G + + + + + KAW+
Sbjct: 231 YIYNFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEGN--------KAWNLF 282
Query: 282 SFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGY-----TFFDPDDVMKGCK 336
P C R CG CS D C+CP G+ +D D GC
Sbjct: 283 WSQPRQQCQVYRY------CGSFGICS--DKSEPFCRCPQGFRPMSQKDWDLKDYSAGCV 334
Query: 337 ENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFR 396
Q C R D+ +F +PN N E T C AC DC C +
Sbjct: 335 RKTELQ-CSRG----DINQFFRLPNMKLADNS-EVLTRTSLSICASACQGDCSCKAYAYD 388
Query: 397 EGE----CWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKENSTLIYILSAT 452
EG W K L+ +++ + +R SD S + N LI+
Sbjct: 389 EGSSKCLVWSKDV-LNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNNKGLIF---GA 444
Query: 453 LGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEG 512
+ GS+ + +LV + +++ + +KG + L F+Y+EL+ T F ++LG G
Sbjct: 445 VLGSLGVIVLVLLVVILILRYRRRKRMRGEKG--DGTLSAFSYRELQNATKNFSDKLGGG 502
Query: 513 AFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE 572
FG V+KG L ++ +AVK+L + +++GE++F+ E+ IG H NLV+L GFC+EG
Sbjct: 503 GFGSVFKGALPDSSD--IAVKRL-EGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGS 559
Query: 573 HRLLVYEYVSNGSLADFLFRKSRRPN----WYKRMQIAFGTARGLFYLHEECKSQIIHCD 628
+LLVY+Y+ NGSL LF W R QIA GTARGL YLH+EC+ IIHCD
Sbjct: 560 KKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCD 619
Query: 629 IKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVY 688
IKP+NILLD F +++DFGLAKL+ D ++ T +RGT+GY+APEW + ITAK DVY
Sbjct: 620 IKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVY 679
Query: 689 SFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA-MDDIKRVE 747
S+G++L ELV R+N E E+ + + A ++ + LV+ E DI+ V
Sbjct: 680 SYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVT 739
Query: 748 KFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPAS 788
+ +A WCIQ++ S RPAM +V Q++EG ++V+ PP P S
Sbjct: 740 RACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRS 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 246/757 (32%), Positives = 360/757 (47%), Gaps = 85/757 (11%)
Query: 49 FAFGFRQV--GDRGFLLAIWFNEIPERTIVWSANRDNLVQR--GSKVELTGDGQLILRDS 104
F GF G + L I + +P T VW ANR V S +ELT G LI+ +
Sbjct: 40 FRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTGYLIVSNL 99
Query: 105 SGKEIWREPPSTGAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIA 164
+W+ +TGNL+L + D S +W+SFD+PTDT LP ++ T + +
Sbjct: 100 RDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAMTS 159
Query: 165 RLTETNYSSGRFMFELQTDGN--LLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQS-- 220
+ + S G + L N L+Y T P YWST G + V +
Sbjct: 160 WRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTP-------YWSTGNWTGEAFVGVPEMTIP 212
Query: 221 -----GFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWP 275
F+ S V + ++ R +V +G + Y + + S
Sbjct: 213 YIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDPQTQS------ 266
Query: 276 KAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGY-----TFFDPDD 330
W+ P + C R+ CG FCS + K C C G+ + DD
Sbjct: 267 --WNMFWLQPEDPC-RVY-----NLCGQLGFCS--SELLKPCACIRGFRPRNDAAWRSDD 316
Query: 331 VMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFC 390
GC+ ++ D E+ D FE D + V + C + CL + C
Sbjct: 317 YSDGCRR----ENGDSG-EKSDTFEAVGDLRYDGDVKMSR--LQVSKSSCAKTCLGNSSC 369
Query: 391 AVAIFREGECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKENSTLIYILS 450
+E L K+ + S + N K N + I+
Sbjct: 370 VGFYHKEKS--------------------NLCKILLE----SPNNLKNSKGNISKSIIIL 405
Query: 451 ATLGGSIFL---HLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKE 507
++ GSI + LLV I R ++K+ + + G +NL+ F++KEL+ T GF +
Sbjct: 406 CSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSD 465
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
++G G FG V+KG L + VAVK+L + GE EF+AE+ IG H NLV+L GF
Sbjct: 466 KVGHGGFGAVFKGTLPGSSTF-VAVKRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGF 523
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQIIH 626
C+E HRLLVY+Y+ GSL+ +L R S + +W R +IA GTA+G+ YLHE C+ IIH
Sbjct: 524 CSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIH 583
Query: 627 CDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVD 686
CDIKP+NILLD +NA++SDFGLAKLL D ++ +RGT GYVAPEW LPIT K D
Sbjct: 584 CDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKAD 643
Query: 687 VYSFGILLLELVCCRKNFEVDA-------TEECQMILADWAYDCFRERKLGLLVENDEEA 739
VYSFG+ LLEL+ R+N V++ TE + WA + + +V++
Sbjct: 644 VYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNG 703
Query: 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776
+ + V + +AIWCIQ++ +RPAM V +M+EG
Sbjct: 704 EYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 289 bits (739), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 234/820 (28%), Positives = 370/820 (45%), Gaps = 109/820 (13%)
Query: 29 SSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFN--EIPERTIVWSANRDNLVQ 86
S+L + + A +S++ F G G +F+ + + +WS+NRD+ V
Sbjct: 37 SNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFYFSVVHVDSGSTIWSSNRDSPVS 96
Query: 87 RGSKVELTGDGQLILRDSSGK-EIWREPPSTGAAYAAML-DTGNLVLASQDSSTMWESFD 144
+ LT G ++ D + +W P + L D GNL+L + ++WESFD
Sbjct: 97 SSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFD 156
Query: 145 DPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWS 204
PTD+++ Q + G + ++ +++S+G + F + L+ + G N YW
Sbjct: 157 FPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQWR------GQN--YWK 208
Query: 205 TQTSIGSGYQVVF-------NQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGV 257
+ I + F SG + L ARNG+++ V + ++ A +D G
Sbjct: 209 LRMHIRANVDSNFPVEYLTVTTSG-LALMARNGTVV--VVRVALPPSSDFRVAKMDSSGK 265
Query: 258 FRHYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGD-DQRKL 316
F + + T P + F+ CG C+L + + +
Sbjct: 266 FIVSRFSGKNLVTEFSGPMDSCQIPFV----------------CGKLGLCNLDNASENQS 309
Query: 317 CQCPPGYTFFDPDDVMKGCKENF-VPQSCD-RAVEEMDLFEFRDMPNTDWPLNDYEHFTS 374
C CP V ++ +P SC+ R + ++L +T HFT
Sbjct: 310 CSCPDEMRMDAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVSYFST--------HFTD 361
Query: 375 VDEDW-----CREACLSDCFCAVAIFREG---ECWKKR------APLSNGRIDPSVGGKA 420
E C + C +C C + +F E C+ + + + N + + G
Sbjct: 362 PVEHGLPLLACHDICSKNCSC-LGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYV 420
Query: 421 LVKVRKDYSDASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVE 480
+ +RK ++A +NR +S + L FL + + +++ R + +++
Sbjct: 421 KLSIRK--TNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIR 478
Query: 481 SQK------------------GMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVL 522
++ G+P Q F ++ELE T FK ++G G FG VYKG L
Sbjct: 479 EKQVTRPGSFESGDLGSFHIPGLP----QKFEFEELEQATENFKMQIGSGGFGSVYKGTL 534
Query: 523 TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582
+E +AVKK+ G QEF EI+ IG H NLV+L GFC G LLVYEY++
Sbjct: 535 --PDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMN 592
Query: 583 NGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641
+GSL LF + W +R IA GTARGL YLH C +IIHCD+KP+NILL F
Sbjct: 593 HGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQ 652
Query: 642 ARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR 701
+ISDFGL+KLL +++ T +RGT+GY+APEW N I+ K DVYS+G++LLELV R
Sbjct: 653 PKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGR 712
Query: 702 KNFEV-----DATEECQ-------------MILADWAYDCFRERKLGLLVENDEEAMDDI 743
KN TE+ + +A D + + L + E
Sbjct: 713 KNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTS 772
Query: 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIP 783
+ EK V IA+ C+ E+P+LRP M V M EG++ + P
Sbjct: 773 QEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 246/860 (28%), Positives = 403/860 (46%), Gaps = 122/860 (14%)
Query: 5 LFFLIPLLLPISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGF---RQVGDRGF 61
+F L L A Q S + GS+L ND+ + +S F GF D
Sbjct: 9 MFLLHIRRLDCFVAVQDSKTLFKGSTLI--NDSHGETLVSAGQRFELGFFTPNGSSDERR 66
Query: 62 LLAIWFNEIPERTIVWSANRDN-LVQRGSKVELTGDGQLILRDSSGKEIWR---EPPSTG 117
L IWF + T+VW ANR++ ++ R ++ DG L + DS G+ W +P S
Sbjct: 67 YLGIWFYNLHPLTVVWVANRESPVLDRSCIFTISKDGNLEVIDSKGRVYWDTGVKPSSVS 126
Query: 118 AA-YAAMLDTGNLVLAS--QDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSG 174
A ++D GNLVL S +++ +W+SF +PTDT LP M + + + + + S G
Sbjct: 127 AERMVKLMDNGNLVLISDGNEANVVWQSFQNPTDTFLPGMRMDENMTLSSWRSFNDPSHG 186
Query: 175 RFMFEL--QTDGNLLLYTTTYPFDGANAAYWSTQTS---IGSG---YQVVFNQSGFI-YL 225
F F++ + D +++ + YW + S IGS Y + + S F +
Sbjct: 187 NFTFQMDQEEDKQFIIWKRS-------MRYWKSGISGKFIGSDEMPYAISYFLSNFTETV 239
Query: 226 TARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGR-WPKAWSFLSFI 284
T N S+ TS R + G +++ G R W + W+
Sbjct: 240 TVHNASVPPLFTSLYTNT-----RFTMSSSGQAQYF------RLDGERFWAQIWA----E 284
Query: 285 PSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSC 344
P + C + ACG +F S ++C+C PG F P+ + K K +F C
Sbjct: 285 PRDEC------SVYNACG--NFGSCNSKNEEMCKCLPG---FRPNFLEKWVKGDF-SGGC 332
Query: 345 DR--------AVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFR 396
R V D+F + P + F + +E CR CL++C C +
Sbjct: 333 SRESRICGKDGVVVGDMFLNLSVVEVGSPDS---QFDAHNEKECRAECLNNCQCQAYSYE 389
Query: 397 E-------GECWKKRAPLSNGRIDPSVGGKAL---VKVRKDYSDASAGSGSNRKENSTLI 446
E +CW L+N + + +G + + V V S G G + + ++
Sbjct: 390 EVDILQSNTKCWIWLEDLNNLK-EGYLGSRNVFIRVAVPDIGSHVERGRGRYGEAKTPVV 448
Query: 447 YILSATLGGSIFLHLL---VTFIFFHRRNQKKQ--------NTVESQKGMPEMNLQDFTY 495
I+ T + L +L +++F RR K+ + +S++ + E+ ++ +
Sbjct: 449 LIIVVTFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKEL-IESGRF 507
Query: 496 K------------ELEVI---TGGFKE--ELGEGAFGKVYKGVLTTENEKPVAVKKLYKA 538
K ELE I T F +LG+G FG VYKG+ + E +AVK+L +
Sbjct: 508 KQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQE--IAVKRLSRC 565
Query: 539 VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS--RR 596
+G +EFK E+ I + H+NLV+LLG+C GE +LL+YEY+ + SL F+F + +R
Sbjct: 566 SGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQR 625
Query: 597 PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656
+W R I G ARGL YLH++ + +IIH D+K NILLD N +ISDFGLA++
Sbjct: 626 LDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGS 685
Query: 657 QTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI 715
+T T + GT GY++PE+ + K DV+SFG++++E + ++N E+ +
Sbjct: 686 ETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSL 745
Query: 716 LADWAYDCFR-ERKLGLLVENDEEAMDDIKRVEKFVM---IAIWCIQEDPSLRPAMKKVT 771
L A+D ++ ER + LL ++A+ + E F+ + + C+QEDP+ RP M V
Sbjct: 746 LGH-AWDLWKAERGIELL----DQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVV 800
Query: 772 QMIEGAVDVSIP-PDPASFI 790
M+ + ++P P +F+
Sbjct: 801 FMLGSSEAATLPTPKQPAFV 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB3|Y1112_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11280 OS=Arabidopsis thaliana GN=At1g11280 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 248/841 (29%), Positives = 397/841 (47%), Gaps = 126/841 (14%)
Query: 6 FFLIPLLLPISAAAQS-SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGD-RGFLL 63
F + L L AA + SS ++LG +L+ S G + GF + + +
Sbjct: 16 FLWLSLFLSCGYAAITISSPLTLGQTLS-----------SPGGFYELGFFSPNNSQNQYV 64
Query: 64 AIWFNEIPERTIVWSANRDN-LVQRGSKVELTGDGQLILRDSSGKEIW--REPPSTGAAY 120
IWF +I R +VW ANR+ + + + ++ +G LIL DSS +W R P + +
Sbjct: 65 GIWFKKITPRVVVWVANREKPITTPVANLTISRNGSLILLDSSKNVVWSTRRPSISNKCH 124
Query: 121 AAMLDTGNLVLASQDS-STMWESFDDPTDTLLPTQVM----SQGTKVI--ARLTETNYSS 173
A +LDTGNLV+ S + +W+SF++P DT+LP + + G K + + + T+ S
Sbjct: 125 AKLLDTGNLVIVDDVSENLLWQSFENPGDTMLPYSSLMYNLATGEKRVLSSWKSHTDPSP 184
Query: 174 GRFMFEL--QTDGNLLLY--TTTYPFDGANAAYWST--------QTSIGSGYQVVFNQSG 221
G F+ L Q ++ ++ Y G A T TS S Q V N +G
Sbjct: 185 GDFVVRLTPQVPAQIVTMRGSSVYKRSGPWAKTGFTGVPLMDESYTSPFSLSQDVGNGTG 244
Query: 222 FIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFL 281
R+ + R ++ +G + + Y G W L
Sbjct: 245 LFSYLQRSSEL---------------TRVIITSEGYLKTFRY------NGTGW-----VL 278
Query: 282 SFI-PSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKG------ 334
FI P+N+C GACG C + + C+C G+ ++ +G
Sbjct: 279 DFITPANLC------DLYGACGPFGLCVTSNPTK--CKCMKGFVPKYKEEWKRGNMTSGC 330
Query: 335 -------CKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSD 387
C+ N ++ + V+ F + N P + YE+ + VD D C + CLS+
Sbjct: 331 MRRTELSCQANLSTKTQGKGVDV-----FYRLANVK-PPDLYEYASFVDADQCHQGCLSN 384
Query: 388 CFCAVAIFREG-ECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKENSTLI 446
C C+ + G C L + I SVGG+ L +R S+ + GS R +
Sbjct: 385 CSCSAFAYITGIGCLLWNHELID-TIRYSVGGEFL-SIRLASSELA---GSRRTK----- 434
Query: 447 YILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVES-----------QKGMPEMNLQDFTY 495
I+ ++ SIF+ +L + + R + KQN + + G+ + T+
Sbjct: 435 -IIVGSISLSIFV-ILAFGSYKYWRYRAKQNVGPTWAFFNNSQDSWKNGLEPQEISGLTF 492
Query: 496 KELEVI---TGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEI 550
E+ I T F +LG+G FG VYKG L+ ++K +AVK+L + +G +EF EI
Sbjct: 493 FEMNTIRAATNNFNVSNKLGQGGFGPVYKGTLS--DKKDIAVKRLSSSSGQGTEEFMNEI 550
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR--PNWYKRMQIAFG 608
I + H+NLV+LLG C +GE +LL+YE++ N SL FLF + + +W KR I G
Sbjct: 551 KLISKLQHRNLVRLLGCCIDGEEKLLIYEFLVNKSLDTFLFDLTLKLQIDWPKRFNIIQG 610
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-TTTAIRGT 667
+RGL YLH + ++IH D+K NILLD N +ISDFGLA++ + Q Q T + GT
Sbjct: 611 VSRGLLYLHRDSCMRVIHRDLKVSNILLDDKMNPKISDFGLARMFQGTQHQDNTRKVVGT 670
Query: 668 KGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER 727
GY++PE+ + K D+Y+FG+LLLE++ +K EE + +L A++C+ E
Sbjct: 671 LGYMSPEYAWTGMFSEKSDIYAFGVLLLEIISGKKISSFCCGEEGKTLLGH-AWECWLET 729
Query: 728 -KLGLLVENDEEAMDDIK-RVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPD 785
+ LL E+ + ++ V + V I + CIQ+ RP + +V M+ A D+ P
Sbjct: 730 GGVDLLDEDISSSCSPVEVEVARCVQIGLLCIQQQAVDRPNIAQVVTMMTSATDLPRPKQ 789
Query: 786 P 786
P
Sbjct: 790 P 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 793 | ||||||
| 255544748 | 797 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.989 | 0.984 | 0.668 | 0.0 | |
| 225435578 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.973 | 0.971 | 0.666 | 0.0 | |
| 225435582 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.967 | 0.953 | 0.623 | 0.0 | |
| 147862348 | 761 | hypothetical protein VITISV_004992 [Viti | 0.930 | 0.969 | 0.638 | 0.0 | |
| 224057533 | 812 | predicted protein [Populus trichocarpa] | 0.979 | 0.956 | 0.615 | 0.0 | |
| 225435588 | 816 | PREDICTED: G-type lectin S-receptor-like | 0.969 | 0.942 | 0.613 | 0.0 | |
| 225435585 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.960 | 0.952 | 0.624 | 0.0 | |
| 224147311 | 671 | predicted protein [Populus trichocarpa] | 0.841 | 0.994 | 0.669 | 0.0 | |
| 147811981 | 771 | hypothetical protein VITISV_011718 [Viti | 0.935 | 0.962 | 0.608 | 0.0 | |
| 225435590 | 806 | PREDICTED: G-type lectin S-receptor-like | 0.969 | 0.954 | 0.596 | 0.0 |
| >gi|255544748|ref|XP_002513435.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223547343|gb|EEF48838.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1120 bits (2897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/796 (66%), Positives = 639/796 (80%), Gaps = 11/796 (1%)
Query: 5 LFFLI--PLLLPISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFL 62
LFFL+ IS AQ+ +NISLGSSLTA D+ + W+S SGDFAFGF+ V G+L
Sbjct: 3 LFFLLLASFAAVISTNAQTHTNISLGSSLTAQKDD--SFWVSPSGDFAFGFQLVDKNGYL 60
Query: 63 LAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYA 121
LAIWFNE+PE+TIVWSANR+NLV RGSKV+LT DG+L+L D S +++W + G +YA
Sbjct: 61 LAIWFNEVPEKTIVWSANRNNLVGRGSKVQLTTDGRLVLNDQSNRQLWSANSAADGVSYA 120
Query: 122 AMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQ 181
AMLDTGN VLA +DS T+WESFD+PTDT+LPTQ M QG ++IAR +ETNYS GRF F LQ
Sbjct: 121 AMLDTGNFVLADKDSITLWESFDEPTDTILPTQTMDQGGELIARYSETNYSDGRFKFMLQ 180
Query: 182 TDGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNV 241
TDGNLLLYT YP D +NAAYWSTQTSIGSG+QV+FNQSG+I L ARNGSILN V SN
Sbjct: 181 TDGNLLLYTRKYPLDTSNAAYWSTQTSIGSGFQVIFNQSGYIILIARNGSILNDVFSNEA 240
Query: 242 TAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGAC 301
+ +DFYQRA +D DGVFRHY+YPK++ S+ G+WP AW+ LSFIP NIC+RI +TGSGAC
Sbjct: 241 STRDFYQRATIDHDGVFRHYVYPKNATSSAGKWPLAWTVLSFIPGNICMRIGGETGSGAC 300
Query: 302 GFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPN 361
GFNS+C LGDDQR CQCPPG+T DP+D KGCK+NFV Q+CD +E D F+ +MPN
Sbjct: 301 GFNSYCRLGDDQRPNCQCPPGHTLLDPNDESKGCKQNFVAQNCDAESQETDSFDLMEMPN 360
Query: 362 TDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKAL 421
TDWPL+DYE+F +V EDWCR+ACLSDC+C+VAI+R CWKK+ PLSNGR+DPSVGGKAL
Sbjct: 361 TDWPLSDYEYFDTVTEDWCRQACLSDCYCSVAIYRNQGCWKKKIPLSNGRMDPSVGGKAL 420
Query: 422 VKVRKDYSDASAGSGSNRKENSTLIYILSATLGGSIFLHLLV---TFIFFHRRNQKKQNT 478
+KVR+D S + A S +K+ STLI I S LG S+FL++L+ T +FF+R +++K
Sbjct: 421 IKVRRDNSTSGATSCYKKKDQSTLILIGSVFLGSSVFLNVLLLVATLVFFYRWSRQKSKI 480
Query: 479 VESQ-KGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE-KPVAVKKLY 536
V+ + M MN + FTY ELEV TGGFKEELG GAFG VYKGV+ N K +AVKKL
Sbjct: 481 VQPHTQVMLAMNPRSFTYNELEVATGGFKEELGSGAFGTVYKGVVIESNSTKFIAVKKLK 540
Query: 537 KAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR 596
K V EGE+EF+ E+ IG TNHKNL +LLGFCNEG+HR+LVYEY+SNG LADFLF S R
Sbjct: 541 KVVAEGEKEFETEVDIIGGTNHKNLAKLLGFCNEGQHRMLVYEYMSNGCLADFLFGDS-R 599
Query: 597 PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656
PNWYKRMQIAFG ARGL YLHEEC SQIIHCDIKPQN+LLD + ARISDFGLAKLLKTD
Sbjct: 600 PNWYKRMQIAFGIARGLSYLHEECSSQIIHCDIKPQNVLLDESLTARISDFGLAKLLKTD 659
Query: 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMIL 716
Q+QT TAIRGTKGYVAPEWF+N+PIT+KVDVYSFGILLLEL+CC+++ E D E +IL
Sbjct: 660 QSQTMTAIRGTKGYVAPEWFRNMPITSKVDVYSFGILLLELICCKRSVEKDTKERYPIIL 719
Query: 717 ADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776
ADWAYD ++E + LLVE+DEEA DD+KRVE+FVM+A+WCIQ+DPSLRPAMKKV M+EG
Sbjct: 720 ADWAYDRYKEGSVNLLVEDDEEATDDVKRVERFVMVAMWCIQDDPSLRPAMKKVIHMLEG 779
Query: 777 AVDVSIPPDPASFISS 792
AV V+IPPDP SFIS+
Sbjct: 780 AVQVAIPPDPDSFIST 795
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435578|ref|XP_002283186.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1067 bits (2760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/782 (66%), Positives = 618/782 (79%), Gaps = 10/782 (1%)
Query: 16 SAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTI 75
S AQ+ SNI+LGSSLTA N+ + W S SG+FAFGF+QVG GFLLAIWFN+IPE+TI
Sbjct: 20 STIAQTYSNITLGSSLTAQNN--GSFWASPSGEFAFGFQQVGAGGFLLAIWFNKIPEKTI 77
Query: 76 VWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPSTGAAYAAMLDTGNLVLASQD 135
+WSAN ++L QR S V+LT DGQL+L D GK+IW +G +YAAM+DTGN VL QD
Sbjct: 78 IWSANGNSLGQRRSIVQLTADGQLVLTDPKGKQIW--DAGSGVSYAAMVDTGNFVLVGQD 135
Query: 136 SSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPF 195
S T+WESF +PTDT+LPTQ ++QG K++AR +ETNYS+GRFMF LQ DGNL++YT +P
Sbjct: 136 SVTLWESFGEPTDTILPTQELNQGGKLVARFSETNYSNGRFMFTLQADGNLVMYTRDFPM 195
Query: 196 DGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPD 255
D N AYWSTQT +GSG+QV+FNQSG+I LTARN SILN V+S+ + +DFYQRA+++ D
Sbjct: 196 DSTNFAYWSTQT-VGSGFQVIFNQSGYIVLTARNKSILNLVSSSETSTEDFYQRAILEYD 254
Query: 256 GVFRHYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRK 315
GVFR Y+YPKS+ S+ GRWP AWS IP NIC+RI +TG GACGFNS+C LGDDQR
Sbjct: 255 GVFRQYVYPKSAGSSSGRWPMAWSPSPSIPGNICMRITENTGGGACGFNSYCILGDDQRP 314
Query: 316 LCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSV 375
C+CP GY F D D M GCK+NFV Q+CD+A E D F F++MPNTDWPL+DY +F V
Sbjct: 315 NCKCPTGYDFLDQSDKMSGCKQNFVTQNCDQASRETDQFYFQEMPNTDWPLSDYGYFQPV 374
Query: 376 DEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGS 435
EDWCREACL+DCFCAVAIFR+G CWKK+ PLSNGRIDPSVGGKAL+K+R+ S G
Sbjct: 375 SEDWCREACLTDCFCAVAIFRDGNCWKKKIPLSNGRIDPSVGGKALIKLRQGNSTTKPGD 434
Query: 436 G-SNRKENSTLIYILSATLGGSIFLH---LLVTFIFFHRRNQKKQNTVESQKGMPEMNLQ 491
G SN+K STLI S LG S+FL+ L T +F R N +K + + MNL+
Sbjct: 435 GDSNKKHQSTLILTGSVLLGSSVFLNFLFFLATVLFIFRFNNRKTKMLHTYLSTLGMNLR 494
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEIS 551
FTY EL+ T GFKEELG GAF VYKGVL E K VAVKK K + E EQEF+ E+
Sbjct: 495 SFTYNELDEATDGFKEELGRGAFATVYKGVLAYEKGKLVAVKKFEKMMRENEQEFQTEVK 554
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR 611
AIG+TNHKNLVQLLGFC EGEHRLLVYE++SNGSL FLF S RPNW+KR+QIAFG AR
Sbjct: 555 AIGQTNHKNLVQLLGFCKEGEHRLLVYEFMSNGSLEKFLFGNS-RPNWHKRIQIAFGIAR 613
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
GLFYLHEEC +QIIHCDIKPQNILLD +F+ARISDFGLAKLLKTDQT+TTT IRGTKGYV
Sbjct: 614 GLFYLHEECSTQIIHCDIKPQNILLDDSFSARISDFGLAKLLKTDQTRTTTGIRGTKGYV 673
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
APEWFK++PIT KVDVYSFGILLLEL+CCRKN E +A +E QMILADWAYDC++ L +
Sbjct: 674 APEWFKSMPITVKVDVYSFGILLLELICCRKNLEFEAKDETQMILADWAYDCYKGGLLEV 733
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFIS 791
LV D+EA+ ++KR+EKFVMIAIWCIQEDPSLRP MKKVTQM+EGAV+VS+PPDP SFIS
Sbjct: 734 LVGYDQEAIVEMKRLEKFVMIAIWCIQEDPSLRPTMKKVTQMLEGAVEVSVPPDPCSFIS 793
Query: 792 SI 793
SI
Sbjct: 794 SI 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435582|ref|XP_002283204.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1006 bits (2601), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/784 (62%), Positives = 601/784 (76%), Gaps = 17/784 (2%)
Query: 16 SAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTI 75
S AQ+ SN +LGSSLTA + + SW S+SG+FAFGF+++G G+LLA+WFN+I E+T+
Sbjct: 28 SVVAQAYSNKTLGSSLTAGD---SESWASESGEFAFGFQEIGTGGYLLAVWFNKISEKTV 84
Query: 76 VWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYAAMLDTGNLVLASQ 134
VWSAN NLV++GSKV+LT DG +L D G++IW + TG AYAAMLD+GN VL Q
Sbjct: 85 VWSANGGNLVKKGSKVQLTSDGNFVLNDQEGEKIWPVDSTITGVAYAAMLDSGNFVLVRQ 144
Query: 135 DSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYP 194
DS +WESFD+PTDT+LPTQ ++QG+K++ARL+E NYSSGRFMF+L+++G+L +YTT +P
Sbjct: 145 DSINLWESFDNPTDTILPTQALNQGSKLVARLSEKNYSSGRFMFKLRSNGSLTMYTTDFP 204
Query: 195 FDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDP 254
D N YWS+QT+ G+QV+FNQSG IYL ARNGS L V +N + +D+YQRA+++
Sbjct: 205 QDSENFPYWSSQTT---GFQVIFNQSGSIYLMARNGSKLMDVLTNEASTEDYYQRAILEY 261
Query: 255 DGVFRHYIYPKSSASTGGRWPKAWSFL-SFIPSNICLRIRADTGSGACGFNSFCSLGDDQ 313
DGVFR Y+YPKS+ S+ GR P AWS L SF+P NIC IRA+ GSGACGFNS+C++G+D
Sbjct: 262 DGVFRQYVYPKSAGSSAGR-PMAWSSLTSFVPKNICKSIRAEIGSGACGFNSYCTMGNDD 320
Query: 314 RKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFT 373
R CQCPP YTF DP D M GCK+NFVP+SC +E LF F +M + DWPL+DY HFT
Sbjct: 321 RPYCQCPPRYTFLDPQDDMSGCKQNFVPESCSEESQEKGLFGFEEMTDVDWPLSDYGHFT 380
Query: 374 SVDEDWCREACLSDCFCAVAIFREGE-CWKKRAPLSNGRIDPSVGGKALVKVRKDYSDAS 432
V EDWCR+ACL DCFC VAIF +G CWKKR PLSNGR + + G L+KVRKD S
Sbjct: 381 KVTEDWCRQACLDDCFCDVAIFGDGGGCWKKRTPLSNGRTESNNGRTILIKVRKDNSTWE 440
Query: 433 AGSGSNRKENSTLIYILSATLGGSIFLH---LLVTFIFFHRRNQKKQNTVESQKGMPEMN 489
S N K+ STLI S LGGS+FL+ LL F++ R+ +K T++ + M N
Sbjct: 441 PRSEGN-KDQSTLIITESVLLGGSVFLNCLLLLSAFMYIFRK--RKSKTLQPHQAMVGAN 497
Query: 490 LQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAE 549
L++F+YK LEV T GFK+ELG GAF VYKG L +N K VA KKL + V E EF+ E
Sbjct: 498 LKNFSYKALEVATDGFKDELGRGAFSTVYKGTLAHDNGKLVAAKKLDRMVRGVEVEFETE 557
Query: 550 ISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT 609
+SAIGRTNHKNLVQLLGFCNE +HRLLVYE++SNGSLA FLF SR P+WY+R QI GT
Sbjct: 558 VSAIGRTNHKNLVQLLGFCNEEQHRLLVYEFMSNGSLATFLFGNSR-PDWYRRTQIILGT 616
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
ARGL YLHEEC +Q IHCDIKPQNILLD ARISDFGLAKLLKTDQTQTTT IRGTKG
Sbjct: 617 ARGLLYLHEECSTQTIHCDIKPQNILLDDFLTARISDFGLAKLLKTDQTQTTTGIRGTKG 676
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
YVAPEWFK +P+TAKVDVYSFGI+LLEL+ CRKNFE +E QM+LADWAYD + ERKL
Sbjct: 677 YVAPEWFKTVPVTAKVDVYSFGIVLLELIFCRKNFEPAVEDENQMVLADWAYDSYLERKL 736
Query: 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASF 789
LLVE D+EA+D+++++EKFVMIAIWCIQEDPS RP MKKVTQM+EGA++V +PPDP+ F
Sbjct: 737 DLLVEKDQEALDNMEKLEKFVMIAIWCIQEDPSQRPTMKKVTQMLEGAIEVPLPPDPSPF 796
Query: 790 ISSI 793
S
Sbjct: 797 SKSF 800
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147862348|emb|CAN84023.1| hypothetical protein VITISV_004992 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2588), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/782 (63%), Positives = 587/782 (75%), Gaps = 44/782 (5%)
Query: 16 SAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTI 75
S AQ+ SNI+LGSSLTA N+ + W S SG+FAFGF+QVG GFLLAIWFN+IPE+TI
Sbjct: 20 STIAQTYSNITLGSSLTAQNN--GSFWASPSGEFAFGFQQVGAGGFLLAIWFNKIPEKTI 77
Query: 76 VWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPSTGAAYAAMLDTGNLVLASQD 135
+WSAN +NL QR S V+LT DGQL+L D GK+IW +G +YAAM DTGN VL QD
Sbjct: 78 IWSANGNNLGQRISIVQLTADGQLVLTDPKGKQIWD--AGSGVSYAAMXDTGNFVLVGQD 135
Query: 136 SSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPF 195
S T+WESF +PTDT+LPTQ ++QG K++AR +ETNYS+GRFMF LQ DGNL++YT +P
Sbjct: 136 SVTLWESFGEPTDTILPTQELNQGGKLVARFSETNYSNGRFMFTLQADGNLVMYTRDFPM 195
Query: 196 DGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPD 255
D N AYWSTQT +GSG+Q RA+++ D
Sbjct: 196 DSTNFAYWSTQT-VGSGFQ----------------------------------RAILEYD 220
Query: 256 GVFRHYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRK 315
GVFR Y+YPKS+ S+ GRWP AWS IP NIC+RI +TG GACGFNS+C LGDDQR
Sbjct: 221 GVFRQYVYPKSAGSSSGRWPMAWSPSPSIPGNICMRITENTGGGACGFNSYCILGDDQRP 280
Query: 316 LCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSV 375
C+CP GY F D D M GCK+NFV Q+CD+A E D F F++MPNTDWPL+DY +F V
Sbjct: 281 NCKCPTGYDFLDQSDKMSGCKQNFVTQNCDQASRETDQFYFQEMPNTDWPLSDYGYFQPV 340
Query: 376 DEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGS 435
EDWCREACL+DCFCAVAIFR+G CWKK+ PLSNGRIDPSVGGKAL+K+R+ S G
Sbjct: 341 SEDWCREACLTDCFCAVAIFRDGNCWKKKIPLSNGRIDPSVGGKALIKLRQGNSTTKPGD 400
Query: 436 G-SNRKENSTLIYILSATLGGSIFLHLL---VTFIFFHRRNQKKQNTVESQKGMPEMNLQ 491
G SN+K S LI S LG S+FL+ L T +F R N +K + + MNL+
Sbjct: 401 GDSNKKHQSXLILTGSVLLGSSVFLNFLFFLATVLFIFRFNNRKTKMLHTYLSTLGMNLR 460
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEIS 551
FTY EL+ T GFKEELG GAF VYKGVL E K VAVKK K + E +QEF+ E+
Sbjct: 461 SFTYNELDEATDGFKEELGRGAFATVYKGVLAYEKGKLVAVKKFEKMMRENDQEFQTEVK 520
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR 611
AIG+TNHKNLVQLLGFC EGEHRLLVYE++SNGSL FLF SR PNW KR+QIAFGTAR
Sbjct: 521 AIGQTNHKNLVQLLGFCKEGEHRLLVYEFMSNGSLEKFLFGNSR-PNWLKRIQIAFGTAR 579
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
GLFYLHEEC +QIIHCDIKPQNILLD +F+ARISDFGLAKLLKTDQT+TTT IRGTKGYV
Sbjct: 580 GLFYLHEECSTQIIHCDIKPQNILLDDSFSARISDFGLAKLLKTDQTRTTTGIRGTKGYV 639
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
APEWFK++PIT KVDVYSFGILLLEL+CCRKN E +A +E QMILADWAYDC++ L +
Sbjct: 640 APEWFKSMPITVKVDVYSFGILLLELICCRKNLEFEAKDETQMILADWAYDCYKGGLLEV 699
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFIS 791
LV D+EA+ +KR+EKFVMIAIWCIQEDPSLRP MKKVTQM+EGAV+VS+PPDP SFIS
Sbjct: 700 LVGYDQEAIXXMKRLEKFVMIAIWCIQEDPSLRPTMKKVTQMLEGAVEVSVPPDPCSFIS 759
Query: 792 SI 793
SI
Sbjct: 760 SI 761
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057533|ref|XP_002299254.1| predicted protein [Populus trichocarpa] gi|222846512|gb|EEE84059.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2575), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/790 (61%), Positives = 592/790 (74%), Gaps = 13/790 (1%)
Query: 5 LFFLIPLLLPISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLA 64
L FL+ L P A A+S I+LG SLTASN++ SW S SG+FAFGF+QV GFLLA
Sbjct: 18 LLFLVILPQPFPATAESYKKITLGLSLTASNND---SWQSPSGEFAFGFQQVAVDGFLLA 74
Query: 65 IWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYAAM 123
IWF++IPE+TI+WSANR+NLVQRG KV+L DGQL+L D GK+IWR + + AYAAM
Sbjct: 75 IWFDKIPEKTILWSANRNNLVQRGDKVKLMKDGQLVLNDRKGKQIWRADTAGSRVAYAAM 134
Query: 124 LDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTD 183
LD+GN VLA DS +WESF +PTDTLLPTQ SQG+K++A + N S+GR+ F LQ+D
Sbjct: 135 LDSGNFVLARHDSVNLWESFREPTDTLLPTQTFSQGSKLVAGYSSMNRSTGRYQFTLQSD 194
Query: 184 GNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTA 243
GNL+LYT +P N+ YWS++T G+G+ + FNQSG IYL A+NG +L ++S+
Sbjct: 195 GNLVLYTLAFPIGSVNSPYWSSKTE-GNGFLLSFNQSGNIYLAAKNGRMLVMLSSDPPPT 253
Query: 244 QDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFL--SFIPSNICLRIRADTGSGAC 301
DFY RA+++ DGVFRHY+YPKS WP WS L SFIP NIC IR + G GAC
Sbjct: 254 SDFYHRAILEYDGVFRHYVYPKSMNPGAAGWPLRWSPLTSSFIPPNICTSIRENNGCGAC 313
Query: 302 GFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPN 361
GFNS+CSLG+DQ+ C CPPGYTF DP+DVMKGCK+NFV Q+C+ A +E +LF N
Sbjct: 314 GFNSYCSLGNDQKPKCSCPPGYTFLDPNDVMKGCKQNFVSQNCEEASQETELFYLEQKEN 373
Query: 362 TDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKAL 421
TDWPL+D EHF++V E+WCR+ACLSDCFCAVAIFR+G CWKK+ PLSNGR DPSVGG+AL
Sbjct: 374 TDWPLSDSEHFSTVTEEWCRKACLSDCFCAVAIFRDGNCWKKKIPLSNGRFDPSVGGRAL 433
Query: 422 VKVRKDYSDASAGSGS--NRKENSTLIYILSATLGGSI---FLHLLVTFIFFHRRNQKKQ 476
+K+R+D S + K ST+I I S + S+ FL +L F+ + +K
Sbjct: 434 IKIRQDNSTLNPADDDVPKNKSRSTIIIIGSLLVISSVSLNFLFILRAFLDVLQFGYEKT 493
Query: 477 NTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLY 536
+ P + L+ FT+ ELE TG F+EELG GAF VYKG L + VAVK L
Sbjct: 494 KKRYLEPTDPGVTLRSFTFSELEKATGNFEEELGSGAFATVYKGTLDFDERTFVAVKNLD 553
Query: 537 KAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR 596
K V + E+EFKAE++AIGRTNHKNLV+LLGFCNEGEHRLLVYE + NG+LA+FLF R
Sbjct: 554 KMVRDCEKEFKAEVNAIGRTNHKNLVKLLGFCNEGEHRLLVYELIRNGNLANFLFGNPRL 613
Query: 597 PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656
NW+KRMQIAFG ARGLFYLHEEC +QIIHCDIKPQNILLD +F A ISDFG+AKLLK D
Sbjct: 614 -NWFKRMQIAFGVARGLFYLHEECSTQIIHCDIKPQNILLDESFRAIISDFGIAKLLKAD 672
Query: 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMIL 716
QT+T+TAIRGTKGY+APEWFKNLP+T KVDVYSFGILLLEL+CCRKNFE + E QM+L
Sbjct: 673 QTRTSTAIRGTKGYLAPEWFKNLPVTVKVDVYSFGILLLELICCRKNFEPEVKNEDQMVL 732
Query: 717 ADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776
A WAYDC+R+ K GLLV ND++A+ D+KRV KFVMIAIWCIQEDPSLRP MKKVT M+EG
Sbjct: 733 AYWAYDCYRDGKAGLLVANDDDAVLDMKRVVKFVMIAIWCIQEDPSLRPTMKKVTLMLEG 792
Query: 777 AVDVSIPPDP 786
V+VS PPDP
Sbjct: 793 TVEVSAPPDP 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435588|ref|XP_002283224.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2562), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/784 (61%), Positives = 602/784 (76%), Gaps = 15/784 (1%)
Query: 18 AAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVW 77
A++ +LGSSLTA +++ + S SG+FAFGF+Q+G FLLAIWFN+IPE+TI+W
Sbjct: 27 VAKTPVKFTLGSSLTAIDNSSYLA--SPSGEFAFGFQQIGSGRFLLAIWFNKIPEKTIIW 84
Query: 78 SANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYAAMLDTGNLVLASQDS 136
SAN +NLVQRGSK+ LT DG+ +L D +GK+IW+ +P S G ++AAMLDTGN VLASQDS
Sbjct: 85 SANGNNLVQRGSKIRLTSDGEFMLNDPTGKQIWKADPVSPGVSHAAMLDTGNFVLASQDS 144
Query: 137 STMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFD 196
+ +WESF+ PTDT+LPTQ+++QG K++AR+++ +YSSGRF+F LQ DGNL+L +
Sbjct: 145 TLLWESFNHPTDTILPTQILNQGGKLVARISDMSYSSGRFLFTLQDDGNLVLSHRDFRKG 204
Query: 197 GANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDG 256
+ AYWS+QT G G+QV+FNQSG +YL+ RN SILN V S + +DF+QRA+++ DG
Sbjct: 205 STSTAYWSSQTE-GGGFQVIFNQSGHVYLSGRNSSILNGVFSTAASTKDFHQRAILEHDG 263
Query: 257 VFRHYIYPKSSA-STGGRWPKAWSFLSFIPS-NICLRIRADTGSGACGFNSFCSLGDDQR 314
VFR Y+YPK +A S+ G WP W+ L+ I + IC I A+TGSGACGFNS+C LGDDQR
Sbjct: 264 VFRQYVYPKKAAVSSAGSWPMTWTSLASIATEKICTIINAETGSGACGFNSYCILGDDQR 323
Query: 315 KLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTS 374
C+CPPGYTF DP D KGCK+NFVPQSC++ E + F+F +M N DWPL DYEHF
Sbjct: 324 PYCKCPPGYTFLDPHDEKKGCKQNFVPQSCNQESRETNEFDFENMTNVDWPLADYEHFKE 383
Query: 375 VDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKALVKVRK-DYSDASA 433
V DWCR ACL DCFCAVAIF +G+CWKK+ PLSNGR DPS G AL+KV K +++
Sbjct: 384 VTVDWCRNACLDDCFCAVAIFGDGDCWKKKNPLSNGRYDPSNGRLALIKVGKGNFTWPPN 443
Query: 434 GSGSNRKENSTLIYILSATLGGSIFLHLL-----VTFIFFHRRNQKKQNTVESQKGMPEM 488
G +K+ STLI S LG S+FL+LL + FIF+ N +K VE + M
Sbjct: 444 WEGFKKKDRSTLITTGSVLLGSSVFLNLLLLLAAIMFIFY--LNDRKSKAVEPRPAMEGA 501
Query: 489 NLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA 548
NL+ FTY ELEV T GFK E+G GAF VYKG L +N VAVK+L + V EGEQEF+
Sbjct: 502 NLRSFTYSELEVATDGFKHEIGRGAFATVYKGTLAHDNGDFVAVKRLDRKVVEGEQEFET 561
Query: 549 EISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFG 608
E S IGRTNHKNLVQLLGFCNEG+H+LLVYE++SNGSL+ FLF KSR P+WY R+QI G
Sbjct: 562 EASVIGRTNHKNLVQLLGFCNEGQHQLLVYEFMSNGSLSAFLFGKSR-PSWYHRIQIILG 620
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
TARGL YLHEEC +QIIHCDIKPQNILLD F ARIS+FGLAKLLK+DQT+T T IRGT+
Sbjct: 621 TARGLLYLHEECSTQIIHCDIKPQNILLDDGFTARISNFGLAKLLKSDQTRTMTGIRGTR 680
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728
GY+APEWFK +PIT KVDVYSFGILLLEL+ CRKNFE++ +E Q++LADWAYDC++E K
Sbjct: 681 GYLAPEWFKTVPITVKVDVYSFGILLLELIFCRKNFELELEDEDQVVLADWAYDCYKEGK 740
Query: 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPAS 788
L ++END+EA++DI+ V KF+MIA WCIQEDPS RP MK VTQM+EGA++VS+PPDP+S
Sbjct: 741 LDQILENDKEALNDIETVRKFLMIAFWCIQEDPSKRPTMKTVTQMLEGALEVSVPPDPSS 800
Query: 789 FISS 792
FISS
Sbjct: 801 FISS 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435585|ref|XP_002283213.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 986 bits (2548), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/780 (62%), Positives = 590/780 (75%), Gaps = 18/780 (2%)
Query: 15 ISAAAQSS-SNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPER 73
+S+ AQSS +NI+LGSSLTA +++ SW S SG+FAFGF+++ GFLLAIWF++IPE+
Sbjct: 20 VSSVAQSSGNNITLGSSLTARDND---SWASPSGEFAFGFQEIIPGGFLLAIWFDKIPEK 76
Query: 74 TIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYAAMLDTGNLVLA 132
TIVWSAN DNLVQ GS+VELT +G+ +L D SGKE+WR + T +YAAMLDTGN VLA
Sbjct: 77 TIVWSANGDNLVQTGSRVELTSNGEFVLNDPSGKEVWRADSGGTEVSYAAMLDTGNFVLA 136
Query: 133 SQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTT 192
SQ+SS +WESF PTDT+LPTQ+++ G++++AR ETNYS+GRFMF LQ+DGNL+LYTT
Sbjct: 137 SQESSNLWESFSHPTDTILPTQILNLGSQLVARFLETNYSNGRFMFALQSDGNLVLYTTD 196
Query: 193 YPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTA-QDFYQRAV 251
+P D N AYWSTQT + SG+QV+FNQSG IYL RN SILN V SN V +DFYQRA+
Sbjct: 197 FPMDSNNFAYWSTQT-MDSGFQVIFNQSGRIYLIGRNRSILNDVLSNEVNMREDFYQRAI 255
Query: 252 VDPDGVFRHYIYPKSSASTGGRWPKAWSFLS-FIPSNICLRIRADTGSGACGFNSFCSLG 310
++ DGVFR Y+YPKS+AS AWS LS FIP NIC RI A TG GACGFNS+C LG
Sbjct: 256 LEYDGVFRQYVYPKSAASG----TMAWSSLSKFIPENICTRIGASTGGGACGFNSYCRLG 311
Query: 311 DDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYE 370
D+QR C CPPGYT+ DP D + GC++NFV Q CD +E LF F +M DWP DY+
Sbjct: 312 DNQRPSCHCPPGYTWLDPLDSLGGCRQNFVQQRCDAGTQEAGLFYFSEMLGVDWPYADYQ 371
Query: 371 HFTSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKALVKVRKDYSD 430
HF V +DWCR+ACL DCFCAVAIFR+G+CW K+ PLSNGR D S +A++KVRKD S
Sbjct: 372 HFKGVTQDWCRQACLGDCFCAVAIFRDGDCWMKKVPLSNGRYDLSNERRAMIKVRKDNST 431
Query: 431 -ASAGSGSNRKENSTLIYILSATLGGSI---FLHLLVTFIFFHRRNQKKQNTVESQKGMP 486
GS K+ STLI S L S FL LL +F R +K + +++ M
Sbjct: 432 LPPIDEGSKGKDQSTLILTGSVLLSSSAFFNFLFLLAIVLFIRRCKHRKTSVLQTSPAME 491
Query: 487 EMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE-KPVAVKKLYKAVNEGEQE 545
NL+ FTY+ELE T GF++ELG GAF VYKG L ++ +AVKKL + EG++E
Sbjct: 492 GTNLRSFTYEELEEATNGFRDELGSGAFATVYKGALPHDDGINLIAVKKLERMEKEGDKE 551
Query: 546 FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI 605
F AE+ AIGRTNHKNLVQLLG+CNEG+HRLLVYE++SNGSLA FLF S RP+W KR +I
Sbjct: 552 FGAEVKAIGRTNHKNLVQLLGYCNEGQHRLLVYEFMSNGSLATFLFGNS-RPDWCKRTRI 610
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
GTARGL YLHEEC +QIIHCDIKPQNILLD ARISDFGLAKLLKTDQT+T T IR
Sbjct: 611 ILGTARGLLYLHEECSTQIIHCDIKPQNILLDDFLTARISDFGLAKLLKTDQTRTMTGIR 670
Query: 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725
GTKGYVAPEWFK +P+TAKVDVYSFGI+LLE++ CRKNFE D +E QMILADW DC++
Sbjct: 671 GTKGYVAPEWFKTVPVTAKVDVYSFGIVLLEIIFCRKNFEPDVRDESQMILADWVQDCYK 730
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPD 785
E++L LLV NDEE D++++EKFVMIAIWC QEDPS RP MKKV QM+EGA +VSIPPD
Sbjct: 731 EKRLDLLVGNDEEVFGDMEKLEKFVMIAIWCTQEDPSRRPTMKKVVQMLEGAAEVSIPPD 790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224147311|ref|XP_002336451.1| predicted protein [Populus trichocarpa] gi|222835053|gb|EEE73502.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2458), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/675 (66%), Positives = 538/675 (79%), Gaps = 8/675 (1%)
Query: 123 MLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQT 182
MLDTGN VLASQ + +W+SFD+PTDTLLPTQ ++ G ++IA E NYS GRF F LQT
Sbjct: 1 MLDTGNFVLASQAGANLWQSFDEPTDTLLPTQNLNLGAQLIAPYLEKNYSHGRFKFSLQT 60
Query: 183 DGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVT 242
DGNL+L TT+YP +N AYWS Q+SIGSGY+V+FNQSG++YL +NG+ LN+V SN+V+
Sbjct: 61 DGNLILSTTSYPKTTSNFAYWSNQSSIGSGYRVIFNQSGYMYLADQNGNTLNSVFSNSVS 120
Query: 243 AQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFL-SFIPSNICLRIRADTGSGAC 301
QDFY RA +D DGVFR Y YPK+ AS+ RWP AW+ L +FIPSNIC+ IR GSGAC
Sbjct: 121 MQDFYLRATLDYDGVFRQYAYPKT-ASSSTRWPMAWTTLPNFIPSNICVVIRGPVGSGAC 179
Query: 302 GFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPN 361
GFNS+C LGDDQR C+CPPGYTFFDP+D KGCK+NF+ Q CD +E+D F DM N
Sbjct: 180 GFNSYCILGDDQRPRCKCPPGYTFFDPNDERKGCKKNFISQDCDHPSQEIDNFMIWDMLN 239
Query: 362 TDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKAL 421
T++P DYE F SVDEDWCR+ACLSDC+CAVA + G CWKKR PLSNG DPS+G KAL
Sbjct: 240 TNFPYTDYEDFFSVDEDWCRQACLSDCYCAVATYNSGHCWKKRGPLSNGVTDPSIGDKAL 299
Query: 422 VKVRKDYSDASAGSGSNRKENSTLIYILSATLGGSIFL---HLLVTFIFFHRRNQKKQNT 478
+KVRK + +AGS + + + S LI S LG SIFL LL ++FF R NQ+KQ
Sbjct: 300 MKVRK--GNRTAGSSAKKSDRSILITTGSVLLGSSIFLIVLSLLGIYVFFTRSNQQKQKV 357
Query: 479 VESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA 538
V MPEMNLQ+FTY ELE TGGFKEE+G GAFG VY+G L E++ +AVKKL K
Sbjct: 358 VPQLHVMPEMNLQNFTYNELETATGGFKEEVGRGAFGIVYRGALANEDKPLIAVKKLEKM 417
Query: 539 VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN 598
EG+ EFK E+ IGRTNHKNLVQL+GFCNEGE+RLLVYEY+S+GSL++++F +R P+
Sbjct: 418 AGEGDTEFKTEVKVIGRTNHKNLVQLVGFCNEGENRLLVYEYMSSGSLSNYIFGYTR-PS 476
Query: 599 WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658
W +RMQIAFG ARGL YLHEEC SQIIHCDIKPQNILLD + NARISDFGLAKLLKTDQT
Sbjct: 477 WNRRMQIAFGVARGLLYLHEECSSQIIHCDIKPQNILLDESLNARISDFGLAKLLKTDQT 536
Query: 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718
+TTTAIRGTKGYVAPEWFKNLP+T KVD+YSFGILLLELVCCRKNFE++A +E Q++LAD
Sbjct: 537 KTTTAIRGTKGYVAPEWFKNLPVTTKVDIYSFGILLLELVCCRKNFEINAMQEHQIVLAD 596
Query: 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778
WA DC +E KL LLVE D EAM+D+KRVE+FVM+AIWCIQEDPSLRP MKKV QM+EG V
Sbjct: 597 WACDCLKEGKLNLLVEEDGEAMEDMKRVERFVMVAIWCIQEDPSLRPGMKKVVQMLEGGV 656
Query: 779 DVSIPPDPASFISSI 793
VS+PPDP+SFIS+I
Sbjct: 657 QVSVPPDPSSFISTI 671
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147811981|emb|CAN59767.1| hypothetical protein VITISV_011718 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 945 bits (2443), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/780 (60%), Positives = 573/780 (73%), Gaps = 38/780 (4%)
Query: 15 ISAAAQSS-SNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPER 73
+S+ AQSS +NI+LGSSLTA +++ SW S SG+FAFGF+++ GFLLAIWF++IPE+
Sbjct: 20 VSSVAQSSGNNITLGSSLTARDND---SWASPSGEFAFGFQEIIPGGFLLAIWFDKIPEK 76
Query: 74 TIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYAAMLDTGNLVLA 132
TIVWSAN DNLVQ GS+VELT +G+ +L D SGKE+WR + T +YAAMLDTGN VLA
Sbjct: 77 TIVWSANGDNLVQTGSRVELTSNGEFVLNDPSGKEVWRADSGGTXVSYAAMLDTGNFVLA 136
Query: 133 SQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTT 192
SQ+SS +WESF PTDT+LPTQ+++ G++++AR ETNYS+GRFMF LQ+DGNL+LYTT
Sbjct: 137 SQESSNLWESFXHPTDTILPTQILNLGSQLVARFLETNYSNGRFMFALQSDGNLVLYTTD 196
Query: 193 YPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTA-QDFYQRAV 251
+P D N AYWST T + SG+QV+FNQSG IYL RN SILN V SN V +DFYQRA+
Sbjct: 197 FPMDSNNFAYWSTXT-MDSGFQVIFNQSGRIYLIGRNRSILNDVLSNEVNMREDFYQRAI 255
Query: 252 VDPDGVFRHYIYPKSSASTGGRWPKAWSFLS-FIPSNICLRIRADTGSGACGFNSFCSLG 310
++ DGVFR Y+YPKS+AS AWS LS FIP NIC I A TG GACGFNS+C LG
Sbjct: 256 LEYDGVFRQYVYPKSAASG----TMAWSSLSKFIPENICTSIGASTGGGACGFNSYCRLG 311
Query: 311 DDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYE 370
DBQR CQCPPGYT+ DP D + GC++NFV Q CD +E LF F +M DWP DY+
Sbjct: 312 DBQRPSCQCPPGYTWLDPLDSLGGCRQNFVQQRCDAGTQEAGLFYFSEMLGVDWPYADYQ 371
Query: 371 HFTSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKALVKVRKDYSD 430
HF V +DWCREACL DCFCAVAIFR+G+CW K+ PLSNGR D S +A++KVRKD S
Sbjct: 372 HFKGVTQDWCREACLGDCFCAVAIFRDGDCWMKKVPLSNGRYDLSNERRAMIKVRKDNST 431
Query: 431 -ASAGSGSNRKENSTLIYILSATLGGSI---FLHLLVTFIFFHRRNQKKQNTVESQKGMP 486
GS K+ STLI S L S FL LL +F R +K + +++ M
Sbjct: 432 LPPIDEGSKGKDQSTLILTGSVLLSSSAFFNFLFLLAIVLFIRRCKHRKTSVLQTSPAME 491
Query: 487 EMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE-KPVAVKKLYKAVNEGEQE 545
NL+ FTY+ELE T GF++ELG GAF VYKG L ++ +AVKKL + EG++E
Sbjct: 492 GTNLRSFTYEELEEATNGFRDELGSGAFATVYKGALPHDDGINLIAVKKLERMEKEGDKE 551
Query: 546 FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI 605
F AE+ AIGRTNHKNLVQLLG+CNEG+HRLLVYE++SNGSLA FLF S RP+W KR +I
Sbjct: 552 FGAEVKAIGRTNHKNLVQLLGYCNEGQHRLLVYEFMSNGSLATFLFGNS-RPDWCKRTRI 610
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
GTARGL YLHEEC +QIIHCDIKPQNILLD ARISDFGLAKLLKTDQT+T T IR
Sbjct: 611 ILGTARGLLYLHEECSTQIIHCDIKPQNILLDDFLTARISDFGLAKLLKTDQTRTMTGIR 670
Query: 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725
GTKGYVAPEWFK +P+TAKVDVYSFGI+LLE++ CRKNFE D +E QMILADW DC++
Sbjct: 671 GTKGYVAPEWFKTVPVTAKVDVYSFGIVLLEIIFCRKNFEPDVRDESQMILADWVQDCYK 730
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPD 785
E++L LLV NDEE EDPS RP MKKV QM+EGA +VSIPPD
Sbjct: 731 EKRLDLLVGNDEE--------------------EDPSRRPTMKKVVQMLEGAAEVSIPPD 770
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435590|ref|XP_002283233.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2437), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/785 (59%), Positives = 585/785 (74%), Gaps = 16/785 (2%)
Query: 15 ISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERT 74
+S+ AQ S N + GSSL A ++N + S +GDFAFGF+QVG GFLLAIWFN++PERT
Sbjct: 32 VSSDAQISRNFTSGSSLIARDNNSFLA--SPNGDFAFGFQQVGSGGFLLAIWFNKVPERT 89
Query: 75 IVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR-EPPSTGAAYAAMLDTGNLVLAS 133
+VWSAN D+LVQ GS+V+LT DG+ +L D GK++W+ + STG AYAAMLDTGN VLA
Sbjct: 90 VVWSANGDSLVQTGSRVQLTTDGEFMLNDPKGKQMWKADLNSTGVAYAAMLDTGNFVLAG 149
Query: 134 QDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTY 193
+S+ +W+SF+ PTDT+LPTQ+++Q +K++AR +E NYSSGRFM LQTDGNL+LYT +
Sbjct: 150 HNSTYLWQSFNHPTDTILPTQILNQDSKLVARFSEVNYSSGRFMLILQTDGNLVLYTIDF 209
Query: 194 PFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVD 253
P D N AYW+T T + SG+QV++N+SG IYL N L+ V SN +FYQRA+++
Sbjct: 210 PMDSNNYAYWATATVL-SGFQVIYNESGDIYLIGNNRIKLSDVLSNKKPTGEFYQRAILE 268
Query: 254 PDGVFRHYIYPKSSASTGGRWPKAWSFLS-FIPSNICLRIRADTGSGACGFNSFCSLGDD 312
DGVFR Y++PKS+ S P AWS LS FIP NIC I A TGSGACGFNS+C+LGD
Sbjct: 269 YDGVFRQYVHPKSAGSGA---PMAWSPLSAFIPENICTNITASTGSGACGFNSYCTLGDH 325
Query: 313 QRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHF 372
QR +C+CPPGYTF DP + +KGC+++F P+ CD E F+F M N DWP +DY+ F
Sbjct: 326 QRPICKCPPGYTFLDPHNEVKGCRQDFYPEICDEGSHETGRFDFERMTNVDWPTSDYDRF 385
Query: 373 TSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPSVGGKALVKV-RKDYSDA 431
ED CR+ACL DCFCAVAIFR+G+CWKK+ PLSNGR + + AL+KV +K+ S
Sbjct: 386 QLFTEDDCRKACLEDCFCAVAIFRDGDCWKKKIPLSNGRFESTNDRIALIKVEKKNSSFP 445
Query: 432 SAGSGSNRKENSTLIYILSATLGGSIFLHLL---VTFIFFHRRNQKKQNTVESQKGMPEM 488
G G K S LI S LG S+ L++L T F R +K +ESQ+ M
Sbjct: 446 HGGEGFKDKHESILILAGSVLLGSSVLLNVLLLLATATFILRLYCRKPAIIESQQVMVGR 505
Query: 489 NLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA 548
NLQ FTY ELE T GFK+ELG+GAFG VYKG + N VAVKKL + V EGE+EF+
Sbjct: 506 NLQSFTYHELEEATNGFKDELGKGAFGTVYKG---SCNGNLVAVKKLERMVKEGEREFET 562
Query: 549 EISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFG 608
E+SAI RTNHKNLVQLLGFCNEG HRLLVYE++SNGSLA FLF S RP W++R+QI G
Sbjct: 563 EVSAIVRTNHKNLVQLLGFCNEGLHRLLVYEFMSNGSLATFLF-GSSRPKWHQRIQIILG 621
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
TA+GL YLHEEC Q IHCDIKPQNILLD + ARISDFGLAK LKTDQT+T T IRGTK
Sbjct: 622 TAKGLLYLHEECSIQTIHCDIKPQNILLDDSLTARISDFGLAKFLKTDQTRTMTGIRGTK 681
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728
GYVAPEWFK +PIT KVDVYSFGI+LLEL+ CRKNFEV+A ++ ++LA+ AY C++E K
Sbjct: 682 GYVAPEWFKTVPITVKVDVYSFGIVLLELIFCRKNFEVEAEDKSPVVLAELAYYCYKEGK 741
Query: 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPAS 788
L +L++NDEEA++D++R+EKFVMIA WCIQ+DP RP MKKVTQM+EGA++VS PPD +S
Sbjct: 742 LDMLLDNDEEALEDMERLEKFVMIAFWCIQDDPHQRPGMKKVTQMLEGAIEVSSPPDSSS 801
Query: 789 FISSI 793
F S+
Sbjct: 802 FTLSV 806
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 793 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.838 | 0.802 | 0.350 | 6.8e-95 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.891 | 0.853 | 0.332 | 4.5e-91 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.896 | 0.866 | 0.318 | 4e-90 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.264 | 0.240 | 0.502 | 8.9e-71 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.578 | 0.579 | 0.324 | 7.7e-70 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.795 | 0.743 | 0.311 | 8.7e-69 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.896 | 0.844 | 0.287 | 1.7e-66 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.393 | 0.398 | 0.383 | 1.7e-65 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.894 | 0.881 | 0.283 | 2e-65 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.607 | 0.600 | 0.316 | 1.8e-64 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 257/734 (35%), Positives = 373/734 (50%)
Query: 87 RGSKVELTGDGQLILRDSSGKEIW-REPPSTGAAYAAMLDTGNLVLASQDSSTMWESFDD 145
RGS + L G L L + SG +W + G ++ DTG +L + S +W SFD+
Sbjct: 83 RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDN 141
Query: 146 PTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTT---YPFDGANAAY 202
PTDT++ +Q + G K++ SG + F+L+ GNL L T Y G N+++
Sbjct: 142 PTDTIVQSQNFTAG-KILR--------SGLYSFQLERSGNLTLRWNTSAIYWNHGLNSSF 192
Query: 203 WSTQTSIGSGYQVVFNQSGFIYLTARN--GSILNAVTSNNVTAQDFYQRAVVDPDGVFRH 260
S +S Q +G + + N G V S + + ++ +D DG R
Sbjct: 193 SSNLSSPRLSLQT----NGVVSIFESNLLGGA-EIVYSGDYGDSNTFRFLKLDDDGNLRI 247
Query: 261 YIYPKSSAS-TGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQC 319
Y SSAS G WS + + CL G CG CS +D +C C
Sbjct: 248 Y----SSASRNSGPVNAHWSAV-----DQCLVY------GYCGNFGICSY-NDTNPICSC 291
Query: 320 PP-GYTFFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDED 378
P + F D +D KGCK C +DL R D P N F
Sbjct: 292 PSRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYEDDP-NSESFFAGSSP- 349
Query: 379 WCREACLSDCFCAVAIFRE---GECWKKR-APLSNGRIDPSVGGKALVKV-----RKDYS 429
CR CLS C ++ G CW+K G PSV + VKV
Sbjct: 350 -CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLE 408
Query: 430 DASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHR-RNQKKQNTVESQKGMPEM 488
A+ G +N K + ++ + A + G + L + +++ R + T+ S + E
Sbjct: 409 RATKGDDNNSKVHLWIVAV--AVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEY 466
Query: 489 NLQ---DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE 545
FTYKEL+ T FKE+LG G FG VY+GVLT N VAVK+L + + +GE++
Sbjct: 467 ASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQL-EGIEQGEKQ 523
Query: 546 FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFR--KSRRPNWYKRM 603
F+ E++ I T+H NLV+L+GFC++G HRLLVYE++ NGSL +FLF ++ W R
Sbjct: 524 FRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRF 583
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLXXXXX-XXXXXXXX 662
IA GTA+G+ YLHEEC+ I+HCDIKP+NIL+D F A++SDFGL
Sbjct: 584 NIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMS 643
Query: 663 XIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEV-DATEECQMILADWAY 721
+RGT+GY+APEW NLPIT+K DVYS+G++LLELV ++NF+V + T + + WAY
Sbjct: 644 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSI--WAY 701
Query: 722 DCFRERKLGLLVEN--DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779
+ F + +++ E+ D+++V + V + WCIQE P RP M KV QM+EG +
Sbjct: 702 EEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITE 761
Query: 780 VSIPPDPASFISSI 793
+ P P + IS +
Sbjct: 762 IKNPLCPKT-ISEV 774
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 260/781 (33%), Positives = 375/781 (48%)
Query: 43 ISQSGDFAFGFRQVGDRG-FLLAIWFNEIPERTIVWSANRDNLVQ-RGSKVELTGDGQLI 100
+S G + GF + G F + +W+ ++ + TI+W ANRD V + S V +G LI
Sbjct: 39 VSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 101 LRDSSGKE-IW----REPPSTGAAYAAMLDTGNLVLASQDSS----TMWESFDDPTDTLL 151
L D + + +W S A A + D GNLVL + SS +W+SFD P DT L
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWL 157
Query: 152 PTQVMSQGTKVIARLTETNYSSGRFM-FELQTDGNLLLYTTTYPFDGANAAYWSTQTSIG 210
P G K+ RL + S R ++ D + L++ A W+
Sbjct: 158 P------GVKI--RLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSNEYW 209
Query: 211 SGYQVVFNQSGFIYLTA---RNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSS 267
S +N I+ + R I N +N T ++ ++ + V R ++ S
Sbjct: 210 SSGP--WNPQSRIFDSVPEMRLNYIYNFSFFSNTT-DSYFTYSIYNQLNVSR-FVMDVSG 265
Query: 268 ASTGGRW---PKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYT 324
W KAW+ P C R CG CS D C+CP G+
Sbjct: 266 QIKQFTWLEGNKAWNLFWSQPRQQCQVYRY------CGSFGICS--DKSEPFCRCPQGFR 317
Query: 325 -----FFDPDDVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDW 379
+D D GC Q C R D+ +F +PN N E T
Sbjct: 318 PMSQKDWDLKDYSAGCVRKTELQ-CSRG----DINQFFRLPNMKLADNS-EVLTRTSLSI 371
Query: 380 CREACLSDCFCAVAIFREG--EC--WKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGS 435
C AC DC C + EG +C W K L+ +++ + +R SD
Sbjct: 372 CASACQGDCSCKAYAYDEGSSKCLVWSKDV-LNLQQLEDENSEGNIFYLRLAASDVPNVG 430
Query: 436 GSNRKENSTLIYILSATLG--GSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDF 493
S + N LI+ A LG G I L LLV + R +K+ + +KG + L F
Sbjct: 431 ASGKSNNKGLIF--GAVLGSLGVIVLVLLVVILILRYRRRKR---MRGEKG--DGTLSAF 483
Query: 494 TYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI 553
+Y+EL+ T F ++LG G FG V+KG L ++ +AVK+L + +++GE++F+ E+ I
Sbjct: 484 SYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD--IAVKRL-EGISQGEKQFRTEVVTI 540
Query: 554 GRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN----WYKRMQIAFGT 609
G H NLV+L GFC+EG +LLVY+Y+ NGSL LF W R QIA GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLXXXXXXXXXXXXXXIRGTKG 669
ARGL YLH+EC+ IIHCDIKP+NILLD F +++DFGL +RGT+G
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRG 660
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCF-RERK 728
Y+APEW + ITAK DVYS+G++L ELV R+N E E+ + WA ++
Sbjct: 661 YLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFF-PSWAATILTKDGD 719
Query: 729 LGLLVENDEEA-MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPA 787
+ LV+ E DI+ V + +A WCIQ++ S RPAM +V Q++EG ++V+ PP P
Sbjct: 720 IRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPR 779
Query: 788 S 788
S
Sbjct: 780 S 780
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 4.0e-90, P = 4.0e-90
Identities = 246/773 (31%), Positives = 378/773 (48%)
Query: 44 SQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRD 103
S + F FGF D L + ++WSANR + V K +G +++
Sbjct: 50 SNNSAFGFGFVTTQDSVTLFTLSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVME- 108
Query: 104 SSGKEIWR-EPPSTGAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKV 162
G E+WR + A+ + D+GNLV+ S D +++WESFD PTDTL+ Q +G K+
Sbjct: 109 --GTEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKL 166
Query: 163 IARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGF 222
+ + +N + + E+++ +L + P YWS + +++ G
Sbjct: 167 TSSPSSSNMT---YALEIKSGDMVLSVNSLTP-----QVYWSMANA---RERIINKDGGV 215
Query: 223 IYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKS--SASTGGRWPKAWSF 280
+ ++ G+ V F D + + + S S G A
Sbjct: 216 VTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADS 275
Query: 281 LSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFV 340
+ IPS++C T CG CS G K+C C G + D CK
Sbjct: 276 STKIPSDLC-----GTPE-PCGPYYVCS-GS---KVCGCVSGLSRARSD-----CKTGIT 320
Query: 341 -P--QSCDRAVEEMDLFEFRDMPNTDWPLNDYEH-FTS-VDEDWCREACLSDCFCAVAIF 395
P ++ D A + L D D+ Y F+ D D C+E C ++C C F
Sbjct: 321 SPCKKTKDNATLPLQLVSAGD--GVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFF 378
Query: 396 RE--GECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKENSTLIYILSATL 453
+ G C+ + + + + GG V K S S G + + Y++ +
Sbjct: 379 QNSSGNCFLFDY-IGSFKTSGN-GGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIVV 436
Query: 454 GGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQD--------FTYKELEVITGGF 505
++F+ ++ F+ F +KK Q+ E N + F YK+L+ T F
Sbjct: 437 V-TVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNF 495
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
+LG+G FG VY+G L + +AVKKL + + +G++EF+AE+S IG +H +LV+L
Sbjct: 496 SVKLGQGGFGSVYEGTLPDGSR--LAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVRLR 552
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---NWYKRMQIAFGTARGLFYLHEECKS 622
GFC EG HRLL YE++S GSL ++FRK +W R IA GTA+GL YLHE+C +
Sbjct: 553 GFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDA 612
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLXXXXXXXXXXXXXXIRGTKGYVAPEWFKNLPIT 682
+I+HCDIKP+NILLD FNA++SDFGL +RGT+GY+APEW N I+
Sbjct: 613 RIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAIS 672
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDAT-EECQMILADWAYDCFRERKLGLLVENDEEAMD 741
K DVYS+G++LLEL+ RKN++ T E+C +A+ E KL +V+ + +D
Sbjct: 673 EKSDVYSYGMVLLELIGGRKNYDPSETSEKCHF--PSFAFKKMEEGKLMDIVDGKMKNVD 730
Query: 742 DI-KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFISSI 793
+RV++ + A+WCIQED RP+M KV QM+EG V PP ++ S +
Sbjct: 731 VTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMGSRL 783
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 8.9e-71, Sum P(4) = 8.9e-71
Identities = 108/215 (50%), Positives = 132/215 (61%)
Query: 491 QDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEI 550
Q F ++ELE T FK ++G G FG VYKG L +E +AVKK+ G QEF EI
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLP--DETLIAVKKITNHGLHGRQEFCTEI 560
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP--NWYKRMQIAFG 608
+ IG H NLV+L GFC G LLVYEY+++GSL LF P W +R IA G
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF-SGNGPVLEWQERFDIALG 619
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLXXXXXXXXXXXXXXIRGTK 668
TARGL YLH C +IIHCD+KP+NILL F +ISDFGL +RGT+
Sbjct: 620 TARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTR 679
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703
GY+APEW N I+ K DVYS+G++LLELV RKN
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 7.7e-70, Sum P(2) = 7.7e-70
Identities = 166/512 (32%), Positives = 259/512 (50%)
Query: 299 GACGFNSFCSLGDDQRKLCQCPPGYTFFDPDDVMKGCKENFVPQSCDRAVE--------E 350
G CG FC + D + C+C G+ P + + + N+ C R E
Sbjct: 279 GVCGPFGFCVISDPPK--CKCFKGFV---PKSIEEWKRGNWT-SGCARRTELHCQGNSTG 332
Query: 351 MDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREG-EC--WKKRAPL 407
D F +PN P + YE+ SVD + C ++CL +C C + G C W K L
Sbjct: 333 KDANVFHTVPNIK-PPDFYEYANSVDAEGCYQSCLHNCSCLAFAYIPGIGCLMWSK--DL 389
Query: 408 SNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKENSTLIYILSATLGGSIFLHL-LVTFI 466
+ + S GG+ L +R +S+ K T++ ++T+ ++F+ L TF
Sbjct: 390 MD-TMQFSAGGEIL-SIRLAHSELDV-----HKRKMTIV---ASTVSLTLFVILGFATFG 439
Query: 467 FFHRR---NQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFK--EELGEGAFGKVYKGV 521
F+ R + +N ++SQ +P L+ F ++ T F +LG G FG VYKG
Sbjct: 440 FWRNRVKHHDAWRNDLQSQD-VP--GLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGK 496
Query: 522 LTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581
L ++ + +AVK+L + +G+QEF EI I + H+NLV++LG C EG+ +LL+YE++
Sbjct: 497 L--QDGREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFM 554
Query: 582 SNGSLADFLF--RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT 639
N SL F+F RK +W KR I G RGL YLH + + ++IH D+K NILLD
Sbjct: 555 KNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEK 614
Query: 640 FNARISDFGLXXXXXXXXXXXXXX-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
N +ISDFGL + GT GY++PE+ + K D+YSFG+LLLE++
Sbjct: 615 MNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEII 674
Query: 699 CCRKNFEVDATEECQMILADWAYDCFRE-RKLGLLVENDEEAMDDIKR---VEKFVMIAI 754
K EE + +LA + ++C+ E R + LL ++A+DD V + V I +
Sbjct: 675 SGEKISRFSYGEEGKALLA-YVWECWCETRGVNLL----DQALDDSSHPAEVGRCVQIGL 729
Query: 755 WCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDP 786
C+Q P+ RP ++ M+ D+ +P P
Sbjct: 730 LCVQHQPADRPNTLELLSMLTTTSDLPLPKQP 761
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 8.7e-69, Sum P(2) = 8.7e-69
Identities = 218/699 (31%), Positives = 330/699 (47%)
Query: 121 AAMLDTGNLVLASQDSST---MWESFDDPTDTLLPTQVMSQGTKVIARLTET-NYSSGRF 176
A + D+GNLVL +S+ +W+SFD P+DT LP + G+++ + S GR+
Sbjct: 157 AVLFDSGNLVLRDGPNSSAAVLWQSFDHPSDTWLPGGKIRLGSQLFTSWESLIDPSPGRY 216
Query: 177 MFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAV 236
E D L T + + +YWS+ G Y + + GF L G+ L+
Sbjct: 217 SLEF--DPKLHSLVTVW---NRSKSYWSS----GPLYDWLQSFKGFPEL---QGTKLS-F 263
Query: 237 TSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWP---KAWSFLSFIPSNICLRIR 293
T N + Y VDP +R + S W ++W + P N C
Sbjct: 264 TLN---MDESYITFSVDPQSRYR-LVMGVSGQFMLQVWHVDLQSWRVILSQPDNRC---- 315
Query: 294 ADTGSGACGFNSFCSLGDDQRKLCQCPPGYT--FF----DPDDVMKGCK-ENFVPQSCDR 346
D + +CG C+ + C+C PG+ F D +D GCK E ++ C +
Sbjct: 316 -DVYN-SCGSFGICNENREPPP-CRCVPGFKREFSQGSDDSNDYSGGCKRETYL--HCYK 370
Query: 347 AVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREG-EC--WKK 403
+E E + TD P TS C C++DC C A +G +C W K
Sbjct: 371 RNDEFLPIENMKLA-TD-PTTA-SVLTSGTFRTCASRCVADCSCQ-AYANDGNKCLVWTK 426
Query: 404 RAPLSNGRIDPSVGGKALVKVRK-DYSDASAGSGSNRKENSTLIYILSATLGGSIFLHL- 461
A + ++D + G +++ + S A+ + K S ++ ++ A+L + +
Sbjct: 427 DA-FNLQQLDANKGHTFFLRLASSNISTANNRKTEHSKGKSIVLPLVLASLVATAACFVG 485
Query: 462 LVTFIFFHRRNQKKQNTVESQKGMPEMNLQD-----FTYKELE---VITGGF--KEELGE 511
L I R +KKQ + + + E L D Y L V T F K++LGE
Sbjct: 486 LYCCISSRIRRKKKQRDEKHSRELLEGGLIDDAGENMCYLNLHDIMVATNSFSRKKKLGE 545
Query: 512 GAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG 571
G FG VYKG L N VA+K+L K ++G EFK E+ I + HKNLV+LLG+C EG
Sbjct: 546 GGFGPVYKGKLP--NGMEVAIKRLSKKSSQGLTEFKNEVVLIIKLQHKNLVRLLGYCVEG 603
Query: 572 EHRLLVYEYVSNGSLADFLFR--KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDI 629
+ +LL+YEY+SN SL LF KSR +W RM+I GT RGL YLHE + +IIH D+
Sbjct: 604 DEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLHEYSRLRIIHRDL 663
Query: 630 KPQNILLDGTFNARISDFGLXXXXX-XXXXXXXXXIRGTKGYVAPEWFKNLPITAKVDVY 688
K NILLD N +ISDFG I GT GY++PE+ I+ K D+Y
Sbjct: 664 KASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMSPEYALGGVISEKSDIY 723
Query: 689 SFGILLLELVCCRKNFE-VDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVE 747
SFG+LLLE++ +K V ++ +I +W C E K +++ ++
Sbjct: 724 SFGVLLLEIISGKKATRFVHNDQKHSLIAYEWESWC--ETKGVSIIDEPMCCSYSLEEAM 781
Query: 748 KFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDP 786
+ + IA+ C+Q+ P RP + ++ M+ + IP P
Sbjct: 782 RCIHIALLCVQDHPKDRPMISQIVYMLSNDNTLPIPKQP 820
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 1.7e-66, P = 1.7e-66
Identities = 233/810 (28%), Positives = 377/810 (46%)
Query: 41 SWISQSGDFAFGFRQVGDRGF-LLAIWFNEIPERTIVWSANRDN-LVQRGSKVELTGDGQ 98
S IS+ F GF + + IW+ I +T+VW ANR+ L+ +++ DG
Sbjct: 43 SLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKIADDGN 102
Query: 99 LILRDSSGKEIWR---EPPSTGAAYAAMLDTGNLVLASQDSSTMW--ESFDDPTDTLLP- 152
L++ + + IW EP S A + TG+LVL S W ESF++PTDT LP
Sbjct: 103 LVIVNGQNETIWSTNVEPESNNTV-AVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPG 161
Query: 153 --TQV---MSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+V + + I +E++ S G++ + G L + + W++
Sbjct: 162 MRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNS-- 219
Query: 208 SIGSGYQVVFNQSGFIY---LTA---RNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261
+I +G + + +IY L++ R+GS+ +++ + DF R + PDGV +
Sbjct: 220 AIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASD--SSDFL-RFWIRPDGVEEQF 276
Query: 262 IYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKL----C 317
+ K + W+ L + PS C + CG S C DD ++ C
Sbjct: 277 RWNKDIRN--------WNLLQWKPSTECEKYNR------CGNYSVC---DDSKEFDSGKC 319
Query: 318 QCPPGYTFFDPD-----DVMKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHF 372
C G+ D D GC+ VP +C++++ F + P D+
Sbjct: 320 SCIDGFEPVHQDQWNNRDFSGGCQRR-VPLNCNQSLVAGQEDGFTVLKGIKVP--DFGSV 376
Query: 373 T-SVDEDWCREACLSDCFC-AVAIFREGEC--WKKRAPLSNGRIDPSVGGKALVKVRKDY 428
+ + C++ C DC C A A+ C W R + + GG + + +R
Sbjct: 377 VLHNNSETCKDVCARDCSCKAYALVVGIGCMIWT-RDLIDMEHFER--GGNS-INIR--L 430
Query: 429 SDASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHRRN------QKKQNTV--- 479
+ + G G KENSTL I+ + +G + L L + ++ +++ +KK TV
Sbjct: 431 AGSKLGGG---KENSTLWIIVFSVIG-AFLLGLCIWILWKFKKSLKAFLWKKKDITVSDI 486
Query: 480 -ESQ--KGMP-------EMNLQD---FTYKELEVITGGFKEE--LGEGAFGKVYKGVLTT 524
E++ P +++ D F++ + TG F EE LG+G FG VYKG +
Sbjct: 487 IENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSE 546
Query: 525 ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584
E +AVK+L +G +EFK EI I + H+NLV+LLG C E ++L+YEY+ N
Sbjct: 547 GRE--IAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNK 604
Query: 585 SLADFLFRKSRRPN--WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642
SL FLF +S++ + W KR ++ G ARGL YLH + + +IIH D+K NILLD N
Sbjct: 605 SLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNP 664
Query: 643 RISDFGLXXXXXXXXXXXXXX-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR 701
+ISDFG+ + GT GY+APE+ + K DVYSFG+L+LE+V R
Sbjct: 665 KISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGR 724
Query: 702 KNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDP 761
KN T+ +I +A+ + + K +++ + D+ + + + + C Q+
Sbjct: 725 KNVSFRGTDHGSLI--GYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSV 782
Query: 762 SLRPAMKKVTQMIEGAVDVSIPPDPASFIS 791
RP M V M+E PP +F S
Sbjct: 783 IHRPNMGSVLLMLESQTSQLPPPRQPTFHS 812
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 1.7e-65, Sum P(2) = 1.7e-65
Identities = 125/326 (38%), Positives = 186/326 (57%)
Query: 473 QKKQNTVESQKGMPEMNLQDFTYKELEVI---TGGFK--EELGEGAFGKVYKGVLTTENE 527
Q++ + V S+K E +L+ + +L+ + T GF +LG+G FG VYKG L E
Sbjct: 432 QRESSRVSSRK-QEEEDLE-LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQE 489
Query: 528 KPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLA 587
VAVK+L + +G +EFK EI I + H+NLV++LG+C + E R+L+YEY N SL
Sbjct: 490 --VAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLD 547
Query: 588 DFLFRKSRRP--NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS 645
F+F K RR +W KR++I G ARG+ YLHE+ + +IIH D+K N+LLD NA+IS
Sbjct: 548 SFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKIS 607
Query: 646 DFGLXXXXXXXXXXXXXX-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF 704
DFGL + GT GY++PE+ + + K DV+SFG+L+LE+V R+N
Sbjct: 608 DFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNR 667
Query: 705 EVDATEECQMILADWAYDCFRERKLGLLVEND-EEAMDDIKRVEKFVMIAIWCIQEDPSL 763
EE ++ L A+ F E K +++ E+ DI V + + I + C+Q+DP
Sbjct: 668 GF-RNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKD 726
Query: 764 RPAMKKVTQMIEGAVDVSIPPDPASF 789
RP M V M+ + + P P F
Sbjct: 727 RPNMSVVVLMLSSEMLLLDPRQPGFF 752
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
Identities = 221/780 (28%), Positives = 355/780 (45%)
Query: 44 SQSGDFAFGFRQVGD-RGFLLAIWFNEIPERTIVWSANRDN-LVQRGSKVELTGDGQLIL 101
S +G + GF + + + IWF I R +VW ANR+ + + ++ +G L+L
Sbjct: 40 SSNGIYELGFFSPNNSQNLYVGIWFKGIIPRVVVWVANRETPTTDTSANLAISSNGSLLL 99
Query: 102 RDSSGKEIWR--EPPSTGAAYAAMLDTGNLVLASQDSS-TMWESFDDPTDTLLP-TQVM- 156
+ +W E ++ + A + D GNLV+ S T+WESF+ DT+LP + +M
Sbjct: 100 FNGKHGVVWSIGENFASNGSRAELTDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMY 159
Query: 157 --SQGTKVIARL--TETNYSSGRFMFEL--QTDGNLLLY--TTTYPFDGANAAYWSTQTS 208
+ G K + T+T+ S G F+ ++ Q +L+ +T Y G W+
Sbjct: 160 NLATGEKRVLTSWKTDTDPSPGVFVGQITPQVPSQVLIMRGSTRYYRTGP----WAKTRF 215
Query: 209 IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSA 268
G S F NGS + R ++ +G + + +
Sbjct: 216 TGIPLMDDTYASPFSLQQDANGSGFFTYFDRSFKLS----RIIISSEGSMKRFRH----- 266
Query: 269 STGGRWPKAWSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFDP 328
G W S+++ P+N C D G CG C + + C+C G+
Sbjct: 267 -NGTDWEL--SYMA--PANSC-----DI-YGVCGPFGLCIVSVPLK--CKCLKGFVPHST 313
Query: 329 DDVMKG-----CKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREA 383
++ +G C C D+ F + N P + YE+ +SVD + C ++
Sbjct: 314 EEWKRGNWTGGCAR-LTELHCQGNSTGKDVNIFHPVTNVKLP-DFYEYESSVDAEECHQS 371
Query: 384 CLSDCFCAVAIFREG-EC--WKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRK 440
CL +C C + G C W + L + + S GG+ L +R +S+ +
Sbjct: 372 CLHNCSCLAFAYIHGIGCLIWNQN--LMDA-VQFSAGGEIL-SIRLAHSELGGNKRNKII 427
Query: 441 ENSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEV 500
ST+ L L + F + H+ K K L+ F ++
Sbjct: 428 VASTVSLSLFVILTSAAFGFW--RYRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQT 485
Query: 501 ITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH 558
T F +LG+G FG VYKG L ++ K +AVK+L + +G++EF EI I + H
Sbjct: 486 ATNNFSLSNKLGQGGFGSVYKGKL--QDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQH 543
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLF--RKSRRPNWYKRMQIAFGTARGLFYL 616
+NLV++LG C EGE +LL+YE++ N SL F+F RK +W KR I G ARGL YL
Sbjct: 544 RNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYL 603
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLXXXXXXXX-XXXXXXIRGTKGYVAPEW 675
H + + ++IH D+K NILLD N +ISDFGL + GT GY++PE+
Sbjct: 604 HRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEY 663
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK-LGLLVE 734
+ K D+YSFG+LLLE++ K EE + +LA +A++ + E K + LL
Sbjct: 664 AWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLA-YAWESWGETKGIDLL-- 720
Query: 735 NDEEAMDDIKRVE--KFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFISS 792
D++ D + +E + V I + C+Q P+ RP ++ M+ D+ P P + S
Sbjct: 721 -DQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTFVVHS 779
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 538 (194.4 bits), Expect = 1.8e-64, Sum P(2) = 1.8e-64
Identities = 169/534 (31%), Positives = 259/534 (48%)
Query: 278 WSFLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYT-FFDPD----DVM 332
W +P+N C D G CG C + + C+C G+ F + +
Sbjct: 266 WVLNIDVPANTC-----DF-YGVCGPFGLCVMSIPPK--CKCFKGFVPQFSEEWKRGNWT 317
Query: 333 KGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAV 392
GC C + F + N P + YE +S + C ++CL +C C
Sbjct: 318 GGCVRR-TELLCQGNSTGRHVNVFHPVANIK-PPDFYEFVSSGSAEECYQSCLHNCSCLA 375
Query: 393 AIFREG-ECWKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKENSTLIYILSA 451
+ G C L + + SVGG+ L+ +R AS+ G N+++ + + I+S
Sbjct: 376 FAYINGIGCLIWNQELMDV-MQFSVGGE-LLSIRL----ASSEMGGNQRKKTIIASIVSI 429
Query: 452 TLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMP-----EMNLQD------FTYKELEV 500
S+F+ L + F R + K N + S+ + ++ +D F K +E+
Sbjct: 430 ----SLFV-TLASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSEDVSGLYFFEMKTIEI 484
Query: 501 ITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH 558
T F +LG+G FG VYKG L ++ K +AVK+L + +G++EF EI I + H
Sbjct: 485 ATNNFSLVNKLGQGGFGPVYKGKL--QDGKEIAVKRLSSSSGQGKEEFMNEILLISKLQH 542
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLF--RKSRRPNWYKRMQIAFGTARGLFYL 616
NLV++LG C EGE RLLVYE++ N SL F+F RK +W KR I G ARGL YL
Sbjct: 543 INLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSIIQGIARGLLYL 602
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLXXXXXXXXXXXXXX-IRGTKGYVAPEW 675
H + + +IIH D+K NILLD N +ISDFGL I GT GY++PE+
Sbjct: 603 HRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVGTLGYMSPEY 662
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK-LGLLVE 734
+ K D YSFG+LLLE++ K +E + +LA +A++ + E +G L
Sbjct: 663 AWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLA-YAWESWCENGGVGFL-- 719
Query: 735 NDEEAMDDI--KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDP 786
D++A D V + V I + C+Q P+ RP ++ M+ D+ +P +P
Sbjct: 720 -DKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLPKEP 772
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4389 | 0.9432 | 0.8990 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024694001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (795 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 793 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 9e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-21 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 5e-54
Identities = 72/197 (36%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
LGEG FG VY K VA+K + K + +E EI + + NH N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTG-KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHC 627
+ H LV EY GSL D L + + + ++I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 628 DIKPQNILLD-GTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITAKV 685
D+KP+NILLD +++DFGL+KLL +D++ T I GT Y+APE + K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 686 DVYSFGILLLELVCCRK 702
D++S G++L EL +
Sbjct: 176 DIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 75/263 (28%), Positives = 114/263 (43%), Gaps = 24/263 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLVQ 563
E+LGEG+FGKVY + VA+K + K + ++E EI + + H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKL-VAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L + + LV EY G L D L ++ R R L YLH +
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-FYLRQILSALEYLHSK---G 117
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
I+H D+KP+NILLD + +++DFGLA+ L + TT GT Y+APE
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGK 175
Query: 684 KVDVYSFGILLLELVCCRKNFEVDATEECQM-ILADWAYDCFRERKLGLLVENDEEAMDD 742
VD++S G++L EL+ + F D + + EA D
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-----DISPEAKDL 230
Query: 743 IKRVEKFVMIAIWCIQEDPSLRP 765
I++ + +DP R
Sbjct: 231 IRK----------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 92/264 (34%), Positives = 125/264 (47%), Gaps = 20/264 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISAIGRTNHKNLV 562
+LG G+FG VYK + VAVK L K ++ +Q + EI + R +H N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKI-VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
+L+ + +H LV EY G L D+L R + IA RGL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKK-IALQILRGLEYLHSN--- 117
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW-FKNLPI 681
IIH D+KP+NILLD +I+DFGLAK L + TT GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741
KVDV+S G++L EL+ + F Q+ L R LG +E DE
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFS-GENILDQLQLIR--------RILGPPLEFDEPKWS 227
Query: 742 DIKRVEKFVMIAIWCIQEDPSLRP 765
K ++ C+ +DPS RP
Sbjct: 228 SGSEEAKDLI--KKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 74/202 (36%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLY-KAVNEGEQEFKAEISAIGRTNHKN 560
++LGEGAFG+VYKG L + E VAVK L A E +EF E S + + +H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+V+LLG C +GE +V EY+ G L DFL + + +Q+A A+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG---YVAPEWFK 677
+H D+ +N L+ +ISDFGL++ + D G K ++APE K
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLK 177
Query: 678 NLPITAKVDVYSFGILLLELVC 699
+ T+K DV+SFG+LL E+
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 49/287 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKN 560
++LGEGAFG+VYKG L + K VAVK L + A + +EF E + + +H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+V+LLG C E E +V EY+ G L +L + + + + A ARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
IH D+ +N L+ +ISDFGL++ L D RG K + APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAPESLK 176
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737
T+K DV+SFG+LL E+ F + M ++E
Sbjct: 177 EGKFTSKSDVWSFGVLLWEI------FTLGEQPYPGM--------------------SNE 210
Query: 738 EAMDDIKR----------VEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774
E ++ +K + + + C EDP RP ++ +++
Sbjct: 211 EVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 76/202 (37%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 505 FKEELGEGAFGKVYKGVLT---TENEKPVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKN 560
++LGEGAFG+VYKG L E VAVK L + A + +EF E + + +H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP--NWYKRMQIAFGTARGLFYLHE 618
+V+LLG C E E ++V EY+ G L D+L RK+R + + A ARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEW 675
+ IH D+ +N L+ +ISDFGL++ L D +G K + APE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV---KGGKLPIRWMAPES 175
Query: 676 FKNLPITAKVDVYSFGILLLEL 697
K T+K DV+SFG+LL E+
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 87/288 (30%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 507 EELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQ 563
++LGEGAFG+VYKG L ++ K VAVK L + +E E+ +F E + + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY---------KRMQIAFGTARGLF 614
LLG C E E LV EY+ G L D+L RKSR + A A+G+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYL-RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV--- 671
YL + + +H D+ +N L+ +ISDFGL++ + D T G +
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIR 172
Query: 672 --APEWFKNLPITAKVDVYSFGILLLELVCCRKN--FEVDATEECQMILADWAYDCFRER 727
APE K+ T+K DV+SFG+LL E+ + E + +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---------- 222
Query: 728 KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
G + E D++ +M++ W Q DP RP ++ + +E
Sbjct: 223 --GYRLPKPEYCPDELYE----LMLSCW--QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E LG G+FG VY + E +AVK L E + + EI + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 565 LGFC--NEGEHRLLVYEYVSNGSLADFLFRKS-------RRPNWYKRMQIAFGTARGLFY 615
G E + EYVS GSL+ L + R+ Y R QI GL Y
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK---YTR-QIL----EGLAY 116
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPE 674
LH I+H DIK NIL+D +++DFG AK L +T T ++RGT ++APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 675 WFKNLPITAKVDVYSFGILLLEL 697
+ D++S G ++E+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEM 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEF-KAEISAIGRTNHKNLVQ 563
+++G+G+FGKVY V + K +K++ ++E E+E E+ + + NH N+++
Sbjct: 5 IKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRRP-------NWYKRMQIAFGTARGLF 614
E +V EY G L+ + +K +P +W+ +Q+ L
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LK 117
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YLH +I+H DIKPQNI L ++ DFG++K+L + T + GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE-CQMIL 716
+N P K D++S G +L EL + FE + E IL
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
E++G+G FG+VYK K VA+K + E +++ EI + + H N+V+
Sbjct: 5 LEKIGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKS 622
G + + +V E+ S GSL D L + + + QIA+ +GL YLH
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKD-LLKSTNQT--LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
IIH DIK NILL ++ DFGL+ L T T GT ++APE P
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPY 174
Query: 682 TAKVDVYSFGILLLELV 698
K D++S GI +EL
Sbjct: 175 DYKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 68/194 (35%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+G+G FG V G +K VAVK L K + Q F AE S + H NLVQL
Sbjct: 10 LGATIGKGEFGDVMLGDY--RGQK-VAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYK-RMQIAFGTARGLFYLHEECKSQ 623
LG +G +V EY++ GSL D+L + R ++ A G+ YL E+
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
+H D+ +N+L+ A++SDFGLAK Q ++ T APE + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 684 KVDVYSFGILLLEL 697
K DV+SFGILL E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (326), Expect = 1e-32
Identities = 82/276 (29%), Positives = 117/276 (42%), Gaps = 27/276 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKAEISAIGRTNH-KN 560
+LGEG+FG+VY + K VA+K L K + +E F EI + NH N
Sbjct: 4 ILRKLGEGSFGEVYLA----RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGLFYLHE 618
+V+L F + LV EYV GSL D L + R+ + + I L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 619 ECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKTDQT-----QTTTAIRGTKGYVA 672
IIH DIKP+NILLD ++ DFGLAKLL + + GT GY+A
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 673 PEWFKNL---PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
PE L ++ D++S GI L EL+ FE + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
L ++ E + + + + +DP R
Sbjct: 237 SPLSPSNPELIS-----KAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTNHKNLV 562
+ +G GAFG VYKG L E VA+K+ L K E + EI + H N+V
Sbjct: 4 LGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLHEE 619
+ +G + ++ EY NGSL + + P +A + +GL YLHE+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP----ESLVAVYVYQVLQGLAYLHEQ 118
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+IH DIK NIL +++DFG+A L D ++ ++ GT ++APE +
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 680 PITAKVDVYSFGILLLEL 697
+ D++S G ++EL
Sbjct: 175 GASTASDIWSLGCTVIEL 192
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 64/194 (32%), Positives = 99/194 (51%), Gaps = 12/194 (6%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLG 566
LG+G+ G VYK K A+KK++ +E ++ E+ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTG-KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 567 -FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM--QIAFGTARGLFYLHEECKSQ 623
F EGE + V EY+ GSLAD L + + + IA +GL YLH K
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRH 120
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
IIH DIKP N+L++ +I+DFG++K+L+ Q T + GT Y++PE + +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 684 KVDVYSFGILLLEL 697
D++S G+ LLE
Sbjct: 180 AADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E+LGEG++G VYK + E + VA+K + V E QE EIS + + + +V+
Sbjct: 7 ILEKLGEGSYGSVYKA-IHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECK 621
G + +V EY GS++D + ++ +IA T +GL YLH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT---EEEIAAILYQTLKGLEYLH---S 117
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
++ IH DIK NILL+ A+++DFG++ L + T I GT ++APE + +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 682 TAKVDVYSFGILLLEL 697
K D++S GI +E+
Sbjct: 177 NNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKP---VAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKN 560
F ++LGEG FGKV + VAVK L + E + +F+ EI + +H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 561 LVQLLGFCNEGEHR---LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
+V+ G C E L+ EY+ +GSL D+L R + N + + + +G+ YL
Sbjct: 68 IVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG--YVAPEW 675
+ + IH D+ +NIL++ +ISDFGLAK+L D+ G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 676 FKNLPITAKVDVYSFGILLLELVC-CRKNFE 705
+ ++ DV+SFG+ L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-29
Identities = 96/345 (27%), Positives = 163/345 (47%), Gaps = 29/345 (8%)
Query: 447 YILSATLGGSIFLHLLVT---FIFFHRRNQKKQNTVESQKGMPEMNLQDFTYKE---LEV 500
+ ++ TLG FL L + F+F RN + VE++ G E+ D + +
Sbjct: 630 FYITCTLG--AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND 687
Query: 501 ITGGFKEE--LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH 558
I KEE + G G YKG + +N VK+ +N+ +EI+ +G+ H
Sbjct: 688 ILSSLKEENVISRGKKGASYKGK-SIKNGMQFVVKE----INDVNSIPSSEIADMGKLQH 742
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
N+V+L+G C + L++EY+ +L++ L R +W +R +IA G A+ L +LH
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHC 798
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
C ++ ++ P+ I++DG + L LL TD ++ YVAPE +
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRET 852
Query: 679 LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738
IT K D+Y FG++L+EL+ + DA + +WA C+ + L + ++
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910
Query: 739 AMDDIKRVEKF-VM-IAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781
+ + E VM +A+ C DP+ RP V + +E A S
Sbjct: 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 507 EELGEGAFGKVYKGVLTTEN--EKPVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNLVQ 563
+ELG G FG V KGV ++ E VAVK L + + G++EF E S + + +H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L+G C +GE +LV E G L +L +K R ++A A G+ YL E
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYL-ESKH-- 115
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT--QTTTAIRGTKGYVAPEWFKNLPI 681
+H D+ +N+LL A+ISDFG+++ L + TTA R + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 682 TAKVDVYSFGILLLELV 698
++K DV+S+G+ L E
Sbjct: 176 SSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E++GEGA G+VYK ++ VA+KK+ + + ++ EI + H N+V
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKE-VAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM---QIAF---GTARGLFYLHE 618
G+ +V EY+ GSL D + + RM QIA+ +GL YLH
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLH- 133
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
+IH DIK NILL + +++DFG A L ++++ + + GT ++APE K
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKR 190
Query: 679 LPITAKVDVYSFGILLLELV 698
KVD++S GI+ +E+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 69/218 (31%), Positives = 109/218 (50%), Gaps = 32/218 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK----PVAVKKLYKAVN-EGEQEFKAEISAIGRTNHK 559
F EELGEGAFGKVYKG LT NE+ VA+K L + + +QEF+ E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS--------------RRPNWYKRM-Q 604
N+V LLG C + + +++EY+++G L +FL R S +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD-----QTQ 659
IA A G+ YL +H D+ +N L+ +ISDFGL++ + + Q++
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
+ +R ++ PE T + D++SFG++L E+
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/200 (37%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
+ +LG G FG+V+ G T VAVK L K + F E + + H LVQL
Sbjct: 11 ERKLGAGQFGEVWMG--TWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFL----FRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
C+E E +V EY+S GSL DFL +K R P + + +A A G+ YL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP---QLVDMAAQIAEGMAYLESR-- 122
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKN 678
IH D+ +NIL+ +I+DFGLA+L++ D+ TA G K + APE
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANY 178
Query: 679 LPITAKVDVYSFGILLLELV 698
T K DV+SFGILL E+V
Sbjct: 179 GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 70/198 (35%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEF-KAEISAIGRTNHKNLVQLL 565
LG+G+FGKV V + K A+K L K + E E E + + R NH +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 566 -GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECK 621
F E E LV EY G L L ++ R + F A L YLH
Sbjct: 60 YAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAAEIVLALEYLHSL-- 112
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
II+ D+KP+NILLD + +++DFGLAK L ++ ++T T GT Y+APE
Sbjct: 113 -GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGY 170
Query: 682 TAKVDVYSFGILLLELVC 699
VD +S G+LL E++
Sbjct: 171 GKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+LG G FG+V++G+ N PVAVK L K ++F AE + + H L+QL
Sbjct: 10 LLRKLGAGQFGEVWEGLWN--NTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQ 623
C E +V E + GSL ++L + R + + +A A G+ YL +
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---N 123
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
IH D+ +N+L+ +++DFGLA+++K D + + + APE +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 684 KVDVYSFGILLLELV 698
K DV+SFGILL E+V
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 30/212 (14%)
Query: 508 ELGEGAFGKVYKG----VLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLV 562
ELG+G+FG VY+G V+ E E VA+K + + + E+ EF E S + N ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-----------WYKRMQIAFGTAR 611
+LLG + G+ L+V E ++ G L +L +SRRP K +Q+A A
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG-- 669
G+ YL + + +H D+ +N ++ +I DFG+ + D +T +G KG
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 670 ---YVAPEWFKNLPITAKVDVYSFGILLLELV 698
++APE K+ T K DV+SFG++L E+
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGE-QEFKAEISA 552
Y+ LE I G+G+FG V K V + K + K++ Y + E E Q+ +E++
Sbjct: 2 YEVLETI--------GKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNI 52
Query: 553 IGRTNHKNLVQLLG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWY----KRMQIA 606
+ H N+V+ + L +V EY G LA + +K ++ Y +I
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRIL 111
Query: 607 FGTARGLFYLH--EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664
L+ H + + ++H D+KP NI LD N ++ DFGLAK+L D + T +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
GT Y++PE ++ K D++S G L+ EL
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 507 EELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQ 563
+ +G G FG+V +G L + E VA+K L ++ ++ +F E S +G+ +H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L G + +++ EY+ NGSL FL + + + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA-----IRGTKGYVAPEWFKN 678
+H D+ +NIL++ ++SDFGL++ L+ + TT IR T APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 679 LPITAKVDVYSFGILLLE 696
T+ DV+SFGI++ E
Sbjct: 183 RKFTSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/195 (30%), Positives = 109/195 (55%), Gaps = 8/195 (4%)
Query: 509 LGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
+G G FG+V++G+L E VA+K L E + Q+F +E S +G+ +H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G + + +++ EY+ NG+L +L + Y+ + + G A G+ YL + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTD--QTQTTTAIRGTKGYVAPEWFKNLPITA 683
H D+ +NIL++ ++SDFGL+++L+ D T TT+ + + APE T+
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 684 KVDVYSFGILLLELV 698
DV+SFGI++ E++
Sbjct: 190 ASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
+LG G FG+V++G+ +N VA+K L +Q+F+ E+ A+ R HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLW--KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT--ARGLFYLHEECKSQI 624
C+ GE ++ E + GSL FL R I A G+ YL E+
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
IH D+ +NIL+ +++DFGLA+L+K + ++ + + APE + + K
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 685 VDVYSFGILLLELV 698
DV+SFGILL E+
Sbjct: 185 SDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 9e-25
Identities = 35/86 (40%), Positives = 45/86 (52%), Gaps = 3/86 (3%)
Query: 72 ERTIVWSANRDN-LVQRGSKVELTGDGQLILRDSSGKEIWR--EPPSTGAAYAAMLDTGN 128
+T+VW ANR N L + L DG L+L D +G+ +W A + D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 129 LVLASQDSSTMWESFDDPTDTLLPTQ 154
LVL +W+SFD PTDTLLP Q
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQ 86
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 66/193 (34%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQLLG 566
ELG G G V K VL K +AVK + +NE Q + E+ + + N +V G
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 567 -FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
F N G+ + + EY+ GSL L R +IA +GL YLHE K +II
Sbjct: 67 AFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
H D+KP NIL++ ++ DFG++ L +T GT Y+APE + + K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVKS 180
Query: 686 DVYSFGILLLELV 698
D++S G+ L+EL
Sbjct: 181 DIWSLGLSLIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 35/273 (12%)
Query: 509 LGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQL 564
LG GAFG VYKGV E EK PVA+K L + + + +E E + +H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
LG C L+ + + G L D++ + A+G+ YL E+ ++
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RL 130
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-----TTAIRGTKGYVAPEWFKNL 679
+H D+ +N+L+ + +I+DFGLAKLL D+ + I+ ++A E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMALESILHR 186
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE- 738
T K DV+S+G+ + EL M Y+ ++ L+E E
Sbjct: 187 IYTHKSDVWSYGVTVWEL----------------MTFGAKPYEGIPAVEIPDLLEKGERL 230
Query: 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771
I ++ + M+ + C D RP K++
Sbjct: 231 PQPPICTIDVY-MVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNL 561
+E+G G FG V+ G ++ VA+K + EG E++F E + + +H L
Sbjct: 8 LVQEIGSGQFGLVWLG--YWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGLFYLHEE 619
VQL G C E LV+E++ +G L+D+L +++R + + + + G+ YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+IH D+ +N L+ ++SDFG+ + + DQ ++T + + +PE F
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 680 PITAKVDVYSFGILLLEL 697
++K DV+SFG+L+ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEF-KAEISAIGRTN-HKN 560
F + +GEG+F V N K A+K L K + E + ++ K E + R N H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETN-KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 561 LVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYL 616
+++L + + E L V EY NG L ++ + F A L YL
Sbjct: 64 IIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD----EKCTRFYAAEILLALEYL 118
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL---------KTDQTQTTTAIR-- 665
H IIH D+KP+NILLD + +I+DFG AK+L K D T + I
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 666 --------GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF 704
GT YV+PE P D+++ G ++ +++ + F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/201 (33%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQE--FKAEISAIGRTNHKNL 561
F + LG G+FG+V V + K A+K L KA + + +Q E + H L
Sbjct: 5 FIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHE 618
V L G + + LV EYV G L L RKS R F A+ L YLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEP---VARFYAAQVVLALEYLHS 119
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
I++ D+KP+N+LLD +I+DFG AK +K +T T + GT Y+APE +
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPEYLAPEIILS 172
Query: 679 LPITAKVDVYSFGILLLELVC 699
VD ++ GIL+ E++
Sbjct: 173 KGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 50/283 (17%)
Query: 494 TYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLY-KAVNEGEQEFKA-EIS 551
YK L I GEGA G V+K E + VA+KK+ + + G EI
Sbjct: 1 RYKILGRI--------GEGAHGIVFKAK-DRETGETVALKKVALRRLEGGIPNQALREIK 51
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP------NWYKRMQI 605
A+ H +V+LL G +LV EY+ L++ L R RP Y RM +
Sbjct: 52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLL 109
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
+G+ Y+H I+H D+KP N+L+ +I+DFGLA+L ++ + +
Sbjct: 110 -----KGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 666 GTKGYVAPE-WFKNLPITAKVDVYSFGILLLELVCCRKNF--EVDATEECQMI------- 715
T+ Y APE + VD+++ G + EL+ F E D + +
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPN 221
Query: 716 ---------LADWAYDCFRERK---LGLLV-ENDEEAMDDIKR 745
L D+ F E K L + + EA+D +K
Sbjct: 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKG 264
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 79/271 (29%), Positives = 135/271 (49%), Gaps = 32/271 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E +GEG FG V +G T + VAVK + V Q F E + + + +HKNLV+LLG
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK---VAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLG 66
Query: 567 -FCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQI 624
+ G + +V E +S G+L +FL + R + + +Q + A G+ YL + ++
Sbjct: 67 VILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D+ +NIL+ A++SDFGLA++ + ++ T APE K+ ++K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744
DV+S+G+LL E+ F +M L + +C + G +E E D+
Sbjct: 178 SDVWSYGVLLWEV------FSYGRAPYPKMSLKE-VKECVEK---GYRMEPPEGCPADV- 226
Query: 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+M + W + +P RP+ K+ + +E
Sbjct: 227 ---YVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 37/218 (16%)
Query: 509 LGEGAFGKV----YKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEIS------AIGRTNH 558
LGEGAFG+V G+ VAVK L K + E++ +S IG+ H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KD-DATEKDLSDLVSEMEMMKMIGK--H 75
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-----------------NWYK 601
KN++ LLG C + +V EY ++G+L DFL ++RRP
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETLTQKD 133
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQT 660
+ A+ ARG+ +L + + IH D+ +N+L+ +I+DFGLA+ + D +
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
TT R ++APE + T + DV+SFG+LL E+
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
K +LG G +G+VY+GV + VAVK L K +EF E + + H NLVQLL
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYS-LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQI 624
G C ++ E+++ G+L D+L +R+ N + +A + + YL K
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKNLPI 681
IH D+ +N L+ +++DFGL++L+ D T TA G K + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 682 TAKVDVYSFGILLLEL 697
+ K DV++FG+LL E+
Sbjct: 183 SIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNL 561
F +ELG G FG V+ G + VA+K + EG E +F E + + +H NL
Sbjct: 8 FLKELGSGQFGVVHLGKW--RGKIDVAIK----MIREGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
VQL G C + +V EY++NG L ++L + + + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES--- 118
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKN 678
+ IH D+ +N L+ ++SDFGLA+ + DQ T+ +GTK + PE F
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDY 175
Query: 679 LPITAKVDVYSFGILLLELVCCRK 702
++K DV+SFG+L+ E+ K
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 32/217 (14%)
Query: 505 FKEELGEGAFGKVYKG---VLTTENEKP-VAVKKLYK-AVNEGEQEFKAEISAIGRTNHK 559
K ELGEGAFGKV+ G L EN+K VAVK L + A N+ ++F+ E + H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-------------MQIA 606
N+V+ G C EG+ ++V+EY+ +G L FL + K +QIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 607 FGTARGLFYLHEECKSQ-IIHCDIKPQNILLDGTFNARISDFGLAK-LLKTD----QTQT 660
A G+ YL SQ +H D+ +N L+ +I DFG+++ + TD T
Sbjct: 129 VQIASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
IR ++ PE T + DV+SFG++L E+
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 27/210 (12%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQL 564
E +GEG +GKVYK + VA+K + + + E+E K E + + + +NH N+
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQL-VAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATF 68
Query: 565 LG-FCNEG----EHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRM---QIAF---GTARG 612
G F + + +L LV E GS+ D L + R+ KR+ IA+ T RG
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKG--KRLKEEWIAYILRETLRG 125
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
L YLHE +++IH DIK QNILL ++ DFG++ L + + T I GT ++A
Sbjct: 126 LAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMA 181
Query: 673 PEWF---KNL--PITAKVDVYSFGILLLEL 697
PE + A+ DV+S GI +EL
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL-G 566
ELG+GAFGKVYK A ++ E E +F EI + H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEA 70
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
+ E + +L+ E+ G+L D + + R QI + L +LH +
Sbjct: 71 YFYENKLWILI-EFCDGGAL-DSIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---K 123
Query: 624 IIHCDIKPQNILLDGTFNARISDFGL-AKLLKTDQTQTTTAIRGTKGYVAPE-----WFK 677
+IH D+K NILL + +++DFG+ AK T Q + T GT ++APE FK
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181
Query: 678 NLPITAKVDVYSFGILLLEL 697
+ P K D++S GI L+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 18/218 (8%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
++G+G+FG V+K V+ +++ A+K+ L K +E E + + + +++
Sbjct: 5 LNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRRPN---WYKRMQIAFGTARGLFYLHE 618
+ +V EY NG L L R P W +QI G L +LH
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLH- 118
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
+I+H DIK N+ LD N +I D G+AKLL +D T I GT Y++PE ++
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCED 175
Query: 679 LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMIL 716
P K DV++ G++L E CC DA + +IL
Sbjct: 176 KPYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 13/195 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLL 565
E++G+G FG VYKGVL E VAVK + +++F E + + +H N+V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE--VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G C + + +V E V GSL FL +K R K +Q++ A G+ YL + I
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK----GYVAPEWFKNLPI 681
H D+ +N L+ +ISDFG++ + ++ T G K + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 682 TAKVDVYSFGILLLE 696
T++ DV+S+GILL E
Sbjct: 173 TSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNL 561
E+LGEG +G VYK E VA+KK+ + NE E + EIS + H N+
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGE-IVALKKI-RLDNEEE-GIPSTALREISLLKELKHPNI 60
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR--PNWYKRMQIAFGTARGLFYLHEE 619
V+LL + LV+EY L +L ++ PN K I + RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSH 117
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKN 678
+I+H D+KPQNIL++ +++DFGLA+ T + T Y APE +
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGS 173
Query: 679 LPITAKVDVYSFGILLLELV 698
+ VD++S G + E++
Sbjct: 174 KHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 509 LGEGAFGKVYKGVLTTEN----EKPVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
LG GAFG+VY+G+ + E VAVK L + E +F E + + NH+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYK----RMQ----IAFGTARGLFY 615
L+G E R ++ E ++ G L FL + RP + M+ A A+G Y
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLAKLLKTDQTQTTTAIRGTKG--- 669
L E + IH DI +N LL R I+DFG+A+ D + + +G +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLP 184
Query: 670 --YVAPEWFKNLPITAKVDVYSFGILLLELVC-------CRKNFEV 706
++ PE F + T+K DV+SFG+LL E+ R N EV
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
++LG G FG+V+ G VA+K L + E F AE + + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYY--NGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA 68
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ E ++ EY+ NGSL DFL + K + +A A G+ ++ + I
Sbjct: 69 VVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKNLPIT 682
H D++ NIL+ T +I+DFGLA+L++ ++ TA G K + APE T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFT 181
Query: 683 AKVDVYSFGILLLELV 698
K DV+SFGILL E+V
Sbjct: 182 IKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 509 LGEGAFGKVYKGVLTT-----ENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLV 562
LG GAFG+VY+G T VAVK L K + E+ EF E + NH N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY-------KRMQIAFGTARGLFY 615
+LLG C E + ++ E + G L +L R +R + + + I A+G Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 616 LHEECKSQIIHCDIKPQNILL-DGTFNAR----ISDFGLAK-LLKTDQTQTTTAIRGTKG 669
L + IH D+ +N L+ + ++A I DFGLA+ + K+D +
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVC-------CRKNFEV 706
++APE + T + DV+SFG+L+ E++ N EV
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC 568
LG+G +G VY + +A+K++ + + Q EI+ H+N+VQ LG
Sbjct: 16 LGKGTYGIVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 569 NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQII 625
+E + E V GSL+ L R P I F T + GL YLH+ QI+
Sbjct: 75 SENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIV 130
Query: 626 HCDIKPQNILLDGTFNA--RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP--I 681
H DIK N+L++ T++ +ISDFG +K L T T GT Y+APE P
Sbjct: 131 HRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGY 188
Query: 682 TAKVDVYSFGILLLELVCCRKNF 704
A D++S G ++E+ + F
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 493 FTYKELEVITGGFKEELGEGAFGKVY----KGVLTTENEKPVAVKKLYKA-VNEGEQEFK 547
F L+ IT LG G FG+V+ KG+ E V VK L K + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 548 AEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYK------ 601
E+ + +HKN+V+LLG C E E ++ EY G L FL + K
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 602 --RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-- 657
++ + A G+ +L ++ +H D+ +N L+ ++S L+K + +
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 658 --TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
+R ++APE + + K DV+SFG+L+ E+
Sbjct: 174 KLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEG--EQEFKAEISAIGRTNHKNLVQL 564
ELG G FG V KG+ ++EK VAVK L N+ + E E + + + ++ +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+G C E E +LV E G L FL +K++ ++ + G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT--QTTTAIRGTKGYVAPEWFKNLPIT 682
+H D+ +N+LL A+ISDFGL+K L D+ + T + + APE +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 683 AKVDVYSFGILLLE 696
+K DV+SFG+L+ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 33/300 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLL 565
LGEGA G V K A+K + N + +++ E+ +V+
Sbjct: 7 SRLGEGAGGSVTK-CRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 566 G-FCNEGEHRL-LVYEYVSNGSLADFLFRKSR----RPNWYKRMQIAFGTARGLFYLHEE 619
G F +E + + EY GSL D +++K + R +IA +GL YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+IIH DIKP NILL ++ DFG++ L T T GT Y+APE +
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGK 178
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDAT------EECQMILADWAYDCFRERKLGLLV 733
P + DV+S G+ LLE+ R F + E I+ +
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----------NMPNPEL 228
Query: 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFISSI 793
+++ + IK E+F C+++DP+ RP + + + + A F++ +
Sbjct: 229 KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVAQV 286
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQE--------FKAEISAIGRT 556
E +G+G +G+VY + T E +AVK+ L + ++EI +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEM-MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GL 613
+H N+VQ LGF E+ + EYV GS+ L R ++ + F T + GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGL 121
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ---TQTTTAIRGTKGY 670
YLH I+H D+K N+L+D +ISDFG++K K+D +++G+ +
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFW 176
Query: 671 VAPEWFKN--LPITAKVDVYSFGILLLELVCCRK 702
+APE + +AKVD++S G ++LE+ R+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKA-EISAIGRTNHKNLVQLLG 566
LG+G++G VYK V + + A+K++ ++++ E+E EI + NH N++
Sbjct: 8 LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFR--KSRRP-----NWYKRMQIAFGTARGLFYLHEE 619
+G +V EY G L+ + + K R+ W +Q+ RGL LHE+
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALHEQ 122
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+I+H D+K NILL +I D G++K+LK + +T GT Y+APE +K
Sbjct: 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGR 176
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739
P + K D++S G LL E+ FE + + D Y R + + ++
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDLRYKVQRGKYPPIPPIYSQD- 228
Query: 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
++ F+ +Q P LRP K+
Sbjct: 229 ------LQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/215 (28%), Positives = 87/215 (40%), Gaps = 33/215 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVK---------KLYKAVNEGEQEFKAEISAIGRTNHK 559
+G G FGKVY V E +AVK K K + E+ + H
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEI-------ADEMKVLELLKHP 59
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
NLV+ G E + EY S G+L + L R + + GL YLH
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHS- 117
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT------QTTTAIRGTKGYVAP 673
I+H DIKP NI LD ++ DFG A LK + T Q+ GT Y+AP
Sbjct: 118 --HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA---GTPAYMAP 172
Query: 674 EWFKNLPITAK---VDVYSFGILLLELVCCRKNFE 705
E D++S G ++LE+ ++ +
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 52/291 (17%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLY-------KAVNEGEQEFK---AEISAIGRT 556
E LG GAFG VYK + +A+K++ K E ++ +E++ I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 557 -NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFL---------FRKSRRPNWYKRMQIA 606
H N+V+ E + +V + + L + F + R N + +M +A
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 607 FGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666
L YLH+E +I+H D+ P NI+L I+DFGLAK K +++ T+ + G
Sbjct: 126 ------LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-G 175
Query: 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE 726
T Y PE KN P K DV++FG +L ++ + F +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-------------------YST 216
Query: 727 RKLGL---LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774
L L +VE E + + E + C+ D RP + +V+ MI
Sbjct: 217 NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE--QEFKAEISAIGRTNHKNLV 562
+ +G G +G VYK + VA+K + + G+ + + EIS + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKAR-DIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 563 QLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHE 618
G +L +V EY GSL D +++ +R P +QIA+ T +GL YLHE
Sbjct: 64 AYFG-SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP--LSELQIAYVCRETLKGLAYLHE 119
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF-- 676
K IH DIK NILL + +++DFG++ L + + I GT ++APE
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAV 175
Query: 677 -KNLPITAKVDVYSFGILLLEL 697
+ K D+++ GI +EL
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 507 EELGEGAFGKVYKG--VLTTENEKPVAVKKL-YKAVNEGEQEFK-AEISAIGRTNHKNLV 562
++GEG +G VYK LT E VA+KK+ + +EG + EI + NH N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEI---VAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTARGLFYLHEECK 621
+LL LV+E++ L + + +R ++ + +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLP 680
I+H D+KP+N+L++ +++DFGLA+ + T + T+ Y APE +
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKG 175
Query: 681 ITAKVDVYSFGILLLELV 698
+ VD++S G + EL+
Sbjct: 176 YSTPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F +ELG G FG V G + VA+K + K + E EF E + + +H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYG--KWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
G C + +V EY+SNG L ++L +R + +++ G+ YL + Q
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
IH D+ +N L+D ++SDFGL++ + D+ ++ + + PE ++K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 685 VDVYSFGILLLEL 697
DV++FG+L+ E+
Sbjct: 182 SDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 29/208 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKA--------EISAIGRTNHK 559
+G G+FG VY G+ + E +AVK++ +V+ ++ K EI+ + H+
Sbjct: 8 IGSGSFGSVYLGMNASSGEL-MAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFL-----FRKSRRPNWYKRMQIAFGTARGLF 614
N+VQ LG + +H + EYV GS+A L F ++ N+ ++ +GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT-----AIRGTKG 669
YLH IIH DIK NIL+D +ISDFG++K L+ + T T +++G+
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLEL 697
++APE K T K D++S G L++E+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 37/269 (13%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE------QEFKAEISAIGRTNHKN 560
E LG G+FG VY+G L ++ AVK++ ++G+ ++ + EI+ + + H N
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLH 617
+VQ LG E ++ + E V GSLA L ++ + I T + GL YLH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
+ +H DIK NIL+D +++DFG+AK + + +G+ ++APE
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVIA 174
Query: 678 NL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736
D++S G +LE+ + + + + + A F+ + L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW-----SQLEGVAA-----VFKIGRSKELPPIP 224
Query: 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
+ D+ K F++ C+Q DPSLRP
Sbjct: 225 DHLSDEAK---DFILK---CLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 38/124 (30%), Positives = 54/124 (43%), Gaps = 13/124 (10%)
Query: 25 ISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNL 84
+S G +L +S + + G F + I + RT+VW ANRDN
Sbjct: 4 LSSGQTLVSSGS------LFELGFFKLIMQS----RDYNLILYKGSS-RTVVWVANRDNP 52
Query: 85 VQRGSKVELTGDGQLILRDSSGKEIWR--EPPSTGAAYAAMLDTGNLVLASQDSSTMWES 142
+ L DG L++ D SG +W G +LD GNLVL D + +W+S
Sbjct: 53 SGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQS 112
Query: 143 FDDP 146
FD P
Sbjct: 113 FDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 77/274 (28%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
E +G GA VY + NEK VA+K++ + E + E+ A+ + NH N+V+
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEK-VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEEC 620
G+ LV Y+S GSL D + + S IA +GL YLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD---QTQTTTAIRGTKGYVAPEWFK 677
+ IH DIK NILL + +I+DFG++ L + GT ++APE +
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 678 NLP-ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736
+ K D++SFGI +EL + + L L ++ND
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY----------------SKYPPMKVLMLTLQND 223
Query: 737 EEAMDDIKRVEKFV-----MIAIWCIQEDPSLRP 765
+++ +K+ MI++ C+Q+DPS RP
Sbjct: 224 PPSLETGADYKKYSKSFRKMISL-CLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 10/200 (5%)
Query: 506 KEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLV 562
+E +G G FG+V +G L + E VA+K L E + ++F +E S +G+ +H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
L G + +++ E++ NG+L FL + + + + + G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-TAIRGTK---GYVAPEWFKN 678
+H D+ +NIL++ ++SDFGL++ L+ D + T T+ G K + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 679 LPITAKVDVYSFGILLLELV 698
T+ DV+S+GI++ E++
Sbjct: 186 RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E +G+G+FG+VYK + N + VA+K L +A +E E + + EI + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTN-QVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKY 64
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECK 621
G +G ++ EY GS D L +P IAF GL YLHEE K
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
IH DIK NILL + +++DFG++ L + ++ T + GT ++APE K
Sbjct: 120 ---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGY 175
Query: 682 TAKVDVYSFGILLLEL 697
K D++S GI +EL
Sbjct: 176 DEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQLL 565
+G G FG+V G L ++ PVA+K L E ++ +F +E S +G+ +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G + + ++V EY+ NGSL FL + + + + + G A G+ YL + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKNLPIT 682
H D+ +NIL++ ++SDFGL+++L+ D T RG K + APE T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRKFT 187
Query: 683 AKVDVYSFGILLLELV 698
+ DV+S+GI++ E++
Sbjct: 188 SASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-20
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 41 SWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLI 100
+ +S + F GF + + I + RT+VW ANRDN V + L DG L+
Sbjct: 9 TLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLV 67
Query: 101 LRDSSGKEIWREPPS--TGAAYAAMLDTGNLVLASQDSSTMWESFD 144
L D G+ +W + G +LD GNLV+ D + +W+SFD
Sbjct: 68 LYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFD 113
|
Length = 114 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 67/211 (31%), Positives = 113/211 (53%), Gaps = 30/211 (14%)
Query: 508 ELGEGAFGKVY----KGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLV 562
ELG+G+FG VY KGV+ E E VA+K + +A + E+ EF E S + N ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR-----------PNWYKRMQIAFGTAR 611
+LLG ++G+ L++ E ++ G L +L +S R P+ K +Q+A A
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG-- 669
G+ YL+ ++ +H D+ +N ++ F +I DFG+ + D +T +G KG
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 670 ---YVAPEWFKNLPITAKVDVYSFGILLLEL 697
+++PE K+ T DV+SFG++L E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EIS---AIGRTNHK 559
E+GEGA+G VYK + VA+KK+ V E+ EI+ + H
Sbjct: 5 AEIGEGAYGTVYKARDLNTG-RFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 560 NLVQLLGFC--NEGEHRL---LVYEYVSNGSLADFLFRKSRR---PNWYKRM--QIAFGT 609
N+V+LL C + L LV+E+V LA +L + + P K + Q+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
RG+ +LH I+H D+KPQNIL+ +I+DFGLA++ + T+ + T
Sbjct: 118 -RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLW 171
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLEL 697
Y APE VD++S G + EL
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 56/287 (19%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNL 561
F +ELG G FG V+ G + +K KA+NEG E++F E + + +H L
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQ------IKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKL 61
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF--GTARGLFYLHEE 619
VQL G C + + +V E++ NG L ++L + R+ K M ++ G+ YL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLE-- 117
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
++ IH D+ +N L+ T ++SDFG+ + + D+ +++ + + PE F
Sbjct: 118 -RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739
++K DV+SFG+L+ E+ F E K+ +++ E
Sbjct: 177 KYSSKSDVWSFGVLMWEV--------------------------FTEGKMPFEKKSNYEV 210
Query: 740 MDDIKRVEKF------------VMIAIWCIQEDPSLRPAMKKVTQMI 774
++ I R + VM + W E P RP ++ + I
Sbjct: 211 VEMISRGFRLYRPKLASMTVYEVMYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 505 FKEELGEGAFGKVYK---GVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL 561
F ++LG+G FG V L + VAVKKL + E ++F+ EI + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 562 VQLLGFC-NEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
V+ G C + G L LV EY+ GSL D+L + R + K + A +G+ YL +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG--YVAPEWFK 677
+ +H D+ +NIL++ +I DFGL K+L D+ G + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 678 NLPITAKVDVYSFGILLLELVC-CRKN 703
+ DV+SFG++L EL K+
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 58/301 (19%)
Query: 509 LGEGAFGKVYKGVLTTENEKP----VAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQ 563
LGEG FGKV K + VAVK L + + E ++ +E + + + NH ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR--PNWYKR------------------- 602
L G C++ LL+ EY GSL FL R+SR+ P++
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 603 ---MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659
+ A+ +RG+ YL E +++H D+ +N+L+ +ISDFGL++ D +
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYE 179
Query: 660 TTTAIRGTKG-----YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM 714
+ ++ +KG ++A E + T + DV+SFG+LL E+V N E
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239
Query: 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774
L Y R EN E M ++ C +++P RP +++ +
Sbjct: 240 NLLKTGYRMERP-------ENCSEEMYNLMLT---------CWKQEPDKRPTFADISKEL 283
Query: 775 E 775
E
Sbjct: 284 E 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 45/277 (16%)
Query: 509 LGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGEQEFKA---EISAIGRTNHKNLV 562
LG G FG V+KG+ E + PVA+K + G Q F+ + A+G +H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRRP----NWYKRMQIAFGTARGLFYL 616
+LLG C G LV + GSL D + R S P NW +QIA +G++YL
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIA----KGMYYL 125
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-TAIRGTKGYVAPEW 675
E ++H ++ +NILL +I+DFG+A LL D + + + ++A E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735
T + DV+S+G+ + E+ M Y R ++ L+E
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEM----------------MSYGAEPYAGMRPHEVPDLLEK 226
Query: 736 DEE-AMDDIKRVEKF-VMIAIWCIQEDPSLRPAMKKV 770
E A I ++ + VM+ W I E+ +RP K++
Sbjct: 227 GERLAQPQICTIDVYMVMVKCWMIDEN--VRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 36/238 (15%)
Query: 505 FKEELGEGAFGKVY----KGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
K ELGEGAFGKV+ +L +++ VAVK L +A Q+F+ E + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY----------------KRMQ 604
+V+ G C EG L+V+EY+ +G L FL +S P+ + +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQ----TQ 659
IA A G+ YL +H D+ +N L+ +I DFG+++ + TD +
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN--FEVDATEECQMI 715
T IR ++ PE T + D++SFG++L E+ K +++ TE + I
Sbjct: 184 TMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF-KAEISAIGRTNHKNLVQLLGF 567
+GEG+FGK+Y +++E V + + E+E K E+ + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 568 CNEGEHRLLVYEYVSNGSLAD-------FLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
E +V EY G L LF + + +W+ +QI+ G L ++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKHIHDR- 120
Query: 621 KSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+I+H DIK QNI L A++ DFG+A+ L D + GT Y++PE +N
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEICQNR 177
Query: 680 PITAKVDVYSFGILLLELVCCRKNFE 705
P K D++S G +L EL + FE
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 92/299 (30%), Positives = 129/299 (43%), Gaps = 44/299 (14%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF-----KAEISAIGRTNHKNLVQ 563
LG+G+FGKV L +E AVK L K V + + + + A+ H L Q
Sbjct: 3 LGKGSFGKVLLAELKGTDEL-YAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEEC 620
L + V EYV+ G L F ++S R + + F A GL +LHE
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLM-FHIQRSGR---FDEPRARFYAAEIVLGLQFLHER- 115
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
II+ D+K N+LLD + +I+DFG+ K TT+ GT Y+APE P
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQP 172
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEEC-QMILAD------W----AYDCFR---- 725
VD ++ G+LL E++ + FE D +E Q IL D W A +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232
Query: 726 ---ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781
E++LG L DIK F I W E ++P K I+G DVS
Sbjct: 233 KNPEKRLGCL----PTGEQDIKGHPFFREID-WDKLERKEIKPPFKP---KIKGRFDVS 283
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 510 GEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGE-QEFKAEISAIGRTNHKNLVQL-L 565
G+GAFGKV V + +K A+K + K V +G + E + NH LV L
Sbjct: 9 GKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKS 622
F +E E+ LV + + G L L +K + + Q+ F L YLH +
Sbjct: 68 SFQDE-ENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYLHSK--- 119
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
IIH DIKP NILLD + I+DF +A + D T+T+ GT GY+APE +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGYS 177
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQMILA 717
VD +S G+ E + ++ + + I A
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 59/294 (20%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK-PVAVKKLYK-AVNEGEQEFKAEISAIGRTN-HKNL 561
F++ +GEG FG+V K + + + A+K++ + A + ++F E+ + + H N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT------------ 609
+ LLG C + L EY +G+L DFL RKSR IA T
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 610 ----ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
ARG+ YL ++ Q IH D+ +NIL+ + A+I+DFGL++ ++
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVK 179
Query: 666 GTKGYVAPEWFK----NLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720
T G + W N + T DV+S+G+LL E+V + T C M A
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV------SLGGTPYCGMTCA--- 230
Query: 721 YDCFRERKLGLLVEN----DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ + + G +E D+E D +++ C +E P RP+ ++
Sbjct: 231 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQ----------CWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 73/199 (36%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
++LG G FG+V+ G T VAVK L K + F E + + H LVQL
Sbjct: 12 KKLGNGQFGEVWMG--TWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLF----RKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
+E E +V EY+S GSL DFL R + PN + +A A G+ Y+ +
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL---VDMAAQVAAGMAYIE---RM 121
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKNL 679
IH D++ NIL+ +I+DFGLA+L++ ++ TA +G K + APE
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYG 178
Query: 680 PITAKVDVYSFGILLLELV 698
T K DV+SFGILL ELV
Sbjct: 179 RFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 78/298 (26%), Positives = 145/298 (48%), Gaps = 48/298 (16%)
Query: 508 ELGEGAFGKVYKGV----LTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLV 562
ELG+G+FG VY+G + E E VAVK + ++ + E+ EF E S + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-----------WYKRMQIAFGTAR 611
+LLG ++G+ L+V E +++G L +L +S RP + +Q+A A
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG-- 669
G+ YL+ + + +H D+ +N ++ F +I DFG+ + D +T +G KG
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 670 ---YVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFR 725
++APE K+ T D++SFG++L E+ + ++ + E+ + D Y
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---L 240
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIP 783
++ +N E + D+ R+ C Q +P +RP ++ +++ + S P
Sbjct: 241 DQP-----DNCPERVTDLMRM---------CWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPV--AVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
+G+G FG VY G L + + + AVK L + + E ++F E + +H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 566 GFC--NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
G C +EG L+V Y+ +G L +F+ ++ P + A+G+ YL + +
Sbjct: 63 GICLPSEGS-PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLL---KTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+H D+ +N +LD +F +++DFGLA+ + + T + ++A E +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 681 ITAKVDVYSFGILLLELV 698
T K DV+SFG+LL EL+
Sbjct: 179 FTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-----QEFKAEISAIGRTNHKNLVQ 563
LG+GAFG+VY + + +AVK++ + E + EI + H+ +VQ
Sbjct: 10 LGQGAFGRVYLCY-DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFL----------FRKSRRPNWYKRMQIAFGTARGL 613
G + E + EY+ GS+ D L RK Y R QI G+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK------YTR-QIL----EGV 117
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TAIRGTKGYV 671
YLH + I+H DIK NIL D N ++ DFG +K L+T + T ++ GT ++
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 672 APEWFKNLPITAKVDVYSFGILLLELV 698
+PE K DV+S G ++E++
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 86/284 (30%), Positives = 133/284 (46%), Gaps = 36/284 (12%)
Query: 505 FKEELGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGEQE-FKAEI---SAIGRT 556
F + LG GAFGKV + G+ ++ VAVK L + E+E +E+ S +G
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-- 96
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR-PNWYKRMQIAFGTARGLFY 615
NH+N+V LLG C G L++ EY G L +FL RK + ++ A+G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK----GYV 671
L K+ IH D+ +N+LL +I DFGLA+ + D + ++G ++
Sbjct: 157 L--ASKN-CIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWM 210
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
APE N T + DV+S+GILL E+ F + + M + Y +E G
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEI------FSLGSNPYPGMPVDSKFYKLIKE---GY 261
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ E A +I +M W DP RP K++ Q+I
Sbjct: 262 RMAQPEHAPAEIYD----IMKTCW--DADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 14/197 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA---EISAIGRTNHKNLVQ 563
+GEGA+G V K E VA+KK +K + E K E+ + + H+N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEI-VAIKK-FKESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
L LV+EYV +L + L P+ + + + + Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---S 118
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF-KNLP 680
IIH DIKP+NIL+ + ++ DFG A+ L+ T T+ Y APE +
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 681 ITAKVDVYSFGILLLEL 697
VDV++ G ++ EL
Sbjct: 179 YGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQE-----FKAEISAIGRTNHKN 560
++LG GAF Y + +AVK++ Y EQE + EI + R NH +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFL-----FRKSRRPNWYKRMQIAFGTARGLFY 615
++++LG E H L E+++ GS++ L F+++ N+ +++ RGL Y
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSY 118
Query: 616 LHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQTQT---TTAIRGTKGYV 671
LHE +QIIH D+K N+L+D T RI+DFG A L T + GT ++
Sbjct: 119 LHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVC 699
APE + DV+S G +++E+
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 51/291 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISAIGRT-NHKNL 561
F++ +GEG FG+V + ++ + K A K+ K A ++F E+ + + +H N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSR----RPNWYKR------------MQI 605
+ LLG C + + EY G+L DFL RKSR P + K +Q
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
A A G+ YL E+ Q IH D+ +N+L+ ++I+DFGL++ ++
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVK 174
Query: 666 GTKGYVAPEWFK----NLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720
T G + W N + T K DV+SFG+LL E+V + T C M A
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV------SLGGTPYCGMTCA--- 225
Query: 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771
+ + + G +E D++ + + C ++ P RP +++
Sbjct: 226 -ELYEKLPQGYRMEKPRNCDDEVYELMR------QCWRDRPYERPPFAQIS 269
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
++LG G FG+V+ G N VAVK L K Q F E + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYY--NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 567 FCNEGEHRLLVYEYVSNGSLADFL-FRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ E ++ EY++ GSL DFL + + K + + A G+ Y+ + I
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKNLPIT 682
H D++ N+L+ + +I+DFGLA++++ ++ TA G K + APE T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 182
Query: 683 AKVDVYSFGILLLELV 698
K DV+SFGILL E+V
Sbjct: 183 IKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQE--FKAEISAIGRTNHKNLVQLL 565
LG G FG+V V + A+K + K + E Q+ +E + NH +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ ++ ++ EY G L L + + R IA YLH II
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV-LAFEYLHNR---GII 115
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
+ D+KP+N+LLD ++ DFG AK LK+ Q +T T GT YVAPE N V
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFSV 173
Query: 686 DVYSFGILLLELVCCRKNFEVDATEECQMI 715
D +S GILL EL+ R F D +E M
Sbjct: 174 DYWSLGILLYELLTGRPPFGED--DEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 508 ELGEGAFGKVYKGVLTTENEKP---VAVKKLYKAVNEGEQ--EFKAEISAIGRTNHKNLV 562
+LGEG FGKV E + VAVK L K + G + K EI + H+N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 563 QLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ G C E L+ E++ +GSL ++L R + N ++++ A +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA--IRGTKGYVAPEWFKN 678
Q +H D+ +N+L++ +I DFGL K ++TD+ T + + APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 679 LPITAKVDVYSFGILLLELV 698
DV+SFG+ L EL+
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 67/227 (29%), Positives = 112/227 (49%), Gaps = 34/227 (14%)
Query: 497 ELEVITGGFKEELGEGAFGKVYKGVL---TTENEKPVAVKKLYKAVNEGEQ--EFKAEIS 551
EL + F EELGE AFGK+YKG L ++ + VA+K L K +N +Q EF+ E S
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEAS 59
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN------------- 598
+ +H N+V LLG + + +++EY++ G L +FL +S +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 599 ---WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655
+ IA A G+ YL +H D+ +NIL+ + +ISD GL++ + +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 656 D-----QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
Q ++ IR ++ PE ++ D++SFG++L E+
Sbjct: 177 ADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 44/224 (19%)
Query: 508 ELGEGAFGKVYK----GVLTTENEKPVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNLV 562
++G+GAFG+V++ G+L E VAVK L + A + + +F+ E + + +H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY---------------------- 600
+LLG C G+ L++EY++ G L +FL + R P
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFL--RHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 601 -KRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL------AKLL 653
+++ IA A G+ YL E + +H D+ +N L+ +I+DFGL A
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
K + IR ++ PE T + DV+++G++L E+
Sbjct: 187 KASEND-AIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL--YKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
+G GAFG V+ ++K V +K++ + + + E + +H N+++
Sbjct: 8 VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626
E + ++V EY G+LA+++ + R + I + L LH I+H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 627 CDIKPQNILLDGTFNA-RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
D+K QNILLD +I DFG++K+L + T + GT Y++PE + P K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKS 182
Query: 686 DVYSFGILLLELVCCRKNFE 705
D+++ G +L EL ++ FE
Sbjct: 183 DIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 33/271 (12%)
Query: 509 LGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQL 564
LG GAFG VYKG+ E E PVA+K L + + EF E + +H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
LG C +L V + + +G L D++ + A+G+ YL E ++
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RL 130
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK---GYVAPEWFKNLPI 681
+H D+ +N+L+ + +I+DFGLA+LL+ D+ + G K ++A E
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALECIHYRKF 188
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE-AM 740
T + DV+S+G+ + EL M YD R++ L+E E
Sbjct: 189 THQSDVWSYGVTIWEL----------------MTFGGKPYDGIPTREIPDLLEKGERLPQ 232
Query: 741 DDIKRVEKF-VMIAIWCIQEDPSLRPAMKKV 770
I ++ + VM+ W I D RP K++
Sbjct: 233 PPICTIDVYMVMVKCWMIDADS--RPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 507 EELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQ 563
++LG+G+FG V +G +T K PVAVK L ++ +F E + + +H+NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 564 LLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPN------WYKRMQIAFGTARGLFYL 616
L G H L +V E GSL D L RK + +QIA G YL
Sbjct: 61 LYGVVLT--HPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMR----YL 113
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQTTTAIRGTK-GYVAPE 674
+ IH D+ +NILL +I DFGL + L + + + APE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 675 WFKNLPITAKVDVYSFGILLLEL 697
+ + DV+ FG+ L E+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 35/272 (12%)
Query: 509 LGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQL 564
LG GAFG VYKG+ E EK PVA+K+L +A + + +E E + ++ ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
LG C +L + + + G L D++ + A+G+ YL E ++
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RL 130
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI--- 681
+H D+ +N+L+ + +I+DFGLAKLL D+ G V +W I
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADE----KEYHAEGGKVPIKWMALESILHR 186
Query: 682 --TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE- 738
T + DV+S+G+ + EL M YD ++ ++E E
Sbjct: 187 IYTHQSDVWSYGVTVWEL----------------MTFGSKPYDGIPASEISSILEKGERL 230
Query: 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
I ++ + MI + C D RP +++
Sbjct: 231 PQPPICTIDVY-MIMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 58/192 (30%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLL 565
E LG+G FG+V+KG L +++ PVAVK + + E + +F +E + + +H N+V+L+
Sbjct: 1 ELLGKGNFGEVFKGTL--KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G C + + +V E V G FL +K + ++ A A G+ YL + I
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK-GYVAPEWFKNLPITAK 684
H D+ +N L+ +ISDFG+++ + D +++ ++ + APE +++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 685 VDVYSFGILLLE 696
DV+S+GILL E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVK--KLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E +G+G+FG+VYKG+ ++ VA+K L +A +E E + + EI+ + + + + +
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRY 67
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECK 621
G +G ++ EY+ GS D L +P + IA +GL YLH E K
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
IH DIK N+LL + +++DFG+A L Q + T + GT ++APE K
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741
K D++S GI +EL D R L L+ +N ++
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNS----------------DLHPMRVLFLIPKNSPPTLE 222
Query: 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ + F C+ +DP RP K++
Sbjct: 223 G-QYSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 72/285 (25%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 502 TGGFKEE--LGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVN-EGEQEFKAEISAIGRT 556
G FK E +G+G F VYK + + + VA+KK +++ ++ + Q+ EI + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG-RVVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRRP-----NWYKRMQIAFGT 609
+H N+++ L E +V E G L+ + F+K +R W +Q+
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC--- 116
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
L ++H + +I+H DIKP N+ + T ++ D GL + + +T ++ GT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPY 171
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
Y++PE K D++S G LL E+ + F D +M L Y ++
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNL----YSLCKK--- 219
Query: 730 GLLVENDEEA--MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+E + D E +++ CI DP RP + V Q
Sbjct: 220 ---IEKCDYPPLPADHYSEELRDLVSR-CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 509 LGEGAFGKV----YKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+G+G FG V Y+G VAVK + + Q F AE S + + H NLVQL
Sbjct: 14 IGKGEFGDVMLGDYRG-------NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 64
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRM-QIAFGTARGLFYLHEECKS 622
LG E + L +V EY++ GSL D+L + R + + + + YL +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---AN 121
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+H D+ +N+L+ A++SDFGL K + Q ++ T APE + +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 177
Query: 683 AKVDVYSFGILLLEL 697
K DV+SFGILL E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLV 562
LGEG FGKV N+ + VAVK L + + +K EI+ + H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 563 QLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ G C+E + L+ EYV GSL D+L + N + + A G+ YLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL--NLAQLLLFAQQICEGMAYLHSQ- 126
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG--YVAPEWFKN 678
IH D+ +N+LLD +I DFGLAK + G + A E K
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 679 LPITAKVDVYSFGILLLELV 698
+ DV+SFG+ L EL+
Sbjct: 185 NKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
E +G+G+FG+V+KG+ ++ VA+K + E E ++ + EI+ + + + + +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKS 622
G +G ++ EY+ GS D L R + QIA +GL YLH E K
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK- 122
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
IH DIK N+LL + +++DFG+A L Q + T + GT ++APE +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYD 179
Query: 683 AKVDVYSFGILLLEL 697
+K D++S GI +EL
Sbjct: 180 SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 505 FKEELGEGAFGKVYKGV---LTTENEKP-VAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
K ELGEGAFGKV+ L E +K VAVK L A + ++F E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN--------------WYKRMQIA 606
+V+ G C EG+ ++V+EY+ +G L FL ++ P+ + + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 607 FGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQ----TT 661
A G+ YL + +H D+ +N L+ +I DFG+++ + TD + T
Sbjct: 127 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
IR ++ PE T + DV+S G++L E+
Sbjct: 184 LPIR----WMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 70/239 (29%), Positives = 108/239 (45%), Gaps = 29/239 (12%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
+LG+G FG+V+ G T VA+K L K + F E + + H+ LVQL
Sbjct: 13 KLGQGCFGEVWMG--TWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGTARGLFYLHEECKSQI 624
+E E +V EY+S GSL DFL K + + Q+ A A G+ Y+ +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D++ NIL+ +++DFGLA+L++ ++ + + APE T K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 685 VDVYSFGILLLELVC-----------------CRKNFEVDATEECQMILADWAYDCFRE 726
DV+SFGILL EL + + + EC L D C+R+
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 242
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 38/291 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQL 564
LG GAFG VYKG+ + E PVA+K L + + + +E E + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
LG C +L V + + G L D++ R + A+G+ YL E ++
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI--- 681
+H D+ +N+L+ + +I+DFGLA+LL D+T+ G V +W I
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE----YHADGGKVPIKWMALESILHR 186
Query: 682 --TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739
T + DV+S+G+ + EL M YD R++ L+E E
Sbjct: 187 RFTHQSDVWSYGVTVWEL----------------MTFGAKPYDGIPAREIPDLLEKGERL 230
Query: 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASFI 790
MI + C D RP +++ + DP+ F+
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS-----RMARDPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 67/238 (28%), Positives = 107/238 (44%), Gaps = 24/238 (10%)
Query: 468 FHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE 527
+K ++ + K +M +DF F LG G+FG+V E+
Sbjct: 7 LQLHKKKDSDSTKEPKRKNKMKYEDFN----------FIRTLGTGSFGRVILATYKNEDF 56
Query: 528 KPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584
PVA+K+ K+ +++ +E + NH V L G + + LV E+V G
Sbjct: 57 PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116
Query: 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS-QIIHCDIKPQNILLDGTFNAR 643
FL R R PN + A + + E +S I++ D+KP+N+LLD +
Sbjct: 117 EFFTFLRRNKRFPN-----DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171
Query: 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE-LVCC 700
++DFG AK++ T T + GT Y+APE N+ D ++ GI + E LV C
Sbjct: 172 MTDFGFAKVVDT----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225
|
Length = 340 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL--YKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+++GEG+FGK V + E+ K +K++ K + +E + E++ + H N+VQ
Sbjct: 6 KKIGEGSFGKAIL-VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 565 LGFCNEGEHRLLVYEYVSNGSL-------ADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
E + +V +Y G L LF + + +W+ +QI L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLA----LKHVH 118
Query: 618 EECKSQIIHCDIKPQNILL--DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
+ +I+H DIK QNI L DGT ++ DFG+A++L + T I GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTI--KLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFE 705
+N P K D+++ G +L E+ + FE
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 40/224 (17%)
Query: 493 FTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEIS 551
FT ++L+ E+G GAFG V K +L + +AVK++ V+E EQ ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 552 AIGRTNH-KNLVQLLG--FCNEGEHRL----------LVYEYVSNGSLADFLFRKSRRPN 598
+ R++ +V+ G F EG+ + Y+YV + KS P
Sbjct: 55 VVMRSSDCPYIVKFYGALF-REGDCWICMELMDISLDKFYKYV-------YEVLKSVIP- 105
Query: 599 WYKRM--QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656
+ + +IA T + L YL EE K IIH D+KP NILLD N ++ DFG++ L
Sbjct: 106 --EEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 657 QTQTTTAIRGTKGYVAPEW---FKNLPITAKVDVYSFGILLLEL 697
+T A G + Y+APE + DV+S GI L E+
Sbjct: 162 IAKTRDA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/192 (29%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLL 565
E +G G FG+V+ G L +N PVAVK + + + + +F E + + +H N+V+L+
Sbjct: 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G C + + +V E V G FL + R + +Q+ A G+ YL + I
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK-GYVAPEWFKNLPITAK 684
H D+ +N L+ +ISDFG+++ + +T ++ + APE +++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 685 VDVYSFGILLLE 696
DV+SFGILL E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 67/238 (28%), Positives = 113/238 (47%), Gaps = 39/238 (16%)
Query: 505 FKEELGEGAFGKVY----KGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
K ELGEGAFGKV+ + T+++ VAVK L ++F+ E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-----------------WYKRM 603
+V+ G C +G+ ++V+EY+ +G L FL ++ P+ + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQ--- 659
IA A G+ YL + +H D+ +N L+ +I DFG+++ + TD +
Sbjct: 127 HIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 660 -TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN--FEVDATE--EC 712
T IR ++ PE T + DV+SFG++L E+ K F++ TE EC
Sbjct: 184 HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 509 LGEGAFGK--VYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
LG+GAFG+ +Y+ TE++ V K+ L + + ++ EI + H N++
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLHEECK 621
+ L+ EY + G+L D + R ++ ++ + F + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
I+H DIK NI L ++ DFG++K+L ++ + T + GT Y++PE + +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVD 707
K D+++ G +L EL+ ++ F+
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 35/272 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
E++G+G+FG+V+KG+ +K VA+K + E E ++ + EI+ + + + + +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKS 622
G + ++ EY+ GS D L P QIA +GL YLH E K
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
IH DIK N+LL +++DFG+A L Q + T + GT ++APE K
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742
+K D++S GI +EL E +E M + L L+ +N+ ++
Sbjct: 180 SKADIWSLGITAIELA----KGEPPHSELHPM------------KVLFLIPKNNPPTLEG 223
Query: 743 --IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
K +++FV C+ ++PS RP K++ +
Sbjct: 224 NYSKPLKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-17
Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 31/187 (16%)
Query: 530 VAVKKLYKAVNEGEQE---FKAEISAIGRTNHKNLVQLLGFCNEGEHRLL-VYEYVSNGS 585
VA+K L E E + F+ E + R H N+V LL L V+EYV +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 586 LADFLFRKSRRPNWYKRMQIAFGTAR-------GLFYLHEECKSQIIHCDIKPQNILL-- 636
L + L P A T R L H I+H D+KPQNI++
Sbjct: 66 LREVLAADGALP--------AGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 637 -DGTFNARISDFGLAKLL----KTDQTQTT--TAIRGTKGYVAPEWFKNLPITAKVDVYS 689
+A++ DFG+ LL D T T + GT Y APE + P+T D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 690 FGILLLE 696
+G++ LE
Sbjct: 175 WGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 88/297 (29%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 482 QKGMP-EMNLQDFTYKE--LEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLY-- 536
+KG+ + + D YK+ E+ G E+G G+FG VY + NE VAVKK+
Sbjct: 1 RKGVVKDPEIADLFYKDDPEEIFVG--LHEIGHGSFGAVYFATNSHTNEV-VAVKKMSYS 57
Query: 537 -KAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKS 594
K NE Q+ E+ + + H N ++ G C EH LV EY GS +D L
Sbjct: 58 GKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG-CYLKEHTAWLVMEYCL-GSASDLLEVHK 115
Query: 595 RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK 654
+ + I G +GL YLH IH DIK NILL +++DFG A
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASK-- 170
Query: 655 TDQTQTTTAIRGTKGYVAPEWFKNL---PITAKVDVYSFGILLLELVCCRKN--FEVDAT 709
+ + GT ++APE + KVDV+S GI +EL RK F ++A
Sbjct: 171 ---SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAM 226
Query: 710 EECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA 766
I +ND + + + F +C+Q+ P RPA
Sbjct: 227 SALYHI-----------------AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 509 LGEGAFGKVYKGVLT--TENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLVQLL 565
LG G FG++ +G L ++ E PVA+ L ++ ++ F AE +G+ +H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G G ++V EY+SNG+L FL + + + M + G A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYV 129
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
H + +L++ +IS F + K++ TT + + + APE + ++
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 686 DVYSFGILLLELV 698
DV+SFGI++ E++
Sbjct: 190 DVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 67/200 (33%), Positives = 96/200 (48%), Gaps = 24/200 (12%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLY---KAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E+G G+FG VY + VA+KK+ K NE Q+ E+ + + H N ++
Sbjct: 22 EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLHEEC 620
G C EH LV EY GS +D L ++P + ++IA G +GL YLH
Sbjct: 81 KG-CYLREHTAWLVMEYCL-GSASDIL-EVHKKP--LQEVEIAAICHGALQGLAYLHSHE 135
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL- 679
+ IH DIK NILL +++DFG A L+ + GT ++APE +
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMD 187
Query: 680 --PITAKVDVYSFGILLLEL 697
KVDV+S GI +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 35/285 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKP-VAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQL 564
+E+G G FGKV G K V VK+L + EQ F E+ NH N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSR-------RPNWYKRMQIAFGTARGLFYLH 617
LG C E LLV E+ G L ++L R +R + + +RM A A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH 117
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVAPEW- 675
++ IH D+ +N L + +I D+GLA + D T ++APE
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 676 ------FKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
T K +++S G+ + EL F + RE+ +
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774
L + D + E VM W DP RP ++V +++
Sbjct: 229 KLPKPQLDLKYSD-RWYE--VMQFCWL---DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 505 FKEELGEGAFGKV----------YKGVLTTE-NEKP--VAVKKLYKAVNE-GEQEFKAEI 550
KE+LGEG FG+V + G E + +P VAVK L V + +F EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA 610
+ R + N+++LLG C + ++ EY+ NG L FL ++ + I +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 611 RGLFYLHEECKS--------QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD-----Q 657
L Y+ + S +H D+ +N L+ + +I+DFG+++ L + Q
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
+ IR ++A E T DV++FG+ L E+
Sbjct: 189 GRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL---YKAVNEGEQ--EFKAEISAIGRTNHKNL 561
++LG+G FG VY E VA+KK+ + + E E K+ + + H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGEL-VAIKKMKKKFYSWEECMNLREVKS-LRKL--NEHPNI 60
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTARGLFYLHEEC 620
V+L E + V+EY+ G+L + + +P ++ I + +GL ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF-KNL 679
K H D+KP+N+L+ G +I+DFGLA+ + T T+ Y APE ++
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 680 PITAKVDVYSFGILLLELVCCRKNF----EVD 707
++ VD+++ G ++ EL R F E+D
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLLG 566
ELG+GAFGKVYK + +A K+ + +E E +++ EI + NH +V+LLG
Sbjct: 19 ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 567 -FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
F +G+ +++ E+ G++ + R + I L YLH +II
Sbjct: 77 AFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KII 132
Query: 626 HCDIKPQNILLDGTFNARISDFGL-AKLLKTDQTQTTTAIRGTKGYVAP-----EWFKNL 679
H D+K N+LL + +++DFG+ AK +KT Q + GT ++AP E K+
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 680 PITAKVDVYSFGILLLEL 697
P K D++S GI L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 509 LGEGAFGKVYKG-VLTTENEKP-----VAVKKLYKAVNEGE-QEFKAEISA---IGRTNH 558
LGEG FG+V L + +KP VAVK L E + + +E+ IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-----------------NWYK 601
KN++ LLG C + ++ EY S G+L ++L ++RRP +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT-DQTQT 660
+ + ARG+ YL + + IH D+ +N+L+ +I+DFGLA+ + D +
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
TT R ++APE + T + DV+SFG+L+ E+
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 51/286 (17%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISAIGRT-NHKNLVQLL 565
+GEG FG+V K + + + A K K A + ++F E+ + + +H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSR----RPNWYKR------------MQIAFGT 609
G C + L EY +G+L DFL RKSR P + + A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
ARG+ YL ++ Q IH D+ +NIL+ + A+I+DFGL++ ++ T G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMG 171
Query: 670 YVAPEWFK----NLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCF 724
+ W N + T DV+S+G+LL E+V + T C M A + +
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV------SLGGTPYCGMTCA----ELY 221
Query: 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ G +E D++ + + C +E P RP+ ++
Sbjct: 222 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 35/217 (16%)
Query: 509 LGEGAFGKVYKG-VLTTENEKP-----VAVKKLYKAVNEGE-QEFKAEISA---IGRTNH 558
LGEG FG+V + + EKP VAVK L E + + +E+ IG+ H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--H 83
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-----------------NWYK 601
KN++ LLG C + ++ EY S G+L ++L ++RRP ++
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQT 660
+ A+ ARG+ YL + IH D+ +N+L+ +I+DFGLA+ + D +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
TT R ++APE + T + DV+SFG+LL E+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG+G FG+V K A KKL K +GEQ E + + + + +V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFY---------- 615
+ LV ++ G L + + Y + F AR +FY
Sbjct: 60 YAFETKDDLCLVMTLMNGGDL---------KYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
LH+ +I++ D+KP+N+LLD N RISD GLA LK + GT GY+APE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRAGTPGYMAPEV 165
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNF-----EVDATEECQMILAD 718
+ VD ++ G L E++ R F +V+ E + L
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF----KAEISAIGRTNHKNLV 562
++GEG +G+VYK + + VA+KK+ + NE ++ F EI + + H N+V
Sbjct: 5 AQIGEGTYGQVYKA-RNKKTGELVALKKI-RMENE-KEGFPITAIREIKLLQKLRHPNIV 61
Query: 563 QLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRR---PN---WYKRMQIAFGTARGLF 614
+L +V+EY+ + L L + + K++ GL
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL------LEGLQ 114
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YLH + I+H DIK NIL++ +++DFGLA+ + T T Y PE
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 675 WFKNLPI-----TAKVDVYSFGILLLEL 697
L + +VD++S G +L EL
Sbjct: 172 ----LLLGATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 70/221 (31%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG+G FG+V V K A KKL K GE+ E + + N +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKS 622
H LV ++ G L ++ R +R + +A+ G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER--VIHYSAQITCGILHLHS---M 114
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
I++ D+KP+N+LLD N R+SD GLA LK +T T A GT GY+APE K P +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172
Query: 683 AKVDVYSFGILLLELVCCRKNF-----EVDATEECQMILAD 718
VD ++ G + E+V R F +V E + L D
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 35/217 (16%)
Query: 509 LGEGAFGKVYKG-VLTTENEKP-----VAVKKLYK-AVNEGEQEFKAEISA---IGRTNH 558
LGEG FG+V + + +KP VAVK L A ++ + +E+ IG+ H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-----------------NWYK 601
KN++ LLG C + ++ EY S G+L ++L ++RRP +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYL--RARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQTQT 660
+ A+ ARG+ YL + + IH D+ +N+L+ +I+DFGLA+ + D +
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
TT R ++APE + T + DV+SFG+LL E+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL- 565
ELG+GAFGKVYK + +A K+ +E E +++ EI + +H N+V+LL
Sbjct: 12 ELGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFG-TARGLFYLHEECKSQI 624
F E +L+ E+ + G++ D + + RP ++++ T L YLHE ++I
Sbjct: 70 AFYYENNLWILI-EFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKI 124
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF-----KNL 679
IH D+K NIL + +++DFG++ T Q + GT ++APE K+
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 680 PITAKVDVYSFGILLLEL 697
P K DV+S GI L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 22/231 (9%)
Query: 485 MPEMNLQDFT--YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG 542
+ +L + K E++ K +L +G FGKV VL + + + V+K+ KA N
Sbjct: 1 NMDKSLSELVQFLKNCEIVK---KLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFN 55
Query: 543 EQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR 602
E + + + ++ N ++L + +L+ +Y+ +G L D L +K + + +
Sbjct: 56 AIEPM--VHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEV 111
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI--SDFGLAKLLKTDQTQT 660
+I L LH K IIH DIK +N+L D RI D+GL K++ T
Sbjct: 112 KKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKIIGTPSCY- 166
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
GT Y +PE K D ++ G+L EL+ + F+ D EE
Sbjct: 167 ----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI-GRTNHKNLVQLL 565
E +G+G +GKVYK +T + + +A K+ +++ ++E +AE + + NH N+V+
Sbjct: 28 ETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 566 GFCNEGEHRL-----LVYEYVSNGSLADF---LFRKSRRPNWYKRMQIAFGTARGLFYLH 617
G + + + LV E + GS+ + L +R + I +G GL +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
++IIH D+K NILL ++ DFG++ L + + + T++ GT ++APE
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201
Query: 678 -----NLPITAKVDVYSFGILLLEL 697
+ A+ DV+S GI +EL
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 65/194 (33%), Positives = 95/194 (48%), Gaps = 12/194 (6%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
+LG+G FG+V+ G T VA+K L K + F E + + H LV L
Sbjct: 13 KLGQGCFGEVWMG--TWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGTARGLFYLHEECKSQI 624
+E E +V E++ GSL DFL K + K Q+ A A G+ Y+ +
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
IH D++ NIL+ +I+DFGLA+L++ ++ + + APE T K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 685 VDVYSFGILLLELV 698
DV+SFGILL ELV
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 507 EELGEGAFGKVYKGV-LTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
E++G+GA G VY + + T E VA+K++ ++ EI + H N+V L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQE--VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKS 622
G+ +V EY++ GSL D + QIA + L +LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS---N 134
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
Q+IH DIK NILL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 683 AKVDVYSFGILLLELV 698
KVD++S GI+ +E+V
Sbjct: 194 PKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-16
Identities = 71/217 (32%), Positives = 111/217 (51%), Gaps = 15/217 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-----EISAIGRTNHKNLVQ 563
LG+G+FGKV L E+ + AVK L K V + + + I ++ R NH L Q
Sbjct: 3 LGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 564 LLGFCNEGEHRLL-VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
L C + RL V E+V+ G L F +KSRR + + A L +LH++
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEITSALMFLHDK--- 115
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
II+ D+K N+LLD + +++DFG+ K +TT+ GT Y+APE + +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEEC-QMILAD 718
VD ++ G+LL E++C FE + ++ + IL D
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 39/219 (17%)
Query: 509 LGEGAFGKVYK----GVLTTENEKP--VAVKKLYKAVNEGEQEFKAEIS------AIGRT 556
LGEG FG+V + G+ + ++ VAVK L N +++ IS IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD--NATDKDLADLISEMELMKLIGK- 76
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-----------------NW 599
HKN++ LLG C + ++ EY + G+L +FL ++RRP ++
Sbjct: 77 -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL--RARRPPGPDYTFDITKVPEEQLSF 133
Query: 600 YKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTDQT 658
+ A+ ARG+ YL + IH D+ +N+L+ +I+DFGLA+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
+ T+ R ++APE + T + DV+SFGIL+ E+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 508 ELGEGAFGKVYKGVLTTENEK-PVAVKKLYKAVNEG--EQEFKAEISAIGRTNHKNLVQL 564
ELG G FG V KGV ++ VA+K L K NE E E + + ++ +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+G C E E +LV E S G L FL K +++ + G+ YL +
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGT---KGYVAPEWFKNLPI 681
+H D+ +N+LL A+ISDFGL+K L D + G K Y APE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY-APECINFRKF 175
Query: 682 TAKVDVYSFGILLLE 696
+++ DV+S+GI + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 83/312 (26%), Positives = 134/312 (42%), Gaps = 47/312 (15%)
Query: 497 ELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGR 555
+LEVI EELG GA+G V K + +AVK++ VN EQ+ ++ R
Sbjct: 2 DLEVI-----EELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR 55
Query: 556 TNH-KNLVQLLG-FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAF 607
+ V G EG+ + + V + SL F ++K + +IA
Sbjct: 56 SVDCPYTVTFYGALFREGD--VWICMEVMDTSLDKF-YKKVYDKG--LTIPEDILGKIAV 110
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGT 667
+ L YLH + +IH D+KP N+L++ ++ DFG++ L +T A G
Sbjct: 111 SIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GC 166
Query: 668 KGYVAPEWF----KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDC 723
K Y+APE K DV+S GI ++EL AT + YD
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIEL----------AT-------GRFPYDS 209
Query: 724 FRE--RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781
++ ++L +VE + K +F C++++ RP ++ Q + +S
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269
Query: 782 IPPDPASFISSI 793
D ASF+S I
Sbjct: 270 KNTDVASFVSLI 281
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR------TNHKNLV 562
LG+G+FGKV L NE A+K L K V + + E + + R H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEF-FAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLT 59
Query: 563 QLLGFCN--EGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
L FC EH V EY++ G L F + S R + + A GL +LH
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLM-FHIQSSGRFDEARARFYAAEIICGLQFLH--- 113
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
K II+ D+K N+LLD + +I+DFG+ K + + +T GT Y+APE K
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQK 172
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
VD +SFG+LL E++ + F + +E
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENE----KPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNL 561
E LG+GA+G VY G LT + + K V + E E ++ + E+ + H N+
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNW----YKRMQIAFGTARGLFYLH 617
VQ LG C + + E+V GS++ L R P Y + QI G A YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLH 119
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL-----KTDQTQTTTAIRGTKGYVA 672
C ++H DIK N++L ++ DFG A+ L + ++ GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 673 PEWFKNLPITAKVDVYSFGILLLEL 697
PE K D++S G + E+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF-----KAEISAIGRTNHKNLVQ 563
LG+G+FGKV L +E A+K L K V + + + I A+ H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEV-YAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 564 LLGFCNEGEHRLL-VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
L C + + RL V EYV+ G L F ++SR+ + + A L +LH +
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDLM-FQIQRSRKFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+I+ D+K NILLD + +++DFG+ K TTT GT Y+APE + L
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEE 711
VD ++ G+L+ E++ + FE D ++
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL-G 566
+GEG+FG+ ++K A+K++ + ++ + E + + H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQK-YAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 567 FCNEGEHRLLVYEYVSNGSLAD-------FLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
F +G H +V EY G L LF + W+ +M + G+ ++HE+
Sbjct: 67 FEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+++H DIK +NI L ++ DFG A+LL + T + GT YV PE ++N+
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDA 708
P K D++S G +L EL + F+ ++
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 45/298 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFK-AEISAIGRTNHKNLVQLL 565
+G+G+FGKV + V + ++ A+K + KA V+ E AE + + + N +V L
Sbjct: 1 IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-----EC 620
E LV +++ G L L R+ R F +R FY E E
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR-----------FDLSRARFYTAELLCALEN 108
Query: 621 --KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
K +I+ D+KP+NILLD + + DFGL KL D T GT Y+APE
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLG 167
Query: 679 LPITAKVDVYSFGILLLELVCCRKNF-EVDATEECQMILADWAY--DCFRERK----LGL 731
T VD ++ G+LL E++ F + + E + IL + D F +GL
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGL 227
Query: 732 LVENDEEAM-----DDIKRVEKFVMIA---IWCIQEDPSLRPAMKKVTQMIEGAVDVS 781
L + + +IK F ++ + P +PA + A+D S
Sbjct: 228 LSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPA-------VSSAIDTS 278
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 39/281 (13%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVN-EGEQEFKAEISAIGRTNHKNLV 562
++++G G F +VY+ + KPVA+KK +++ ++ + Q+ EI + + NH N++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDR-KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVI 65
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRR--PN---WYKRMQIAFGTARGLFY 615
+ L E +V E G L+ + F+K +R P W +Q+ + +
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
+H +++H DIKP N+ + T ++ D GL + + T + + GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVDAT---EECQMILADWAYDCFRERKLGLL 732
K D++S G LL E+ + F D CQ I
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----------------- 220
Query: 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773
+ D + EK + CI DP RP + V Q+
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 64/194 (32%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISA-IGRTNHKNLVQL 564
+G+G+FGKV + K AVK L K ++E K AE + + H LV L
Sbjct: 3 IGKGSFGKVLL-AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+ V +YV+ G L L R+ P R A A L YLH I
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSL---NI 117
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
I+ D+KP+NILLD + ++DFGL K + ++TT+ GT Y+APE + P
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 685 VDVYSFGILLLELV 698
VD + G +L E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 11/193 (5%)
Query: 508 ELGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
++GEG+ G V + TE K VAVKK+ + + E+ + +H+N+V +
Sbjct: 29 KIGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G+ +V E++ G+L D + R N + + R L YLH + +I
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
H DIK +ILL ++SDFG + + + + + GT ++APE LP +V
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 686 DVYSFGILLLELV 698
D++S GI+++E++
Sbjct: 200 DIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLV 562
E LG G+FG+V E A+K L K + Q E S + +H +V
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEY-YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 563 QLL-GFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPN-----WYKRMQIAFGTARGLFY 615
++ F +E +R+ + E+V G L L + R PN ++ + +AF Y
Sbjct: 82 NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------Y 133
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
LH + II+ D+KP+N+LLD + +++DFG AK + D+T T + GT Y+APE
Sbjct: 134 LHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPEV 186
Query: 676 FKNLPITAKVDVYSFGILLLELV 698
++ VD ++ G+LL E +
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 25/241 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+++LG G FG+V+ + T VAVK + K + + F AE + + H LV+L
Sbjct: 10 LEKKLGAGQFGEVW--MATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFL-FRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
+ E ++ E+++ GSL DFL + + K + + A G+ ++ +
Sbjct: 67 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRN 122
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
IH D++ NIL+ + +I+DFGLA++++ ++ + + APE T
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 684 KVDVYSFGILLLELV-----------------CCRKNFEVDATEECQMILADWAYDCFRE 726
K DV+SFGILL+E+V + + + E C L + C++
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKN 242
Query: 727 R 727
R
Sbjct: 243 R 243
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 507 EELGEGAFGKVYKG-VLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQL 564
+E+G G FGKV G V + V VK+L + + EQ +F E H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR-----PNWYKRMQIAFGTARGLFYLHEE 619
LG C E LLV E+ G L +L R R+ P+ ++A A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKL-LKTDQTQTTTAIRGTKGYVAPEWFK- 677
K+ IH D+ +N LL +I D+GL+ K D T + ++APE
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 678 ---NLPI---TAKVDVYSFGILLLEL 697
NL + T + +V+S G+ + EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE----QEFKAEI 550
Y+ LE+I G GA+G VY+G + VA+K + + + Q A +
Sbjct: 3 YQRLELI--------GRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF--- 607
S + ++ N+ + G +G ++ EY GS+ R + I+
Sbjct: 54 SQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIR 108
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGT 667
L Y+H K +IH DIK NIL+ T N ++ DFG+A LL + ++ +T + GT
Sbjct: 109 EVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GT 164
Query: 668 KGYVAPEWFKNLPIT------AKVDVYSFGILLLELV 698
++APE IT K D++S GI + E+
Sbjct: 165 PYWMAPE-----VITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 40/207 (19%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-----GEQEFKAEISAIGRTNHKNLVQ 563
+G G FG+V+ V +E A+K + A+ E EQ E + +H +++
Sbjct: 9 VGTGTFGRVHL-VRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 564 LLGFCNEGEHRLL--VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF------- 614
L F E + R L + EYV G L +L R S R F + GLF
Sbjct: 66 L--FWTEHDQRFLYMLMEYVPGGELFSYL-RNSGR----------FSNSTGLFYASEIVC 112
Query: 615 ---YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
YLH + +I++ D+KP+NILLD + +++DFG AK L+ D+T T + GT Y+
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT---LCGTPEYL 165
Query: 672 APEWFKNLPITAKVDVYSFGILLLELV 698
APE ++ VD ++ GIL+ E++
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNLVQL 564
+GEG++G V K E + VA+KK ++ E ++ K EI + + H+NLV L
Sbjct: 9 VGEGSYGMVMK-CKHKETGQIVAIKKFLES--EDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNW--YKRMQ-IAFGTARGLFYLHEECK 621
+ + LV+E+V + L D + PN R++ F RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
IIH DIKP+NIL+ + ++ DFG A+ L T + T+ Y APE
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTK 177
Query: 682 TAK-VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740
+ VD+++ G L+ E++ F D+ D Y + LG L+ +E
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSD-------IDQLYHII--KCLGNLIPRHQEIF 228
Query: 741 D-----------DIKRVE-------KFVMIAI----WCIQEDPSLRPA 766
++K +E K + + C++ DP RP+
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 54/192 (28%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E++G+GA G VY + + VA+K++ ++ EI + + N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626
G+ +V EY++ GSL D + + + + L +LH +Q+IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALDFLHS---NQVIH 138
Query: 627 CDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVD 686
DIK NILL + +++DFG + +Q++ +T + GT ++APE KVD
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 687 VYSFGILLLELV 698
++S GI+ +E+V
Sbjct: 198 IWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 52/191 (27%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
++GEG+ G V + + K VAVKK+ + + E+ + H+N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSG-KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHC 627
G+ +V E++ G+L D + R N + + + L LH + +IH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 628 DIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDV 687
DIK +ILL ++SDFG + + + ++ GT ++APE LP +VD+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 688 YSFGILLLELV 698
+S GI+++E+V
Sbjct: 200 WSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 36/225 (16%)
Query: 482 QKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV 539
G P L +F ++GEG+ G V + T+ + VAVKK+
Sbjct: 13 DPGDPRSYLDNFV-------------KIGEGSTGIV---CIATDKSTGRQVAVKKMDLRK 56
Query: 540 NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNW 599
+ + E+ + H N+V++ G+ +V E++ G+L D +
Sbjct: 57 QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-------- 108
Query: 600 YKRM---QIAF---GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653
+ RM QIA + L +LH + +IH DIK +ILL ++SDFG +
Sbjct: 109 HTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165
Query: 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+ + + + GT ++APE LP +VD++S GI+++E+V
Sbjct: 166 SKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA---EISAIGRTNHKNLVQLL 565
LG+G FG+V + K A KKL K + + ++ E + + + + +V L
Sbjct: 1 LGKGGFGEVSACQMRATG-KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKS 622
LV ++ G L ++ + + F TA+ GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+II+ D+KP+N+LLD N RISD GLA LK Q++ T GT G++APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 683 AKVDVYSFGILLLELVCCRKNF-----EVDATEECQMILAD 718
VD ++ G+ L E++ R F +V+ E Q IL D
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI-GRTNHKNLVQLL 565
E +G+G +GKV+K VL +N AVK L +++ ++E +AE + + ++H N+V+
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 566 GF-----CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
G G+ LV E + GS+ D + +R + IA+ L L
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF---K 677
++ IH D+K NILL ++ DFG++ L + + + T++ GT ++APE +
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 678 NLPIT--AKVDVYSFGILLLEL 697
L T A+ DV+S GI +EL
Sbjct: 201 QLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG+G FG+V K A KKL K +GE E + + N + +V L
Sbjct: 8 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC----- 620
+ E + L + + NG D F + Y + F R +FY E C
Sbjct: 66 AYAYETKDALCLVLTLMNG--GDLKF------HIYHMGEAGFEEGRAVFYAAEICCGLED 117
Query: 621 --KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
+ +I++ D+KP+NILLD + RISD GLA + + QT GT GY+APE KN
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 679 LPITAKVDVYSFGILLLELVCCRKNFE 705
T D ++ G LL E++ + F+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLL 565
E +G G +G+VYKG + +A K+ + E+E K EI+ + + ++H+N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQ--LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 566 G-FCNEG-----EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYL 616
G F + + LV E+ GS+ D + K+ + N K IA+ RGL +L
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
H+ ++IH DIK QN+LL ++ DFG++ L + T I GT ++APE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183
Query: 677 ---KNLPITA--KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
+N T K D++S GI +E+ A C M R L L
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMA-------EGAPPLCDM---------HPMRALFL 227
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+ N + K +KF C+ ++ S RP +++ +
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 17/199 (8%)
Query: 512 GAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE---QEFKAEISAIGRTNHKNLVQLLGFC 568
GA+G+V+ A+K + KA + + E + + +V+L +
Sbjct: 4 GAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YS 61
Query: 569 NEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHC 627
+G+ L LV EY+ G LA L R+ IA L YLH + IIH
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGIIHR 117
Query: 628 DIKPQNILLDGTFNARISDFGLAK-------LLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
D+KP NIL+D + +++DFGL+K + D + I GT Y+APE
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 681 ITAKVDVYSFGILLLELVC 699
+ VD +S G +L E +
Sbjct: 178 HSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 42/210 (20%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL----YKAVNEG-------EQEFKAEISAIGRTN 557
LGEG + VYK E + VA+KK+ K +G E + E+
Sbjct: 8 LGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------ 60
Query: 558 HKNLVQLLG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRR--PNWYKRMQIAFGTARGL 613
H N++ LL F ++ + LV+E++ L + KS P K T RGL
Sbjct: 61 HPNIIGLLDVFGHKS--NINLVFEFME-TDLEKVIKDKSIVLTPADIK--SYMLMTLRGL 115
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVA 672
YLH + I+H D+KP N+L+ +++DFGLA+ + + T + T+ Y A
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 673 PEWFKNLPITAK-----VDVYSFGILLLEL 697
PE L A+ VD++S G + EL
Sbjct: 171 PE----LLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 58/234 (24%)
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEIS 551
YK +E I G GA+G V + T +K VA+KK+ A F
Sbjct: 4 GSRYKPIENI--------GSGAYGVVCSAIDTRSGKK-VAIKKIPHA-------FDVPTL 47
Query: 552 AIGRT----------NHKNLVQLLGFC----NEGEHRLLVYEYV---------SNGSLAD 588
A RT H N++ + + + +V + + S+ L +
Sbjct: 48 A-KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTE 106
Query: 589 FLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648
R Y Q+ RGL Y+H + +IH D+KP N+L++ RI DFG
Sbjct: 107 EHIR-------YFLYQLL----RGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFG 152
Query: 649 LAKLLKTDQTQTT---TAIRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELV 698
+A+ L + T+ T T+ Y APE +LP T +D++S G + E++
Sbjct: 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQL 564
E+LGEG++ VYKG+ + N + VA+K + EG F A E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGI-SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLL 68
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+ E V+EY+ LA ++ + + Y F RGL Y+H + I
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITA 683
+H D+KPQN+L+ +++DFGLA+ K+ +QT ++ T Y P+ ++
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 684 KVDVYSFGILLLELV 698
+D++ G + +E++
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E++G+GA G V+ + ++ VA+K++ ++ EI + + N+V L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQE-VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
G+ +V EY++ GSL D + QIA + L +LH +Q
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETC-----MDEAQIAAVCRECLQALEFLH---ANQ 135
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
+IH DIK N+LL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 684 KVDVYSFGILLLELV 698
KVD++S GI+ +E+V
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA---EISAIGRTNHKNL 561
F +G+G++G+V V + K +KKL N +E KA E + + H N+
Sbjct: 4 FVRVVGKGSYGEV-SLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 562 VQ--------------LLGFCNEGE--HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI 605
V ++GFC G+ H+L G L +++ W+ +QI
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKL----KEQKGKL----LPENQVVEWF--VQI 111
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
A L YLHE+ I+H D+K QN+ L T ++ D G+A++L+ +T I
Sbjct: 112 AMA----LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI- 163
Query: 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF 704
GT Y++PE F N P K DV++ G + E+ + F
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 67/200 (33%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLY---KAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E+G G+FG VY +E VA+KK+ K NE Q+ E+ + + H N +Q
Sbjct: 22 EIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLHEEC 620
G C EH LV EY GS +D L ++P + ++IA G +GL YLH
Sbjct: 81 RG-CYLREHTAWLVMEYCL-GSASDLL-EVHKKP--LQEVEIAAVTHGALQGLAYLHSH- 134
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL- 679
+IH D+K NILL ++ DFG A ++ GT ++APE +
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMD 187
Query: 680 --PITAKVDVYSFGILLLEL 697
KVDV+S GI +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 497 ELEVITGGFKEELGEGAFGKVYKGVL----TTENEKPVAVKKLY-KAVNEGEQEFKAEIS 551
E+ + T F EELGE FGKVYKG L E + VA+K L KA +EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--------- 602
R H N+V LLG + + +++ Y S+ L +FL +S +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 603 ------MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKT 655
+ I A G+ +L ++H D+ +N+L+ N +ISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 656 DQTQ----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
D + + IR +++PE + D++S+G++L E+
Sbjct: 178 DYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 509 LGEGAFGKVYKGVLTTENE-KPVAVKKLYKAV-NEGEQE-FKAEISAIGRTNHKNLVQLL 565
LGEG FG V +G L ++ VAVK + A+ E E F +E + +H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 566 GFCNEGEHR------LLVYEYVSNGSLADFLF--RKSRRPNWY-KRMQIAFGT--ARGLF 614
G C + +++ ++ +G L FL R P + +M + F T A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVAP 673
YL + IH D+ +N +L+ N ++DFGL+ K+ D + + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 674 EWFKNLPITAKVDVYSFGILLLEL 697
E + T K DV+SFG+ + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-----EISAIGRTNHKNLVQ 563
LG+G+FGKV L + E AVK L K V + + + + A+ N L
Sbjct: 3 LGKGSFGKVLLAELKGKGEY-FAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTH 60
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L EH V E+++ G L F + R + Y+ A GL +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
II+ D+K N++LD + +I+DFG+ K + +T GT Y+APE + L T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTF 175
Query: 684 KVDVYSFGILLLELVCCRKNFEVDATEE 711
VD +SFG+LL E++ + F D +E
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 509 LGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQ 563
LG+G+FGKV +L ++ A+K L K V ++ + E + +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 564 LLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEE 619
L C + RL V EYV+ G D ++ ++ +K F A GLF+LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGG---DLMYH-IQQVGKFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
II+ D+K N++LD + +I+DFG+ K TT GT Y+APE
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQ 176
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
P VD ++FG+LL E++ + F+ + +E
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 67/197 (34%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLY---KAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E+G G+FG VY NE VA+KK+ K NE Q+ E+ + R H N ++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
G C EH LV EY GS +D L + + I G +GL YLH
Sbjct: 91 KG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL---P 680
+IH DIK NILL +++DFG A + + GT ++APE +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 681 ITAKVDVYSFGILLLEL 697
KVDV+S GI +EL
Sbjct: 201 YDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-14
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNLVQLL 565
+G+G FG+VY+ V + + A+K L K ++E E + + RT ++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 566 G--FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
G F + + L LV +Y+S G L L ++ R + IA L +LH K
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KY 115
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPI 681
I++ D+KP+NILLD T + + DFGL+K TD +TT GT Y+APE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEE 711
T VD +S G+L+ E+ C F + T++
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 65/243 (26%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKP-------------------VAVKKLYKAVNEGE-Q 544
F E+LGEG FG+V+ E + VAVK L ++ +
Sbjct: 9 FVEKLGEGQFGEVH----LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 545 EFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNW--YKR 602
+F E+ + R + N+ +LLG C ++ EY+ NG L FL + +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 603 MQIAFGT--------ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LL 653
++F T A G+ YL +H D+ +N L+ + +I+DFG+++ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPI-------------TAKVDVYSFGILLLE-LVC 699
+D + ++G AP LPI T K DV++FG+ L E L
Sbjct: 182 SSDYYR----VQGR----AP-----LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 700 CRK 702
CR+
Sbjct: 229 CRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 497 ELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGR 555
E+EV+ +ELG+G +G VYK VL +A+K++ ++E + + E+ + +
Sbjct: 2 EIEVL-----DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK 55
Query: 556 TNHKNLVQLLG-FCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR 611
+V G F EG VY EY+ GSL D L+ + T
Sbjct: 56 AVSPYIVDFYGAFFIEGA----VYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYA 110
Query: 612 ---GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
GL +L EE IIH D+KP N+L++G ++ DFG++ L +T G +
Sbjct: 111 VVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQ 165
Query: 669 GYVAPEWFK------NLPITAKVDVYSFGILLLEL 697
Y+APE K N T + DV+S G+ +LE+
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 507 EELGEGAFGKVYKGVLTTEN---------EKPVAVKKLYKAVNEGEQEFKAEISAIGRTN 557
E LG+G F +YKGVL ++ E V +K L + F S + + +
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLS 59
Query: 558 HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
HK+LV+L G C E+ ++V EYV G L FL R+ + + ++ +A A L YL
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE 118
Query: 618 EECKSQIIHCDIKPQNILL-------DGTFNARISDFGLAK-LLKTDQTQTTTAIRGTKG 669
++ +++H ++ +NIL+ ++SD G+ +L ++
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------ 169
Query: 670 YVAPEWFKNLP--ITAKVDVYSFGILLLELVCCR 701
++APE +N +T D +SFG LLE +C
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE-ICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 62/204 (30%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-------EISAIGRTNHKNL 561
+GEG +G VY+ TT E VA+KK+ + E EI+ + H N+
Sbjct: 15 IGEGTYGIVYRARDTTSGEI-VALKKV-----RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 562 VQLLGFC--NEGEHRLLVYEYVSN--GSLADFLFRKSRRPNWYKRMQ---IAFGTARGLF 614
V+L + LV EY SL D + P + Q + RGL
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRGLQ 122
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YLHE IIH D+K N+LL +I+DFGLA+ T + T Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 675 -WFKNLPITAKVDVYSFGILLLEL 697
T +D+++ G +L EL
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLL 565
E +G G +G+VYKG + +A K+ + E+E K EI+ + + ++H+N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQ--LAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 566 G-FCNEG-----EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYL 616
G F + + LV E+ GS+ D + K+ + N K IA+ RGL +L
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGLAHL 137
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
H ++IH DIK QN+LL ++ DFG++ L + T I GT ++APE
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 193
Query: 677 ---KNLPIT--AKVDVYSFGILLLEL 697
+N T + D++S GI +E+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 509 LGEGAFGKVYKGVLTTENEKP--VAVKKLYKAVNEGE---QEFKAEISAIGRTNHKNLVQ 563
LGEG FG V +G L+ ++ VAVK + K +EF +E + + +H N+++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 564 LLGFCNEGEHR------LLVYEYVSNGSLADFLF--RKSRRPNWY---KRMQIAFGTARG 612
L+G C E +++ ++ +G L FL R P ++ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYV 671
+ YL IH D+ +N +L ++DFGL+ K+ D + + ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 672 APEWFKNLPITAKVDVYSFGILLLEL 697
A E + T+K DV++FG+ + E+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 506 KEELGEGAFGKVYKGVLTT-ENEK-PVAVKKLYKAVNEGE--QEFKAEISAIGRTNHKNL 561
+GEG FG VY+GV + ENEK VAV K K ++F E + + +H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAV-KTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L+G E +V E G L +L + + ++ + L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---S 125
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+ +H DI +N+L+ ++ DFGL++ L+ + + + ++APE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 682 TAKVDVYSFGILLLEL 697
T+ DV+ FG+ + E+
Sbjct: 186 TSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 52/192 (27%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E++G+GA G VY + ++ VA++++ ++ EI + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE-VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626
G+ +V EY++ GSL D + + + + L +LH +Q+IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHS---NQVIH 139
Query: 627 CDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVD 686
DIK NILL + +++DFG + +Q++ +T + GT ++APE KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 687 VYSFGILLLELV 698
++S GI+ +E++
Sbjct: 199 IWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 509 LGEGAFGKVY--KGVLTTENEKPVAVKKLYKAV---NEGEQEF-KAEISAIGRTNHKNLV 562
LG GA+GKV+ + V + K A+K L KA E + E + + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 563 QLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
L + + E +L L+ +YVS G + L+++ + + ++ F + + L K
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHK 123
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
I++ DIK +NILLD + ++DFGL+K +++ + T + GT Y+APE +
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 682 TAK-VDVYSFGILLLELVCCRKNFEVDATEECQ 713
K VD +S GIL+ EL+ F ++ Q
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 66/194 (34%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQE-FKAEISAIGRT-NHKNLVQL 564
+G+G+FGKV + K AVK L K + N EQ+ AE + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDG-KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
E V ++V+ G L L R+ P R A A L YLH I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INI 117
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
++ D+KP+NILLD + ++DFGL K Q+ TTT GT Y+APE + P
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 685 VDVYSFGILLLELV 698
VD + G +L E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-------EISAIGRTNHK 559
E++GEG +G VYK NE +A+KK+ EQE + EIS + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNET-IALKKI-----RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRK--SRRPNWYKRMQIA----FGTARGL 613
N+V+L + + LV+EY+ D +K P++ K ++ + RG+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNA-RISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
Y H +++H D+KPQN+L+D NA +++DFGLA+ +T T T Y A
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRA 171
Query: 673 PE-WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDA 708
PE + + VD++S G + E+V + F D+
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
|
Length = 294 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKAEISAIGRTNHKNLVQLL 565
+G G FG+V + V A+K + K+V ++ F+ E + +N + QL
Sbjct: 9 VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ ++ LV EY G L L +R + + F A + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK- 684
H DIKP+N+L+D T + +++DFG A L ++ + GT Y+APE + K
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 685 -----VDVYSFGILLLELVCCRKNFEVDATEE 711
D +S G++ E++ R F + +
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 509 LGEGAFGKVY--KGVLTTENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNHKNLV 562
LG GA+GKV+ + V ++ K A+K L KA + + + E + +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 563 QLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
L + + + +L L+ +Y++ G L L ++ R +K ++ + + L K
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHK 123
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK--NL 679
II+ DIK +NILLD + ++DFGL+K D+ + + GT Y+AP+ + +
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDATEECQ 713
VD +S G+L+ EL+ F VD + Q
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-----EISAIGRTNHKNL 561
E++GEG +G VYK E VA+KK+ E E E EIS + NH N+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEI-VALKKIRL---ETEDEGVPSTAIREISLLKELNHPNI 60
Query: 562 VQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLH 617
V+LL + E++L LV+E++ + L ++ I + +G+ Y H
Sbjct: 61 VRLLDVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGL--DPPLIKSYLYQLLQGIAYCH 116
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+++H D+KPQN+L+D +++DFGLA+
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG-EQEFKAEISAI 553
ELE + +G GA G VYK V+ + A+K +Y + ++ EI +
Sbjct: 73 LSELERV-----NRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 554 GRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM-QIAFGTARG 612
NH N+V+ + ++ E++ GSL + + + +A G
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL------EGTHIADEQFLADVARQILSG 180
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
+ YLH + I+H DIKP N+L++ N +I+DFG++++L +++ GT Y++
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMS 236
Query: 673 PEWFKNLPITAKV------DVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720
PE N + D++S G+ +LE R F V DWA
Sbjct: 237 PERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWA 282
|
Length = 353 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 66/241 (27%)
Query: 494 TYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----- 548
Y+ L I GEGA+G V K VA+KK+ F+
Sbjct: 6 RYQNLSYI--------GEGAYGMVCSATHKPTGVK-VAIKKI--------SPFEHQTFCQ 48
Query: 549 ----EISAIGRTNHKNLVQLL------GFCNEGE------------HRLLVYEYVSNGSL 586
EI + R H+N++ +L F + + ++L+ +++SN +
Sbjct: 49 RTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI 108
Query: 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646
FL+ QI RGL Y+H + ++H D+KP N+LL+ + +I D
Sbjct: 109 QYFLY------------QIL----RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICD 149
Query: 647 FGLAKL--LKTDQTQTTTAIRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKN 703
FGLA++ + D T T T+ Y APE N T +D++S G +L E++ R
Sbjct: 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
Query: 704 F 704
F
Sbjct: 210 F 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 16/215 (7%)
Query: 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKN 560
F LG+G+FGKV +E A+K L K V + + + E + +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDEL-YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 561 LVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYL 616
+ L C + RL V EYV+ G L + + + +K Q F A GLF+L
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFL 117
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
H II+ D+K N++LD + +I+DFG+ K D TT GT Y+APE
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEII 173
Query: 677 KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
P VD +++G+LL E++ + F+ + +E
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 489 NLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FK 547
+LE + E+G G G+VYK +AVK++ + N+ E +
Sbjct: 8 QKYPADLNDLENL-----GEIGSGTCGQVYKMRFKKTG-HVMAVKQMRRTGNKEENKRIL 61
Query: 548 AEISAIGRTNH-KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---NWYKRM 603
++ + +++ +V+ G+ + E +S + D L ++ + P + +M
Sbjct: 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKM 119
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663
+A + L YL E K +IH D+KP NILLD + N ++ DFG++ L + +T +A
Sbjct: 120 TVA--IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 664 IRGTKGYVAPE------WFKNLPITAKVDVYSFGILLLELVC-------CRKNFEV 706
G Y+APE I A DV+S GI L+EL C+ FEV
Sbjct: 176 --GCAAYMAPERIDPPDPNPKYDIRA--DVWSLGISLVELATGQFPYKNCKTEFEV 227
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG+G FG+V K A KKL K +GE E + + N + +V L
Sbjct: 8 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC----- 620
+ E + L + + NG D F + Y F R +FY E
Sbjct: 66 AYAYETKDALCLVLTLMNG--GDLKF------HIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 621 --KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR---GTKGYVAPEW 675
+ +I++ D+KP+NILLD + RISD GLA + +T IR GT GY+APE
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-----IRGRVGTVGYMAPEV 172
Query: 676 FKNLPITAKVDVYSFGILLLELV 698
KN T D + G L+ E++
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 61/222 (27%), Positives = 84/222 (37%), Gaps = 39/222 (17%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEIS------AIGRTNHKNLV 562
LG G FGKV E A+K L K E ++ + H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGEL-YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGTARGLFY---- 615
L +H V EY + G L M I F R +FY
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLM---------------MHIHTDVFSEPRAVFYAACV 110
Query: 616 ------LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
LHE ++I++ D+K N+LLD +I+DFGL K T+ GT
Sbjct: 111 VLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPE 166
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
++APE T VD + G+L+ E++ F D EE
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNLV 562
++GEG++G V+K E + VA+KK ++ E + K EI + + H NLV
Sbjct: 7 SKIGEGSYGVVFK-CRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
L+ LV+EY + ++ + L + R + +I + T + + + H K
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF-KNLPI 681
IH D+KP+NIL+ ++ DFG A++L T + T+ Y APE +
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQY 178
Query: 682 TAKVDVYSFGILLLELVC 699
VDV++ G + EL+
Sbjct: 179 GPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 24/87 (27%), Positives = 37/87 (42%), Gaps = 6/87 (6%)
Query: 340 VPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREGE 399
P +C + F +P+ P N T++ + CREACLS+C C + G
Sbjct: 1 TPLNCGG---DGSTDGFLKLPDVKLPDNASA-ITAISLEECREACLSNCSCTAYAYNNGS 56
Query: 400 --CWKKRAPLSNGRIDPSVGGKALVKV 424
C L+N R S GG +++
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISAIGRT-NHKNLVQL 564
+G+G+FGKV ++ AVK L K ++E AE + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSF-YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSR----RPNWYKRMQIAFGTARGLFYLHEEC 620
E V +YV+ G L L R+ R +Y A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-----AAEVASAIGYLHSL- 115
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
II+ D+KP+NILLD + ++DFGL K + +TT+ GT Y+APE + P
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 681 ITAKVDVYSFGILLLELV 698
VD + G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVN-EGEQEFKAEISAIGRTNHKNLV 562
++++G G F +VY+ + PVA+KK ++ ++ + + EI + + NH N++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRR--PN---WYKRMQIAFGTARGLFY 615
+ E +V E G L+ + F+K +R P W +Q+ L +
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEH 121
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
+H +++H DIKP N+ + T ++ D GL + + +T ++ GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 177
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVD 707
K D++S G LL E+ + F D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 8/207 (3%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQLL 565
++LGEG + VYKG + + VA+K++ EG E+S + H N+V L
Sbjct: 12 DKLGEGTYATVYKG-RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ + LV+EY+ + L +L N + F RGL Y H + +++
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVL 126
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITAK 684
H D+KPQN+L++ +++DFGLA+ K+ T+T + T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEE 711
+D++ G + E+ R F EE
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 509 LGEGAFGKVY--KGVLTTENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNHKNLV 562
LG GA+GKV+ + V + K A+K L KA + + + E + +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 563 QLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE--- 618
L + + + +L L+ +YV+ G L L+++ F + Y+ E
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-----------FTESEVRVYIAEIVL 116
Query: 619 --ECKSQ--IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
+ Q II+ DIK +NILLD + ++DFGL+K ++ + + GT Y+APE
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 675 WFKNLPI--TAKVDVYSFGILLLELVCCRKNFEVDATEECQ 713
+ VD +S G+L EL+ F VD + Q
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG+G FG+V K A KKL K +GE E + + N + +V L
Sbjct: 8 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC----- 620
+ E + L + + NG D F + Y F R +FY E C
Sbjct: 66 AYAYETKDALCLVLTIMNG--GDLKF------HIYNMGNPGFDEQRAIFYAAELCCGLED 117
Query: 621 --KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
+ +I++ D+KP+NILLD + RISD GLA ++ + +T GT GY+APE N
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 679 LPITAKVDVYSFGILLLELV 698
T D + G L+ E++
Sbjct: 176 EKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK-----AEISAIGRTNHKNLV 562
E+GEGA+GKV+K + VA+K++ E A + + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 563 QLLGFCN----EGEHRL-LVYEYVSNGSLADFLFRKSRR---PNWYKRMQIAFGTARGLF 614
+L C + E +L LV+E+V L +L + K M RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 124
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
+LH +++H D+KPQNIL+ + +++DFGLA++ T+ + T Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 675 WFKNLPITAKVDVYSFGILLLELV----CCRKNFEVD 707
VD++S G + E+ R + +VD
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNL 561
F LG+G+FGKV +E A+K L K V + + + E + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDEL-YAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 562 VQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLH 617
+ L C + RL V EYV+ G L + + R +K F A GLF+LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLH 118
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
+ II+ D+K N++LD + +I+DFG+ K D TT GT Y+APE
Sbjct: 119 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIA 174
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
P VD ++FG+LL E++ + FE + +E
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 509 LGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNLVQ 563
LG+G FGKV +L E K A+K L K V + E E + T H L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 564 LLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEE 619
L + + RL V EY + G L F R + + F A L YLH
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+++ D+K +N++LD + +I+DFGL K +D T GT Y+APE ++
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDN 170
Query: 680 PITAKVDVYSFGILLLELVCCRKNF 704
VD + G+++ E++C R F
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 11/154 (7%)
Query: 556 TNHKNLVQLLGFCNEGEHRLL-VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF 614
+NH LV L C + E RL V EYV+ G L + R+ + P + R A + L
Sbjct: 53 SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALN 110
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK--LLKTDQTQTTTAIRGTKGYVA 672
YLHE II+ D+K N+LLD + +++D+G+ K L D TT+ GT Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIA 164
Query: 673 PEWFKNLPITAKVDVYSFGILLLELVCCRKNFEV 706
PE + VD ++ G+L+ E++ R F++
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 11/225 (4%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF---KAEISAIGRTNHKNLVQLL 565
+G G++ KV V +N++ A+K + K + +++ + E + + + L
Sbjct: 3 IGRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 566 GFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
C + RL LV EYV+ G L + R+ + P + R A L +LHE I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHER---GI 117
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
I+ D+K N+LLD + +++D+G+ K TT+ GT Y+APE +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
VD ++ G+L+ E++ R F++ T+ M D+ + E+ +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDI-ITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 42/222 (18%)
Query: 509 LGEGAFGKVYKGVLTTENE--KPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQ 563
+G GAFG+V+ L + + + A+K L K+ +AE + + +V+
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEECKS 622
L + EH LV EY+ G L + L RK + F A + L K
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETAR-----FYIAELVLALDSVHKL 120
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAK-------------LLKTDQTQTTTAIR---- 665
IH DIKP NIL+D + +++DFGL K + +R
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 666 -----------GTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696
GT Y+APE + P + D +S G++L E
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLY--KAVNEGEQEFKA---EISAIGRTNHKNLVQ 563
LG+GAFG+VY + + +AVK++ E +E A EI + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 564 LLGFCNEGEHRLL--VYEYVSNGSLADFLF-------RKSRRPNWYKRMQIAFGTARGLF 614
G + R L E++ GS+ D L +R+ Y R QI G+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK---YTR-QIL----EGVS 120
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TAIRGTKGYVA 672
YLH + I+H DIK NIL D N ++ DFG +K L+T T ++ GT +++
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 673 PEWFKNLPITAKVDVYSFGILLLELV 698
PE K D++S G ++E++
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 57/230 (24%), Positives = 87/230 (37%), Gaps = 48/230 (20%)
Query: 507 EELGEGAFGKVY----KGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHK 559
+ LG+G G+V+ KG K A+K L K + K E + +H
Sbjct: 7 KLLGKGDVGRVFLVRLKGT-----GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYL 616
L L + LV +Y G L F + + F A L YL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR----------- 665
H I++ D+KP+NILL + + +SDF L+K + + A+R
Sbjct: 120 H--LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 666 -----------------GTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
GT+ Y+APE + VD ++ GILL E++
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 506 KEELGEGAFGKVYKGVLTTE---NEKPVAVKKLYKAVNEGEQE-----FKAEISAIGRTN 557
+ L EG FG+++ G+L E E+ V VK V + E E + +
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVK----TVKDHASEIQVTLLLQESCLLYGLS 66
Query: 558 HKNLVQLLGFCNE-GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA------FGT- 609
H+N++ +L C E GE ++Y Y++ G+L FL ++ R ++
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 610 -ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTD-QTQTTTAIRG 666
A G+ YLH K +IH DI +N ++D +I+D L++ L D R
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
K ++A E N ++ DV+SFG+LL EL+
Sbjct: 183 VK-WMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 507 EELGEGAFGKVY--KGVLTTENEKPVAVKKLYKAVNEGEQE---FKAEISAIGRTNHK-N 560
+ + +GAFG VY K T + A+K L K+ + + KAE + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDY---FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ +L ++ LV EY++ G A + P + + IA G+ LH
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLH--- 114
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAK--LLKTDQTQTTTAIRGTKGYVAPEWFKN 678
+ IIH DIKP+N+L+D T + +++DFGL++ L GT Y+APE
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLAPETILG 167
Query: 679 LPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
+ D +S G ++ E + F + +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 549 EISAIGRTNHKNLVQLLG-FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF 607
E+ + N +V G F ++GE + + E++ GSL D + ++++R +++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL-DQVLKEAKRIPEEILGKVSI 110
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGT 667
RGL YL E K QI+H D+KP NIL++ ++ DFG++ L + GT
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GT 165
Query: 668 KGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR 701
+ Y++PE + + + D++S G+ L+EL R
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 28/288 (9%)
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLY-KAVNEGEQEFKAEI 550
D ++LE I +LG G G V K V +A K ++ A + ++ E+
Sbjct: 1 DLRNEDLETI-----SDLGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVRKQILREL 54
Query: 551 SAIGRTNHKNLVQLLG-FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT 609
+ +V G F NE + + E++ GSL D +++K +IA
Sbjct: 55 QIMHECRSPYIVSFYGAFLNEN-NICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAV 112
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
GL YL+ +I+H DIKP NIL++ ++ DFG++ L T GT
Sbjct: 113 VEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTST 167
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF----EVDATEECQMILADWAYDCFR 725
Y++PE + T K DV+S GI ++EL + F D ++ M + D +
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773
E L + E + D FV C+ +DP+ RP +++ M
Sbjct: 228 EPPPRLPSSDFPEDLRD------FVDA---CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 508 ELGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
++GEG+ G V + E + VAVK + + + E+ + H+N+V++
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
GE ++ E++ G+L D + R N + + + L YLH + +I
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
H DIK +ILL ++SDFG + D + + + GT ++APE P +V
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198
Query: 686 DVYSFGILLLELV 698
D++S GI+++E+V
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 47/150 (31%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-EISAIGRTNHKNLVQLL 565
E+LGEG + VYKG T E VA+K+++ EG EIS + H+N+V+L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEI-VALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFL----FRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
+ +LV+EY+ L ++ R + PN K + +G+ + HE
Sbjct: 65 DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT--YQLLKGIAFCHE--- 118
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAK 651
++++H D+KPQN+L++ +++DFGLA+
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKA-EISAIGRTNHKNLVQL 564
E++GEG +G VYK + VA+KK+ EG EIS + NH N+V+L
Sbjct: 6 EKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLHEECK 621
L + LV+E++ + L F+ + + I F +GL + H
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCHSH-- 119
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+++H D+KPQN+L++ +++DFGLA+ +T T T Y APE
Sbjct: 120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 682 -TAKVDVYSFGILLLELVCCRKNFEVDA 708
+ VD++S G + E+V R F D+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 26/161 (16%)
Query: 510 GEGAFGKVYKGV-LTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNLVQL 564
G G +G+VYK ++ K A+KK +K E EI+ + H+N+V L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 565 LG-FCNEGEHRL-LVYEYVSNGSLADFL-----FRKSRRPNWYKRM--QIAFGTARGLFY 615
+ F + + L+++Y + D R+++R + M + + G+ Y
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNAR----ISDFGLAKL 652
LH + ++H D+KP NIL+ G R I D GLA+L
Sbjct: 124 LHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 21/231 (9%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGE-----QEFKAEISAIGRTNHKNLV 562
+G G++ KV L + A+K + K VN+ E Q K +NH LV
Sbjct: 3 IGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA--SNHPFLV 59
Query: 563 QLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
L C + E RL V E+VS G L + R+ + P + R A + L +LHE
Sbjct: 60 GLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHER-- 115
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAK--LLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
II+ D+K N+LLD + +++D+G+ K + D TT+ GT Y+APE +
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGE 171
Query: 680 PITAKVDVYSFGILLLELVCCRKNFE-VDATEECQMILADWAYDCFRERKL 729
VD ++ G+L+ E++ R F+ V ++ D+ + E+++
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQL 564
E+LGEG++ VYKG + N K VA+K + EG F A E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGK-SKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLL 68
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FGTARGLFYLHEECK 621
+ E LV+EYV D + P + F RGL Y+H+
Sbjct: 69 HDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-- 122
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLP 680
I+H D+KPQN+L+ T +++DFGLA+ K+ + T + T Y P+ +
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 681 ITAKVDVYSFGILLLELV 698
+ +D++ G + +E++
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 509 LGEGAFGKVY--KGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQL 564
LG+G+FGKV+ + + + + A+K L KA + K E + NH +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 565 -LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM--QIAFGTARGLFYLHEECK 621
F EG+ L++ DFL R + + R+ ++ F FYL E
Sbjct: 64 HYAFQTEGKLYLIL----------DFL----RGGDLFTRLSKEVMFTEEDVKFYLAELAL 109
Query: 622 S-------QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
+ II+ D+KP+NILLD + +++DFGL+K D + + GT Y+APE
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 168
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFE-VDATEECQMIL 716
T D +SFG+L+ E++ F+ D E MIL
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI-------GRTNHKNL 561
LG GAFG+VY + + +AVK++ + QE E++A+ H +
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQV--PFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 562 VQLLGFCNEGEHRLL--VYEYVSNGSLADFLF-------RKSRRPNWYKRMQIAFGTARG 612
VQ G + E + L EY+ GS+ D L +RR Y R QI +G
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR---YTR-QIL----QG 118
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TAIRGTKGY 670
+ YLH + I+H DIK NIL D N ++ DFG +K ++T T ++ GT +
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 671 VAPEWFKNLPITAKVDVYSFGILLLELV 698
++PE K DV+S ++E++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 67/264 (25%), Positives = 113/264 (42%), Gaps = 50/264 (18%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKP---------------VAVKKLY-KAVNEGEQEFKA 548
FKE+LGEG FG+V+ + + P VAVK L A +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 549 EISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR------------ 596
E+ + R N+++LLG C + + ++ EY+ NG L FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 597 ------PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650
++ + +A A G+ YL +H D+ +N L+ +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 651 KLLKTD-----QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE-LVCCRKNF 704
+ L Q + IR ++A E T DV++FG+ L E L+ C++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 705 EVDATEECQMILADWAYDCFRERK 728
+ T+E Q+I + A + FR++
Sbjct: 242 YGELTDE-QVI--ENAGEFFRDQG 262
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGR-TNHKNL 561
++LG+GA+G V+K + E VA+KK++ A + ++ F+ EI + +H N+
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEV-VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNI 69
Query: 562 VQLLGFCNEGEHR-------LLVYEYVSNGSLADF--LFRKSRRPNWYKRMQIAFGTARG 612
V+LL + LV+EY+ D + R + + +KR I + +
Sbjct: 70 VKLLNV-----IKAENDKDIYLVFEYME----TDLHAVIRANILEDVHKRY-IMYQLLKA 119
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
L Y+H +IH D+KP NILL+ +++DFGLA+ L + + T YVA
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL-TD-YVA 174
Query: 673 PEWFKNLPI-------TAKVDVYSFGILLLELVCCRKNF 704
W++ I T VD++S G +L E++ + F
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT------NHKNLV 562
LG+G+FGKV+ L N+ A+K L K V + + E + + + H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQF-FAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLT 59
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
L E+ V EY++ G L F + + + + A GL +LH +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLM-FHIQSCHKFDLPRATFYAAEIICGLQFLHSK--- 115
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
I++ D+K NILLD + +I+DFG+ K +T T GT Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYN 174
Query: 683 AKVDVYSFGILLLELVCCRKNFE-VDATEECQMILAD 718
VD +SFG+LL E++ + F D E Q I D
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 50/217 (23%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISA---------IGRTNHK 559
+G GA+G V V K VA+KK+ F I A + H+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRK-VAIKKISNV-------FDDLIDAKRILREIKLLRHLRHE 59
Query: 560 NLVQLL---------GFCNEGEHRLLVYEYVSNGSLADFLFR--KSRRPNWYKRMQ-IAF 607
N++ LL F +V E + D L + KS +P +Q +
Sbjct: 60 NIIGLLDILRPPSPEDF----NDVYIVTELME----TD-LHKVIKSPQPLTDDHIQYFLY 110
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TAIR 665
RGL YLH + +IH D+KP NIL++ + +I DFGLA+ + D+ + T
Sbjct: 111 QILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 666 GTKGYVAPE----WFKNLPITAKVDVYSFGILLLELV 698
T+ Y APE + T +D++S G + EL+
Sbjct: 168 VTRWYRAPELLLSSSR---YTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 11/193 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNLVQL 564
+GEGA+G V K E ++ VA+KK + E +E K E+ + +N+V+L
Sbjct: 9 VGEGAYGVVLK-CRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
LV+EYV L + P R I + + + + H K+ I
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH---KNDI 121
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H DIKP+N+L+ ++ DFG A+ L T T+ Y +PE P
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 685 VDVYSFGILLLEL 697
VD++S G +L EL
Sbjct: 182 VDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 66/228 (28%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT----------NH 558
+G GA+G+V T K VA+KKL + F++ I A RT +H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK-VAIKKLS-------RPFQSAIHA-KRTYRELRLLKHMDH 73
Query: 559 KNLVQLLGFCNEGEHR------LLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-------- 604
+N++ LL LV + AD N + Q
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADL--------NNIVKCQKLSDDHIQ 121
Query: 605 -IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663
+ + RGL Y+H + IIH D+KP NI ++ +I DFGLA+ + T
Sbjct: 122 FLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT----- 173
Query: 664 IRGTKGYVAPEWFKNLPI-------TAKVDVYSFGILLLELVCCRKNF 704
GYVA W++ I VD++S G ++ EL+ + F
Sbjct: 174 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLY--KAVNEGEQEFKA---EISAIGRTNHKNLVQ 563
LG+GAFG+VY + + +A K++ E +E A EI + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 564 LLG-FCNEGEHRLLVY-EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
G + E L ++ EY+ GS+ D L R + G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TAIRGTKGYVAPEWFKNL 679
+ I+H DIK NIL D N ++ DFG +K L+T T ++ GT +++PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 680 PITAKVDVYSFGILLLELV 698
K DV+S G ++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 14/196 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG+G FG+V K A K+L K +GE E + + N + +V L
Sbjct: 8 LGKGGFGEVC-ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL- 65
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKS 622
+ E + L + + NG F P ++ + F A GL LH E
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHRE--- 121
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
++ D+KP+NILLD + RISD GLA +K + ++ GT GY+APE N T
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 683 AKVDVYSFGILLLELV 698
D + G L+ E++
Sbjct: 180 LSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 46/222 (20%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKK-LYKAVNEGEQEFKA----EISAIGRTNHKNL 561
+LGEG FG+VYK + + VA+KK L +G F EI + + H N+
Sbjct: 14 GKLGEGTFGEVYKAR-QIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNV 69
Query: 562 VQLLGFC-----NEGEHRLLVY---EYVS---NGSLA--DFLFRKSRRPNWYKRMQIAFG 608
V L+ R VY Y+ +G L +S+ + Q+ G
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML--QLLEG 127
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG-- 666
YLHE + I+H DIK NIL+D +I+DFGLA+ G
Sbjct: 128 IN----YLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 667 --------TKGYVAPEWF---KNLPITAKVDVYSFGILLLEL 697
T+ Y PE + T VD++ G + E+
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRY--TTAVDIWGIGCVFAEM 220
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 8/207 (3%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQLL 565
++LGEG + V+KG + E VA+K++ EG E+S + H N+V L
Sbjct: 11 DKLGEGTYATVFKG-RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ LV+EY+ + L +L + + F RGL Y H K +I+
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKIL 125
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITAK 684
H D+KPQN+L++ +++DFGLA+ K+ T+T + T Y P+ + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEE 711
+D++ G +L E+ R F +E
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 509 LGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNLVQ 563
LG+G FGKV +L E K A+K L K V + E E + T H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT--ARGLFYLHEECK 621
L + V EYV+ G L F SR + + +G L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS--- 113
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+I++ D+K +N++LD + +I+DFGL K TD T GT Y+APE ++
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLEDNDY 172
Query: 682 TAKVDVYSFGILLLELVCCRKNF 704
VD + G+++ E++C R F
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 40/272 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQ 563
++E LG G G VYK + +AVK + + E +++ +E+ + + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 564 LLG--FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTARGLF 614
G F E+R+ + E++ GSL + Y+++ +IA +GL
Sbjct: 64 FYGAFFV---ENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLT 109
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YL +I+H D+KP N+L++ ++ DFG++ L +T GT Y+APE
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPE 163
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734
DV+S GI +EL R + + ++ L +V+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL---------LQCIVD 214
Query: 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA 766
D + + EKFV C+++ P RPA
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 45/231 (19%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLL 565
+G GAFG V+ V + K VA+KK+ ++ F+ E+ + H N++ L
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 566 GFCNEG-----EHRLLVYEY---------VSNGSLAD-----FLFRKSRRPNWYKRMQIA 606
E +V E VS L+ FL+ QI
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY------------QIL 113
Query: 607 FGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666
RGL YLH + I+H DIKP N+L++ +I DFGLA++ + D+++ T
Sbjct: 114 ----RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 667 TKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKNFEVDA-TEECQMI 715
T+ Y APE T+ VD++S G + EL+ R F+ + ++ +I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 90/344 (26%), Positives = 128/344 (37%), Gaps = 105/344 (30%)
Query: 509 LGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGEQ-----EFKAEISAIGRTNHK 559
LG GAFGKV + G+ + VAVK L + E E K I IG NH
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH-IG--NHL 71
Query: 560 NLVQLLGFCNEGEHRLLV-YEYVSNGSLADFLFRK--------SRRPNWYKRMQ------ 604
N+V LLG C + L+V E+ G+L++FL K + P R +
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 605 -----IAFGTARGLFYLHEECKSQ------------------------------------ 623
I G A LF + S
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191
Query: 624 ---IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT-AIRGTKGYVAPEWFKNL 679
IH D+ +NILL +I DFGLA+ + D + R ++APE +
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDAT---------EECQMILADWAYDCFRERKLG 730
T + DV+SFG+LL E+ F + A+ E CQ + K G
Sbjct: 252 VYTTQSDVWSFGVLLWEI------FSLGASPYPGVQINEEFCQRL------------KDG 293
Query: 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774
+ E A +I R +M+A W Q DP RP + +++
Sbjct: 294 TRMRAPENATPEIYR----IMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 63/198 (31%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISA----IGRTNHKNLVQL 564
+G+G+FGKV E EK AVK L K ++E K +S + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAE-EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRK----SRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ V +Y++ G L L R+ R +Y A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLHS-- 114
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
I++ D+KP+NILLD + ++DFGL K + TT+ GT Y+APE P
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 681 ITAKVDVYSFGILLLELV 698
VD + G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQL 564
E++GEG +G VYKG + VA+KK+ E A EIS + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTG-QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIA----FGTARGLFYLHEE 619
+ E RL L++E++S L +L S Y ++ + +G+ + H
Sbjct: 65 QDVLMQ-ESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+++H D+KPQN+L+D +++DFGLA+ T + T Y APE
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGS 176
Query: 680 P-ITAKVDVYSFGILLLELVCCRKNFEVDA 708
P + VD++S G + E+ + F D+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 32/221 (14%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNLVQ 563
++GEG +G+VYK E VA+KK+ + NE E F EI + + NH+N+V
Sbjct: 14 QIGEGTYGQVYKARDKDTGEL-VALKKV-RLDNEKEG-FPITAIREIKILRQLNHRNIVN 70
Query: 564 L----------LGFCNEGEHRLLVYEYVSN---GSLADFL--FRKSRRPNWYKRMQIAFG 608
L L F + LV+EY+ + G L L F + ++ K++
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
GL Y H K +H DIK NILL+ +++DFGLA+L +++++ T T
Sbjct: 126 -LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 669 GYVAPE-WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDA 708
Y PE +DV+S G +L EL + F+ +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKA-EISAIGRTNHKNLVQL 564
E++GEG +G V+K E + VA+K++ +EG EI + HKN+V+L
Sbjct: 6 EKIGEGTYGTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
+ + +L LV+EY L + + + F +GL + H
Sbjct: 65 YDVLH-SDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAK 651
++H D+KPQN+L++ +++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 43/133 (32%), Positives = 74/133 (55%), Gaps = 11/133 (8%)
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRR--PNWYKRMQIAFGTARGLFYLHEECKSQI 624
F ++GE + + E++ GSL D + +K+ R N ++ IA RGL YL E K +I
Sbjct: 68 FYSDGEISICM-EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKI 121
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D+KP NIL++ ++ DFG++ L + GT+ Y++PE + T +
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYTVQ 178
Query: 685 VDVYSFGILLLEL 697
D++S G+ L+E+
Sbjct: 179 SDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 8/207 (3%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQLL 565
E+LGEG + V+KG + E VA+K++ EG E+S + H N+V L
Sbjct: 12 EKLGEGTYATVFKG-RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ + LV+EY+ + L ++ + + + RGL Y H + +++
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVL 126
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITAK 684
H D+KPQN+L++ +++DFGLA+ K+ T+T + T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEE 711
+D++ G + E+ R F E+
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 31/202 (15%)
Query: 509 LGEGAFGKV--YKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQ 563
+G GAFG V + LT +N VA+KK+ K + ++ ++ E+ + H+N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQN---VAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIIS 73
Query: 564 LLG-FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNW--YKRMQIAFGTARGLFYLHEEC 620
L F + E V E + L L + + Y QI RGL Y+H
Sbjct: 74 LSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL----RGLKYVHS-- 126
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE----WF 676
+ ++H D+KP NIL++ + +I DFGLA++ Q T T+ Y APE W
Sbjct: 127 -AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQ 181
Query: 677 KNLPITAKVDVYSFGILLLELV 698
K +VD++S G + E++
Sbjct: 182 K---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 39/213 (18%)
Query: 508 ELGEGAFGKVYKGVLT-TENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT---------- 556
ELG+GA+G V T E+ VA+KK+ F +I A R
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNV-------FSKKILA-KRALRELKLLRHF 58
Query: 557 -NHKNLVQL--LGFCNEGEHR-LLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTAR 611
HKN+ L + G L +YE + L + +S +P Q +
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILC 116
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
GL Y+H + ++H D+KP N+L++ +I DFGLA+ + + + YV
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM---TEYV 170
Query: 672 APEWFK-------NLPITAKVDVYSFGILLLEL 697
A W++ T +DV+S G +L EL
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 51/284 (17%)
Query: 507 EELGEGAFGKVYKGVLTTE------NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
E LG+G F K++KG+ ++ V +K L K+ + F S + + +HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
LV G C G+ ++V EYV GSL +L + N ++++A A L +L ++
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK- 119
Query: 621 KSQIIHCDIKPQNILL-----DGTFNA---RISDFG-----LAKLLKTDQTQTTTAIRGT 667
+ H ++ +N+LL T N ++SD G L K + ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-------- 169
Query: 668 KGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE 726
+V PE +N ++ D +SFG L E + + + A + + + F E
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWE-IFSGGDKPLSALDSQKKLQ-------FYE 219
Query: 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ L E + I + C+ +P RP+ + +
Sbjct: 220 DRHQLPAPKWTELANLINQ----------CMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 39/230 (16%)
Query: 505 FKEELGEGAFGKVY----KGVLTTENE---------KP--VAVKKLYKAVNE-GEQEFKA 548
FKE+LGEG FG+V+ +G+ ++ +P VAVK L + N+ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 549 EISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR--PNWYKRMQIA 606
EI + R N+++LL C + ++ EY+ NG L FL R + + I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 607 FGT--------ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK-LLKTD- 656
+ T A G+ YL +H D+ +N L+ + +I+DFG+++ L D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 657 ---QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE-LVCCRK 702
Q + IR +++ E T DV++FG+ L E L C++
Sbjct: 186 YRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 494 TYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EIS 551
TYK+L+ LGEG++ VYKG + + VA+K++ EG F A E S
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGR-SKLTGQLVALKEIRLEHEEG-APFTAIREAS 55
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA---FG 608
+ H N+V L + + LV+EY+ L ++ + F
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYM---DDCGGGLSMHNVRLFLFQ 111
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
RGL Y H + +++H D+KPQN+L+ +++DFGLA+
Sbjct: 112 LLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 509 LGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVNEGEQE----FKAEISAIGRTNHKNLV 562
LG+G +GKV++ T K A+K L KA Q+ KAE + + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
L+ G L+ EY+S G L F R + F + L +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
II+ D+KP+NILLD + +++DFGL K + T T T GT Y+APE
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRSGHG 178
Query: 683 AKVDVYSFGILLLELV 698
VD +S G L+ +++
Sbjct: 179 KAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 51/215 (23%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-----EISAIGRTNHKNLVQ 563
+G GA+G V + NEK VA+KK+ A + A EI + +H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEK-VAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 564 LLGFCNEGEHR------LLVYEYV---------SNGSLAD-----FLFRKSRRPNWYKRM 603
+ HR +VYE + S+ +L+D FL+
Sbjct: 69 IKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY------------ 115
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663
Q+ RGL Y+H + ++H D+KP N+LL+ + +I DFGLA+ T
Sbjct: 116 QLL----RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168
Query: 664 IRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLEL 697
+ T+ Y APE N T +DV+S G + EL
Sbjct: 169 VV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL--YKAVNEGEQEFKAEISAI-GRTNHKNLVQLL 565
+G GAFG+V + V ++K A+K L ++ + + F E I N +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ ++ +V EY+ G L + + W K F TA + L +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVLALDAIHSMGLI 164
Query: 626 HCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVAPEWFKNLP---- 680
H D+KP N+LLD + +++DFG K+ +T + TA+ GT Y++PE K+
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGY 223
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDA 708
+ D +S G+ L E++ F D+
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 509 LGEGAFGKVYKGVLTTENEKPV--AVKKLYKAVNEGEQEFK---AEISAIGRTNHKNLVQ 563
LG+G FGKV +L E A+K L K V + E E + T H L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT--ARGLFYLHEECK 621
L + V EY + G L F SR + + +G L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSR-- 114
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+++ DIK +N++LD + +I+DFGL K +D T GT Y+APE ++
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDY 172
Query: 682 TAKVDVYSFGILLLELVCCRKNF 704
VD + G+++ E++C R F
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
+ +G G +G VYK E AVK + + + EI + H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGEL-AAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
E + EY GSL D +QIA+ T +GL YLH + K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF---KNLP 680
+H DIK NILL + +++DFG+A + + + I GT ++APE KN
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGG 185
Query: 681 ITAKVDVYSFGILLLEL 697
D+++ GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG-EQEFKAEISAIGRTNHKNLVQLLG 566
ELG G G V+K V + +A K ++ + + E+ + N +V G
Sbjct: 12 ELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 567 -FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
F ++GE + + E++ GSL L + R P +++ +GL YL E K +I+
Sbjct: 71 AFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLRE--KHKIM 126
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
H D+KP NIL++ ++ DFG++ L + GT+ Y++PE + + +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 183
Query: 686 DVYSFGILLLELVCCR 701
D++S G+ L+E+ R
Sbjct: 184 DIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 44/222 (19%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----------------EISA 552
LGEG +GKV K T K VA+KK+ + E + E+
Sbjct: 17 LGEGTYGKVEKA-YDTLTGKIVAIKKV--KIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 553 IGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR---MQIAFGT 609
+ H+N++ L+ EG+ LV + ++ L + RK R + +QI
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQIL--- 129
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA----------KLLKTDQTQ 659
GL LH K +H D+ P NI ++ +I+DFGLA L K + Q
Sbjct: 130 -NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 660 TT---TAIRGTKGYVAPE-WFKNLPITAKVDVYSFGILLLEL 697
T+ T Y APE VD++S G + EL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227
|
Length = 335 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-----FKAEISAIGRTNHKN- 560
E++GEG +GKVYK K VA+KK E ++E EIS + +
Sbjct: 7 EKIGEGTYGKVYKA-RDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 561 LVQLLGF----CNEGEHRL-LVYEYVSNG--SLADFLFRKSRRPNWYKRMQ-IAFGTARG 612
+V+LL G+ L LV+EY+ + D R RP K ++ + +G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNA-RISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
+ + H K ++H D+KPQN+L+D +I+D GL + T I T Y
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 672 APE-WFKNLPITAKVDVYSFGILLLELVCCRKN 703
APE + + VD++S G + E+ RK
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENE-KPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKNLVQL 564
+E+G G FGKV + T+ V VK+L + EQ EF + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-------MQIAFGTARGLFYLH 617
LG C E LLV+EY G L +L + W++R ++A A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVAPEW- 675
K +H D+ +N L ++ D+G+ K D +T ++APE
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 676 --FKNLPITAK----VDVYSFGILLLELVCCRK 702
F ITA+ +V++ G+ L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRT---NHKNLV 562
E+G GA+G VYK + VA+K + NE E++ + R +H N+V
Sbjct: 7 EIGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 563 QLLGFC----NEGEHRL-LVYEYVSNGSLADFLFRKSRRPNW----YKRMQIAFGTARGL 613
+L+ C + E ++ LV+E+V L +L K P K + F RGL
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL-DKVPPPGLPAETIKDLMRQF--LRGL 121
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAP 673
+LH C I+H D+KP+NIL+ +++DFGLA++ T + T Y AP
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAP 176
Query: 674 EWFKNLPITAKVDVYSFGILLLEL 697
E VD++S G + E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 64/256 (25%), Positives = 100/256 (39%), Gaps = 50/256 (19%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQ--EFKAEISAIGRTNHKNLVQLL 565
+G GAFG+V V + A+K L KA V Q KAE + +++ +V+L
Sbjct: 9 IGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ ++ V +Y+ G + L R R IA T + +H K I
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC-AIESVH---KMGFI 123
Query: 626 HCDIKPQNILLDGTFNARISDFGLA----------------------------------- 650
H DIKP NIL+D + +++DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 651 -----KLLKTDQTQTTTA--IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703
+ + Q Q A + GT Y+APE T D +S G++L E++ +
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 704 FEVDATEECQMILADW 719
F D E Q+ + +W
Sbjct: 244 FLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 1/137 (0%)
Query: 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNIL 635
LV +Y + G L + +++ ++ + + L +H +IH DIK NIL
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 636 LDGTFNARISDFGLAKLL-KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILL 694
L ++ DFG +K+ T GT YVAPE ++ P + K D++S G+LL
Sbjct: 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235
Query: 695 LELVCCRKNFEVDATEE 711
EL+ ++ F+ + EE
Sbjct: 236 YELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVK--KLYKAVNEGE----QEFKAEISA--IGRTN 557
++ LG+G+FG VY +++K VA + K+ K + GE + +A A + + +
Sbjct: 5 QQRLGKGSFGTVY----LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 558 HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFL---------FRKSRRPNWYKRMQIAFG 608
H +V+ E + ++ EY L L +++ W+ ++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
G+ Y+H+ +I+H D+K +NI L +I DFG+++LL TT GT
Sbjct: 118 ---GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTP 169
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFE 705
Y++PE K+ +K D++S G +L E+ C FE
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 27/202 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK-AEISAIGR-TNHKNLVQLLG 566
+GEG F +V K + + K A+K + K EQ EI A+ R + H N+++L+
Sbjct: 7 IGEGTFSEVLK-AQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 567 FCNEGEH-RL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS-- 622
+ + RL LV+E + + +L + L + +RP R Y+++ KS
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYE-LIKGRKRP---------LPEKRVKSYMYQLLKSLD 114
Query: 623 -----QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WF 676
I H DIKP+NIL+ +++DFG + T T+ Y APE
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLL 171
Query: 677 KNLPITAKVDVYSFGILLLELV 698
+ K+D+++ G + E++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 512 GAFGKVYKGVLTTENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNHKNLVQLLGF 567
GA+G VY V E + A+KK+ K N+ +Q F E + + +V +
Sbjct: 12 GAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSMFCS 69
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHC 627
H +V EYV G A L P RM A T L YLH I+H
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHR 125
Query: 628 DIKPQNILLDGTFNARISDFGLAKL-------------LKTDQTQ-TTTAIRGTKGYVAP 673
D+KP N+L+ + +++DFGL+K+ ++ D + + GT Y+AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 674 EWFKNLPITAKVDVYSFGILLLE-LVCCRKNFEVDATEE 711
E VD ++ GI+L E LV C F D EE
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 509 LGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNLVQ 563
LG+G FGKV +L E + A+K L K V + E E + + H L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT--ARGLFYLHEECK 621
L + V EY + G L F SR + + +G L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKL-LKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+++ D+K +N++LD + +I+DFGL K +K T T GT Y+APE ++
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 681 ITAKVDVYSFGILLLELVCCRKNF 704
VD + G+++ E++C R F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL---YKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
+G GA+G V T +K VAVKKL ++++ + ++ E+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLL 80
Query: 566 GF---CNEGEHRLLVYEYVSNGSLADF--LFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
E+ VY V+N AD + + + + + + I + RGL Y+H
Sbjct: 81 DVFTPATSIENFNEVY-LVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIHS-- 136
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+ IIH D+KP N+ ++ RI DFGLA+ + D T GYVA W++
Sbjct: 137 -AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT--------GYVATRWYRAPE 185
Query: 681 I-------TAKVDVYSFGILLLELV 698
I VD++S G ++ EL+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 507 EELGEGAFGKVY--KGVLTTENEKPVAVKKLYKAVNEGEQEFK---AEISAIGRTNHKNL 561
++G+G +G+V+ K T E VA+K++ K++ E + E + T + L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE--- 618
V+LL + E+ L EYV G L + R FY+ E
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-----------FYMAEMFE 112
Query: 619 ---EC-KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
+ IH D+KP+N L+D + + +++DFGL+K + T ++ G+ Y+APE
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPE 168
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW 719
+ VD +S G +L E +C F E L W
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 6/144 (4%)
Query: 555 RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF 614
NH +++++ G +V + + L +L ++SR + + I GL
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YLH + +IIH D+K +NI ++ I D G A+ A GT APE
Sbjct: 172 YLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVETNAPE 226
Query: 675 WFKNLPITAKVDVYSFGILLLELV 698
+K D++S GI+L E++
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 70/283 (24%), Positives = 111/283 (39%), Gaps = 50/283 (17%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
+ +G G +G VYK E A+K + E + EI + H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGEL-AAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
+ + E+ GSL D QIA+ T +GL+YLH + K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVA-PEWFKNLPIT 682
+H DIK NILL + +++DFG++ Q T I K ++ P W P
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA--PEV 177
Query: 683 AKV----------DVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732
A V D+++ GI +EL A + M +D R L L+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL----------AELQPPM------FDLHPMRALFLM 221
Query: 733 VEND---EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+++ + D +K F + ++P RP +K+ Q
Sbjct: 222 TKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 509 LGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNEGE--QEFKAEISAIGRTNHKNLVQL 564
LG+G FG V + L +E+ + VAVK L + +EF E + + +H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 565 LGFC--NEGEHRL----LVYEYVSNGSLADFLF--RKSRRP-NWYKRMQIAF--GTARGL 613
+G + + RL ++ ++ +G L FL R P + + F A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVA 672
YL + IH D+ +N +L+ ++DFGL+ K+ D + A + ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 673 PEWFKNLPITAKVDVYSFGILLLELV 698
E + T DV++FG+ + E++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 36/232 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC 568
LG G+ G V+ V ++ +K VAVKK+ + + EI I R +H N+V++
Sbjct: 13 LGCGSNGLVFSAV-DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 569 NEGEHRL--------------LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF 614
L +V EY+ LA+ L + + R+ + RGL
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARL-FMYQLLRGLK 128
Query: 615 YLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQ------TQTTTAIRGT 667
Y+H + ++H D+KP N+ ++ +I DFGLA+++ ++ T
Sbjct: 129 YIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV----T 181
Query: 668 KGYVAPEWFKNLP--ITAKVDVYSFGILLLELVCCRKNFEVD-ATEECQMIL 716
K Y +P + P T +D+++ G + E++ + F E+ Q+IL
Sbjct: 182 KWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQE 545
M +DF ++VI G GAFG+V + V +++ A+K L K + +
Sbjct: 40 MKAEDF--DVIKVI--------GRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSA 88
Query: 546 FKAEISAI-GRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ 604
F E I N + +VQL + ++ +V EY+ G L + + W +
Sbjct: 89 FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWAR--- 145
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTA 663
F TA + L IH D+KP N+LLD + + +++DFG K+ + TA
Sbjct: 146 --FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 664 IRGTKGYVAPEWFKNLPITA----KVDVYSFGILLLELV 698
+ GT Y++PE K+ + D +S G+ L E++
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 30/185 (16%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKK-LYKAVNEGEQEFKA----EISAIGRTNHKNLVQ 563
+G+G FG+V+K + ++ VA+KK L + EG F EI + H+N+V
Sbjct: 20 IGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 564 LLGFCN---EGEHR-----LLVYEYVSNGSLADFLFRKSRR---PNWYKRMQIAFGTARG 612
L+ C +R LV+E+ + LA L K+ + K M++ G
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN---G 131
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK---LLKTDQTQTTTAIRGTKG 669
L+Y+H +++I+H D+K NIL+ +++DFGLA+ L K + T T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 670 YVAPE 674
Y PE
Sbjct: 189 YRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQLLG 566
+G GA G V T VAVKKL + +A E+ + NHKN++ LL
Sbjct: 29 IGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87
Query: 567 F------CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTARGLFYLHEE 619
E + LV E + + +L + + ++RM + + G+ +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELD----HERMSYLLYQMLCGIKHLHS- 141
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+ IIH D+KP NI++ +I DFGLA+ T+ T + T+ Y APE +
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197
Query: 680 PITAKVDVYSFGILLLELV 698
VD++S G ++ ELV
Sbjct: 198 GYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 45/230 (19%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQ--EFKAEISAIGRTNHKNLVQLL 565
+G GAFG+V + V + A+KKL K+ + E EQ +AE + ++ +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ + L+ EY+ G + L +K + + + F A + + K I
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQT--------------------------- 658
H DIKP N+LLD + ++SDFGL LK
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 659 QTTTAIR----------GTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+ T R GT Y+APE F + D +S G+++ E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 40/210 (19%)
Query: 509 LGEGAFGKV---YKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQ 563
+G GA G V Y +L E+ VA+KKL + +A E+ + NHKN++
Sbjct: 32 IGSGAQGIVCAAYDAIL----ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADF----LFRKSRRPNWYKRMQIAFGTAR-------- 611
LL + SL +F + + N + +Q+ R
Sbjct: 88 LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 612 --GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
G+ +LH + IIH D+KP NI++ +I DFGLA+ T T + T+
Sbjct: 136 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVC 699
Y APE + VD++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 19/174 (10%)
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
+ ++ A+G+ +L IH D+ +NILL +I DFGLA+ ++ D
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 663 A-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY 721
R ++APE N T + DV+S+GILL E+ F + ++ M + Y
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI------FSLGSSPYPGMPVDSKFY 327
Query: 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+E L E M DI + C DP RP K++ Q+IE
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKS---------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 57/200 (28%), Positives = 82/200 (41%), Gaps = 30/200 (15%)
Query: 509 LGEGAFGKVYKGVLTT---ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
L G+ G+V+ V T E K V VK + G EI + +H+ ++ L+
Sbjct: 100 LTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLI 152
Query: 566 GFCNEGEHRLLV---YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF----YLHE 618
+V Y+ L ++ R P ++ A R L YLH
Sbjct: 153 HAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLP-----LEQAITIQRRLLEALAYLHG 203
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVAPEWFK 677
IIH D+K +NI LD NA + DFG A KL T GT +PE
Sbjct: 204 R---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA 260
Query: 678 NLPITAKVDVYSFGILLLEL 697
P AK D++S G++L E+
Sbjct: 261 LDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL--YKAVNEGEQEFKAEISAI-GRTNHKNLVQLL 565
+G GAFG+V + V K A+K L ++ + + F E I N +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ + +V EY+ G L + + W + F TA + L I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR-----FYTAEVVLALDAIHSMGFI 164
Query: 626 HCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQTTTAIRGTKGYVAPEWFKNLP---- 680
H D+KP N+LLD + + +++DFG K+ K + TA+ GT Y++PE K+
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 223
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDA 708
+ D +S G+ L E++ F D+
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL---YKAVNEGEQE-FKAEISAIGRTNHKNLVQL 564
+G GAFG+V V+ +N V K+ ++ + E F+ E + +++ + L
Sbjct: 9 IGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFR-KSRRPN-----WYKRMQIAFGTARGLFYLHE 618
+ + LV +Y G L L + + R P + M IA + L Y+H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
DIKP NIL+D + R++DFG L D T ++ GT Y++PE +
Sbjct: 127 ---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 679 LP-----ITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
+ + D +S G+ + E++ F ++ E
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL---YKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
+G GA+G V T+ VAVKKL ++++ ++ ++ E+ + H+N++ LL
Sbjct: 25 VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 566 GFCN-----EGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
E + + + ++ L + + K ++ + + RGL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHS-- 138
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+ IIH D+KP N+ ++ +I DFGLA+ TD T GYVA W++
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT--------GYVATRWYRAPE 187
Query: 681 I-------TAKVDVYSFGILLLELVCCRKNFE-VDATEECQMIL 716
I VD++S G ++ EL+ R F D ++ ++IL
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 36/208 (17%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKL---YKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
+G GA G V T + VA+KKL ++ V ++ ++ E+ + NHKN++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLL 81
Query: 566 GFCNEGEHRLLVYEYVSNGSLADF----LFRKSRRPNWYKRMQIAFGTAR---------- 611
+ SL +F L + N + +Q+ R
Sbjct: 82 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
G+ +LH + IIH D+KP NI++ +I DFGLA+ T T + T+ Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 184
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVC 699
APE + VD++S G ++ E++
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 509 LGEGAFGKV---YKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQ 563
+G GA G V Y VL ++ VA+KKL + +A E+ + NHKN++
Sbjct: 25 IGSGAQGIVCAAYDAVL----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 564 LLGF------CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTARGLFYL 616
LL E + LV E + + +L + + ++RM + + G+ +L
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELD----HERMSYLLYQMLCGIKHL 135
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
H + IIH D+KP NI++ +I DFGLA+ T T + T+ Y APE
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 190
Query: 677 KNLPITAKVDVYSFGILLLELV 698
+ VD++S G ++ E+V
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 505 FKEELGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGEQE-FKAEI---SAIGRT 556
F + LG GAFGKV + G+ +N VAVK L + + E+E +E+ S +G
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-- 99
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS 594
HKN+V LLG C G L++ EY G L +FL +K+
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISA 552
Y++L+ + G GA+G V + K VA+KKLY+ +A E+
Sbjct: 17 YRDLKQV--------GSGAYGTVCSALDRRTGAK-VAIKKLYRPFQSELFAKRAYRELRL 67
Query: 553 IGRTNHKNLVQLLGFCNEGEHR------LLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-I 605
+ H+N++ LL LV ++ G+ L + + R+Q +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSE--DRIQFL 123
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
+ +GL Y+H + IIH D+KP N+ ++ +I DFGLA+ +TD T +
Sbjct: 124 VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV- 177
Query: 666 GTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFE 705
T+ Y APE N + T VD++S G ++ E++ + F+
Sbjct: 178 -TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 505 FKEELGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRT-NH 558
F + LG GAFGKV + G+ ++ VAVK L + + E+E +E+ + NH
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRK 593
N+V LLG C G L++ EY G L +FL RK
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 44/213 (20%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL---- 564
+G G+FG VY+ + +EK VA+KK V + Q E+ + NH N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEK-VAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 565 -----------------LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF 607
+ F + H+ + + +N +L FL + ++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK-----------LYSY 177
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKTDQTQTTTAIRG 666
R L Y+H + I H D+KPQN+L+D T ++ DFG AK L Q +
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-- 232
Query: 667 TKGYVAPE-WFKNLPITAKVDVYSFGILLLELV 698
++ Y APE T +D++S G ++ E++
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC 568
+G GAFG+V V+ ++ + + K+ +N+ E +AE +A R LV G C
Sbjct: 9 IGRGAFGEV--AVVKMKHTERIYAMKI---LNKWEMLKRAE-TACFREERNVLVN--GDC 60
Query: 569 N----------EGEHRLLVYEYVSNGSLADFLFR-KSRRPNWYKRMQIAFGTARGLFYLH 617
+ + LV +Y G L L + + R P R F A + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIH 116
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
+ +H DIKP N+LLD + R++DFG + D T ++ GT Y++PE +
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 678 NL-----PITAKVDVYSFGILLLELV 698
+ + D +S G+ + E++
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 51/214 (23%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISA---------IGRTNHK 559
+G GA+G V + EK VA+KKL + F++EI A + H+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK-VAIKKLSRP-------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADF----LFRKSRRPNWYKRMQIAFG------- 608
N++ LL + S S +F L + + K M
Sbjct: 75 NVIGLLDV------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL 122
Query: 609 ---TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
GL Y+H + IIH D+KP N+ ++ +I DFGLA+ D T +
Sbjct: 123 VYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV- 176
Query: 666 GTKGYVAPEWFKN-LPITAKVDVYSFGILLLELV 698
T+ Y APE N + VD++S G ++ E++
Sbjct: 177 -TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 54/265 (20%), Positives = 110/265 (41%), Gaps = 39/265 (14%)
Query: 517 VYKGVLTTENEKPVAV---KKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF----CN 569
+YKG+ N K V + KK +K + EI + R + N++++ GF +
Sbjct: 36 IYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 570 EGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDI 629
+ L+ EY + G L + L K + ++ ++ +A +GL+ L++ + ++
Sbjct: 93 DLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 630 KPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL--PITAKVDV 687
+ L+ + +I GL K+L + + + Y + + ++ T K D+
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDI 205
Query: 688 YSFGILLLELVCCRKNFE-VDATEECQMILADWAYDCFRERKLGLLVENDEEAMD-DIKR 745
YS G++L E+ + FE + E +I+ N+ + D
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYDLIINK----------------NNSLKLPLDCPL 249
Query: 746 VEKFVMIAIWCIQEDPSLRPAMKKV 770
K ++ A C D RP +K++
Sbjct: 250 EIKCIVEA--CTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 507 EELGEGAFGKVYKGVL-----------TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR 555
E LG G ++Y G+L + E E V +K L + + F S + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 556 TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFY 615
+HK++V L G C ++V E+V G L F+ RKS + ++A A L Y
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 616 LHEECKSQIIHCDIKPQNILL--DGTFNA-----RISDFGLAKLLKTDQTQTTTAIRGTK 668
L ++ ++H ++ +NILL +G ++SD G+ + + Q
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI----- 172
Query: 669 GYVAPEWF---KNLPITAKVDVYSFGILLLEL 697
++APE KNL I A D +SFG L E+
Sbjct: 173 PWIAPECVEDSKNLSIAA--DKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 39/125 (31%), Positives = 58/125 (46%), Gaps = 16/125 (12%)
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT-AIRGTKG 669
R + YLHE ++IIH DIK +NI ++ + + DFG A D GT
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN-FEVDATEECQMILADWAYDCFRERK 728
APE P VD++S GI+L E+ C + FE D + DC +R+
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG----------DCDSDRQ 298
Query: 729 LGLLV 733
+ L++
Sbjct: 299 IKLII 303
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 508 ELGEGAFGKVY--------------KGVLTTENEKPVAVKKLYKAVNEGEQ---EFKAEI 550
+L GAFGK++ +GV +T KP + + K V G + + + EI
Sbjct: 155 DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEI 214
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLV---YEYVSNGSLADFLFRKSRRPNWYKRMQIAF 607
A+GR NH+N++++ + ++ Y++ + D F RP + I
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMK 274
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGT 667
+ Y+H++ ++IH DIK +NI L+ + DFG A + ++ GT
Sbjct: 275 QLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331
Query: 668 KGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+PE D++S G++LL+++
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
GL ++H +++ D+KP NILLD + RISD GLA + + GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 672 APEWF-KNLPITAKVDVYSFGILLLELV 698
APE K + + D +S G +L +L+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 42/248 (16%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQ--EFKAEISAIGRTNHKNLVQLL 565
+G GAFG+V + V + A+K L KA + E EQ +AE + + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ + L+ E++ G + L +K + IA T + +H+ I
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQ---LGFI 123
Query: 626 HCDIKPQNILLDGTFNARISDFGL----------------------------------AK 651
H DIKP N+LLD + ++SDFGL A+
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 652 LLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
K ++ Q + GT Y+APE F D +S G+++ E++ F + +E
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 712 CQMILADW 719
+ +W
Sbjct: 244 TYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 66/302 (21%), Positives = 107/302 (35%), Gaps = 47/302 (15%)
Query: 500 VITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTN 557
+I F++ + K VAVKK L E + + EI +
Sbjct: 5 LIGKCFED----LMIVHLAK---HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 558 HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLF 614
H N++ + +V ++ GS D L K+ P + IAF L
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALD 115
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA-KLLKTDQTQT-----TTAIRGTK 668
Y+H IH +K +ILL G +S + ++K + Q +
Sbjct: 116 YIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 669 GYVAPEWF-KNLP-ITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMIL------ADW 719
+++PE +NL K D+YS GI EL ++ AT QM+L
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPC 229
Query: 720 AYDC---------FRERKLGLLVENDEEAMDDI-KRV--EKFVMIAIWCIQEDPSLRPAM 767
D + + N+ +++D R E F C+Q DP RP+
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289
Query: 768 KK 769
+
Sbjct: 290 SQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 42/248 (16%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQ--EFKAEISAIGRTNHKNLVQLL 565
+G GAFG+V + V + A+K L KA + E EQ +AE + + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ + L+ E++ G + L +K + IA T + +H+ I
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ---LGFI 123
Query: 626 HCDIKPQNILLDGTFNARISDFGL----------------------------------AK 651
H DIKP N+LLD + ++SDFGL A+
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 652 LLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
K ++ Q + GT Y+APE F D +S G+++ E++ F + +E
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 712 CQMILADW 719
+ +W
Sbjct: 244 TYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 9/108 (8%)
Query: 594 SRRPNWYKRMQIAFGTARGLF----YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649
R Q+ AR L Y+H E IIH DIK +N+L++G + + DFG
Sbjct: 251 GARLRPLGLAQVT-AVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 650 AKLLK-TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696
A + + T I GT APE P T VD++S G+++ E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 15/96 (15%)
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGY 670
R L Y+H + + H D+KP+NIL + +I DFGLA++ D T TAI T Y
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWTD-Y 166
Query: 671 VAPEWFKNLPI--------TAKVDVYSFGILLLELV 698
VA W++ + T +D++S G + E++
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
GL ++H +++ D+KP NILLD + RISD GLA + + GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 672 APEWF-KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
APE K + D +S G +L +L+ F T++
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 39/229 (17%)
Query: 496 KELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI 553
++++V T FK LGEG FGKV + K K+ + V + ++ K EI +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEA--WDRKRKEYCAVKIVRNVPKYTRDAKIEIQFM 179
Query: 554 GRTNHKNLVQLLG-------FCNEGEHRLLVY-EYVSNGSLADFLFRKSRRPNWYKRM-Q 604
+ + F NE H +V +Y L D++ + P ++ + Q
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHG--PFSHRHLAQ 235
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA----------------RISDFG 648
I F T L Y H E ++H D+KP+NIL++ + RI D G
Sbjct: 236 IIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
D+ + TAI T+ Y +PE L D++S G ++ EL
Sbjct: 294 GC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
|
Length = 467 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 36/132 (27%), Positives = 53/132 (40%), Gaps = 23/132 (17%)
Query: 584 GSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642
SLAD L RP N + + L LH + KS NILL T++
Sbjct: 1 VSLADIL-EVRGRPLNEEEIWAVCLQCLGALRELHRQAKSG---------NILL--TWDG 48
Query: 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702
+ G +T R ++APE + T K D+YS GI L E +
Sbjct: 49 LLKLDGSVAF------KTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL---- 98
Query: 703 NFEVDATEECQM 714
++E+ EE ++
Sbjct: 99 DYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 62/260 (23%), Positives = 97/260 (37%), Gaps = 54/260 (20%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
LG GAFG+V + A+K L K +N + KAE + +++ +V+L
Sbjct: 9 LGIGAFGEVCLAC-KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ ++ V +Y+ G + L R P R IA T + K I
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT----LAIESVHKMGFI 123
Query: 626 HCDIKPQNILLDGTFNARISDFGLA----------------------------------- 650
H DIKP NIL+D + +++DFGL
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 651 ----KLLKTDQTQTTTAIR-------GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+L +Q T R GT Y+APE T D +S G++L E++
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243
Query: 700 CRKNFEVDATEECQMILADW 719
+ F E Q+ + +W
Sbjct: 244 GQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 13/185 (7%)
Query: 547 KAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA 606
++E+ + +H +V+ + LL+ EY S G L + ++ + ++ ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 607 FGTARGLFY-----LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-- 659
LFY L E +++H D+K NI L T ++ DFG +K +D
Sbjct: 173 L-----LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SDSVSLD 226
Query: 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW 719
++ GT Y+APE ++ + K D++S G++L EL+ + F+ + E +
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 720 AYDCF 724
YD F
Sbjct: 287 KYDPF 291
|
Length = 478 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 46/226 (20%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE---QEFKAEISAIGRTNHKNLVQLL 565
+G+G G+VY + + VA+KK+ + ++E + F E H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRR-VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 566 GFCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF-------- 614
C++G+ VY Y+ +L L KS ++A T+ G F
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLL--KSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 615 ----YLHEECKSQIIHCDIKPQNILLDGTFN-ARISDFGLAKL----------LKTDQTQ 659
Y+H + ++H D+KP NILL G F I D+G A + D+
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 660 TTTA-------IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+ I GT Y+APE +P + D+Y+ G++L +++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 512 GAFGKVYKGVLTTENEKPVAVKKLYKA--VNEG-EQEFKAEISAIGRTNHKNLVQLLGFC 568
GAFGKVY G N K AVK + KA +N+ + +AE A+ + +V L
Sbjct: 15 GAFGKVYLG-RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 569 NEGEHRLLVYEYVSNGSLADFL-----FRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
+ LV EY+ G + L F + + + +A L YLH +
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLH---RHG 124
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKL 652
IIH D+KP N+L+ + +++DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 509 LGEGAFGKVYKGVLTTEN-EKPVAVKKLYK--AVNEGEQE-FKAEISAIGRTNHKNLVQL 564
+G GAFG+V V+ +N + A+K L K + E F+ E + + + + L
Sbjct: 9 IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFR-KSRRPNWYKR-----MQIAFGTARGLFYLHE 618
+ + LV +Y G L L + + R P R M +A + L Y+H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
DIKP N+LLD + R++DFG L D T + GT Y++PE
Sbjct: 127 ---------DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 54/260 (20%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLL 565
LG GAFG+V + + A+K L K + KAE + +++ +V+L
Sbjct: 9 LGIGAFGEVCLA-RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
+ ++ V +Y+ G + L R P R IA T + +H K I
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC-AVESVH---KMGFI 123
Query: 626 HCDIKPQNILLDGTFNARISDFGLA----------------------------------- 650
H DIKP NIL+D + +++DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 651 -----------KLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+ + Q ++ GT Y+APE T D +S G++L E++
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243
Query: 700 CRKNFEVDATEECQMILADW 719
+ F E QM + +W
Sbjct: 244 GQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 59/248 (23%), Positives = 94/248 (37%), Gaps = 70/248 (28%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQ--EFKAEISAIGRTNHKNLVQLL 565
+G+GAFG+V + V + K A+K L K+ + + +Q KAE + ++ +V L
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC----- 620
+ ++ L+ E++ G L L + F FY+ EC
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYD-----------TFSEDVTRFYM-AECVLAIE 115
Query: 621 ---KSQIIHCDIKPQNILLDGTFNARISDFGLA-------------KLLKTDQTQTTTAI 664
K IH DIKP NIL+D + ++SDFGL+ KLL+ +
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 665 R---------------------------------GTKGYVAPEWFKNLPITAKVDVYSFG 691
R GT Y+APE F + D +S G
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235
Query: 692 ILLLELVC 699
++ E +
Sbjct: 236 AIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 19/174 (10%)
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
++ + A+G+ +L IH D+ +N+LL A+I DFGLA+ + D
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 663 A-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY 721
R ++APE + T + DV+S+GILL E+ K+ IL + +
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF 324
Query: 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
++ K G + + A +I + K C +P+ RP +++Q+I+
Sbjct: 325 --YKMVKRGYQMSRPDFAPPEIYSIMKM------CWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
+ + ARG+ +L +H D+ +N+LL +I DFGLA+ + D +
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS- 295
Query: 663 AIRGTK----GYVAPE-WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILA 717
+G+ ++APE F NL T DV+S+GILL E+ F + T MI+
Sbjct: 296 --KGSTFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEI------FSLGGTPYPGMIVD 346
Query: 718 DWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
Y+ + K G + + A ++ +M+ W +P RP+ ++ ++E
Sbjct: 347 STFYN---KIKSGYRMAKPDHATQEVYD----IMVKCW--NSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNLVQ 563
++G G +G VYK ++EK A+K++ EG EI+ + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIA 62
Query: 564 LLG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFY-----L 616
L F + + ++ L+++Y + F ++ + N K MQ+ + L Y +
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGI 121
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNAR----ISDFGLAKLLKT--DQTQTTTAIRGTKGY 670
H + ++H D+KP NIL+ G R I+D G A+L + + T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 671 VAPEWFKNLP-ITAKVDVYSFGILLLELV 698
APE T +D+++ G + EL+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNLVQ 563
++G G +G VYK ++++ A+K++ EG EI+ + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVIS 62
Query: 564 LLG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFY-----L 616
L F + + ++ L+++Y + F ++ + N K +Q+ G + L Y +
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGI 121
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNAR----ISDFGLAKLLKT--DQTQTTTAIRGTKGY 670
H + ++H D+KP NIL+ G R I+D G A+L + + T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 671 VAPEWFKNLP-ITAKVDVYSFGILLLELV 698
APE T +D+++ G + EL+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 509 LGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTN-HKNLV 562
LG GAFG+V + G+ +++ VAVK L E Q +E+ + H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFR 592
LLG C +G ++ EY G L D+L R
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 22/63 (34%), Positives = 30/63 (47%), Gaps = 7/63 (11%)
Query: 172 SSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSI-GSGYQVVFNQSGFIYLTARNG 230
+ + LQ+DGNL+LY DG WS+ TS GSG V G + L +G
Sbjct: 15 TDSSYTLILQSDGNLVLY------DGNGRVVWSSNTSGKGSGCVAVLQDDGNLVLYDNSG 68
Query: 231 SIL 233
+L
Sbjct: 69 KVL 71
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA-I 664
+F A+G+ +L + IH D+ +NILL +I DFGLA+ + D
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
R ++APE + T + DV+SFG+LL E+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 64/249 (25%), Positives = 89/249 (35%), Gaps = 74/249 (29%)
Query: 509 LGEGAFGKVYKGVLT---TENEKPVAVKKLYKAVNEGEQEFKAEI---SAIGRTNHKNLV 562
LGEGAFG VYK L ++ E +KK A G EI + R +
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKK---ATEYGA----VEIWMNERVRRACPNSCA 192
Query: 563 QLL-GF-----CNEGEHRLLVYEYVSNGSLAD-------------FLFRK-------SRR 596
+ GF + + LV+ Y +LAD +L K R
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLER 252
Query: 597 PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLL 653
N K +Q LF L + I+H D+KPQNI+ G+F +I D G A L
Sbjct: 253 EN--KIIQTIMRQI--LFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLGAAADL 306
Query: 654 KTDQTQTTTAIRGTKGYVAPE------------------------WFKNLPITAKVDVYS 689
+ Y APE W NLP + D+YS
Sbjct: 307 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP--DRFDIYS 364
Query: 690 FGILLLELV 698
G++ L++
Sbjct: 365 AGLIFLQMA 373
|
Length = 566 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA-I 664
+F ARG+ +L + IH D+ +NILL +I DFGLA+ + D
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
R ++APE + T + DV+SFG+LL E+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 41/207 (19%)
Query: 511 EGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKA----EISAIGRTNHKNLVQL- 564
EG +G VY+ E VA+KKL + EG F EI+ + + H N+V +
Sbjct: 15 EGTYGVVYRARDKKTGEI-VALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVK 70
Query: 565 ---LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA----------R 611
+G + + +V EYV + L + + M+ F +
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEH-DLKSLM----------ETMKQPFLQSEVKCLMLQLLS 117
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
G+ +LH+ + I+H D+K N+LL+ +I DFGLA+ + T + T Y
Sbjct: 118 GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYR 173
Query: 672 APEWFKNLPI-TAKVDVYSFGILLLEL 697
APE + +D++S G + EL
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 15/102 (14%)
Query: 505 FKEELGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGEQ-----EFKAEISAIGR 555
+ LG GAFGKV + G+ + + + VAVK L + E E K I IG
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH-IG- 68
Query: 556 TNHKNLVQLLGFCNEGEHRLLV-YEYVSNGSLADFLFRKSRR 596
+H N+V LLG C + L+V EY G+L+++L +S+R
Sbjct: 69 -HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL--RSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 18/144 (12%)
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-----WYKRMQIAFGTARGLF 614
N+V L + + LV ++ G L + + P W M +A L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
LH E I+ D+ P NILLD + +++ F + + + + A+ Y APE
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAV--ENMYCAPE 152
Query: 675 WFKNLPITAKVDVYSFGILLLELV 698
T D +S G +L EL+
Sbjct: 153 VGGISEETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 40/239 (16%)
Query: 497 ELEVITGGFKEELGEGAFGKVY--KGVLTTENEKPVAVKKLYKAVNEGEQ-EFKAEISAI 553
E EVI +++G G FG+V+ K T E A+ Y+ + E E+ + E++ +
Sbjct: 14 EYEVI-----KKIGNGRFGEVFLVKHKRTQEFFCWKAIS--YRGLKEREKSQLVIEVNVM 66
Query: 554 GRTNHKNLVQLLG-FCNEGEHRL-LVYEYVSNGSLADFL---FRKSRRPNWYKRMQIAFG 608
HKN+V+ + F N+ +L ++ E+ G L+ + ++ + + + I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 609 TARGLFYLHE----ECKSQIIHCDIKPQNIL-----------------LDGTFNARISDF 647
L Y H +++H D+KPQNI L+G A+I DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 648 GLAKLLKTDQTQTTTAIRGTKGYVAPEWF--KNLPITAKVDVYSFGILLLELVCCRKNF 704
GL+K + + + GT Y +PE + K D+++ G ++ EL + F
Sbjct: 187 GLSKNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFR--KSRRPNWYKRMQIAFG 608
S + + +H +L + G C G ++V E+V +G L D R K R P +K + +A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWK-ITVAQQ 125
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILL------DGTFN-ARISDFG--LAKLLKTDQTQ 659
A L YL ++ ++H ++ +NILL +GT ++SD G L + ++ +
Sbjct: 126 LASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE 182
Query: 660 TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLEL 697
++APE ++ D +SFG LLE+
Sbjct: 183 RIP-------WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 36/111 (32%), Positives = 49/111 (44%), Gaps = 11/111 (9%)
Query: 509 LGEGAFGKVYKGV-LTTENEKPV---AVKKLYKAVNEGE-QEFKAEISAIGRTN-HKNLV 562
LG GAFGKV +G +PV AVK L E Q +E+ + H N+V
Sbjct: 45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIV 104
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRK-----SRRPNWYKRMQIAFG 608
LLG C + ++ EY G L ++L + SR P K+ FG
Sbjct: 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFG 155
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 509 LGEGAFGKVYK----GVLTTENEKPVAVKKLYKAVNEGE-----QEFKAEISAIGRTNHK 559
LG GAFG+V + G+ T + VAVK L + E E K I IG +H
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IG--HHL 71
Query: 560 NLVQLLGFCNE-GEHRLLVYEYVSNGSLADFLFRKSRR 596
N+V LLG C + G +++ E+ G+L+++L +S+R
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL--RSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 793 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.61 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.27 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.14 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.8 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.37 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.34 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.98 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.36 | |
| PLN02236 | 344 | choline kinase | 96.15 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.03 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.48 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.8 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.51 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=444.05 Aligned_cols=288 Identities=47% Similarity=0.774 Sum_probs=250.4
Q ss_pred cCCCCCHHHHHHHhcccc--cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeee
Q 003818 489 NLQDFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566 (793)
Q Consensus 489 ~~~~~~~~el~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 566 (793)
....|+|+++..+|++|+ ..||+|+||.||+|.+.++ +.||||++.....+..++|.+|+.++.+++|||||+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~--~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG--TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC--CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 577899999999999998 5899999999999998643 789999887654321567999999999999999999999
Q ss_pred EEecCC-ceEEEEeecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003818 567 FCNEGE-HRLLVYEYVSNGSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI 644 (793)
Q Consensus 567 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 644 (793)
||.+.+ +.+||||||++|+|.++|+.... .++|..|++|+.++|+||+|||+.+.+.|||||||++|||+|+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999998 59999999999999999998766 8899999999999999999999998889999999999999999999999
Q ss_pred eecCCccccCC-CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHH
Q 003818 645 SDFGLAKLLKT-DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDC 723 (793)
Q Consensus 645 ~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~ 723 (793)
+|||+|+.... ....... ..||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+..... ....+.+|+...
T Consensus 219 sDFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHHHHH
Confidence 99999976554 2211111 16999999999999999999999999999999999999988765422 223378899999
Q ss_pred hhccccceeecccch-hhhhH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 724 FRERKLGLLVENDEE-AMDDI-KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 724 ~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
+.++++..++|+... ..... +.+.++..++.+|++.+|++||+|.||+++|+.....
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999875 44443 6888999999999999999999999999999765543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=384.87 Aligned_cols=249 Identities=34% Similarity=0.514 Sum_probs=207.9
Q ss_pred cccccccceeEEEeEeCCCCcee-EEEEEechhcccc--hHHHHHHHHHHhcCCccccceeeeEEecCC-ceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKP-VAVKKLYKAVNEG--EQEFKAEISAIGRTNHKNLVQLLGFCNEGE-HRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~ 582 (793)
+.||+|+||+||+|.+. |+. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 47 ~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 56999999999999985 444 9999997643222 568999999999999999999999999988 7999999999
Q ss_pred CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFR-KSRRPNWYKRMQIAFGTARGLFYLHEECKSQ-IIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 659 (793)
+|+|.++++. ....+++..+++++.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999988 478899999999999999999999998 6 99999999999999997 99999999998655432 2
Q ss_pred ceecccCcccccCccccc--CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 660 TTTAIRGTKGYVAPEWFK--NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~--~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
..+...||+.|||||++. ...|+.|+||||||+++|||+||+.||......+.. ......+....+..
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~-------~~v~~~~~Rp~~p~--- 269 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA-------SAVVVGGLRPPIPK--- 269 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcCCCCCCCc---
Confidence 233366999999999999 569999999999999999999999999987653321 12222222222111
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....+..++.+||+.||+.||++.+++..|+...
T Consensus 270 ------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 270 ------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred ------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 14456788899999999999999999999998644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=365.15 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=211.0
Q ss_pred CCCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEec
Q 003818 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE 570 (793)
Q Consensus 492 ~~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 570 (793)
.++..+++.. +.||+|..|+|||+.++ .+++.+|+|.+.... ....+++.+|+++++..+||+||+++|.|..
T Consensus 75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 75 GISLSDLERL-----GVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred ccCHHHhhhh-----hhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 3556677654 67999999999999975 467899999995543 3445789999999999999999999999998
Q ss_pred CC-ceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 571 GE-HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 571 ~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
.. ...|+||||.+|+|++++..- +..++....+|+.+|++||.|||+. .+||||||||+|||++..|.+||+|||.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 88 599999999999999998654 5688899999999999999999963 2999999999999999999999999999
Q ss_pred ccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchh-HHHHHHHHHHHHHhhccc
Q 003818 650 AKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATE-ECQMILADWAYDCFRERK 728 (793)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~-~~~~~l~~~~~~~~~~~~ 728 (793)
+..+... ...+..||..|||||.+.+..|+.++||||||+.++|+..|+.|+...... .....+.. .+-.
T Consensus 226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~----~Iv~-- 296 (364)
T KOG0581|consen 226 SGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC----AIVD-- 296 (364)
T ss_pred cHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH----HHhc--
Confidence 9876544 445577999999999999999999999999999999999999999875211 11111111 1111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
++.+..+.. ....++++++..||++||.+||+++|+++.
T Consensus 297 -----~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 -----EPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----CCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112222211 467889999999999999999999998864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=380.26 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=215.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|.||.|+.|.++.. ..||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++.++||||||+.|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~--~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGS--TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHhcCCccceEEEEEEcCC--CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 457899999999999999643 36999999775 345578999999999999999999999999999999999999999
Q ss_pred CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFR-KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.++|+. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+....+.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999987 677889999999999999999999998 99999999999999999999999999999666655544444
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..-...|.|||.+....++.|||||||||+||||+| |+.|+......+... .+.+|.. ...+
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~--------~le~GyR---------lp~P 426 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE--------LLERGYR---------LPRP 426 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH--------HHhccCc---------CCCC
Confidence 445678999999999999999999999999999998 778888777665322 2223321 2223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
..+++.+.+++..||..+|++|||++.+...|+..-..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 34667788999999999999999999999999875543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=361.59 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=200.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc-------chHHHHHHHHHHhcCCccccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||.|-+|. ...+++.||||++.+.... .....++|+++|++++|||||++++++...+..|||
T Consensus 176 i~~~LGsGafg~Vkla~-e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV 254 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAY-EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV 254 (475)
T ss_pred eeeeecCCceeEEEEEE-EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence 35789999999999988 5567899999999764322 123457999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CcEEEeecCCccccC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT---FNARISDFGLAKLLK 654 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~ 654 (793)
|||++||+|.+.+..+. .+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+...
T Consensus 255 lE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred EEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999997663 344555677999999999999999 99999999999999765 889999999999876
Q ss_pred CCCCcceecccCcccccCcccccCCCC--C-CccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPI--T-AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--s-~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
....+.+.+||+.|.|||++.+... . .++|+||+||+||-+|+|.+||........ +.+.+..++...
T Consensus 331 --~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI~~G~y~f 401 (475)
T KOG0615|consen 331 --EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQILKGRYAF 401 (475)
T ss_pred --cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHHhcCcccc
Confidence 3445667889999999999987643 3 378999999999999999999987654431 112222333221
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .....+-.++.+++|.+||..||++|||++|+++
T Consensus 402 ~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 G------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 1122344567889999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=358.83 Aligned_cols=200 Identities=32% Similarity=0.511 Sum_probs=178.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.++||+|+|++||+|+++..+ ..||||.+.+. ..+..+.+..|+.+|+.++|||||++++++..++.++||||||.+
T Consensus 15 ~~~iG~GsfavVykg~h~~~~-~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSG-TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred hhhccCcceEEEEEeEeccCC-ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 356999999999999987654 89999999776 344456688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC------CcEEEeecCCccccCCCC
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT------FNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgla~~~~~~~ 657 (793)
|+|.+|+++++ .+++.....++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+.+..
T Consensus 94 GDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 94 GDLSDYIRRRG-RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 99999997764 688899999999999999999999 99999999999999764 568999999999887433
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC 712 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~ 712 (793)
...+.+|++-|||||++...+|+.|+|+||+|++|||+++|+.||+.....|.
T Consensus 170 --~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 170 --MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred --HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 34457899999999999999999999999999999999999999998877663
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=390.83 Aligned_cols=263 Identities=29% Similarity=0.471 Sum_probs=220.2
Q ss_pred HHHhcccccccccccceeEEEeEeC----CCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCc
Q 003818 499 EVITGGFKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH 573 (793)
Q Consensus 499 ~~~t~~f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 573 (793)
..-...|.++||+|+||.||+|... ......||||.+++.... ..++|++|+++++.++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3333456788999999999999854 234579999999887665 67899999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcC---------CCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 574 RLLVYEYVSNGSLADFLFRK---------SRR----PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 574 ~~lV~Ey~~~gsL~~~l~~~---------~~~----~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
.+||+|||..|+|.+||... +.. ++..+.+.||.|||.||.||-++ .+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 99999999999999999742 122 77889999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccC-CCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHH
Q 003818 641 NARISDFGLAKLLK-TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILAD 718 (793)
Q Consensus 641 ~~kl~Dfgla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~ 718 (793)
.+||+||||++..- .+..+....-.-..+|||||.+...+||.+||||||||+|||+++ |+.|+.....+|.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------ 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------ 714 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------
Confidence 99999999998543 333333323335679999999999999999999999999999998 8899988877763
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.+++..+++... +..++.++..|+..||+.+|++||+++||-..|+......
T Consensus 715 --Ie~i~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 --IECIRAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --HHHHHcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 344555554322 2345677899999999999999999999999998865543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=371.99 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=208.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+|+.||.++. ..+|+.||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.++.|||+|+|+
T Consensus 23 g~~LGkGgFA~cYe~~~-~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARD-LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeccCcceEEEEEEE-cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 46799999999999984 3567899999997743 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|..++. .++.+++.++..++.||+.||.|||++ +|+|||||..|++++++.++||+|||||..+..+... ..
T Consensus 102 ~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er-k~ 176 (592)
T KOG0575|consen 102 RGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER-KK 176 (592)
T ss_pred CccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccc-cc
Confidence 999999986 667899999999999999999999999 9999999999999999999999999999988765433 34
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
+.+|||.|+|||++....++..+||||+||+||-||.|++||+...-.+....+ ....... .
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--------k~~~Y~~--P-------- 238 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--------KLNEYSM--P-------- 238 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH--------HhcCccc--c--------
Confidence 578999999999999999999999999999999999999999988666543322 2111111 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+||..+|++||.+|||+++|+..
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0223445789999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.02 Aligned_cols=253 Identities=27% Similarity=0.366 Sum_probs=206.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeee-EEecCCc-eEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLG-FCNEGEH-RLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV~Ey~ 581 (793)
.++||+|.||.|||+.. ..+++.||.|.++-. ..+..+....|+.+|++++|||||++++ .+.++++ ++||||||
T Consensus 24 l~~IG~GsFg~vykv~~-~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKVQC-LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHcCCcchheEEeee-ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 36799999999999984 457889999999743 2334567889999999999999999998 5555555 89999999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 582 SNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECK-SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 582 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
..|+|...+.. ..+.+++..+++++.|++.||..+|..-+ .-|+||||||.||+++.+|.+||+|||+++.+....
T Consensus 103 ~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~ 182 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT 182 (375)
T ss_pred cccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh
Confidence 99999998854 45678899999999999999999998422 138999999999999999999999999999887654
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
.. ....+|||.||+||.+.+.+|+.++||||+||++|||..-++||.+++-.+.. ..+..+....+
T Consensus 183 tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~--------~KI~qgd~~~~----- 248 (375)
T KOG0591|consen 183 TF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC--------KKIEQGDYPPL----- 248 (375)
T ss_pred HH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH--------HHHHcCCCCCC-----
Confidence 43 34467999999999999999999999999999999999999999988544422 22233322211
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.+.-++..+..+|..|+..||+.||+...+++.+..
T Consensus 249 ---p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 ---PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 124577889999999999999999996666655544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=379.85 Aligned_cols=255 Identities=24% Similarity=0.442 Sum_probs=220.3
Q ss_pred ccccccccccceeEEEeEeCCCC--ceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 504 GFKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.++||.|.||.|++|.++..+ ...||||.++... ++...+|+.|+.+|.+++||||++|.|+....+..+||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 34578999999999999987543 5789999998754 44457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
|++|+|+.||+.+..++++.++..+.++||.||.||.++ +.|||||..+||||+.+..+|++|||+++.+.++....
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 999999999999999999999999999999999999998 99999999999999999999999999999886665333
Q ss_pred eeccc--CcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 661 TTAIR--GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 661 ~~~~~--gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
.+..- -..+|.|||.+...+++.++||||||++|||.++ |.+|+..+...+....+ +...
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-----------------e~gy 851 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-----------------EQGY 851 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-----------------Hhcc
Confidence 33322 2468999999999999999999999999999887 89999877766532222 2223
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..+.+++++..|.+|+..|||+|-.+||.+.||+..|++++
T Consensus 852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 34456678888999999999999999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.30 Aligned_cols=237 Identities=29% Similarity=0.345 Sum_probs=198.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+++.. .+++.+|+|++++... ...+...+|..+|.+++||.||+++-.|++.+++|||+||+.
T Consensus 30 lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 478999999999999855 6789999999987532 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
||.|..+|.+. ..+++....-++.+|+.||.|||+. +||||||||+|||+|++|+++|+|||+++..-... ....
T Consensus 109 GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~ 183 (357)
T KOG0598|consen 109 GGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATR 183 (357)
T ss_pred CccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Cccc
Confidence 99999999765 4567777777888999999999998 99999999999999999999999999998544332 2334
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
+.+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+..+....+ ..+++.....
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------~~~k~~~~p~-------- 247 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------LKGKLPLPPG-------- 247 (357)
T ss_pred cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH--------hcCcCCCCCc--------
Confidence 478999999999999999999999999999999999999999988766533322 2222111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRP 765 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RP 765 (793)
-...+.++++...|+.||++|.
T Consensus 248 -~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 -YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -cCCHHHHHHHHHHhccCHHHhc
Confidence 1224567889999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.00 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=204.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++|+|+||+|||++. .++|+.||||++.+... ...+-..+|+++|++++|+|+|.++.+|.....++||+|||+..
T Consensus 8 gkvGEGSYGvV~KCrn-k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRN-KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hccccCcceEEEEecc-CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 4699999999999984 56789999999976533 22356789999999999999999999999999999999999775
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
-|.+ |.+.....+...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+.. .....+..
T Consensus 87 vL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDY 161 (396)
T KOG0593|consen 87 VLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDY 161 (396)
T ss_pred HHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhh
Confidence 5544 555666788889999999999999999998 999999999999999999999999999998764 22233445
Q ss_pred cCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH-------Hhhcc-ccceeecc
Q 003818 665 RGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-------CFRER-KLGLLVEN 735 (793)
Q Consensus 665 ~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-------~~~~~-~~~~~~~~ 735 (793)
+.|..|.|||.+.+ .+|...+||||+||++.||++|.+-|.+..+-+....+...+-. .+... .+.-+.-+
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 68999999999987 68999999999999999999999999888776654433322211 11111 11111111
Q ss_pred cchhhh-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMD-----DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.++... -.....-+++++..||+.||.+|++-+|++.
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 1233456889999999999999999998874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=344.21 Aligned_cols=261 Identities=25% Similarity=0.271 Sum_probs=212.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 582 (793)
++||+|+||.||||+ +..+|+.||+|+++... ........+||.+|++|+||||++|.+...+. ..+|||+|||+
T Consensus 123 ~kIGeGTyg~VYkAr-~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKAR-DLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHhcCcchhheeEee-ecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 579999999999998 55678999999998765 33446678999999999999999999988776 68999999996
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+ +|.-++....-.++..++..++.|++.||.|+|.+ +|+|||||.+|||||.+|.+||+|||||+.+........+
T Consensus 202 h-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 202 H-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred c-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence 5 88888888888999999999999999999999999 9999999999999999999999999999988877776677
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhhcccccee--ecc
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFRERKLGLL--VEN 735 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~~~~~~~~--~~~ 735 (793)
..+-|+.|.|||++.+. .|+.++|+||.||||.||+.|++.|.+....++...+.... ...|...++... ..+
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 77789999999998876 79999999999999999999999999987766544332211 112222222211 111
Q ss_pred cch-----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEE-----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .+.........++|+..+|..||.+|.|+.++++
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 0011122455788999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.38 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=199.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC--ceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--HRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||++.... ++...|||.+........+.+.+|+.+|.+++|||||+++|.....+ .+++.|||+++
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hccccCccceEEEEEEecC-CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4679999999999998653 47889999886653333567899999999999999999999854444 68999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCC--CCCcc
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKT--DQTQT 660 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~--~~~~~ 660 (793)
|+|.+++.+.+..+++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~ 177 (313)
T KOG0198|consen 101 GSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS 177 (313)
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence 999999988766789999999999999999999998 9999999999999999 79999999999987663 22223
Q ss_pred eecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCC-chhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 661 TTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVD-ATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.....||+.|||||++... ...+++|||||||++.||+||+.||... ...+ +............+.
T Consensus 178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-------~~~~ig~~~~~P~ip----- 245 (313)
T KOG0198|consen 178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-------ALLLIGREDSLPEIP----- 245 (313)
T ss_pred cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-------HHHHHhccCCCCCCC-----
Confidence 3446799999999999963 3445999999999999999999999863 1111 111111222122111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
...+....+++..|++.+|++|||++++++..-
T Consensus 246 ----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 246 ----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 113455778999999999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=344.61 Aligned_cols=247 Identities=26% Similarity=0.330 Sum_probs=204.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
|.+.||+|+|++|++|+.. .+++.+|||++.+.. +...+.+..|-.+|.+| .||.|++|+-.|+++..+|+|+||
T Consensus 77 Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred hhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 5678999999999999954 578899999997642 33445678899999999 899999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+++|+|.++|.+. +.+++.....++.+|+.||+|||++ |||||||||+|||+|+++++||+|||.|+.+......
T Consensus 156 A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 156 APNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred cCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 9999999999766 5678888889999999999999998 9999999999999999999999999999987643221
Q ss_pred ---------ce--ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 660 ---------TT--TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 660 ---------~~--~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
.. ..++||..|.+||++.....++.+|+|+|||+||+|+.|.+||...+.--....+... .
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--------~ 303 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--------D 303 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--------c
Confidence 11 3478999999999999999999999999999999999999999987654322222110 0
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.. . .....+...+|+.+.|..||.+|+|..+|.+..
T Consensus 304 y~----f------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 304 YE----F------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred cc----C------CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 00 0 111125567899999999999999998887754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.85 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=208.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
++||+|+-|.||.+. ....++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++++|||||++|+|
T Consensus 279 ~kigqgaSG~vy~A~-~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVAR-KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeee-eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 579999999999998 4456788999999877666677889999999999999999999999888999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.|.+... .+++.++..|.+++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...... ..+..|
T Consensus 358 TDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~TmVG 431 (550)
T KOG0578|consen 358 TDVVTKT--RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTMVG 431 (550)
T ss_pred hhhhhcc--cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccccC
Confidence 9998543 488999999999999999999999 9999999999999999999999999999887766553 344679
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
|+.|||||++....|+++.||||||++++||+-|.+||-.+..-.....+. .++ .+.........
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~ng--------~P~lk~~~klS 496 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNG--------TPKLKNPEKLS 496 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hcC--------CCCcCCccccC
Confidence 999999999999999999999999999999999999998755433222221 121 12222333455
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..|.+++.+||+.|+++||++.|+++.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 678999999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=311.72 Aligned_cols=261 Identities=24% Similarity=0.274 Sum_probs=206.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
++||+|.||.||+|. +..+++.||||+++..... ......+|++.|++++|+||+.+++.|...+...||+||| ..
T Consensus 8 ~~lGEG~~gvVyka~-d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~t 85 (318)
T KOG0659|consen 8 EKLGEGTYGVVYKAR-DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PT 85 (318)
T ss_pred hhhcCcceEEEEEEE-ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cc
Confidence 579999999999999 5567889999999764322 2356789999999999999999999999999999999999 46
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|+..+..+...++...+..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+|+.+..........
T Consensus 86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~- 161 (318)
T KOG0659|consen 86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ- 161 (318)
T ss_pred cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc-
Confidence 89999999999999999999999999999999998 99999999999999999999999999999887554433332
Q ss_pred cCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhhcc-cccee-----e
Q 003818 665 RGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFRER-KLGLL-----V 733 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~~~-~~~~~-----~ 733 (793)
+-|..|.|||.+.+. .|+...|+||.||++.||+-+.+-|.+.++-++...+.... .+.|.+- .+... .
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~ 241 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF 241 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence 568999999988765 79999999999999999999888887776655433322111 0011100 00000 0
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
................++++..|+..||.+|+|++|.+++
T Consensus 242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0111111223345667899999999999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.73 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=208.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccch-HHHHHHHHHHhcCC-ccccceeeeEEecCC-ceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTN-HKNLVQLLGFCNEGE-HRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lV~Ey~~ 582 (793)
.++||.|.||.||+|+- ..++..||||++++....-+ -.-.+|+..|++++ |||||++.+++.+.+ .+++|||||
T Consensus 15 i~klGDGTfGsV~la~~-~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M- 92 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKS-KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM- 92 (538)
T ss_pred HHHhcCCcceeEEEeee-cCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-
Confidence 36799999999999994 45677899999977543322 23468999999998 999999999998887 999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
..+|..++..+.+.+++..+..|+.||++||+|+|.+ |+.||||||+|||+..+..+||+|||+||...... ..+
T Consensus 93 d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp--PYT 167 (538)
T KOG0661|consen 93 DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP--PYT 167 (538)
T ss_pred hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC--Ccc
Confidence 5699999998889999999999999999999999999 99999999999999999999999999999765433 233
Q ss_pred cccCcccccCccccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhhcc---------c
Q 003818 663 AIRGTKGYVAPEWFK-NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFRER---------K 728 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~-~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~~~---------~ 728 (793)
..+.|..|.|||++. ..-|+.+.|+||+|||++|+.+-++-|.+....++...+.+.. ...+.++ +
T Consensus 168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~ 247 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR 247 (538)
T ss_pred hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence 456799999999875 5578999999999999999999999998887766655554322 1111111 1
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
+.......... -......++.+++..|++.||.+|||++|.++.-
T Consensus 248 ~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 248 FPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111111111 1123667889999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.45 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=205.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|.||+||+|.+. | .||||++.... .+..+.|++|+..+++-+|.||+-+.|+|..... .||..+|+|
T Consensus 397 ~~rIGsGsFGtV~Rg~wh---G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 397 GERIGSGSFGTVYRGRWH---G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred cceeccccccceeecccc---c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 478999999999999984 3 39999997643 3355789999999999999999999999998887 999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC-CCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD-QTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~ 662 (793)
.+|+.+|+.....++..+...|+.|||+||.|||.+ +|||||||..||++.+++.+||+|||++..-..- ......
T Consensus 472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 999999998888899999999999999999999998 9999999999999999999999999998643322 112222
Q ss_pred cccCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 663 AIRGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
...|...|||||+++. .+|++.+||||||+++|||++|..||.....+...+. +..|.+ ..+ ..
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm--------VGrG~l--~pd---~s 615 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM--------VGRGYL--MPD---LS 615 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE--------eccccc--Ccc---ch
Confidence 3447889999999964 4799999999999999999999999984443331111 011100 000 01
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
....+...++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1223455678899999999999999999999998887554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.94 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=214.6
Q ss_pred ccccccccccceeEEEeEeCCCCce----eEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEK----PVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
.+.+.||+|+||.||.|.+.+..+. .||||.+.+.. .+...+|.+|..+|+.++|||||+++|+|.+....+|++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 3457899999999999998876654 59999997753 455678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 579 EYVSNGSLADFLFRK------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
|||++|+|..||++. ...++...++.|+.+||+|+.||+++ ++|||||..+|+||++...+||+|||||+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999987 67789999999999999999999998 999999999999999999999999999994
Q ss_pred c-CCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 653 L-KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 653 ~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
+ ..+.........-..+|||||.+....++.|+|||||||+|||++| |..||......+... .....+++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-------~~~~ggRL- 923 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-------DVLEGGRL- 923 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-------HHHhCCcc-
Confidence 3 3333322222233468999999999999999999999999999998 778888776654221 12233322
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
..+..+++.+.+|+..||+.+|++||++..|++.++.+...
T Consensus 924 ---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 924 ---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 22345667888999999999999999999999998775544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=351.59 Aligned_cols=257 Identities=29% Similarity=0.409 Sum_probs=211.1
Q ss_pred ccccccccceeEEEeEeCCCCc--ee-EEEEEech---hcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENE--KP-VAVKKLYK---AVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.++||+|+||.||+|.+...++ .. ||+|..+. ......++|.+|+++|++++|||||+++|++.....+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4789999999999999987644 23 89999875 335566899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+|.||+|.++|.+....++..++..++.++|.||+|||++ ++|||||..+|+|++.++.+||+|||+++........
T Consensus 242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~ 318 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK 318 (474)
T ss_pred ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999998754311111
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
. ....-..+|+|||.+....|++++|||||||++||+++ |..|+......+....+. .++......
T Consensus 319 ~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-------~~~~r~~~~----- 385 (474)
T KOG0194|consen 319 K-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-------KNGYRMPIP----- 385 (474)
T ss_pred c-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-------hcCccCCCC-----
Confidence 1 01124578999999999999999999999999999998 788998877665332221 222111111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSI 782 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 782 (793)
...+..+..++.+|++.+|++||+|.+|.+.|+.......
T Consensus 386 ----~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 386 ----SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1234556778889999999999999999999987655543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.76 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=207.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.++||.|.-++||+|..... ++.||||++.-... .....+++|+..|..++||||++++-.|..+..+|+||.||.+
T Consensus 30 L~e~IG~G~sa~V~~A~c~p~-~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 30 LQEVIGVGASAVVYLARCIPT-NEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred EEEEEeccceeEeeeeeeccc-CCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence 357899999999999997654 48899999965433 2358899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc--
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-- 660 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 660 (793)
|++.+++... ...+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.+||+|||.+--+.......
T Consensus 109 GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred CcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9999999764 45588899999999999999999999 99999999999999999999999999876544332221
Q ss_pred -eecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 661 -TTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
.....||+.|||||++.. ..|+.|+||||||++..||.+|..||......... ...+ .+....+.....
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-------l~tL-qn~pp~~~t~~~ 257 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-------LLTL-QNDPPTLLTSGL 257 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-------HHHh-cCCCCCcccccC
Confidence 134579999999999643 36899999999999999999999999877654321 1111 122222222223
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...........+.+++..||++||++|||++++++.
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 333445566689999999999999999999998863
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.34 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=208.5
Q ss_pred CCCCCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEe
Q 003818 490 LQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCN 569 (793)
Q Consensus 490 ~~~~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 569 (793)
+-++.++++... +=||.|+.|.||+|++. ++.||||+++... +.+|+-|++|+|+||+.+.|+|.
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~---netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH---NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc---CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 344556655443 45999999999999984 5679999886532 45788899999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 570 EGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 570 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
...-+|||||||+.|-|...|.. ++.++......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999954 46678888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc
Q 003818 650 AKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729 (793)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (793)
++..... .....+.||..|||||++++.+.++|+|||||||+|||||||..|+.......+ +
T Consensus 259 S~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----------------I 320 (904)
T KOG4721|consen 259 SKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----------------I 320 (904)
T ss_pred hHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------------E
Confidence 9876543 334456799999999999999999999999999999999999999975433211 1
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.-.-...+...-+..+++-|.-|+++||+-.|..||++++|+..|+...
T Consensus 321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 1111222333334556777888999999999999999999999997644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.58 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=210.8
Q ss_pred cccccccccccceeEEEeEeCCCCceeEEEEEechhcccch-HHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 503 GGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 503 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
..|.++||+|.||.|...... .+..||||+++....... .+|.+|+++|.+++|||||+++|+|..++.+++|+|||
T Consensus 540 L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred eehhhhhcCcccceeEEEEec--CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 346789999999999999874 358899999988665544 89999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-Cc
Q 003818 582 SNGSLADFLFRKSRR-PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-TQ 659 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~-~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 659 (793)
++|+|..|+.++.-. .......+|+.|||.||+||.+. ++|||||.++|+|++.++++||+|||+++-+-... ..
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999876333 35566778999999999999998 99999999999999999999999999999554433 33
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHH--hCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV--CCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ell--tg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
......-..+|||||.+..++++.++|||+||+++||++ |...||.....++..... -..+..........
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~----~~~~~~~~~~~~l~--- 767 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA----GEFFRDQGRQVVLS--- 767 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh----hhhcCCCCcceecc---
Confidence 333445678999999999999999999999999999965 678899877655432222 22222222111111
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
-+.-+...+.+++..||+.+-++||++++|...|...
T Consensus 768 ---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 ---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223556788999999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=339.83 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=202.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh----cc-cchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA----VN-EGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|.||.|+.|.... ++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....+.++||
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~-t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivm 99 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRL-TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVM 99 (370)
T ss_pred eeeeecCCCCeeEEEeeecc-CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEE
Confidence 34789999999999998654 4588999977553 11 23456778999999998 999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 657 (793)
||+.+|+|.+++.+ ...+.+.....++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||++.... ..
T Consensus 100 Ey~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~ 174 (370)
T KOG0583|consen 100 EYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GE 174 (370)
T ss_pred EecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-CC
Confidence 99999999999988 67788899999999999999999998 99999999999999999 999999999998774 23
Q ss_pred CcceecccCcccccCcccccCCC-CC-CccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLP-IT-AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+........ ..+..+......
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~--------~ki~~~~~~~p~-- 244 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY--------RKIRKGEFKIPS-- 244 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH--------HHHhcCCccCCC--
Confidence 34455678999999999999987 86 7899999999999999999999985433211 112222221111
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
... ...+..++.+||+.||.+|+|+.+|+
T Consensus 245 ------~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 245 ------YLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------CcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111 46678999999999999999999999
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.04 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=198.9
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecC-CceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEG-EHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV 577 (793)
+.++||+|+||.||+|... ...++.||+|++..... ...+.+.+|+.++..+ +||||+++++++... ...++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 3578999999999999742 23456899999875432 2345788999999999 899999999988764 467899
Q ss_pred EeecCCCCHHHHHhcCC-------------------------------------------------------------CC
Q 003818 578 YEYVSNGSLADFLFRKS-------------------------------------------------------------RR 596 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~-------------------------------------------------------------~~ 596 (793)
|||+++|+|.+++.... ..
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 99999999999996532 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-ceecccCcccccCccc
Q 003818 597 PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEW 675 (793)
Q Consensus 597 ~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~ 675 (793)
+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ......++..|+|||+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 56778889999999999999998 9999999999999999999999999999865433221 1222345678999999
Q ss_pred ccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHH
Q 003818 676 FKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAI 754 (793)
Q Consensus 676 ~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 754 (793)
+.+..++.++||||||+++|||++ |..||......+.. ...+..+..... .......+.+++.
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~l~~li~ 311 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-------CQRLKDGTRMRA---------PENATPEIYRIML 311 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-------HHHHhcCCCCCC---------CCCCCHHHHHHHH
Confidence 999899999999999999999997 99999765432211 111122211111 1122346789999
Q ss_pred HccccCCCCCCCHHHHHHHHhcCc
Q 003818 755 WCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 755 ~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+||+.||++|||+.||++.|+...
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.93 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=204.5
Q ss_pred ccccccccccceeEEEeEeC--CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 504 GFKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.+.||+|+||.||+|.+. ...+..||+|.++.... .....+.+|+..+.+++||||+++++++..++..++||||
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence 45678999999999999764 34467899999876432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++......+++..++.++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+..........
T Consensus 88 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (266)
T cd05064 88 MSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164 (266)
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence 999999999987666789999999999999999999998 99999999999999999999999999876543222111
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++|||||||++||+++ |+.||......+... .+.++.....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~--------~~~~~~~~~~------- 229 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK--------AVEDGFRLPA------- 229 (266)
T ss_pred ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH--------HHHCCCCCCC-------
Confidence 112235678999999999999999999999999999775 999998765443211 1112211100
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.......+.+++..||+.+|++||++++|.+.|++.
T Consensus 230 --~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 --PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.96 Aligned_cols=260 Identities=19% Similarity=0.292 Sum_probs=204.6
Q ss_pred CCCCCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhcccc---hHHHHHHHHHHhcCCccccceeee
Q 003818 490 LQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNLVQLLG 566 (793)
Q Consensus 490 ~~~~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~ 566 (793)
+..+++++++..+ ...||+|+++.||+|.+ +++.||||+++...... .+.+.+|+.++.+++|||||++++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3444555553321 14699999999999997 57789999997653333 367789999999999999999999
Q ss_pred EEec----CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcE
Q 003818 567 FCNE----GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642 (793)
Q Consensus 567 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 642 (793)
++.+ ....++||||+++|+|.+++... ..+++.....++.+++.||.|||+. .+++||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcE
Confidence 9876 35788999999999999999654 4678889999999999999999973 278899999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~ 720 (793)
||+|||+++.+.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+
T Consensus 163 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i---- 234 (283)
T PHA02988 163 KIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI---- 234 (283)
T ss_pred EEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH----
Confidence 999999998654322 12347889999999976 68899999999999999999999999876544322111
Q ss_pred HHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
...+.... .+......+.+++.+||+.||++|||++||++.|+...
T Consensus 235 ---~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 ---INKNNSLK---------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---HhcCCCCC---------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111100 01123456889999999999999999999999998654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=308.84 Aligned_cols=232 Identities=27% Similarity=0.313 Sum_probs=195.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||.|+||.|.+++.+. ++..+|+|++.+...- ..+...+|..+|+.+.||.++++++.+.+.+.++|||||++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred eeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 3679999999999998654 5889999999775432 33556789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
||.|..+|++. ++++.....-++.+|+.||+|||+. +|++|||||+|||+|.+|.+||+|||.|+..... ..
T Consensus 128 GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 128 GGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred CccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 99999999765 5577778888999999999999998 9999999999999999999999999999876533 45
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
+.+|||.|+|||++...++..++|.|||||++|||+.|.+||......... +.+-++++....-
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY--------~KI~~~~v~fP~~-------- 263 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY--------EKILEGKVKFPSY-------- 263 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH--------HHHHhCcccCCcc--------
Confidence 678999999999999999999999999999999999999999988764433 3333444332211
Q ss_pred HHHHHHHHHHHHHccccCCCCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLR 764 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~R 764 (793)
....+.+|+...|+.|-.+|
T Consensus 264 --fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 --FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCHHHHHHHHHHHhhhhHhh
Confidence 22345678888889888888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.70 Aligned_cols=242 Identities=29% Similarity=0.447 Sum_probs=204.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|.||.||||+ ++.+.+.||+|.+.+..+ +..+.+++|+++++.++|||||.+++.|+...+.++|.||+.+
T Consensus 8 e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGR-RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHhcCCccceeeecc-cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 679999999999999 556788999999976432 3346789999999999999999999999999999999999977
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|..+|... ..+.+..+..|+.++..||.|||+. +|+|||+||.|||++..+.+|++|||+|+.+... ....+.+
T Consensus 86 ~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsi 160 (808)
T KOG0597|consen 86 DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSI 160 (808)
T ss_pred hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeec
Confidence 999999655 5678889999999999999999998 9999999999999999999999999999987653 3345567
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.|||-|||||+..+.+|+..+|.||+||++||++.|++||......+ .+.....+. . ..+.+
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv~~I~~d~-v----------~~p~~ 222 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LVKSILKDP-V----------KPPST 222 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HHHHHhcCC-C----------CCccc
Confidence 89999999999999999999999999999999999999997654332 122222211 1 11224
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+..++...|++||..|.|..+++..
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 55678889999999999999999988753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.48 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=206.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+-|.|-.|++ ..+|+.+|||++.+..+ .....+++|+.+|+.+.|||++++++++++..++|||.||+
T Consensus 16 LgkTLG~Gstg~vrlakh-~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKH-AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhc-ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 346799999999999995 56889999999976522 23457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|.|++++.+++ .+.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||||.+-.++ ...
T Consensus 95 ~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klL 168 (786)
T KOG0588|consen 95 PGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLL 168 (786)
T ss_pred CCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--ccc
Confidence 9999999998775 466788889999999999999998 9999999999999999999999999999764433 334
Q ss_pred ecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.+.+|++.|.|||++.+.+| ..++||||.|||||.||+|+.||++++... +...+..|..+..-.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--------LLlKV~~G~f~MPs~------ 234 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--------LLLKVQRGVFEMPSN------ 234 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCcccCCCc------
Confidence 45679999999999999998 468999999999999999999999765443 223344555443311
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
-..++.+|+.+|+..||++|.|++||++.-
T Consensus 235 ----Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 235 ----ISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ----CCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 224567899999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.57 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=204.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|.||.||||.. ...++.||+|++.-... ...++++.|+.+|.+++|+||.++++.+..+..++++||||.+|+
T Consensus 19 ~~IgrGsfG~Vyk~~d-~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAID-NKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeee-ccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 6799999999999984 45678999999976433 345788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
+.+.|... ..+++....-|+++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++..+....... .+.+
T Consensus 98 v~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 98 VLDLLKSG-NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred hhhhhccC-CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 99999544 3347778888999999999999998 99999999999999999999999999998877665555 5678
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc-cchhhhhHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN-DEEAMDDIK 744 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 744 (793)
||+.|||||++....|+.|+||||||++.+||.+|.+|+....... -+..+... ++.... .
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~--~ 234 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDG--D 234 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCcccc--c
Confidence 9999999999998899999999999999999999999997654321 11111111 112211 5
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....|.+++..||++||+.||+++++++.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 66778999999999999999999998753
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.30 Aligned_cols=250 Identities=34% Similarity=0.553 Sum_probs=196.8
Q ss_pred cccccccccceeEEEeEeC---CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||.|.||.||+|.+. ...+..|+||.++.... +..+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 23467899999965433 3467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-
Q 003818 581 VSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT- 658 (793)
Q Consensus 581 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~- 658 (793)
+++|+|.++|... ...+++..+..|+.||++||+|||++ +++|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887 67789999999999999999999998 999999999999999999999999999987632222
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
...........|+|||.+....++.++||||||+++|||++ |+.||......+... .+.++.....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~--------~~~~~~~~~~----- 226 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE--------KLKQGQRLPI----- 226 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH--------HHHTTEETTS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccee-----
Confidence 12222346778999999999889999999999999999999 678987664433111 1122211111
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.......+.+++..||+.+|++|||+.+|++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111245578899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=327.28 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=199.4
Q ss_pred cccccccccceeEEEeEeCC---------------CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEE
Q 003818 505 FKEELGEGAFGKVYKGVLTT---------------ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFC 568 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~---------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 568 (793)
+.++||+|+||.||++.... ..+..||+|.+.... .....++.+|+.++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 45789999999999997532 234579999987643 22346789999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003818 569 NEGEHRLLVYEYVSNGSLADFLFRKS------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIK 630 (793)
Q Consensus 569 ~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 630 (793)
.+.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+|||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlk 165 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcc
Confidence 99999999999999999999985421 2357788899999999999999998 99999999
Q ss_pred CCCEEEcCCCcEEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh--CCcCCCCC
Q 003818 631 PQNILLDGTFNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC--CRKNFEVD 707 (793)
Q Consensus 631 p~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt--g~~pf~~~ 707 (793)
|+|||+++++.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||+++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 99999999999999999999865433221 1222345788999999988899999999999999999986 55677665
Q ss_pred chhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 708 ATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 708 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...+..... ...+........... ....+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 246 ~~~~~~~~~----~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 TDEQVIENA----GEFFRDQGRQVYLFR------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHHHHHHHH----HHHhhhccccccccC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 443322111 111111111100000 11223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=375.80 Aligned_cols=257 Identities=27% Similarity=0.525 Sum_probs=204.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|+.. .+++.||+|++..... ...+|++.+++++|||||++++++.+++..++||||+++|+
T Consensus 695 ~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 695 ENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred ccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 457999999999999864 3567899999865332 22356889999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.++++ .++|..+.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. |+.+...... ....
T Consensus 770 L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~ 839 (968)
T PLN00113 770 LSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCF 839 (968)
T ss_pred HHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcc
Confidence 999994 37899999999999999999997767799999999999999999988876 6665433221 1224
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch--hhhhH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE--AMDDI 743 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 743 (793)
+|+.|+|||++.+..++.++|||||||++|||++|+.||+..... ...+.+|++............++... .....
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 788999999999999999999999999999999999999643221 12244455544444333333333221 12234
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
++..++.+++.+|++.+|++||||+||++.|++...
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 566788999999999999999999999999998654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.38 Aligned_cols=240 Identities=23% Similarity=0.315 Sum_probs=197.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
..||+|+||.||+++ +..+|+.+|+|++++..- ...+..+.|-.+|...++|.||+++-.|++.+.+||||||++|
T Consensus 147 k~IgkGAfGeVrLar-Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLAR-KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred eeeccccceeEEEEE-EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 579999999999998 556889999999988643 3345678999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC--------
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT-------- 655 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~-------- 655 (793)
|++..+|.+. ..+++.....++.+++-||..||+. |+|||||||+|+|||..|++||+||||+..+..
T Consensus 226 GD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 226 GDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred ccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 9999999766 4567777777888999999999998 999999999999999999999999999853311
Q ss_pred ---------------CCCc----c-------------------eecccCcccccCcccccCCCCCCccceehhHHHHHHH
Q 003818 656 ---------------DQTQ----T-------------------TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697 (793)
Q Consensus 656 ---------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~el 697 (793)
+... . ....+|||.|||||++.+..|+..+|.||||||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 0000 0 0113599999999999999999999999999999999
Q ss_pred HhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC
Q 003818 698 VCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA 766 (793)
Q Consensus 698 ltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 766 (793)
|.|.+||..+...+....+..|-...-.. . ......+..+||.+|+. ||++|.-
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP------~--------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKFP------E--------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccCC------C--------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999998888766666554221111 1 11122566789999999 9999976
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=337.92 Aligned_cols=254 Identities=31% Similarity=0.453 Sum_probs=199.9
Q ss_pred cccccccccceeEEEeEe----CCCCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVL----TTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~----~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|+. ....+..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+++..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 357899999999999874 23456789999986533 23345788999999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC----------------------------------------------------------------
Q 003818 579 EYVSNGSLADFLFRKS---------------------------------------------------------------- 594 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~---------------------------------------------------------------- 594 (793)
||+++|+|.+++....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 9999999999986432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-eec
Q 003818 595 ----------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-TTA 663 (793)
Q Consensus 595 ----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 663 (793)
..+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 1357778899999999999999998 99999999999999999999999999998654432211 112
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||+++|||++ |..||......... ...+..+..... +.
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~~~~----~~---- 340 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-------YKMIKEGYRMLS----PE---- 340 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH-------HHHHHhCccCCC----CC----
Confidence 335667999999999999999999999999999998 88898765433211 111122111100 00
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
....++.+++.+||+.||++||+++||+++|+..
T Consensus 341 -~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 -CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1134678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.66 Aligned_cols=244 Identities=24% Similarity=0.401 Sum_probs=205.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccch---HHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE---QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
|.+.||+|.||.|-+|. ....|+.||||.+++...+++ -.+++|+++|..++||||+.++.+|+..+.+.|||||.
T Consensus 57 ~~etLGkGTYGKVk~A~-e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYa 135 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAY-EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYA 135 (668)
T ss_pred HHHHhcCCcccceeehh-hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEec
Confidence 34679999999999987 445789999999988765544 45789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
.+|.|.||+.+. +.+++.+...+++||..|+.|+|++ +++|||||.+|||+|+++++||+|||++.++... ...
T Consensus 136 S~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfL 209 (668)
T KOG0611|consen 136 SGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFL 209 (668)
T ss_pred CCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc--cHH
Confidence 999999999655 5688889999999999999999998 9999999999999999999999999999876543 345
Q ss_pred ecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.+++|++-|.+||++.+.+| .+.+|-|||||+||-|+.|..||++.+..... ..+..+...+.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv--------rQIs~GaYrEP-------- 273 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV--------RQISRGAYREP-------- 273 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH--------HHhhcccccCC--------
Confidence 66889999999999999998 67899999999999999999999987654321 11222222111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
+.+....-||+|||..||++|.|+.+|....
T Consensus 274 ---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1123346799999999999999999998876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=317.71 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=199.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc--CCccccceeeeEEecCC----ceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR--TNHKNLVQLLGFCNEGE----HRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~E 579 (793)
.+.||+|+||.||||.+. ++.||||++... ..+.|.+|-.+.+. ++|+||+++++.-..+. +++||+|
T Consensus 215 ~eli~~Grfg~V~KaqL~---~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD---NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HHHhhcCccceeehhhcc---CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 467999999999999984 578999998653 44678888877765 69999999999876665 8899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE------CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
|.+.|+|.++|.. ...+|....+|+..+++||+|||+. ++++|+|||||.+||||..++++.|+|||+|..+
T Consensus 289 fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999954 4689999999999999999999975 3678999999999999999999999999999988
Q ss_pred CCCCCcc-eecccCcccccCcccccCC-CCC-----CccceehhHHHHHHHHhCCcCCC--------CCchhHH--HHHH
Q 003818 654 KTDQTQT-TTAIRGTKGYVAPEWFKNL-PIT-----AKVDVYSFGILLLELVCCRKNFE--------VDATEEC--QMIL 716 (793)
Q Consensus 654 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~s-----~~~Dvws~Gvil~elltg~~pf~--------~~~~~~~--~~~l 716 (793)
....... ....+||.+|||||++.+. .+. .+.||||+|.+||||++.=.-++ ..-..+. ...+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 7554332 2236799999999999764 233 37999999999999998433221 1111111 0111
Q ss_pred HHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 717 ADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.+.-...+.++....+.+.-. ....+..+++.+..||..||+.|.|+.=|-+.+.++.-..
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111112222333333332221 1245677899999999999999999988888887655443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=330.14 Aligned_cols=242 Identities=25% Similarity=0.301 Sum_probs=196.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999854 467889999997643 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++... ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 80 GELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 9999998654 4678889999999999999999998 99999999999999999999999999987532221 12233
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........... +....... +.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~----------p~ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------ILMEEIRF----------PR 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH--------HHcCCCCC----------CC
Confidence 5689999999999999999999999999999999999999976544332111 11111110 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1235678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.33 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=216.5
Q ss_pred ccccccccccceeEEEeEeCCC---CceeEEEEEechh-cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 504 GFKEELGEGAFGKVYKGVLTTE---NEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
...++||.|.||.||+|++... ..-.||||..+.+ .....+.|..|..+|++++|||||+++|+|.+ ...+||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 4467899999999999998643 2347889988773 44556889999999999999999999999976 57899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
.++-|.|..||+.+...++......++.||+.||+|||+. +.|||||..+|||+....-+||+|||+++.+..+...
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999999988999999999999999999999998 9999999999999999999999999999998877766
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
......-...|||||.+.-..++.++|||.|||++||+++ |..||.+....+ +...++....
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------VI~~iEnGeR 610 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------VIGHIENGER 610 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------eEEEecCCCC
Confidence 6665556778999999999999999999999999999876 889998754332 3333444444
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.+-+.+++..|..++.+||..+|.+||++.++...|+.
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 55566778889999999999999999999998887744
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.95 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=200.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++.... +..+|+|.+... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 8 FMKELGSGQFGVVHLGKWRA--QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred EeeEecCCcCceEEEEEecc--CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 45789999999999998643 457999987643 233567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.+++.||.|||++ +|+|+||||+||++++++.+||+|||+++.............
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 99999976656788999999999999999999998 999999999999999999999999999876543322222222
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.... .+ .
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i--------~~~~~~~--~~-------~ 224 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--------SRGFRLY--RP-------K 224 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCCCC--CC-------C
Confidence 35568999999998889999999999999999999 89999766544322111 1111100 00 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.....+.+++.+|++.+|++||+++++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1234678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.68 Aligned_cols=248 Identities=27% Similarity=0.294 Sum_probs=198.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|+||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 5 YRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 468999999999999854 457889999986532 2233467889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........ .
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--V 158 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--e
Confidence 99999888653 34678889999999999999999998 999999999999999999999999999986543221 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||..|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+...... .
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~----------~ 224 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----RRVKEDQEE----------Y 224 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH----HHhhccccc----------C
Confidence 23458999999999999999999999999999999999999998654332111111 111111100 1
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 773 (793)
.......+.+|+.+||+.||++||+ ++++++.
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1123356788999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.81 Aligned_cols=261 Identities=21% Similarity=0.224 Sum_probs=201.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccc--hHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG--EQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 582 (793)
.+|++|+||.||+|+ +..+++.||+|+++...+.. .-.-.+|+.+|.+.+|||||.+..+... -+.+|||||||+
T Consensus 82 nrI~EGtyGiVYRak-dk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAK-DKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred hhcccCcceeEEEec-cCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 579999999999998 55677899999997654321 2456889999999999999999987754 457999999996
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
. +|..++......+...+...++.|+++|++|||.+ .|+|||||++|+|+...|.+||+|||+|+.+... ....+
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T 235 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYT 235 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccCc
Confidence 5 89999988888899999999999999999999998 9999999999999999999999999999988755 33445
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhhccccceee----
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFRERKLGLLV---- 733 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~~~~~~~~~---- 733 (793)
..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....++...+.... ...|..-.....+
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 56679999999998765 69999999999999999999999998876655433332211 0011100000000
Q ss_pred -----cccchhhhhH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 734 -----ENDEEAMDDI-KRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 734 -----~~~~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......... .-.+.-++++...|..||.+|.|++|-++.
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000000000 022556788999999999999999997753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.84 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=199.0
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|+.. ..+++.||+|++..... ...+.+.+|+.+++.+ +|+|||++++++......++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 4578999999999998742 22345799999975432 2345688999999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC----------------------------------------------------------------
Q 003818 579 EYVSNGSLADFLFRKS---------------------------------------------------------------- 594 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~---------------------------------------------------------------- 594 (793)
||+++|+|.++++.+.
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 9999999999986431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-eecccCcc
Q 003818 595 -----RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-TTAIRGTK 668 (793)
Q Consensus 595 -----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~ 668 (793)
..+++..+.+++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++......... .....++.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 1356778899999999999999998 99999999999999999999999999997654332211 11233566
Q ss_pred cccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHH
Q 003818 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVE 747 (793)
Q Consensus 669 ~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (793)
.|+|||++.+..++.++|||||||++|||++ |+.||.......... .....+..... + .....
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~-------~~~~~~~~~~~--~-------~~~~~ 342 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY-------KMVKRGYQMSR--P-------DFAPP 342 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH-------HHHHcccCccC--C-------CCCCH
Confidence 8999999998899999999999999999997 999997654332111 11111110000 0 01135
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 748 KFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 748 ~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.75 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=201.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++..++||||+++++++.+++..++||||+
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 3478999999999999864 4567899999976432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... ..
T Consensus 84 ~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 84 PGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 999999999654 4578888899999999999999998 999999999999999999999999999976543 22
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..+. ....... ....
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~----~~~~ 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK------ETLQRPV----YDDP 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc------ccccCCC----CCcc
Confidence 33458999999999999999999999999999999999999998766544322221110 0000000 0000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+||+.+|++||+++++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12234567889999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=316.03 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=204.8
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|..... +...||+|.+.... ......|.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 457899999999999987543 34689999886543 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-c
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-T 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 660 (793)
++++|.+++......+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++........ .
T Consensus 88 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd05033 88 ENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164 (266)
T ss_pred CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccccee
Confidence 99999999987666789999999999999999999998 9999999999999999999999999999877522211 1
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+.... +...... +.
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~----~~--- 229 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA--------VEDGYRL----PP--- 229 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHH--------HHcCCCC----CC---
Confidence 112234678999999998899999999999999999998 9999976544332111 1111100 00
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.......+.+++.+|++.+|++||++.+|++.|++.
T Consensus 230 --~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 --PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.71 Aligned_cols=238 Identities=26% Similarity=0.310 Sum_probs=192.4
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||.||++... .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999854 457789999987542 2334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++..+ ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 80 L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 80 LFHHLQRE-GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99999754 4578889999999999999999998 99999999999999999999999999997543222 1223356
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
||+.|+|||.+.+..++.++|||||||++|||++|+.||......+... .. ....... +...
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~-------~~-~~~~~~~----------~~~~ 216 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR-------KI-LQEPLRF----------PDGF 216 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH-------HH-HcCCCCC----------CCcC
Confidence 8999999999999999999999999999999999999998665433211 11 1111110 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKV 770 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~ev 770 (793)
...+.+++.+||+.||++||++..+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 3457889999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.90 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=202.7
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.+.||+|++|.||+|... +++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 9 QLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred eeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 45688999999999999854 34679999986543 3456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++.... ..+++..+..++.+++.||.|||+. +|+|+||||+||++++++.+||+|||++............
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 99999997643 5688999999999999999999998 9999999999999999999999999999876533222111
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .+...... . .
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--------~~~~~~~~---~------~ 225 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ--------QVDQGYRM---P------C 225 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------HHHcCCCC---C------C
Confidence 1223457999999999899999999999999999999 999997654332111 11111100 0 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.......+.+++.+|++.+|++||++.+|++.||.
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.88 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=212.1
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+..+||-|.||.||.|+++.. .-.||||.++++. ...++|..|..+|+.++|||+|+++|+|..+...|||.|||.+
T Consensus 270 tMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeccCCCcccceeeeeeecc-ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 4567899999999999999764 4679999997754 3468999999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+||++. +..++...++.++.||+.||+||..+ ++|||||..+|+|+.++..+||+|||+++++..+......
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 9999999875 44566677889999999999999988 9999999999999999999999999999999877655444
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...-...|.|||.+....++.|+|||+|||+||||.| |..|+.+....+ ++..+..+.. ...
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--------VY~LLEkgyR---------M~~ 487 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYGLLEKGYR---------MDG 487 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--------HHHHHhcccc---------ccC
Confidence 4445678999999999999999999999999999998 777887655433 2333332221 112
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
+..++..+.+|++.||+.+|.+||+++|+-+.+|.+
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 233566788999999999999999999999988764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=293.60 Aligned_cols=257 Identities=27% Similarity=0.325 Sum_probs=206.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC-----ceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE-----HRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~E 579 (793)
+.+.||+|||+-||.++ .-.+++.+|+|++.....++.+..++|++..++++|||+++++++...+. ..||+++
T Consensus 25 i~~~LgeGGfsfv~LV~-~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 25 IQRLLGEGGFSFVDLVK-GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EeeeecCCCceeeeeec-ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 45789999999999988 44577899999998877777888999999999999999999999875544 4899999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 580 YVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 580 y~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|...|+|.+.+.. ++...++.+.+.|+.+|++||.+||+. .++..||||||.|||+.+.+.++|.|||.+....-.
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 9999999999975 456789999999999999999999987 346999999999999999999999999998755422
Q ss_pred CCcc--------eecccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhh
Q 003818 657 QTQT--------TTAIRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725 (793)
Q Consensus 657 ~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~ 725 (793)
-... -.....|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------------- 247 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------------- 247 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------------
Confidence 1111 11134788999999986 446789999999999999999999999753221
Q ss_pred ccccceeecc-cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 726 ERKLGLLVEN-DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 726 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.+.+...+.. ....+....+++.+.+++.+|+|.||.+||++.+++..++...
T Consensus 248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1222222211 1122222237788999999999999999999999999987653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.94 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=203.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... ..++.||+|++... .....++.+|+.++++++|+||+++++++..++..+++|||++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred EeeecCCcccceEEEEEEe-cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 4578999999999999865 35678999998653 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++.............
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 999999654 34578899999999999999999998 99999999999999999999999999998765432222222
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||+++|||++ |..||......+.... +...... . ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~---~------~~ 227 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--------LEKGYRM---E------RP 227 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------HHCCCCC---C------CC
Confidence 234567999999999899999999999999999998 8999976544332111 1111000 0 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
...+..+.+++.+|++.+|++||++.+++++|+..
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11235688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.93 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=200.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred EEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 3478999999999999864 457789999987542 2234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++.+..+. .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++............
T Consensus 84 ~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 84 KNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred CCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 87776544 3445688889999999999999999998 9999999999999999999999999999876543333333
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH--------HHHhhccccceeec
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA--------YDCFRERKLGLLVE 734 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~~ 734 (793)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..............
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 4568999999999998899999999999999999999999998765433222111100 00000000000000
Q ss_pred ccch------hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEE------AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+... ..........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0001113456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.89 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=197.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++||+|+||.||+|... .+++.||+|+++.... .....+.+|+.++++++||||+++++++.+++..++||||++ +
T Consensus 10 ~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (288)
T cd07871 10 LDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-S 87 (288)
T ss_pred eeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-c
Confidence 468999999999999854 4678899999865432 234567899999999999999999999999999999999997 4
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......++...+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 88 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~ 163 (288)
T cd07871 88 DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNE 163 (288)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCc
Confidence 99999877666778889999999999999999998 999999999999999999999999999975433221 12234
Q ss_pred cCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhhcc----ccceeecc
Q 003818 665 RGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFRER----KLGLLVEN 735 (793)
Q Consensus 665 ~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~~~----~~~~~~~~ 735 (793)
.+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... ...+... .......+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 57899999998865 568999999999999999999999998765544322221110 0000000 00000000
Q ss_pred cch----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEE----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... ..........+.+++.+||+.||.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.79 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=197.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--------------cchHHHHHHHHHHhcCCccccceeeeEEec-
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--------------EGEQEFKAEISAIGRTNHKNLVQLLGFCNE- 570 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~- 570 (793)
.+.||+|.||.|-+|. ...+++.||||++.+... ...+..++|+.+|++++|||||+|+.+..+
T Consensus 102 ~~eiG~G~yGkVkLar-~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLAR-DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhcCCccceEEEEe-ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 4679999999999987 556789999999965321 112578899999999999999999999965
Q ss_pred -CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 571 -GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 571 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
.+.+|||+|||..|.+...--. ...++..+..++++++..||+|||.+ +||||||||+|+||+++|++||+|||.
T Consensus 181 ~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGV 256 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGV 256 (576)
T ss_pred ccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccce
Confidence 5689999999998887653321 12278889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC----CCcceecccCcccccCcccccCCC----CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH
Q 003818 650 AKLLKTD----QTQTTTAIRGTKGYVAPEWFKNLP----ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY 721 (793)
Q Consensus 650 a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~ 721 (793)
+...... .........|||.|+|||...+.. .+.+.||||+||+||.|+.|+.||..+...+....
T Consensus 257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K------ 330 (576)
T KOG0585|consen 257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK------ 330 (576)
T ss_pred eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH------
Confidence 9766322 112223356999999999987632 35689999999999999999999988765442221
Q ss_pred HHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
+.+ ..+......+.-+++.+||.++|++||+.|.+..+|....--
T Consensus 331 --Ivn--------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 331 --IVN--------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --Hhc--------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 122 122222222445678899999999999999999999877643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=293.64 Aligned_cols=244 Identities=26% Similarity=0.385 Sum_probs=205.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|.||.||.|..+ .++..||+|++.+.. .+.++++++|+++-..++||||++++++|.+....||++||.
T Consensus 26 igr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred ccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 3578999999999999965 467899999997753 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 582 SNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+.|+|...|+.. ..+++......++.|+|.||.|+|.. ++|||||||+|+|++.++.+||+|||.+...+ ...
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k 178 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK 178 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence 999999999853 45578888899999999999999988 99999999999999999999999999997544 233
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
..+.+||..|++||...+..++..+|+|++|++.||++.|.+||......+....+ ..-++..
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--------~k~~~~~--------- 241 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--------RKVDLKF--------- 241 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--------HHccccC---------
Confidence 45577999999999999999999999999999999999999999887755433332 1111111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+..-.....++|..|+..+|.+|.+..||+..
T Consensus 242 -p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 -PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11223456789999999999999999998864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.37 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=198.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|+||.||+|... .+++.||+|.+.... .+....+.+|+.++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999864 356789999876432 2334678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce-ecc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-TAI 664 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 664 (793)
|.+++......+++..+..++.|+++||.|||++ +|+|+||||+||+++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999977666788999999999999999999998 999999999999999999999999999876543211111 111
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..+..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ....... ...
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~--------~~~~~~~---------~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--------EQGVRLP---------CPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCCCC---------Ccc
Confidence 23456999999998889999999999999999998 88888765443221111 1110000 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
..+..+.+++.+|++.+|++|||+.+|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.09 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=201.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||+|++..... +..+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred EEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 4578999999999999854 4678899999976432 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++.+....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++..+........
T Consensus 84 ~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 84 PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99999999987767788999999999999999999998 999999999999999999999999999987654443333
Q ss_pred ecccCcccccCccccc------CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 662 TAIRGTKGYVAPEWFK------NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~------~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+ .........
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i-------~~~~~~~~~--- 230 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI-------MNFQRFLKF--- 230 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH-------HcCCCccCC---
Confidence 3456899999999986 456789999999999999999999999876544322111 111110000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.........+.+++..|++ +|++|||+.++++
T Consensus 231 ----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 ----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0111233557788999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.99 Aligned_cols=252 Identities=31% Similarity=0.495 Sum_probs=203.0
Q ss_pred cccccccccceeEEEeEeCCCC----ceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN----EKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|...... .+.||+|.+..... .....+.+|+.++.+++||||+++++++...+..+++||
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 3478999999999999864332 36799998865432 234578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003818 580 YVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI 644 (793)
Q Consensus 580 y~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 644 (793)
|+++++|.+++.... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEE
Confidence 999999999996532 3467888899999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHH
Q 003818 645 SDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYD 722 (793)
Q Consensus 645 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~ 722 (793)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~-------- 237 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE-------- 237 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------
Confidence 99999976543222 12223346788999999998899999999999999999998 999998765443211
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.+..+..... ....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 238 ~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1122211111 12345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.87 Aligned_cols=243 Identities=26% Similarity=0.309 Sum_probs=196.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||++... .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999854 467889999997642 22345778899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 80 GELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9999888654 4678889999999999999999998 99999999999999999999999999987543221 12233
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ...... + +.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--------~~~~~~-~---------p~ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEDIK-F---------PR 216 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--------ccCCcc-C---------CC
Confidence 56899999999999989999999999999999999999999765443321111 111110 0 01
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1234578899999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.90 Aligned_cols=242 Identities=25% Similarity=0.276 Sum_probs=198.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 3478999999999999854 457889999986532 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 84 PGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 999999999654 4578888899999999999999998 9999999999999999999999999999865432 1
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+....
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~~---------- 217 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--------LAGKLEF---------- 217 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCcCC----------
Confidence 2345899999999999989999999999999999999999999876544322111 1111110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 773 (793)
+......+.+++.+||+.||.+||+ ++++++.
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0011345788999999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.41 Aligned_cols=242 Identities=24% Similarity=0.270 Sum_probs=197.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 22 ~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 22 MGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 4578999999999999864 456789999987542 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 101 VGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred CCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 999999999754 4567788888999999999999998 99999999999999999999999999998654322
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+... .+.++.....
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--------~i~~~~~~~p--------- 235 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE--------KILAGRLKFP--------- 235 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH--------HHhcCCcCCC---------
Confidence 23458999999999999999999999999999999999999997655433211 1112221100
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 773 (793)
......+.+++.+||+.||++||+ ++++++.
T Consensus 236 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 -NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 012245778999999999999997 6777643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.70 Aligned_cols=239 Identities=28% Similarity=0.343 Sum_probs=199.5
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEe
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.|.++||+|.||.|+++.++. +++.+|||++++.. .+..+..+.|.+++... +||.|++++..|++.++++.|||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred EEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 356889999999999999765 55699999998854 34456678888888877 59999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+.||++..+ .+...+++....-++..|+.||.|||++ +||+||||.+|||+|.+|++||+||||++..... ..
T Consensus 450 y~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~ 523 (694)
T KOG0694|consen 450 YVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GD 523 (694)
T ss_pred ecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CC
Confidence 9999993322 3456788888999999999999999999 9999999999999999999999999999864322 23
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
...+++||+.|||||++.+..|+.++|.|||||+|||||.|..||.+++.++....|. .. +.
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--------~d----------~~ 585 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--------ND----------EV 585 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--------cC----------CC
Confidence 5567899999999999999999999999999999999999999999888776433321 11 11
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
.++.-.+.+...++.++|.++|++|.-+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2233345567789999999999999877
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.80 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=195.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||++... .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36899999999999854 4678899999976432 2335677899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 80 GELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9999888654 4678899999999999999999998 99999999999999999999999999987532221 12233
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ...... . +.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--------~~~~~~----~------p~ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEIR----F------PR 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCCC----C------CC
Confidence 56899999999999999999999999999999999999999765543321111 111110 0 01
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1235678899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.87 Aligned_cols=243 Identities=26% Similarity=0.316 Sum_probs=199.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|......+..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 34 ~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 45789999999999998765555789999986542 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 114 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~ 185 (340)
T PTZ00426 114 IGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185 (340)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----c
Confidence 999999999654 4578888999999999999999998 9999999999999999999999999999865432 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..+.... .
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--------i~~~~~~~----p----- 248 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK--------ILEGIIYF----P----- 248 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH--------HhcCCCCC----C-----
Confidence 234689999999999998899999999999999999999999987654332111 11111110 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
......+.+++.+|++.+|++|+ +++++++.
T Consensus 249 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 -KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01123467899999999999995 88888764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=312.62 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=201.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..+++|||++++
T Consensus 10 ~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred EeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 3478999999999999864 34579999876532 23568899999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.............
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 87 SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 999999754 45678888999999999999999998 99999999999999999999999999998765433222222
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+....++.++||||||+++|||++ |+.||......+.... +...... +. .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~--------~~~~~~~----~~-----~ 226 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA--------LQRGYRM----PR-----M 226 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH--------HHcCCCC----CC-----C
Confidence 335678999999988889999999999999999998 9999976554432111 1111110 00 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
......+.+++.+|++.+|++||++++|.+.|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.93 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=194.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcC---CccccceeeeEEe-----cCCce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRT---NHKNLVQLLGFCN-----EGEHR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~~~~ 574 (793)
+.+.||+|+||.||+|.....+++.||+|++..... .....+.+|+.+++.+ +||||+++++++. .....
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 346899999999999986555678899999865332 2234566777777665 6999999999885 34568
Q ss_pred EEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 575 LLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
++|+||+. ++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred EEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 99999996 6899988654 34578899999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhcc-c
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRER-K 728 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~-~ 728 (793)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.+.... .+... .
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred cCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 433 2223345899999999999889999999999999999999999999877655433322211100 00000 0
Q ss_pred cc-eeecccc---hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 LG-LLVENDE---EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ~~-~~~~~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. ....... ...........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000 00000122356779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=340.67 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=200.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|......++.||+|.+..........+++|+.+++.++|||||++++++..++..+|||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 45789999999999998655446788889875544444567888999999999999999999999999999999999999
Q ss_pred CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cc
Q 003818 585 SLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QT 660 (793)
Q Consensus 585 sL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 660 (793)
+|.+++... ...+++.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 999988642 34578888999999999999999998 999999999999999999999999999986644322 12
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .. .+.....
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~-------~~-~~~~~~~-------- 291 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ-------VL-YGKYDPF-------- 291 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HH-hCCCCCC--------
Confidence 3345689999999999999999999999999999999999999986654332111 11 1111100
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++..||+.+|++||+++++++
T Consensus 292 -~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 -PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0112346789999999999999999998864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=325.70 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=200.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+++.. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 10 ~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 367999999999999854 467789999986542 233467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 89 ~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~ 162 (331)
T cd06649 89 SLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSF 162 (331)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cccC
Confidence 999998654 4578888999999999999999975 269999999999999999999999999987654322 2234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcc--ccc------------
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER--KLG------------ 730 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~--~~~------------ 730 (793)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+........... ...
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 589999999999998999999999999999999999999976554332211110000000000 000
Q ss_pred ----------------eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 731 ----------------LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 731 ----------------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.+................+.+++.+||+.||++|||+++|++.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000112346789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.73 Aligned_cols=255 Identities=24% Similarity=0.439 Sum_probs=206.3
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+++... .++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 34689999999999997532 34567999998766555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEe
Q 003818 581 VSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS 645 (793)
Q Consensus 581 ~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 645 (793)
+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence 99999999996532 3478889999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHH
Q 003818 646 DFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDC 723 (793)
Q Consensus 646 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~ 723 (793)
|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--------~~ 237 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI--------EC 237 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------HH
Confidence 9999975543221 11223346788999999999899999999999999999998 99998766544311 11
Q ss_pred hhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 724 FRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
+..+...... ...+..+.+++.+||+.+|++|||+++|+++|+.+..
T Consensus 238 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 2222211111 1134568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=311.55 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=200.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|.... +..+|+|.+... .....++.+|+.++.+++||||+++++++.+....++||||++++
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred EeeEecCcccceEEEEEecC--CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 45789999999999997643 346999988653 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.............
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 99999977656789999999999999999999998 999999999999999999999999999876544332222223
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+..... . .
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~----~-----~ 224 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK--------VSQGLRLYR----P-----H 224 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH--------HhcCCCCCC----C-----C
Confidence 35678999999998889999999999999999998 9999976554331111 111111100 0 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.....+.+++.+||+.+|++||++.+|++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=338.53 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=206.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeE-Eec------CCceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGF-CNE------GEHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~~~~lV 577 (793)
.+.|.+|||+.||.|.... .+..+|+|++-...+...+.+.+|+.+|++|+ |+|||.+++. ... .-+.+|.
T Consensus 42 ~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEccCCcEEEEEEEecC-CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 4679999999999998653 34789999998777778889999999999997 9999999993 221 2367899
Q ss_pred EeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 578 YEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
||||.+|.|-|++..+ ...+++.++++|+.++++|+++||.. +++|||||||-+||||..+++.||||||.+......
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~ 199 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS 199 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence 9999999999999754 44599999999999999999999986 788999999999999999999999999998643222
Q ss_pred C-Ccc-------eecccCcccccCcccc---cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhh
Q 003818 657 Q-TQT-------TTAIRGTKGYVAPEWF---KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725 (793)
Q Consensus 657 ~-~~~-------~~~~~gt~~y~aPE~~---~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~ 725 (793)
. ... .....-|+.|.|||.+ .+.++++|+|||||||+||-|+-...||+.....
T Consensus 200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------------- 264 (738)
T KOG1989|consen 200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------------- 264 (738)
T ss_pred CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------------
Confidence 2 111 0112368999999977 5778999999999999999999999999865221
Q ss_pred ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.++...........+...|.+||..||+.||.+||++-+|+..+-++...+
T Consensus 265 -----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 122222233334578899999999999999999999999999997765544
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.88 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=194.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecC--C---ceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--E---HRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~---~~~lV~Ey~ 581 (793)
+++|.|+||.||+|++... ++.||||+.....+ .-.+|+.+|+.++|||||+++-+|... . ...+|||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~-~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRET-EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeecccceEEEEEEcCC-CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 6799999999999998765 78899999865433 235799999999999999998887532 2 345899999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCCCC
Q 003818 582 SNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 582 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 657 (793)
+. +|.++++. ....++...+.-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.+..++
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 65 78888864 355667777778999999999999997 99999999999999965 999999999999887766
Q ss_pred CcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhh---cc--
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFR---ER-- 727 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~---~~-- 727 (793)
.... ...|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.++...++...+.... .+.+. ..
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 5533 3468899999998765 79999999999999999999999999987766544443221 11111 00
Q ss_pred --ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 728 --KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 728 --~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+...+...............+.++++.++|+.+|.+|.++.|++..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111110000122234567899999999999999999988753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.88 Aligned_cols=248 Identities=28% Similarity=0.438 Sum_probs=204.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.++||+|+||.||+|.... ++.+++|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 11 ~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred hhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCC
Confidence 4789999999999998754 67899999877655556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 586 LADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 586 L~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
|.+++... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+||+|||++.......... ...
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~-~~~ 164 (261)
T cd05148 89 LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS-SDK 164 (261)
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc-cCC
Confidence 99999764 45678999999999999999999998 99999999999999999999999999997664332221 123
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+ ..+... ....
T Consensus 165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~---------~~~~ 227 (261)
T cd05148 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI--------TAGYRM---------PCPA 227 (261)
T ss_pred CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--------HhCCcC---------CCCC
Confidence 35678999999988899999999999999999998 89999765533321111 111100 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...+.+.+++.+|++.+|++|||++++++.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 233567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.90 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=200.2
Q ss_pred ccccccccceeEEEeEeCCCC---ceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTEN---EKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|+....+ ...||+|++.... ....+++.+|+.+++.++||||+++++++... ..++++||+
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 367999999999999864322 2348999986543 23456788999999999999999999999764 578999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+........
T Consensus 91 ~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (316)
T cd05108 91 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167 (316)
T ss_pred CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCccee
Confidence 99999999988777788999999999999999999998 999999999999999999999999999987654332211
Q ss_pred -ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 662 -TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 662 -~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+.... .
T Consensus 168 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~--------~~~~~~~~~--~----- 232 (316)
T cd05108 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--------ILEKGERLP--Q----- 232 (316)
T ss_pred ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHhCCCCCC--C-----
Confidence 11224668999999999999999999999999999998 999997655433211 111111100 0
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+.+++.+||+.+|++||++.+|+..|....
T Consensus 233 --~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 233 --PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0112345788999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.75 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=199.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++...+..++|+||++++
T Consensus 8 ~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred hhhhhccCCCceEEEeEec--CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 4578999999999999864 34579999886432 23457888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++..+...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.............
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 99999987666789999999999999999999998 999999999999999999999999999976543322222222
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ....... . ...
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~---~------~~~ 224 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES--------VSAGYRL---Y------RPK 224 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--------HHcCCcC---C------CCC
Confidence 23457999999998899999999999999999999 7899976554432111 1111100 0 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
..+..+.+++.+|++.+|++|||+.||++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2345688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.48 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=200.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999854 467899998865432 233568899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++......+++..+..++.++++||.|||++ +++|+||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9999977666788999999999999999999988 9999999999999999999999999999754433222222223
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
++..|+|||++.+..++.++||||||+++||+++ |..||......+.... ...+..... ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~---------~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ--------VEKGYRMSC---------PQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------CCC
Confidence 4567999999998889999999999999999998 9999976644332111 111110000 111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
....+.+++.+|++.+|++||++.+|++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=315.38 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=203.0
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.... ..++.||+|.+...... ..+.+.+|+++++.++|+||+++++++......++|||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 34789999999999998643 23578999998765443 45789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 580 YVSNGSLADFLFRKS-------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 580 y~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
|+++++|.+++.... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECC
Confidence 999999999996542 3467788899999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHh
Q 003818 647 FGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCF 724 (793)
Q Consensus 647 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~ 724 (793)
||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+... ..
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~--------~~ 237 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE--------CI 237 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------HH
Confidence 999975533222 11222335678999999999999999999999999999998 999997655443211 11
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..+...... ......+.+++.+||+.+|++||++.||++.|++
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 122211111 1233567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=317.04 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=200.3
Q ss_pred ccccccccccceeEEEeEeC---CCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 504 GFKEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+.+.||+|+||.||+|... ...++.|++|.+.... .+....+.+|+.++++++||||+++++++..++..++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 34578999999999999852 2345789999987532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEE
Q 003818 580 YVSNGSLADFLFRK----------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643 (793)
Q Consensus 580 y~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 643 (793)
|+++++|.+++... ...+++.....++.|++.||.|||++ +|+|+||||+|||+++++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEE
Confidence 99999999998532 12467788899999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHH
Q 003818 644 ISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAY 721 (793)
Q Consensus 644 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~ 721 (793)
|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~------- 237 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE------- 237 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------
Confidence 999999986543322 11222335678999999988889999999999999999998 888987654332111
Q ss_pred HHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.......... .......+.+++.+|++.+|++||++.+|.+.|.+
T Consensus 238 -~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -MVRKRQLLPC---------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111110 01123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=329.18 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=202.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred EEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 3478999999999999864 357889999997642 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC----
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ---- 657 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~---- 657 (793)
++++|.+++.+. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 84 PGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999766 5688889999999999999999998 99999999999999999999999999998665433
Q ss_pred ------------------------CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH
Q 003818 658 ------------------------TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ 713 (793)
Q Consensus 658 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~ 713 (793)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11222345899999999999999999999999999999999999999876644332
Q ss_pred HHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003818 714 MILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA-MKKVTQM 773 (793)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~ 773 (793)
..+..+. .... ... .......+.+++..|++ +|++||+ ++++++.
T Consensus 240 ~~i~~~~------~~~~--~p~------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 240 NKIINWK------ESLR--FPP------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHhccC------Cccc--CCC------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2221100 0000 000 00134567889999998 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=320.28 Aligned_cols=261 Identities=24% Similarity=0.277 Sum_probs=194.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++||||+. +
T Consensus 10 ~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 10 LEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred eeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 478999999999999854 4577899999875432 223467889999999999999999999999999999999995 6
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......++...+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++....... ......
T Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 163 (303)
T cd07869 88 DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNE 163 (303)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCC
Confidence 88888877667788889999999999999999998 99999999999999999999999999987543221 122234
Q ss_pred cCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH-HHHHHHH----HHHhhcc-ccceeec---
Q 003818 665 RGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ-MILADWA----YDCFRER-KLGLLVE--- 734 (793)
Q Consensus 665 ~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~-~~l~~~~----~~~~~~~-~~~~~~~--- 734 (793)
.+++.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+.... ...+... .......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 57899999999865 45788999999999999999999999865432211 1110000 0000000 0000000
Q ss_pred --ccc-hhh---hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 --NDE-EAM---DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 --~~~-~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... ... ........+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 000 00112346789999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.97 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=198.9
Q ss_pred ccccccceeEEEeEeCC-CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.||+|+||.||+|++.. ..+..||+|++..... ...+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 38999999999998653 3456799999865432 23467899999999999999999999885 457899999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce--ec
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TA 663 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--~~ 663 (793)
|.+++..+...+++..+++++.|+++||.|||++ +++|+||||+||+++.++.+||+|||++........... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999987667789999999999999999999998 999999999999999999999999999986544322211 11
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||+++||+++ |..||......+... .+..+.... .+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--------~~~~~~~~~---------~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS--------FIEQGKRLD---------CP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH--------HHHCCCCCC---------CC
Confidence 223568999999988889999999999999999996 999998665443211 111111110 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
....+.+.+++..||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12346678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.90 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=199.4
Q ss_pred ccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||.||+|+... .....||||++..... ...+.+.+|+.+++++. ||||+++++++.+....+||||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 4789999999999998532 2235799999965433 23457899999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-----------------------------------------------------------------
Q 003818 580 YVSNGSLADFLFRKS----------------------------------------------------------------- 594 (793)
Q Consensus 580 y~~~gsL~~~l~~~~----------------------------------------------------------------- 594 (793)
|+++|+|.+++..+.
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 999999999986431
Q ss_pred ------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003818 595 ------------------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI 644 (793)
Q Consensus 595 ------------------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 644 (793)
..+++..+..++.|+++||.|||+. +|+|+||||+|||+++++.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEE
Confidence 2356677889999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHH
Q 003818 645 SDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYD 722 (793)
Q Consensus 645 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~ 722 (793)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. ..
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-------~~ 351 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-------YN 351 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-------HH
Confidence 999999865433221 1122346778999999998899999999999999999997 88998765332211 11
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....+.... ........+.+++.+||+.+|++||++.+|+++|+...
T Consensus 352 ~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111000 01123456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.90 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=207.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCc-eEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH-RLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~Ey~~~ 583 (793)
+.+|+|+||.++...++ ..++.+++|++.-.. ....+....|+.++++++|||||.+.+.|.+++. .+|||+||+|
T Consensus 10 ~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhcCccccchhhhhhhc-cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 67999999999988755 455689999886532 3334567899999999999999999999998888 9999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+.+.+.. ..+++..+..++.|++.|+.|||++ .|+|||||+.||+++.+..+||+|||+|+.+..+.. ...
T Consensus 89 g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~a~ 164 (426)
T KOG0589|consen 89 GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-LAS 164 (426)
T ss_pred CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh-hhh
Confidence 99999997654 7788999999999999999999988 999999999999999999999999999999877653 334
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.||.||.+.+.+|..|+|||||||++|||++-+.+|...+..+....+. ++. ..+ .+
T Consensus 165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~--------~~~----~~P-----lp 227 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN--------RGL----YSP-----LP 227 (426)
T ss_pred eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh--------hcc----CCC-----CC
Confidence 4679999999999999999999999999999999999999999887665332221 111 111 12
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..+...+..++..|++.+|+.||++.+++.+
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3456778899999999999999999999875
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.99 Aligned_cols=256 Identities=24% Similarity=0.438 Sum_probs=205.4
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... ..++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 4578999999999998742 234567999998765555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecC
Q 003818 581 VSNGSLADFLFRKS------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648 (793)
Q Consensus 581 ~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 648 (793)
+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCC
Confidence 99999999996432 3478899999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhc
Q 003818 649 LAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRE 726 (793)
Q Consensus 649 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~ 726 (793)
+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+... .+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~--------~i~~ 237 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE--------CITQ 237 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHc
Confidence 99765432221 1122335678999999998899999999999999999998 899987655433211 1122
Q ss_pred cccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
+...... ......+.+++.+||+.+|.+|||+.+|.+.|+.+...
T Consensus 238 ~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 GRVLQRP---------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCcCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2211110 01234588999999999999999999999999886644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.54 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=193.4
Q ss_pred cccccccceeEEEeEeCCC-----------CceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceE
Q 003818 507 EELGEGAFGKVYKGVLTTE-----------NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~-----------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 575 (793)
+.||+|+||.||+|++... ....|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986432 12468899887655555567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc-------EEEeecC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN-------ARISDFG 648 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~Dfg 648 (793)
+||||+++++|..++..+...+++..+..++.||++||+|||++ +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999877667789999999999999999999998 9999999999999987664 8999999
Q ss_pred CccccCCCCCcceecccCcccccCccccc-CCCCCCccceehhHHHHHHHH-hCCcCCCCCchhHHHHHHHHHHHHHhhc
Q 003818 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFK-NLPITAKVDVYSFGILLLELV-CCRKNFEVDATEECQMILADWAYDCFRE 726 (793)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dvws~Gvil~ell-tg~~pf~~~~~~~~~~~l~~~~~~~~~~ 726 (793)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+......+.... ..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---------~~ 223 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---------YE 223 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---------Hh
Confidence 98754322 1234678899999887 467899999999999999998 58888865543321110 01
Q ss_pred cccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.... .. ......+.+++.+||+.||++||++.+|++.|+
T Consensus 224 ~~~~-~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM-LV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc-CC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 00 011245788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.55 Aligned_cols=253 Identities=25% Similarity=0.451 Sum_probs=203.4
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
..+.||+|+||.||+|+..... ...+|+|.+.... ....+.+..|++++++++|+||+++++++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 3578999999999999875432 2479999986542 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++..+...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...........
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 165 (268)
T cd05063 89 ENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165 (268)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence 99999999987767789999999999999999999998 999999999999999999999999999976643322221
Q ss_pred ec--ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TA--IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~--~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.. ...+..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +...... +
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~--------i~~~~~~----~--- 230 (268)
T cd05063 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA--------INDGFRL----P--- 230 (268)
T ss_pred eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH--------HhcCCCC----C---
Confidence 11 123457999999998889999999999999999997 9999976544331111 1111100 0
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 231 --~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 --APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112345678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.37 Aligned_cols=249 Identities=21% Similarity=0.255 Sum_probs=197.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 3578999999999999864 457789999996532 223355788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... .++......++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...........
T Consensus 126 ~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 126 PGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 999999998543 467778888999999999999998 999999999999999999999999999986654333233
Q ss_pred ecccCcccccCcccccCC----CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 662 TAIRGTKGYVAPEWFKNL----PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~----~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+ ...... .
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~------~ 266 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--------MDHKNS------L 266 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH--------HcCCCc------C
Confidence 345699999999998654 4788999999999999999999999876544321111 111100 0
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQM 773 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 773 (793)
...........+.+++..||+.+|++ ||+++++++.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01111123456788999999999998 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.37 Aligned_cols=261 Identities=26% Similarity=0.291 Sum_probs=201.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccc-cceeeeEEecCC------ceEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKN-LVQLLGFCNEGE------HRLLV 577 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~~~lV 577 (793)
++||+|+||+||+|+.. .+|+.||+|+++-...+ ......+|+.+++.++|+| ||++++++...+ ..++|
T Consensus 17 eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 56999999999999955 46689999999765442 3456789999999999999 999999998877 78999
Q ss_pred EeecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC
Q 003818 578 YEYVSNGSLADFLFRKS---RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK 654 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 654 (793)
+||+ .-+|..++.... ..++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+|+...
T Consensus 96 fe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 9999 668999997654 4567788999999999999999999 99999999999999999999999999999654
Q ss_pred CCCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhccc-
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRERK- 728 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~~- 728 (793)
-.. ...+..++|..|.|||++.+. .|+...||||+|||++||++++.-|.+....+....+.+.+-. .|..-.
T Consensus 172 ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 172 IPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred CCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 322 224455689999999999877 7999999999999999999999999888775544333221100 111000
Q ss_pred cceeecccchh---hhhH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 LGLLVENDEEA---MDDI----KRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ~~~~~~~~~~~---~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........... .... .......+++.+||+.+|.+|.|++..+++
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000000000 0000 111356789999999999999999999886
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.43 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=199.3
Q ss_pred ccccccccceeEEEeEeCCCCc---eeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|+....+. ..+++|.+..... ....++..|+..+++++||||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence 3679999999999998643322 2478888754322 223577888889999999999999998864 5678999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-c
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-T 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 660 (793)
++|+|.+++......+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++........ .
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T cd05111 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167 (279)
T ss_pred CCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccc
Confidence 99999999987777789999999999999999999998 9999999999999999999999999999865433221 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .+..+...... .
T Consensus 168 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~--------~~~~~~~~~~~----~- 234 (279)
T cd05111 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD--------LLEKGERLAQP----Q- 234 (279)
T ss_pred cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHCCCcCCCC----C-
Confidence 223446778999999998899999999999999999998 999997664433211 11121111100 0
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.....+.+++.+|++.+|++|||+.|+++.|+....
T Consensus 235 ----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 122456788999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.68 Aligned_cols=243 Identities=27% Similarity=0.317 Sum_probs=195.0
Q ss_pred cccccccceeEEEeEeC--CCCceeEEEEEechhc----ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.||+|+||.||++... ...++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999998753 2457889999997532 12235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++++|.+++... ..+.......++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 9999999998654 4567778888999999999999998 999999999999999999999999999875432221 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..+....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~--------~~~~~~~~--------- 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK--------ILKGKLNL--------- 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCCC---------
Confidence 2234689999999999998899999999999999999999999987654332111 11111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 220 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 -PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011234578999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.37 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=191.6
Q ss_pred ccccccceeEEEeEeCC-----------------------CCceeEEEEEechhcccchHHHHHHHHHHhcCCcccccee
Q 003818 508 ELGEGAFGKVYKGVLTT-----------------------ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~-----------------------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 564 (793)
.||+|+||.||+|.+.. ..+..|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998632 1224689999876555455678899999999999999999
Q ss_pred eeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----
Q 003818 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---- 640 (793)
Q Consensus 565 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---- 640 (793)
++++.+....++||||+++++|..++......+++..+..++.|+++||+|||++ +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999977667788999999999999999999988 999999999999997644
Q ss_pred ---cEEEeecCCccccCCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHH-hCCcCCCCCchhHHHHH
Q 003818 641 ---NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELV-CCRKNFEVDATEECQMI 715 (793)
Q Consensus 641 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~ell-tg~~pf~~~~~~~~~~~ 715 (793)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 37999999886432221 1236778999998875 56899999999999999984 78999976544332111
Q ss_pred HHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 716 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
+ .... .... .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 234 ~--------~~~~--~~~~---------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y--------EKKH--RLPE---------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--------Hhcc--CCCC---------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1000 0000 01235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.95 Aligned_cols=241 Identities=26% Similarity=0.340 Sum_probs=190.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... .+++.||+|+++... ....+.+..|..++.. .+||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999865 456789999997642 2223445566666664 589999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... ..++......++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 80 GGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999988654 4578888899999999999999998 99999999999999999999999999997543322 2223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..... .. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~-~~---------~ 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--------LNDRP-HF---------P 216 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCC-CC---------C
Confidence 356899999999999989999999999999999999999999876543321111 11100 00 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMK-KVT 771 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 771 (793)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234567899999999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.16 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=201.9
Q ss_pred cccccccccceeEEEeEe----CCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVL----TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.++||+|+||.||++.. ....+..+|+|.+..........+.+|+++++.++|+||+++++++......++++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 357899999999999864 2345678999998776555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 581 VSNGSLADFLFRKS--------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 581 ~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECC
Confidence 99999999996542 3467889999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHh
Q 003818 647 FGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCF 724 (793)
Q Consensus 647 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~ 724 (793)
||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+.... .
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--------~ 237 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC--------I 237 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH--------H
Confidence 9999755432211 1122235678999999999899999999999999999998 8999876544332111 1
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..+.... . .......+.+++.+||+.||++||++.+|++.|++
T Consensus 238 ~~~~~~~---~------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 TQGRELE---R------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcCccCC---C------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111000 0 01123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.56 Aligned_cols=243 Identities=25% Similarity=0.304 Sum_probs=195.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||++... .+++.||+|++.... ......+.+|++++..++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999854 467889999997642 22335677899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+++... ..+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 80 GELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9999988654 467888999999999999999997 5 999999999999999999999999999875332221 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--------~~~~~~~----------p 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEIRF----------P 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--------hcCCCCC----------C
Confidence 345899999999999999999999999999999999999999766543321111 1111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
......+.+++.+||+.||++|+ +++++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11234577899999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.82 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=193.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||+||+|... .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 6 IKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 468999999999999854 467889999997542 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT---- 658 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---- 658 (793)
+|+|.+++.+. ..+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 85 GGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999998754 3567788888999999999999998 999999999999999999999999999764321000
Q ss_pred ------------------------------------------cceecccCcccccCcccccCCCCCCccceehhHHHHHH
Q 003818 659 ------------------------------------------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696 (793)
Q Consensus 659 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~e 696 (793)
.......||+.|+|||.+.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00122469999999999999899999999999999999
Q ss_pred HHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 003818 697 LVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIW--CIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 697 lltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--Cl~~dP~~RPt~~evl~~ 773 (793)
|++|+.||......+....+..+ ..... .. ........+.+++.+ |+..+|..||++++|++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~------~~~~~--~~------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINW------ENTLH--IP------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHcc------ccccC--CC------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999876544322221110 00000 00 011122345566665 556677779999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.42 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=194.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... .+++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36999999999999854 456789999987642 22335577888888865 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 80 GGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 99999988654 4578888999999999999999998 999999999999999999999999999875432221 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i--------~~~~~~~----------p 216 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--------LHDDVLY----------P 216 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCCC----------C
Confidence 356899999999999999999999999999999999999999876654322111 1111100 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRP-------AMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~~ 773 (793)
......+.+++..||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01234578899999999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.97 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=199.9
Q ss_pred cccccccceeEEEeEeCCCC--ceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
++||+|+||.||+|+....+ +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999865443 36899999876543 24567899999999999999999999876 5568999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce--
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-- 661 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-- 661 (793)
++|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997654 678999999999999999999988 999999999999999999999999999986644332211
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+.... +.......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~--------~~~~~~~~--------- 218 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM--------LESGERLP--------- 218 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------HHcCCcCC---------
Confidence 11223567999999998899999999999999999998 9999976554332111 11111100
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
........+.+++.+|++.+|++||++.+|++.|++..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01122356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.78 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=192.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||++.. ..+++.||+|+... ..+.+|+.++++++|||||++++++......++|+|++. ++
T Consensus 97 ~~~lg~G~~g~V~~~~d-~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 97 LETFTPGAEGFAFACID-NKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEEEcCCCCeEEEEEEE-CCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 47899999999999985 45677899997532 356789999999999999999999999999999999995 78
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...............
T Consensus 169 L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 244 (391)
T PHA03212 169 LYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244 (391)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence 88888654 4578889999999999999999998 9999999999999999999999999999754333223333456
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhH----HHHHHHHHHHHH------------------
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE----CQMILADWAYDC------------------ 723 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~----~~~~l~~~~~~~------------------ 723 (793)
||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~ 324 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI 324 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence 9999999999999999999999999999999999998875432110 000000000000
Q ss_pred ---hhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 724 ---FRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 724 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... .....+...........+.+++.+||+.||++|||++|+++
T Consensus 325 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 325 YIGLAKKSSR-KPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHhccCC-CCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000011111233457889999999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.38 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=191.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+++.. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999854 457789999987542 23345667788888776 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 80 GGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred CchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 99999988654 4578889999999999999999998 99999999999999999999999999987543221 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.... +....... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--------i~~~~~~~----------~ 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA--------ILNDEVVY----------P 216 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH--------HhcCCCCC----------C
Confidence 34689999999999999999999999999999999999999987654432111 11111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123467889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=309.89 Aligned_cols=254 Identities=25% Similarity=0.446 Sum_probs=202.9
Q ss_pred ccccccccccceeEEEeEeCCCC--ceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 504 GFKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.+.||+|+||.||+|...... +..||+|.+.... ....++|..|+.++++++||||+++++++.++...++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 86 (269)
T cd05065 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEF 86 (269)
T ss_pred EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEec
Confidence 45688999999999999875433 3479999987542 33456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 87 MENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred CCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999999999987777789999999999999999999998 99999999999999999999999999987654332211
Q ss_pred e-e-ccc--CcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 661 T-T-AIR--GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 661 ~-~-~~~--gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
. . ... .+..|+|||.+.+..++.++||||||+++|||++ |..||......+.... .. .......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~----i~---~~~~~~~---- 232 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA----IE---QDYRLPP---- 232 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH----HH---cCCcCCC----
Confidence 1 1 111 2357999999998899999999999999999886 9999976544332111 11 0000000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
....+..+.+++..|++.+|++||++.+|++.|++.
T Consensus 233 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.82 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=196.9
Q ss_pred ccccccceeEEEeEeC-CCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 508 ELGEGAFGKVYKGVLT-TENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+||+|+||.||+|.+. ..+++.+|+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 34567899999864432 23467899999999999999999999885 45678999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce--e
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--T 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--~ 662 (793)
+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.+........ .
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998654 4678899999999999999999998 999999999999999999999999999987654332211 1
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...++..|+|||.+....++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--------i~~~~~~~~--------- 219 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM--------IESGERMEC--------- 219 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHCCCCCCC---------
Confidence 1234578999999988889999999999999999998 9999976544332111 111111111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
+......+.+++.+|++.||++||++++|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01133567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.08 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=200.7
Q ss_pred cccccccccceeEEEeEeCCCCc-eeEEEEEechh-cccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE-KPVAVKKLYKA-VNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~-~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|.....+. ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|+||+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 45789999999999998754332 35788887642 223346788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 582 SNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 582 ~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~d 162 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIAD 162 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECC
Confidence 9999999996532 2477888999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhh
Q 003818 647 FGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFR 725 (793)
Q Consensus 647 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~ 725 (793)
||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |+.||......+... .+.
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~--------~~~ 232 (297)
T cd05089 163 FGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE--------KLP 232 (297)
T ss_pred cCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHh
Confidence 999864321111 111123457999999998889999999999999999997 999997665433111 111
Q ss_pred ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003818 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPP 784 (793)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~p~ 784 (793)
.+..... .......+.+++.+|++.+|.+|||+++|++.|+.+.....+.
T Consensus 233 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 233 QGYRMEK---------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 1110000 1112356789999999999999999999999998866554443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.54 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=200.1
Q ss_pred ccccccccceeEEEeEeC---CCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey 580 (793)
.+.||+|+||.||++.+. ...++.||+|++........+.+.+|+.++++++||||+++++++.. ....++|+||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 467999999999999753 44678899999876655556788999999999999999999998753 3568899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++++|.+++.+....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (284)
T cd05081 89 LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY 165 (284)
T ss_pred cCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcce
Confidence 999999999977666789999999999999999999998 99999999999999999999999999998765432211
Q ss_pred e--ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH--------HHHHHHHHHhhccccc
Q 003818 661 T--TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM--------ILADWAYDCFRERKLG 730 (793)
Q Consensus 661 ~--~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~--------~l~~~~~~~~~~~~~~ 730 (793)
. ....++..|+|||.+.+..++.++||||||+++|||++|..++.......... .+.............
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (284)
T cd05081 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR- 244 (284)
T ss_pred eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc-
Confidence 1 11123456999999998889999999999999999999877654332111000 000000011111100
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
..........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 245 --------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 245 --------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.92 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=198.4
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|... ...++.||+|++.... .....++.+|+.+++.++||||+++++++.++...++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 3478999999999998753 2345789999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 580 YVSNGSLADFLFRKS---------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
|+++++|.+++.+.. ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCc
Confidence 999999999986532 2356778899999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+... ...+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~--------~~~~~~ 238 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR--------FVMEGG 238 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHcCC
Confidence 7554322211 112235678999999998899999999999999999999 688887654433111 111111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..... ......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 LLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11110 1123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.81 Aligned_cols=266 Identities=26% Similarity=0.360 Sum_probs=198.5
Q ss_pred ccccccccceeEEEeEeC---CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 579 (793)
.+.||+|+||+||++.+. ...++.||+|.+..... .....+.+|+.+++.++||||+++++++... ...+++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 467999999999886542 34567899999875432 3456788999999999999999999988653 45789999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++... .+++..+..++.|+++||.|||++ +|+|+||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 89 YVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred CCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99999999999653 488999999999999999999998 9999999999999999999999999999866543221
Q ss_pred c--eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 660 T--TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
. .....++..|+|||.+.+..++.++||||||+++|||++|..|+.......... + ...........+........
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-I-GPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-h-cccccccchhhhhhhhhcCC
Confidence 1 111235567999999998889999999999999999999999986543211000 0 00000000000000000000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
...........+.+++..|++.+|++|||+++|+++|+.+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00111123467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.18 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=196.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++||+|+||.||++... .+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||++++
T Consensus 10 ~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 10 ISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence 468999999999999864 456789999886542 223467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++... ..+++.....++.+++.||.|||+. .+|+|+||||+|||+++++.+||+|||++..+.... ....
T Consensus 89 ~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~ 162 (333)
T cd06650 89 SLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSF 162 (333)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---cccC
Confidence 999999654 4577888899999999999999974 269999999999999999999999999987553321 1234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc--------------
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG-------------- 730 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~-------------- 730 (793)
.|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+..............
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 588999999999998899999999999999999999999976544322111100000000000000
Q ss_pred --------------eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 731 --------------LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 731 --------------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.................++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000000123568899999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.79 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=195.4
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||+||++... .+++.||+|++..... ...+.+..|+.+++.++|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999854 4577899999865422 223567789999999999999999999999999999999999999
Q ss_pred HHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 586 LADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 586 L~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++..+...... ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 9988854 334678899999999999999999998 9999999999999999999999999999765443222 22
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+. ........ ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~----------~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRILNDSV----------TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----HhhcccCC----------CCc
Confidence 3468999999999999999999999999999999999999997654321111110 00001000 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
......+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12345678999999999999999 77777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.59 Aligned_cols=253 Identities=26% Similarity=0.456 Sum_probs=203.0
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|..... .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 457899999999999986433 23479999886532 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++......+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+........
T Consensus 88 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd05066 88 ENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164 (267)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceee
Confidence 99999999987767789999999999999999999998 999999999999999999999999999987654332221
Q ss_pred ec--ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TA--IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~--~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.. ..++..|+|||.+.+..++.++||||||+++||+++ |+.||......+....+ .++.. . +
T Consensus 165 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~~~--~--~--- 229 (267)
T cd05066 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--------EEGYR--L--P--- 229 (267)
T ss_pred ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH--------hCCCc--C--C---
Confidence 11 123567999999998899999999999999999886 99999765443321111 11110 0 0
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.....+..+.+++.+|++.+|++||+|.+|++.|++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 --APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=324.28 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=196.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.+|+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 47 ~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 47 VVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 3478999999999999864 456789999986532 223456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... .++......++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++...........
T Consensus 126 ~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 126 PGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 999999998543 467888899999999999999998 999999999999999999999999999987644333233
Q ss_pred ecccCcccccCcccccCCC----CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 662 TAIRGTKGYVAPEWFKNLP----ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~----~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+ .......
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~~------ 266 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI--------MDHKNSL------ 266 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCccc------
Confidence 3456999999999987643 788999999999999999999999876543322111 1111000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQM 773 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 773 (793)
...........+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 01111223445678888999866654 8999998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.74 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=200.0
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.... ..++.||+|++...... ..+.+.+|+.++..++||||+++++++.+....++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 34789999999999998643 23578999999754332 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003818 580 YVSNGSLADFLFRK---------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI 644 (793)
Q Consensus 580 y~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 644 (793)
|+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEe
Confidence 99999999998532 13467778899999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHH
Q 003818 645 SDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYD 722 (793)
Q Consensus 645 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~ 722 (793)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. .
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--------~ 237 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI--------E 237 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--------H
Confidence 99999886543322 11222345778999999988889999999999999999998 88888765443321 1
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.+..+..... .......+.+++..|++.+|++||++++|++.|+.
T Consensus 238 ~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1122221111 11234557899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.86 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=195.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 478999999999999854 457789999997542 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc---
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--- 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--- 659 (793)
+|+|.+++... ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 85 GGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999764 4578889999999999999999998 9999999999999999999999999998754321110
Q ss_pred ----------------------------------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCC
Q 003818 660 ----------------------------------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFE 705 (793)
Q Consensus 660 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~ 705 (793)
......||+.|+|||++....++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112358999999999999999999999999999999999999998
Q ss_pred CCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 003818 706 VDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA---MKKVTQ 772 (793)
Q Consensus 706 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~ 772 (793)
.....+....+..+ . ..+. . . ........+.+++.+|+. +|.+|++ ++++++
T Consensus 241 ~~~~~~~~~~i~~~-----~-~~~~-~-~------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 241 SDNPQETYRKIINW-----K-ETLQ-F-P------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCHHHHHHHHHcC-----C-CccC-C-C------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 76554322221110 0 0000 0 0 011123456788888986 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=305.86 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=202.0
Q ss_pred cccccccceeEEEeEeCCCCc--eeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|++|.||+|......+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998755334 3699999977655 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc--c
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--T 660 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--~ 660 (793)
++|.+++.... ..+++.....++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997755 5688999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ...... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~--~~------ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-------DKEGER--LE------ 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HhcCCc--CC------
Confidence 112346788999999998899999999999999999999 99999765444321111 111100 00
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.....+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.77 Aligned_cols=253 Identities=23% Similarity=0.409 Sum_probs=199.5
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCc------e
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH------R 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~ 574 (793)
+.+.||+|+||.||+|..... .+..||+|+++.... .....+.+|+..++.++||||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 357899999999999987543 247799999875322 234578999999999999999999998866554 7
Q ss_pred EEEEeecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 575 LLVYEYVSNGSLADFLFRK-----SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
++++||+++++|..++... ...+++.....++.|++.||.|||++ +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 9999999999999998542 24578888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcc
Q 003818 650 AKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRER 727 (793)
Q Consensus 650 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~ 727 (793)
++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~--------~~~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD--------YLRHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcC
Confidence 98654332221 112234678999999988899999999999999999999 888887654333111 11111
Q ss_pred ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 728 KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
..... .......+.+++.+|++.||++|||+.||++.|+.+
T Consensus 232 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.25 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=189.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36999999999999854 456789999997642 22335577888888776 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 80 GGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 99999888654 4678889999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH-HHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC-QMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+....+.......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---------- 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---------- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC----------
Confidence 35689999999999999999999999999999999999999963211110 0011112222222222110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA 766 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt 766 (793)
+......+.+++.+||+.||++||+
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCC
Confidence 1112345778999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.24 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.++||+|+||.||+|+... ...||+|++.... ...+.+.+|+.+++.++|+||+++++++. ....++||||+++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~--~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 9 RLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred eEeeecCCCCCCcEEEEEecC--CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 356789999999999998643 2459999987532 23467899999999999999999999875 4568999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||.++.+.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 9999999753 34578899999999999999999998 9999999999999999999999999999866543322222
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...++..|+|||...+..++.++||||||+++|||++ |+.||......+.... ....... ..
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~--------~~~~~~~---------~~ 224 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRM---------PC 224 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--------HhcCCCC---------CC
Confidence 3346678999999988899999999999999999999 8888876544332111 1111000 00
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.......+.+++.+|++++|++||+++++++.|+..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.11 Aligned_cols=247 Identities=28% Similarity=0.354 Sum_probs=208.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccc---hHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|.||.||+++.+ .+|+.+|+|.+.+..... ...+.+|+.+|+++. |||||.+++.+++....++|||+
T Consensus 39 l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL 117 (382)
T KOG0032|consen 39 LGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMEL 117 (382)
T ss_pred ehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEe
Confidence 3478999999999999865 458899999998765433 358999999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC----CCcEEEeecCCccccCCC
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG----TFNARISDFGLAKLLKTD 656 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~~ 656 (793)
+.||.|.+.+... ..++.....++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||++.....
T Consensus 118 ~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 118 CEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred cCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 9999999999777 389999999999999999999998 9999999999999953 35799999999998776
Q ss_pred CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
.......+||+.|+|||++...+|+..+||||+|+++|.|++|..||......+.... +..+.....
T Consensus 192 -~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~--------i~~~~~~f~---- 258 (382)
T KOG0032|consen 192 -GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA--------ILRGDFDFT---- 258 (382)
T ss_pred -CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH--------HHcCCCCCC----
Confidence 4456667899999999999999999999999999999999999999998876653322 222222111
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...-....+.+.+++..|+..||.+|+|+.++++.
T Consensus 259 --~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 --SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122335667889999999999999999999985
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.41 Aligned_cols=242 Identities=27% Similarity=0.340 Sum_probs=192.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... .+++.||+|+++... ......+..|..++.. ++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36999999999999864 456789999997642 2233456677777775 599999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... ..+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 80 GGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 99999998654 4578888999999999999999998 999999999999999999999999999875322221 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...... . +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i--------~~~~~~--~--------~ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--------RMDNPC--Y--------P 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--C--------C
Confidence 346899999999999989999999999999999999999999876543321111 111100 0 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMK-KVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 772 (793)
......+.+++.+||+.+|++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11234577899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.47 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=198.5
Q ss_pred ccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEec-CCceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNE-GEHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-~~~~~lV~ 578 (793)
.+.||+|+||.||+|.... .+++.||+|++..... ...+.+..|+.++.++ +|+||+++++++.. +...++++
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 4789999999999987432 2347899999865432 2235678899999999 89999999998764 46788999
Q ss_pred eecCCCCHHHHHhcCC------------------------------------------------------------CCCC
Q 003818 579 EYVSNGSLADFLFRKS------------------------------------------------------------RRPN 598 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~------------------------------------------------------------~~~~ 598 (793)
||+++++|.+++.... ..++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 9999999999985421 2567
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-eecccCcccccCccccc
Q 003818 599 WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFK 677 (793)
Q Consensus 599 ~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~ 677 (793)
+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+|||++.
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 888999999999999999998 99999999999999999999999999998664332221 22234567899999999
Q ss_pred CCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHc
Q 003818 678 NLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWC 756 (793)
Q Consensus 678 ~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~C 756 (793)
+..++.++|||||||++|||++ |..||......+. + ...+..+..... +......+.+++.+|
T Consensus 249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~~~~~---------~~~~~~~~~~l~~~c 312 (337)
T cd05054 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---F----CRRLKEGTRMRA---------PEYATPEIYSIMLDC 312 (337)
T ss_pred CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---H----HHHHhccCCCCC---------CccCCHHHHHHHHHH
Confidence 9999999999999999999998 9999975433221 1 111111111100 112235678999999
Q ss_pred cccCCCCCCCHHHHHHHHhcCcC
Q 003818 757 IQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 757 l~~dP~~RPt~~evl~~Le~~~~ 779 (793)
|+.+|++||++.||+++|+....
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.01 Aligned_cols=272 Identities=22% Similarity=0.285 Sum_probs=202.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEec-----CCceEEEEe
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-----GEHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~~lV~E 579 (793)
+.||+|+||.|..++.. .+++.||||++... .....++..+|+++|+.++|+||+.+.+.+.. -+..|+|+|
T Consensus 28 ~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred ccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 56999999999999854 56689999999843 33445778899999999999999999998854 457899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-C
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-T 658 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~ 658 (793)
+| ..+|...+... ..++......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|+...... .
T Consensus 107 lM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99 66888887543 4478888888999999999999998 99999999999999999999999999999875431 1
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhccccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRERKLG 730 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 730 (793)
...+....|..|.|||++.+ ..|+.+.||||.|||+.||++|+.-|.+....++...+.... ...+......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 22344567999999998754 579999999999999999999999998776554433222111 0011100000
Q ss_pred eeecccc------hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 003818 731 LLVENDE------EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAVDVSIPP 784 (793)
Q Consensus 731 ~~~~~~~------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~~~p~ 784 (793)
..+...+ -............+|+.+||..||.+|+|++|.++. |+...+....|
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 0000000 000111223456789999999999999999998864 44444444333
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.62 Aligned_cols=240 Identities=25% Similarity=0.291 Sum_probs=193.9
Q ss_pred cccccccceeEEEeEeC--CCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||++... ...++.||+|++..... .....+..|+.++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 56999999999998642 34678999999976432 233467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++.+. ..+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999998654 4578899999999999999999998 999999999999999999999999999976543322 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ....... +
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i--------~~~~~~~----------p 218 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI--------LKAKLGM----------P 218 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH--------HcCCCCC----------C
Confidence 356899999999999888999999999999999999999999876543321111 1111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKK 769 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~e 769 (793)
......+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112345778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.98 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=194.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||++... .+++.||+|+++.... .....+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36899999999999864 4578899999976422 2335678899999888 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 80 GGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 99999988654 5688999999999999999999998 99999999999999999999999999987432211 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH-HHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC-QMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .....++....+.......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI---------- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----------
Confidence 35689999999999999999999999999999999999999964321110 0011112222222222110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA------MKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~ 772 (793)
+......+.+++.+||+.||++||+ ++++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0012345788999999999999997 667754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.71 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=195.8
Q ss_pred cccccccceeEEEeEeCCCCc-eeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENE-KPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||+|.....+. ..+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754332 357888886532 33446788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecC
Q 003818 584 GSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648 (793)
Q Consensus 584 gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 648 (793)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 2467888999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcc
Q 003818 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRER 727 (793)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~ 727 (793)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||......+... .....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~--------~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--------KLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH--------HHhCC
Confidence 986322111 1111223567999999988889999999999999999997 999997654332111 11111
Q ss_pred ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 728 KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
... +. .......+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus 228 ~~~---~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL---EK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---CC------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 00 0112345789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.70 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=190.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|+.. .+++.||+|++.... ......+.+|+.++++++|+||+++++.+.+++..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 6 IKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999854 467889999997542 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ----- 657 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~----- 657 (793)
+|+|.+++.+. ..++......++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 85 GGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999998655 4567788888999999999999998 99999999999999999999999999975332100
Q ss_pred -----------------------------------------CcceecccCcccccCcccccCCCCCCccceehhHHHHHH
Q 003818 658 -----------------------------------------TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696 (793)
Q Consensus 658 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~e 696 (793)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 003818 697 LVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA---MKKVTQ 772 (793)
Q Consensus 697 lltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~ 772 (793)
|++|+.||......+....+..+ ..... . . ........+.+++.+++ .+|++|++ +.++++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~------~~~~~-~-p------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINW------QTSLH-I-P------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcc------CCCcC-C-C------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999876544322222110 00000 0 0 00111234556666655 49999997 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.55 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=197.1
Q ss_pred cccccccccceeEEEeEeCCCCc-eeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC------CceE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE-KPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRL 575 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~-~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~ 575 (793)
+.+.||+|+||.||+|+...... ..||+|.++... ....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999998754432 368999876532 23346788999999999999999999987432 2568
Q ss_pred EEEeecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 576 LVYEYVSNGSLADFLFR-----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
+++||+++|+|.+++.. +...+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998743 234478889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+.+....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--------~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY--------DYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--------HHHHcCC
Confidence 8764332211 122235678999999999999999999999999999999 78899765433211 1112221
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.... .......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 232 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.64 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=195.4
Q ss_pred cccccccccceeEEEeEeC--CCCceeEEEEEechhc----ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||.||++... ...++.||+|++.+.. ....+.+..|+.++..+ +|+||+++++++..++..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 4578999999999998753 2357889999987532 12235678899999999 599999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 84 LDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 9999999999998654 4578888999999999999999998 99999999999999999999999999998654443
Q ss_pred CcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+. ..+...... .
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~----~~~~~~~~~--~--- 230 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS----RRILKCDPP--F--- 230 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH----HHHhcCCCC--C---
Confidence 3333345689999999999865 47889999999999999999999997543221111111 111111000 0
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
.......+.+++.+||+.||++|| +++++++
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 -----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011234567899999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.22 Aligned_cols=243 Identities=26% Similarity=0.324 Sum_probs=192.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHH---hcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAI---GRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++ +.++||||+++++++...+..++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 3578999999999999854 457889999997542 22234566676655 5678999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|..++.. ..+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 99999999988854 4688999999999999999999998 99999999999999999999999999987533222
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i--------~~~~~~~------- 220 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--------VNDEVRY------- 220 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCC-------
Confidence 1223356899999999999999999999999999999999999999876544322111 1111110
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
+......+.+++.+||+.||++|| ++.++++
T Consensus 221 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 ---PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011234567899999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.56 Aligned_cols=241 Identities=28% Similarity=0.357 Sum_probs=191.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... .+++.||+|.++... ....+.+..|..++.. .+||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36999999999999865 457789999997642 2234556677777765 589999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++..+ ..++......++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 80 GGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 99999998654 4578888999999999999999998 99999999999999999999999999987432211 2233
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +...... . +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~--------~~~~~~~-~---------~ 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES--------IRVDTPH-Y---------P 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCC-C---------C
Confidence 45689999999999999999999999999999999999999986654332111 1111100 0 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMK-KVT 771 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 771 (793)
......+.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01234577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.42 Aligned_cols=201 Identities=26% Similarity=0.361 Sum_probs=172.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 6 ~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred eEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 478999999999999854 457889999997642 2233567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT---- 658 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---- 658 (793)
+|+|.+++.+. ..+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 85 GGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999754 4678899999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCc
Q 003818 659 ------------------------------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDA 708 (793)
Q Consensus 659 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~ 708 (793)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 00123469999999999999999999999999999999999999998765
Q ss_pred hhH
Q 003818 709 TEE 711 (793)
Q Consensus 709 ~~~ 711 (793)
..+
T Consensus 241 ~~~ 243 (363)
T cd05628 241 PQE 243 (363)
T ss_pred HHH
Confidence 544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.94 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=201.9
Q ss_pred ccccccccceeEEEeEeCC----CCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||.||++.... .....+|+|.+.... .+...++.+|+.++.++ +|+||+++++++..+...+++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 4689999999999998643 234689999987542 23345688999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003818 580 YVSNGSLADFLFRK---------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI 644 (793)
Q Consensus 580 y~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 644 (793)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEe
Confidence 99999999998642 34578889999999999999999988 9999999999999999999999
Q ss_pred eecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHH
Q 003818 645 SDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYD 722 (793)
Q Consensus 645 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~ 722 (793)
+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-------- 245 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-------- 245 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH--------
Confidence 9999998765432211 122235678999999998899999999999999999998 899987655433211
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....+... . .+......+.+++.+|++.+|++|||+.+|++.|+...
T Consensus 246 ~~~~~~~~---~------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGYRM---E------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCCcC---C------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111 0 01123456789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=323.62 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=199.6
Q ss_pred ccccccccceeEEEeEeCC----CCceeEEEEEechhccc-chHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||.||+|.+.. ..++.||+|++...... ..+.+.+|+.++.++. |||||++++++...+..++|+|
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 4789999999999998642 34568999999764332 2356889999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-----------------------------------------------------------------
Q 003818 580 YVSNGSLADFLFRKS----------------------------------------------------------------- 594 (793)
Q Consensus 580 y~~~gsL~~~l~~~~----------------------------------------------------------------- 594 (793)
|+++|+|.++++...
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 999999999996532
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcE
Q 003818 595 --------------------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642 (793)
Q Consensus 595 --------------------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 642 (793)
..+++.....++.|++.||.|||+. +|+||||||+|||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEE
Confidence 1245667788999999999999988 99999999999999999999
Q ss_pred EEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHH
Q 003818 643 RISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWA 720 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~ 720 (793)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~------ 352 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY------ 352 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH------
Confidence 9999999986533221 11122346788999999998889999999999999999998 888987654332111
Q ss_pred HHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..+..+.... .+......+.+++..||+.+|++||++++|++.|+...
T Consensus 353 -~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 -NAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111000 01112356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.04 Aligned_cols=242 Identities=29% Similarity=0.364 Sum_probs=195.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||++... .+++.||+|++++.. ......+..|..++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999864 456789999997643 22345667888888877 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++.+. ..+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 80 GGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 99999988654 4688999999999999999999998 999999999999999999999999999875322221 122
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......+.... +....... +
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~--------i~~~~~~~----------~ 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS--------ILEDEVRY----------P 216 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH--------HHcCCCCC----------C
Confidence 34589999999999999999999999999999999999999986654332111 11111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAM-----KKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 772 (793)
......+.+++.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1123567899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.08 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=197.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|.|+.||+.. ...+|+.+|+|.+... ...+.+++.+|+++-+.++|||||++.+.+.+....|||+|+|+|
T Consensus 16 ~e~igkG~FSvVrRc~-~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHccCchHHHHHHH-hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 3679999999999976 4567788888887542 234568899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCCCCCcc
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
++|..-+..+ ...++...-..+.||+++|.|+|.+ +|||||+||+|+++. ...-+||+|||+|..+.. ...
T Consensus 95 ~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--g~~ 168 (355)
T KOG0033|consen 95 GELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--GEA 168 (355)
T ss_pred hHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC--ccc
Confidence 9998766443 3445666778999999999999999 999999999999994 344589999999998772 233
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....|||+|||||+++..+|+..+|||+.||+||-||.|..||.++...... +.+..+...... ++.
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly--------e~I~~g~yd~~~---~~w- 236 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY--------EQIKAGAYDYPS---PEW- 236 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH--------HHHhccccCCCC---ccc-
Confidence 34456999999999999999999999999999999999999999986655432 222333322111 111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..-.+...+|+++||..||.+|.|+.|.++
T Consensus 237 --~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 237 --DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 112345678999999999999999988764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.62 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=193.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV 577 (793)
+.+.||+|+||.||+|+.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++... ...++|
T Consensus 4 i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 3578999999999999854 467889999987532 22345688999999999999999999988543 247999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+. ++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 83 FELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 99995 6898888644 4578899999999999999999998 99999999999999999999999999997643322
Q ss_pred Cc--ceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhc
Q 003818 658 TQ--TTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRE 726 (793)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~ 726 (793)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+.. ...+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 11 1123468999999999876 578999999999999999999999997654332211111000 000000
Q ss_pred ccc----ceeecc--cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 727 RKL----GLLVEN--DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 727 ~~~----~~~~~~--~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
... ..+... .............+.+++.+||+.+|++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 000000 00000001123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.71 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=201.4
Q ss_pred ccccccccceeEEEeEeCCCCc---eeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||+||+|.....+. ..||+|++.... .....++.+|+.++..++|+||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 4789999999999998643322 258999986533 2335678899999999999999999999875 4578999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT- 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 660 (793)
++|+|.+++..+...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 91 ~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~ 167 (279)
T cd05109 91 PYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167 (279)
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceee
Confidence 99999999987767789999999999999999999998 99999999999999999999999999998765332211
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+... .+..+.....
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--------~~~~~~~~~~------- 232 (279)
T cd05109 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD--------LLEKGERLPQ------- 232 (279)
T ss_pred cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHCCCcCCC-------
Confidence 111234678999999998899999999999999999998 889987654433211 1111111100
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.......+.+++..||+.||++||++.++++.|+.....+
T Consensus 233 --~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 --PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1123346788999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=304.32 Aligned_cols=248 Identities=29% Similarity=0.413 Sum_probs=198.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.++||+|+||.||+|... .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 3478999999999999754 345699999865433 4567899999999999999999999885 45689999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..++.+++.||.|||++ +|+|+||||+||++++++.++|+|||++..+..........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 999999764 34578899999999999999999998 99999999999999999999999999998665433222222
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.... ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~~---------~~ 225 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ--------VERGYRMP---------CP 225 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCCC---------CC
Confidence 235568999999988889999999999999999999 8899976544332111 11110000 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=309.07 Aligned_cols=248 Identities=27% Similarity=0.362 Sum_probs=194.8
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||.||++... .+++.+|+|++..... .....+..|+.++++++||||+++++++.++.+.++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999865 4578899999865321 223456679999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 586 LADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 586 L~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888654 34578888899999999999999998 99999999999999999999999999987654332 22234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... ...... . ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~~-~~~~~~----~-----~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTL-EDEVKF----E-----HQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHhh-cccccc----c-----ccc
Confidence 5889999999999888999999999999999999999999754322111111 11111 111100 0 012
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
....+.+++..||+.||++||+++|+++.+.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 3456789999999999999999977665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.83 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=202.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|++|.||++... .+++.|++|.+... .......+.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred EeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 4578999999999999865 45678999988643 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||+++.+...... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence 99999999765 56788899999999999999999988 9999999999999999999999999998866543222 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....+++.|+|||++.+..++.++||||||++++||++|+.||......+.... ...+......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~-------- 222 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK--------IIRGVFPPVS-------- 222 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCCCCc--------
Confidence 234578899999999998999999999999999999999999987654321111 1111111111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+|++.+|++||++.+|++.
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 -QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.57 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=195.5
Q ss_pred cccccccceeEEEeEeCC--CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEe-cCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCN-EGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|.... .....||+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998643 234679999885432 233467889999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc---
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--- 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--- 659 (793)
+++|.+++.+....+++..+..++.|+++||.|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999999987666678888899999999999999998 9999999999999999999999999999755332211
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
......++..|+|||.+.+..++.++||||||+++|||++| ..||......+.. .......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~------ 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT-------VYLLQGRRLL-Q------ 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhcCCCCC-C------
Confidence 11123356789999999888999999999999999999995 5566544332211 1111111100 0
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....+..+.+++..||+.+|++||++.+|++.|+...
T Consensus 224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0012346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.91 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=189.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
++||+|+||.||+|+.. .+++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++||||+++++
T Consensus 80 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 67999999999999854 4578899999865432 234678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+.. ......+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.+..... ......
T Consensus 159 L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~ 229 (353)
T PLN00034 159 LEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSV 229 (353)
T ss_pred ccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccc
Confidence 86532 345667788999999999999998 999999999999999999999999999986543221 122346
Q ss_pred CcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 666 GTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 666 gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
||..|+|||.+.. ...+.++|||||||++|||++|+.||......+...... .. ...... .
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~-~~~~~~---------~ 295 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC----AI-CMSQPP---------E 295 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HH-hccCCC---------C
Confidence 8999999998753 234568999999999999999999997443222111110 00 000000 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.||++|||+.||++.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011234568899999999999999999999976
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=304.28 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=200.7
Q ss_pred cccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 503 GGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 503 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
..+.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++++||++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred ceeeeeeccCccceEEeeecC--CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 345688999999999999854 45679999987543 33567899999999999999999999874 467899999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999998653 45678899999999999999999988 999999999999999999999999999987653332222
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~-------- 224 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN--------LERGYRMPR-------- 224 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH--------HHcCCCCCC--------
Confidence 23345678999999998889999999999999999999 9999976554332111 111111000
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.......+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=311.68 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=202.0
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++... ...+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..++||
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 4578999999999998742 2345689999887543 22345789999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
||+++++|.+++.... ..+++.++..++.+++.||.|||++ +|+|+||||+|||+++++.+||+|||+++......
T Consensus 119 e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 119 EYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195 (302)
T ss_pred EcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence 9999999999997643 3478999999999999999999998 99999999999999999999999999998654432
Q ss_pred Cc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+... .....+....
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~---- 264 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-------KLIKEGYRMA---- 264 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH-------HHHHcCCcCC----
Confidence 21 1122345678999999998899999999999999999998 999987654332111 1111111000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
. .......+.+++.+|++.+|++|||+.||++.|+..
T Consensus 265 ~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 Q-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 011235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.24 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=197.3
Q ss_pred cccccccccceeEEEeEeCC-------------CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEec
Q 003818 505 FKEELGEGAFGKVYKGVLTT-------------ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE 570 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~-------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 570 (793)
+.+.||+|+||.||++.... .....||+|+++... ......+.+|++++++++|+||+++++++..
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 34789999999999987532 123468999987542 2334578999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC
Q 003818 571 GEHRLLVYEYVSNGSLADFLFRKS-----------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT 639 (793)
Q Consensus 571 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~ 639 (793)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCC
Confidence 999999999999999999985432 2357788899999999999999998 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh--CCcCCCCCchhHHHHHH
Q 003818 640 FNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC--CRKNFEVDATEECQMIL 716 (793)
Q Consensus 640 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt--g~~pf~~~~~~~~~~~l 716 (793)
+.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ +..||......+.....
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~ 245 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH
Confidence 99999999999765433221 1122335678999999998899999999999999999988 56677765443321111
Q ss_pred HHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 717 ADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
. ..+........... ....+..+.+++.+|++.+|++||+|++|++.|+
T Consensus 246 ~----~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 246 G----EFFRNQGRQIYLSQ------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H----HhhhhccccccCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 11111100000000 1112357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=310.04 Aligned_cols=248 Identities=27% Similarity=0.302 Sum_probs=198.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 5 YRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 468999999999999854 4578899999865322 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--I 158 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--c
Confidence 99999988654 34678899999999999999999998 999999999999999999999999999986543322 1
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....|++.|+|||++.+..++.++||||+|+++|||++|+.||...........+. ..+..... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~----------~~ 224 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE----RRVKEDQE----------EY 224 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH----HHhhhccc----------cc
Confidence 23458899999999998899999999999999999999999998654432211111 11111100 01
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
.......+.+++..||+.||++|| +++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112345678999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.39 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=211.9
Q ss_pred ccccccccceeEEEeEeCCCCc---eeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.++||+|+||+||||.+--+.+ .+||+|++.+.. .+..+++.+|+-+|..++||||+|++|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 4689999999999999865532 489999987654 344578999999999999999999999998766 88999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+.|.|.||++.++..+-....+.+..|||+||.|||++ +++||||..+||||.+-..+||.|||+++.+..+.....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 99999999999888899999999999999999999998 999999999999999999999999999999887765543
Q ss_pred ec-ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 662 TA-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 662 ~~-~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.. ..-.+.|||-|.+....|+.++|||||||++||++| |..|++....++....+. . ....
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle--------~---------geRL 919 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE--------K---------GERL 919 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh--------c---------cccC
Confidence 33 223568999999999999999999999999999998 889998887776443321 1 1122
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..+..+...+..++.+||..|+..||+++++...+..
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2334456677889999999999999999999988865
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.69 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=196.3
Q ss_pred cccccccccceeEEEeEeCCCC-ceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN-EKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|.....+ ...+++|++.... ......+.+|+.++.++ +|+||+++++++.+++..++|+||+
T Consensus 11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 4578999999999999865432 2356888776432 23446788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 582 SNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 582 ~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
++++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCc
Confidence 9999999996542 2467889999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhh
Q 003818 647 FGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFR 725 (793)
Q Consensus 647 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~ 725 (793)
||++....... .......+..|+|||.+.+..++.++||||||+++|||++ |..||......+... ...
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--------~~~ 237 (303)
T cd05088 168 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--------KLP 237 (303)
T ss_pred cccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH--------HHh
Confidence 99986432111 1111224567999999988889999999999999999998 999997654433111 111
Q ss_pred ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.+... .. .......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 238 ~~~~~---~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 238 QGYRL---EK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred cCCcC---CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11000 00 111234578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.00 Aligned_cols=238 Identities=29% Similarity=0.329 Sum_probs=189.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHH-HHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEIS-AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... .+++.||+|++..... ...+.+..|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36999999999999854 4678899999975422 22234445544 5678999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... ..+++.....++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 80 GGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99999998654 4577888889999999999999998 99999999999999999999999999987532221 2223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~~----~------ 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--------LNKPLRL----K------ 216 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--------HcCCCCC----C------
Confidence 356899999999999999999999999999999999999999876544321111 1111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMK 768 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~ 768 (793)
......+.+++.+||+.||++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01235678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.45 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=199.4
Q ss_pred ccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.||+|+||.||+|.... .....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 4679999999999998542 1235688888865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc
Q 003818 581 VSNGSLADFLFRK-----------------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD 637 (793)
Q Consensus 581 ~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 637 (793)
+.+++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~ 161 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVA 161 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEc
Confidence 9999999998542 12467888899999999999999988 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHH
Q 003818 638 GTFNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMI 715 (793)
Q Consensus 638 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~ 715 (793)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||......+..
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-- 239 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-- 239 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence 9999999999999765332221 1122335678999999988889999999999999999998 99999765443311
Q ss_pred HHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 716 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
......... . .+......+.+++.+|++.+|++||++++|++.|+++.
T Consensus 240 ------~~~~~~~~~---~------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 240 ------NLLKTGYRM---E------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHhCCCCC---C------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111100 0 01122356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.61 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=191.7
Q ss_pred cccccccceeEEEeEeCCCC------ceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLTTEN------EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.||+|+||.||+|...... ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999864321 235888887655444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc--------EEEeecCCccc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN--------ARISDFGLAKL 652 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla~~ 652 (793)
+++|+|.+++..+...+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999987767789999999999999999999998 9999999999999987765 69999999865
Q ss_pred cCCCCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCC-cCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCR-KNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~-~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
.... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.......... + ... ..
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~-------~~~-~~- 222 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-F-------YED-RH- 222 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-H-------HHc-cc-
Confidence 4322 123477899999999864 5799999999999999999995 5554433222110 0 010 00
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.+. ......+.+++.+||+.+|++|||+++|++.|+
T Consensus 223 ~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 QLP---------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cCC---------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 011245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.79 Aligned_cols=249 Identities=31% Similarity=0.488 Sum_probs=204.3
Q ss_pred cccccccceeEEEeEeCC--CCceeEEEEEechhcccc-hHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVNEG-EQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||++.... ..+..|++|.+....... .+.+.+|+..+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 226789999997654433 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 584 GSLADFLFRK--------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 584 gsL~~~l~~~--------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
++|.+++... ...+++..+..++.|+++||.|||++ +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999776 47789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceee
Q 003818 656 DQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLV 733 (793)
Q Consensus 656 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (793)
... .......++..|+|||.+....++.++||||||+++|||++ |..||......+.... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY--------LRKGYRL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCC---
Confidence 431 12223457889999999988889999999999999999999 5999987644332111 1111100
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.11 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=201.5
Q ss_pred cccccccccceeEEEeEeCCCC---------------ceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN---------------EKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFC 568 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~---------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~ 568 (793)
+.+.||+|+||.||++.....+ +..||+|++..... ...+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 3478999999999998865322 24689999875432 3456789999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 003818 569 NEGEHRLLVYEYVSNGSLADFLFRKS----------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG 638 (793)
Q Consensus 569 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 638 (793)
..+...++++||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecC
Confidence 99999999999999999999996543 2578899999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh--CCcCCCCCchhHHHHH
Q 003818 639 TFNARISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC--CRKNFEVDATEECQMI 715 (793)
Q Consensus 639 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt--g~~pf~~~~~~~~~~~ 715 (793)
++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ +..||......+....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~ 245 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHH
Confidence 99999999999976543322 12223346778999999988889999999999999999998 6778865543332111
Q ss_pred HHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 716 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
+ ...+........... ....+.++.+++.+|++.+|++|||+.+|++.|+
T Consensus 246 ~----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 246 A----GHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H----HhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 111111111111111 1123357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=323.65 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=193.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred eEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 478999999999999854 467889999986532 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc---
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--- 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--- 659 (793)
+|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 85 GGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999654 4577888888999999999999998 9999999999999999999999999998643211000
Q ss_pred -------------------------------------------ceecccCcccccCcccccCCCCCCccceehhHHHHHH
Q 003818 660 -------------------------------------------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696 (793)
Q Consensus 660 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~e 696 (793)
......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012358999999999999999999999999999999
Q ss_pred HHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 003818 697 LVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLR---PAMKKVTQM 773 (793)
Q Consensus 697 lltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~~ 773 (793)
|++|+.||......+....+..+ ...+. . .........+.+++.+||+ +|.+| +++.|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~------~~~~~-~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINW------RETLY-F-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcc------CCccC-C-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999876544322222111 00000 0 0011123457788999998 66664 699998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.41 Aligned_cols=243 Identities=28% Similarity=0.298 Sum_probs=190.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHH-HHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEI-SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+++.. .+++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999854 4567899999875321 2223444444 45678999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+.......++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 80 GGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 99999998654 4466777888999999999999998 99999999999999999999999999997543222 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------~~~~~~----~------~ 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------LNKPLQ----L------K 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH--------HhCCcC----C------C
Confidence 456899999999999999999999999999999999999999876544322111 111111 0 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.+|.+||++.+.+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1123457889999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.88 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=203.3
Q ss_pred cccccccccceeEEEeEeC------CCCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLT------TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||++... ...+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++......++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 4578999999999999742 1234579999886532 23446789999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
||||+++++|.+++.... ..+++..+..++.||++||.|||++ +|+||||||+||++++++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCc
Confidence 999999999999997532 3467788899999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----- 250 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----- 250 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-----
Confidence 9999999998665432221 222335678999999998889999999999999999998 788887654433211
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.+..+..... .......+.+++.+||+.+|++|||+.+|++.|+++..+.
T Consensus 251 ---~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 251 ---LLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1111111100 1123456788999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.26 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=198.8
Q ss_pred cccccccccceeEEEeEeC---------------CCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEE
Q 003818 505 FKEELGEGAFGKVYKGVLT---------------TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFC 568 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~---------------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 568 (793)
+.+.||+|+||.||++... ..+...||+|++.... ......+.+|+.+++.++|+||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4578999999999997532 2234579999987543 23346789999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 003818 569 NEGEHRLLVYEYVSNGSLADFLFRKS----------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG 638 (793)
Q Consensus 569 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 638 (793)
..++..++||||+++++|.+++.... ..+++.....++.|++.||+|||+. +++|+||||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcC
Confidence 99999999999999999999996532 2356778999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh--CCcCCCCCchhHHHHH
Q 003818 639 TFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC--CRKNFEVDATEECQMI 715 (793)
Q Consensus 639 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt--g~~pf~~~~~~~~~~~ 715 (793)
++.++|+|||+++.+....... .....++..|+|||...+..++.++|||||||++|||++ |..||......+....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 245 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 9999999999998654332211 112234678999999888889999999999999999998 6788865544332211
Q ss_pred HHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 716 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
... .+........... .......+.+++.+||+.||++||++.+|++.|+.
T Consensus 246 ~~~----~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 246 TGE----FFRDQGRQVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH----HHhhccccccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 1111100000000 11123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.21 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=200.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
++||+|+||.||++.... ++.|++|.+...... ....+.+|+.++++++|+||+++++++.+.+..++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 369999999999998643 778999988764333 45678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce-ecc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-TAI 664 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 664 (793)
|.+++......++...+..++.++++||.|||++ +++||||||+||+++.++.+||+|||++........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9999977666778889999999999999999998 999999999999999999999999999976542221111 112
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..+..|+|||.+.+..++.++||||||+++|||++ |..||...........+ ..... . ....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~--------~~~~~--~-------~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--------ESGYR--M-------PAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH--------hcCCC--C-------CCCc
Confidence 23567999999988899999999999999999999 88888765543221111 11100 0 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..+..+.+++.+|++.+|++|||+.||++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 224568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.80 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=191.7
Q ss_pred cccccccceeEEEeEeCC-CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|+||.||+|+... ..+..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 3456799998865432 23457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 585 SLADFLFRKS----RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 585 sL~~~l~~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+|.+++.... ...++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999996532 2456677788999999999999998 9999999999999999999999999998754332221
Q ss_pred ceecccCcccccCcccccCC-------CCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 660 TTTAIRGTKGYVAPEWFKNL-------PITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+..... ..... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~-~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-------VREQQ-LK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------hhccc-CC
Confidence 11223467889999998643 35789999999999999996 99999765443321110 11111 11
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
...+... ....+.+.+++..|+ .+|++|||++||+..|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 112234677888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=306.82 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=197.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|+.. .+++.||+|++..........+++|+.++.+++||||+++++++..++..++|+||+++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 14 IQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 467999999999999854 4567899999876544455678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... ..++...+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||++........ ......
T Consensus 93 L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 167 (267)
T cd06646 93 LQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFI 167 (267)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccc
Confidence 99998654 4578889999999999999999998 999999999999999999999999999986543221 112245
Q ss_pred CcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 666 GTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 666 gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
++..|+|||.+. ...++.++||||||+++|||++|+.||......+.... +...... .. .....
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~---~~--~~~~~ 234 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSKSNFQ---PP--KLKDK 234 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eecCCCC---CC--CCccc
Confidence 788999999884 34578899999999999999999999865432221100 0000000 00 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
......+.+++.+||+.+|++|||+++|++.|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 12345788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=322.36 Aligned_cols=261 Identities=23% Similarity=0.271 Sum_probs=197.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC-----ceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE-----HRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~ 578 (793)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..++|+
T Consensus 5 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred cceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 467999999999999853 467889999986532 223467889999999999999999999998776 789999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+. ++|.+.+... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9996 5788877543 4688899999999999999999998 999999999999999999999999999986554433
Q ss_pred cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHH---------------HHH
Q 003818 659 QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW---------------AYD 722 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~---------------~~~ 722 (793)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.+. ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 333344578899999998774 4789999999999999999999999876544332222110 001
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+....... ..............+.+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCCC-CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 110000000 00000000001124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.46 Aligned_cols=239 Identities=27% Similarity=0.360 Sum_probs=191.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCcc-ccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHK-NLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+..|..++..++|+ +|+++++++.+.+..++||||
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred EEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 4578999999999999854 456789999997642 23345678899999998764 688899999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 83 ~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 83 VNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 9999999998654 4578889999999999999999998 99999999999999999999999999987432211 12
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--------~~~~~~~--------- 220 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--------MEHNVSY--------- 220 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCCC---------
Confidence 23456899999999999999999999999999999999999999876544322111 1111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
+......+.+++.+||+.+|++||+.
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 -PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00123457789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=306.50 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=201.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|+... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 6 i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 35789999999999998543 56789999875422 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 582 SNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 582 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
++++|.+++.. +...++...+..++.|+++||.|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999988853 334577888999999999999999998 999999999999999999999999999886643322
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
. .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||......... + . ..+........
T Consensus 162 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~---~-~~~~~~~~~~~------ 228 (267)
T cd08228 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--L---C-QKIEQCDYPPL------ 228 (267)
T ss_pred H-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--H---H-HHHhcCCCCCC------
Confidence 1 12245788999999999888999999999999999999999999654322111 1 1 11111110000
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0112346688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.24 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=201.0
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.... ..++.||+|.+..... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 34789999999999998653 2347899999865432 334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 580 YVSNGSLADFLFRKS---------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccc
Confidence 999999999996432 2467888999999999999999988 9999999999999999999999999999
Q ss_pred cccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--------~~~~~~ 238 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK--------FVIDGG 238 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH--------HHhcCC
Confidence 76543322 12223346788999999988889999999999999999998 899997655443211 111111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..... ......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 239 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 HLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 1124568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.88 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=197.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++.... +..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~--~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 10 LDVKLGQGCFGEVWMGTWNG--TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeecCcCCCeEEEEEEcC--CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 45789999999999998643 3459999876532 34467889999999999999999999875 45689999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 999999764 34578889999999999999999988 99999999999999999999999999997664333222222
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||...+..++.++||||||+++|||++ |+.||......+.... +...... . ..
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~----~-----~~ 225 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ--------VERGYRM----P-----CP 225 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC----C-----CC
Confidence 335678999999988889999999999999999999 8999976554332111 1111100 0 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
......+.+++.+||+.+|++||++++|++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=324.30 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=192.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+++.. .+++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 478999999999999854 457899999986532 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ----- 657 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~----- 657 (793)
+|+|.+++... ..++......++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 85 GGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999654 4567788888999999999999998 99999999999999999999999999975331100
Q ss_pred -------------------------------------CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhC
Q 003818 658 -------------------------------------TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700 (793)
Q Consensus 658 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg 700 (793)
........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 0001124689999999999999999999999999999999999
Q ss_pred CcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 003818 701 RKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRP---AMKKVTQM 773 (793)
Q Consensus 701 ~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~~evl~~ 773 (793)
+.||......+....+.. ......... .......+.+++.+|+ .+|++|+ ++.++++.
T Consensus 241 ~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAETQLKVIN--------WETTLHIPS------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHHHHHhc--------cCccccCCC------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999987665432221111 000000000 0112234556677765 4999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.51 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=202.5
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|..... ....|++|...... .+..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 457899999999999986543 23468999886544 3345678999999999999999999998875 5578999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++......+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 165 (270)
T cd05056 89 PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA 165 (270)
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccceec
Confidence 99999999987666789999999999999999999998 999999999999999999999999999986654432222
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....++..|+|||.+....++.++||||||+++|||++ |..||......+.... +..+.....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~--------~~~~~~~~~-------- 229 (270)
T cd05056 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR--------IENGERLPM-------- 229 (270)
T ss_pred CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------HHcCCcCCC--------
Confidence 22234568999999988889999999999999999986 9999977654432211 111111100
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+.+++.+|+..+|++|||+.++++.|++..
T Consensus 230 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 -PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112356788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.03 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=210.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.++||+|+||.|||+.++ ..|+.||||++.. ..+.+++..|+.++++.+.|++|+++|.+-....+++|||||--|+
T Consensus 38 ~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHhcCCcchHHHHHHHh-ccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 368999999999999865 5788999999854 3467889999999999999999999999988999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
..|.++.+.+.+++.++..++...++||+|||.. .-||||||..|||++.+|.+||+|||.+-.+.....+ ..++.
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNTVI 190 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNTVI 190 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCccc
Confidence 9999999999999999999999999999999998 8899999999999999999999999999766543332 33467
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee-ecccchhhhhHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL-VENDEEAMDDIK 744 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 744 (793)
||+.|||||++..-.|+.++||||||++..||..|++|+..-..-. -+..+ -.+++....+..
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCCCCCChHh
Confidence 9999999999999999999999999999999999999997543221 11111 223334455677
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+.++++.||-++|++|.|+-++++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 88899999999999999999999888764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.15 Aligned_cols=250 Identities=29% Similarity=0.400 Sum_probs=197.6
Q ss_pred ccccccccceeEEEeEeCCC----CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTE----NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.||+|+||.||+|..... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 46899999999999987541 45789999886543 23345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---cEEEeecCCcc
Q 003818 581 VSNGSLADFLFRKS------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---NARISDFGLAK 651 (793)
Q Consensus 581 ~~~gsL~~~l~~~~------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~ 651 (793)
+++++|.+++.... ..+++..+.+++.||+.||+|||++ +++|+||||+||+++.++ .+||+|||+++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcccc
Confidence 99999999996543 2578899999999999999999998 999999999999998765 59999999998
Q ss_pred ccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcccc
Q 003818 652 LLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKL 729 (793)
Q Consensus 652 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (793)
......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~~~ 240 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-------TGGGRL 240 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HcCCcC
Confidence 663322111 112223567999999998899999999999999999997 99999865544321111 111111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
. .+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 ~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 D----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 01122356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.71 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=195.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+++..++||||+
T Consensus 47 i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 47 VVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 3478999999999999865 457789999986532 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 126 ~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 126 PGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 999999998543 467788888999999999999998 999999999999999999999999999987654333333
Q ss_pred ecccCcccccCcccccCCC----CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 662 TAIRGTKGYVAPEWFKNLP----ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~----~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+ .........
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~~~~~~----- 268 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-------MNHKNSLTF----- 268 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCCCcccC-----
Confidence 4456999999999987543 788999999999999999999999876543321111 111100000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQMI 774 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 774 (793)
.........+.+++..||+.++.+ ||++++|++..
T Consensus 269 --~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 --PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111123455778999999855544 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.44 Aligned_cols=243 Identities=28% Similarity=0.301 Sum_probs=191.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHH-HHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEIS-AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+++.. .+++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36999999999999854 467889999997542 222344555554 5677999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|..++... ..+++.....++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 80 GGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 99999888654 4678889999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~--------~~~~~~~----~------ 216 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI--------LHKPLVL----R------ 216 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH--------HcCCccC----C------
Confidence 356899999999999999999999999999999999999999876544321111 1111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+|++.+|++||++++.++.
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 0123456789999999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=315.70 Aligned_cols=252 Identities=20% Similarity=0.228 Sum_probs=194.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred EEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 3578999999999999865 456789999987532 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++.+....++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999977666788889999999999999999998 999999999999999999999999999876544333222
Q ss_pred ecccCcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 662 TAIRGTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+ ........+...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i-------~~~~~~~~~~~~- 232 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-------MNHKEHFQFPPD- 232 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH-------HcCCCcccCCCc-
Confidence 33458999999999863 45788999999999999999999999876544322111 111100001000
Q ss_pred chhhhhHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDP--SLRPAMKKVTQM 773 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP--~~RPt~~evl~~ 773 (793)
.....+.+.+++.+|+..++ ..||+++++++.
T Consensus 233 -----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 -----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01123456677777665433 348899888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.73 Aligned_cols=251 Identities=31% Similarity=0.482 Sum_probs=199.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccch--HHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE--QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||+||+++.. .+++.+|+|++........ ....+|+.++++++||||+++++++.+....++||||++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 4578999999999999965 4567899999976543322 234569999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++. +...++...+..++.|+++||.+||++ +|+|+||||+||++++++.++|+|||.+.... .......
T Consensus 82 ~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 82 GGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 999999997 445678999999999999999999998 99999999999999999999999999997642 2222333
Q ss_pred cccCcccccCccccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFK-NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~-~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...++..|+|||++. +..++.++||||+|+++++|++|+.||......+....+.......... . ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------S---SQQ 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------H---TTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------c---ccc
Confidence 455889999999998 8889999999999999999999999998763332222221111100000 0 000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++..||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011267899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.83 Aligned_cols=244 Identities=29% Similarity=0.424 Sum_probs=200.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++||||++++
T Consensus 10 ~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 10 LGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred ceeeeecCCCceEEEEEe---cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 457899999999999985 367899999976543 4678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||.++....... .
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~ 158 (256)
T cd05039 86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----S 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----c
Confidence 9999997653 3689999999999999999999998 999999999999999999999999999986633222 2
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...+..|+|||.+....++.++||||||++++||++ |+.||......+... .+..+..... .
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------~~~~~~~~~~---------~ 221 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------HVEKGYRMEA---------P 221 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------HHhcCCCCCC---------c
Confidence 224567999999988889999999999999999997 999997665433211 1111111000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...+..+.+++.+|++.+|++||++++|+++|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1224567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.36 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=198.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|... .++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 10 ~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 10 IGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 367999999999999864 4567899999866554556778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|..++.+....+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........ ......
T Consensus 89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 164 (282)
T cd06643 89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFI 164 (282)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cccccc
Confidence 9998877666789999999999999999999998 999999999999999999999999999875433221 122345
Q ss_pred CcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 666 GTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 666 gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
++..|+|||++. +..++.++|||||||++|||++|+.||......+....+ ..... ... .
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~~~~~-~~~-------~ 229 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-------AKSEP-PTL-------A 229 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-------hhcCC-CCC-------C
Confidence 888999999984 345788999999999999999999999765433221111 01100 000 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111234567899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.02 Aligned_cols=239 Identities=28% Similarity=0.359 Sum_probs=191.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|... .+++.||+|++.+... ...+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 4578999999999999864 4667899999876432 2234566777887776 689999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~ 157 (323)
T cd05616 83 VNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-T 157 (323)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-c
Confidence 9999999988654 4578889999999999999999998 999999999999999999999999999875432221 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i--------~~~~~~~--------- 220 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNVAY--------- 220 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCC---------
Confidence 23356899999999999999999999999999999999999999876544322111 1111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
+......+.+++.+||+.+|++|++.
T Consensus 221 -p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 -PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11123567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.40 Aligned_cols=246 Identities=23% Similarity=0.266 Sum_probs=201.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||.|.-|+||++.+.. ++..+|+|++.+.. .+...+.+.|.+||+.++||.++.|+..++.++..||+||||+|
T Consensus 83 k~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 679999999999999764 45899999997753 33445678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC-------
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT------- 655 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~------- 655 (793)
|+|..+++++ .+.++...+.-++.+++-||+|||-. |||.|||||+||||.++|++.|+||.|+.....
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9999999765 56788888889999999999999988 999999999999999999999999998743210
Q ss_pred --------------------------CCC----------------------cceecccCcccccCcccccCCCCCCccce
Q 003818 656 --------------------------DQT----------------------QTTTAIRGTKGYVAPEWFKNLPITAKVDV 687 (793)
Q Consensus 656 --------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 687 (793)
... ......+||-.|+|||++.+..++.++|.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 000 00112468999999999999999999999
Q ss_pred ehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC-
Q 003818 688 YSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA- 766 (793)
Q Consensus 688 ws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt- 766 (793)
|+|||++||||.|..||.+....+-...+. ...+........+..+.+||+..|.+||++|..
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv----------------~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIV----------------GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchhhHHHHh----------------cCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999887765432221 111111122244567889999999999999998
Q ss_pred ---HHHHHH
Q 003818 767 ---MKKVTQ 772 (793)
Q Consensus 767 ---~~evl~ 772 (793)
+.||-+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 677655
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.86 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=208.1
Q ss_pred ccccccccceeEEEeEeCCCCc--eeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~--~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.|+||+|.||+|++|.+...+| ..||||.++..... ...+|.+|+.+|-+|+|+|+++|||+..+ ....||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 3789999999999999986655 47899999876543 56899999999999999999999999988 78899999999
Q ss_pred CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFR-KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
.|+|.+.|++ ....+-...+..++.|||.||.||..+ ++|||||..+|+|+-..-.+||+||||.+.++..+....
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999987 556677788889999999999999998 999999999999999999999999999998876554432
Q ss_pred ec--ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TA--IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~--~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.. ..-...|.|||.+....++.++|||+|||++|||++ |..||-+....++... ++....
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~-----------------iD~~er 333 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN-----------------IDAGER 333 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh-----------------cccccc
Confidence 22 234568999999999999999999999999999998 5778877665442221 122222
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
......+.+++.+++..||..+|++|||+..|.+.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 333455778899999999999999999999997443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.17 Aligned_cols=245 Identities=28% Similarity=0.378 Sum_probs=203.2
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCHH
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLA 587 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 587 (793)
+||+|.||+||.|+ +..+...+|||.+.....+..+-+.+|+.+.++++|.|||+++|.+.+++..-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~R-D~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAAR-DMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeec-cccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 69999999999998 45567889999998877777788999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccccCCCCCcceecc
Q 003818 588 DFLFRKSRRP--NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 588 ~~l~~~~~~~--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
++|+.+-+.+ ++.....+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++.+..-. ....++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 9999876666 7778888999999999999999 999999999999996 57889999999998764322 222335
Q ss_pred cCcccccCcccccCC--CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 665 RGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~--~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
-||..|||||++..+ .|..++|||||||++.||.||++||-........+ ++-|.... .+ ..+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVGmyKv----HP--~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVGMYKV----HP--PIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhcceec----CC--CCc
Confidence 599999999999765 58899999999999999999999997665443221 11111111 11 113
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+...+...+|.+|+.++|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 345567889999999999999999999986
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.38 Aligned_cols=261 Identities=20% Similarity=0.300 Sum_probs=196.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 11 LEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 467999999999999854 4567899999865432 2335678899999999999999999999999999999999975
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......++...+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++........ .....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 164 (309)
T cd07872 89 DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNE 164 (309)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccccc
Confidence 88888877666788899999999999999999998 999999999999999999999999999975433221 12223
Q ss_pred cCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhcc-ccce--ee
Q 003818 665 RGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRER-KLGL--LV 733 (793)
Q Consensus 665 ~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~-~~~~--~~ 733 (793)
.+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... +..+... .... ..
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence 47889999998865 468899999999999999999999998765543322211100 0000000 0000 00
Q ss_pred cccch--hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 ENDEE--AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..... ..........+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 0000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=315.78 Aligned_cols=252 Identities=20% Similarity=0.235 Sum_probs=196.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+++.. .+++.||+|.+.+.. ......+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus 5 i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 3578999999999999854 457789999986532 223345788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 84 VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999987666788888999999999999999998 999999999999999999999999999986654433333
Q ss_pred ecccCcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 662 TAIRGTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+ ......... ..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i-------~~~~~~~~~-p~- 231 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-------MNHEERFQF-PS- 231 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH-------HcCCCcccC-CC-
Confidence 34568999999999875 46788999999999999999999999876544322111 111000000 00
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQM 773 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 773 (793)
. .....+.+.+++.+|+..++++ |++++++++.
T Consensus 232 -~---~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 -H---ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -c---cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0112356778888888866554 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.45 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=197.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC--------ce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--------HR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~ 574 (793)
+.+.||+|+||.||++... .+++.||||++.... ......+.+|+..+..++|+||++++..+...+ ..
T Consensus 36 i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence 4578999999999999854 457889999986532 233456889999999999999999988765432 36
Q ss_pred EEEEeecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 575 LLVYEYVSNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
++||||+++|+|.+++... ...++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 7999999999999998653 34578888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 652 LLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 652 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. ..+...
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~-------~~-~~~~~~ 263 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH-------KT-LAGRYD 263 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HH-hcCCCC
Confidence 6543322 22234568999999999999999999999999999999999999998765433211 11 111111
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+ +......+.+++.+||+.+|++||++.++++.
T Consensus 264 ~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 11223567899999999999999999999864
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.61 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=201.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.+++|.+.... .....++.+|+.+++.++|+||+++++++.+++..+++|||++
T Consensus 7 ~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 7 EKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 467999999999999854 456789999876432 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++|.+++.. ....+++..+..++.++++||.|||++ +++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 9999998864 234578899999999999999999998 9999999999999999999999999998765433221
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++||||||+++|||++|..||........ .+. ..+..... ...
T Consensus 163 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~~~~~-----~~~-- 228 (267)
T cd08229 163 -AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLC----KKIEQCDY-----PPL-- 228 (267)
T ss_pred -cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHh----hhhhcCCC-----CCC--
Confidence 1234578899999999988899999999999999999999999975432211 110 11111100 000
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
........+.+++.+|++.+|++||||.+|++++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0112345688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.85 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=204.0
Q ss_pred ccccccccceeEEEeEeC---CCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E 579 (793)
.+.||+|+||.||++++. ...++.+|+|.+...... ..+.+.+|+.+++.++|+||+++++++.. +...++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 477999999999999864 235688999999765443 45789999999999999999999999877 668899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++......+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.........
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05038 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165 (284)
T ss_pred cCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc
Confidence 9999999999987766789999999999999999999998 9999999999999999999999999999876533221
Q ss_pred c--eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH--------HHHHHHHHHHhhcccc
Q 003818 660 T--TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ--------MILADWAYDCFRERKL 729 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~--------~~l~~~~~~~~~~~~~ 729 (793)
. .....++..|+|||.+.+..++.++||||||++++||++|+.|+......... ..... ....+.....
T Consensus 166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (284)
T cd05038 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-LLELLKEGER 244 (284)
T ss_pred eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH-HHHHHHcCCc
Confidence 1 11123456799999998889999999999999999999999998654322110 00000 1111111110
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
..........+.+++.+|++.+|++|||+.||+++|+.+
T Consensus 245 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 245 ---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000112335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.27 Aligned_cols=238 Identities=28% Similarity=0.312 Sum_probs=187.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHH-HHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEIS-AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|+.. .+++.||+|++.+... .....+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999854 4578899999875321 22334555554 6788999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|..++... ..+.......++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 80 GGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 99999888654 4567788888999999999999998 99999999999999999999999999987532221 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.... +....... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--------i~~~~~~~----------~ 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN--------ILHKPLQL----------P 216 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH--------HhcCCCCC----------C
Confidence 35689999999999998999999999999999999999999987654332111 11111110 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMK 768 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~ 768 (793)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11234678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.21 Aligned_cols=247 Identities=25% Similarity=0.447 Sum_probs=199.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... .++.+|+|.+.... .....+.+|++++++++|||++++++++......++|+||++++
T Consensus 8 ~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 8 LVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred EEeeecCcccceEEEEEEe--CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 4578999999999999864 35679999886532 23467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++..+...+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++..............
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 99999987666778899999999999999999998 999999999999999999999999999876543322222222
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +.++... ..+.
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~--~~~~------- 224 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET--------INAGFRL--YKPR------- 224 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH--------HhCCCCC--CCCC-------
Confidence 34568999999998889999999999999999998 8999976554332111 1111100 0000
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.....+.+++.+||+.+|++|||+.+|++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.46 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=199.3
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|...+ ..+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 34789999999999987542 3456899998864432 233467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 580 YVSNGSLADFLFRKS---------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
|+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 999999999996421 2345677889999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.... ...+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~--------~~~~~ 238 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF--------VMDGG 238 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCC
Confidence 855432221 1122235678999999998899999999999999999998 7888876544332111 11111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.... .......+.+++.+|++.+|++|||+.++++.|++...
T Consensus 239 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 239 YLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 1110 01123578899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.58 Aligned_cols=249 Identities=30% Similarity=0.469 Sum_probs=201.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... +++.||+|.+.... ...+++.+|+.++++++|+||+++++++......++||||++++
T Consensus 10 i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (261)
T cd05034 10 LERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86 (261)
T ss_pred eeeeeccCcceEEEEEEEc--CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence 4578999999999999864 34679999987543 34568999999999999999999999999989999999999999
Q ss_pred CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++.... ..+++..+..++.+++.||.|||++ +++|+||||+||++++++.+||+|||++..+..........
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 9999997653 5688999999999999999999998 99999999999999999999999999998765432222222
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...+..|+|||.+.+..++.++||||||++++||++ |+.||......+.... +..+. .. .. .
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--------~~~~~-~~---~~-----~ 226 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ--------VERGY-RM---PR-----P 226 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCC-CC---CC-----C
Confidence 234568999999998889999999999999999998 9999976543321111 11110 00 00 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1124568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=309.22 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=200.0
Q ss_pred ccccccccceeEEEeEeC---CCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 579 (793)
.+.||+|+||.||++.+. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 467999999999998753 3457789999986543 23346789999999999999999999998775 56889999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++.+....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.+......
T Consensus 89 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05079 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165 (284)
T ss_pred ccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccc
Confidence 9999999999976656689999999999999999999998 9999999999999999999999999999866543221
Q ss_pred --ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhH--------HHHHHHHHHHHHhhcccc
Q 003818 660 --TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE--------CQMILADWAYDCFRERKL 729 (793)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~--------~~~~l~~~~~~~~~~~~~ 729 (793)
......++..|+|||.+.+..++.++||||||+++|||++++.|........ ........ ......+..
T Consensus 166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (284)
T cd05079 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-VRVLEEGKR 244 (284)
T ss_pred eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-HHHHHcCcc
Confidence 1122346678999999988889999999999999999999876653321100 00000000 111111110
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.. ........+.+++.+|++.+|++|||+++|++.|+.+
T Consensus 245 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 245 LP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 0112346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.78 Aligned_cols=240 Identities=26% Similarity=0.442 Sum_probs=192.0
Q ss_pred cccccccceeEEEeEeCCCC---------ceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEE
Q 003818 507 EELGEGAFGKVYKGVLTTEN---------EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 577 (793)
+.||+|+||.||+|...... ...|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 135788877554333 6788999999999999999999999988 788999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-------cEEEeecCCc
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-------NARISDFGLA 650 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfgla 650 (793)
+||+++++|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999987666788999999999999999999988 999999999999999887 7999999999
Q ss_pred cccCCCCCcceecccCcccccCcccccCC--CCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcc
Q 003818 651 KLLKTDQTQTTTAIRGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRER 727 (793)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~ 727 (793)
...... ....++..|+|||.+... .++.++||||||+++|||++ |..||......+.... +...
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--------~~~~ 222 (259)
T cd05037 156 ITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--------YQDQ 222 (259)
T ss_pred cccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--------HhcC
Confidence 765431 123356789999999876 78999999999999999999 5777765542221110 0000
Q ss_pred ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 728 KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
. ..... ....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 223 ~--~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H--RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00000 0157789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.76 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=201.8
Q ss_pred cccccccccceeEEEeEeCCC---CceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTE---NEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 579 (793)
+.+.||+|+||.||+|..... .+..|++|++..... ...+.+.+|+.++++++|+||+++++++.. +...++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 457899999999999997652 267899998865432 334668899999999999999999998766 577899999
Q ss_pred ecCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 580 YVSNGSLADFLFRKS-------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 580 y~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
|+++++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 999999999986532 4578999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 653 LKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 653 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+.. . .+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~----~~~~~~~~ 238 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA----A----YLKDGYRL 238 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH----H----HHHcCCCC
Confidence 64433221 112335678999999998899999999999999999999 99999765443311 1 11111100
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
. ......+.+.+++.+|++.+|++|||+.+|++.|+...
T Consensus 239 ---~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 239 ---A------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ---C------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 01112356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.25 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=195.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.++||+|+||.||+++.. .+++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred EEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 3578999999999999865 456789999986532 222345888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++.+....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999987666788889999999999999999998 999999999999999999999999999976543333333
Q ss_pred ecccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 662 TAIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+ ............
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i-------~~~~~~~~~p~~- 232 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-------MNHKERFQFPAQ- 232 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH-------hCCCccccCCCc-
Confidence 3356899999999986 346789999999999999999999999876544322211 111100000000
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQM 773 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 773 (793)
.......+.+++.+|+..++++ |++++++++.
T Consensus 233 -----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 -----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0112345677888877655444 7899988766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.93 Aligned_cols=257 Identities=20% Similarity=0.226 Sum_probs=191.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||++.... .++.||||... ...+.+|+.++++++|+|||++++++..++..++|||++ .++
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~ 245 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPD-YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSD 245 (461)
T ss_pred EEEEccCCCeEEEEEEECC-CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCC
Confidence 4789999999999998654 56789999642 234578999999999999999999999999999999999 478
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-ceecc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-TTTAI 664 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~ 664 (793)
|.+++......+++..++.|+.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 246 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 9998877666789999999999999999999998 9999999999999999999999999999865433221 12235
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhH----HHHHHHHHHHHHhh-ccccceeec-----
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE----CQMILADWAYDCFR-ERKLGLLVE----- 734 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~----~~~~l~~~~~~~~~-~~~~~~~~~----- 734 (793)
.||..|+|||++.+..++.++|||||||++|||++|..++....... ....+...+...-. .........
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 68999999999999999999999999999999999876553321110 00111111111000 000000000
Q ss_pred --------------ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 735 --------------NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 735 --------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..............+.+|+.+||+.||++|||+.||++.
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000001112357889999999999999999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.64 Aligned_cols=246 Identities=27% Similarity=0.344 Sum_probs=194.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
..||+|+||.||+|... .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 57999999999999854 45678999998766555567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCCCCCcceec
Q 003818 587 ADFLFRKSRRP--NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 587 ~~~l~~~~~~~--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
.+++......+ +...+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 99997654444 7788889999999999999988 9999999999999976 67999999999876543222 1222
Q ss_pred ccCcccccCcccccCCC--CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 664 IRGTKGYVAPEWFKNLP--ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~--~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
..++..|+|||.+.+.. ++.++||||||+++|||++|+.||........... .... . .... . .
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~----~~~~-~-~~~~-------~--~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF----KVGM-F-KIHP-------E--I 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh----hhhh-h-ccCC-------C--C
Confidence 34788999999986643 78899999999999999999999975432211100 0000 0 0000 0 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+....+.+.+++.+||+.+|++|||+.||++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1123356788999999999999999999885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.51 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=199.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|+. ..+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+.+.++||||+++++
T Consensus 25 ~~~lg~g~~~~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 25 FEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred EEEecCCCCeEEEEEEE-CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 36799999999999984 34567899999876555556778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.. ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......... .....
T Consensus 104 L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 177 (296)
T cd06654 104 LTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 177 (296)
T ss_pred HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCccc
Confidence 9999854 3478889999999999999999998 9999999999999999999999999998765433221 22235
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
+++.|+|||.+.+..++.++|||||||++|||++|+.||......+... ....... .. .......
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-------~~~~~~~-~~-------~~~~~~~ 242 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNGT-PE-------LQNPEKL 242 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-------HHhcCCC-CC-------CCCcccc
Confidence 7889999999998889999999999999999999999997654322110 1111110 00 0011123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+.+++.+||+.+|++|||+.+|++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 3567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.23 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=197.3
Q ss_pred ccccccceeEEEeEeCC-----CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 508 ELGEGAFGKVYKGVLTT-----ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.||+|+||.||+|+... ..++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 223679999886543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-----cEEEeecCCc
Q 003818 582 SNGSLADFLFRK------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-----NARISDFGLA 650 (793)
Q Consensus 582 ~~gsL~~~l~~~------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgla 650 (793)
++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999652 23467888999999999999999988 999999999999999877 8999999999
Q ss_pred cccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~ 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV--------TAGG 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH--------hcCC
Confidence 76543221 11122335678999999999999999999999999999998 99999765443321111 1111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.. . .....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ~~---~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---Q------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---C------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0 011234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.01 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=200.2
Q ss_pred ccccccccccceeEEEeEeCC------CCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceE
Q 003818 504 GFKEELGEGAFGKVYKGVLTT------ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 575 (793)
.+.+.||+|+||.||++.... .....+|+|.+.... .....++.+|+.++..+ +|+||+++++++...+..+
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 356789999999999987532 123569999987542 23345788899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 576 LVYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN 177 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCC
Confidence 9999999999999997532 2477889999999999999999988 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHH
Q 003818 641 NARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILAD 718 (793)
Q Consensus 641 ~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~ 718 (793)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~--- 254 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL--- 254 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---
Confidence 99999999997654322111 111224568999999998889999999999999999998 8888876544332111
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+..+... +. .......+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 255 -----~~~~~~~---~~------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 255 -----LKEGHRM---DK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -----HHcCCCC---CC------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111110 00 1122356788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.47 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=188.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecC--------CceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--------EHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~l 576 (793)
+.+.||+|+||.||+|+.. .+++.||||++... .....+|+.+++.++|||||++++++... ...++
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 3578999999999999864 45678999988543 23345799999999999999999876432 24678
Q ss_pred EEeecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccc
Q 003818 577 VYEYVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKL 652 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~ 652 (793)
||||+++ +|.+++.. ....+++.....++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999975 67766643 345688889999999999999999998 999999999999998665 699999999986
Q ss_pred cCCCCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHh---
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCF--- 724 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~--- 724 (793)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||......+....+..... ..+
T Consensus 221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 643322 2234579999999998654 689999999999999999999999987655443222211100 000
Q ss_pred ----hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 725 ----RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 725 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..-..............+.....++.+++.+||+.||++|||+.|+++.
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000000000000011124578899999999999999999998843
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.46 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=188.6
Q ss_pred ccccccceeEEEeEeCC-CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+||+|+||.||+|.... .....+++|.+.... ......+.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 234578888875432 2234578899999999999999999999999999999999999999
Q ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cc
Q 003818 586 LADFLFRKS----RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QT 660 (793)
Q Consensus 586 L~~~l~~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 660 (793)
|.+++.... ...++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643 2235677889999999999999998 999999999999999999999999999865432221 11
Q ss_pred eecccCcccccCcccccC-------CCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 661 TTAIRGTKGYVAPEWFKN-------LPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-------~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+... ......... +
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~~~~~~~-~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK-------QVVREQDIK-L 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH-------HHhhccCcc-C
Confidence 122335678999998743 356889999999999999999 778887654433111 111111111 1
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
..+. ........+.+++..|+ .||++|||+++|+++|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 11123345567778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.24 Aligned_cols=256 Identities=18% Similarity=0.205 Sum_probs=194.1
Q ss_pred cccccccc--cceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEG--AFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G--~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.++||+| +|++||++... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 34679999 78899998854 567889999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 581 VSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999654 34578899999999999999999998 9999999999999999999999999865433211110
Q ss_pred ------ceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 660 ------TTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 660 ------~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. .+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--------~~~~~~ 229 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--------NGTVPC 229 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--------cCCccc
Confidence 0111236678999999976 468999999999999999999999997654332111100 000000
Q ss_pred eecc------------------------------------cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 LVEN------------------------------------DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~~~~------------------------------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+. .............+.+++.+||+.||++|||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0000011123457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.88 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=196.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-----cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-----EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.||+|++|.||++... .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 7 ~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred cceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 468999999999999854 4567899998864321 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++++|.+++... ..++......++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||+++.........
T Consensus 86 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 86 MPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred CCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999988654 4577888899999999999999998 99999999999999999999999999997654322211
Q ss_pred e--ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 661 T--TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 661 ~--~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+..... ........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~------- 227 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-------ATQPTNPQ------- 227 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH-------hccCCCCC-------
Confidence 1 2344778999999999988999999999999999999999999765433211111 01100000
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+......+.+++.+||+.+|++|||+.++++.
T Consensus 228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 --LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011233567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.80 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=190.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||++... .+++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36999999999999864 4567899999976432 2345678899998887 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 80 GGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99999888654 4688899999999999999999998 99999999999999999999999999987532211 1223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..+.....+....... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~----------p 223 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRI----------P 223 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCC----------C
Confidence 4568999999999999999999999999999999999999996432211100 0111122222211110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
......+.+++.+||+.||++||++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.94 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=197.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++... .++..+|+|.+..... ....++.+|++++.+++||||+++++++.+++..++|+||+++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred EEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 3478999999999999854 4567899998865322 2345688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++... ..+++.....++.|+++||.|||+. .+++|+||||+|||+++++.+||+|||++....... ...
T Consensus 84 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 84 GSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 9999999655 5578888999999999999999973 289999999999999999999999999987553321 123
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc--------------
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL-------------- 729 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~-------------- 729 (793)
..++..|+|||.+.+..++.++||||||+++|||++|+.||...........+... .........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP-VSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc-cccccccCCcccccCCCCCccch
Confidence 45788999999998888999999999999999999999999755432211111000 000000000
Q ss_pred -------ceeecc-cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 730 -------GLLVEN-DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 730 -------~~~~~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
...... .+... .......+.+++.+||+.+|++|||+++|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000 00000 001344688999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.81 Aligned_cols=240 Identities=27% Similarity=0.367 Sum_probs=191.7
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEe
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 579 (793)
++.+.||+|+||.||++... .+++.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45678999999999999854 467889999997642 223356778888888875 5778889999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 82 YVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 99999999998654 4588899999999999999999998 999999999999999999999999999875432221
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--------~~~~~~~-------- 220 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--------MEHNVSY-------- 220 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCC--------
Confidence 223345899999999999999999999999999999999999999876543321111 1111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
+......+.+++.+||+.+|.+|++.
T Consensus 221 --p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 --PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01123457889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.85 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=203.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 6 IEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 4578999999999999965 467789999886422 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 582 SNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 582 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
++++|.+++.. ....++...+..++.++++||.|||+. +|+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999864 245578899999999999999999998 999999999999999999999999999876543322
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+. ...+..+......
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~-~~~~~~~~~~~~~----- 229 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSL-CKKIEKCDYPPLP----- 229 (267)
T ss_pred c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HHH-HhhhhcCCCCCCC-----
Confidence 1 222357889999999998889999999999999999999999996543211 011 1111111111110
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.......+.+++.+|++.+|++|||+.+|+++|+.+
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 113345688999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.49 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=201.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|.... +++.+++|.+..... .+++.+|+.++++++|+||+++++++.+....++++||+++++
T Consensus 8 ~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4679999999999998654 467899999865433 6789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++......+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........ ......
T Consensus 85 L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 160 (256)
T cd06612 85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVI 160 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccccc
Confidence 9999977777889999999999999999999998 999999999999999999999999999986654321 222334
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..... .........
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~-------~~~~~~~~~ 225 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PNKPP-------PTLSDPEKW 225 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------ccCCC-------CCCCchhhc
Confidence 788999999999889999999999999999999999999765433211100 00000 001112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.+++.+|++.+|++|||++||++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 456889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.44 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=198.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... .+..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+ ...+++|||++++
T Consensus 10 ~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~ 85 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG 85 (260)
T ss_pred EEeEecCccceEEEEEEec--CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence 4578999999999999754 34569999886532 234678899999999999999999999887 7789999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ....++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred cHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 999999763 45578888999999999999999988 99999999999999999999999999997654332222222
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+....++.++|+||||+++||+++ |+.||......+.... +..+.... ..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~--------~~~~~~~~---------~~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--------LERGYRMP---------RP 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------HhCCCCCC---------Cc
Confidence 335677999999998889999999999999999999 8999976544332111 11111100 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
......+.+++.+|++.+|++||++.+|.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.18 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=199.8
Q ss_pred cccccccccceeEEEeEeC------CCCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLT------TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||++... ......+|+|+++... .....++.+|+.+++++ +||||+++++++......++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 4578999999999998742 2234679999887532 23345788999999999 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCc
Confidence 999999999999996532 3477888999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---- 248 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL---- 248 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 9999999998654322111 112224567999999998899999999999999999999 8889876544332211
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
...+..... .......+.+++.+|++.+|++|||+.++++.|++..
T Consensus 249 ----~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 249 ----LREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111100 1122346778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.18 Aligned_cols=250 Identities=32% Similarity=0.503 Sum_probs=202.6
Q ss_pred cccccccccceeEEEeEeCCCC---ceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN---EKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~---~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+++..... +..||+|++...... ..+.+..|+..+..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999976533 478999999765433 457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 581 VSNGSLADFLFRKSRR-PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++++|.+++...... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999765444 89999999999999999999998 9999999999999999999999999999866544322
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
......+++.|+|||.+.+..++.++||||+|++++||++ |+.||......+.... .........
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~------ 225 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY--------LKKGYRLPK------ 225 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HhcCCCCCC------
Confidence 2222336789999999988889999999999999999998 7888876543321111 111111110
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.......+.+++.+|++.+|++|||+.|+++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011345688899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.82 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=199.1
Q ss_pred ccccccccceeEEEeEeCC----CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.||+|+||.||++.... ..+..||+|++.... ....+++.+|+.++++++||||+++++++.++...++|+||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 4679999999999998642 356789999987543 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC
Q 003818 581 VSNGSLADFLFRKS---------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT 639 (793)
Q Consensus 581 ~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~ 639 (793)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGEN 166 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCC
Confidence 99999999996421 2356778899999999999999998 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHH
Q 003818 640 FNARISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILA 717 (793)
Q Consensus 640 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~ 717 (793)
+.+||+|||++..+..... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~--- 243 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY--- 243 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 9999999999875533221 11122234567999999998899999999999999999997 888887654433211
Q ss_pred HHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 718 DWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.+..+..... .......+.+++.+|++.+|++|||+.||++.|+.
T Consensus 244 -----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 -----YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112221110 01123568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=297.84 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=203.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++.... +++.+++|.+........+.+.+|+.++++++||||+++++++.+++..+++|||++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 34789999999999998643 45789999987665556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......++...+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++........ .....
T Consensus 86 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 161 (262)
T cd06613 86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSF 161 (262)
T ss_pred cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccc
Confidence 99999977656788999999999999999999998 999999999999999999999999999876543221 12234
Q ss_pred cCcccccCcccccCC---CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 665 RGTKGYVAPEWFKNL---PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~---~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
.++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+ ...... . .....
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--------~~~~~~---~--~~~~~ 228 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--------SKSNFP---P--PKLKD 228 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhccCC---C--ccccc
Confidence 578899999999877 8899999999999999999999999765433221111 011000 0 01111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+|++.+|.+|||+.+|+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2334567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.96 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=197.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.++||+|+||.||+|... .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++++
T Consensus 17 ~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 17 IGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 367999999999999854 4567899999876655556788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|..++.+....+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++........ ......
T Consensus 96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 171 (292)
T cd06644 96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-RRDSFI 171 (292)
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc-ccceec
Confidence 9998877667789999999999999999999988 999999999999999999999999999875432211 122345
Q ss_pred CcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 666 GTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 666 gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
+++.|+|||.+. ...++.++|||||||++|||++|+.||......+.... +....... ..
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~-------~~ 236 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--------IAKSEPPT-------LS 236 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH--------HhcCCCcc-------CC
Confidence 788999999984 34578899999999999999999999976543321111 11111000 00
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
........+.+++.+||+.+|++||++++|++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11123345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=302.66 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=193.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|+.. .+++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 6 QEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred eeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 468999999999999854 457789999986542 233467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|..+. .+++.....++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 85 ~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (279)
T cd06619 85 SLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTY 153 (279)
T ss_pred ChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCC
Confidence 997653 456778889999999999999998 99999999999999999999999999997654322 2234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.++..|+|||.+.+..++.++||||||+++|||++|+.||......+....... ............. ....
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~--------~~~~ 224 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ-LLQCIVDEDPPVL--------PVGQ 224 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH-HHHHHhccCCCCC--------CCCc
Confidence 588999999999998999999999999999999999999965332211100000 0111111110000 0111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+.+++.+|++.+|++||+++|+++.
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 23467899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.03 Aligned_cols=243 Identities=27% Similarity=0.369 Sum_probs=195.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEE-ecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC-NEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++|+|++++++++ .+++..++++||+++
T Consensus 10 ~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 10 LLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred eeeeecccCCCeEEEEEE---cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 457899999999999975 3567999988643 2346789999999999999999999976 455678999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++.... ..+++..+..++.+++.||+|||++ +++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---- 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC----
Confidence 99999997643 3478899999999999999999998 999999999999999999999999999875433221
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....+..|+|||++.+..++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~--------- 220 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDA--------- 220 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HhcCCCCCC---------
Confidence 2234568999999998899999999999999999997 9999876543331111 111110000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01123567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=335.28 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=196.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.++||+|+||.||+|... .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 i~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 478999999999999854 4578899999975432 224578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 583 NGSLADFLFRK----------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 583 ~gsL~~~l~~~----------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
+++|.+++... ....++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCccee
Confidence 99999998642 12345667789999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC-----------------cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHH
Q 003818 653 LKTDQT-----------------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI 715 (793)
Q Consensus 653 ~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~ 715 (793)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~- 241 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY- 241 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh-
Confidence 521110 01112458999999999999999999999999999999999999997643322100
Q ss_pred HHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 003818 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRP-AMKKVTQMIEGA 777 (793)
Q Consensus 716 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~ 777 (793)
. ..+.... ........+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 242 ------~----~~i~~P~----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 242 ------R----DVILSPI----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ------h----hhccChh----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0000000 0000112335678899999999999995 667777777654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.38 Aligned_cols=261 Identities=25% Similarity=0.300 Sum_probs=192.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcC---CccccceeeeEEec-----CCce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRT---NHKNLVQLLGFCNE-----GEHR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~ 574 (793)
+.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ....
T Consensus 4 ~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred EeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 3478999999999999854 45788999998653222 234566777777665 79999999998864 3457
Q ss_pred EEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 575 LLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
++|+||++ ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 99999997 4888888654 34578999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhhcc-c
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFRER-K 728 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~~~-~ 728 (793)
..... .....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+..... ..+... .
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 43221 2234578899999999988999999999999999999999999977654433222211110 000000 0
Q ss_pred c--ceeecccch--hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 L--GLLVENDEE--AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ~--~~~~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. ......... ........+.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000000 0001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=298.29 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=199.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++... .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+++..++|+||+++
T Consensus 4 ~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred EEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 4578999999999999854 456789999885432 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++... ...++......++.|++.||.|||++ +|+|+||||+||++++++.++|+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YAC 158 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccc
Confidence 9999988653 44578888999999999999999998 999999999999999999999999999976543222 122
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||........... +..+..... .
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~---------~ 221 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK--------VCQGSYKPL---------P 221 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH--------HhcCCCCCC---------C
Confidence 34578899999999998999999999999999999999999986543322111 111111111 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.+|++||++.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.38 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=196.3
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEec-CCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNE-GEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-~~~~~lV 577 (793)
+.+.||+|+||.||+|... ...++.||||+++.... .....+.+|+.++.++ +||||+++++++.. +...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 4578999999999999742 23567899999975432 2345688999999999 78999999998865 4567899
Q ss_pred EeecCCCCHHHHHhcCC---------------------------------------------------------------
Q 003818 578 YEYVSNGSLADFLFRKS--------------------------------------------------------------- 594 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~--------------------------------------------------------------- 594 (793)
|||+++|+|.+++....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 99999999999986432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cceecccCcccc
Q 003818 595 ---RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTTTAIRGTKGY 670 (793)
Q Consensus 595 ---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y 670 (793)
..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++........ .......++..|
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 1256777888999999999999998 999999999999999999999999999976533221 111223356789
Q ss_pred cCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHH
Q 003818 671 VAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKF 749 (793)
Q Consensus 671 ~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 749 (793)
+|||.+.+..++.++||||||+++|||++ |..||......+.. ......+...... . .....+
T Consensus 248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~----~-----~~~~~~ 311 (343)
T cd05103 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------CRRLKEGTRMRAP----D-----YTTPEM 311 (343)
T ss_pred ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-------HHHHhccCCCCCC----C-----CCCHHH
Confidence 99999988899999999999999999997 88998754332211 1111111111100 0 112457
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 750 VMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 750 ~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.+++..|++.+|++|||+.+|++.|+.+.+
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.42 Aligned_cols=187 Identities=25% Similarity=0.346 Sum_probs=161.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|..... ....|+.++++++|+||+++++++..++..++|+||+ .+
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~ 141 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS 141 (357)
T ss_pred EEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence 3478999999999999864 45678999975332 2356999999999999999999999999999999999 56
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 142 ~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~ 216 (357)
T PHA03209 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGL 216 (357)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccc
Confidence 89999877777889999999999999999999998 99999999999999999999999999997533221 12234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCC
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF 704 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf 704 (793)
.||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5899999999999999999999999999999999866554
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.57 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=196.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|... .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+++++
T Consensus 14 ~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 14 IQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 367999999999999854 4578899999876544445668889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... ..++..+...++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ......
T Consensus 93 L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 167 (267)
T cd06645 93 LQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRKSFI 167 (267)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cccccc
Confidence 99988654 4678899999999999999999998 999999999999999999999999999876543221 222345
Q ss_pred CcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 666 GTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 666 gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
|+..|+|||.+. ...++.++|||||||++|||++|+.||............ ....... .. ....
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~---~~--~~~~ 234 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------TKSNFQP---PK--LKDK 234 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--------hccCCCC---Cc--cccc
Confidence 889999999874 456889999999999999999999998654432211100 0011000 00 0001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+++.+|++.+|++||++++|++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 122346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.83 Aligned_cols=248 Identities=24% Similarity=0.314 Sum_probs=192.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 468999999999999854 467889999997532 2234578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT---- 658 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---- 658 (793)
+|+|.+++.+. ..++......++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 85 GGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999998654 4578888999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCc
Q 003818 659 ------------------------------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDA 708 (793)
Q Consensus 659 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~ 708 (793)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00112468999999999999999999999999999999999999998765
Q ss_pred hhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003818 709 TEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA---MKKVTQM 773 (793)
Q Consensus 709 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 773 (793)
..+....+. .......... . ......+.+++.+++. +|++|++ +.++++.
T Consensus 241 ~~~~~~~i~--------~~~~~~~~p~--~----~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQETYRKVM--------NWKETLVFPP--E----VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHHHH--------cCCCceecCC--C----CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 544222211 1000000010 0 0122455667777664 9999986 5555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=308.51 Aligned_cols=241 Identities=28% Similarity=0.375 Sum_probs=201.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||.|+||.||-+.. ..+.+.||||++.-.- .+..+++..|++.|.+++|||++.+.|++..+...+|||||| -
T Consensus 32 rEIGHGSFGAVYfArd-~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHhcCCccceeEEeec-cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 5699999999999884 4567899999996543 334568899999999999999999999999999999999999 6
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|+-.|++.-..+.+-...+..|..+.++||+|||++ +.||||||..|||+.+.|.+||+|||.|....+ ...
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans 181 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS 181 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence 788888877777888889999999999999999999 999999999999999999999999999976543 334
Q ss_pred ccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 664 IRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 664 ~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
++|||.|||||++. .+.|+-++||||||++..||.-.++|...++.-....-+ ..... + ..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--------AQNes-------P-tL 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNES-------P-TL 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--------HhcCC-------C-CC
Confidence 67999999999885 568999999999999999999999998776544322111 11111 1 11
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+..+.|+.++..||++-|.+|||.++++..
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 134577889999999999999999999988753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.40 Aligned_cols=244 Identities=20% Similarity=0.331 Sum_probs=205.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|.|.+|-+|++. -+|..||||++.+..-. ....+..|++.|+.++|||||++|.+......+|||+|.-.+
T Consensus 23 ekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhcCCceehhhhhhhh-cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCC
Confidence 467999999999988854 36788999999775433 235678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE-cCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL-DGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.|||.+....+.+....+++.||..||.|+|+. .+|||||||+||.+ .+-|-+||.|||++..+.++. ...
T Consensus 102 GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--kL~ 176 (864)
T KOG4717|consen 102 GDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--KLT 176 (864)
T ss_pred chHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc--hhh
Confidence 999999999989999999999999999999999998 89999999999887 567889999999998766543 345
Q ss_pred cccCcccccCcccccCCCCC-CccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPIT-AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s-~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
+.+|+..|.|||++.+..|+ +++||||||||||.|+||+.||+..++.|-...+. +--. ..
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm----------------DCKY--tv 238 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM----------------DCKY--TV 238 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh----------------cccc--cC
Confidence 56799999999999999986 58999999999999999999998876655322221 1110 11
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+-....++++||..||..||++|.+.+||+..
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22345678999999999999999999998764
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=302.52 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=202.5
Q ss_pred cccccccccceeEEEeEeCCCC---ceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN---EKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|.....+ ...+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++|+||
T Consensus 11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence 3478999999999999865432 23689998865432 334678899999999999999999999987 788999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++......+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.........
T Consensus 90 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 166 (279)
T cd05057 90 MPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166 (279)
T ss_pred CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence 999999999988777789999999999999999999998 99999999999999999999999999998765332211
Q ss_pred e-ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 661 T-TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 661 ~-~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
. ....++..|+|||.+....++.++||||||+++||+++ |+.||......+.... +..+... ..
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~---~~--- 232 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL--------LEKGERL---PQ--- 232 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--------HhCCCCC---CC---
Confidence 1 11223567999999988889999999999999999998 9999987654432111 1111110 00
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
+......+.+++..||..+|++||++.++++.|+....
T Consensus 233 ---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 ---PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01122457789999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=302.26 Aligned_cols=248 Identities=26% Similarity=0.283 Sum_probs=197.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||+||++... .+++.||+|.+..... .....+.+|+.+++.++|+||+++.+.+..++..++||||++
T Consensus 5 ~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 5 YRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 367999999999999865 4577899999865422 223457889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--I 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--c
Confidence 99999988654 34689999999999999999999998 999999999999999999999999999876543221 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....|+..|+|||.+.+..++.++|+||||+++|||++|..||...........+. ......... .
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~----~~~~~~~~~----------~ 224 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD----RRVLETEEV----------Y 224 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----Hhhhccccc----------c
Confidence 23458999999999998899999999999999999999999998654433211111 111111100 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 773 (793)
.......+.+++..|++.+|++||+ ++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1112345678999999999999999 6677663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.81 Aligned_cols=259 Identities=25% Similarity=0.337 Sum_probs=199.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-c-----cccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-H-----KNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~lV~ 578 (793)
..+.||+|.||.|.|+. +..+++.||||+++... .-..+-..|+++|..++ | -|+|+++++|...++.|||+
T Consensus 190 V~e~LGkGtFGQVvk~~-d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAY-DHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred EEEEecccccceeEEEE-ecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 35789999999999987 55678899999997643 23455677999999986 4 38999999999999999999
Q ss_pred eecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCcEEEeecCCccccCC
Q 003818 579 EYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--TFNARISDFGLAKLLKT 655 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~ 655 (793)
|.+ ..+|.++|..+ -..++...+..|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.|.....
T Consensus 268 ELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 268 ELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred hhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 999 67999999764 45678899999999999999999998 9999999999999964 34699999999975433
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhh---
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFR--- 725 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~--- 725 (793)
.. .....+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+++..+....+.+.. .....
T Consensus 344 ~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 344 RV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred cc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 22 13456789999999999999999999999999999999998888887766544443221 11110
Q ss_pred ----c-cccce-eecc-----------------------cc-hhh-----hhHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003818 726 ----E-RKLGL-LVEN-----------------------DE-EAM-----DDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770 (793)
Q Consensus 726 ----~-~~~~~-~~~~-----------------------~~-~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 770 (793)
. ..... .... .+ ... .....-..+.+++.+||+.||.+|+|..+.
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 1 00000 0000 00 000 001223467899999999999999999998
Q ss_pred HHH
Q 003818 771 TQM 773 (793)
Q Consensus 771 l~~ 773 (793)
++.
T Consensus 500 l~H 502 (586)
T KOG0667|consen 500 LNH 502 (586)
T ss_pred hcC
Confidence 875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.63 Aligned_cols=195 Identities=22% Similarity=0.362 Sum_probs=159.6
Q ss_pred cccccccceeEEEeEeCC-CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~ 583 (793)
.+||+|+||.||+|.... ..++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 579999999999998643 356789999986432 23567889999999999999999998854 456789999985
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCcEEEeecCCcc
Q 003818 584 GSLADFLFRK--------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAK 651 (793)
Q Consensus 584 gsL~~~l~~~--------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 651 (793)
++|.+++... ...++...+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 5888877432 23477888899999999999999998 99999999999999 466789999999998
Q ss_pred ccCCCCCc--ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCC
Q 003818 652 LLKTDQTQ--TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVD 707 (793)
Q Consensus 652 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~ 707 (793)
........ ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76433221 22335689999999998764 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=301.98 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=199.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||++.... +++.+|+|.+........+.+.+|+.++++++|+||+++++++..+...++||||+++++
T Consensus 10 ~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 3679999999999998653 578899999876555555778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.+....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ ......
T Consensus 89 L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 164 (280)
T cd06611 89 LDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFI 164 (280)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceee
Confidence 9999987667789999999999999999999998 999999999999999999999999999875543222 122345
Q ss_pred CcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 666 GTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 666 gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
+++.|+|||.+. ...++.++||||||+++|||++|+.||......+.... +.......+ .
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~-~------ 229 (280)
T cd06611 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK--------ILKSEPPTL-D------ 229 (280)
T ss_pred cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH--------HhcCCCCCc-C------
Confidence 788999999975 34577899999999999999999999976543321111 111111000 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++..||+.+|.+||++.+|++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011223457789999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=303.70 Aligned_cols=263 Identities=23% Similarity=0.251 Sum_probs=198.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc-----chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-----GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|... .+++.||+|++...... ....+..|+.++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 3467999999999999854 34678999999764322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+ +++|.+++......+++..+..++.||++||.|||++ +|+|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 99 9999999976655789999999999999999999998 9999999999999999999999999999866543221
Q ss_pred ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhhc-cccceee
Q 003818 660 TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFRE-RKLGLLV 733 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~~-~~~~~~~ 733 (793)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|..+|......+....+..... ..+.. .......
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 159 -MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred -ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 122346778999998854 4678999999999999999999888876554332211111000 00000 0000000
Q ss_pred c-----ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 734 E-----NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 734 ~-----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
. ..............+.+++.+||+.+|++|||++||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000000112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.90 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=198.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 24 FEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 467999999999999843 4577899999976555555778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.+ ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......... .....
T Consensus 103 L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 176 (297)
T cd06656 103 LTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (297)
T ss_pred HHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCccc
Confidence 9999854 3468889999999999999999998 9999999999999999999999999998765433221 12235
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....+ .+........
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~~~--------~~~~~~~~~~ 241 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG--------TPELQNPERL 241 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eeccCC--------CCCCCCcccc
Confidence 7889999999999889999999999999999999999997654322100 000000 0001111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.+++.+||+.+|++||++++|++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 355788999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=295.73 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=197.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc--CCccccceeeeEEecC----CceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR--TNHKNLVQLLGFCNEG----EHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~lV~ 578 (793)
+.+.||+|.||.||+|.+. |+.||||++... +++.+.+|.++.+. |+|+||+.+++.=..+ .+++||.
T Consensus 215 L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred EEEEecCccccceeecccc---CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 4578999999999999985 567999998654 34566777777665 6999999998865443 3789999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE-----CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
+|.++|||.|||.+ ..++....++++..+|.||++||.+ .++.|.|||||.+||||..++.+.|+|+|||...
T Consensus 289 dYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred ecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999999965 5788899999999999999999964 4788999999999999999999999999999866
Q ss_pred CCCCCc---ceecccCcccccCcccccCC----CCC--CccceehhHHHHHHHHh----------CCcCCCCCchhHHHH
Q 003818 654 KTDQTQ---TTTAIRGTKGYVAPEWFKNL----PIT--AKVDVYSFGILLLELVC----------CRKNFEVDATEECQM 714 (793)
Q Consensus 654 ~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~s--~~~Dvws~Gvil~ellt----------g~~pf~~~~~~~~~~ 714 (793)
..+... .....+||.+|||||++... .+. ..+||||||.++||+.. -+.||....+.+...
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 544221 22335699999999999653 121 36999999999999975 234554432221100
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
.+ +++.+ -+..+....+......+.+..+.++++.||..+|..|-|+-.|-+.|.++.+.
T Consensus 447 --ee-MrkVV---Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 447 --EE-MRKVV---CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred --HH-Hhcce---eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 00 11111 12222233333444556778899999999999999999999998888776643
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.52 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=187.1
Q ss_pred ccccccceeEEEeEeCCC-CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 508 ELGEGAFGKVYKGVLTTE-NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+||+|+||.||+|..... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 23456677665432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC-CCcce
Q 003818 586 LADFLFRKS---RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD-QTQTT 661 (793)
Q Consensus 586 L~~~l~~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~ 661 (793)
|.+++.+.. ..........++.||++||+|||+. +++||||||+|||++.++.+||+|||++...... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 3345667788999999999999998 9999999999999999999999999998643221 11122
Q ss_pred ecccCcccccCcccccC-------CCCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHHHHHHhhccccceee
Q 003818 662 TAIRGTKGYVAPEWFKN-------LPITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADWAYDCFRERKLGLLV 733 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-------~~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (793)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||......+... ..+.+... .+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~~~~~~-~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN-------HVIKDQQV-KLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHhhccc-ccC
Confidence 23457889999998753 2457899999999999999974 66776544332111 11112111 111
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.+.... ...+.+.+++..|+ .+|++||++++|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111 13356677888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.14 Aligned_cols=257 Identities=27% Similarity=0.413 Sum_probs=201.7
Q ss_pred ccccccccccceeEEEeEeCC------CCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceE
Q 003818 504 GFKEELGEGAFGKVYKGVLTT------ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 575 (793)
.+.+.||+|+||.||++.... .....||+|.+.... ....+++.+|+.+++++ +||||+++++++..++..+
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 456789999999999987422 123468999886533 23346789999999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 576 LVYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
+++||+++|+|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~ 171 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDN 171 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence 9999999999999996532 3467888899999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHH
Q 003818 641 NARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILAD 718 (793)
Q Consensus 641 ~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~ 718 (793)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--- 248 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--- 248 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---
Confidence 99999999998654322111 112234567999999999899999999999999999998 8888876554332111
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
+..+..... .......+.+++.+|++.+|++||++.||++.|+.....
T Consensus 249 -----~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 249 -----LKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----HHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111100 112235678999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=303.51 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=199.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||.|+||.||+|+. ..+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 24 ~~~lg~g~~g~vy~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 24 YEKIGQGASGTVFTAID-VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEecCCCeEEEEEEE-cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 36799999999999984 34677899999876555556778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... .+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .....
T Consensus 103 L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 103 LTDVVTET--CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence 99988543 578999999999999999999998 9999999999999999999999999998765443221 22345
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||.+.+..++.++|||||||++|+|++|+.||......+....+ .... .... ......
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------~~~~-~~~~-------~~~~~~ 241 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG-TPEL-------QNPEKL 241 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcC-Cccc-------CCcccC
Confidence 788999999999888999999999999999999999999876543321111 0010 0000 011122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+.+++.+||+.+|++||++.+|++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 3457789999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=311.33 Aligned_cols=258 Identities=24% Similarity=0.273 Sum_probs=190.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV 577 (793)
.+.||+|+||.||++... ..++.||+|++.... ......+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 478999999999999854 467889999986532 233467889999999999999999999886543 57999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++ +|.+.+. ..++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 105 MELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred EeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 999965 5666553 2367788889999999999999998 99999999999999999999999999997543221
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHH---------------HHHHH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILA---------------DWAYD 722 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~---------------~~~~~ 722 (793)
......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .....
T Consensus 178 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 178 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred --cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 1223458899999999999999999999999999999999999998664332111100 00000
Q ss_pred Hhhccc-cc-----eeecc---cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERK-LG-----LLVEN---DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~-~~-----~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... .. ..... .............+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00 00000 00000011123567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.94 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=196.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|+||++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 11 LDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred eeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 467999999999999854 456789999986543 2234567889999999999999999999999999999999997 5
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||++........ .....
T Consensus 89 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 164 (301)
T cd07873 89 DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNE 164 (301)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-ccccc
Confidence 89998877666788899999999999999999998 999999999999999999999999999975433221 11223
Q ss_pred cCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhh----ccccceeecc
Q 003818 665 RGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFR----ERKLGLLVEN 735 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~----~~~~~~~~~~ 735 (793)
.+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+..... ..+. .........+
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 468899999988654 578899999999999999999999987654432221111000 0000 0000000000
Q ss_pred cchh----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEA----MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.... .........+.+++.+||+.||.+|||++||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=302.41 Aligned_cols=247 Identities=28% Similarity=0.309 Sum_probs=196.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|.+...... ....+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 5 YRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 367999999999999865 45788999998654322 23457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...++...+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........ .
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I 158 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence 99999998654 34578889999999999999999988 999999999999999999999999999876543322 1
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||.............. ...... ...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----~~~~~~-~~~--------- 224 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEVQ-EEY--------- 224 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----hhhhhh-hhc---------
Confidence 223589999999999998999999999999999999999999986533211111110 000000 000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
.......+.+++..||+.||++||| ++|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112345788999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=315.47 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=195.4
Q ss_pred cccccccccceeEEEeEeCC-CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++.... ..++.||+|.+... ....+|+.++++++|||||++++++......++|||++.
T Consensus 96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 44789999999999987533 34578999987543 345689999999999999999999999999999999995
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-ccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~ 662 (793)
++|.+++ .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+..... ....
T Consensus 170 ~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 170 CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence 6888888 3446788999999999999999999998 999999999999999999999999999976544322 2223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec--------
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE-------- 734 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-------- 734 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ..+..........
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCCccchhHHHH
Confidence 4568999999999999999999999999999999999999997654322111111111 1111000000000
Q ss_pred ---------c---cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 735 ---------N---DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 735 ---------~---~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
. .+...........+.+++.+||+.||++|||+.|+++.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000001123457789999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.42 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=197.3
Q ss_pred cccccccceeEEEeEeCCCCc---eeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|.....+. ..||+|.+..... ....++.+|+.+++.++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 679999999999998654332 3578888865432 2234688999999999999999999998754 5679999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-e
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-T 661 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 661 (793)
+|+|.+++......+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+||+|||+++......... .
T Consensus 92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 168 (303)
T cd05110 92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168 (303)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccccc
Confidence 9999999987766788899999999999999999998 99999999999999999999999999998665332211 1
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .+..+.....
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~--------~~~~~~~~~~-------- 232 (303)
T cd05110 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD--------LLEKGERLPQ-------- 232 (303)
T ss_pred CCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHCCCCCCC--------
Confidence 12235678999999998899999999999999999997 889997654332211 1111111100
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+.+++..|+..+|++||++++|++.|+.+.
T Consensus 233 -~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 233 -PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112345788999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.58 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=196.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc---------chHHHHHHHHHHhcCCccccceeeeEEecCCceE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 575 (793)
+.+.||+|+||.||+|... ..++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred ccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 3468999999999999854 45678999988643221 1256788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+++||+++++|.+++... ..++...+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999654 4567888889999999999999998 999999999999999999999999999986653
Q ss_pred CCCc-----ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 656 DQTQ-----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 656 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~ 230 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENASP 230 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccCCC
Confidence 2111 111234788999999999888999999999999999999999999865433211110 111000
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .+......+.+++.+||+.+|++||++.+|++
T Consensus 231 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 E---------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c---------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 01123456788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=281.87 Aligned_cols=246 Identities=28% Similarity=0.368 Sum_probs=198.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc----cc----hHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN----EG----EQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~----~~----~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
++.||.|..++|.+..++ .+++..|+|++..... +. .+.-..|+.+|+++ .||+|+++.++++.....++
T Consensus 22 keilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred HHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 467999999999998865 4566788888854211 11 23446799999997 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|+|.|+.|.|.|+|... -.+++....+|++|+.+|++|||.+ +||||||||+|||++++.++||+|||++..+.++
T Consensus 101 VFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999654 5678889999999999999999998 9999999999999999999999999999877654
Q ss_pred CCcceecccCcccccCcccccC------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKN------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
. .....+|||+|+|||.+.. ..|+...|+||.||+||-|+.|-+||....+-- +...+.+|+..
T Consensus 177 e--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml--------MLR~ImeGkyq 246 (411)
T KOG0599|consen 177 E--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML--------MLRMIMEGKYQ 246 (411)
T ss_pred h--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH--------HHHHHHhcccc
Confidence 3 4556789999999998853 257889999999999999999999997543321 22334444433
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.-. ++ -.+..+...+||.+||+.||.+|.|.+|.++
T Consensus 247 F~s---pe---Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 FRS---PE---WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cCC---cc---hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 211 11 2234556788999999999999999999875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=299.25 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=192.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecC------CceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEG------EHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~~~~lV~ 578 (793)
.+.||+|+||.||+|... ..++.||+|++... ......+..|+.++.++ +|+||+++++++... ...++||
T Consensus 11 ~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 11 VELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred HHheeecCCeEEEEEEEc-CCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 367999999999999864 45678999998654 33456788999999998 799999999998653 4678999
Q ss_pred eecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 89 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 999999999999764 35678899999999999999999998 99999999999999999999999999997654322
Q ss_pred CcceecccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 658 TQTTTAIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
. ......|+..|+|||++. ...++.++|||||||++|||++|+.||...........+ ........
T Consensus 166 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~ 236 (272)
T cd06637 166 G-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNPAPRL 236 (272)
T ss_pred c-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH--------hcCCCCCC
Confidence 1 223355889999999986 335788999999999999999999999754433211111 01000000
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .......+.+++.+||+.+|.+|||+.+|++
T Consensus 237 ~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 237 K--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 1122346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.24 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=191.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 577 (793)
.+.||+|+||.||++... ..++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 468999999999999843 456789999986532 23346778899999999999999999987543 357999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++ +|.+.+.. .++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 108 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 108 MELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred EeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 999965 67776643 467788899999999999999998 99999999999999999999999999997653322
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH---------------HHHH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD---------------WAYD 722 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~---------------~~~~ 722 (793)
......+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ....
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 181 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred --cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 12234589999999999999999999999999999999999999987654432211110 0000
Q ss_pred Hhhccc-cc-----eeecc---cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERK-LG-----LLVEN---DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~-~~-----~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... .. ..... .............+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00 00000 00000011123567899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.59 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=199.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc----------ccchHHHHHHHHHHhc-CCccccceeeeEEecCCce
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----------NEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHR 574 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~ 574 (793)
.+.||+|+||.||+|.....+++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+++..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999776567889999875321 1123456778887765 7999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 575 LLVYEYVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
+++|||+++++|.+++.. ....++...++.++.|++.||.|||+. .+++|+||+|+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccccee
Confidence 999999999999998743 345688889999999999999999963 279999999999999999999999999998
Q ss_pred ccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 652 LLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ .+.....
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~ 232 (269)
T cd08528 163 QKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI--------VEAVYEP 232 (269)
T ss_pred eccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--------hhccCCc
Confidence 655433 223345888999999999888999999999999999999999999765433221111 1111111
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
. . .......+.+++.+|++.||++||++.||.++++
T Consensus 233 ~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 L----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0 0112356789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=300.95 Aligned_cols=264 Identities=23% Similarity=0.275 Sum_probs=202.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|... .+++.|++|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred EEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 4578999999999999854 357789999987643 233467899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++......+++..+..++.||++||.|||+. +++|+||||+||+++.++.++|+|||++............
T Consensus 82 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 82 PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 9999999977667789999999999999999999998 9999999999999999999999999999876544332233
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhhc-------cccc
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFRE-------RKLG 730 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~~-------~~~~ 730 (793)
...++..|+|||.+.+. .++.++||||+|++++||++|..+|......+....+..... ..+.+ ..+.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 44588999999998654 468999999999999999999888876554332211111000 00000 0000
Q ss_pred eeecccch-hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 731 LLVENDEE-AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 731 ~~~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........ .....+....+.+++.+||+.+|++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00001234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.94 Aligned_cols=241 Identities=27% Similarity=0.304 Sum_probs=186.8
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcC---CccccceeeeEEecCCceEEEEeecC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRT---NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
||+|+||.||+|... .+++.||+|++...... ....+..|..++... +||||+++++.+.+.+..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999854 45788999998653221 223344566666554 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 80 GGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred CChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 99999988654 5678889999999999999999998 999999999999999999999999999875432221 223
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+.... +..+..... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~--------i~~~~~~~~-~------- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN--------IAFGKVRFP-K------- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH--------HHcCCCCCC-C-------
Confidence 35689999999998764 489999999999999999999999987654432111 111111100 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA----MKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~ 772 (793)
......+.+++.+||+.||++||+ +.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012345678999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.63 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=199.1
Q ss_pred ccccccccceeEEEeEeCCC----CceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTE----NEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.||+|+||.||+|..... ..+.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 36799999999999986432 3467999988654333 346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 581 VSNGSLADFLFRKS--------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 581 ~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999997543 1578999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||......... .....+....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~--------~~~~~~~~~~ 238 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL--------NRLQAGKLEL 238 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH--------HHHHcCCcCC
Confidence 43322222223345678999999988888999999999999999998 78888654332211 1111111111
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
.. .......+.+++.+||+.+|++||++.++++.|+
T Consensus 239 ~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 PV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10 1123356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.31 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=201.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||.+... .+++.+++|++.... ....+++.+|+.++++++|+||+++++++.+.+..+++|||++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred EeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 3478999999999988854 456789999876432 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~ 158 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA 158 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence 99999999765 45678899999999999999999988 999999999999999999999999999986644332 22
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+.....
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~~--------- 221 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------VQGNYTPV--------- 221 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCCCC---------
Confidence 3345889999999999888999999999999999999999999765443321111 11111111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+|++.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=300.98 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=196.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||+++++
T Consensus 10 ~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 10 ERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 56999999999999864 456789999886433 2334678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.. ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++..+..... ......
T Consensus 89 L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06642 89 ALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhccc
Confidence 9998854 4578889999999999999999988 999999999999999999999999999976543321 112235
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||.+.+..++.++||||||+++|||++|+.|+......+... .+....... .....
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~---------~~~~~ 225 (277)
T cd06642 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------LIPKNSPPT---------LEGQY 225 (277)
T ss_pred CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------hhhcCCCCC---------CCccc
Confidence 7889999999999899999999999999999999999987543322111 111111000 01123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+.+++.+|++.+|++||++.+|++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4567899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.96 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=197.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|+.. .+++.||+|++..... ...+.+.+|+.++++++|+||+++++++......++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 467999999999999864 4578899998865422 2345678999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+.|..++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ....
T Consensus 85 ~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 85 TVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 888877644 34688999999999999999999998 999999999999999999999999999987654322 1222
Q ss_pred ccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhh-------cccc-ceeec
Q 003818 664 IRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR-------ERKL-GLLVE 734 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~-------~~~~-~~~~~ 734 (793)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......... .... .....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 346788999999876 45789999999999999999999999876554432222111111000 0000 00000
Q ss_pred ccchhhh-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMD-----DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+...... .......+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 1122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.31 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=199.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||.|+||.||+|+.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 367999999999999865 457889999986543 333467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++....... .....
T Consensus 85 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (274)
T cd06609 85 SCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTF 158 (274)
T ss_pred cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccc
Confidence 999998654 678999999999999999999998 999999999999999999999999999987654322 22234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.++..|+|||.+.+..++.++||||||+++|||++|+.||......+... .+.......... ..
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~~--------~~ 222 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF--------LIPKNNPPSLEG--------NK 222 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--------HhhhcCCCCCcc--------cc
Confidence 57889999999998889999999999999999999999997654322111 111111111110 01
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+.+++.+||+.+|++|||++++++.
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 34567889999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.82 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=197.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
..||+|+||.||++... .+++.||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46999999999999854 45678999998765555566789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||++........ ......+
T Consensus 107 ~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 180 (292)
T cd06658 107 TDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG 180 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence 998843 3578889999999999999999998 999999999999999999999999999875543322 1223457
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
+..|+|||.+.+..++.++||||||+++|||++|+.||......+.... +... ...... ......
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--------~~~~-~~~~~~------~~~~~~ 245 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR--------IRDN-LPPRVK------DSHKVS 245 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhc-CCCccc------cccccC
Confidence 8899999999888899999999999999999999999976543321111 1110 000000 111233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..+.+++.+|++.+|++|||++++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=303.02 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=198.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
..||+|+||.||++... .+++.||+|++........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999854 45678999998665445556788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......... .....+
T Consensus 106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~ 179 (297)
T cd06659 106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVG 179 (297)
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccceec
Confidence 998744 4578899999999999999999998 9999999999999999999999999998755433221 223458
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ........ .......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~~~ 244 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDSPPPKL-------KNAHKIS 244 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCCCc-------cccCCCC
Confidence 89999999999888999999999999999999999999765443321111 11110000 0011123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..+.+++.+|++.+|++||++++|++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.00 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=198.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 581 (793)
+.+.||+|++|.||+++.. .+++.||+|++.... ....+.+.+|+.++++++|+|++++++.+.. ....+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred EEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 4578999999999999864 456789999986532 2334578899999999999999999998764 44678999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 582 SNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
++++|.+++... ...+++.++..++.+++.||+|||+. +|+|+||||+||++++++.++|+|||++........ .
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 158 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M 158 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence 999999999764 44578999999999999999999998 999999999999999999999999999986643322 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....+++.|+|||.+.+..++.++||||||++++||++|+.||.......... . +..+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-------~-~~~~~~~~~-------- 222 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-------R-IIEGKLPPM-------- 222 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-------H-HHhcCCCCC--------
Confidence 233457889999999999999999999999999999999999997654332111 1 111111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+|++.+|++||++.++++.
T Consensus 223 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 -PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=311.59 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=191.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 577 (793)
.+.||+|+||.||++.. ...++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 22 ~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 22 LKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEeeecCCEEEEEEEe-cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 46899999999999974 3467889999986532 22345678899999999999999999988543 357999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++ +|.+.+.. .++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 101 MELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred hhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 999965 66666642 467888889999999999999998 99999999999999999999999999997653322
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH---------------HHHH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD---------------WAYD 722 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~---------------~~~~ 722 (793)
......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....... ....
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred --ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 12234589999999999999999999999999999999999999986654332111100 0000
Q ss_pred Hhhccc-cc-----eee-ccc--chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERK-LG-----LLV-END--EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~-~~-----~~~-~~~--~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... .. ... +.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 00 000 000 0000111224567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.61 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=194.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|++|.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|+||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred eeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 468999999999999854 4567899999865322 234678899999999999999999999999999999999997
Q ss_pred CCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 584 GSLADFLFRK--SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 584 gsL~~~l~~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|.+++... ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||++........ ..
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VY 158 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cc
Confidence 6898888653 25678899999999999999999998 999999999999999999999999999976543221 11
Q ss_pred ecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhhcc--------c
Q 003818 662 TAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFRER--------K 728 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~~~--------~ 728 (793)
....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.......... ..+... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 223468899999988654 578999999999999999999999986654332111110000 000000 0
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......... .........++.+++.+||+.||++|||+.+|++
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 239 FPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0000112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.25 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=199.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 10 ~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88 (284)
T ss_pred HHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence 367999999999999854 456789999876532 334568899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++... ..+++.....++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++....... ....
T Consensus 89 ~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~ 162 (284)
T cd06620 89 SLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTF 162 (284)
T ss_pred CHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCcc
Confidence 999988653 4578899999999999999999963 279999999999999999999999999986543221 1234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH----HHHHHHHHHHHhhccccceeecccchhh
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC----QMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.++..|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+.........+.. .. .
T Consensus 163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--------~ 233 (284)
T cd06620 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PR--------L 233 (284)
T ss_pred ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-CC--------C
Confidence 588999999999888999999999999999999999999986544211 1111122222111110 00 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
........+.+++.+|++.||++|||++||+++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111345678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.45 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=197.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+++++
T Consensus 10 ~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 10 ERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 57999999999999854 356789999886543 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.. ..++......++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 89 L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06640 89 ALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cccccc
Confidence 9999854 3578888899999999999999988 999999999999999999999999999976543322 122234
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||.+.+..++.++|+||||+++|||++|..||........... ....... ......
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------~~~~~~~---------~~~~~~ 225 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL--------IPKNNPP---------TLTGEF 225 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--------hhcCCCC---------CCchhh
Confidence 78889999999888899999999999999999999999976543321111 1111110 011234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+.+++.+||+.+|++||+++++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5667899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.93 Aligned_cols=242 Identities=28% Similarity=0.434 Sum_probs=194.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++.+++||||+++++++... ..++||||++++
T Consensus 10 ~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred eeeeeccCCCCceEeccc---CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 457899999999999874 46679999986532 346788999999999999999999998754 479999999999
Q ss_pred CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++.... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~----~ 156 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD----N 156 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC----C
Confidence 9999997643 4578889999999999999999988 999999999999999999999999999875432211 1
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+.... ...+.... . .
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~---~------~ 219 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC--------VEKGYRME---P------P 219 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------HhCCCCCC---C------C
Confidence 224567999999998899999999999999999998 9999976654332111 11111110 0 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...+..+.+++.+|++.+|++||++++|++.|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.11 Aligned_cols=262 Identities=20% Similarity=0.215 Sum_probs=194.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 3467999999999999864 4577899999865322 223567889999999999999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++......+++.....++.||++||.|||++ +|+|+||||+||+++.++.+||+|||+++.+..... ...
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (284)
T cd07839 83 -QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYS 157 (284)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcC
Confidence 588888876666789999999999999999999998 999999999999999999999999999986543221 122
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhH-HHHHHHHHH-------HHHhhccccceee
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEE-CQMILADWA-------YDCFRERKLGLLV 733 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~-~~~~l~~~~-------~~~~~~~~~~~~~ 733 (793)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+ ....+.... +..+....-....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 23468899999998765 47899999999999999999998865433322 111111000 0000000000000
Q ss_pred cccch----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 ENDEE----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..... ..........+.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0011123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.21 Aligned_cols=262 Identities=25% Similarity=0.336 Sum_probs=197.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|... .+++.||+|++...... ..+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred EeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 3478999999999999864 35788999988654322 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.++.... ..+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||++....... ....
T Consensus 84 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (286)
T cd07846 84 HTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT 158 (286)
T ss_pred ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence 99998876543 4488999999999999999999998 99999999999999999999999999987654332 2222
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH-------Hhhccc------
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-------CFRERK------ 728 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-------~~~~~~------ 728 (793)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...... .+....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 34478899999998753 5788999999999999999999999766543322222111100 000000
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....................+.+++.+||+.+|++||++++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.20 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=195.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---c-------chHHHHHHHHHHhcCCccccceeeeEEecCCceE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---E-------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 575 (793)
.+.||+|+||.||+|... .+++.||+|.+..... . ..+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 367999999999999854 4578899998753211 0 1246788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+|+||+++++|.+++.+. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999765 4678888999999999999999998 999999999999999999999999999976543
Q ss_pred CCCcc-eecccCcccccCcccccCCC--CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 656 DQTQT-TTAIRGTKGYVAPEWFKNLP--ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 656 ~~~~~-~~~~~gt~~y~aPE~~~~~~--~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
..... .....++..|+|||.+.... ++.++|+||||+++||+++|..||......+.... ...... ...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~-~~~ 232 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-------LGNKRS-APP 232 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH-------hhcccc-CCc
Confidence 22211 22345788999999987654 78999999999999999999999965443321111 001110 000
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
... .........+.+++.+|++.+|++||++++|++.
T Consensus 233 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0111234678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.97 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=198.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
+.||+|++|.||++... .+++.+++|++........+.+.+|+.+++.++|+||+++++++..++..++++||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 57999999999999854 45678999998655444556788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.+++.. ..+++..+..++.|++.||+|||++ +|+||||+|+||++++++.++|+|||++........ ......|
T Consensus 104 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 177 (285)
T cd06648 104 TDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVG 177 (285)
T ss_pred HHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccC
Confidence 999866 4578889999999999999999998 999999999999999999999999998875543322 1223458
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ........ .......
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~~~ 242 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDNLPPKL-------KNLHKVS 242 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HhcCCCCC-------cccccCC
Confidence 88999999998888999999999999999999999999765433221111 11110000 0111133
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 56889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.73 Aligned_cols=195 Identities=23% Similarity=0.373 Sum_probs=159.0
Q ss_pred cccccccceeEEEeEeCC-CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEe--cCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCN--EGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey~~~ 583 (793)
.+||+|+||.||+|.... ..++.||+|.+.... ....+.+|+.++++++||||+++++++. .+...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998643 355789999886532 2346788999999999999999999885 35678999999864
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCcEEEeecCCcc
Q 003818 584 GSLADFLFRK--------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAK 651 (793)
Q Consensus 584 gsL~~~l~~~--------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 651 (793)
+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 23467888899999999999999998 99999999999999 567789999999998
Q ss_pred ccCCCCCc--ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCC
Q 003818 652 LLKTDQTQ--TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVD 707 (793)
Q Consensus 652 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~ 707 (793)
........ ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 66443221 12234578999999998764 5799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.04 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=196.3
Q ss_pred ccccccccceeEEEeEeCC--CCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceE
Q 003818 506 KEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~ 575 (793)
.+.||+|+||.||+|.... .+++.||+|++.... ....+++.+|+.++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 4679999999999998643 346889999986542 233467889999999999999999999886532 247
Q ss_pred EEEeecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 576 LVYEYVSNGSLADFLFRK-----SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
+++||+++|+|.+++... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccccc
Confidence 889999999999887532 23467888999999999999999988 9999999999999999999999999999
Q ss_pred cccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+........ ......+++.|++||.+....++.++||||||+++|||++ |+.||......+.... +....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~--------~~~~~ 232 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY--------LIKGN 232 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH--------HHcCC
Confidence 865433211 1122335678999999998889999999999999999999 8888876544321111 11111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.. . ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 233 ~~--~-------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RL--K-------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC--C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 0112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.63 Aligned_cols=263 Identities=24% Similarity=0.289 Sum_probs=199.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++|+||++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred EEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 45789999999999998653 46789999886532 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++.+..++. +...++...+..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++............
T Consensus 84 ~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 84 RTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 877766554 345578899999999999999999998 9999999999999999999999999999876554432333
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH-------Hh-hccccce--
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-------CF-RERKLGL-- 731 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-------~~-~~~~~~~-- 731 (793)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+...... .+ .......
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 34578899999999888 8899999999999999999999999766543322211110000 00 0000000
Q ss_pred eecccc----hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 LVENDE----EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~~~~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...... ...........+.+++.+||+.+|++||++++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 00001112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.44 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=193.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|++|.||+|... .+++.||+|.+...... ....+.+|+.++++++|+||+++++++.+++..++||||+.+
T Consensus 10 ~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 10 LDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 468999999999999854 45678999998654322 234577899999999999999999999999999999999974
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++.....++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... .....
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 163 (291)
T cd07844 88 DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNE 163 (291)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccccc
Confidence 99999877666788999999999999999999998 999999999999999999999999999875432111 11222
Q ss_pred cCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcc---cc---------ce
Q 003818 665 RGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER---KL---------GL 731 (793)
Q Consensus 665 ~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~---~~---------~~ 731 (793)
.++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............ ....+... .. ..
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK---IFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH---HHHhcCCCChhhhhhhhhcccccc
Confidence 36788999999865 45889999999999999999999999765422111100 00000000 00 00
Q ss_pred ----eecccc--hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 ----LVENDE--EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ----~~~~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...... ...........+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 00001112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.80 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=192.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecC-----CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEG-----EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----~~~~lV~E 579 (793)
.+.||+|+||.||++... .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++... ...++|+|
T Consensus 27 ~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 27 IETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 367999999999999854 457789999986532 2345678899999998 899999999998653 35899999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 580 YVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 580 y~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 9999999998863 345678899999999999999999998 9999999999999999999999999998765432
Q ss_pred CCcceecccCcccccCcccccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNL-----PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
... .....++..|+|||.+... .++.++|||||||++|||++|+.||......+.... +.......
T Consensus 182 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~ 252 (291)
T cd06639 182 RLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK--------IPRNPPPT 252 (291)
T ss_pred ccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH--------HhcCCCCC
Confidence 221 1223578899999998643 368899999999999999999999976543322111 11111111
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+. ........+.+++.+|++.+|++||++.|+++.
T Consensus 253 ~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 253 LL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111233468899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.21 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=194.2
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEe--chh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCc--eEEE
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKL--YKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH--RLLV 577 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l--~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV 577 (793)
.|.++||+|+|-+||||. +...|..||=-.+ .+. .....+.|..|+.+|+.|+|||||+++.++.+... ..+|
T Consensus 43 k~~evLGrGafKtVYka~-De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAF-DEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeecc-ccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 355789999999999998 4566766763222 222 22334789999999999999999999999987665 6789
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTD 656 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 656 (793)
+|.|..|+|+.|+.+. +..+...+..+++||++||.|||++ .++|||||||.+||+|+. .|.+||+|+|||..+...
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999999655 5677888999999999999999997 779999999999999974 688999999999877644
Q ss_pred CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
.. ..+.|||.|||||... ..|++.+||||||++++||+|+..|+..-...- . .++.+..|..+..+..
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------Q-IYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------Q-IYKKVTSGIKPAALSK- 267 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------H-HHHHHHcCCCHHHhhc-
Confidence 33 3367999999999998 689999999999999999999999997554331 1 1222222322211111
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. -.++.++|.+||.. .++|||+.|+++
T Consensus 268 ---V~----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 ---VK----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---cC----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11 13568899999999 899999999986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=290.61 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=199.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||++... .+++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++|+||++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred EEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 3578999999999999854 467789999986532 2334578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 158 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-A 158 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-h
Confidence 99999998764 34578889999999999999999998 9999999999999999999999999999765433221 1
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+.. .... .+.....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~-------~~~~-~~~~~~~--------- 221 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV-------LKII-RGSYPPV--------- 221 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH-------HHHh-cCCCCCC---------
Confidence 2234788999999999888999999999999999999999999765443321 1111 1111100
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+|++.+|++||++++|++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=319.57 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=185.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc------cccceeeeEEecC-CceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH------KNLVQLLGFCNEG-EHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~~~-~~~~lV~ 578 (793)
.++||+|+||.||+|... ..++.||||+++... ....++..|+.+++.++| .+++++++++..+ .+.++||
T Consensus 134 ~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 468999999999999854 456789999986432 223445667777766644 4688999988764 5788999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----------------cE
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----------------NA 642 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----------------~~ 642 (793)
|++ +++|.+++.+. ..+++..+..|+.||+.||.|||++ .+||||||||+|||++.++ .+
T Consensus 212 ~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 212 PKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred ecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 988 77898888654 4688889999999999999999962 2899999999999998765 49
Q ss_pred EEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHH---
Q 003818 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW--- 719 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~--- 719 (793)
||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+...
T Consensus 288 kl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 288 RICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred EECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 999999875322 1223456899999999999999999999999999999999999999876544322221110
Q ss_pred -----HHH--------Hhhc-cccceeecccc-------hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 720 -----AYD--------CFRE-RKLGLLVENDE-------EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 720 -----~~~--------~~~~-~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .+.. +.+....+... ...........+.+|+.+||+.||++|||++|+++
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 0000 00000000000 00001112356789999999999999999999987
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.53 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=195.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||++... ..++.||+|.+.... ......+.+|+.++++++|+||+++++.+...+..++|+||++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 6 LDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 467999999999999864 457889999886532 223467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRK--SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|..++... ...+++..+..++.++++||.|||+. .+|+|+||||+||+++.++.+||+|||++..+..... .
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~ 159 (286)
T cd06622 85 SLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---K 159 (286)
T ss_pred CHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc---c
Confidence 999988654 33678999999999999999999963 2899999999999999999999999999876533221 2
Q ss_pred cccCcccccCcccccCC------CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 663 AIRGTKGYVAPEWFKNL------PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~------~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+ .. ...+....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~~-~~~~~~~~----- 229 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL----SA-IVDGDPPT----- 229 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----HH-HhhcCCCC-----
Confidence 23478899999998554 3588999999999999999999999764332211111 01 11111110
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.+|++||+++++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111244667899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=295.65 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=191.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEe-----cCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCN-----EGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~-----~~~~~~lV~E 579 (793)
.+.||+|+||.||++... .+++.+|+|.+... ......+.+|+.++..+ +||||+++++++. .++..++|||
T Consensus 23 ~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 23 IETIGKGTYGKVFKVLNK-KNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeccCCCcEEEEEEEC-CCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 367999999999999864 45678999987643 22346788899999998 6999999999873 4467899999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 580 YVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 580 y~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|+++++|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 9999999998753 345678888999999999999999998 9999999999999999999999999998765432
Q ss_pred CCcceecccCcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
.. ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........... ........
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~ 248 (286)
T cd06638 178 RL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK--------IPRNPPPT 248 (286)
T ss_pred CC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh--------ccccCCCc
Confidence 22 1223458899999999853 4578899999999999999999999976543221110 00110000
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.. ........+.+++.+||+.+|++|||+.||++.
T Consensus 249 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 249 LH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 011123468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=290.57 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=196.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-----ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.||+|+||.||+|+.. .+++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++..+...++++||
T Consensus 5 ~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 5 GELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred cceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 467999999999999864 356789999886533 12346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++++|.+++.+. ..+++..+..++.|+++||+|||+. +|+|+||+|+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 84 VPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 9999999999654 3578889999999999999999998 99999999999999999999999999987654433 1
Q ss_pred eecccCcccccCcccccCCC-CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~-~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.... ++.++|+||||+++|+|++|+.||......+....+ .........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~~~~~------- 223 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-------GRSKELPPI------- 223 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH-------HhcccCCCc-------
Confidence 23345788999999987766 899999999999999999999999765432211110 010111111
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.+|++||+++++++
T Consensus 224 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 --PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112355678999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=291.37 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=200.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||.|+||+||+|.... ++..+++|++.... ....+.+.+|+..++.++|+||+++++.+..++..++|+|++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 35789999999999998554 56789999986533 23457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc--
Q 003818 584 GSLADFLFRK--SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-- 659 (793)
Q Consensus 584 gsL~~~l~~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 659 (793)
++|.+++... ...+++.....++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++..+......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999764 24678899999999999999999988 9999999999999999999999999998766543322
Q ss_pred -ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 660 -TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
......++..|+|||.+... .++.++|+||||++++||++|+.||......+.... .... ..... .
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-------~~~~-~~~~~-~--- 228 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-------TLQN-DPPSL-E--- 228 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH-------HhcC-CCCCc-C---
Confidence 12234578899999998877 789999999999999999999999976544321111 1111 00000 0
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...........+.+++..|++.||++||++++|++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00001133466789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=292.51 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=188.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-----cchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-----EGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 578 (793)
.+.||+|+||.||+|... .+++.|++|++..... +....+.+|+.++++++||||+++++++.+ +...++++
T Consensus 7 ~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred cceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 468999999999999854 4567899998864321 223568889999999999999999998865 35778999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|.+++... ..+++.....++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 86 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 86 EYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999654 3478888899999999999999988 999999999999999999999999999976543211
Q ss_pred --cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 659 --QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......+... ........ +
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-------~~~~~~~~-----~- 228 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-------KIATQPTN-----P- 228 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-------HHhcCCCC-----C-
Confidence 11122447889999999999889999999999999999999999997653322111 11111000 0
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .+....+.+..++ +|+..+|++||+++||++
T Consensus 229 -~--~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 -Q--LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -C--CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0 0111223445565 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.39 Aligned_cols=243 Identities=27% Similarity=0.356 Sum_probs=194.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|... .+++.||+|++..... +..+.+.+|+.+++.++||||+++++++.+.+..++|+||+.
T Consensus 20 ~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred heeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 367999999999999864 3567899998864322 233568899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+++......+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 99 -g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~----- 169 (307)
T cd06607 99 -GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----- 169 (307)
T ss_pred -CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC-----
Confidence 678787766566789999999999999999999998 99999999999999999999999999987553321
Q ss_pred cccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 663 AIRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
...++..|+|||.+. ...++.++||||||+++|||++|+.||...........+ .......
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~-------- 233 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNDSPT-------- 233 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--------hcCCCCC--------
Confidence 234778999999874 456889999999999999999999999765443321111 1110000
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.........+.+++.+||+.+|++||++.+|++..
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00112445689999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.23 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=199.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||++... .+++.|++|++.... ....+++.+|+.++++++||||+++++.+...+..++++||++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 467999999999999864 456789999987643 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++......++......++.|+++||.|||+ . +++|+||||+||++++++.++|+|||.+..........
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--- 158 (265)
T cd06605 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--- 158 (265)
T ss_pred cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc---
Confidence 9999997765678888999999999999999998 6 99999999999999999999999999987654322211
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+........ ... ... ..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~-~~~-------~~~-~~ 227 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQYIVNE-PPP-------RLP-SG 227 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHHHhcC-CCC-------CCC-hh
Confidence 4578899999999998999999999999999999999999975432110 011111111111 100 000 00
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.....+.+++..|+..+|++|||+.+++..
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 144568899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=290.08 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=197.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.|++|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 468999999999999854 35678999998765443 457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee-
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT- 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~- 662 (793)
++|.+++... ..+++..+..++.+++.||.|||+. +|+|+||+|+||++++++.+||+|||++............
T Consensus 84 ~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 84 GTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999998754 4578888999999999999999998 9999999999999999999999999999876543332221
Q ss_pred --cccCcccccCcccccCCC---CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 663 --AIRGTKGYVAPEWFKNLP---ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 663 --~~~gt~~y~aPE~~~~~~---~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
...++..|+|||.+.+.. ++.++||||||++++||++|+.||.......... ... ......
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~------~~~-~~~~~~------- 225 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM------FHV-GAGHKP------- 225 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH------HHH-hcCCCC-------
Confidence 245788999999998766 8899999999999999999999997543221110 000 001000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...........+.+++.+|++.+|++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111122455678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=320.29 Aligned_cols=264 Identities=20% Similarity=0.286 Sum_probs=184.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEe--------------ch---hcccchHHHHHHHHHHhcCCccccceeeeE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKL--------------YK---AVNEGEQEFKAEISAIGRTNHKNLVQLLGF 567 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l--------------~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 567 (793)
+.+.||+|+||.||++.+....+...+.|.+ .+ ........+.+|+.++++++|||||+++++
T Consensus 152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 3478999999999998765444333333311 11 111223568899999999999999999999
Q ss_pred EecCCceEEEEeecCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEE
Q 003818 568 CNEGEHRLLVYEYVSNGSLADFLFRKS----RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643 (793)
Q Consensus 568 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 643 (793)
+...+..++|+|++. ++|.+++.... ..........|+.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 999999999999984 57777765431 2234556778999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcC-CCCCchhHHHHHHHHHHHH
Q 003818 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN-FEVDATEECQMILADWAYD 722 (793)
Q Consensus 644 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~p-f~~~~~~~~~~~l~~~~~~ 722 (793)
|+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +........ ..+......
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~-~~~~~~~~~ 386 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG-KQLLKIIDS 386 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH-HHHHHHHHh
Confidence 999999987654433333345689999999999999999999999999999999998754 432221111 111111100
Q ss_pred -----------------HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 -----------------CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+....+...................+.+++.+||+.||++|||+.|+++.
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000000000000001112356778999999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.18 Aligned_cols=256 Identities=22% Similarity=0.271 Sum_probs=189.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 578 (793)
+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++... ...++++
T Consensus 21 ~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 21 TPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred eecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 67999999999999854 4567899999865322 2345677899999999999999999987543 4568999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
|++ +++|.+++.. ..++...+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 100 ~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 171 (343)
T cd07878 100 NLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-- 171 (343)
T ss_pred ecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC--
Confidence 988 7899887743 4588899999999999999999998 9999999999999999999999999999865432
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH-------HHhhccc--
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY-------DCFRERK-- 728 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~-------~~~~~~~-- 728 (793)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..... ..+....
T Consensus 172 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred --cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 223458899999999877 5689999999999999999999999976543332111111000 0000000
Q ss_pred --cceeecccchh--hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 --LGLLVENDEEA--MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 --~~~~~~~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+....... .........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000112346789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.57 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=190.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-----ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 578 (793)
.+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++++
T Consensus 7 ~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred eeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 478999999999999854 457889999885321 12235788899999999999999999988764 4678999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|.+++.+. ..+++....+++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 86 EHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999998654 4467888899999999999999998 999999999999999999999999999976543211
Q ss_pred --cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 659 --QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ........
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-------KIATQPTN------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-------HHhcCCCC-------
Confidence 11222457889999999988889999999999999999999999997653322111 11011000
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+......+.+++.+|+. +|++||++++|++
T Consensus 228 --~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 --PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00112234567788888885 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=294.06 Aligned_cols=262 Identities=23% Similarity=0.251 Sum_probs=199.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|+.. .+++.+|+|++.... ......+.+|+.++++++|+|++++++++... +..++|+||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 3468999999999999864 356789999997653 33345788999999999999999999999888 899999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++ +|.+++......+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 974 89998876656789999999999999999999998 99999999999999999999999999998665443222
Q ss_pred eecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc---ee----
Q 003818 661 TTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG---LL---- 732 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~---~~---- 732 (793)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... ...... .+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhccccccchhhh
Confidence 233446788999998765 467899999999999999999999998766443222211110000 000000 00
Q ss_pred -ecccc----hhhhhH-H-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 -VENDE----EAMDDI-K-RVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 -~~~~~----~~~~~~-~-~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..... ...... . +...+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 000001 1 2567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=291.15 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=195.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++++|
T Consensus 5 ~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 5 GEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 46799999999999975 3567899998864321 123568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC--
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-- 657 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-- 657 (793)
|+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 83 FVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999654 3567888889999999999999998 99999999999999999999999999987543211
Q ss_pred ---CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 658 ---TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 658 ---~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
........++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+. .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~-- 230 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG------AHRGLMPRL-- 230 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh------hccCCCCCC--
Confidence 111223458889999999999889999999999999999999999997654332111110 000111111
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.+|++||++.++++
T Consensus 231 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 -------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=288.61 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=197.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||++... .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+..++..++|+||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred EEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 3478999999999998854 467789999986532 2335678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCCCCCcc
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|.+++... ...+++..+..++.++++||.|||++ +++|+||+|+||+++++ ..+||+|||++........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999765 34578889999999999999999998 99999999999999855 4589999999986644322
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... .... +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~------- 222 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL-------KIMS-GTFAPIS------- 222 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH-------HHHh-cCCCCCC-------
Confidence 122457889999999998889999999999999999999999997654332111 1111 1111111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.+|++|||++|+++.
T Consensus 223 --~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 --DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=326.77 Aligned_cols=248 Identities=19% Similarity=0.277 Sum_probs=191.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... ..++.||+|.+.... ......+..|+.++++++|||||++++++.. ....+|||||
T Consensus 17 Il~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY 95 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF 95 (1021)
T ss_pred EEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeC
Confidence 3578999999999999865 456789999886432 2334678899999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeecCCCCCCEEEcC---------------
Q 003818 581 VSNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEEC----KSQIIHCDIKPQNILLDG--------------- 638 (793)
Q Consensus 581 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~----~~~ivH~Dlkp~NIll~~--------------- 638 (793)
+++++|.++|... ...+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 9999999999652 356889999999999999999999852 135999999999999964
Q ss_pred --CCcEEEeecCCccccCCCCCcceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH
Q 003818 639 --TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM 714 (793)
Q Consensus 639 --~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~ 714 (793)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql- 252 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL- 252 (1021)
T ss_pred CCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH-
Confidence 33489999999986543321 223468999999999854 45889999999999999999999999755432211
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+..... + . .......+.+||..||+.+|.+||++.|+++
T Consensus 253 ------i~~lk~~p~--l---p-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 253 ------ISELKRGPD--L---P-----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ------HHHHhcCCC--C---C-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111111110 0 0 0112356789999999999999999999984
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=294.91 Aligned_cols=261 Identities=21% Similarity=0.237 Sum_probs=196.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|... .+++.+++|.++..... ....+.+|+.++.+++||||+++++++... ...++|+||+
T Consensus 10 ~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 10 LNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 367999999999999864 45678999998654322 234567899999999999999999998877 8999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
. ++|.+++......+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||++......... .
T Consensus 89 ~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~ 163 (293)
T cd07843 89 E-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-Y 163 (293)
T ss_pred C-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc-c
Confidence 7 599999877666789999999999999999999998 9999999999999999999999999999866543221 1
Q ss_pred ecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhc------c
Q 003818 662 TAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRE------R 727 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~------~ 727 (793)
....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||......+....+.... +..+.. .
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 223467889999998764 46899999999999999999999998765543322221100 000000 0
Q ss_pred ccceeecccchhhhh-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 728 KLGLLVENDEEAMDD-IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 728 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
............... ......+.+++.+||+.+|++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000 002456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=296.96 Aligned_cols=251 Identities=23% Similarity=0.243 Sum_probs=197.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... ..++.|++|.+..... .....+.+|+.+++.++||||+++++.+..+++.++||||++
T Consensus 6 ~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 6 IKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred eeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 478999999999999854 4567899999876432 234577899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT---- 658 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---- 658 (793)
+++|.+++... ..+++.....++.++++||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 85 GGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999655 4578888889999999999999998 999999999999999999999999999864211100
Q ss_pred ----------cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 659 ----------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 659 ----------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
.......++..|+|||.+.+..++.++|+||||+++|||++|..||......+.... ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~--------~~~~~ 232 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--------VISDD 232 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhcc
Confidence 011123467889999999888899999999999999999999999976544331111 11111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...... .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 233 ~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 IEWPEG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cCCCCc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110000 01234567899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=291.34 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=197.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~ 581 (793)
.+.||.|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.. +...+++|||+
T Consensus 5 ~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 5 LETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 467999999999999854 456789999886432 2334578889999999999999999997754 45678999999
Q ss_pred CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 582 SNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEEC--KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 582 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
++++|.+++... ...+++.....++.++++||.|||..+ ..+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999998653 456888999999999999999999322 239999999999999999999999999999876543
Q ss_pred CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+.. ..+..+....+
T Consensus 164 ~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~---- 230 (265)
T cd08217 164 SSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA--------SKIKEGKFRRI---- 230 (265)
T ss_pred ccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH--------HHHhcCCCCCC----
Confidence 321 22345889999999999888999999999999999999999999876533211 11122211111
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+|++.+|++||++.+|++.
T Consensus 231 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 -----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.58 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=202.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|++|.||++.... +++.+++|++........+.+.+|+..+++++|+|++++++++...+..++++||+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeccCCceEEEEEEECC-CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4679999999999998653 567899999977655556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++......+++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||.+........ .....
T Consensus 84 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 9999977656789999999999999999999997 999999999999999999999999999987654432 23345
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||.+.+..++.++||||||+++++|++|+.||......+..... ........ ......
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~~ 223 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------ATNGPPGL-------RNPEKW 223 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--------HhcCCCCc-------Cccccc
Confidence 788999999998888999999999999999999999999866433211111 00111111 111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.+++.+|++.+|++|||+.+|++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 456889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=277.76 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=211.4
Q ss_pred CCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecC
Q 003818 493 FTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEG 571 (793)
Q Consensus 493 ~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 571 (793)
-+++++.+.|. +.||+|+|+.|-.++ .-.++..+|||++.+..........+|++++.+. .|+||+.++++|+++
T Consensus 73 g~F~d~YkLt~---e~LGeGAyasVqtcv-~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 73 GKFEDMYKLTS---ELLGEGAYASVQTCV-SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred chHHHHHHhHH---HHhcCccceeeeeee-eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 35777777774 789999999998776 4457889999999888777788899999999998 599999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecC
Q 003818 572 EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFG 648 (793)
Q Consensus 572 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg 648 (793)
...|||||-|.||+|..+|+++ ..+++.+..++..+|+.||.|||.+ +|.||||||+|||-..... +||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999999654 5688899999999999999999998 9999999999999865443 7999999
Q ss_pred CccccCC--C----CCcceecccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH---
Q 003818 649 LAKLLKT--D----QTQTTTAIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM--- 714 (793)
Q Consensus 649 la~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~--- 714 (793)
+..-... + ......+.+|+..|||||+.. ...|+.+.|.||||||||-||+|..||.+...+++.+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8764322 1 122233457899999999874 2358999999999999999999999997765544321
Q ss_pred ----HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 715 ----ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 715 ----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.-...+.+.+.+++.+..-.. -..-+.+..++++..+-.++.+|.++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEGkYeFPdkd------WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYEFPDKD------WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCCcCChhh------hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 222334555666665432211 1122345667888889999999999999887
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=295.05 Aligned_cols=258 Identities=23% Similarity=0.297 Sum_probs=192.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|++...... ....+.+|+.+++.++|+||+++++++..++..++|+||+. +
T Consensus 10 ~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 10 LEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 468999999999999854 34678999998654332 23467889999999999999999999999999999999995 7
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++....... .....
T Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~ 163 (291)
T cd07870 88 DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSE 163 (291)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCCc
Confidence 78777766556677888889999999999999998 999999999999999999999999999875432211 11223
Q ss_pred cCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhc-------------cccc
Q 003818 665 RGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE-------------RKLG 730 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~-------------~~~~ 730 (793)
.+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .+.. ....+.. ....
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEK-IWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHH-HHHHcCCCChhhhhhhhhcccccc
Confidence 468899999998764 578899999999999999999999976543211 1111 0000000 0000
Q ss_pred eeecc--cc---hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVEN--DE---EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~--~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..... .. ...........+.+++.+|++.||++|||++|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 00 00001112456788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.67 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=200.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
+.||+|++|.||+|.... .++.|++|++..... ..+.+.+|++.+++++|+||+++++++...+..++|+||+++++|
T Consensus 25 ~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 25 EKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred HhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 579999999999998654 467899999876433 456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.+++......+++..+..++.+++.||.|||+. +|+|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 103 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 178 (286)
T cd06614 103 TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVG 178 (286)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccC
Confidence 999987655789999999999999999999998 999999999999999999999999999875543222 1222347
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
+..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ....... ........
T Consensus 179 ~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~-------~~~~~~~~ 243 (286)
T cd06614 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--------TTKGIPP-------LKNPEKWS 243 (286)
T ss_pred CcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCCC-------CcchhhCC
Confidence 78999999999888999999999999999999999999765443221111 0111100 00111134
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..+.+++.+|++.+|.+||++.+|++.
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 567899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=294.98 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=198.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||++... .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 24 FEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 467999999999999743 4567899999865544455678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.+. .+++..+..++.+++.||.|||++ +++|+||||+||+++.++.+||+|||++........ ......
T Consensus 103 L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 176 (293)
T cd06647 103 LTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 176 (293)
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccccc
Confidence 99998643 467888999999999999999998 999999999999999999999999999875543322 122235
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
+++.|+|||.+.+..++.++||||||+++||+++|+.||......+....+ ...+. .........
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~--------~~~~~~~~~ 241 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT--------PELQNPEKL 241 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCC--------CCCCCcccc
Confidence 788999999998888999999999999999999999999765433211000 00000 001111122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+.+++.+||+.+|++||++.+++..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3467889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.71 Aligned_cols=260 Identities=25% Similarity=0.283 Sum_probs=194.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|++|.||+|+.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 5 VEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 467999999999999864 456789999886532 2233578899999999999999999999999999999999995
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT 158 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccc
Confidence 6898888653 45678899999999999999999988 999999999999999999999999999876543221 122
Q ss_pred cccCcccccCcccccCCC-CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH-------H---hhcc--cc
Q 003818 663 AIRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-------C---FRER--KL 729 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~-~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-------~---~~~~--~~ 729 (793)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+....+...... . +.+. ..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 234678899999887644 688999999999999999999999766543322111110000 0 0000 00
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......... .........+.+++.+|++.||++|||++++++
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 239 PKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 000112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=292.02 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=196.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||.||++.. ..+++.||+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus 5 ~~~lg~g~~~~v~~~~~-~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARD-VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEE-cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 36799999999999985 45677899999864321 124678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCC
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQT 658 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 658 (793)
|+++++|.+++.+. ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .+||+|||++..+.....
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 84 WMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred ccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999998654 4577888999999999999999998 999999999999998776 599999999976654321
Q ss_pred c---ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 659 Q---TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 659 ~---~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
. ......++..|+|||.+.+..++.++||||+|+++++|++|+.||...........+ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~------ 229 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTA------ 229 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----HHHhccCCC------
Confidence 1 112345788999999998888999999999999999999999999754332211111 010000000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+......+.+++.+|++.+|++||++.++++
T Consensus 230 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 ---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111223456788999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.01 Aligned_cols=260 Identities=21% Similarity=0.237 Sum_probs=194.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCC-ccccceeeeEEecC--CceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTN-HKNLVQLLGFCNEG--EHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|... .+++.||+|+++.... .......+|+..+.++. |+||+++++++.+. +..++|+||
T Consensus 3 ~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 3567999999999999854 4567899999876432 22234457888888885 99999999999887 889999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
++ ++|.+++......+++..+..++.|++.||+|||+. +++|+||+|+||+++. +.+||+|||++.........
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 96 588888876666789999999999999999999998 9999999999999999 99999999999865433221
Q ss_pred eecccCcccccCccccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhcccccee
Q 003818 661 TTAIRGTKGYVAPEWFK-NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRERKLGLL 732 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~-~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~~~~ 732 (793)
....++..|+|||.+. +..++.++|||||||++|||++|..||......+....+.... ............
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 2234788999999764 4557889999999999999999999997765443222211100 001111000000
Q ss_pred ecccch----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VENDEE----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+... ..........+.+++.+||+++|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 0001133578899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.52 Aligned_cols=241 Identities=28% Similarity=0.305 Sum_probs=196.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 35789999999999998654 56889999986532 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..++...+..++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++...... .
T Consensus 84 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 84 PGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 999999998665 5678889999999999999999998 9999999999999999999999999999876543 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......+.... ...+....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~---------- 217 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK--------ILEGKVRF---------- 217 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HhcCCccC----------
Confidence 234578899999999888899999999999999999999999976553221111 11111110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
+......+.+++.+||+.+|++|| +++|+++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011235678899999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.30 Aligned_cols=247 Identities=24% Similarity=0.270 Sum_probs=197.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++.... +++.||+|.+...... ..+.+.+|+.+++.++|+||+++++.+..++..++||||+.
T Consensus 6 ~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred eeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 4679999999999998654 5788999998754322 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc--
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-- 659 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 659 (793)
+++|.+++... ...+++.....++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999998653 35678889999999999999999998 9999999999999999999999999998754322110
Q ss_pred --------------------------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH
Q 003818 660 --------------------------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ 713 (793)
Q Consensus 660 --------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~ 713 (793)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 241 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence 011235788999999999888999999999999999999999999766543321
Q ss_pred HHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003818 714 MILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA----MKKVTQ 772 (793)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~ 772 (793)
..+ . ..... ..........+.+++.+||+.+|++||| ++|+++
T Consensus 242 ~~~-------~-~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 242 SNI-------L-KKEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH-------h-cCCcc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111 1 11110 0011114567899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=294.51 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=190.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEec------CCceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNE------GEHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~ 578 (793)
.+.||+|+||.||+|... ..++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....+++|
T Consensus 21 ~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred heeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 368999999999999965 456789999885532 2345688899999988 79999999998853 46789999
Q ss_pred eecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence 999999999998753 34577888889999999999999998 99999999999999999999999999987553221
Q ss_pred CcceecccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 658 TQTTTAIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
. ......++..|+|||.+. ...++.++||||||+++|||++|+.||......+....+ .......
T Consensus 176 ~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~- 245 (282)
T cd06636 176 G-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNPPPK- 245 (282)
T ss_pred c-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--------hhCCCCC-
Confidence 1 122345888999999875 346788999999999999999999999755432211100 0000000
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.........+.+++.+||+.||.+||++.||++
T Consensus 246 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 246 -------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 001123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=291.08 Aligned_cols=253 Identities=28% Similarity=0.365 Sum_probs=196.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 582 (793)
.+.||.|++|.||++.... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...++||||++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEeccCCceEEEEEEECC-CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4689999999999999654 578899999875432 3456789999999999999999999988653 46899999999
Q ss_pred CCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++|.+++.. ....++......++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999988753 345578888999999999999999998 999999999999999999999999999875443221
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhH-HHHHHHHHHHHHhhccccceeecccch
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE-CQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+. .......+....
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-- 232 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEP-- 232 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhhccCC--
Confidence 12346788999999998899999999999999999999999998653210 001111111 111111111111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.........+.+++.+||+.+|++|||+.||++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111223467889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.38 Aligned_cols=246 Identities=28% Similarity=0.367 Sum_probs=193.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCC------ceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGE------HRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------~~~lV~ 578 (793)
.+.||+|++|.||+|... .+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.... ..++||
T Consensus 11 ~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 11 VEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred eeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 478999999999999865 3467899998865433 346789999999998 7999999999996644 489999
Q ss_pred eecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 579 EYVSNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
||+++++|.+++... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 999999999998653 36788999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcceecccCcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||........... +.....
T Consensus 166 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~- 235 (275)
T cd06608 166 TLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--------IPRNPP- 235 (275)
T ss_pred chh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH--------hhccCC-
Confidence 222 1223457889999998753 3467899999999999999999999975433221111 111111
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
............+.+++.+||+.||++|||+.+|++
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 ------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.68 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=195.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|... .+++.||+|.+.... .....++.+|+.++++++ |||++++++++..+...++||||+
T Consensus 6 ~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 6 LELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 367999999999999964 457789999986542 334467889999999986 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... .+++.....++.++++||.|||+. +|+|+||+|+||++++++.++|+|||++..+...... .
T Consensus 85 ~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06917 85 EGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-R 158 (277)
T ss_pred CCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-c
Confidence 999999998553 678899999999999999999998 9999999999999999999999999999876544322 2
Q ss_pred ecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... .........+. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~~-----~- 224 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--------LIPKSKPPRLE-----D- 224 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------ccccCCCCCCC-----c-
Confidence 23458889999998865 457899999999999999999999997654332111 01111001000 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.+|++||++.++++.
T Consensus 225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 --NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0134567889999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=302.11 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=203.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
..||-|+||.||+|+.+ .++-..|.|++.....+..+++.-|+.+|...+||+||++++.+..++.++++.|||.||-.
T Consensus 38 GELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred hhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 56899999999999854 66677788888777777778899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
+..+..-+..++..++.-+.+|++.||.|||++ +|||||||..|||++-+|.++|+|||.+-..... ......+.|
T Consensus 117 DaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDsFIG 192 (1187)
T KOG0579|consen 117 DAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDSFIG 192 (1187)
T ss_pred hHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-HhhhccccC
Confidence 999988888999999999999999999999999 9999999999999999999999999998543221 122234679
Q ss_pred cccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 667 TKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 667 t~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
||.|||||+.. ..+|+.++||||||++|.||..+.+|-...+.-.....+ .. ..++....
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi--------aK-------SePPTLlq 257 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--------AK-------SEPPTLLQ 257 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH--------hh-------cCCCcccC
Confidence 99999999874 458999999999999999999999987654432211111 01 11122223
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+-.....+.+++..||.+||..||+++++++.
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 44566778999999999999999999998753
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.88 Aligned_cols=260 Identities=24% Similarity=0.284 Sum_probs=195.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|++|.||+|.... +++.||+|++.... ......+.+|+.++++++|||++++++++.+++..+++|||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred heEecCCCCeEEEEEEEcC-CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4679999999999998643 57889999986543 2233568899999999999999999999999999999999995
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++.... ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++..+...... ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~ 157 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YT 157 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cC
Confidence 68999886543 4688999999999999999999998 9999999999999999999999999999765432211 12
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHH----------hhcc--cc
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDC----------FRER--KL 729 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~----------~~~~--~~ 729 (793)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.+..... ..+. ..
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 23467899999987654 57899999999999999999999998765443322221110000 0000 00
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... ...........+.+++.+|++.+|++|||++|+++
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 238 PKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 00001122356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=293.72 Aligned_cols=246 Identities=27% Similarity=0.356 Sum_probs=195.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||+++.. .++..||+|++..... +..+.+.+|+.++++++|+|++++++++.+++..++||||++
T Consensus 31 ~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 31 REIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred heeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 57999999999999854 3567899999864322 233578889999999999999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|+|.+++......+++.++..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++...... ..
T Consensus 109 g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~ 180 (317)
T cd06635 109 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NS 180 (317)
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-----cc
Confidence 588888766666789999999999999999999998 9999999999999999999999999998754322 22
Q ss_pred ccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 664 IRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 664 ~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
..++..|+|||.+. ...++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~-~-------- 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPT-L-------- 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HhccCCC-C--------
Confidence 34788999999974 456889999999999999999999998765433221111 1111100 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
........+.+++.+|++.+|++||++.+|++.+.-..
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01123346789999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=289.54 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=196.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 467999999999999854 456789999876432 233467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++.. ..+++.....++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+..... .....
T Consensus 88 ~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06641 88 SALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccc
Confidence 99999854 3578899999999999999999998 999999999999999999999999999876543321 12223
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.++..|+|||.+.+..++.++|+||||+++|||++|..||........... ......... ...
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~---------~~~ 224 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--------IPKNNPPTL---------EGN 224 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH--------HhcCCCCCC---------Ccc
Confidence 578899999999888899999999999999999999999976543321111 111111100 112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 23557889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=289.37 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=198.9
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||.||+++.. .+++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999864 4577899999865433 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-------
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT------- 658 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------- 658 (793)
|.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 999997644 678899999999999999999998 999999999999999999999999999875443321
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.......++..|+|||.......+.++||||||+++|||++|+.||......+....+ ..+.....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------ 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--------LNGKIEWP------ 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCcCCC------
Confidence 1222345788999999998888999999999999999999999999866544321111 11111100
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 011124667899999999999999999777777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=285.98 Aligned_cols=249 Identities=28% Similarity=0.363 Sum_probs=202.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|++|.||+++... +++.|++|++..... ...+.+.+|+..+.+++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 34789999999999998654 578899999876543 3457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++... ..++...+..++.|+++||.|||+ . +++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 84 ~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 84 GSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 9999999765 567889999999999999999998 7 99999999999999999999999999998765433322 2
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...++..|+|||.+.+..++.++|+||||+++|||++|+.||.......... + ..... ....... .
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-~---~~~~~-~~~~~~~---------~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-L---MQAIC-DGPPPSL---------P 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH-H---HHHHh-cCCCCCC---------C
Confidence 3347889999999999899999999999999999999999997664211101 1 11111 1111100 1
Q ss_pred HH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IK-RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.. ....+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 44678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.28 Aligned_cols=240 Identities=26% Similarity=0.279 Sum_probs=197.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh---cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
++||+|+||.||-.+. ..+|+.+|.|++.+. ..+++....+|-.+|.+++.+.||.+-..+++.+.+++|+..|.|
T Consensus 191 RvlGkGGFGEV~acqv-raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQV-RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEE-ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 6899999999998774 457899999998653 344556778999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.-||.+.+ ..+++.....++.+|+.||++||++ +||.|||||+|||+|+.|+++|+|+|+|..+........
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~- 345 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG- 345 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc-
Confidence 99999998764 4578888889999999999999998 999999999999999999999999999998776554433
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..||.+|||||++.+..|+...|.||+||+||||+.|+.||...........+.+ .. +.. .....
T Consensus 346 -rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----r~----~~~------~~ey~ 410 (591)
T KOG0986|consen 346 -RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----RT----LED------PEEYS 410 (591)
T ss_pred -ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH----HH----hcc------hhhcc
Confidence 3699999999999999999999999999999999999999986644322211111 00 110 01122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPA 766 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt 766 (793)
....+++..+....|++||++|.-
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhcc
Confidence 334556677888889999999964
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=293.27 Aligned_cols=263 Identities=25% Similarity=0.262 Sum_probs=195.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|... .+++.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 12 ~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 12 LNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred eeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 467999999999999864 46788999998643322 233567899999999999999999998755 5689999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
. ++|.+++......+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||++........ ..
T Consensus 91 ~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~ 165 (309)
T cd07845 91 E-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PM 165 (309)
T ss_pred C-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-CC
Confidence 6 589888876667789999999999999999999998 999999999999999999999999999987654321 11
Q ss_pred ecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhcc---cc-ce-
Q 003818 662 TAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRER---KL-GL- 731 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~---~~-~~- 731 (793)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...... .+... .. ..
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 22235778999999865 46789999999999999999999999876554433222211000 00000 00 00
Q ss_pred -eecccchh-h-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 732 -LVENDEEA-M-DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 732 -~~~~~~~~-~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
........ . ........+.+++.+||+.||++|||+.++++.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000000 0 0011245678899999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.75 Aligned_cols=247 Identities=26% Similarity=0.328 Sum_probs=188.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHH-HhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISA-IGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+++.. .+++.||+|++..... +...++..|+.. ++.++||||+++++++..++..+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred EEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 3467999999999999854 4578999999875432 233455556664 666799999999999999999999999996
Q ss_pred CCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
++|.+++.. ....+++..+..++.|++.||+|||++ .+++||||||+||+++.++.+||+|||++........
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 688887754 235678899999999999999999974 2799999999999999999999999999986543221
Q ss_pred ceecccCcccccCcccccC----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 660 TTTAIRGTKGYVAPEWFKN----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ .+ ....... .....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~~~-~~~~~-- 229 (283)
T cd06617 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QL----KQVVEEP-SPQLP-- 229 (283)
T ss_pred -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--HH----HHHHhcC-CCCCC--
Confidence 122347889999998865 4568899999999999999999999964322110 11 1111110 00000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.+|++||++.+|++
T Consensus 230 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.07 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=196.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
.+||+|+||.||++... .+++.||+|++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46999999999999864 45778999998655444556789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......+
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 998743 3578888999999999999999998 999999999999999999999999999875543321 1223457
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
+..|+|||.+.+..++.++|+||||+++|||++|..||......+....+ ..... .. ... .....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~----~~~~~----~~-~~~------~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----RDNLP----PK-LKN------LHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhhCC----cc-cCC------cccCC
Confidence 88999999998888999999999999999999999999765443321111 11110 00 000 01123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+.+++.+||+.+|.+||++.+|++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45678999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=295.51 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=192.1
Q ss_pred cccccc--cceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEG--AFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G--~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+| +||+||++.. ...++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARH-TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEE-cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356776 9999999985 3467899999986432 2234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT- 660 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 660 (793)
+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998764 34578888899999999999999988 99999999999999999999999998654332211110
Q ss_pred -----eecccCcccccCcccccCC--CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------------
Q 003818 661 -----TTAIRGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA------------- 720 (793)
Q Consensus 661 -----~~~~~gt~~y~aPE~~~~~--~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~------------- 720 (793)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......+.........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0011245679999999764 47899999999999999999999997654332211100000
Q ss_pred HHHhh-----------cccc-----ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 721 YDCFR-----------ERKL-----GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 721 ~~~~~-----------~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..... +... ...................+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 0000 00000011111123455678999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.89 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=200.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|++|.||++... .+++.+++|++...... ....+.+|+.++++++|+||+++++++..++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred ceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 467999999999999854 45788999998654322 346788899999999999999999999999999999999975
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++..+...+++..+..++.++++||.|||+. +|+|+||||+||++++++.+||+|||.+....... .....
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 88888877667789999999999999999999998 99999999999999999999999999998765543 12222
Q ss_pred ccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH-------HHhhc---ccccee
Q 003818 664 IRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY-------DCFRE---RKLGLL 732 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~-------~~~~~---~~~~~~ 732 (793)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+..... ..+.. ......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 3477889999998876 789999999999999999999999976654432211111000 00000 000000
Q ss_pred ec-ccch-hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VE-NDEE-AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~-~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. .... ..........+.+++..||+.||.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0000 0111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=286.66 Aligned_cols=245 Identities=26% Similarity=0.283 Sum_probs=198.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||.|+||.||++... .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.++...++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred EEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 4578999999999999854 4577899999975432 34568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..++......++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 83 LGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 999999999665 5678889999999999999999998 99999999999999999999999999987654432 12
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........... ...... ... ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~-~~~---------~~ 221 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-----RAKQET-ADV---------LY 221 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH-----HHHhcc-ccc---------cC
Confidence 234578899999999988899999999999999999999999987654211111 111110 000 00
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAM--KKVT 771 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl 771 (793)
+......+.+++.+||+.+|.+||++ +|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11223678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.05 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=193.8
Q ss_pred cccccccccceeEEEeEeCCC-CceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTE-NEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 578 (793)
+.+.||+|+||.||+|..... .++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 346799999999999996542 57899999997643 33346778899999999999999999999888 7899999
Q ss_pred eecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC----CCcEEEeecCCc
Q 003818 579 EYVSNGSLADFLFRK----SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG----TFNARISDFGLA 650 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla 650 (793)
||+++ +|.+++... ...++...+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 676666432 23578888999999999999999998 9999999999999999 999999999999
Q ss_pred cccCCCCC--cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHH------HHHHHHHHH
Q 003818 651 KLLKTDQT--QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEEC------QMILADWAY 721 (793)
Q Consensus 651 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~------~~~l~~~~~ 721 (793)
........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||........ ...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF- 238 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH-
Confidence 86543322 112234578899999988664 578999999999999999999999976543320 00111100
Q ss_pred HHhhc---------------------cccceeecccchhhhhH--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 722 DCFRE---------------------RKLGLLVENDEEAMDDI--KRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 722 ~~~~~---------------------~~~~~~~~~~~~~~~~~--~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+.. ................. .....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000011 23456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=284.92 Aligned_cols=243 Identities=27% Similarity=0.325 Sum_probs=194.4
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||.||+++... +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6999999999999653 567899999865432 334678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.+. ..++...+..++.|+++||.|||++ +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 80 LWTILRDR-GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99999664 3478888999999999999999998 99999999999999999999999999998665432 122235
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||.+.+..++.++|+||||+++|||++|..||......... + ........... ..+...
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~---~~~~~~~~~~~---------~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME--I---YNDILKGNGKL---------EFPNYI 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH--H---HHHHhccCCCC---------CCCccc
Confidence 788999999998888999999999999999999999999766521110 0 11111100000 001111
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=290.67 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=190.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 10 ~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 10 GEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 57999999999999854 457889999986543 234467889999999996 99999999999999999999999864
Q ss_pred CHHHHH---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 585 SLADFL---FR-KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 585 sL~~~l---~~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+|.++. .. ....+++.....++.++++||+|||+. .+|+||||||+||+++.++.+||+|||++..+......
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK- 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc-
Confidence 554433 22 235688899999999999999999963 28999999999999999999999999999765432221
Q ss_pred eecccCcccccCcccccCC---CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 661 TTAIRGTKGYVAPEWFKNL---PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~---~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ........ +....+
T Consensus 165 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~-~~~~~~----- 231 (288)
T cd06616 165 -TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF------DQLTQVVK-GDPPIL----- 231 (288)
T ss_pred -ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH------HHHhhhcC-CCCCcC-----
Confidence 223478899999998776 68999999999999999999999997543110 00111111 110111
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...........+.+++.+|++.+|++|||+.+|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112345578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=288.22 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=196.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|++|.||+|+.. .+++.||+|++..... .....+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 5 LEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred eeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 478999999999999964 4578899999876433 2345678899999999999999999999999999999999985
Q ss_pred CHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........ ...
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFS 158 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccc
Confidence 8888886543 4578999999999999999999988 999999999999999999999999999975543221 112
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhccccceeec
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRERKLGLLVE 734 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~~~~~~ 734 (793)
...++..|++||.+.+. .++.++||||||+++|||++|+.||......+....+.+.. ...+.. ......
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 236 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKP 236 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cchhcc
Confidence 23467899999988654 57889999999999999999999998765444322221110 000000 000000
Q ss_pred ccch------hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEE------AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+. ..........+.+++.+|++.+|.+||++++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0001123466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=288.42 Aligned_cols=244 Identities=29% Similarity=0.342 Sum_probs=192.8
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||+||++... .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++|+||+++++
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999998754 457889999986532 2234566789999999999999999999999999999999999999
Q ss_pred HHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 586 LADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 586 L~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
|.+++.+.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... .....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999997653 4678889999999999999999998 99999999999999999999999999987654321 12223
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ......... ....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--------RRTLEMAVE------YPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--------hcccccccc------CCcc
Confidence 47789999999988889999999999999999999999997654321111111 000100000 0111
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 245678999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=285.39 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=197.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|.... ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred EEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45789999999999999654 56779999986532 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc-EEEeecCCccccCCCCCcc
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN-ARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|.+++... ...+++..+..++.|+++||.|||+. +++|+||||+||++++++. +||+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 99999998654 34578899999999999999999998 9999999999999998854 69999999976653322 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....|++.|+|||.+.+..++.++|+||||++++||++|+.||......+.. .... .......
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~-~~~~~~~-------- 222 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV-------LKIC-QGYFAPI-------- 222 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-------HHHh-cccCCCC--------
Confidence 22345888999999998888999999999999999999999999765433211 1111 1111111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+|++.+|++|||+.+|++.
T Consensus 223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=291.44 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=192.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCC--------ceE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--------HRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~ 575 (793)
.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++++...+ ..+
T Consensus 17 ~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 17 LAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 468999999999999854 4678999998864322 22345678999999999999999999987654 349
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+||||+. ++|.+++......+++..+..++.|+++||.|||++ +++|+||||+||+++.++.+||+|||++..+..
T Consensus 96 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred EEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 9999996 588888876666789999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc---ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 656 DQTQ---TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 656 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
.... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+... ...+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 250 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL-CGSITPEVWPG 250 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhhccc
Confidence 3221 11223467889999988664 4788999999999999999999999876544322222110 00000000000
Q ss_pred e-----------ecccchh----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 L-----------VENDEEA----MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~-----------~~~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. ....... .........+.+++.+||+.||++|||++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 0000000 000012345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=291.57 Aligned_cols=261 Identities=23% Similarity=0.255 Sum_probs=195.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCC----------c
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----------H 573 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----------~ 573 (793)
.+.||+|+||.||+|.... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.. .
T Consensus 12 ~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeecccCCEEEEEEEECC-CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 4789999999999999754 567899999865432 23356788999999999999999999987655 7
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 574 RLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 574 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
.++|+||+++ +|..++......+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++...
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 8999999976 77777766666789999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+......... .....+
T Consensus 167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (302)
T cd07864 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP-AVWPDV 245 (302)
T ss_pred cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-hhcccc
Confidence 5433222222345778999998865 35789999999999999999999999866544332222211100000 000000
Q ss_pred ecc--------cc----h-hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VEN--------DE----E-AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~--------~~----~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .. . ..........+.+++..||+.+|++||++++|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00 0 0000012456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=269.24 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=192.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
..||.|..|.|++..+. .++..+|||.+..... +..+.+...+.++..-+ +|.||+.+|||..+....+.||.| ..
T Consensus 98 ~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 56999999999999975 4678999999976543 33456777777776654 899999999999999999999988 44
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
-++.++.+......+..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++||+|||++-.+..... .+..
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--htrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--HTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--cccc
Confidence 566666665566777777789999999999999864 999999999999999999999999999976654333 2334
Q ss_pred cCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 665 RGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 665 ~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
.|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.....+-. . +...+.+ .++....
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~----ltkvln~--------ePP~L~~ 317 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--V----LTKVLNE--------EPPLLPG 317 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--H----HHHHHhc--------CCCCCCc
Confidence 58899999999864 3688999999999999999999999987543311 1 1111111 1111222
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+..+.+++..||++|+.+||...++++.
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22356778999999999999999999988753
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=290.22 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=191.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|++|.||+|... .+++.||+|++..... .....+.+|+.++++++|+||+++++++.+++..++||||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 468999999999999854 4577899998865322 234578899999999999999999999999999999999995
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCCCCCcce
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|.+++.... ...++.....++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++....... ...
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTF 160 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-ccc
Confidence 57888775433 3357778889999999999999998 9999999999999985 5679999999997654322 112
Q ss_pred ecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhcc-cccee---
Q 003818 662 TAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRER-KLGLL--- 732 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~-~~~~~--- 732 (793)
....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+...... .+... .+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 22346789999998866 45789999999999999999999999876544322221110000 00000 00000
Q ss_pred e---cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 V---ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~---~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. ...............+.+++.+|++.+|++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000011123456789999999999999999999986
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=289.28 Aligned_cols=257 Identities=23% Similarity=0.256 Sum_probs=191.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCC-ccccceeeeEEecCCc-----eEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEH-----RLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~-----~~lV 577 (793)
.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.+++.++ |+||+++++++...+. .++|
T Consensus 6 ~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 6 LEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred eeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 467999999999999864 4578899998865432 23357888999999994 6999999999877665 8999
Q ss_pred EeecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccc
Q 003818 578 YEYVSNGSLADFLFRK----SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKL 652 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 652 (793)
|||+++ +|.+++... ...+++..+..++.||++||.|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999985 888888653 24578899999999999999999998 9999999999999998 89999999999875
Q ss_pred cCCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc--
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL-- 729 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~-- 729 (793)
+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||......+....+... +.....
T Consensus 161 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 235 (295)
T cd07837 161 FSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL----LGTPTEQV 235 (295)
T ss_pred cCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH----hCCCChhh
Confidence 5332211 122246788999998865 45789999999999999999999999876544432222111 000000
Q ss_pred -cee---------ecccch--hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 -GLL---------VENDEE--AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 -~~~---------~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... ...... ..........+.+++.+||+.+|++||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000000 0001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=298.20 Aligned_cols=258 Identities=22% Similarity=0.269 Sum_probs=192.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 577 (793)
.+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++++++|+||+++++++... ...++|
T Consensus 21 ~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 367999999999999854 457889999986432 22345677899999999999999999988543 357999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+. ++|.+.+... ++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 100 MELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 99995 5888877543 77888899999999999999998 99999999999999999999999999998654332
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH---------------HHHH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD---------------WAYD 722 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~---------------~~~~ 722 (793)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.. ....
T Consensus 173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 173 M--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred C--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2 2223478899999999999999999999999999999999999976543322111100 0000
Q ss_pred Hhhcccc------ceeecc----cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERKL------GLLVEN----DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~~------~~~~~~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....... ...... .............+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000 00000011235567899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=284.25 Aligned_cols=245 Identities=22% Similarity=0.246 Sum_probs=190.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHH-HhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISA-IGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... ..++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999854 4567899999865321 122334445444 445689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..++...+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||+++.... ..
T Consensus 81 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 81 GGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999998654 4578888999999999999999998 999999999999999999999999999875433 12
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...++..|+|||.+.+..++.++||||||+++|||++|..||......+.... ...+...... ...
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~------~~~ 217 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN--------ILSRRINWPE------EVK 217 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHhcccCCCC------ccc
Confidence 23478899999999888889999999999999999999999976554332111 1111111000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
......+.+++.+||+.+|++||++.++.+.|+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123456889999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=288.00 Aligned_cols=243 Identities=24% Similarity=0.254 Sum_probs=186.5
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHh---cCCccccceeeeEEecCCceEEEEeec
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIG---RTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.||+|+||.||++... .+++.+|+|.+..... .....+.+|..++. ..+||||+.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999854 4578899998865322 12233444544333 347999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+|||+++++.++|+|||++........
T Consensus 80 ~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 80 NGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 999999988654 4588999999999999999999998 999999999999999999999999999875433221
Q ss_pred ecccCcccccCccccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFK-NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~-~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....|+..|+|||.+. +..++.++|||||||++|||++|+.||......... .+. ....... . .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~----~~~~~~~----~------~ 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID----RMTLTVN----V------E 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH----HHhhcCC----c------C
Confidence 2235899999999986 456899999999999999999999999754332211 110 0000000 0 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
.+......+.+++..||+.||++|| +++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112345678999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=317.20 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=205.5
Q ss_pred cccccccccceeEEEeEeCCC------CceeEEEEEechhccc-chHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTE------NEKPVAVKKLYKAVNE-GEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|.||.|++|..... ....||||+++..... ..+.+..|+.+|+.+ +|+||+.++|.|.+.+..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 456899999999999986522 2468999999875443 457889999999998 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
|.||++.|+|.++|+.++ ..++....+.++.|||.|++||++. ++|||||..+|||+.++..
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKV 456 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCE
Confidence 999999999999998776 3478889999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCcceecccC--cccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQTTTAIRG--TKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILAD 718 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~ 718 (793)
+||+|||+++..............+ ...|||||.+....|+.++||||||++||||++ |..|+......+ +
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~------~ 530 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE------E 530 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH------H
Confidence 9999999999655544333222222 346999999999999999999999999999998 667886533121 1
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
+.+.+.+|.... .+..+..++.++++.||+.+|++||++.++++.++.
T Consensus 531 -l~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 -LLEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred -HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 122334443222 122345677899999999999999999999999987
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=280.64 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=201.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||++... .+++.+++|++..... ...+.+.+|+++++.++|+|++++++.+..+...++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 467999999999999864 3567899999875433 4456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 584 GSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 584 gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
++|.+++... ...+++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 9999999765 37789999999999999999999998 99999999999999999999999999998665443 12
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....+++.|+|||.+.+..++.++|+||+|+++++|++|+.||......+... .. .......+..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~-~~~~~~~~~~------ 225 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL-------KI-LKGQYPPIPS------ 225 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH-------HH-hcCCCCCCCC------
Confidence 223457889999999988889999999999999999999999997665332111 11 1111111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.....+.+++.+||+.+|++|||+.++++
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22356788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=293.38 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=193.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcC-CccccceeeeEEecC--CceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEG--EHRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~~lV~Ey 580 (793)
.+.||+|+||.||+|... .+++.+|+|++.... ......+.+|+.+++++ +||||+++++++... ...++|+||
T Consensus 12 ~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred hHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 367999999999999854 456789999885432 22345677899999999 999999999988653 468999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
++ ++|..++... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.........
T Consensus 91 ~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 91 ME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred cc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 97 5999888654 678888899999999999999998 9999999999999999999999999999865443221
Q ss_pred ---ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-----------HHHh
Q 003818 660 ---TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-----------YDCF 724 (793)
Q Consensus 660 ---~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-----------~~~~ 724 (793)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... ....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 2223458889999998765 457889999999999999999999997654433221111100 0000
Q ss_pred hccccceeeccc--chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 725 RERKLGLLVEND--EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 725 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+....... ............+.+++.+|++.+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000 0000011134678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=279.42 Aligned_cols=247 Identities=27% Similarity=0.356 Sum_probs=200.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~ 581 (793)
.+.||+|++|.||+|.... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++++||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEECC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4679999999999998653 577899999866542 3457889999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-c
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-T 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 660 (793)
++++|.+++.... .+++..+..++.++++||+|||+. +++|+||+|+||++++++.++|+|||.+......... .
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 84 SGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999997654 789999999999999999999998 9999999999999999999999999999876554321 1
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....++..|+|||.+.....+.++||||||+++++|++|+.||........ . ............+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~~~~-------- 225 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--A----LYKIGSSGEPPEI-------- 225 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H----HHhccccCCCcCC--------
Confidence 2234578899999999988899999999999999999999999987652111 0 1111100111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+|++.+|++||++.++++
T Consensus 226 -~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 -PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112467889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=283.56 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=196.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|++|.||+|+.. .+++.|++|++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 4578999999999999964 3567899999866433 22334567999999999 999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++.... ..+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 889999887654 5679999999999999999999998 999999999999999999999999999976543222 1
Q ss_pred ecccCcccccCccccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHH---------HHHHhhccccce
Q 003818 662 TAIRGTKGYVAPEWFK-NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW---------AYDCFRERKLGL 731 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~-~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~---------~~~~~~~~~~~~ 731 (793)
....++..|+|||.+. +..++.++|+||||++++||++|+.||......+........ ............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2234788999999875 446789999999999999999999999766543322111110 000000001110
Q ss_pred eecccch---hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 LVENDEE---AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~~~~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... ..........+.+++.+|++.+|++|||++||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0000112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=289.33 Aligned_cols=243 Identities=28% Similarity=0.361 Sum_probs=193.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh---cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||+|+.. .+++.+|+|.+... .....+++.+|+.+++.++|+|++++++++......++|+||+.
T Consensus 21 ~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 21 REIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 57999999999999865 35678999988642 12233567889999999999999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 99 ~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~ 170 (308)
T cd06634 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NX 170 (308)
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-----cc
Confidence 688887766556688899999999999999999998 9999999999999999999999999998765432 22
Q ss_pred ccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 664 IRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 664 ~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
..++..|+|||.+. ...++.++|||||||++|||++|+.||......+....+ ..+.....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------- 234 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNESPAL-------- 234 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--------hhcCCCCc--------
Confidence 34788999999974 346788999999999999999999998765433211111 11111100
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
........+.+++.+||+.+|++||++.+|++...
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01123456789999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=282.46 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=200.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+++.. .+++.+++|.+.... .....++.+|+.+++.++|+||+++++++.+....++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred EeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 3478999999999999854 456789999986532 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++|.+++.+. ...+++..+..++.++++||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 99999998652 35678889999999999999999988 99999999999999999999999999998765442
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||......+... ....+.....
T Consensus 158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~~------- 221 (256)
T cd08530 158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--------KVQRGKYPPI------- 221 (256)
T ss_pred -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHhcCCCCCC-------
Confidence 122347889999999999899999999999999999999999998765433211 1111111111
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+|++.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 --PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11344668999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=323.05 Aligned_cols=247 Identities=27% Similarity=0.360 Sum_probs=198.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
..||.|.||.||-|+ +..+|...|+|-+.-. .....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1241 ~~Ig~G~fG~VYtav-N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAV-NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEee-cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 469999999999998 5567889999977532 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC---cce
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT---QTT 661 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~ 661 (793)
+|.+.+... +..++.....+..|++.|++|||++ +||||||||.||+++.+|.+|++|||.|+.+..+.. ...
T Consensus 1320 sLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred cHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999998543 4455566667889999999999999 999999999999999999999999999988766532 223
Q ss_pred ecccCcccccCcccccCC---CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TAIRGTKGYVAPEWFKNL---PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~---~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....||+.|||||++.+. ...-++||||+||++.||+||++||...+.+-..+. .+..++.+.+.+.
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-------~V~~gh~Pq~P~~--- 1465 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-------HVAAGHKPQIPER--- 1465 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-------HHhccCCCCCchh---
Confidence 346799999999999754 456789999999999999999999976554322111 1223333333222
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
...+=.+++..||+.||++|-++.|+++.-
T Consensus 1466 ------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1466 ------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 334456899999999999999998877653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=290.50 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=191.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+||.+.||++.-. +.+.+|+|++... ..+....|.+|+..|.++ .|.+||++++|-..++.+||||||= .
T Consensus 367 k~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d 443 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-D 443 (677)
T ss_pred HhhcCCCcceeeeeecC--CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-c
Confidence 67999999999998642 3356888877543 344557899999999999 4899999999999999999999986 6
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee-
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT- 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~- 662 (793)
.+|...|.++...+....+..+..|+++++.++|++ +|||.||||.|+|+-. |.+||+|||+|..+..+......
T Consensus 444 ~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 444 IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeec
Confidence 699999988766666457888999999999999999 9999999999999864 68999999999988877655433
Q ss_pred cccCcccccCcccccCC-----------CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 663 AIRGTKGYVAPEWFKNL-----------PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-----------~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
..+||+.||+||.+... +.+.++||||+|||||+|+.|+.||......-. ++..
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a---------------Kl~a 584 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA---------------KLHA 584 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH---------------HHHh
Confidence 35799999999998533 256799999999999999999999975432211 1111
Q ss_pred eecccchhhh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 732 LVENDEEAMD-DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 732 ~~~~~~~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+.++..+.+. ....-.++.++++.||+.||++|||..+|++.
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2222111110 01111238899999999999999999999863
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=283.50 Aligned_cols=261 Identities=26% Similarity=0.278 Sum_probs=194.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcC---CccccceeeeEEecCCc-----e
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRT---NHKNLVQLLGFCNEGEH-----R 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----~ 574 (793)
+.+.||+|+||.||+|+... +++.||+|++...... ....+.+|+.++.++ +|+||+++++++...+. .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 34689999999999999754 5778999999643222 234566777776655 69999999999988776 8
Q ss_pred EEEEeecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 575 LLVYEYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
+++|||+. ++|.+++.... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 99999997 58988886643 3688999999999999999999998 9999999999999999999999999999776
Q ss_pred CCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhccc-
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRERK- 728 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~~- 728 (793)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.+.... .+....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 43322 12234678899999999989999999999999999999999999876654432222110000 000000
Q ss_pred --cceeecc--cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 --LGLLVEN--DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 --~~~~~~~--~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... .............+.+++.+||+.||++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 0001111233466789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=287.02 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=197.9
Q ss_pred cccccccccceeEEEeEeC--CCCceeEEEEEechhc----ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||.||++... ..+++.||+|.+.+.. ....+.+.+|+.++.++ +||||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 3578999999999998753 2356789999987532 22345688999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++++|.+++... ..+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 84 LDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999998654 4578888899999999999999988 99999999999999999999999999988655443
Q ss_pred CcceecccCcccccCcccccCCC--CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLP--ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
........++..|+|||.+.+.. .+.++||||||+++|||++|..||...........+ ........ ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~-----~~- 230 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SRRILKSK-----PP- 230 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH---HHHHHccC-----CC-
Confidence 32233345788999999987665 788999999999999999999999643221111111 11111110 00
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
........+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 231 -----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 -----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011123457789999999999999999999888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=287.42 Aligned_cols=241 Identities=28% Similarity=0.380 Sum_probs=191.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
++||+|+||.||+|+.. .+++.|++|++..... ...+.+.+|+.+++.++|||++++++++.+.+..++||||+.
T Consensus 27 ~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 27 HEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred eeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 56999999999999854 4578899999865322 223567889999999999999999999999999999999995
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..... ...
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 678888876666788999999999999999999998 999999999999999999999999999864322 123
Q ss_pred ccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 664 IRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 664 ~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
..++..|+|||.+. ...++.++||||||+++|||++|..||...........+ .. .......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~~-~~~~~~~------- 241 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQ-NDSPTLQ------- 241 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------Hh-cCCCCCC-------
Confidence 45788999999984 456888999999999999999999999765433221111 01 1111000
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+||+.+|++||++.++++.
T Consensus 242 -~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123457889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=294.43 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=201.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|.|+.|..|.+.. ++..||||.+.+.... ..+.+.+|+.+|..++|||||+++.+......+|+||||+.+
T Consensus 61 ~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 4689999999999999765 4678999999875433 235688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|.+++++.+.++..+ .....++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+.. ......
T Consensus 140 ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~lqt 213 (596)
T KOG0586|consen 140 GELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLMLQT 213 (596)
T ss_pred chhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--cccccc
Confidence 999999988766555 77888999999999999998 999999999999999999999999999987763 334456
Q ss_pred ccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
.+|++.|.|||++.+.++ .+++|+||+|+++|-|++|..||++..-.+... ....+++.. +
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~--------rvl~gk~rI----------p 275 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP--------RVLRGKYRI----------P 275 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc--------hheeeeecc----------c
Confidence 779999999999999877 679999999999999999999999765443211 111111110 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.....++.++++++|-.+|.+|++++++.+.-
T Consensus 276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 11224566889999999999999999987643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=288.64 Aligned_cols=258 Identities=19% Similarity=0.196 Sum_probs=191.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+|.|+++.|+++.. +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||++++
T Consensus 8 ~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 8 KCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred HhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 3445555655565542 6788999998754 2334568999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc----
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ---- 659 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~---- 659 (793)
+|.+++... ...++......++.|+++||.|||++ +|+|+||||+||+++.++.+||+|||.+..+......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999754 34578888899999999999999998 9999999999999999999999999988754322111
Q ss_pred --ceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHh----hccc---
Q 003818 660 --TTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCF----RERK--- 728 (793)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~----~~~~--- 728 (793)
......++..|+|||.+.. ..++.++||||||+++|||++|+.||......... + +...... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--L-EKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHHhccCccccccCchhh
Confidence 1122346778999999876 35889999999999999999999999865433211 1 0000000 0000
Q ss_pred ----cce----e----ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 ----LGL----L----VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ----~~~----~----~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
... . ................+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0 00000111122334678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.80 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=191.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|+... +++.||||++..... ....++..|+.++.+. .|+||+++++++.++...+++|||+.
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 35789999999999999653 478899999875432 2335566777766666 49999999999999999999999985
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++......+++..+..++.++++||+|||+. .+|+||||+|+||++++++.+||+|||++..+...... .
T Consensus 98 -~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--~ 172 (296)
T cd06618 98 -TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--T 172 (296)
T ss_pred -cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--c
Confidence 578877766556788999999999999999999963 28999999999999999999999999998765432222 2
Q ss_pred cccCcccccCcccccCCC----CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 663 AIRGTKGYVAPEWFKNLP----ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~----~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .+ ...+... ....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~-~~~~------ 239 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VL----TKILQEE-PPSL------ 239 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HH----HHHhcCC-CCCC------
Confidence 234678899999987654 78899999999999999999999975432211 11 1111111 0000
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.........+.+++.+||+.+|++||++.++++.-
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 -PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00112345688999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=278.78 Aligned_cols=245 Identities=26% Similarity=0.386 Sum_probs=199.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|++|.||+++.. ..++.|++|.+..... .....+.+|++++.+++|+|++++++++.+++..++++||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 3478999999999999854 4567899999976543 344678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 83 ~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 83 NGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99999998655 5688999999999999999999988 9999999999999999999999999999866543322 22
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...++..|+|||...+..++.++|||++|+++++|++|+.||............ ........ .
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--------VQDDHPPL---------P 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--------hccCCCCC---------C
Confidence 345788999999998888899999999999999999999999765432211110 11111110 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112356789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=292.39 Aligned_cols=262 Identities=23% Similarity=0.237 Sum_probs=194.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccc--------------hHHHHHHHHHHhcCCccccceeeeEEecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG--------------EQEFKAEISAIGRTNHKNLVQLLGFCNEGE 572 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 572 (793)
+.||+|+||.||+|... ..++.||+|++....... ...+.+|+.++++++|+||+++++++..++
T Consensus 15 ~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 56999999999999854 467889999986532211 125778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 573 HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 573 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
..++||||+. ++|.+++... ..++......++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999996 6899988543 4578889999999999999999998 999999999999999999999999999976
Q ss_pred cCCCC-------------CcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 653 LKTDQ-------------TQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 653 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
..... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54111 1111122367889999998764 468999999999999999999999987765443222211
Q ss_pred HHHH----Hhhccc-cc---eeecccc--hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 719 WAYD----CFRERK-LG---LLVENDE--EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 719 ~~~~----~~~~~~-~~---~~~~~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.... .+.... .. ....... ...........+.+++..||+.+|++|||++|++..-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1100 000000 00 0000000 0000112346688999999999999999999999754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=284.50 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=199.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|++|.||+|+.. .+++.+|+|++.... ....+.+..|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 4 ~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 4 LEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred ehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 467999999999999864 457789999987653 2334678889999999999999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++.+....+++..+..++.+++.||.|||+. +|+|+||+|+||++++++.+||+|||++........ ....
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 589999977656789999999999999999999998 999999999999999999999999999986544322 1222
Q ss_pred ccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH-------HHhh-----ccccc
Q 003818 664 IRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY-------DCFR-----ERKLG 730 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~-------~~~~-----~~~~~ 730 (793)
..++..|+|||.+.+. .++.++||||||++++||++|+.||......+....+..... ..+. .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3356789999998776 789999999999999999999999987654433222211100 0000 00000
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... ..........+.+++..||+.+|++||++++|++
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 0001112457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=297.91 Aligned_cols=199 Identities=33% Similarity=0.480 Sum_probs=171.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 578 (793)
.+.||+|+||.||+|+ +..+|+.||||.+..... ...+..-+|+++|++++|+|||++++.-++. ....+||
T Consensus 18 ~e~LG~Ga~g~V~rgr-nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGR-NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeec-ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 4789999999999998 456889999999876432 3345667899999999999999999976554 3678999
Q ss_pred eecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc----CCCcEEEeecCCccc
Q 003818 579 EYVSNGSLADFLFRK--SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD----GTFNARISDFGLAKL 652 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~----~~~~~kl~Dfgla~~ 652 (793)
|||.+|+|+..|.+. ...+++.+.+.+..++..||.|||++ +|+||||||.||++- .....||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999864 56688999999999999999999998 999999999999982 333479999999998
Q ss_pred cCCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchh
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATE 710 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~ 710 (793)
+..+. ....+.||+.|++||...+ ..|+..+|.|||||++||.+||..||......
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 76654 5667889999999999995 78999999999999999999999999765433
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=293.27 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=196.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~ 578 (793)
.+.||+|+||.||++... .+++.||+|++... .......+.+|+.+++.++|+||+++++++... ...++|+
T Consensus 10 ~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 367999999999999854 56789999998653 223345677899999999999999999988654 3579999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+. ++|.+++... ..++......++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 89 ELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred eCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 9995 7898888654 5688999999999999999999998 99999999999999999999999999998654332
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH-------Hhhccccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-------CFRERKLG 730 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-------~~~~~~~~ 730 (793)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+...... ........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 12223457889999998865 46889999999999999999999999765433222111110000 00000000
Q ss_pred -------eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 003818 731 -------LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAV 778 (793)
Q Consensus 731 -------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~ 778 (793)
........ .........+.+++.+||+.+|++|||++++++. ++...
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 243 RYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 0011234668899999999999999999999977 55533
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=276.26 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=203.9
Q ss_pred ccccccccceeEEEeEeCCCC----ceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTEN----EKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 579 (793)
+..+-+|.||.||+|.+.+++ .+.|.+|.++....+ ....+..|...+..+.|||+..+.+++.+ ....+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 456899999999999876443 356777777554332 33567889999999999999999998854 567889999
Q ss_pred ecCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 580 YVSNGSLADFLFR-------KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 580 y~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
++.-|+|+.||.. ..+..+..+...++.|++.|++|||++ ++||.||..+|.+||+..++||+|-.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence 9999999999972 234567778889999999999999998 999999999999999999999999999997
Q ss_pred cCCCCCcceec-ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 653 LKTDQTQTTTA-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 653 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
+.+.+...... ......||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.|... .+++|.
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--------ylkdGy-- 515 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--------YLKDGY-- 515 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--------HHhccc--
Confidence 66554443322 335678999999999999999999999999999998 788987776665332 233332
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
+...+.+++++|..++..||+..|++||+++|++..|.+
T Consensus 516 -------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 516 -------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 223355678889999999999999999999999999865
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=284.90 Aligned_cols=254 Identities=19% Similarity=0.210 Sum_probs=179.7
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhcccch-----------HHHHHHHHHHhcCCccccceeeeEEecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAVNEGE-----------QEFKAEISAIGRTNHKNLVQLLGFCNEG 571 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~~~~~~ 571 (793)
+.+.||+|+||.||+|...... +..+|+|+......... .....+...+..++|+|++++++++...
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 4578999999999999865431 34566665432211110 1122334455677999999999976544
Q ss_pred C----ceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeec
Q 003818 572 E----HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDF 647 (793)
Q Consensus 572 ~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 647 (793)
. ..++++|++. .++.+.+... ...++..+..++.|+++||.|||+. +|+||||||+|||++.++.++|+||
T Consensus 96 ~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 96 RCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred cCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEc
Confidence 3 3467778763 4566655432 3346777889999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCC------cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH--HHHHH
Q 003818 648 GLAKLLKTDQT------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM--ILADW 719 (793)
Q Consensus 648 gla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~--~l~~~ 719 (793)
|+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...+.
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~ 250 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF 250 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence 99986643221 11122459999999999999999999999999999999999999998763322111 01111
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
. ..+..++.. .......+.+++..|++.+|++||++.+|++.|+
T Consensus 251 ~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 251 I-KRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H-HHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 111111110 0112356788999999999999999999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=293.29 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=194.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec----CCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE----GEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~E 579 (793)
.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 10 IENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 467999999999999854 457889999987542 2334667889999999999999999998753 356899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+. ++|.+++... ..+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 89 ~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 89 LME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred hhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 995 6898888654 4488999999999999999999998 9999999999999999999999999999765432221
Q ss_pred ---ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhccc
Q 003818 660 ---TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRERK 728 (793)
Q Consensus 660 ---~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~ 728 (793)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 1123457889999999865 468899999999999999999999997664432211110000 00000000
Q ss_pred cceeecc---cch---hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 729 LGLLVEN---DEE---AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 729 ~~~~~~~---~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
+...... ... ..........+.+++.+||+.+|++||+++++++.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000000 000 000112356789999999999999999999988743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=293.48 Aligned_cols=269 Identities=22% Similarity=0.269 Sum_probs=202.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC-----ceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE-----HRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV 577 (793)
+.+.||+|+||.||+|+.. .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+++
T Consensus 4 i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 3478999999999999854 457789999987643 334567899999999999999999999998775 78999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||++ ++|.+++.... .+++..+..++.++++||.|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 83 TELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred ecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 99997 58888886543 788999999999999999999998 99999999999999999999999999998765443
Q ss_pred C--cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hh---hcc
Q 003818 658 T--QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CF---RER 727 (793)
Q Consensus 658 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~---~~~ 727 (793)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...... .+ ...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 112234578899999999887 7899999999999999999999999877654432222111000 00 000
Q ss_pred ccceeecccc-h-----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcC
Q 003818 728 KLGLLVENDE-E-----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAVD 779 (793)
Q Consensus 728 ~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~ 779 (793)
.....+.... . ..........+.+++.+||+.+|++|||++++++. +++..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000 0 00011134567899999999999999999999984 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=279.06 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=192.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh-----cccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA-----VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 577 (793)
+.+.||+|+||.||+|... .+++.||+|.+... ..+....+++|+.++++++|+||+++++++.+. ...+++
T Consensus 6 ~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 3578999999999999854 56788999987432 122345788999999999999999999998764 457899
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
+||+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 99999999999986543 477888899999999999999998 99999999999999999999999999998654321
Q ss_pred C--cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 T--QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
. .......++..|+|||.+.+..++.++|+||||++++||++|+.||......+... ..........
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---- 229 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-------KIATQPTKPM---- 229 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-------HHHcCCCCCC----
Confidence 1 11123457889999999998889999999999999999999999997654332111 1111110000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+....+.+.+++.+|++ +|.+||+..++++
T Consensus 230 -----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 -----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111233567889999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=294.30 Aligned_cols=266 Identities=22% Similarity=0.250 Sum_probs=193.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 579 (793)
.+.||+|+||.||+|+.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++... ...++|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 10 LSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 478999999999999854 457889999986432 22345678899999999999999999987554 35799999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+. ++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 89 LME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred hcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 996 488877743 4578889999999999999999998 9999999999999999999999999999765432221
Q ss_pred --ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH--------HHhhc--
Q 003818 660 --TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY--------DCFRE-- 726 (793)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~--------~~~~~-- 726 (793)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... .....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 1122457889999998754 4689999999999999999999999976543221111110000 00000
Q ss_pred -cccceeec-ccch-hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 003818 727 -RKLGLLVE-NDEE-AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAV 778 (793)
Q Consensus 727 -~~~~~~~~-~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~ 778 (793)
........ .... ..........+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 0000 00011234668899999999999999999999986 55433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=309.56 Aligned_cols=253 Identities=28% Similarity=0.403 Sum_probs=188.1
Q ss_pred HHhcccc--cccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEec------
Q 003818 500 VITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE------ 570 (793)
Q Consensus 500 ~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------ 570 (793)
+...+|. +.||+||||.|||++ +.-+|+.+|||+|.-.. .+.-..+.+|++.+++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVR-NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVR-NKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEe-ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3444454 469999999999998 55678999999997643 2334578899999999999999999853100
Q ss_pred --------------------------------------------------------------------------------
Q 003818 571 -------------------------------------------------------------------------------- 570 (793)
Q Consensus 571 -------------------------------------------------------------------------------- 570 (793)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003818 571 -------------------------G--------EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617 (793)
Q Consensus 571 -------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH 617 (793)
+ ..+||-||||+...|.+++.++.........++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1346789999998888888765433346678899999999999999
Q ss_pred hcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC-----------------CCCCcceecccCcccccCcccccCCC
Q 003818 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK-----------------TDQTQTTTAIRGTKGYVAPEWFKNLP 680 (793)
Q Consensus 618 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~ 680 (793)
++ +||||||||.||+++++..+||+|||+|.... .......+...||.-|+|||++.+..
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998621 00111234457999999999997654
Q ss_pred ---CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHcc
Q 003818 681 ---ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCI 757 (793)
Q Consensus 681 ---~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl 757 (793)
|+.|+|+||+|+|++||+. ||...... ... ...++.+.++.. .....++...=..+|.|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~i-----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--ASI-----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH--HHH-----HHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 9999999999999999985 56543321 111 123334433332 1112223333457999999
Q ss_pred ccCCCCCCCHHHHHH
Q 003818 758 QEDPSLRPAMKKVTQ 772 (793)
Q Consensus 758 ~~dP~~RPt~~evl~ 772 (793)
+.||.+|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999885
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.43 Aligned_cols=262 Identities=24% Similarity=0.266 Sum_probs=191.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCC--------ceE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--------HRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~ 575 (793)
.+.||+|+||.||+|+.. .+++.+|+|++...... ....+.+|+++++.++|+||+++++++.+.. ..+
T Consensus 13 ~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 13 LGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 467999999999999854 45678999988654322 2346788999999999999999999875433 469
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+|+||+.+ +|...+......+++..+..++.|+++||.|||++ +|+|+||||+||++++++.+||+|||+++....
T Consensus 92 lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 167 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167 (311)
T ss_pred EEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence 99999964 77777776666789999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCc----------ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH--
Q 003818 656 DQTQ----------TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-- 722 (793)
Q Consensus 656 ~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-- 722 (793)
.... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T cd07866 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247 (311)
T ss_pred CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 2211 11223467889999987654 5889999999999999999999999866554322221110000
Q ss_pred --Hhhc-cccceee-------cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 723 --CFRE-RKLGLLV-------ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 723 --~~~~-~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+.. ..+.... ...............+.+++.+||+.+|++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 248 EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0000000 000000001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.09 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=194.2
Q ss_pred cccccccccceeEEEeEeCC--CCceeEEEEEechhcc----cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVN----EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||.||++.... .+++.||+|++..... ...+.+.+|+.++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 34689999999999987542 3578899999875322 2346678899999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
+||+++++|.+++... ..+++.....++.|+++||.|||+. +++||||+|+|||+++++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 84 LDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999999654 4577888888999999999999998 99999999999999999999999999998765443
Q ss_pred CcceecccCcccccCcccccCC--CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
........|+..|+|||.+... .++.++||||||+++|+|++|+.||...........+ ......... .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~--~---- 230 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSEP--P---- 230 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH---HHHhhccCC--C----
Confidence 3333345588899999998753 4688999999999999999999999754322111111 111111100 0
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
........+.+++.+|++.+|++|| +..+++..
T Consensus 231 -----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 -----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0111235678899999999999997 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=290.35 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=194.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 578 (793)
+.||+|+||.||+|+.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.... ..++|+
T Consensus 21 ~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 21 KQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 67999999999999854 457789999986532 222356789999999999999999999886543 468999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+. .+|..++ ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~- 171 (342)
T cd07879 100 PYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM- 171 (342)
T ss_pred cccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-
Confidence 9996 4776665 23578888999999999999999998 99999999999999999999999999987643221
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhccccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRERKLG 730 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 730 (793)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ...+......
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 172 ---TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred ---CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 22346788999999876 468899999999999999999999998754332211111000 0000000000
Q ss_pred eeec---ccch--h-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCCCCCCCc
Q 003818 731 LLVE---NDEE--A-MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAVDVSIPPDPA 787 (793)
Q Consensus 731 ~~~~---~~~~--~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~~~p~~p~ 787 (793)
.... .... . .........+.+++.+||+.||++||+++++++. ++...+.+..+.|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~ 313 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQ 313 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCC
Confidence 0000 0000 0 0001123467899999999999999999999954 77766554444443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=281.22 Aligned_cols=243 Identities=23% Similarity=0.251 Sum_probs=186.6
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHH---HHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEIS---AIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.||+|+||.||++... .+++.||+|.+..... .....+..|.. .+....||||+++++++...+..++|+||+
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999854 4578899999865321 11223344443 344468999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++..+.....
T Consensus 80 ~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 80 NGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999999988644 5688999999999999999999998 999999999999999999999999999875533221
Q ss_pred ecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.......... + ......... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~----~~~~~~~~~--------~~- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I----DRMTLTMAV--------EL- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-H----HHHhhccCC--------CC-
Confidence 223588999999998754 68999999999999999999999997653221110 0 000000000 00
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
+......+.+++.+|++.+|.+|| ++.++++.
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111245688899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=270.60 Aligned_cols=236 Identities=26% Similarity=0.284 Sum_probs=190.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccch---HHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE---QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.++||+|.||.|.+++. +.+++.+|+|++++...-.. ..-..|-++|+..+||.+..+...|+..+++|.||||..
T Consensus 173 LKvLGkGTFGKVIL~rE-Kat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCRE-KATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHhcCCccceEEEEee-cccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 46799999999999884 45789999999987543332 334678999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
||.|.-+|.+. +.+++.....+...|..||.|||++ +||.||||.+|.|+|.+|++||+|||+++.-.. ......
T Consensus 252 GGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~k 326 (516)
T KOG0690|consen 252 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDTTK 326 (516)
T ss_pred CceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-ccceec
Confidence 99999999654 4566666667788999999999998 999999999999999999999999999975332 234456
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
+.+|||.|+|||++....|..+.|.|.+||++|||+||+.||.....+.... .+....+...
T Consensus 327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe--------LIl~ed~kFP---------- 388 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE--------LILMEDLKFP---------- 388 (516)
T ss_pred cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH--------HHHhhhccCC----------
Confidence 6889999999999999999999999999999999999999998765543211 1111111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRP 765 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RP 765 (793)
.....+...|+...|.+||++|.
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhc
Confidence 11123345677778999999995
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=277.64 Aligned_cols=235 Identities=23% Similarity=0.282 Sum_probs=182.5
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecCCCCHH
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLA 587 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 587 (793)
||+|+||.||++... .+++.+|+|.+....... .|+..... .+||||+++++.+...+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 699999999999854 456789999886532211 12222222 27999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCCcceecccC
Q 003818 588 DFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 588 ~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++....... ...+
T Consensus 98 ~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~ 168 (267)
T PHA03390 98 DLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDG 168 (267)
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCC
Confidence 9996653 789999999999999999999998 999999999999999988 99999999987654322 2347
Q ss_pred cccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHH
Q 003818 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV 746 (793)
Q Consensus 667 t~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (793)
+..|+|||++.+..++.++||||||+++|||++|+.||......+.. +..+.... ..... ......
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~--~~~~~----------~~~~~~ 234 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ--QKKLP----------FIKNVS 234 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh--cccCC----------cccccC
Confidence 88999999999989999999999999999999999999854333211 11111111 00000 011234
Q ss_pred HHHHHHHHHccccCCCCCCC-HHHHHH
Q 003818 747 EKFVMIAIWCIQEDPSLRPA-MKKVTQ 772 (793)
Q Consensus 747 ~~l~~li~~Cl~~dP~~RPt-~~evl~ 772 (793)
..+.+++.+||+.+|.+||+ ++++++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhc
Confidence 56789999999999999996 688874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=269.37 Aligned_cols=265 Identities=26% Similarity=0.336 Sum_probs=201.5
Q ss_pred CCcCCCCCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhc-CCcccccee
Q 003818 487 EMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGR-TNHKNLVQL 564 (793)
Q Consensus 487 ~~~~~~~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~H~niv~l 564 (793)
...+..|+-++|+.. ..||.|+||+|+|-.++ ..|+..|||+++.... ...++++.|.....+ -++||||++
T Consensus 55 ~~~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred cccccccccchHHHH-----HHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 345566777777654 56999999999997754 5788999999987654 455678888876555 579999999
Q ss_pred eeEEecCCceEEEEeecCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 565 LGFCNEGEHRLLVYEYVSNGSLADFLFR----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 565 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
+|.+-.++..++-||.| ..||+.+-.. +...+++..+-.|......||.||.... .|||||+||+|||++..|
T Consensus 129 yGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G 205 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG 205 (361)
T ss_pred hhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence 99999999999999999 5566654421 3456777778888889999999999763 899999999999999999
Q ss_pred cEEEeecCCccccCCCCCcceecccCcccccCcccccCC--CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 641 NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 641 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
.+||+|||++-.+..... .+.-.|-..|||||.+... .|+.++||||||++|||+.||+.|+......-. .+
T Consensus 206 ~vKLCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe--ql-- 279 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE--QL-- 279 (361)
T ss_pred CEeeecccchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH--HH--
Confidence 999999999876543222 2223477899999998643 489999999999999999999999976544211 11
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
... ..+....+..+ ....+....+..++..|+.+|..+||...++.++
T Consensus 280 --~~V-v~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 --CQV-VIGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --HHH-HcCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 12222222221 2234566788999999999999999999987653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=281.87 Aligned_cols=245 Identities=25% Similarity=0.337 Sum_probs=197.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++.+++ |+||+++++++..++..++||||
T Consensus 5 ~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred EeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 3467999999999999864 467889999986532 233467888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC--
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-- 658 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-- 658 (793)
+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 84 APNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999655 4689999999999999999999998 999999999999999999999999999886544321
Q ss_pred -----------------cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH
Q 003818 659 -----------------QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY 721 (793)
Q Consensus 659 -----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~ 721 (793)
.......++..|+|||.+.+..++.++||||||++++|+++|+.||...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------ 233 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK------ 233 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH------
Confidence 122234578899999999888899999999999999999999999986653221111
Q ss_pred HHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 003818 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAM----KKVTQ 772 (793)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl~ 772 (793)
. ...... ........+.+++.+||+.+|++||++ +++++
T Consensus 234 -~-~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 -I-LKLEYS----------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -H-HhcCCC----------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 011000 011124567899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=306.09 Aligned_cols=247 Identities=24% Similarity=0.280 Sum_probs=202.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechh---cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.|..++++ .+++.+|+|++.+. ......-|..|-.+|..-+.+-|++++-.|++++++|+|||||+|
T Consensus 81 KvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 67999999999998865 46789999999873 233446789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|+|-.++.+.. .++......++..|..||.-||+. |+|||||||+|||||..|++||+|||.+..+..+..-.+..
T Consensus 160 GDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~ 235 (1317)
T KOG0612|consen 160 GDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSV 235 (1317)
T ss_pred chHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecc
Confidence 99999997766 777777888888999999999998 99999999999999999999999999998888777766777
Q ss_pred ccCcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 664 IRGTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.+|||.|++||++.. +.|++.+|.||+||++|||+.|..||..+.-.+-...|.+. ...+.
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h------k~~l~-------- 301 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH------KESLS-------- 301 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch------hhhcC--------
Confidence 789999999999953 46899999999999999999999999988766644444321 00111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPA---MKKVTQM 773 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 773 (793)
.+++.+-++...+||+..+. +|+.|.. +.++-..
T Consensus 302 FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11122244556677776665 6788887 7777654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=264.38 Aligned_cols=260 Identities=21% Similarity=0.256 Sum_probs=202.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEec----CCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNE----GEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~lV~Ey~ 581 (793)
++||-|-.|.|.....+ .+++.+|+|++... ...++|+++.-.. .|||||.++++++. ...+.+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHK-RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEec-cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 68999999999988754 46778999988653 4567888876664 69999999998854 34567899999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCCCC
Q 003818 582 SNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 582 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~ 657 (793)
+||.|..-+..++ ..+++.+..+|+.||+.|+.|||+. +|.||||||+|+|.. .+..+||+|||+|+....
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 9999999998764 4688999999999999999999998 999999999999995 466799999999986543
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
.....+.+-|+.|.|||++...+|+...|+||+||++|-||||.+||....... +...++..+..+..... .+
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy~FP---~p 289 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQYEFP---EP 289 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCccCC---Ch
Confidence 233445668999999999999999999999999999999999999998765422 22233344443333221 11
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCCc
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPA 787 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~p~~p~ 787 (793)
+ --.-++...++|+.+|..+|.+|.|+.+++..---...-..|-.|.
T Consensus 290 E---Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 290 E---WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred h---HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 1 1223456778999999999999999999987654444444455443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=264.75 Aligned_cols=198 Identities=27% Similarity=0.418 Sum_probs=162.8
Q ss_pred ccccccccceeEEEeEeCCCCc---eeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 579 (793)
...||+|.||.||||+-...++ +.+|+|+++.... ......-+|+.+++.++||||+.+..++.+ +...+|++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 3679999999999997554443 3799999865422 123456789999999999999999998877 788999999
Q ss_pred ecCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC----CcEEEeecCCcc
Q 003818 580 YVSNGSLADFLFR----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT----FNARISDFGLAK 651 (793)
Q Consensus 580 y~~~gsL~~~l~~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~ 651 (793)
|.+. +|...|+. +.+.++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |.+||+|||+++
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 9976 67776643 245678888999999999999999998 99999999999999766 999999999999
Q ss_pred ccCCCCCc--ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCC
Q 003818 652 LLKTDQTQ--TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVD 707 (793)
Q Consensus 652 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~ 707 (793)
.+...-.. ....++-|..|.|||.+.+. .||++.||||.|||+.||++-.+.|...
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 87653222 22335678999999998775 6899999999999999999988887654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.86 Aligned_cols=237 Identities=30% Similarity=0.323 Sum_probs=192.5
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
||+|+||.||++... ..++.+++|.+...... ....+..|+.++++++|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999865 35678999998764322 34578899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... ..+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 80 LFSHLSKE-GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99999655 3578899999999999999999998 99999999999999999999999999997654432 1223345
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
++..|+|||...+...+.++|+||||+++|||++|+.||......+....+ ...... .+...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~----------~~~~~ 216 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--------LKDPLR----------FPEFL 216 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------hcCCCC----------CCCCC
Confidence 788999999998888999999999999999999999999765442211111 111100 00111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKK 769 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~e 769 (793)
...+.+++.+||+.||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=275.15 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=190.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-----ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+++... .+..+++|.++... ......+..|+.+++.++||||+++++++.+.+..++|+|
T Consensus 4 i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 45789999999999988543 23445555554321 1223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 580 YVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 580 y~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|+++++|.+++.. ....+++..+..++.|+++||.|||+. +++|+||+|+||++++ +.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999998864 345688999999999999999999998 9999999999999975 56999999998765433
Q ss_pred CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.... ...+....
T Consensus 159 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~--------~~~~~~~~----- 224 (260)
T cd08222 159 CD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR--------IVEGPTPS----- 224 (260)
T ss_pred cc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHcCCCCC-----
Confidence 22 22234578899999999888889999999999999999999999975443221111 11111111
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+......+.+++.+|++.+|++||++.++++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01233456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.38 Aligned_cols=273 Identities=21% Similarity=0.279 Sum_probs=196.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV 577 (793)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 20 LKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 367999999999999854 457889999985432 223356889999999999999999999887654 35899
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 99 ~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 99 MPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred EecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 9999 7799888753 4578899999999999999999998 99999999999999999999999999997654321
Q ss_pred CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhcccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRERKL 729 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~ 729 (793)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.... ...+.....
T Consensus 173 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 173 ----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 22346889999999876 458899999999999999999999998665432211111000 000000000
Q ss_pred ceeecccch------hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcCcCCCCCCCCchh
Q 003818 730 GLLVENDEE------AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT--QMIEGAVDVSIPPDPASF 789 (793)
Q Consensus 730 ~~~~~~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl--~~Le~~~~~~~p~~p~~~ 789 (793)
......... ..........+.+++.+|++.||++|||+.+++ ..++...+...++.+.+|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY 316 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence 000000000 000012234578999999999999999999998 445554444333333333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=287.86 Aligned_cols=260 Identities=21% Similarity=0.258 Sum_probs=189.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecC--------------
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-------------- 571 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------------- 571 (793)
.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 468999999999999854 56788999998765555567788999999999999999999876543
Q ss_pred CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCc
Q 003818 572 EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLA 650 (793)
Q Consensus 572 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla 650 (793)
...++|+||++ ++|.+++.. ..+++.....++.||++||.|||+. +|+||||||+||+++ +++.+||+|||++
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35789999997 589888753 3578889999999999999999998 999999999999997 4567899999999
Q ss_pred cccCCCCCcc--eecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------
Q 003818 651 KLLKTDQTQT--TTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA------- 720 (793)
Q Consensus 651 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~------- 720 (793)
..+....... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+..-.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 7654322111 122347889999998654 567889999999999999999999997665433221111000
Q ss_pred HHHhhccccceee----cc-cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 721 YDCFRERKLGLLV----EN-DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 721 ~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
............. .. .+...........+.+++.+||+.||++|||+++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000 00 0000000123356789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=283.45 Aligned_cols=257 Identities=23% Similarity=0.268 Sum_probs=190.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. .+..++++||+
T Consensus 15 ~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 368999999999999844 467889999886432 2234678899999999999999999998865 56789999998
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++.. ..+.......++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++....... .
T Consensus 93 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~----~ 163 (328)
T cd07856 93 GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM----T 163 (328)
T ss_pred ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc----C
Confidence 5689888753 3467777888999999999999998 99999999999999999999999999987543221 2
Q ss_pred cccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH--------HHHhhccccceee
Q 003818 663 AIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA--------YDCFRERKLGLLV 733 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~ 733 (793)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.. .............
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 2346788999998765 568999999999999999999999997665433222111110 0000000000000
Q ss_pred c-----ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 734 E-----NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 734 ~-----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
. ..+...........+.+++.+||+.+|++|||+++++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000001124678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=285.31 Aligned_cols=268 Identities=22% Similarity=0.278 Sum_probs=193.5
Q ss_pred HHHHHHhcccc--cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC
Q 003818 496 KELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG 571 (793)
Q Consensus 496 ~el~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 571 (793)
.++..++++|. +.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34444555553 67999999999999854 467889999986532 22345678899999999999999999988543
Q ss_pred ------CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEe
Q 003818 572 ------EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS 645 (793)
Q Consensus 572 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 645 (793)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 7899888754 3578899999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----
Q 003818 646 DFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA---- 720 (793)
Q Consensus 646 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~---- 720 (793)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998764322 122357889999999876 468899999999999999999999997654332211111100
Q ss_pred ---HHHhhccccceee---cccch---hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 721 ---YDCFRERKLGLLV---ENDEE---AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 721 ---~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
...+......... ...+. ..........+.+++.+|++.+|.+||++.++++.=
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000000000 00000 000001234678999999999999999999988653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=280.14 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=189.0
Q ss_pred cccccccccceeEEEeEeCCC-CceeEEEEEechhcc--cchHHHHHHHHHHhcC-CccccceeeeEEec----CCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTE-NEKPVAVKKLYKAVN--EGEQEFKAEISAIGRT-NHKNLVQLLGFCNE----GEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~l 576 (793)
+.+.||+|+||.||++..... +++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.. ....++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 457899999999999986532 167899999865322 2245678899999998 59999999987543 245788
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
++||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 84 YEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 889885 689888854 35678899999999999999999998 9999999999999999999999999999865432
Q ss_pred CCc---ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhh
Q 003818 657 QTQ---TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFR 725 (793)
Q Consensus 657 ~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~ 725 (793)
... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+.... ...+.
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 221 1122458899999998765 468999999999999999999999997654332211111000 00000
Q ss_pred cccccee---ecccch---hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 726 ERKLGLL---VENDEE---AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 726 ~~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... ...... ..........+.+++.+|++.+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 000000 0000112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=270.60 Aligned_cols=242 Identities=27% Similarity=0.329 Sum_probs=193.6
Q ss_pred HHhcccccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcC-CccccceeeeEEecCCceE
Q 003818 500 VITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 500 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 575 (793)
....+|..+||+|+||.|.+|. +.++.+.+|||++++...- +.+--..|-++|+.. +-|.++.++.+|+.-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeec-ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3344678899999999999998 5567789999999875432 222234577777776 5689999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
.||||+.||+|--++++- ..+.+....-++.+||.||-+||++ +||.||||.+|||+|.+|++||+|||+++.---
T Consensus 427 FVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999988654 3455567778899999999999998 999999999999999999999999999975322
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
......+.+||+.|+|||++...+|+.++|.|||||+||||+.|..||+++..++....+. +..
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--------ehn------- 566 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--------EHN------- 566 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------Hcc-------
Confidence 2334556889999999999999999999999999999999999999999987766433321 111
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCC
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 765 (793)
..++...+.+...+....|.+.|.+|.
T Consensus 567 ---vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112223344556677778889999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=286.39 Aligned_cols=236 Identities=27% Similarity=0.325 Sum_probs=190.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+...+|.|+|+.|..+... .+++..++|++.+.. .+-.+|+.++.. -+||||+++.+.+.++.+.++|||.+.+
T Consensus 326 ~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESS-PTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred cccccCCCCccceeeeecc-ccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 3456999999999998854 456789999987652 233556655544 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE-cCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL-DGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+.|.+.+..+.... ..+..|+.+|+.|+.|||.+ ++|||||||+|||+ ++.++++|+|||.++..... ..
T Consensus 401 ~ell~ri~~~~~~~--~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~ 471 (612)
T KOG0603|consen 401 GELLRRIRSKPEFC--SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD 471 (612)
T ss_pred cHHHHHHHhcchhH--HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence 99888886653322 67778999999999999998 99999999999999 69999999999999877665 22
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..+-|..|.|||++....+++++|+||||++||+||+|+.||........ ....+..++..
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-------i~~~i~~~~~s------------ 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-------IHTRIQMPKFS------------ 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-------HHHhhcCCccc------------
Confidence 33457899999999999999999999999999999999999987765511 12222222221
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..-++...+|+.+||+.||.+||+|.++...
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2334567889999999999999999998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=237.79 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=193.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
++||+|.||+||||+ +..+++.||+|+++-.. +.......+|+.+++.++|+|||++++....++.+-+|+||| ..
T Consensus 8 ekigegtygtvfkar-n~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKAR-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HhhcCCcceeeEecc-cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 679999999999998 55677899999987543 233467889999999999999999999999999999999999 56
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|..+...-...++......++.|+++||.|+|++ ++.||||||.|.||+.+|.+|++|||+++.++-... .....
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-cysae 161 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSAE 161 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeece
Confidence 88888877778889999999999999999999998 999999999999999999999999999997754322 22233
Q ss_pred cCcccccCcccccCC-CCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHHHHHHhhccccc---eeecccc--
Q 003818 665 RGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADWAYDCFRERKLG---LLVENDE-- 737 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~~~~~-- 737 (793)
.-|..|.+|.++.+. -|+...|+||-||++.|+... ++.|.+....++...+.. ......+.... .+.+..+
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~-~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH-HhCCCccccCCccccCCCCcccC
Confidence 468899999998776 589999999999999999874 455555544443333321 11111111111 1111100
Q ss_pred ------hhhhh-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 ------EAMDD-IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ------~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..... ......=++++...+.-+|..|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00000 011112245666667779999999988765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=285.99 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=191.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCc------eEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH------RLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV 577 (793)
.+.||+|++|.||+|.... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+. .++|
T Consensus 20 ~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEeccCCceEEEEEEECC-CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3679999999999998653 56789999886532 2233567789999999999999999998766554 8999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 99 ~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 99 THLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 9998 6799998864 4588899999999999999999998 9999999999999999999999999999865432
Q ss_pred CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH-------HHhhcccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY-------DCFRERKL 729 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~-------~~~~~~~~ 729 (793)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.+... ..+.....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 222347888999999865 3678999999999999999999999976554332221111000 00000000
Q ss_pred ceeecc-----cch-hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVEN-----DEE-AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~-----~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...... ... ..........+.+++.+||+.+|++|||+.+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 000 0000122567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.02 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=191.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|.||+||-|+++ .+|+.||||++.+.. .+.+.++++|+.+|++++||.||.+.-.|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 368999999999999965 578999999997632 34557899999999999999999999999999999999999955
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCCCcc
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
.-|.-.|.....++++.....++.||+.||.|||.+ +|+|+||||+|||+.. --.+||+|||.|+..+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 445545555567788887888899999999999998 9999999999999964 35699999999998765432
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
...+.||+.|+|||+++++.|...-|+||.|||+|--|+|..||..+.+-.. .+.. ..+.....+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQN--------AaFMyPp~PW---- 788 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQN--------AAFMYPPNPW---- 788 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhc--------cccccCCCch----
Confidence 3456799999999999999999999999999999999999999986543221 1111 1011111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 770 (793)
.+-.....++|...||..-.+|-|..+-
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 1122345677777788888888887654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=267.17 Aligned_cols=220 Identities=21% Similarity=0.160 Sum_probs=175.5
Q ss_pred ccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCHHHHHh
Q 003818 512 GAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLF 591 (793)
Q Consensus 512 G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 591 (793)
|.+|.||++.. ..+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~-~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMD-TRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEE-ccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999985 4567889999986642 23445555666679999999999999999999999999999999986
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCccccc
Q 003818 592 RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671 (793)
Q Consensus 592 ~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 671 (793)
+. ..+++.....++.|+++||.|||+. +|+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 78 ~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 78 KF-LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred Hh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 54 3578899999999999999999998 99999999999999999999999999876554321 1223567899
Q ss_pred CcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHH
Q 003818 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVM 751 (793)
Q Consensus 672 aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 751 (793)
|||.+....++.++||||+|+++|||++|+.|+....... ... .. .. .+......+.+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~-~~--~~------~~~~~~~~~~~ 207 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTH-TT--LN------IPEWVSEEARS 207 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccc-cc--cC------CcccCCHHHHH
Confidence 9999988889999999999999999999998875432110 000 00 00 01112356788
Q ss_pred HHHHccccCCCCCCCH
Q 003818 752 IAIWCIQEDPSLRPAM 767 (793)
Q Consensus 752 li~~Cl~~dP~~RPt~ 767 (793)
++.+|++.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=299.93 Aligned_cols=142 Identities=31% Similarity=0.399 Sum_probs=125.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.++||+|+||.||+|... ..++.||||++..... .....+.+|+.++..++|+||+++++++......+|||||+
T Consensus 8 i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 3478999999999999864 4578899999875432 22367889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
++++|.+++... ..+++.....|+.||+.||.|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999998654 4577888899999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=284.98 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=205.4
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEec-----CCceEEE
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNE-----GEHRLLV 577 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lV 577 (793)
.|.+.||.|.+|.||+++.. .+++.+|+|++... .+..++++.|..+++.. +|||++.++|++.. +++++||
T Consensus 22 ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred EEEEEEeeccceeEEEEeee-ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 35688999999999999854 56778888887554 44567888899999887 79999999998843 5789999
Q ss_pred EeecCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 578 YEYVSNGSLADFLFR-KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
||||.+|+..|++.. .+..+.|..+..|++.++.||.+||.+ .++|||||-.|||+++++.+||.|||++..+...
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999999999865 467789999999999999999999998 9999999999999999999999999999766443
Q ss_pred CCcceecccCcccccCcccccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNL-----PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
.... .+..||+.|||||++... .|+.++|+||||++..||--|.+|+..+..... . +..
T Consensus 177 ~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----------L-----F~I 240 (953)
T KOG0587|consen 177 VGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----------L-----FLI 240 (953)
T ss_pred cccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----------h-----ccC
Confidence 3222 235699999999999643 477899999999999999999999876654321 1 222
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+++....+.+...++.++|..||.+|-++||++.++++
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 34455556667788999999999999999999999988775
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=264.95 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=189.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---c----chHHHHHHHHHHhcCCccccceeeeEEe-cCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---E----GEQEFKAEISAIGRTNHKNLVQLLGFCN-EGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~----~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~ 578 (793)
..||+|+|+.|||+.. -...+.||+|+-.-... + -.+..-+|.++.+.++||.||++++|+. +.+..|-|+
T Consensus 469 hLLGrGGFSEVyKAFD-l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFD-LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHhccccHHHHHHhcc-cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 5699999999999974 44567899997543221 1 1134567999999999999999999985 556788999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKT 655 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~ 655 (793)
|||+|.+|+-||..+ +.+++.+...|+.||..||.||.+. +++|||-||||.|||+. .-|.+||.|||+++.+..
T Consensus 548 EYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 999999999999654 5678889999999999999999987 78999999999999994 468899999999998876
Q ss_pred CCCc------ceecccCcccccCcccccCC----CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhh
Q 003818 656 DQTQ------TTTAIRGTKGYVAPEWFKNL----PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725 (793)
Q Consensus 656 ~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~ 725 (793)
+... ......||..|++||.+.-. .++.|+||||.|||+|+.+-|+.||........ .+.. ...++
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqe--NTIlk 701 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQE--NTILK 701 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhh--hchhc
Confidence 5443 22335699999999987532 578899999999999999999999987654331 1110 01111
Q ss_pred ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
...+.....+ ....+...+|++||+...++|....++.
T Consensus 702 AtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 702 ATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111111 1123456789999999999998877765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=253.39 Aligned_cols=263 Identities=21% Similarity=0.318 Sum_probs=195.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec--------CCceEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--------GEHRLL 576 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~~~l 576 (793)
.+||+|.||.||+|... .+++.||+|++.... +.-.....+|+++|..++|+|++.++..|.. ....+|
T Consensus 23 ~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 46999999999999854 456779988764422 2223567889999999999999999998843 234799
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|+.+|+. +|.-+|.+...+++...+.+++.++..||.|+|.. .|+|||+|++|+||+.++.+||+|||+++.+...
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999965 78888877778899999999999999999999988 9999999999999999999999999999876533
Q ss_pred CCc---ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhhccc
Q 003818 657 QTQ---TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFRERK 728 (793)
Q Consensus 657 ~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~~~~ 728 (793)
... ..+...-|..|.+||.+.+. .++++.|||.-||++.||.++.+-++..........+.... .+.|++-.
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 221 12234468999999988765 79999999999999999999998888776554433322111 11122111
Q ss_pred ccee---e--cccchhh--hhHHHH------HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 729 LGLL---V--ENDEEAM--DDIKRV------EKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 729 ~~~~---~--~~~~~~~--~~~~~~------~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
--.+ + ++.++.. ...+.. +..++++..++..||.+|+++++++..-
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0000 0 0001100 011112 2567899999999999999999987643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=258.70 Aligned_cols=239 Identities=30% Similarity=0.381 Sum_probs=193.3
Q ss_pred cceeEEEeEeCCCCceeEEEEEechhcccc-hHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCHHHHHh
Q 003818 513 AFGKVYKGVLTTENEKPVAVKKLYKAVNEG-EQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLF 591 (793)
Q Consensus 513 ~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 591 (793)
+||.||+|+.. .+++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999965 356789999997654444 6789999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCccccc
Q 003818 592 RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671 (793)
Q Consensus 592 ~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 671 (793)
.... +++..+..++.+++++|.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 5433 78899999999999999999998 99999999999999999999999999998765432 223345788999
Q ss_pred CcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHH
Q 003818 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVM 751 (793)
Q Consensus 672 aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 751 (793)
+||.+.+..++.++|||+||+++++|++|..||......+. +. ............. .......+.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---~~----~~~~~~~~~~~~~-------~~~~~~~~~~ 219 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE---LF----KKIGKPKPPFPPP-------EWKISPEAKD 219 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HH----HHHhccCCCCccc-------cccCCHHHHH
Confidence 99999988899999999999999999999999976322221 11 1111111110000 0003457889
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 003818 752 IAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 752 li~~Cl~~dP~~RPt~~evl~ 772 (793)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=260.00 Aligned_cols=256 Identities=24% Similarity=0.326 Sum_probs=193.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc--c----ccceeeeEEecCCceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH--K----NLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+|+|.||.|-+..... .+..||+|+++... .-.+..+-|+.+|+++.+ | -+|.+.++|.-.++.+||+|.
T Consensus 95 ~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfel 172 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRE-TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFEL 172 (415)
T ss_pred hhhcCCcccceEEEeecC-CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEec
Confidence 579999999999977544 48899999997643 334556779999999832 2 367888899999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--------------------C
Q 003818 581 VSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--------------------T 639 (793)
Q Consensus 581 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--------------------~ 639 (793)
+ |.|+.++|.++ -.......+..|+.|++++++|||+. +++|.||||+|||+.+ +
T Consensus 173 l-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks 248 (415)
T KOG0671|consen 173 L-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS 248 (415)
T ss_pred c-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence 8 77999999774 45567888999999999999999998 9999999999999831 3
Q ss_pred CcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH----HH
Q 003818 640 FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ----MI 715 (793)
Q Consensus 640 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~----~~ 715 (793)
..++|+|||.|..-..+. ..++.|.-|.|||++.+..++.++||||+||||+|+.+|...|+.....|.. ..
T Consensus 249 ~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 249 TAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred cceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 458999999998654443 3455788999999999999999999999999999999999999887654421 11
Q ss_pred HHHH---------HHHHhhccccce-----------eecccch----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 716 LADW---------AYDCFRERKLGL-----------LVENDEE----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 716 l~~~---------~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
+... ..+.+..+++.- ..+.... ....-.+..+|.+|+..||..||.+|+|++|++
T Consensus 325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 1111 111112221110 0000000 001123456799999999999999999999987
Q ss_pred H
Q 003818 772 Q 772 (793)
Q Consensus 772 ~ 772 (793)
+
T Consensus 405 ~ 405 (415)
T KOG0671|consen 405 S 405 (415)
T ss_pred c
Confidence 5
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=286.97 Aligned_cols=257 Identities=21% Similarity=0.224 Sum_probs=163.6
Q ss_pred ccccccccceeEEEeEeCCC---CceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeE------EecCCceEE
Q 003818 506 KEELGEGAFGKVYKGVLTTE---NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF------CNEGEHRLL 576 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~~~~~~~l 576 (793)
.+.||+|+||.||+|++... .+..||+|++..... .+....| .+....+.+++.++.. ...+...++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 47899999999999997543 167899998754321 1111111 1122222333322221 245678999
Q ss_pred EEeecCCCCHHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc
Q 003818 577 VYEYVSNGSLADFLFRKSRRP-------------------NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD 637 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~ 637 (793)
|+||+.+++|.+++....... ....+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEe
Confidence 999999999999986542111 1223457899999999999998 999999999999998
Q ss_pred C-CCcEEEeecCCccccCCCCCcceecccCcccccCcccccCC----------------------CCCCccceehhHHHH
Q 003818 638 G-TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL----------------------PITAKVDVYSFGILL 694 (793)
Q Consensus 638 ~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~Dvws~Gvil 694 (793)
+ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||||+|
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 5 68999999999986654443344456689999999965322 234567999999999
Q ss_pred HHHHhCCcCCCCCchhHHHHHHHH--HHHHHhhccccceeecccchhhhhHH----HHHHHHHHHHHccccCCCCCCCHH
Q 003818 695 LELVCCRKNFEVDATEECQMILAD--WAYDCFRERKLGLLVENDEEAMDDIK----RVEKFVMIAIWCIQEDPSLRPAMK 768 (793)
Q Consensus 695 ~elltg~~pf~~~~~~~~~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~Cl~~dP~~RPt~~ 768 (793)
|||+++..+++.....- ...+.. .....+... .... ...+.....+ ......+|+.+||+.||++|||++
T Consensus 370 ~el~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQF-NRQLKRNDYDLVAWRKL-VEPR--ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHhCcCCCchHHHHH-HHHHHhcCCcHHHHHHh-hccc--cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 99999776644321110 000000 000000000 0000 0000000000 112345899999999999999999
Q ss_pred HHHHH
Q 003818 769 KVTQM 773 (793)
Q Consensus 769 evl~~ 773 (793)
|+++.
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=275.81 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=173.5
Q ss_pred ccccccccceeEEEeEeC---------------CCCceeEEEEEechhcccchHH--------------HHHHHHHHhcC
Q 003818 506 KEELGEGAFGKVYKGVLT---------------TENEKPVAVKKLYKAVNEGEQE--------------FKAEISAIGRT 556 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~---------------~~~~~~vavK~l~~~~~~~~~~--------------~~~E~~~l~~l 556 (793)
.++||+|+||.||+|... ...++.||||++........++ ...|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 478999999999999742 1234679999986533222222 33466777777
Q ss_pred Ccccc-----ceeeeEEec--------CCceEEEEeecCCCCHHHHHhcCC-----------------------CCCCHH
Q 003818 557 NHKNL-----VQLLGFCNE--------GEHRLLVYEYVSNGSLADFLFRKS-----------------------RRPNWY 600 (793)
Q Consensus 557 ~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~~~~~ 600 (793)
+|.++ ++++++|.. ....+|||||+++++|.++++... ..+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66554 677787753 356899999999999999986431 123456
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCC
Q 003818 601 KRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680 (793)
Q Consensus 601 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 680 (793)
.+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|||.+....
T Consensus 310 ~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~ 386 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ 386 (507)
T ss_pred HHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence 7788999999999999998 9999999999999999999999999999765433222222223578999999875432
Q ss_pred C----------------------CCccceehhHHHHHHHHhCCc-CCCCCchhHHH-----HHHHHHHHHHhhcccccee
Q 003818 681 I----------------------TAKVDVYSFGILLLELVCCRK-NFEVDATEECQ-----MILADWAYDCFRERKLGLL 732 (793)
Q Consensus 681 ~----------------------s~~~Dvws~Gvil~elltg~~-pf~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~ 732 (793)
. ..+.||||+||+++||+++.. |+......... ..+..| ..........
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~~~~- 463 (507)
T PLN03224 387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQKYDF- 463 (507)
T ss_pred CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccCCCc-
Confidence 1 134799999999999999875 66532211111 111111 1111111110
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDP---SLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~ 772 (793)
. ......+...+++.++|..+| .+|+|++|+++
T Consensus 464 ---~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 464 ---S----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ---c----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 011123556788889998766 68999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=250.75 Aligned_cols=244 Identities=24% Similarity=0.336 Sum_probs=195.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.++||+|+|..|..+.+.. +.+.+|+|++++.. .+...-.+.|-.+..+. +||.+|.++.+|+.+..+++|.||+
T Consensus 255 l~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeecCcchhhhhheehcc-cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3689999999999988754 56889999998743 23344567777777665 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|--++++.+ .++++....+...|.-||.|||++ +||.||||..|||+|..|++||.|+|+++.--.+ ....
T Consensus 334 ~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred cCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 9999988886654 455666666788999999999999 9999999999999999999999999999853322 2344
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
.+.+||+.|+|||++++..|....|.|++||+++||+.|+.||+.......+..-.+++.+.+.++.+.....
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs------- 481 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS------- 481 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce-------
Confidence 5678999999999999999999999999999999999999999765443333344456666666665543222
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP 765 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP 765 (793)
.+.+...+++.-|++||++|.
T Consensus 482 ---lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 ---LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---eehhhHHHHHHhhcCCcHHhc
Confidence 223345677778999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=265.72 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=200.4
Q ss_pred CCCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEE
Q 003818 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFC 568 (793)
Q Consensus 492 ~~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 568 (793)
+..+++++.+ ..||-|+||.|-+...+.. ...+|+|.+++.. ...++.+..|-.+|...+.|.||+++.-|
T Consensus 416 ~v~l~dl~~i-----aTLGvGgFGRVELV~~~~~-~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 416 QVKLSDLKRI-----ATLGVGGFGRVELVKVNSQ-KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred ccchhhhhhh-----hhcccCccceEEEEEeccc-chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 3444555443 3599999999998876533 2358888887643 33446678899999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecC
Q 003818 569 NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648 (793)
Q Consensus 569 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 648 (793)
.+.+..|++||-|-||.|...|++++ .++......++..+.+|++|||.+ +||.|||||+|.+++.+|-+||.|||
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 99999999999999999999997664 456666677888999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+|+.+.... ...+++||+.|.|||++.++.++.++|.||||+++||||+|++||...++-.....+.......
T Consensus 566 FAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----- 638 (732)
T KOG0614|consen 566 FAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----- 638 (732)
T ss_pred hHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----
Confidence 999876543 4456789999999999999999999999999999999999999999876654433332211110
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQM 773 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 773 (793)
..+..-.....+++++....+|.+|.- +.+|-+.
T Consensus 639 -----------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 -----------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -----------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 001111234567888888999999975 5555543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=275.30 Aligned_cols=239 Identities=27% Similarity=0.362 Sum_probs=185.0
Q ss_pred ccccccccee-EEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGK-VYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~-Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+|.|.-|+ ||+|.+ .++.||||++-.. -.....+|+..|+.- +||||||+++.-.+....||..|.| ..
T Consensus 515 eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY---EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred HHcccCCCCcEEEEEee---CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 6799999985 599997 5789999998543 234568899999987 6999999999999999999999999 66
Q ss_pred CHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----CCcEEEeecCCccccCCC
Q 003818 585 SLADFLFRKSRR---PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-----TFNARISDFGLAKLLKTD 656 (793)
Q Consensus 585 sL~~~l~~~~~~---~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~~~ 656 (793)
+|.+++...... ........+..|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999774111 11134567889999999999997 9999999999999975 357899999999988766
Q ss_pred CCcce--ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHHHHHHhhccccceee
Q 003818 657 QTQTT--TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADWAYDCFRERKLGLLV 733 (793)
Q Consensus 657 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (793)
..... ....||-+|+|||.+....-+.++||+|+||++|+.++| ..||...-..+ ..+. ....--..+
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl-------~~~~~L~~L 735 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANIL-------TGNYTLVHL 735 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhh-------cCccceeee
Confidence 54433 345699999999999998888899999999999999987 78997654332 1111 111100001
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .+.++ +..+||.+|+.++|..||++.+|+.
T Consensus 736 ~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 E------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 11111 5678999999999999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=259.75 Aligned_cols=205 Identities=25% Similarity=0.363 Sum_probs=170.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||-|+||.|.++. +.++...+|+|.+++... ......+.|-.||+.-+.+-||+|+-.|.+.+.+|+||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVR-KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEe-ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 469999999999987 444578999999987542 2334578899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC---------
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK--------- 654 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~--------- 654 (793)
|++-.+|.+.+- +.+.....++.++..|+++.|.. |+|||||||+|||||.+|++||.||||+.-++
T Consensus 714 GDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 714 GDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 999999987753 45555556677899999999988 99999999999999999999999999985432
Q ss_pred CCC-C---------------c----------------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCc
Q 003818 655 TDQ-T---------------Q----------------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702 (793)
Q Consensus 655 ~~~-~---------------~----------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~ 702 (793)
.+. . . .....+||+.|+|||++....++..+|.||.|||||||+.|+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 000 0 0 0112459999999999999999999999999999999999999
Q ss_pred CCCCCchhHHHHHH
Q 003818 703 NFEVDATEECQMIL 716 (793)
Q Consensus 703 pf~~~~~~~~~~~l 716 (793)
||-.+...+.+..+
T Consensus 870 pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 870 PFLADTPGETQYKV 883 (1034)
T ss_pred CccCCCCCcceeee
Confidence 99888776654444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=241.90 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=193.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEEEe
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 579 (793)
+.||-|+||.||... +..+++.||+|++..... ..-+.+.+|+++|.-++|.|++..++...-. +++|++.|
T Consensus 59 RPIGYGAFGVVWsVT-DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVT-DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEecc-CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 569999999999877 445688999999876432 2346788999999999999999988876543 35678888
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
.| ..+|...+.. ...++...+.-+..||++||.|||+. +|.||||||.|.|++.+..+||+|||+++.-..++..
T Consensus 138 Lm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 138 LM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 88 4466666543 35667777788999999999999998 9999999999999999999999999999987777776
Q ss_pred ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH---------------HHH
Q 003818 660 TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA---------------YDC 723 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~---------------~~~ 723 (793)
..+...-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|......+....+.+.. +..
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 66766778899999999876 68999999999999999999998888766655433332211 111
Q ss_pred hhccccceeecccc-hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 724 FRERKLGLLVENDE-EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 724 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
+.++......-..+ ........-.+.+++...++.+||..|.+..+.+..+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111000000000 0000001112345777888999999999988877655
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=227.41 Aligned_cols=197 Identities=29% Similarity=0.398 Sum_probs=163.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|++|.|-+-++. .+|+..|+|++..... +..++..+|+.+..+ ..+|.+|.++|........++.||.| ..
T Consensus 52 ~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 56999999999877754 5789999999977543 334567778877655 57999999999998999999999999 55
Q ss_pred CHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 585 SLADFLF---RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 585 sL~~~l~---~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
||+.+-. +++...++..+-+|+..+..||.|||++ ..+||||+||+|||++.+|++|++|||++-.+.+.-....
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 7766553 4677788888999999999999999987 4899999999999999999999999999977654332221
Q ss_pred ecccCcccccCcccccC----CCCCCccceehhHHHHHHHHhCCcCCCCCch
Q 003818 662 TAIRGTKGYVAPEWFKN----LPITAKVDVYSFGILLLELVCCRKNFEVDAT 709 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~ 709 (793)
..|-..|||||.+.. ..|+.++||||||+.+.||.+++.|+.....
T Consensus 208 --daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 208 --DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred --hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 337788999998853 3689999999999999999999999976543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=231.84 Aligned_cols=211 Identities=36% Similarity=0.568 Sum_probs=182.6
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCHH
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLA 587 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 587 (793)
||+|.+|.||++.... +++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998643 4778999998765332 3467899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCCCCCcceecccC
Q 003818 588 DFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 588 ~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
+++......+++..+..++.+++++|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 99976545688899999999999999999998 9999999999999999 89999999999986654321 1222346
Q ss_pred cccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 667 TKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 667 t~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999887 788999999999999998
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456788999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=222.54 Aligned_cols=253 Identities=18% Similarity=0.326 Sum_probs=186.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEecC--CceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEG--EHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~Ey~~~ 583 (793)
+++|+|.|+.||.|... .+.+.++||+++.. ..+.+.+|+.+|..+. ||||+++++...+. ....||+||+.+
T Consensus 44 rk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEGINI-TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHcCccHhhHhccccc-CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 67999999999999843 45567999998764 3467899999999997 99999999998764 466899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
.+...+- ..++...+...+.++++||.|+|++ ||+|||+||.|++||. .-.++|+|+|+|..+.+.......
T Consensus 120 ~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVR 192 (338)
T KOG0668|consen 120 TDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 192 (338)
T ss_pred ccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeee
Confidence 8877655 4466677888999999999999999 9999999999999985 456999999999988765543322
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCch-hHHHHHHHHHH-----HHHhhccc------c
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDAT-EECQMILADWA-----YDCFRERK------L 729 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~-~~~~~~l~~~~-----~~~~~~~~------~ 729 (793)
..+..|.-||.+-.. .|+..-|+|||||+|..|+..+.||..... .++...++..+ ...+..-. .
T Consensus 193 --VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 193 --VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred --eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 356678999998655 578899999999999999999999864433 23222222211 11111101 1
Q ss_pred ceeecccc--------hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVENDE--------EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~~~--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..++.... ......-...+..+++...|..|-.+|||++|...
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11110000 00000111356678889999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=232.33 Aligned_cols=255 Identities=24% Similarity=0.273 Sum_probs=187.6
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEec------CCceEEEEe
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE------GEHRLLVYE 579 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lV~E 579 (793)
.+|.|.- .|-.+. ..-.+++||+|++... .....+...+|..++..++|+||++++.++.- ..+.|+|||
T Consensus 24 p~~~g~~-~v~~a~-D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAF-DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred ccCCCCc-eEEecc-hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 4677777 444433 3445788999988653 23345678899999999999999999999853 346799999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+| ..+|...+. ..++-.....|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.-..+ -
T Consensus 102 ~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 102 LM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred hh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 99 668888776 3355567788999999999999998 9999999999999999999999999999854433 3
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHH---------------HHHHHHHHh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI---------------LADWAYDCF 724 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~---------------l~~~~~~~~ 724 (793)
..+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+...-+.... +...++...
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 45556788999999999999999999999999999999999998876543332111 111111111
Q ss_pred hccc------cceee-cc--cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 725 RERK------LGLLV-EN--DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 725 ~~~~------~~~~~-~~--~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.... ....+ +. ......+......+++++.+||-.+|++|.+++++++.
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1100 00000 00 00111122344568899999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=246.25 Aligned_cols=191 Identities=28% Similarity=0.396 Sum_probs=164.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc--------chHHHHHHHHHHhcCC---ccccceeeeEEecCCceE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--------GEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~ 575 (793)
+.+|+|+||.|+.++++.. ...|+||.+.+...- ..-..-.|+.+|..++ |+||++++++|++++..|
T Consensus 567 q~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 5799999999999998765 678999999764211 1123457999999997 999999999999999999
Q ss_pred EEEeec-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC
Q 003818 576 LVYEYV-SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK 654 (793)
Q Consensus 576 lV~Ey~-~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 654 (793)
|++|.. ++.+|.+++..+ ..+++.+..-|++||+.|+++||+. +|||||||-+||.++.+|-+||+|||.+.+.+
T Consensus 646 l~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 999965 566999999665 4578888899999999999999999 99999999999999999999999999998766
Q ss_pred CCCCcceecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCC
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFE 705 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~ 705 (793)
.+... ..+||..|.|||++.+.+| ...-|||++|++||-++-...||.
T Consensus 722 sgpfd---~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SGPFD---VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCCcc---eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 54433 3569999999999999987 567899999999999998888875
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=209.90 Aligned_cols=101 Identities=40% Similarity=0.686 Sum_probs=74.3
Q ss_pred CCeEEEeeCCCCCCC---CCceEEEecCCcEEEECCCCCeeecC-CCCC---ccceeeEecCcCEEEEecCCCceeeecc
Q 003818 72 ERTIVWSANRDNLVQ---RGSKVELTGDGQLILRDSSGKEIWRE-PPST---GAAYAAMLDTGNLVLASQDSSTMWESFD 144 (793)
Q Consensus 72 ~~t~vW~anr~~p~~---~~~~l~~~~~g~l~l~~~~~~~~Wst-~~~~---~~~~~~lld~GNlvl~~~~~~~~WqSFd 144 (793)
++||||+|||++|+. ...+|.|+.||||+|+|..++.+|++ ++.. ....|+|+|+|||||++..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 479999999999994 34789999999999999999999999 5432 3679999999999999999999999999
Q ss_pred CCCCcccCCccccCC------ceEEEecCCCCCC
Q 003818 145 DPTDTLLPTQVMSQG------TKVIARLTETNYS 172 (793)
Q Consensus 145 ~Ptdtllp~~~l~~~------~~L~s~~s~~dps 172 (793)
|||||+||+|+|+.+ ..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999998873 3499999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=226.55 Aligned_cols=198 Identities=35% Similarity=0.506 Sum_probs=171.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|++|.||++.... +++.+++|.+...... ..+.+.+|+..+.+++|+|++++++++......++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 35679999999999998653 4678999999765444 567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++......+++.....++.+++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999976543378899999999999999999998 99999999999999999999999999998765543112233
Q ss_pred ccCcccccCcccc-cCCCCCCccceehhHHHHHHHHhCCcCCCC
Q 003818 664 IRGTKGYVAPEWF-KNLPITAKVDVYSFGILLLELVCCRKNFEV 706 (793)
Q Consensus 664 ~~gt~~y~aPE~~-~~~~~s~~~Dvws~Gvil~elltg~~pf~~ 706 (793)
..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4577889999998 666788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=202.25 Aligned_cols=105 Identities=34% Similarity=0.610 Sum_probs=96.9
Q ss_pred eeecCCCeEEeeeeecCCCC-eEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEEECCCCCeeecCCCCC--c
Q 003818 41 SWISQSGDFAFGFRQVGDRG-FLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPST--G 117 (793)
Q Consensus 41 ~l~S~~g~F~lgF~~~~~~~-~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~--~ 117 (793)
+|+|++|.|++|||.+.... .+.+|||.+++ +++||.||++.|....+.|.|+.||+|+|+|.+|.++|+|++.. .
T Consensus 9 ~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~~ 87 (116)
T cd00028 9 TLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNG 87 (116)
T ss_pred EEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccCCCC
Confidence 89999999999999998776 99999999887 89999999999977788999999999999999999999997653 4
Q ss_pred cceeeEecCcCEEEEecCCCceeeeccCC
Q 003818 118 AAYAAMLDTGNLVLASQDSSTMWESFDDP 146 (793)
Q Consensus 118 ~~~~~lld~GNlvl~~~~~~~~WqSFd~P 146 (793)
...|+|+|+|||||++.++.+||||||||
T Consensus 88 ~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 88 NYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred ceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 56899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=231.02 Aligned_cols=126 Identities=33% Similarity=0.469 Sum_probs=106.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-----c---cccceeeeEEe----cCCc
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-----H---KNLVQLLGFCN----EGEH 573 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~----~~~~ 573 (793)
.++||-|.|++||++. .....+.||+|+.+.. ..-.+....||++|++++ | .+||+|+++|. .+.+
T Consensus 83 ~rKLGWGHFSTVWLaw-Dtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAW-DTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EEeccccccceeEEEe-eccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 4789999999999986 5567789999998764 334456778999999873 3 47999999995 4679
Q ss_pred eEEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 574 RLLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 574 ~~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
++||+|++ |-+|..+|... -+.+....+.+|+.||+.||.|||.+| +|||.||||+|||+
T Consensus 161 VCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999999 77787777654 456788899999999999999999987 99999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=238.26 Aligned_cols=257 Identities=20% Similarity=0.248 Sum_probs=194.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC------ccccceeeeEEecCCceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN------HKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
...|+|-|++|.+|... ..+..||||+|..... ..+.=+.|+++|++|+ --|+++++-.|...+++|||+|.
T Consensus 438 ~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~ 515 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEP 515 (752)
T ss_pred eccccceeeeeeecccc-CCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehh
Confidence 45899999999999854 4456899999977522 2244467999999985 34899999999999999999998
Q ss_pred cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCCCC
Q 003818 581 VSNGSLADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 581 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 657 (793)
+ ..+|.++|.+-+ ..+....+..++.|+.-||..|... +|+|.||||.||||++. ..+||||||.|.....++
T Consensus 516 L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 516 L-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENE 591 (752)
T ss_pred h-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccccccccc
Confidence 8 678999997643 3466778889999999999999988 99999999999999865 558999999997665443
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH----HHHHHhhcccc----
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD----WAYDCFRERKL---- 729 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~----~~~~~~~~~~~---- 729 (793)
. +...-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+...........+ +...++..+.+
T Consensus 592 i---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH 668 (752)
T KOG0670|consen 592 I---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH 668 (752)
T ss_pred c---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence 2 223345689999999999999999999999999999999999988776654332221 11111111100
Q ss_pred --------------------ce-e--ecccc-----------hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 --------------------GL-L--VENDE-----------EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 --------------------~~-~--~~~~~-----------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. + +.+.- ...+....+..|.+|+..||..||++|.|..+.++
T Consensus 669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred cccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 0 00000 01223456778999999999999999999998775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=248.77 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=198.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
.++|.|.||.|||++ +..+++..|+|+++-......+-++.|+.+++..+|||||.++|.+...+..++.||||.+|+|
T Consensus 21 qrvgsgTygdvyKaR-d~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKAR-DKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeecCCcccchhhhc-ccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 579999999999998 4456789999999877666777888999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 666 (793)
.+.-+- ...+++.++....+..++||.|||+. +-+|||||-.|||+++.+.+|++|||.+-.+...- .......|
T Consensus 100 Qdiy~~-TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~KrksfiG 174 (829)
T KOG0576|consen 100 QDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIG 174 (829)
T ss_pred cceeee-cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhhhcccC
Confidence 986543 45678888899999999999999998 88999999999999999999999999986544322 22334679
Q ss_pred cccccCcccc---cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 667 TKGYVAPEWF---KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 667 t~~y~aPE~~---~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
|+.|||||+. +...|...+|||+.|+...|+--...|.......... ..... -...++...+..
T Consensus 175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l--------~LmTk-----S~~qpp~lkDk~ 241 (829)
T KOG0576|consen 175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL--------FLMTK-----SGFQPPTLKDKT 241 (829)
T ss_pred CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH--------HHhhc-----cCCCCCcccCCc
Confidence 9999999986 3557899999999999999998777765433222111 11110 011122333445
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.|-++++.|+.++|++|||+..+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 66778889999999999999999977553
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=194.27 Aligned_cols=105 Identities=33% Similarity=0.604 Sum_probs=96.3
Q ss_pred CeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEEECCCCCeeecCCCC--Cc
Q 003818 40 ASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPS--TG 117 (793)
Q Consensus 40 ~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~--~~ 117 (793)
+.|+|++|.|++|||.+.....+.+|||++.+ +++||+||++.|+..++.|.|+.||+|+|+|.+|.++|+|++. .+
T Consensus 8 ~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~ 86 (114)
T smart00108 8 QTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANG 86 (114)
T ss_pred CEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCCC
Confidence 38999999999999998877899999999887 8999999999998777899999999999999999999999765 44
Q ss_pred cceeeEecCcCEEEEecCCCceeeeccC
Q 003818 118 AAYAAMLDTGNLVLASQDSSTMWESFDD 145 (793)
Q Consensus 118 ~~~~~lld~GNlvl~~~~~~~~WqSFd~ 145 (793)
...++|+|+|||||++..+.++||||||
T Consensus 87 ~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 87 NYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 5689999999999999999999999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-25 Score=264.38 Aligned_cols=196 Identities=18% Similarity=0.258 Sum_probs=140.3
Q ss_pred cCCc-cccceeeeEE-------ecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 003818 555 RTNH-KNLVQLLGFC-------NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626 (793)
Q Consensus 555 ~l~H-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 626 (793)
.++| +||+++++++ .+....++++|++ +++|.++|......+++..++.++.||++||.|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 3456 6888888887 2334567788987 6699999977666789999999999999999999998 9999
Q ss_pred cCCCCCCEEEcCC-------------------CcEEEeecCCccccCCCCC---------------cceecccCcccccC
Q 003818 627 CDIKPQNILLDGT-------------------FNARISDFGLAKLLKTDQT---------------QTTTAIRGTKGYVA 672 (793)
Q Consensus 627 ~Dlkp~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~a 672 (793)
|||||+||||+.. +.+||+|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4456666666653211000 00011347888999
Q ss_pred cccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHH
Q 003818 673 PEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMI 752 (793)
Q Consensus 673 PE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 752 (793)
||++.+..++.++|||||||+||||+++..|+..... .+....... . .+ ...........+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~~-----~----~~-----~~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHRV-----L----PP-----QILLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHhh-----c----Ch-----hhhhcCHHHHHH
Confidence 9999999999999999999999999998887653211 111111110 0 00 001112334578
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 003818 753 AIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 753 i~~Cl~~dP~~RPt~~evl~~ 773 (793)
+.+||+++|.+||+|.||++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=210.22 Aligned_cols=262 Identities=17% Similarity=0.286 Sum_probs=186.1
Q ss_pred CCCcCCCCCHHHHHHHhcccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-Ccccccee
Q 003818 486 PEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQL 564 (793)
Q Consensus 486 ~~~~~~~~~~~el~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 564 (793)
+...++..++.+...+ .+.||+|.||.+-++.++. +.+.+++|.+.... ...++|.+|..---.| .|.||+.-
T Consensus 13 ~~~el~kv~l~d~y~I----~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~t 86 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTI----NKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDT 86 (378)
T ss_pred ccccccccchhhhhhH----HHHhcccceeeEEeeeccC-CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHH
Confidence 3344555555554433 4689999999999998764 56789999886643 3457888887654444 68999987
Q ss_pred ee-EEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCc
Q 003818 565 LG-FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD--GTFN 641 (793)
Q Consensus 565 ~~-~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~ 641 (793)
++ .|+..+..+.++||++.|+|.+-+... .+.+....+++.|++.||.|+|++ ++||||||.+||||- +..+
T Consensus 87 Y~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~r 161 (378)
T KOG1345|consen 87 YEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYR 161 (378)
T ss_pred HHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccE
Confidence 66 567778888999999999999988553 345566778999999999999998 999999999999993 4568
Q ss_pred EEEeecCCccccCCCCCcceecccCcccccCcccccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL-----PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMIL 716 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l 716 (793)
+||+|||+.+..+..- ....-+..|.+||..... ...+.+|||.||++++.+|+|..||+.....+.
T Consensus 162 vKlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---- 233 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---- 233 (378)
T ss_pred EEeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc----
Confidence 9999999987543221 112235679999977532 357899999999999999999999984432221
Q ss_pred HHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 717 ADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.-|-+..|..++.....+.. ....+++..+.++-|.++|++|=-..++.+
T Consensus 234 ~Y~~~~~w~~rk~~~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNPALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hHHHHHHHhcccCccCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11233444444443322221 112345667777889999999944444333
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=206.94 Aligned_cols=168 Identities=23% Similarity=0.225 Sum_probs=127.4
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|+|.+++..+...+++..+..|+.|+++||.|||++ + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999987677799999999999999999999987 4 999999999999999 99987654322
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+....... .. ...... ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~-~~----~~~~~~-~~~~~~ 135 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGM-PA----DDPRDR-SNLESV 135 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHh-cc----CCcccc-ccHHHH
Confidence 2488999999999999999999999999999999999999975433211 111111110 00 000000 011111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.....+.+++.+||+.+|++||++.|+++.+..
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111368999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=219.63 Aligned_cols=193 Identities=27% Similarity=0.415 Sum_probs=159.8
Q ss_pred ccccccccceeEEEeEeCCC--CceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.++||+|.|++||++++... ..+.||+|.+... .....+.+|+++|..+ .+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 36899999999999987652 5678999998653 2345689999999998 58999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccccCCC-----
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKTD----- 656 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~----- 656 (793)
+....++.. .++...+...+..+.+||.++|.+ |||||||||.|+|.+ ..+.-.|.|||+|......
T Consensus 119 H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 119 HDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred ccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 999999884 455788889999999999999998 999999999999997 4567899999999721000
Q ss_pred --------CC------------------------------cceecccCcccccCcccccCC-CCCCccceehhHHHHHHH
Q 003818 657 --------QT------------------------------QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLEL 697 (793)
Q Consensus 657 --------~~------------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~el 697 (793)
.. .......||++|.|||++... ..++++||||.|||++.+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 00 001113599999999998765 468899999999999999
Q ss_pred HhCCcCCCCC
Q 003818 698 VCCRKNFEVD 707 (793)
Q Consensus 698 ltg~~pf~~~ 707 (793)
++++.||...
T Consensus 272 ls~~~PFf~a 281 (418)
T KOG1167|consen 272 LSRRYPFFKA 281 (418)
T ss_pred hccccccccC
Confidence 9999999654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=214.10 Aligned_cols=168 Identities=21% Similarity=0.202 Sum_probs=128.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-----ccchHHHHHHHHHHhcCCccccce-eeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-----NEGEQEFKAEISAIGRTNHKNLVQ-LLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||+||+|.....+++.||||++.... ....+.|.+|+++|++++|+|+++ +++ .+..+||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEE
Confidence 4789999999999998766567788999875321 123456899999999999999985 443 246799999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDI-KPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
|+++++|... . .. ....++.+++++|.|||++ +|+|||| ||+|||++.++.+||+|||+++.+.....
T Consensus 99 ~~~G~~L~~~-~-~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 99 WTEGVPLHLA-R-PH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred ccCCCCHHHh-C-cc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 9999999732 1 11 1246788999999999998 9999999 99999999999999999999987654321
Q ss_pred cc-------eecccCcccccCcccccCCC------CCCcccee
Q 003818 659 QT-------TTAIRGTKGYVAPEWFKNLP------ITAKVDVY 688 (793)
Q Consensus 659 ~~-------~~~~~gt~~y~aPE~~~~~~------~s~~~Dvw 688 (793)
.. .....+++.|+|||.+.... .+..+|-|
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 11 13456788899999986432 23445666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-23 Score=201.94 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=190.6
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEech--hcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
++..+|.+...|..|+|++. |..+++|++.. ......++|.+|.-.|+.+.||||+.++|.|....++.++..||
T Consensus 193 nl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34457899999999999985 44477777643 23344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEe--ecCCccccCCCCC
Q 003818 582 SNGSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS--DFGLAKLLKTDQT 658 (793)
Q Consensus 582 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfgla~~~~~~~~ 658 (793)
+.|+|+..|+.... ..+..+..+++.++|+|++|||+. .+-|.---|..+.|++|++.+++|+ |--++..
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 99999999987543 456778899999999999999986 3345556789999999999988874 3222211
Q ss_pred cceecccCcccccCcccccCCCCC---CccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPIT---AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s---~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.....-.+.||+||.++..+-+ .++|+|||.+++|||.|...||.....-|+.+.+. .++....+
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------leglrv~i--- 410 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------LEGLRVHI--- 410 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------hccccccC---
Confidence 1111236789999999877644 47999999999999999999999888888766553 12211111
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+..-..-+.+++.-|+..||.+||.+..|+-+||+..
T Consensus 411 ------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 ------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1112234567888899999999999999999999754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=203.78 Aligned_cols=256 Identities=23% Similarity=0.278 Sum_probs=189.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc----cccceeeeEE-ecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH----KNLVQLLGFC-NEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~lV~E 579 (793)
+.++||+|+||.||++.......+.+|+|............+..|..++..+.+ +++..+++.. ..+...++||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 457899999999999985443345788887765433333377888888888863 6889999988 57788999999
Q ss_pred ecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-----CcEEEeecCCcc--
Q 003818 580 YVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-----FNARISDFGLAK-- 651 (793)
Q Consensus 580 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgla~-- 651 (793)
.+ |.+|.++..... +.++....++|+.|++.+|.+||+. +++||||||.|+++... ..+.|.|||+++
T Consensus 102 l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred cc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 88 889999886554 7899999999999999999999998 99999999999999755 468999999998
Q ss_pred ccCCCCCc------c-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHh
Q 003818 652 LLKTDQTQ------T-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCF 724 (793)
Q Consensus 652 ~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~ 724 (793)
.+...... . ....+||.+|.+++...+...+.+.|+||++.++.|++.|..||...........+........
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~ 257 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL 257 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence 33222111 1 2235699999999999999999999999999999999999999966543322111111111111
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
. .. . .......+.++...+-..+..++|....+...|+..
T Consensus 258 ~----~~------~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 258 T----DR------F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred c----cc------c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 0 00 0 001123344444445558999999999999887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-19 Score=195.06 Aligned_cols=256 Identities=30% Similarity=0.380 Sum_probs=194.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCcc-ccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHK-NLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred EEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 467999999999999865 67999998775443 367899999999999988 7999999997777789999999
Q ss_pred CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCC
Q 003818 582 SNGSLADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQT 658 (793)
Q Consensus 582 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 658 (793)
.++++.+++.... ..........++.|++.++.|+|.. +++|||+||+||+++... .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999997775544 2678889999999999999999998 899999999999999988 799999999986554433
Q ss_pred c-----ceecccCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 659 Q-----TTTAIRGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 659 ~-----~~~~~~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
. ......|+..|+|||.+.+ ...+...|+|++|++++++++|..||...................... ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLA 236 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccc
Confidence 2 2345679999999999987 578899999999999999999999977665310000111111111100 000
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........ ......+.+++..|+..+|..|.++.+....
T Consensus 237 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 2223467788999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-21 Score=222.44 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=185.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechh--cccch----HHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGE----QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
...+|.|++|.|+...... ..+..+.|..... ....+ ..+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4679999999777665332 2223333332210 11111 125567777778899999888887777666666699
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT- 658 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~- 658 (793)
||+. +|..++... ..++..++..++.|++.|+.|||+. +|.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988554 4678888999999999999999999 999999999999999999999999999987765444
Q ss_pred --cceecccCcccccCcccccCCCCCC-ccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 659 --QTTTAIRGTKGYVAPEWFKNLPITA-KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~-~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.......|+..|+|||.+.+..|++ ..||||.|+++..|++|+.||......+.... .. ..... ....
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~--~~~~~-~~~~ 547 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TN--NYSDQ-RNIF 547 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hh--ccccc-cccc
Confidence 3445577999999999999999987 58999999999999999999977655432210 00 00000 0000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
............+.+.++.++|+.+|.+|.|+++|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 01111123345567889999999999999999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=185.05 Aligned_cols=198 Identities=24% Similarity=0.344 Sum_probs=171.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++||+|.||.++.|+ +.-++++||||.-.. .....+++.|.+..+.| ..++|...+-|-.++.+-.||+|.. |.
T Consensus 33 GkKIGeGsFG~lf~G~-Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGK-NLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred ccccccCcceeeeccc-ccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 4789999999999998 556788999996433 23346788888888887 4689999999999999999999998 89
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----CCcEEEeecCCccccCCCCCc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-----TFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~~~~~~ 659 (793)
||+|+..-.++.++...++.||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.....+
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 99999988999999999999999999999999999 9999999999999963 344889999999987665443
Q ss_pred c------eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchh
Q 003818 660 T------TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATE 710 (793)
Q Consensus 660 ~------~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~ 710 (793)
. .....||.+||+-....+.+-+.+.|+=|+|-++.+.|-|..||++....
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 3 23355999999999999999999999999999999999999999876544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=174.85 Aligned_cols=199 Identities=22% Similarity=0.289 Sum_probs=168.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc-cccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH-KNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++||.|+||.+|.|..- .+|..||||.-+.... ..++..|.++...++| ..|..+..|..+..+-.|||+.. |.
T Consensus 20 vrkiGsGSFGdIy~~~~i-~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISI-TSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred EEeecCCchhheeeeeec-cCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 478999999999999854 5678899998655433 3467788999988876 68888899999999999999998 89
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCCCc--
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQTQ-- 659 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~~-- 659 (793)
+|.+++.-..+.++..+.+-++-|++.-++|+|.+ +.|||||||+|+|+.- ...+.++|||+|+.+......
T Consensus 96 sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H 172 (341)
T KOG1163|consen 96 SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH 172 (341)
T ss_pred cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence 99999988888899999999999999999999998 9999999999999963 345899999999876543322
Q ss_pred ----ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhH
Q 003818 660 ----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711 (793)
Q Consensus 660 ----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~ 711 (793)
......||.+|.+-....+...+.+.|+=|+|.+|.++.-|..||++.....
T Consensus 173 Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 173 IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 2233559999999888888888999999999999999999999999876544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-20 Score=198.87 Aligned_cols=217 Identities=24% Similarity=0.420 Sum_probs=166.5
Q ss_pred HhcCCccccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eecCCCC
Q 003818 553 IGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI-IHCDIKP 631 (793)
Q Consensus 553 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~Dlkp 631 (793)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.....++++|++||.|||+. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 3568999999999999999999999999999999999998888999999999999999999999986 44 9999999
Q ss_pred CCEEEcCCCcEEEeecCCccccCCC-CCcceecccCcccccCcccccCC-------CCCCccceehhHHHHHHHHhCCcC
Q 003818 632 QNILLDGTFNARISDFGLAKLLKTD-QTQTTTAIRGTKGYVAPEWFKNL-------PITAKVDVYSFGILLLELVCCRKN 703 (793)
Q Consensus 632 ~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~Dvws~Gvil~elltg~~p 703 (793)
+|.++|....+||+|||+....... ............-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431 11111112234579999999764 146789999999999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 704 FEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 704 f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
|......+....+...+.. +.. ....+.... ..+..+.+..++..||..+|++||++++|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~----~~~-~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK----GGS-NPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh----cCC-CCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9875444332222222222 111 111111111 11333468899999999999999999999999876543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=161.83 Aligned_cols=107 Identities=25% Similarity=0.506 Sum_probs=78.3
Q ss_pred ccccccCCcceeEEeccc---ceEEEEecCCeeEEEEeeccccCcceEEEEEEcCCCcEEEEEecCCCCCCCCCCccccc
Q 003818 203 WSTQTSIGSGYQVVFNQS---GFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWS 279 (793)
Q Consensus 203 w~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~w~~~~~~~~~~w~~~w~ 279 (793)
|++++|+|..+..+.... -+.+.+..+..++++++. ..+.+.++|++|+++|++|+|.|.+.+ +. |.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~--~~~~s~~~r~~ld~~G~l~~~~w~~~~----~~----W~ 70 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYS--LSNSSVLSRLVLDSDGQLQRYIWNEST----QS----WS 70 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEe--cCCCceEEEEEEeeeeEEEEEEEecCC----Cc----EE
Confidence 555666554443332222 234455666667666663 457788999999999999999998543 34 55
Q ss_pred eeeccccccccccccCCCCCCCCCCcccccCCCCCcccccCCCCcccC
Q 003818 280 FLSFIPSNICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFFD 327 (793)
Q Consensus 280 ~~~~~p~~~C~~~~~~~~~g~CG~~~~C~~~~~~~~~C~C~~Gf~~~~ 327 (793)
.+|.+|.|+||+ |+.||+||+|+. +..|.|+||+||+|++
T Consensus 71 ~~~~~p~d~Cd~------y~~CG~~g~C~~--~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 71 VFWSAPKDQCDV------YGFCGPNGICNS--NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EEEEecccCCCC------ccccCCccEeCC--CCCCceECCCCcCCCc
Confidence 555999999999 799999999975 4578899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.9e-19 Score=174.10 Aligned_cols=138 Identities=15% Similarity=0.139 Sum_probs=106.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc--c-------hH-----------------HHHHHHHHHhcCCccc
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--G-------EQ-----------------EFKAEISAIGRTNHKN 560 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~-------~~-----------------~~~~E~~~l~~l~H~n 560 (793)
+.||+|+||.||+|... +|+.||+|+++..... . .. ....|+..+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 3 GCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 57999999999999864 6789999999754211 1 11 2234999999998887
Q ss_pred cceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCEEEcCC
Q 003818 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL-HEECKSQIIHCDIKPQNILLDGT 639 (793)
Q Consensus 561 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NIll~~~ 639 (793)
+.....+.. ...+|||||++++++...+.. ...++......++.|++.+|.|| |+. +|+||||||+|||++ +
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 754433322 234899999998877655332 34678888999999999999999 677 999999999999998 4
Q ss_pred CcEEEeecCCcccc
Q 003818 640 FNARISDFGLAKLL 653 (793)
Q Consensus 640 ~~~kl~Dfgla~~~ 653 (793)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=174.34 Aligned_cols=164 Identities=15% Similarity=0.100 Sum_probs=126.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHH---------HHHHHHHHhcCCccccceeeeEEecC-----
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---------FKAEISAIGRTNHKNLVQLLGFCNEG----- 571 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~~~~~~~----- 571 (793)
.+.||.|+||.||.... ++..+|+|.+.......+.. +++|+..+.+++|++|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~ 112 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL 112 (232)
T ss_pred EEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence 36899999999998543 35579999997654333322 68999999999999999999886533
Q ss_pred ---CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecC
Q 003818 572 ---EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648 (793)
Q Consensus 572 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 648 (793)
...+|||||++|.+|.++.. .+. ....+++++|..||+. +++|||+||+||++++++ ++|+|||
T Consensus 113 ~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 113 RYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988742 121 3456899999999998 999999999999999988 9999999
Q ss_pred CccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHH
Q 003818 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698 (793)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ell 698 (793)
.......+... ..++....+..++|+|+||+++..+.
T Consensus 180 ~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88654322111 01334445667999999999988764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=168.91 Aligned_cols=140 Identities=15% Similarity=0.089 Sum_probs=109.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccc--------------------------hHHHHHHHHHHhcCCccc
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG--------------------------EQEFKAEISAIGRTNHKN 560 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~H~n 560 (793)
+.||+|+||.||+|... +|+.||||+++...... ...+..|...+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 3 GCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred ceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 57999999999999864 68899999987542110 112357899999999998
Q ss_pred cceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCC
Q 003818 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGT 639 (793)
Q Consensus 561 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~ 639 (793)
+.....+... ..+|||||++++++...... ...++......++.+++.+|.+||+ . +|+||||||+||+++ +
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 8555444333 34899999998865443222 2456777889999999999999999 7 999999999999999 8
Q ss_pred CcEEEeecCCccccCC
Q 003818 640 FNARISDFGLAKLLKT 655 (793)
Q Consensus 640 ~~~kl~Dfgla~~~~~ 655 (793)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=166.11 Aligned_cols=184 Identities=18% Similarity=0.108 Sum_probs=137.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccc----hHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG----EQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
..|++|+||+||.+. ..+..++.+.+.....-. ...+.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 8 ~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 8 EPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred eeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 579999999999654 356678877775543211 125789999999995 5889999886 4579999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDI-KPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+|.+|...+.. ....++.+++++|.++|.+ +|+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99998754311 1235778999999999998 9999999 799999999999999999999855433211
Q ss_pred ---c--------eecccCcccccCcccccCC-CCC-CccceehhHHHHHHHHhCCcCCCCCc
Q 003818 660 ---T--------TTAIRGTKGYVAPEWFKNL-PIT-AKVDVYSFGILLLELVCCRKNFEVDA 708 (793)
Q Consensus 660 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~~~Dvws~Gvil~elltg~~pf~~~~ 708 (793)
. ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.++..+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0012256778888754332 233 57899999999999999998876554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9e-19 Score=199.33 Aligned_cols=249 Identities=25% Similarity=0.269 Sum_probs=175.2
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHH--HhcCCccccceeeeEEecCCceEEEEee
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISA--IGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.+.||.+.|=.|.+++.+ .| .|+||++-+.. .-..+.|.++++. ...++|||.+++.-........|||-+|
T Consensus 26 ~~~~~LGstRFlKv~r~k~~--eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDR--EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeecccCchhhhhhhhccCC--Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 34578999999999999753 34 39999886543 2233444433332 5567999999999888888888999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc--CCCCC
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL--KTDQT 658 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~--~~~~~ 658 (793)
.. -+|.|-|.. +..+...+..-|+.|++.||.-+|.. +|+|||||.+||||+.-.-+.|+||..-+.. +.+..
T Consensus 103 vk-hnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VK-HNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hh-hhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 84 477777632 24456667788999999999999998 9999999999999999999999999877643 33222
Q ss_pred cce----ecccCcccccCcccccC----------CC-CCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHH
Q 003818 659 QTT----TAIRGTKGYVAPEWFKN----------LP-ITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYD 722 (793)
Q Consensus 659 ~~~----~~~~gt~~y~aPE~~~~----------~~-~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~ 722 (793)
... .+.+.-..|+|||.+-. .+ .+++-||||+||+++||++ |+++|....-..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a----------- 246 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA----------- 246 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh-----------
Confidence 221 12233457999997743 12 6789999999999999988 567775321110
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.+.+. ....+..++... -..+++++..|++.||+.|.+++++++.-.+.
T Consensus 247 -Yr~~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 -YRSGN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -HhccC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 01110 111111111111 12578999999999999999999999886553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=162.40 Aligned_cols=133 Identities=19% Similarity=0.270 Sum_probs=103.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-----CccccceeeeEEecCC---ceE-EE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-----NHKNLVQLLGFCNEGE---HRL-LV 577 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lV 577 (793)
+.||+|+||.||. +.. ... .+||++........+.+.+|+.+++.+ .||||++++|+++++. ..+ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp~-~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPE-DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CCC-CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999996 343 333 368888664444567899999999999 5799999999998864 333 78
Q ss_pred Eee--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCEEEcC----CCcEEEeecCCc
Q 003818 578 YEY--VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGL-FYLHEECKSQIIHCDIKPQNILLDG----TFNARISDFGLA 650 (793)
Q Consensus 578 ~Ey--~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla 650 (793)
+|| +++++|.+++.+. .++.. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 6689999999553 24433 35677888777 999998 9999999999999974 347999995544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=170.57 Aligned_cols=228 Identities=24% Similarity=0.298 Sum_probs=144.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCC----------ccccceeeeEE----
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTN----------HKNLVQLLGFC---- 568 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~---- 568 (793)
.+.||.|+++.||.++.. .+++.+|+|+..... ....+++++|.-....+. |-.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred ccccccCCceEEEEEEEc-cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 467999999999999854 567889999875432 223456676665555532 22333333322
Q ss_pred -----ecCC--------ceEEEEeecCCCCHHHHHh---cCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 003818 569 -----NEGE--------HRLLVYEYVSNGSLADFLF---RKSRR---PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDI 629 (793)
Q Consensus 569 -----~~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~~---~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 629 (793)
.... ..+++|+-+ -++|.+++. ..... +....++.+..|+++.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 1111 235677766 568877753 22222 23344567778999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccC--------CCCCCccceehhHHHHHHHHhCC
Q 003818 630 KPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN--------LPITAKVDVYSFGILLLELVCCR 701 (793)
Q Consensus 630 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dvws~Gvil~elltg~ 701 (793)
+|+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.|++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999887654332111 224577999997643 25788999999999999999999
Q ss_pred cCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCC
Q 003818 702 KNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLR 764 (793)
Q Consensus 702 ~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 764 (793)
.||........... ..... .+.++.+..||..+|+++|.+|
T Consensus 248 lPf~~~~~~~~~~~--------------------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 99987654321100 00111 1455678889999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-18 Score=186.96 Aligned_cols=234 Identities=23% Similarity=0.221 Sum_probs=174.7
Q ss_pred ccccccceeEEEeEe--CCCCceeEEEEEechhcccc--hHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecC
Q 003818 508 ELGEGAFGKVYKGVL--TTENEKPVAVKKLYKAVNEG--EQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~--~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+|+|.||.|+...- ..+.++.+|+|.+++..... ......|..++...+ ||.+|++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999986431 12346788899887643221 124456788888887 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.|...+.+. ...+..........++-+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99998887544 3445555666777888999999998 9999999999999999999999999999865443322
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
+||..|||||++. ....++|.||||++++||++|..||..+... .| ++. +...+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~----~I-------l~~-----------~~~~p 207 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMK----RI-------LKA-----------ELEMP 207 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHH----HH-------hhh-----------ccCCc
Confidence 6899999999998 5778999999999999999999999872111 11 000 01112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAM--KKVTQMI 774 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~--~evl~~L 774 (793)
.+......+++..++..+|..|.-. ..+.++.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 2334445666777777888887654 3444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=183.67 Aligned_cols=190 Identities=24% Similarity=0.286 Sum_probs=150.9
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEEEEee
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
.+.+.||+|+||.||+|+... ++.||+|+-+.... -+|.--.+++.+|+ -+-|..+.....-.+..+||+||
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred EEEeeeccccceEEEEeecCC--CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 346789999999999998654 88999998654322 23333334444444 23344455555667788999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-------CCCcEEEeecCCcccc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-------GTFNARISDFGLAKLL 653 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~Dfgla~~~ 653 (793)
.+.|+|.+++. ..+.+++.....++.|++..+..||.. +|||+||||+|.||. +...++|+|||.+..+
T Consensus 776 ~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 776 SPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred cccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99999999997 556788999999999999999999998 999999999999994 3456899999999755
Q ss_pred CCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCc
Q 003818 654 KTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702 (793)
Q Consensus 654 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~ 702 (793)
..-.. ......++|-.+-.+|...+.+++.++|.|.++.+++-||.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 43322 24555678999999999999999999999999999999998763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.1e-16 Score=155.68 Aligned_cols=134 Identities=20% Similarity=0.294 Sum_probs=112.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc--------chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.||+|++|.||+|.. .+..|++|+....... ....+.+|+.++..++|++++....++...+..++||
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 4689999999999986 4556889976532211 1245778999999999999988888877788899999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
||+++++|.+++.... . .+..++.+++.+|.+||+. +++|+|++|+|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999985432 2 7789999999999999998 999999999999999 78999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=159.21 Aligned_cols=196 Identities=20% Similarity=0.294 Sum_probs=134.7
Q ss_pred CccccceeeeEEec---------------------------CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHH
Q 003818 557 NHKNLVQLLGFCNE---------------------------GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT 609 (793)
Q Consensus 557 ~H~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~i 609 (793)
+|||||++.++|.+ ...+|+||..+ .-+|..++..+ .++.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence 68899888887633 24567888776 45888888654 45666777889999
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCCEEE--cCCC--cEEEeecCCccccCCCC-----CcceecccCcccccCcccccCCC
Q 003818 610 ARGLFYLHEECKSQIIHCDIKPQNILL--DGTF--NARISDFGLAKLLKTDQ-----TQTTTAIRGTKGYVAPEWFKNLP 680 (793)
Q Consensus 610 a~gL~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 680 (793)
++|+.|||++ +|.|||||.+|||+ |+++ .+.|+|||.+-...... .......-|...-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999998 99999999999998 3443 36889999875332211 11111123667889999986542
Q ss_pred -----C-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHH
Q 003818 681 -----I-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAI 754 (793)
Q Consensus 681 -----~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 754 (793)
. -.|+|.|+.|.+.||++....||...... .+.. ....+..+..+.+. ....+++++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~---r~Yqe~qLPalp~~---------vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDT---RTYQESQLPALPSR---------VPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eech---hhhhhhhCCCCccc---------CChHHHHHHH
Confidence 1 24899999999999999999999863221 1110 11222233332222 2234678889
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 003818 755 WCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 755 ~Cl~~dP~~RPt~~evl~~L 774 (793)
..|+.||++|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999875544444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.9e-16 Score=157.95 Aligned_cols=139 Identities=18% Similarity=0.189 Sum_probs=106.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc------------------------chHHHHHHHHHHhcCCccc-
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE------------------------GEQEFKAEISAIGRTNHKN- 560 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~H~n- 560 (793)
.+.||+|+||.||+|.....+++.||+|++...... ....+..|+..+.++.+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 467999999999999723346789999998653210 0123568999999997633
Q ss_pred -cceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCEEEcC
Q 003818 561 -LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ-IIHCDIKPQNILLDG 638 (793)
Q Consensus 561 -iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dlkp~NIll~~ 638 (793)
+.+++++ ...++||||+++.+|....... ..........++.|++.+|.+||+. + |+|+||||+||+++
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~- 183 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH- 183 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-
Confidence 3444443 2358999999998887654332 2345556678999999999999998 8 99999999999999
Q ss_pred CCcEEEeecCCcccc
Q 003818 639 TFNARISDFGLAKLL 653 (793)
Q Consensus 639 ~~~~kl~Dfgla~~~ 653 (793)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=152.95 Aligned_cols=130 Identities=19% Similarity=0.281 Sum_probs=106.3
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcc--------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.||+|+||.||+|.+ .+..|++|+...... .....+.+|+.++..++|+++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999985 356799998643211 112567789999999999887666666667777899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
|+++++|.+++..... .++.+++++|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999998754311 7899999999999998 999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=173.60 Aligned_cols=131 Identities=21% Similarity=0.288 Sum_probs=107.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEe-chhcc-------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVN-------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l-~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 577 (793)
.+.||+|+||.||+|.+... .+++|+. .+... ...+.+.+|++++..++|++++....++......++|
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~---~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR---DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cceeccCCcEEEEEEeecCc---cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 47899999999999986432 3444432 21111 1235688999999999999999988888887888999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
|||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999884 4567899999999999998 99999999999999 678999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-16 Score=170.87 Aligned_cols=171 Identities=24% Similarity=0.354 Sum_probs=128.1
Q ss_pred ceEEEEeecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 573 HRLLVYEYVSNGSLADFLFRK--SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 573 ~~~lV~Ey~~~gsL~~~l~~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
..++.|++|...+|.++|.++ ....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 4567788889999999999999 4 8999999999999999999999999998
Q ss_pred cccCCCC-----CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHh
Q 003818 651 KLLKTDQ-----TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCF 724 (793)
Q Consensus 651 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~ 724 (793)
....... ....+...||..||+||.+.+..|+.++||||||++|+|++. -...+... . +...+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~-----t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------A-----TLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------H-----hhhhh
Confidence 7665544 223344569999999999999999999999999999999986 22222111 0 11223
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKK 769 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 769 (793)
..+.++... ..+..++ ..++.+++...|.+||+..+
T Consensus 473 r~g~ip~~~-----~~d~p~e----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIPPEF-----LQDYPEE----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCChHH-----hhcCcHH----HHHHHHhcCCCcccCchHHH
Confidence 333333110 1111111 35778889999999994443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.7e-15 Score=147.79 Aligned_cols=133 Identities=18% Similarity=0.172 Sum_probs=103.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc----------------------cchHHHHHHHHHHhcCCccc--c
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN----------------------EGEQEFKAEISAIGRTNHKN--L 561 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~n--i 561 (793)
.+.||+|+||.||++... +++.||||++..... .....+..|..++..+.|++ +
T Consensus 20 ~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 20 GNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred CCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 477999999999999863 578899998754210 01123567888888888774 4
Q ss_pred ceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 562 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
+..++ ....++||||+++++|.+.... .....++.++++++.++|+. +|+|+||||+||++++++.
T Consensus 98 ~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 98 PKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred Cceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCc
Confidence 44443 2456899999999998775421 23567889999999999998 9999999999999999999
Q ss_pred EEEeecCCccccC
Q 003818 642 ARISDFGLAKLLK 654 (793)
Q Consensus 642 ~kl~Dfgla~~~~ 654 (793)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-14 Score=139.30 Aligned_cols=136 Identities=18% Similarity=0.188 Sum_probs=95.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccc---hHH---------------------HHHHHHHHhcCCccc-
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQE---------------------FKAEISAIGRTNHKN- 560 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~---~~~---------------------~~~E~~~l~~l~H~n- 560 (793)
.+.||+|+||.||+|... +++.||||++....... ... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 357999999999999864 57789999886532111 111 134555555554332
Q ss_pred -cceeeeEEecCCceEEEEeecCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEc
Q 003818 561 -LVQLLGFCNEGEHRLLVYEYVSNGSLADF-LFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLD 637 (793)
Q Consensus 561 -iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~ 637 (793)
+.+++++ ...++||||++++.+... +..... ......++.+++.++.++|. . +|+|+||||+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 3444433 246899999999543211 111100 15677899999999999998 6 999999999999999
Q ss_pred CCCcEEEeecCCccccC
Q 003818 638 GTFNARISDFGLAKLLK 654 (793)
Q Consensus 638 ~~~~~kl~Dfgla~~~~ 654 (793)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.7e-15 Score=168.26 Aligned_cols=205 Identities=25% Similarity=0.313 Sum_probs=136.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
+.|..|+||.||...++ ...+++|+|+-+... -+++ ++.....|.+| |+-
T Consensus 89 klisngAygavylvrh~-~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHK-ETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred EeeccCCCCceeeeecc-ccccchhhcccccch-----hhhc---cccccCCccee---------------------chh
Confidence 67899999999998754 345678884322210 0111 11222222222 444
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC--------CCC
Q 003818 587 ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT--------DQT 658 (793)
Q Consensus 587 ~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~--------~~~ 658 (793)
...+...+..+- +.+.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++.... +..
T Consensus 139 ~tllk~~g~lPv---------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 139 ATLLKNIGPLPV---------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhcccCCCCcc---------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 444433222211 226789999988 999999999999999999999999999864211 111
Q ss_pred c------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 659 Q------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 659 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
. .-+.++||+.|+|||++....|...+|.|++|+|+||.+-|..||..+..++....+.. . .
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis---d---------~ 274 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---D---------D 274 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh---h---------h
Confidence 1 12235799999999999999999999999999999999999999999987764322211 0 0
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMK 768 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 768 (793)
+.-... +.....+..+++...|+.+|..|--..
T Consensus 275 i~wpE~---dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 IEWPEE---DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred cccccc---CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 000001 122234567788888999999995433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.2e-14 Score=132.32 Aligned_cols=133 Identities=20% Similarity=0.173 Sum_probs=112.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc--cccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH--KNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|.++.||++... +..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK---DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEec---CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56999999999999863 25799998865433 5678999999999977 58999999988888999999999988
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 4556778899999999999986445799999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.6e-15 Score=171.18 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=186.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+|+.|-...........+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++.||..
T Consensus 25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~ 104 (601)
T KOG0590|consen 25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD 104 (601)
T ss_pred cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence 3569999999998877655666778888775543 222234445777766776 9999999999999999999999999
Q ss_pred CCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCC--CC
Q 003818 583 NGSLADFL-FRKSRRPNWYKRMQIAFGTARGLFYLH-EECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKT--DQ 657 (793)
Q Consensus 583 ~gsL~~~l-~~~~~~~~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~--~~ 657 (793)
++++.+.+ .......+.........|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|..+.. ..
T Consensus 105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~ 181 (601)
T KOG0590|consen 105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA 181 (601)
T ss_pred ccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence 99999988 444335666677788999999999999 77 999999999999999999 999999999987766 33
Q ss_pred CcceecccC-cccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc--ceee
Q 003818 658 TQTTTAIRG-TKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL--GLLV 733 (793)
Q Consensus 658 ~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~ 733 (793)
........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.......... ..+.+.+. ....
T Consensus 182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------SSWKSNKGRFTQLP 254 (601)
T ss_pred ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-------eeecccccccccCc
Confidence 333444568 9999999999885 45778999999999999999999997665443110 11111110 0000
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. -.......+++..++..+|..|.+.+++..
T Consensus 255 ~--------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 W--------NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--------ccCChhhhhcccccccCCchhccccccccc
Confidence 0 011233456777888899999999887643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.3e-13 Score=136.97 Aligned_cols=134 Identities=14% Similarity=0.122 Sum_probs=102.7
Q ss_pred cccc-cccceeEEEeEeCCCCceeEEEEEechhc-------------ccchHHHHHHHHHHhcCCcccc--ceeeeEEec
Q 003818 507 EELG-EGAFGKVYKGVLTTENEKPVAVKKLYKAV-------------NEGEQEFKAEISAIGRTNHKNL--VQLLGFCNE 570 (793)
Q Consensus 507 ~~LG-~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~ 570 (793)
..|| .|+.|+||+.... +..+++|+..... ......+.+|+.++.+++|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4687 8999999987753 5568998774310 1123467889999999998885 667776543
Q ss_pred CC----ceEEEEeecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEe
Q 003818 571 GE----HRLLVYEYVSN-GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS 645 (793)
Q Consensus 571 ~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 645 (793)
.. ..++|+|++++ .+|.+++... .++. ..+.+++++|.+||+. +|+|+||||+|||++.++.++|+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA--PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC--CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 22 23599999997 6899887542 2332 2357899999999998 99999999999999999999999
Q ss_pred ecCCccc
Q 003818 646 DFGLAKL 652 (793)
Q Consensus 646 Dfgla~~ 652 (793)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.5e-13 Score=132.67 Aligned_cols=202 Identities=20% Similarity=0.281 Sum_probs=140.1
Q ss_pred HHHHHhcCCccccceeeeEEecCC-----ceEEEEeecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 003818 549 EISAIGRTNHKNLVQLLGFCNEGE-----HRLLVYEYVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEEC 620 (793)
Q Consensus 549 E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~ 620 (793)
-...|-++.|.|||+++.|+.+.+ +..++.|||+.|+|..+|++ +...+......++..||..||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 344455677999999999986543 46789999999999999975 345566777789999999999999985
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEeecCCccc---cCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHH
Q 003818 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKL---LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~el 697 (793)
.++|+|+++..+-|++..++-+|+.--.-... .............+-++|.+||.-.....+.++|||+||+..+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 78999999999999999999999853221110 000011111112356889999998877888899999999999999
Q ss_pred HhCCcC-CCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 698 VCCRKN-FEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 698 ltg~~p-f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.-+..- -......+....+.. ......... -+.++..|++..|..||+|.+++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIAN----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhhh----------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 876543 222222221111110 000111111 134677899999999999998764
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1e-12 Score=105.13 Aligned_cols=56 Identities=30% Similarity=0.546 Sum_probs=49.3
Q ss_pred eeEEecCCCCCCCCccccc-cccChhhHHHHhhcCCCcceeeecc----CcceeeccCCCC
Q 003818 354 FEFRDMPNTDWPLNDYEHF-TSVDEDWCREACLSDCFCAVAIFRE----GECWKKRAPLSN 409 (793)
Q Consensus 354 ~~f~~~~~~~~~~~~~~~~-~~~~~~~C~~~Cl~nCsC~a~~~~~----~~C~~~~~~l~~ 409 (793)
++|++|++|++|+.+.... .++++++|+..||+||||+||+|.+ ++|++|.++|.|
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 6899999999999865543 6799999999999999999999973 679999998876
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.4e-12 Score=140.76 Aligned_cols=141 Identities=22% Similarity=0.275 Sum_probs=97.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccc----------------------------------------hHHH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG----------------------------------------EQEF 546 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~ 546 (793)
+.||.|++|.||+|++. +|+.||||+.+....+. +-+|
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 46999999999999985 56789999986431100 0124
Q ss_pred HHHHHHHhcC----CccccceeeeEE-ecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 003818 547 KAEISAIGRT----NHKNLVQLLGFC-NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR-GLFYLHEEC 620 (793)
Q Consensus 547 ~~E~~~l~~l----~H~niv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~-gL~yLH~~~ 620 (793)
.+|...+.++ +|.+-+.+-..+ ......+|||||++|++|.++........ .+.+++..++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 4555555554 232223322222 33456799999999999988764322222 23456666665 46778877
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+++|+|+||.||++++++.++++|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.8e-12 Score=138.25 Aligned_cols=257 Identities=20% Similarity=0.209 Sum_probs=182.7
Q ss_pred CHHHHHHHhccccccccc--ccceeEEEeEeC-CCCceeEEEEEechhcc--cchHHHHHHHHHHhcC-CccccceeeeE
Q 003818 494 TYKELEVITGGFKEELGE--GAFGKVYKGVLT-TENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRT-NHKNLVQLLGF 567 (793)
Q Consensus 494 ~~~el~~~t~~f~~~LG~--G~fg~Vy~~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~ 567 (793)
...+....+.++.+.+|. |.+|.||.+... ..++..+|+|+-+.... .....-.+|+.....+ .|+|.++.+..
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 334445555566788999 999999998751 34567789887433222 2222334566555565 59999999999
Q ss_pred EecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCEEEcCC-CcE
Q 003818 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR----GLFYLHEECKSQIIHCDIKPQNILLDGT-FNA 642 (793)
Q Consensus 568 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ 642 (793)
+...+..++-+|++ +.+|..+.+.....+.......+..+..+ ||.++|.. +|+|-|+||.||++.++ ...
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 99999999999999 57888888777666777777888888888 99999998 99999999999999999 889
Q ss_pred EEeecCCccccCCCCCcc----eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQT----TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
+++|||+...+....... .....+...|++||...+ .++...|+|++|.++.+..++..+........
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------- 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------- 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-------
Confidence 999999998776554221 222357788999999876 56889999999999999988766544321100
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
| ..+..+.+. .+....-..++..++.++++.+|-.|++.+.+..
T Consensus 335 W--~~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 W--SQLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--cccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 000111100 0001111233445888899999999999776653
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-11 Score=105.59 Aligned_cols=72 Identities=31% Similarity=0.524 Sum_probs=60.8
Q ss_pred ceeEEecCCCCCCCCccccccccChhhHHHHhhcCCCcceeeecc--CcceeeccCCCCCccCCCCCCceEEeec
Q 003818 353 LFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFRE--GECWKKRAPLSNGRIDPSVGGKALVKVR 425 (793)
Q Consensus 353 ~~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~--~~C~~~~~~l~~~~~~~~~~~~~ylkv~ 425 (793)
.++|+.++++++|+..+.. .++++++|++.||+||+|.||+|.+ ++|++|..++.+.+.....+...|||++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3579999999999876655 7789999999999999999999974 7899999999987765544578898873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.4e-10 Score=112.90 Aligned_cols=129 Identities=20% Similarity=0.143 Sum_probs=95.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccc-eeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLV-QLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.|+.|.++.||++.. .++.+++|....... ....+..|+..++.+.+.+++ +++.+. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEE---CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 4688999999999875 356799998754422 234568899999988765554 455443 334589999999988
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC--KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
+.+.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 112345678999999999872 22369999999999999 6689999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-10 Score=130.92 Aligned_cols=143 Identities=16% Similarity=0.193 Sum_probs=87.9
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc----------------------------------ch------HHH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE----------------------------------GE------QEF 546 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~----------------------------------~~------~~~ 546 (793)
+.||+|++|.||+|++.+ +|+.||||+++....+ -. -++
T Consensus 125 ~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 469999999999999864 4788999999743210 01 123
Q ss_pred HHHHHHHhcCC----ccccceeeeEEe-cCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003818 547 KAEISAIGRTN----HKNLVQLLGFCN-EGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621 (793)
Q Consensus 547 ~~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~ 621 (793)
.+|+..+.+++ +.+.+.+-.++. -....+|||||++|+.+.++..-.....+... ++...++ .|+++-..
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~--~~~~Qif~ 278 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVE--VFFTQVFR 278 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHH--HHHHHHHh
Confidence 34444444432 333333322222 24567899999999999875321111122122 2221111 12222222
Q ss_pred CCeeecCCCCCCEEEcCCC----cEEEeecCCccccCC
Q 003818 622 SQIIHCDIKPQNILLDGTF----NARISDFGLAKLLKT 655 (793)
Q Consensus 622 ~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~ 655 (793)
.+++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3999999999999999888 999999999976654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=121.54 Aligned_cols=165 Identities=17% Similarity=0.225 Sum_probs=123.1
Q ss_pred CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHH
Q 003818 525 ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ 604 (793)
Q Consensus 525 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~ 604 (793)
..+.+|.|...+...........+-++.|+.++||||++++...+.+...|||+|.+. .|..++.+.+ .....-
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~ 108 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCL 108 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHH
Confidence 3456788887766544334567888999999999999999999999999999999884 4666664332 455666
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCc
Q 003818 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684 (793)
Q Consensus 605 i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 684 (793)
.+.||+.||.|||+.+ +++|++|....|+|+..|..||++|.++........ ......---.|..|+.+.... -.
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cc
Confidence 7889999999999764 899999999999999999999999988754322111 011111122466666554332 34
Q ss_pred cceehhHHHHHHHHhC
Q 003818 685 VDVYSFGILLLELVCC 700 (793)
Q Consensus 685 ~Dvws~Gvil~elltg 700 (793)
.|.|-||++++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999998
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-10 Score=95.68 Aligned_cols=64 Identities=16% Similarity=0.072 Sum_probs=55.5
Q ss_pred eEEecCCCCCCCCccccccccChhhHHHHhhc---CCCcceeeec--cCcceeeccCC-CCCccCCCCCCceEEe
Q 003818 355 EFRDMPNTDWPLNDYEHFTSVDEDWCREACLS---DCFCAVAIFR--EGECWKKRAPL-SNGRIDPSVGGKALVK 423 (793)
Q Consensus 355 ~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~ylk 423 (793)
.|+++.++++|+... ++++||++.|++ ||||+||+|. +++|++|.++| .+.+.....+.++|+|
T Consensus 10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 688999999997643 689999999999 9999999995 46899999999 9988887777788876
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-10 Score=126.39 Aligned_cols=242 Identities=19% Similarity=0.210 Sum_probs=168.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHH--HHHHHHHhcC-CccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF--KAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
...||.|.|+.|++...+..++..+++|.+.+.......++ ..|+.+...+ .|.++++....+....+.++--|||+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35799999999999886657788899998876543332222 3455554444 68899999888888888889999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++...+ .-...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||....+.- ...
T Consensus 350 ~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---~~~ 422 (524)
T KOG0601|consen 350 GGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---SSG 422 (524)
T ss_pred Ccchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce---ecc
Confidence 99887666 2234456677889999999999999987 99999999999999876 8889999999864211 111
Q ss_pred ecccCcccc-cCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGY-VAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y-~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....+..| .+|+......+..+.|+++||.-+.|.+++..--...... ..+..+.+.. ..
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----------~~i~~~~~p~-------~~ 484 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----------LTIRSGDTPN-------LP 484 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----------eeeecccccC-------CC
Confidence 111122334 3566666778899999999999999999876432211100 0011111111 11
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
. ....+..+...++.+++..||.+.++....+
T Consensus 485 ~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 485 G---LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred c---hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 1144556677789999999999888776554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-09 Score=103.18 Aligned_cols=139 Identities=12% Similarity=0.139 Sum_probs=97.3
Q ss_pred cccccccceeEEEeEeCCC-----CceeEEEEEechhcc----------------------cchHHH----HHHHHHHhc
Q 003818 507 EELGEGAFGKVYKGVLTTE-----NEKPVAVKKLYKAVN----------------------EGEQEF----KAEISAIGR 555 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~-----~~~~vavK~l~~~~~----------------------~~~~~~----~~E~~~l~~ 555 (793)
..||.|.=+.||.|.-.+. .+..+|||+.+.... ...+.+ ++|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999974321 346899997753110 001222 379999998
Q ss_pred CCc--cccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCC
Q 003818 556 TNH--KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL-HEECKSQIIHCDIKPQ 632 (793)
Q Consensus 556 l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~ 632 (793)
+.. -++.+++++ ...+|||||+.+..+.....+ ...++..+...+..+++.+|..| |+. +|+|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 854 456666654 567899999976543221111 11233445667788999999999 776 9999999999
Q ss_pred CEEEcCCCcEEEeecCCccccC
Q 003818 633 NILLDGTFNARISDFGLAKLLK 654 (793)
Q Consensus 633 NIll~~~~~~kl~Dfgla~~~~ 654 (793)
|||+++ +.+.|+|||.+....
T Consensus 155 NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEEC-CcEEEEECCCceeCC
Confidence 999974 679999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.1e-09 Score=105.95 Aligned_cols=142 Identities=19% Similarity=0.238 Sum_probs=107.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCcc--ccceeeeEEecCC---ceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHK--NLVQLLGFCNEGE---HRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~---~~~lV~Ey 580 (793)
+.|+.|..+.||++... +|+.+++|....... .....+..|+.+++.+++. ++.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 45899999999998763 246799998765432 1345788999999998763 4577787776543 66899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC---------------------------------------- 620 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 620 (793)
+++.++.+.+.. ..++......++.+++++|..||+..
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 999888775421 34566677788888888888888521
Q ss_pred -------------CCCeeecCCCCCCEEEcC--CCcEEEeecCCccc
Q 003818 621 -------------KSQIIHCDIKPQNILLDG--TFNARISDFGLAKL 652 (793)
Q Consensus 621 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~ 652 (793)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=96.21 Aligned_cols=140 Identities=20% Similarity=0.256 Sum_probs=105.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEe-chhc-------ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAV-------NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l-~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.|-+|+=+.|+++.. .|+...||.= .+.- .-..+...+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 13 ~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred eeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5688999999999886 4555566532 2211 112356778999999987767766666777888889999
Q ss_pred eecCC-CCHHHHHhcCCCCCCH-HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecCCccc
Q 003818 579 EYVSN-GSLADFLFRKSRRPNW-YKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKL 652 (793)
Q Consensus 579 Ey~~~-gsL~~~l~~~~~~~~~-~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~ 652 (793)
||+++ .++.+++...-..... .....++..|-+.+.-||.. +|+|+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4788888764333333 33378889999999999998 9999999999999965443 58999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=95.87 Aligned_cols=130 Identities=23% Similarity=0.329 Sum_probs=99.5
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEE-echhccc-------chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKK-LYKAVNE-------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
.+++|+=+.+|.+.+. +..+++|. +.+.-.. ....-.+|++++.+++--.|...+=+..+.....|+||
T Consensus 3 ~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 5788999999998653 33355553 3322111 12345679999999877777766667778888899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
|++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998655 245667777788889988 999999999999998765 99999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.5e-08 Score=104.18 Aligned_cols=167 Identities=20% Similarity=0.306 Sum_probs=127.7
Q ss_pred eeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec----CCceEEEEeecCC-CCHHHH
Q 003818 515 GKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE----GEHRLLVYEYVSN-GSLADF 589 (793)
Q Consensus 515 g~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 589 (793)
.+.||+... .+|..+++|+++............-++.++++.|.|+|++.+++.. +..+++||+|.++ ++|.++
T Consensus 290 ~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSN-VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeec-cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 467888754 4678899999954433333344556888999999999999998863 4577899999986 578877
Q ss_pred HhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 590 LFRK--------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 590 l~~~--------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
-+.. .....+..++.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6542 12345678899999999999999998 999999999999999999999999988876655
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcC
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~p 703 (793)
+.... +.. -.+-|.=.||.+++.|.||...
T Consensus 446 d~~~~---------------le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP---------------LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc---------------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 44111 111 2356888999999999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2e-09 Score=124.14 Aligned_cols=241 Identities=16% Similarity=0.163 Sum_probs=157.4
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
-+-+|.++.++-+. ....+...++|...... ....+....+-.++-..+||-+++..--+......+|+++|..++
T Consensus 811 p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPAS-PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred cccCCCCcccccCC-ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 46778888887765 33344344444332211 111122233333333334566665555556677889999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC----------
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK---------- 654 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~---------- 654 (793)
+|...|+... ..+.......+..+.+.++|||.. .+.|+|++|.|+++..+++.+++||+......
T Consensus 890 ~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 890 DLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred CchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 9999987654 233333334555677899999987 79999999999999999999999998432211
Q ss_pred -----------CCC---------CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH
Q 003818 655 -----------TDQ---------TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM 714 (793)
Q Consensus 655 -----------~~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~ 714 (793)
... ........+|+.|.+||...+......+|.|++|++++|.++|..||..........
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE 1045 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh
Confidence 000 011223468999999999999999999999999999999999999999876654221
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMK 768 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 768 (793)
.+..+.+.... + ..+......+++...+..+|.+|-.|.
T Consensus 1046 --------ni~~~~~~~p~-----g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1046 --------NILNRDIPWPE-----G--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred --------ccccCCCCCCC-----C--ccccChhhhhhhhhhhccCchhccCcc
Confidence 11222221111 1 112223445566667888999987775
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.1e-07 Score=95.48 Aligned_cols=138 Identities=17% Similarity=0.075 Sum_probs=98.4
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcc-----------cchHHHHHHHHHHhcCCcccc--ceeeeEEec-----
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-----------EGEQEFKAEISAIGRTNHKNL--VQLLGFCNE----- 570 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~----- 570 (793)
+-+-....|++..+ +|+.+.||+...... .....+.+|...+.++...+| +.++++...
T Consensus 30 v~~~~~rrvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 30 FRELEGRRTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EecCCCceEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333444666655 456799997633210 111247789999888854444 445556543
Q ss_pred CCceEEEEeecCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------CCc
Q 003818 571 GEHRLLVYEYVSNG-SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-------TFN 641 (793)
Q Consensus 571 ~~~~~lV~Ey~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~ 641 (793)
....+||+|++++. +|.+++... ....+...+..++.++++.+.-||.. +|+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999886 899988532 23445566778999999999999998 9999999999999975 567
Q ss_pred EEEeecCCccc
Q 003818 642 ARISDFGLAKL 652 (793)
Q Consensus 642 ~kl~Dfgla~~ 652 (793)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-07 Score=85.50 Aligned_cols=84 Identities=25% Similarity=0.508 Sum_probs=64.5
Q ss_pred Eec-CCcEEEECCC-CCeeecCCCCC---ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEecC
Q 003818 93 LTG-DGQLILRDSS-GKEIWREPPST---GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLT 167 (793)
Q Consensus 93 ~~~-~g~l~l~~~~-~~~~Wst~~~~---~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~s 167 (793)
+.. ||+||+++.. +.++|++++.. ....+.|.++|||||++.++.++|+|--.
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~---------------------- 83 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT---------------------- 83 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc----------------------
Confidence 444 8999999765 58999997643 34578999999999999988999998211
Q ss_pred CCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 168 ETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 168 ~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
. +.+.+.+.|+.+|+++++... ....|.+.+
T Consensus 84 --~-~~~~~~~~L~ddGnlvl~~~~------~~~~W~Sf~ 114 (116)
T cd00028 84 --R-VNGNYVLVLLDDGNLVLYDSD------GNFLWQSFD 114 (116)
T ss_pred --C-CCCceEEEEeCCCCEEEECCC------CCEEEcCCC
Confidence 0 246789999999999998753 255787654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.4e-07 Score=89.68 Aligned_cols=126 Identities=21% Similarity=0.227 Sum_probs=79.9
Q ss_pred eEEEeEeCCCCceeEEEEEechhc--------------c------------cchHHHHHHHHHHhcCCcc--ccceeeeE
Q 003818 516 KVYKGVLTTENEKPVAVKKLYKAV--------------N------------EGEQEFKAEISAIGRTNHK--NLVQLLGF 567 (793)
Q Consensus 516 ~Vy~~~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~~~ 567 (793)
.||.|.- .++..+|+|.-+... . ......++|.+.|.++... ++.+++++
T Consensus 1 ~Vy~~~~--~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAID--PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEE--CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEEC--CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 3788874 356789999775311 0 0113457899999999765 45666655
Q ss_pred EecCCceEEEEeecC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003818 568 CNEGEHRLLVYEYVS--NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFY-LHEECKSQIIHCDIKPQNILLDGTFNARI 644 (793)
Q Consensus 568 ~~~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 644 (793)
- ...|||||++ +..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.||+++++ .+.|
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred e----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 2 4579999998 65555443222 1133455677777775555 4666 99999999999999988 9999
Q ss_pred eecCCccccC
Q 003818 645 SDFGLAKLLK 654 (793)
Q Consensus 645 ~Dfgla~~~~ 654 (793)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.6e-07 Score=83.24 Aligned_cols=85 Identities=27% Similarity=0.488 Sum_probs=64.2
Q ss_pred EEEecCCcEEEECCC-CCeeecCCCCC---ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEec
Q 003818 91 VELTGDGQLILRDSS-GKEIWREPPST---GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARL 166 (793)
Q Consensus 91 l~~~~~g~l~l~~~~-~~~~Wst~~~~---~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~ 166 (793)
+.+..||+||+++.. +.++|++++.. ....+.|.++|||||++.++.++|+|-..
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~--------------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTT--------------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEeccc---------------------
Confidence 345689999999765 58999997643 22578899999999999988999998111
Q ss_pred CCCCCCcceEEEEEecCCceEEeeccCCCCCCCccccccc
Q 003818 167 TETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQ 206 (793)
Q Consensus 167 s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~ 206 (793)
...|.+.+.|+.+|+++++...+ .+.|.+.
T Consensus 83 ----~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf 112 (114)
T smart00108 83 ----GANGNYVLVLLDDGNLVIYDSDG------NFLWQSF 112 (114)
T ss_pred ----CCCCceEEEEeCCCCEEEECCCC------CEEeCCC
Confidence 13467899999999999986432 4567664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5e-07 Score=101.61 Aligned_cols=142 Identities=20% Similarity=0.263 Sum_probs=94.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc----------------------------------------chHHH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE----------------------------------------GEQEF 546 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~~~ 546 (793)
+-|+.++-|.||+|++.+ |+.||||+.+....+ .+-++
T Consensus 131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 458999999999999964 789999988642211 01123
Q ss_pred HHHHHHHhcCC-----ccccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003818 547 KAEISAIGRTN-----HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621 (793)
Q Consensus 547 ~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~ 621 (793)
.+|...+.+++ .+++.-..=|.+-.....|+|||++|-.+.+....+....+...+.....++.--.-+-|
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d---- 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD---- 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 44555555442 333333333444467789999999999998886444444554443333322221111222
Q ss_pred CCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 622 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1e-07 Score=106.54 Aligned_cols=152 Identities=15% Similarity=0.246 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC--------cceecccCcccccCcccc
Q 003818 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT--------QTTTAIRGTKGYVAPEWF 676 (793)
Q Consensus 605 i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~--------~~~~~~~gt~~y~aPE~~ 676 (793)
-+.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+........ ...........|.|||++
T Consensus 104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 344566999999976 5899999999999999999999999998764433111 111112345679999999
Q ss_pred cCCCCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHH
Q 003818 677 KNLPITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIW 755 (793)
Q Consensus 677 ~~~~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 755 (793)
.+...+.++|++|+|+++|-+..+ +.-+.......... . ... .+........-+-+.++++=+.+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~---~~~----------~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-F---SRN----------LLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-h---hhc----------ccccccccccccCcHHHHHHHHH
Confidence 998889999999999999999954 44444332221100 0 000 00000000112234556667777
Q ss_pred ccccCCCCCCCHHHHHH
Q 003818 756 CIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 756 Cl~~dP~~RPt~~evl~ 772 (793)
++..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 89999999998776644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.4e-06 Score=84.76 Aligned_cols=123 Identities=20% Similarity=0.237 Sum_probs=91.3
Q ss_pred CceeEEEEEechhcc-------cchHHHHHHHHHHhcCCccc--cceeeeEEecC----CceEEEEeecCCC-CHHHHHh
Q 003818 526 NEKPVAVKKLYKAVN-------EGEQEFKAEISAIGRTNHKN--LVQLLGFCNEG----EHRLLVYEYVSNG-SLADFLF 591 (793)
Q Consensus 526 ~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~l~ 591 (793)
..+.+.+|....... -......+|...+..+.... .++.+++.+.. ...+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 345566665432211 23346778888888775443 45566666543 2458999999884 8999986
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---cEEEeecCCccc
Q 003818 592 RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---NARISDFGLAKL 652 (793)
Q Consensus 592 ~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~ 652 (793)
.... ++......++.++++.+.-||.. +|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQ-LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcc-cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 5322 56667788999999999999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.1e-06 Score=75.11 Aligned_cols=99 Identities=28% Similarity=0.546 Sum_probs=68.4
Q ss_pred eeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeC-CCCCCCCCceEEEecCCcEEEECCCCCeeecCCCCCccc
Q 003818 41 SWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSAN-RDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPSTGAA 119 (793)
Q Consensus 41 ~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~an-r~~p~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~ 119 (793)
.+.+.+|.+.|-|...|+ |-| |. ..+++||.++ ..........+.|..||||||+|.++.++|+|......+
T Consensus 13 p~~~~s~~~~L~l~~dGn----Lvl-~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ptdt 85 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN----LVL-YD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYPTDT 85 (114)
T ss_dssp EEEECETTEEEEEETTSE----EEE-EE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSSS-E
T ss_pred ccccccccccceECCCCe----EEE-Ec--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCCccE
Confidence 455555889999887775 323 32 2367899994 333333568899999999999999999999996555556
Q ss_pred eeeEec--CcCEEEEecCCCceeeeccCCC
Q 003818 120 YAAMLD--TGNLVLASQDSSTMWESFDDPT 147 (793)
Q Consensus 120 ~~~lld--~GNlvl~~~~~~~~WqSFd~Pt 147 (793)
.+..++ .||++ ......+.|.|=+.|+
T Consensus 86 ~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 86 LLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEEEET--TSEEE-EESTSSEEEESS----
T ss_pred EEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 677777 89998 7666788999988774
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.6e-06 Score=81.61 Aligned_cols=137 Identities=16% Similarity=0.108 Sum_probs=103.3
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhc------ccchHHHHHHHHHHhcCCccc--cceeeeEEec-----CCceE
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAV------NEGEQEFKAEISAIGRTNHKN--LVQLLGFCNE-----GEHRL 575 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~-----~~~~~ 575 (793)
-|+||-+.|++-.+. |+.+-+|+-.... ..+...|.+|...|.++...+ +.+++ ++.. ....+
T Consensus 26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 467999999987653 3468899875211 235678999999999985433 44444 3321 22467
Q ss_pred EEEeecCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc--EEEeecCCcc
Q 003818 576 LVYEYVSN-GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN--ARISDFGLAK 651 (793)
Q Consensus 576 lV~Ey~~~-gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~ 651 (793)
||+|-+++ -+|.+++.+. ...++...+..+..++++.|.-||+. ++.|+|+-+.||+++.++. ++++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997764 5898888553 34567777889999999999999998 9999999999999986667 9999998775
Q ss_pred c
Q 003818 652 L 652 (793)
Q Consensus 652 ~ 652 (793)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.1e-06 Score=82.66 Aligned_cols=133 Identities=18% Similarity=0.181 Sum_probs=91.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc----------------c------cchHHHHHHHHHHhcCCcc--c
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----------------N------EGEQEFKAEISAIGRTNHK--N 560 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~----------------~------~~~~~~~~E~~~l~~l~H~--n 560 (793)
+.+.||.|.=+.||.|... .+..+|||.=+... . ......++|.++|.++.-. .
T Consensus 95 iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4578999999999999854 56789999432100 0 0123457899999998655 5
Q ss_pred cceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 561 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
+.+.+++ +...+||||+++-.|...-- +....-.|+..|++-+.-+-.. ||||+|+++-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 6666653 56689999999877654321 2222333344444434333344 999999999999999999
Q ss_pred cEEEeecCCccc
Q 003818 641 NARISDFGLAKL 652 (793)
Q Consensus 641 ~~kl~Dfgla~~ 652 (793)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.24 E-value=2e-06 Score=71.57 Aligned_cols=68 Identities=24% Similarity=0.391 Sum_probs=51.7
Q ss_pred eeEEecCCCCCCCCccccccccChhhHHHHhhc-CCCcceeeec--cCcceeec-cCCCCCccCCCCCCceE
Q 003818 354 FEFRDMPNTDWPLNDYEHFTSVDEDWCREACLS-DCFCAVAIFR--EGECWKKR-APLSNGRIDPSVGGKAL 421 (793)
Q Consensus 354 ~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~~~~~~~~~~y 421 (793)
..|+.++++.+++.........++++|++.|+. +|+|.|+.|. .++|++|. .++.+.+..+....+.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y 75 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLY 75 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeE
Confidence 358899999998655433456799999999999 9999999997 57899999 77776664444343333
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.6e-06 Score=91.77 Aligned_cols=142 Identities=22% Similarity=0.284 Sum_probs=93.1
Q ss_pred cc-cccccccceeEEEeEeCCCCceeEEEEEechhccc-------------------------------------chHHH
Q 003818 505 FK-EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-------------------------------------GEQEF 546 (793)
Q Consensus 505 f~-~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-------------------------------------~~~~~ 546 (793)
|+ +.||.-+.|.||+|+++. |+.||||+-+...++ .+-+|
T Consensus 164 f~~~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 164 FDEEPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred cCcchhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 44 569999999999999874 788999987642211 01124
Q ss_pred HHHHHHHhcC----Cccc------cceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 003818 547 KAEISAIGRT----NHKN------LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL 616 (793)
Q Consensus 547 ~~E~~~l~~l----~H~n------iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yL 616 (793)
..|.+-..+. .|-+ |.+++- .-.....|+||||+|..+.|...-....++...+..-+.++ |+
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~-----~~ 314 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA-----YL 314 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH-----HH
Confidence 4454444332 3444 333332 23457899999999998877654444455555444444333 33
Q ss_pred HhcCCCCeeecCCCCCCEEEcC----CCcEEEeecCCccccCC
Q 003818 617 HEECKSQIIHCDIKPQNILLDG----TFNARISDFGLAKLLKT 655 (793)
Q Consensus 617 H~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~ 655 (793)
+.-...|++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3333349999999999999984 67899999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.3e-05 Score=82.85 Aligned_cols=190 Identities=14% Similarity=0.152 Sum_probs=122.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc-CCccccceeeeE------EecC-CceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLLGF------CNEG-EHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~------~~~~-~~~~lV 577 (793)
...||+|+-+.+|..-. -.+ -+.|+..........+. +..|.. -.||-+-.-+.+ -.++ ...-++
T Consensus 16 gr~LgqGgea~ly~l~e--~~d--~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRD--QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecch--hhc--hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 46799999999996321 111 33466654332222222 222333 245533221110 1112 225677
Q ss_pred EeecCCCC-HHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 578 YEYVSNGS-LADFLFR-----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 578 ~Ey~~~gs-L~~~l~~-----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
|..+++.. ...++.. +-...+|...++.++.+|.+.+.||+. |.+-+|+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77776642 2333321 123357999999999999999999998 99999999999999999999998855433
Q ss_pred ccCCCCCcceecccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhC-CcCCCCC
Q 003818 652 LLKTDQTQTTTAIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCC-RKNFEVD 707 (793)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg-~~pf~~~ 707 (793)
.... ........|...|.+||.-. +..-+...|-|.||+++++++.| +.||.+.
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2211 11223345888999999754 34567889999999999999887 8898654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.2e-05 Score=77.20 Aligned_cols=137 Identities=16% Similarity=0.209 Sum_probs=84.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|..+.||+.. +..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~~-----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEec-----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 468999999999831 2346778765422 3355788999998886544 467788888888888999999986
Q ss_pred C-HHHHH---------------------hcC-CCCCCHHHH-HHHHH----------HHHH-HHHHHHhc-CCCCeeecC
Q 003818 585 S-LADFL---------------------FRK-SRRPNWYKR-MQIAF----------GTAR-GLFYLHEE-CKSQIIHCD 628 (793)
Q Consensus 585 s-L~~~l---------------------~~~-~~~~~~~~~-~~i~~----------~ia~-gL~yLH~~-~~~~ivH~D 628 (793)
. +...+ +.- ......... ..+.. .+.+ ...+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 22111 000 000010000 00000 0111 12222211 133578999
Q ss_pred CCCCCEEEcCCCcEEEeecCCcc
Q 003818 629 IKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 629 lkp~NIll~~~~~~kl~Dfgla~ 651 (793)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.3e-06 Score=96.53 Aligned_cols=182 Identities=20% Similarity=0.144 Sum_probs=129.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc-cceeeeEEecCCceEEEEeecCCC-
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN-LVQLLGFCNEGEHRLLVYEYVSNG- 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~Ey~~~g- 584 (793)
..+++++++.++|.+- . ..+....+.+.. .....-++++|.+++||| .++.++-++.+...+++++++..+
T Consensus 248 h~fvK~altknpKkRp-t-aeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRP-T-AEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCC-C-hhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 3478899999998652 1 222333444322 245667899999999999 777788888888899999999876
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+-..........+...+...+.+.-++++++||+. .-+|+| ||+..+ ...|..||+....+.+.. .....
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 22211111112223334455666677899999976 558998 776655 678999999988766544 33445
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCC
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFE 705 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~ 705 (793)
.+++.++|||+..+..+....|+|++|+-..++--|..|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 68999999999999999999999999987777776666543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=7.3e-05 Score=73.57 Aligned_cols=102 Identities=24% Similarity=0.310 Sum_probs=82.5
Q ss_pred HHHHHHHhcCCc-cccceeeeEEecCCceEEEEeecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 003818 547 KAEISAIGRTNH-KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLF--RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623 (793)
Q Consensus 547 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~--~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ 623 (793)
..|..+++.+++ +++++++|+|- .++|.||...+++...-. ..-...+|..+++|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 69999999994 378999998776643210 11134689999999999999999999865556
Q ss_pred eeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 624 IIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 624 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
+.-.|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00021 Score=73.95 Aligned_cols=137 Identities=14% Similarity=0.077 Sum_probs=82.3
Q ss_pred cccccc-eeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 509 LGEGAF-GKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 509 LG~G~f-g~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
|-.|.. ..||+... .+..+.+|+..... ..++.+|++++..+. +--+.+++++...++..++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDG---KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcC---CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444555 78898753 22467788765432 345678888888774 34466778877777778999999999877
Q ss_pred HHHHh-------------------cCC--C-CCC--HHHHHHH-HH-------------------HHHHHHHHHHhc---
Q 003818 587 ADFLF-------------------RKS--R-RPN--WYKRMQI-AF-------------------GTARGLFYLHEE--- 619 (793)
Q Consensus 587 ~~~l~-------------------~~~--~-~~~--~~~~~~i-~~-------------------~ia~gL~yLH~~--- 619 (793)
..... .-. . ... ......- .. .+...+..|-..
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64321 000 0 000 0000000 00 011112222111
Q ss_pred -CCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 620 -CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 620 -~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12458999999999999998778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00015 Score=71.79 Aligned_cols=129 Identities=17% Similarity=0.132 Sum_probs=78.9
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcccchHHH---------HHHHHHHhcCCc---cccceeeeEEe-----c
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF---------KAEISAIGRTNH---KNLVQLLGFCN-----E 570 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~~~~~-----~ 570 (793)
++-......|.+-.. +++.+.+|..+......++.| .+++..+.+++. ...+.++-..+ -
T Consensus 38 v~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~ 114 (229)
T PF06176_consen 38 VFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY 114 (229)
T ss_pred eecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence 444455555555443 345678887665433322222 233333333322 22233222222 2
Q ss_pred CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 571 GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 571 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
....+|+|||++|..|.++.. ++. .++..+.++|.-||+. |+.|+|..|.|+++++++ ++++||+..
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccc
Confidence 245568999999988876542 111 3455677889999998 999999999999998655 999999876
Q ss_pred cc
Q 003818 651 KL 652 (793)
Q Consensus 651 ~~ 652 (793)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0002 Score=71.68 Aligned_cols=136 Identities=21% Similarity=0.216 Sum_probs=87.4
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcccc---------h---------------HHHHHHHHHHhcCC--cccc
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---------E---------------QEFKAEISAIGRTN--HKNL 561 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~---------~---------------~~~~~E~~~l~~l~--H~ni 561 (793)
.|+.|.-+.||+|.- .++..+|+|+.+...... . .-..+|..-|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 578888999999863 456789999886432111 0 11235666666653 3344
Q ss_pred ceeeeEEecCCceEEEEeecCCCCH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 562 VQLLGFCNEGEHRLLVYEYVSNGSL-ADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 562 v~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
.+.+++. +-.|||||+....+ .-.| +...+.......+..++++.+.-|-.. .++||+||+.-|||+. ++
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence 4455543 34799999965311 0011 111222224555666677777766652 3999999999999999 88
Q ss_pred cEEEeecCCccccC
Q 003818 641 NARISDFGLAKLLK 654 (793)
Q Consensus 641 ~~kl~Dfgla~~~~ 654 (793)
.+.|+||+-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00017 Score=73.69 Aligned_cols=140 Identities=20% Similarity=0.210 Sum_probs=82.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeeeEEec---CCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLGFCNE---GEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~---~~~~~lV~Ey~ 581 (793)
+.|+.|..+.||+..... ..+++|..... .....+.+|..++..+.... +.+++.+... ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~---~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD---GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT---SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC---cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 468899999999987532 37999987554 34567788888888875443 4566765433 23468999999
Q ss_pred CCCCHHH----------------HHh---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 003818 582 SNGSLAD----------------FLF---RK---SRRPNWYK---------RMQI------------AFGTAR-GLFYLH 617 (793)
Q Consensus 582 ~~gsL~~----------------~l~---~~---~~~~~~~~---------~~~i------------~~~ia~-gL~yLH 617 (793)
++..+.. .+. .. ........ .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 111 11 01111100 0000 111222 334444
Q ss_pred hc----CCCCeeecCCCCCCEEEc-CCCcEEEeecCCcc
Q 003818 618 EE----CKSQIIHCDIKPQNILLD-GTFNARISDFGLAK 651 (793)
Q Consensus 618 ~~----~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~ 651 (793)
+. ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 345799999999999999 56666799998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0005 Score=68.04 Aligned_cols=127 Identities=16% Similarity=0.216 Sum_probs=88.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc----------------ccchHHHHHHHHHHhcCC------cccccee
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----------------NEGEQEFKAEISAIGRTN------HKNLVQL 564 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 564 (793)
..||+|+.-.||. +... ....||+..... ....++..+|+.....+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~--HP~d--p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDD--PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CCCC--CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 5699999999996 3333 347788876544 112355666666655554 8899999
Q ss_pred eeEEecCCceEEEEeecCC------CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 003818 565 LGFCNEGEHRLLVYEYVSN------GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG 638 (793)
Q Consensus 565 ~~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 638 (793)
+|+.+++.-.-+|+|.+.+ .+|.+++.+. .++. ... ..+-+-..||-++ .|+.+||+|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEEEEe
Confidence 9999999999999998764 2688888443 2333 222 3333445666666 8999999999999953
Q ss_pred CC----cEEEee
Q 003818 639 TF----NARISD 646 (793)
Q Consensus 639 ~~----~~kl~D 646 (793)
.. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 22 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00092 Score=81.44 Aligned_cols=79 Identities=11% Similarity=0.253 Sum_probs=55.8
Q ss_pred cccccccceeEEEeEeCCCCc-eeEEEEEechhc-ccchHHHHHHHHHHhcCC-cccc--ceeeeEEecC---CceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENE-KPVAVKKLYKAV-NEGEQEFKAEISAIGRTN-HKNL--VQLLGFCNEG---EHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV~ 578 (793)
+.|+.|.+..+|+........ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 568899999999876543221 356777654322 223457889999999985 6665 7788888764 4678999
Q ss_pred eecCCCC
Q 003818 579 EYVSNGS 585 (793)
Q Consensus 579 Ey~~~gs 585 (793)
||+++..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0013 Score=62.40 Aligned_cols=124 Identities=18% Similarity=0.268 Sum_probs=83.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccce-eeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQ-LLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.|++|.+|.||+|.+. +..+|+|+-+.+. ....++.|+++|..++-.++-+ ++.|-. ..+.|||+.|-.
T Consensus 28 ~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 28 KELAKGTTSVVYLGEWR---GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhcccccEEEEeecc---CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 57999999999999874 4579999865543 3467889999999887666644 444322 234599999888
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC--CCEEEcCCCcEEEeecCCcc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKP--QNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp--~NIll~~~~~~kl~Dfgla~ 651 (793)
|.+.-... +... ...+++.---|... +|-|+.|.- +||++.+. .+.|+||.-|.
T Consensus 99 L~~~~~~~----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At 154 (201)
T COG2112 99 LGKLEIGG----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSAT 154 (201)
T ss_pred hhhhhhcc----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchh
Confidence 87765321 2222 23344443334433 899998874 45555554 99999999886
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0025 Score=67.82 Aligned_cols=75 Identities=9% Similarity=0.020 Sum_probs=53.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc---cccceeeeEEec---CCceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH---KNLVQLLGFCNE---GEHRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~---~~~~~lV~Ey 580 (793)
+.||.|..+.||+... .++ .+.+|..+. ......+.+|...|+.+.. -.+.++++++.. .+..+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~--~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYD--SQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEc--CCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4699999999998653 233 366666332 1133578999999988853 367888888754 3668999999
Q ss_pred cCCCCH
Q 003818 581 VSNGSL 586 (793)
Q Consensus 581 ~~~gsL 586 (793)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0013 Score=67.52 Aligned_cols=73 Identities=14% Similarity=0.164 Sum_probs=44.5
Q ss_pred cccccccce-eEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcc---ccceeeeEEecC---CceEEEEe
Q 003818 507 EELGEGAFG-KVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHK---NLVQLLGFCNEG---EHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg-~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~---~~~~lV~E 579 (793)
+.|+.|+.. .||+.. ..+++|..+. ......+.+|.+.+..+... .+.++++..... ...+++||
T Consensus 3 ~~~~~gG~~n~vy~~~------~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRLG------DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEcC------CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 346767666 588731 2366676443 22345788999999887532 344445444332 23588999
Q ss_pred ecCCCCHH
Q 003818 580 YVSNGSLA 587 (793)
Q Consensus 580 y~~~gsL~ 587 (793)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00026 Score=57.98 Aligned_cols=49 Identities=20% Similarity=0.416 Sum_probs=38.4
Q ss_pred ecCCCCCCCCccccccccChhhHHHHhhcCCCcceeeec--cCcceeeccC
Q 003818 358 DMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFR--EGECWKKRAP 406 (793)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~ 406 (793)
.+++++++..++......+.++|++.|+.+|+|.||.|. .+.|++|...
T Consensus 8 ~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 8 QGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred ccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 335666666665544567899999999999999999995 4779999873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.003 Score=64.78 Aligned_cols=75 Identities=17% Similarity=0.199 Sum_probs=46.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.|..|-...+|+.......++.+++|+...... ......+|+.++..+...++ +++++... -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 4577788889998764321245688887654321 12234578888888754444 44444433 248999999876
Q ss_pred H
Q 003818 586 L 586 (793)
Q Consensus 586 L 586 (793)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0025 Score=66.34 Aligned_cols=135 Identities=10% Similarity=0.055 Sum_probs=76.5
Q ss_pred cccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEeecCCCCHH
Q 003818 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYEYVSNGSLA 587 (793)
Q Consensus 509 LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~ 587 (793)
+..|-...+|+.. .+++.+++|..............+|..+++.+....+ .+++.... -.+|+||++|..+.
T Consensus 4 ~~~G~tn~~y~~~---~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIE---HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEE---eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 5567788899865 2455688887544322211245778888888865444 34444432 36899999986653
Q ss_pred HH--------------H---hcC---CCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeeecCCCCC
Q 003818 588 DF--------------L---FRK---SRRPNWYKR-MQIAFG---------TARGLFYLHEE-----CKSQIIHCDIKPQ 632 (793)
Q Consensus 588 ~~--------------l---~~~---~~~~~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlkp~ 632 (793)
.. + +.. ....+.... .....+ +...+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 111 111111111 111101 11112222211 1235899999999
Q ss_pred CEEEcCCCcEEEeecCCcc
Q 003818 633 NILLDGTFNARISDFGLAK 651 (793)
Q Consensus 633 NIll~~~~~~kl~Dfgla~ 651 (793)
||++++++ +.|+||..+.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99999877 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0044 Score=60.91 Aligned_cols=123 Identities=26% Similarity=0.345 Sum_probs=84.9
Q ss_pred cccccccccccc-eeEEEeEeCCCCceeEEEEEechh-----------cc----------cchHHHHHHHHHHhcCC---
Q 003818 503 GGFKEELGEGAF-GKVYKGVLTTENEKPVAVKKLYKA-----------VN----------EGEQEFKAEISAIGRTN--- 557 (793)
Q Consensus 503 ~~f~~~LG~G~f-g~Vy~~~~~~~~~~~vavK~l~~~-----------~~----------~~~~~~~~E~~~l~~l~--- 557 (793)
..|.+.||.|.- |.|||+.+ .|+.+|+|..+.- .. ....-|..|.+...+++
T Consensus 39 I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 39 IEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred EeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 345688999999 99999997 5678999993220 00 01134778998888774
Q ss_pred cccc--ceeeeEEecC------------------CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003818 558 HKNL--VQLLGFCNEG------------------EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617 (793)
Q Consensus 558 H~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH 617 (793)
+.++ |+.+||..-. ....||.||++... .+ ..+-+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHHH
Confidence 4466 9999987321 12246788776533 11 1233456667778888
Q ss_pred hcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 618 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
.. +|+-+|+++.|.. .-||+|||.+
T Consensus 182 k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HC---CeeeccCcccccc-----CCEEEecccC
Confidence 87 9999999999975 3588999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0018 Score=77.19 Aligned_cols=196 Identities=20% Similarity=0.173 Sum_probs=132.8
Q ss_pred HHHHHHHHhcCCccccceeeeEEecCCce----EEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003818 546 FKAEISAIGRTNHKNLVQLLGFCNEGEHR----LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621 (793)
Q Consensus 546 ~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~ 621 (793)
.+.|...+.++.|+|++.++.|-.+.... .+..|++..-++...+... ...+......+..++.+||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 44577778889999999999987654332 2445788888888887544 4566777788888999999999987
Q ss_pred CCeeecCCCCC---CEEEcCCCcEEEe--ecCCccccCCCCCcceecccCcccccCcccccCCCCCC--ccceehhHHHH
Q 003818 622 SQIIHCDIKPQ---NILLDGTFNARIS--DFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA--KVDVYSFGILL 694 (793)
Q Consensus 622 ~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~~Dvws~Gvil 694 (793)
...|.-+..+ +.-++..+...++ ||+.+..+........ ...+..+.+||......+.. ..|+|.+|..+
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4444444444 4445666777777 8888876654332221 22345678888887766554 47999999999
Q ss_pred HHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 695 LELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 695 ~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
..+..|..+-....... .+.+.. . ...+.+....|+..++++|++..+++...
T Consensus 383 ~~~~~~~~i~~~~~~~~-------------------~~l~~~-----~---~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPV-------------------SLLDVL-----S---TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccchh-------------------hhhccc-----c---chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99998765432211100 000000 0 01355677889999999999999998766
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0043 Score=66.15 Aligned_cols=139 Identities=16% Similarity=0.201 Sum_probs=83.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeee------EEecCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLG------FCNEGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~------~~~~~~~~~lV~ 578 (793)
+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +++++. +...++..++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~---~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 20 EGISAGIENTNYFVTTD---SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ecccCccccceEEEEeC---CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45777877899986532 23588887754 23455677888877775433 444443 223345678999
Q ss_pred eecCCCCHHH----HH----------hc--CC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 003818 579 EYVSNGSLAD----FL----------FR--KS--------RRPNWYKRM----------QIAFGTARGLFYLHE----EC 620 (793)
Q Consensus 579 Ey~~~gsL~~----~l----------~~--~~--------~~~~~~~~~----------~i~~~ia~gL~yLH~----~~ 620 (793)
++++|..+.. .. +. .. ....|.... .....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876421 11 10 00 001111110 011123344555553 22
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
...++|+|+.|.||+++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3479999999999999998778899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.019 Score=63.17 Aligned_cols=76 Identities=21% Similarity=0.242 Sum_probs=51.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc-------ccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-------NEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 576 (793)
+.||.|.+..||+....+ +++.|+||.-.... ......+..|.+.|..+. ..++++++.+ +.+..++
T Consensus 32 ~elggGn~N~VyrV~~~~-g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE-GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCC-CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 568999999999988642 22579999753211 123456677888877752 2456777776 4466889
Q ss_pred EEeecCCCC
Q 003818 577 VYEYVSNGS 585 (793)
Q Consensus 577 V~Ey~~~gs 585 (793)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.021 Score=61.10 Aligned_cols=139 Identities=23% Similarity=0.258 Sum_probs=80.3
Q ss_pred ccccccceeEEEeEeCCC-----CceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEeec
Q 003818 508 ELGEGAFGKVYKGVLTTE-----NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~ 581 (793)
.|..|--..+|+...... .++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 455566678888764321 24678888865432 233456778888877754333 345655542 3589999
Q ss_pred CCCCHHHHH-----------------hcCCCC--------C-C-HHHHHH--------------------------HHHH
Q 003818 582 SNGSLADFL-----------------FRKSRR--------P-N-WYKRMQ--------------------------IAFG 608 (793)
Q Consensus 582 ~~gsL~~~l-----------------~~~~~~--------~-~-~~~~~~--------------------------i~~~ 608 (793)
+|..+.... +..... . . +..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 887654311 111000 0 0 000000 1112
Q ss_pred HHHHHHHHHh------cCCCCeeecCCCCCCEEEcCC----CcEEEeecCCcc
Q 003818 609 TARGLFYLHE------ECKSQIIHCDIKPQNILLDGT----FNARISDFGLAK 651 (793)
Q Consensus 609 ia~gL~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~ 651 (793)
+...+..|.. .....++|+|+.+.|||++++ +.+.++||..+.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2223334432 134578999999999999985 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.014 Score=57.29 Aligned_cols=137 Identities=18% Similarity=0.148 Sum_probs=85.7
Q ss_pred eEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHH
Q 003818 529 PVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF 607 (793)
Q Consensus 529 ~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~ 607 (793)
...+|++....-. ...-|+.+.+++++++ .|+++..- .+...-++.|+|..... ... .++.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~-N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFS-NFIT 148 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chh-HHHH
Confidence 3566777654333 4566788999998886 57777632 34456688999843210 111 1222
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccce
Q 003818 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDV 687 (793)
Q Consensus 608 ~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 687 (793)
-=++.|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+.... .+.-|.--| ....++++.+
T Consensus 149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN~~---Y~~lT~~aE~ 211 (308)
T PF07387_consen 149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVNIE---YESLTQEAEV 211 (308)
T ss_pred HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEeee---ccccChHHHH
Confidence 224677888865 45899999999999999999999999765321 011122211 1234667777
Q ss_pred ehhHHHHHHHHhC
Q 003818 688 YSFGILLLELVCC 700 (793)
Q Consensus 688 ws~Gvil~elltg 700 (793)
-+|=.-++++...
T Consensus 212 ~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 212 KVFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHHH
Confidence 7776666776643
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.046 Score=59.50 Aligned_cols=140 Identities=19% Similarity=0.193 Sum_probs=79.9
Q ss_pred ccccccceeEEEeEeCCC---CceeEEEEEechhcccchHHHHHHHHHHhcCCccccc-eeeeEEecCCceEEEEeecCC
Q 003818 508 ELGEGAFGKVYKGVLTTE---NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLV-QLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.|-.|-.-.+|+...... .++.|++|....... ..-...+|..+++.+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 344577778888764322 235788887765432 222346788888887655553 566666443 58999987
Q ss_pred CCHHHH-----------------HhcCC----CCCC-HHHHHHHHH-----------------HHHHHHHHHHh-----c
Q 003818 584 GSLADF-----------------LFRKS----RRPN-WYKRMQIAF-----------------GTARGLFYLHE-----E 619 (793)
Q Consensus 584 gsL~~~-----------------l~~~~----~~~~-~~~~~~i~~-----------------~ia~gL~yLH~-----~ 619 (793)
.+|... ++... .... +....++.. .+...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 01111 0011 111112111 11122222221 1
Q ss_pred CCCCeeecCCCCCCEEEcC-CCcEEEeecCCccc
Q 003818 620 CKSQIIHCDIKPQNILLDG-TFNARISDFGLAKL 652 (793)
Q Consensus 620 ~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 652 (793)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 47899999998853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.033 Score=58.66 Aligned_cols=72 Identities=15% Similarity=0.287 Sum_probs=46.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.|+-|....+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+++++++....+..+||+||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 468889999999865 356679999765 233457888888888873 44677889988888888999999987
Q ss_pred C
Q 003818 584 G 584 (793)
Q Consensus 584 g 584 (793)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.038 Score=59.24 Aligned_cols=140 Identities=17% Similarity=0.216 Sum_probs=79.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeeeE------EecCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLGF------CNEGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~ 578 (793)
+.++.|.-..+|+..- .++ .+++|+..... ...+...|.+++..+.... +++++.. ....+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t--~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT--DVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEe--CCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3467777789998653 233 47778764421 2344556677776664322 3444332 12245678999
Q ss_pred eecCCCCHH-----------HHH---hcCCC-----------CCCHHHHH------------HHHHHHHHHHHHHHh---
Q 003818 579 EYVSNGSLA-----------DFL---FRKSR-----------RPNWYKRM------------QIAFGTARGLFYLHE--- 618 (793)
Q Consensus 579 Ey~~~gsL~-----------~~l---~~~~~-----------~~~~~~~~------------~i~~~ia~gL~yLH~--- 618 (793)
||++|..+. ..+ +.... ...|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885431 111 11000 01111110 011123345555543
Q ss_pred -cCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 619 -ECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 619 -~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
....+++|+|+.+.||++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234689999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.094 Score=56.48 Aligned_cols=139 Identities=13% Similarity=0.167 Sum_probs=74.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeee------EEecCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLG------FCNEGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~------~~~~~~~~~lV~ 578 (793)
+.|+.|....+|+.... ++ .+++|+... .....+..|+.++..+...+ +.+++. +....+..++++
T Consensus 28 ~~l~~G~~n~~y~v~t~--~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT--QG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred chhccccccceEEEEeC--CC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 34667777889986532 33 588887652 12234444555555543222 333332 123355678999
Q ss_pred eecCCCCHH-----------HHH---hcCCC----------CCCH-HHHHH------------HH-HHHHHHHHHHHhc-
Q 003818 579 EYVSNGSLA-----------DFL---FRKSR----------RPNW-YKRMQ------------IA-FGTARGLFYLHEE- 619 (793)
Q Consensus 579 Ey~~~gsL~-----------~~l---~~~~~----------~~~~-~~~~~------------i~-~~ia~gL~yLH~~- 619 (793)
||++|..+. ..| +.... .+.| ..... .. ..+...+..+...
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999987431 111 11000 0111 11111 11 1111222333211
Q ss_pred ---CCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 620 ---CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 620 ---~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
...+++|+|+.|.||+++++...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 35589999999999999977666899999874
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.082 Score=56.14 Aligned_cols=127 Identities=21% Similarity=0.275 Sum_probs=72.9
Q ss_pred ceeEEEEEec-hhcccchHHHHHHHHHHhcCCc--cccceeeeEEecCC--ceEEEEeecCCCCHHHHHhcCC-------
Q 003818 527 EKPVAVKKLY-KAVNEGEQEFKAEISAIGRTNH--KNLVQLLGFCNEGE--HRLLVYEYVSNGSLADFLFRKS------- 594 (793)
Q Consensus 527 ~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~------- 594 (793)
++.+++++-. ...........+|..+|+.+.- --+.+.+++|.++. ..+.||+|++|..+.+.+....
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 5567777221 1222334556778888877643 23455677777766 6799999998843222111000
Q ss_pred ---------------------CC--------C-CHHHHHHHH--------HHHHHHHHHHHhcC-----CCCeeecCCCC
Q 003818 595 ---------------------RR--------P-NWYKRMQIA--------FGTARGLFYLHEEC-----KSQIIHCDIKP 631 (793)
Q Consensus 595 ---------------------~~--------~-~~~~~~~i~--------~~ia~gL~yLH~~~-----~~~ivH~Dlkp 631 (793)
.. + .|....+.+ -....-..+|+.+. ++.++|+|+.+
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 00 0 011111000 01222344554432 34699999999
Q ss_pred CCEEEcCCCcEEEeecCCcccc
Q 003818 632 QNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 632 ~NIll~~~~~~kl~Dfgla~~~ 653 (793)
.|+++++...+-|.||+++.+-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999888999999998753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.0021 Score=78.23 Aligned_cols=156 Identities=12% Similarity=-0.003 Sum_probs=108.9
Q ss_pred HHHHHHhcCCccccceeeeEEe--cCCceEEEEeecCCCCHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhcC--
Q 003818 548 AEISAIGRTNHKNLVQLLGFCN--EGEHRLLVYEYVSNGSLADFLFRKSRR---PNWYKRMQIAFGTARGLFYLHEEC-- 620 (793)
Q Consensus 548 ~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~~~~~~~i~~~ia~gL~yLH~~~-- 620 (793)
.|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|.+.... ++.........+......-+|...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444555668998877665443 344678899999999999999764222 222222222222233334444332
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhC
Q 003818 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg 700 (793)
..--+|++||+-|.+|..+.++|++++|+.+... ......+...+++-|++|+......++.++|+|..|+-+|+.-.|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 2236899999999999999999999999998433 233334445578889999999888999999999999999998777
Q ss_pred CcCC
Q 003818 701 RKNF 704 (793)
Q Consensus 701 ~~pf 704 (793)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 6665
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.25 Score=54.29 Aligned_cols=72 Identities=17% Similarity=0.261 Sum_probs=47.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-------cchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-------EGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 576 (793)
+.||-|....||+... .+..++||+-..... .....-..|...|+.+. ..++.+++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 5689999999999653 234688997652111 12233344566665553 347788888887 45788
Q ss_pred EEeecCC
Q 003818 577 VYEYVSN 583 (793)
Q Consensus 577 V~Ey~~~ 583 (793)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.05 Score=60.00 Aligned_cols=162 Identities=25% Similarity=0.295 Sum_probs=88.8
Q ss_pred HHHHHHHHHHhcCCccccceeeeEEecCC-ceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003818 544 QEFKAEISAIGRTNHKNLVQLLGFCNEGE-HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622 (793)
Q Consensus 544 ~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~ 622 (793)
.++.-....++.++|+|+..++++..... ...+|+|++ +.+|.+.+.... +-.. +++ -|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~----------s~~--~~----- 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDE----------SLL--AH----- 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchh----------hhc--cc-----
Confidence 45566677888899999999999886543 467789998 778998885432 1100 000 11
Q ss_pred CeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCc
Q 003818 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702 (793)
Q Consensus 623 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~ 702 (793)
++.|- || .+++| -++. .| |- +..+|+|||++|.++.|+.-|..
T Consensus 87 ~~~~~-----~~-------~~~td-~~~t-----------------~~--~~-----~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----NI-------IYITD-HFLT-----------------KY--PS-----PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----hh-------hhccc-cccc-----------------cC--CC-----CCCcchhhhhHHHHHHHHHHhhH
Confidence 22221 11 22233 0000 00 11 11259999999999999998876
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 003818 703 NFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMK 768 (793)
Q Consensus 703 pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 768 (793)
-+......+....+..+. ..+..... ...+...-.+....++++...|+-..|..||...
T Consensus 130 l~~~~~~s~~l~~i~k~~---~~d~~~~~---~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYY---TDDQELLS---TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred HHHHHHHHHHHHHHHHhc---cCchhHHH---HHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 554332222211111100 00000000 0001122234456788999999999999998543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.14 Score=53.81 Aligned_cols=31 Identities=29% Similarity=0.548 Sum_probs=25.7
Q ss_pred CCeeecCCCCCCEEEcCCCc-EEEeecCCccc
Q 003818 622 SQIIHCDIKPQNILLDGTFN-ARISDFGLAKL 652 (793)
Q Consensus 622 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~ 652 (793)
..++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.22 Score=53.86 Aligned_cols=74 Identities=20% Similarity=0.310 Sum_probs=45.9
Q ss_pred ccccccceeEEEeEeCCCC--ceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEeecCCC
Q 003818 508 ELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.|..|--..+|+......+ +..|++|+...... ..-...+|..+++.+...++ .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 3545666778887654322 23688887755432 22344678888888866555 4566666332 589999776
Q ss_pred CH
Q 003818 585 SL 586 (793)
Q Consensus 585 sL 586 (793)
.|
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 55
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.25 Score=52.65 Aligned_cols=139 Identities=17% Similarity=0.172 Sum_probs=89.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc---------cc-----------------hHHHHHHHHHHhcCCccc
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---------EG-----------------EQEFKAEISAIGRTNHKN 560 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---------~~-----------------~~~~~~E~~~l~~l~H~n 560 (793)
..|..|.=+.||.+.- .+|..+|||+.+...- .+ .-....|++-|.+++...
T Consensus 150 GCiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4688899999999864 4567799998763210 00 012345777777776555
Q ss_pred cceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 561 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
|...--... ....|||+++.... .-.-.-+.-.++...+..+-.+++.-|.-|-+.| ++||.||.--|+|+.+ |
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdg-w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDG-WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCC-CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence 432222111 23468999985221 1111112234555566777778888787777665 8999999999999865 5
Q ss_pred cEEEeecCCcccc
Q 003818 641 NARISDFGLAKLL 653 (793)
Q Consensus 641 ~~kl~Dfgla~~~ 653 (793)
.+.|+|.+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 7889998877543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.022 Score=59.22 Aligned_cols=144 Identities=15% Similarity=0.179 Sum_probs=89.3
Q ss_pred CCCCHHHHHHHhc-----ccccccccccceeEEEeEeCCCCceeEEEEEechh---------cc-------c------ch
Q 003818 491 QDFTYKELEVITG-----GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---------VN-------E------GE 543 (793)
Q Consensus 491 ~~~~~~el~~~t~-----~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---------~~-------~------~~ 543 (793)
.-+.|--|...+. .+.+.||-|.=+.||.+.. ..|++.++|.=+-. .+ . ..
T Consensus 77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred ccchHHHHHHHHhcchhhhhccccccccccceEEEec--CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 3445555554433 2457899999999999874 35667777732110 00 0 01
Q ss_pred HHHHHHHHHHhcCCcc--ccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003818 544 QEFKAEISAIGRTNHK--NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621 (793)
Q Consensus 544 ~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~ 621 (793)
-...+|...|+.+... -+.+.+++ +..++|||++.+-.|...-+ ..+...+.. .+..-|.-|..+
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly~---~lm~~Iv~la~~-- 221 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPTLYD---DLMGLIVRLANH-- 221 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee----cCChHHHHH---HHHHHHHHHHHc--
Confidence 2345677778777532 23444443 45688999998877765431 122223222 222333444455
Q ss_pred CCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 622 SQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 622 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
|+||+|..-=||++++++.++++||--.
T Consensus 222 -GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 222 -GLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred -CceecccchheeEEecCCCEEEeechHh
Confidence 9999999999999999999999999644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 793 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-125
Identities = 120/295 (40%), Positives = 177/295 (60%), Gaps = 9/295 (3%)
Query: 489 NLQDFTYKELEVITGGFKEE--LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG-EQE 545
L+ F+ +EL+V + F + LG G FGKVYKG L + VAVK+L + +G E +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRLKEERTQGGELQ 73
Query: 546 FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---NWYKR 602
F+ E+ I H+NL++L GFC RLLVY Y++NGS+A L + +W KR
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
+IA G+ARGL YLH+ C +IIH D+K NILLD F A + DFGLAKL+ T TT
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVD-ATEECQMILADWAY 721
A+RGT G++APE+ + K DV+ +G++LLEL+ ++ F++ + ++L DW
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776
+E+KL LV+ D + + VE+ + +A+ C Q P RP M +V +M+EG
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-117
Identities = 120/313 (38%), Positives = 166/313 (53%), Gaps = 37/313 (11%)
Query: 485 MPEMNLQDFTYKELEVITGGFKEE--------LGEGAFGKVYKGVLTTENEKPVAVKKLY 536
+ + F++ EL+ +T F E +GEG FG VYKG + N VAVKKL
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLA 63
Query: 537 KAVN----EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFR 592
V+ E +Q+F EI + + H+NLV+LLGF ++G+ LVY Y+ NGSL D L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 593 KSRRP--NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650
P +W+ R +IA G A G+ +LHE IH DIK NILLD F A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 651 KLLKT-DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDAT 709
+ + QT T+ I GT Y+APE + IT K D+YSFG++LLE++ VD
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPA--VDEH 237
Query: 710 EECQMILADWAYDCFRERKLGLLVENDEEAMD------DIKRVEKFVMIAIWCIQEDPSL 763
E Q+ L D + E K E+ +D D VE +A C+ E +
Sbjct: 238 REPQL-LLDIKEEIEDEEK------TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNK 290
Query: 764 RPAMKKVTQMIEG 776
RP +KKV Q+++
Sbjct: 291 RPDIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-114
Identities = 107/318 (33%), Positives = 165/318 (51%), Gaps = 12/318 (3%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEE--LGEGAFGKVYKGVLTTEN 526
+ + N S + +LE T F + +G G FGKVYKGVL +
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL--RD 62
Query: 527 EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586
VA+K+ ++G +EF+ EI + H +LV L+GFC+E +L+Y+Y+ NG+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 587 ADFLFRKSRRP---NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643
L+ +W +R++I G ARGL YLH IIH D+K NILLD F +
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 644 ISDFGLAKL-LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702
I+DFG++K + DQT +T ++GT GY+ PE+F +T K DVYSFG++L E++C R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 703 NFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPS 762
E + LA+WA + +L +V+ + + + KF A+ C+
Sbjct: 240 AIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 763 LRPAMKKVTQMIEGAVDV 780
RP+M V +E A+ +
Sbjct: 299 DRPSMGDVLWKLEYALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 7e-75
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 32/309 (10%)
Query: 492 DFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAE 549
D + L + + E G FG V+K L + VAVK ++ + + E
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIF-PIQDKQSWQNEYE 68
Query: 550 ISAIGRTNHKNLVQLLGFCNEGEH----RLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI 605
+ ++ H+N++Q +G G L+ + GSL+DFL K+ +W + I
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHI 126
Query: 606 AFGTARGLFYLHEE-------CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658
A ARGL YLHE+ K I H DIK +N+LL A I+DFGLA + ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 659 Q-TTTAIRGTKGYVAPE-----WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC 712
T GT+ Y+APE ++D+Y+ G++L EL + +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV-DEY 245
Query: 713 QMILAD--WAYDCFRERKLGLLVEND----EEAMDDIKRVEKFVMIAIWCIQEDPSLRPA 766
+ + + + + ++ + + + C D R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 767 MKKVTQMIE 775
V + I
Sbjct: 306 AGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-67
Identities = 81/323 (25%), Positives = 148/323 (45%), Gaps = 34/323 (10%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFT--YKELEVITGGFKEELGEGAFGKVYKGVLTTEN 526
H + T E+ M+ D + +L KE++G G+FG V++ +
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-----IKEKIGAGSFGTVHRAEW---H 59
Query: 527 EKPVAVKKLYK--AVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584
VAVK L + E EF E++ + R H N+V +G + + +V EY+S G
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 585 SLADFLFRKSRRP--NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642
SL L + R + +R+ +A+ A+G+ YLH I+H ++K N+L+D +
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702
++ DFGL++L K ++ + GT ++APE ++ P K DVYSFG++L EL ++
Sbjct: 179 KVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 703 NFEVDATEECQMILADWAYD-CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDP 761
+ + A F+ ++L + + + I+ C +P
Sbjct: 238 PWG-------NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG----------CWTNEP 280
Query: 762 SLRPAMKKVTQMIEGAVDVSIPP 784
RP+ + ++ + ++PP
Sbjct: 281 WKRPSFATIMDLLRPLIKSAVPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-62
Identities = 81/284 (28%), Positives = 125/284 (44%), Gaps = 34/284 (11%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIG 554
YKE+E +E +G GAFG V K K VA+K++ + F E+ +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW---RAKDVAIKQIESE--SERKAFIVELRQLS 56
Query: 555 RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP--NWYKRMQIAFGTARG 612
R NH N+V+L G C LV EY GSL + L P M ++G
Sbjct: 57 RVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 613 LFYLHEECKSQIIHCDIKPQNILLDGTFN-ARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
+ YLH +IH D+KP N+LL +I DFG A D T +G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
APE F+ + K DV+S+GI+L E++ RK F +E + + L
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPL 225
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ + + R C +DPS RP+M+++ +++
Sbjct: 226 IKNLPKPIESLMTR----------CWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-62
Identities = 71/309 (22%), Positives = 128/309 (41%), Gaps = 51/309 (16%)
Query: 486 PEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-- 543
P+ L E+E +++++G+G FG V+KG L ++ VA+K L +EGE
Sbjct: 9 PKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETE 62
Query: 544 -----QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN 598
QEF+ E+ + NH N+V+L G + +V E+V G L L K+
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 599 WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-----GTFNARISDFGLAKLL 653
W ++++ A G+ Y+ I+H D++ NI L A+++DFGL++
Sbjct: 121 WSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 654 KTDQTQTTTAIRGTKGYVAPEWF--KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
+ + + G ++APE + T K D YSF ++L ++ F+
Sbjct: 178 --QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------ 229
Query: 712 CQMILADWAYDCFRERKLGLLVENDE-----EAMDDIKRVEKFVMIAIWCIQEDPSLRPA 766
Y + + + ++ E E + + C DP RP
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCP-----PRLRNVIELCWSGDPKKRPH 276
Query: 767 MKKVTQMIE 775
+ + +
Sbjct: 277 FSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-62
Identities = 78/321 (24%), Positives = 121/321 (37%), Gaps = 45/321 (14%)
Query: 492 DFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAE 549
+ E + K E +G G +G VYKG L +E+PVAVK Q F E
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSF---ANRQNFINE 55
Query: 550 --ISAIGRTNHKNLVQLLGFCNEGE-----HRLLVYEYVSNGSLADFLFRKSRRPNWYKR 602
I + H N+ + + LLV EY NGSL +L + +W
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113
Query: 603 MQIAFGTARGLFYLHEE------CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL--- 653
++A RGL YLH E K I H D+ +N+L+ ISDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 654 ----KTDQTQTTTAIRGTKGYVAPEWFKNL-------PITAKVDVYSFGILLLELVC-CR 701
++ + GT Y+APE + +VD+Y+ G++ E+ C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 702 KNFEVDATEECQMILADWAYDCFRERKLGLLVEND-------EEAMDDIKRVEKFVMIAI 754
F ++ E QM + + +LV + E ++ V
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 755 WCIQEDPSLRPAMKKVTQMIE 775
C +D R + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 8e-60
Identities = 73/294 (24%), Positives = 113/294 (38%), Gaps = 43/294 (14%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK----AVNEGEQEFKAEI 550
+ EL +E +G G FGKVY+ VAVK +++ + + E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA 610
H N++ L G C + + LV E+ G L L +R + A A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIA 115
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR--------ISDFGLAKLLKTDQTQTTT 662
RG+ YLH+E IIH D+K NIL+ I+DFGLA+ +T +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173
Query: 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD 722
A G ++APE + + DV+S+G+LL EL+ F + AY
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-------GIDGLAVAYG 225
Query: 723 -CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ L + E ++ C DP RP+ + +
Sbjct: 226 VAMNKLALPIPSTCPEPFAKLMED----------CWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-58
Identities = 71/298 (23%), Positives = 122/298 (40%), Gaps = 35/298 (11%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E LG+G FG+ K E + + +K+L + E ++ F E+ + H N+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+G + + + EY+ G+L + + W +R+ A A G+ YLH I
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-------------TAIRGTKGYV 671
IH D+ N L+ N ++DFGLA+L+ ++TQ + G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
APE KVDV+SFGI+L E++ V+A + D+ +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGR-----VNADPDYLPRTMDFGLNVRGFLDR-- 242
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG---AVDVSIPPDP 786
+ F I + C DP RP+ K+ +E + +P P
Sbjct: 243 ------YCPPNC--PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-57
Identities = 58/290 (20%), Positives = 108/290 (37%), Gaps = 41/290 (14%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISA 552
+K+L F +L E G+++KG + VK L ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 553 IGRTNHKNLVQLLGFCNE--GEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGT 609
+ +H N++ +LG C H L+ ++ GSL + L + + + ++ A
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
ARG+ +LH + I + +++++D ARIS + + +
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 670 YVAPEWFKNLP---ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-CFR 725
+VAPE + P D++SF +LL ELV F + +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-------DLSNMEIGMKVALE 226
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ + +K C+ EDP+ RP + ++E
Sbjct: 227 GLRPTIPPGISPHVSKLMKI----------CMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-56
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLV 562
+ +G G+FG VYKG + VAVK L + Q FK E+ + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
+G+ +V ++ SL L + K + IA TARG+ YLH
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AK 139
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLL-KTDQTQTTTAIRGTKGYVAPEWFKN--- 678
IIH D+K NI L +I DFGLA + + + G+ ++APE +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 679 LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738
P + + DVY+FGI+L EL+ + + + Q+I V
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEM---------------VGRG-S 242
Query: 739 AMDDIKRV-----EKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
D+ +V ++ + C+++ RP+ ++ IE
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-55
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 50/320 (15%)
Query: 475 KQNTVESQKGMPEMNLQDFT--YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAV 532
+ + + LQ++ +++LE E +G+G FG+VY G E VA+
Sbjct: 10 SARSFPRKASQTSIFLQEWDIPFEQLE-----IGELIGKGRFGQVYHGRWHGE----VAI 60
Query: 533 KKLYKAVNEGE--QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFL 590
+ + + + + FK E+ A +T H+N+V +G C H ++ +L +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 591 FRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650
+ K QIA +G+ YLH I+H D+K +N+ D I+DFGL
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 651 KLLK----TDQTQTTTAIRGTKGYVAPEWFKN---------LPITAKVDVYSFGILLLEL 697
+ + G ++APE + LP + DV++ G + EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 698 VCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV--EKFVMIAIW 755
F+ T+ + I+ + + + + ++ I ++
Sbjct: 237 HAREWPFK---TQPAEAIIW--------------QMGTGMK-PNLSQIGMGKEISDILLF 278
Query: 756 CIQEDPSLRPAMKKVTQMIE 775
C + RP K+ M+E
Sbjct: 279 CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 70/319 (21%), Positives = 129/319 (40%), Gaps = 38/319 (11%)
Query: 481 SQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN 540
S G+P + Q K+++ +++G+G +G+V+ G + VAVK
Sbjct: 23 SGSGLPLLV-QRTIAKQIQ-----MVKQIGKGRYGEVWMGKW---RGEKVAVKVF-FTTE 72
Query: 541 EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHR----LLVYEYVSNGSLADFLFRKSRR 596
E + EI H+N++ + +G L+ +Y NGSL D+L KS
Sbjct: 73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTT 130
Query: 597 PNWYKRMQIAFGTARGLFYLHEE-----CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+ +++A+ + GL +LH E K I H D+K +NIL+ I+D GLA
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 652 LL---KTDQTQTTTAIRGTKGYVAPE------WFKNLPITAKVDVYSFGILLLELVCCRK 702
+ GTK Y+ PE + D+YSFG++L E+
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 703 NFEVDATEECQMILAD--WAYDCFRERKLGLLVEND----EEAMDDIKRVEKFVMIAIWC 756
+ + EE Q+ D + + + + + ++ + + + + C
Sbjct: 251 SGGI--VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308
Query: 757 IQEDPSLRPAMKKVTQMIE 775
+P+ R +V + +
Sbjct: 309 WAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-52
Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 37/310 (11%)
Query: 490 LQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAE 549
+Q +++ E +G+G +G+V++G + VAVK + +E + E
Sbjct: 2 MQRTVARDIT-----LLECVGKGRYGEVWRGSW---QGENVAVKIF-SSRDEKSWFRETE 52
Query: 550 ISAIGRTNHKNLVQLLGFCNEGEHR----LLVYEYVSNGSLADFLFRKSRRPNWYKRMQI 605
+ H+N++ + H L+ Y GSL D+L + + ++I
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRI 110
Query: 606 AFGTARGLFYLHEE-----CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL---KTDQ 657
A GL +LH E K I H D+K +NIL+ I+D GLA +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 658 TQTTTAIRGTKGYVAPEWFKNLPITA------KVDVYSFGILLLELVCCRKNFEVDATEE 711
GTK Y+APE +VD+++FG++L E+ + + E+
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI--VED 228
Query: 712 CQMILADWAYD--CFRERKLGLLVEND----EEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
+ D + F + + + V+ + + C ++PS R
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 766 AMKKVTQMIE 775
++ + +
Sbjct: 289 TALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-52
Identities = 72/319 (22%), Positives = 122/319 (38%), Gaps = 38/319 (11%)
Query: 481 SQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN 540
S G+P + Q + + +E +G+G FG+V++G + VAVK +
Sbjct: 28 SGSGLPLLV-QRTIARTIV-----LQESIGKGRFGEVWRGKW---RGEEVAVKIF-SSRE 77
Query: 541 EGEQEFKAEISAIGRTNHKNLVQLLGFC----NEGEHRLLVYEYVSNGSLADFLFRKSRR 596
E +AEI H+N++ + LV +Y +GSL D+L
Sbjct: 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYT 135
Query: 597 PNWYKRMQIAFGTARGLFYLHEE-----CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+++A TA GL +LH E K I H D+K +NIL+ I+D GLA
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 652 LLKTDQTQTTTAI---RGTKGYVAPE------WFKNLPITAKVDVYSFGILLLELVCCRK 702
+ A GTK Y+APE K+ + D+Y+ G++ E+
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 703 NFEVDATEECQMILADWAY-DCFRERKLGLLVENDE-----EAMDDIKRVEKFVMIAIWC 756
+ E+ Q+ D D E ++ E + + I C
Sbjct: 256 IGGI--HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313
Query: 757 IQEDPSLRPAMKKVTQMIE 775
+ + R ++ + +
Sbjct: 314 WYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
E++G G FG+V+ G L + VAVK + + +F E + + +H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L+G C + + +V E V G FL + R +Q+ A G+ YL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-TQTTTA----IRGTKGYVAPEWFKN 678
IH D+ +N L+ +ISDFG+++ + ++ T APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNY 289
Query: 679 LPITAKVDVYSFGILLLELV-------CCRKNFEVDATEECQMILADWAYDCFRERKLGL 731
+++ DV+SFGILL E N + + + G
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-----REFVEK------------GG 332
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ E D + R +M W +P RP+ + Q ++
Sbjct: 333 RLPCPELCPDAVFR----LMEQCW--AYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 67/268 (25%), Positives = 118/268 (44%), Gaps = 24/268 (8%)
Query: 447 YILSATLGGSIFLHLLVTF------IFFHRRNQKKQ----NTVESQKGMPEMNLQDFTYK 496
Y ++ G +++ F + H + ++ P + Y
Sbjct: 154 YRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYD 213
Query: 497 ELEV----ITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISA 552
+ E+ IT K +LG G +G+VY+GV + VAVK L K +EF E +
Sbjct: 214 KWEMERTDIT--MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTL-KEDTMEVEEFLKEAAV 269
Query: 553 IGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTA 610
+ H NLVQLLG C ++ E+++ G+L D+L R+ R + +A +
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 328
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGY 670
+ YL ++ IH ++ +N L+ +++DFGL++L+ D + +
Sbjct: 329 SAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 385
Query: 671 VAPEWFKNLPITAKVDVYSFGILLLELV 698
APE + K DV++FG+LL E+
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIA 413
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 29/268 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVK--KLYKAVNEGEQEFKAEISAIGRTNHKNLV 562
F E+G G+F VYKG L TE VA + K Q FK E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 563 QLLGFC---NEGEHRLLVY-EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
+ +G+ +++ E +++G+L +L ++ + +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 619 ECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
IIH D+K NI + G + +I D GLA L + + + GT ++APE ++
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYE 203
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737
VDVY+FG+ +LE+ + ECQ + +
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSEYPY-----SECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
E + + CI+++ R
Sbjct: 258 EVKE-------IIE---GCIRQNKDERY 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-40
Identities = 66/265 (24%), Positives = 113/265 (42%), Gaps = 23/265 (8%)
Query: 447 YILSATLGGSIFLHLLVTF------IFFHRRNQKK-QNTVESQKGMPEMNLQDFTYKELE 499
Y + G ++ F + ++ ++ + + + + Q E
Sbjct: 121 YKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWE 180
Query: 500 V----ITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR 555
+ + + +LG+G FG+V+ G VA+K L K + F E + +
Sbjct: 181 IPRESLR--LEVKLGQGCFGEVWMGTW--NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK 235
Query: 556 TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGL 613
H+ LVQL +E E +V EY+S GSL DFL + + +A A G+
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 293
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAP 673
Y+ +H D++ NIL+ +++DFGLA+L++ ++ + + AP
Sbjct: 294 AYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 674 EWFKNLPITAKVDVYSFGILLLELV 698
E T K DV+SFGILL EL
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELT 375
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+++LG G FG+V+ VAVK + K + + F AE + + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATY--NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLF-RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
+ E ++ E+++ GSL DFL + + K + + A G+ ++ +
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNLP 680
IH D++ NIL+ + +I+DFGLA++++ ++ TA G K + APE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 681 ITAKVDVYSFGILLLELV 698
T K DV+SFGILL+E+V
Sbjct: 362 FTIKSDVWSFGILLMEIV 379
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 64/313 (20%), Positives = 119/313 (38%), Gaps = 47/313 (15%)
Query: 473 QKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAV 532
+ Q + M L + ++ + I G G F +VY+ + PVA+
Sbjct: 14 PQFQPQKALRPDMGYNTLAN--FRIEKKI--------GRGQFSEVYR-AACLLDGVPVAL 62
Query: 533 KK--LYKAVNEGE-QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADF 589
KK ++ ++ + EI + + NH N+++ E +V E G L+
Sbjct: 63 KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 590 L--FRKSRRP-------NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640
+ F+K +R ++ Q+ L ++H +++H DIKP N+ + T
Sbjct: 123 IKHFKKQKRLIPERTVWKYFV--QLC----SALEHMHSR---RVMHRDIKPANVFITATG 173
Query: 641 NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700
++ D GL + + T + + GT Y++PE K D++S G LL E+
Sbjct: 174 VVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 701 RKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQED 760
+ F D + + + D + E+ + CI D
Sbjct: 233 QSPFYGDKMNLYSLCK--------------KIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 761 PSLRPAMKKVTQM 773
P RP + V +
Sbjct: 279 PEKRPDVTYVYDV 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-39
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+ +LG+G FG+V+ G VA+K L K + F E + + H+ LVQL
Sbjct: 271 LEVKLGQGCFGEVWMGTWN--GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGLFYLHEECKS 622
+E E +V EY+S GSL DFL + + +A A G+ Y+
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM--- 382
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+H D++ NIL+ +++DFGLA+L++ ++ + + APE T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 683 AKVDVYSFGILLLELV 698
K DV+SFGILL EL
Sbjct: 443 IKSDVWSFGILLTELT 458
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F +ELG G FG V G + VA+K + K + E EF E + +H+ LVQL
Sbjct: 28 FLKELGTGQFGVVKYGKWR--GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
G C + ++ EY++NG L ++L R + +++ + YL + Q
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNLPI 681
+H D+ +N L++ ++SDFGL++ + D+ T+ G+K V PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 682 TAKVDVYSFGILLLELV 698
++K D+++FG+L+ E+
Sbjct: 199 SSKSDIWAFGVLMWEIY 215
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL 561
F ++LG+G FG V + VAVKKL + E ++F+ EI + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 562 VQLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
V+ G C R L+ EY+ GSL D+L + R + K +Q +G+ YL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWF 676
+ IH D+ +NIL++ +I DFGL K+L D+ + + + APE
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWYAPESL 189
Query: 677 KNLPITAKVDVYSFGILLLELV 698
+ DV+SFG++L EL
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+ELG G FG V G + VAVK + K + E EF E + + +H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWK--GQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
G C++ +V EY+SNG L ++L + + +++ + G+ +L E Q
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESH-QF 125
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA----IRGTKGYVAPEWFKNLP 680
IH D+ +N L+D ++SDFG+ + + DQ ++ ++ + APE F
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 681 ITAKVDVYSFGILLLELV 698
++K DV++FGIL+ E+
Sbjct: 182 YSSKSDVWAFGILMWEVF 199
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 505 FKEELGEGAFGKVYKGVLTT------ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH 558
F E LG+G F K++KGV +E V +K L KA + F S + + +H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
K+LV G C G+ +LV E+V GSL +L + N ++++A A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-E 130
Query: 619 ECKSQIIHCDIKPQNILLDGTFNAR--------ISDFGLAKLLKTDQTQTTTAIRGTKGY 670
E +IH ++ +NILL + + +SD G++ + I
Sbjct: 131 ENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWV--- 184
Query: 671 VAPEWFKNLPI-TAKVDVYSFGILLLELV 698
PE +N D +SFG L E+
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 20/246 (8%)
Query: 467 FFHRRNQ------KKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKG 520
++H + +N +D T E + F ++LG+G FG V
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLK--FLQQLGKGNFGSVEMC 60
Query: 521 VLTTENEK---PVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHR--L 575
+ VAVKKL + E ++F+ EI + H N+V+ G C R
Sbjct: 61 RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120
Query: 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNIL 635
L+ EY+ GSL D+L + R + K +Q +G+ YL + + IH D+ +NIL
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNIL 177
Query: 636 LDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNLPITAKVDVYSFGI 692
++ +I DFGL K+L D+ + + + APE + DV+SFG+
Sbjct: 178 VENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 693 LLLELV 698
+L EL
Sbjct: 237 VLYELF 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL 561
+ +LG+G FG V + VAVK+L + + +++F+ EI + + +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 562 VQLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
V+ G + LV EY+ +G L DFL R R + + + + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWF 676
+ +H D+ +NIL++ + +I+DFGLAKLL D+ + + APE
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPESL 202
Query: 677 KNLPITAKVDVYSFGILLLELV 698
+ + + DV+SFG++L EL
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELF 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKN 560
+LGEG FGKV E + VAVK L ++ + K EI + H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 561 LVQLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
+V+ G C E L+ E++ +GSL ++L + + N ++++ A +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEW 675
Q +H D+ +N+L++ +I DFGL K ++TD+ + T V APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDRDSPVFWYAPEC 200
Query: 676 FKNLPITAKVDVYSFGILLLELV 698
DV+SFG+ L EL+
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELL 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 58/231 (25%), Positives = 110/231 (47%), Gaps = 28/231 (12%)
Query: 487 EMNLQDFTYKELE---VITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEG 542
++ ++ ++ +E + +++GEG+FGK V +TE+ + +K++ ++
Sbjct: 12 DLGTENLYFQSMEKYVRL-----QKIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSK 65
Query: 543 E-QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---- 597
E +E + E++ + H N+VQ E +V +Y G L + +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 598 ---NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK 654
+W+ +QI L ++H+ +I+H DIK QNI L ++ DFG+A++L
Sbjct: 126 QILDWF--VQIC----LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 655 TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFE 705
+ I GT Y++PE +N P K D+++ G +L EL + FE
Sbjct: 177 STVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F +E+G G FG V+ G ++ VA+K + + E++F E + + +H LVQL
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKD--KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
G C E LV E++ +G L+D+L + + + G+ YL E + +
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACV 125
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNLPI 681
IH D+ +N L+ ++SDFG+ + + DQ T+ GTK V +PE F
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRY 182
Query: 682 TAKVDVYSFGILLLELV 698
++K DV+SFG+L+ E+
Sbjct: 183 SSKSDVWSFGVLMWEVF 199
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 63/201 (31%), Positives = 111/201 (55%), Gaps = 11/201 (5%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHKN 560
++ +G G FG+VYKG+L T + K PVA+K L E ++ +F E +G+ +H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+++L G ++ + +++ EY+ NG+L FL K + + + + G A G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
+H D+ +NIL++ ++SDFGL+++L+ D + T G K + APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 678 NLPITAKVDVYSFGILLLELV 698
T+ DV+SFGI++ E++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVM 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 505 FKEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNL 561
++ +G G G+V G L + + PVA+K L ++F +E S +G+ +H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
++L G G ++V EY+ NGSL FL + + + + G G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKN 678
+H D+ +N+L+D ++SDFGL+++L+ D G K + APE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 679 LPITAKVDVYSFGILLLELV 698
++ DV+SFG+++ E++
Sbjct: 229 RTFSSASDVWSFGVVMWEVL 248
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-38
Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+ +G+G FG V G VAVK + + Q F AE S + + H NLVQL
Sbjct: 197 LLQTIGKGEFGDVMLGDY---RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 565 LGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQ---IAFGTARGLFYLHEEC 620
LG E + L +V EY++ GSL D+L +SR + + + YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+H D+ +N+L+ A++SDFGL K + Q ++ T APE +
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 362
Query: 681 ITAKVDVYSFGILLLELV 698
+ K DV+SFGILL E+
Sbjct: 363 FSTKSDVWSFGILLWEIY 380
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 59/285 (20%), Positives = 115/285 (40%), Gaps = 57/285 (20%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E +G G FG+V+K + K +K+ V ++ + E+ A+ + +H N+V G
Sbjct: 17 ELIGSGGFGQVFK-AKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVHYNG 71
Query: 567 FCNEGEHRL----------------LVYEYVSNGSLADFLFRKSRRP-----NWYKRMQI 605
+ ++ + E+ G+L ++ ++ QI
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665
+G+ Y+H + ++I+ D+KP NI L T +I DFGL LK D +T +
Sbjct: 132 T----KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725
GT Y++PE + +VD+Y+ G++L EL+ + ++ + D F
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDLRDGIISDIF- 240
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
D++ ++ + + P RP ++
Sbjct: 241 ----------DKKEKTLLQ----------KLLSKKPEDRPNTSEI 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKN 560
+ LG GAFG VYKG+ E EK PVA+K+L +A + +E E + ++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ +LLG C L+ + + G L D++ + A+G+ YL E+
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDR 136
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
+ ++H D+ +N+L+ + +I+DFGLAKLL ++ + G K + A E
Sbjct: 137 R--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 678 NLPITAKVDVYSFGILLLELV 698
+ T + DV+S+G+ + EL+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 63/307 (20%), Positives = 111/307 (36%), Gaps = 41/307 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F ++LGEG F V V + A+K++ + +E + E NH N+++L
Sbjct: 33 FIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 565 LGFC----NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR---MQIAFGTARGLFYLH 617
+ +C L+ + G+L + + R + N+ + + G RGL +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR--------GTKG 669
+ H D+KP NILL + D G + A+ T
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 670 YVAPEWF---KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE 726
Y APE F + I + DV+S G +L ++ +++ + + LA
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA--------- 259
Query: 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDP 786
V+N + + + DP RP + + +E PP P
Sbjct: 260 ------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE----ALQPPAP 309
Query: 787 ASFISSI 793
+ I
Sbjct: 310 GQHTTQI 316
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 24/237 (10%)
Query: 470 RRNQKKQNTVESQKGMPEMNLQDFTYKE-LEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
+R + E ++ D+ Y+E + +T +G G+FG+V++ +
Sbjct: 28 QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ--PRVGRGSFGEVHRM-KDKQTGF 84
Query: 529 PVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLAD 588
AVKK+ + E E+ A + +V L G EG + E + GSL
Sbjct: 85 QCAVKKV--RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 589 FLFRKSRRPNWYKRMQIAFGTA---RGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARI 644
+ K + + GL YLH +I+H D+K N+LL A +
Sbjct: 140 LI--KQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAAL 192
Query: 645 SDFGLAKLLKTDQTQTTTA----IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
DFG A L+ D + I GT+ ++APE P AKVD++S ++L +
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEF-KAEISAIGRTNHKNLVQL 564
+G G++G+ K + + K + K+L Y ++ E E++ +E++ + H N+V+
Sbjct: 12 YTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 565 LG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPN-------WYKRMQIAFGTARGLFY 615
+ L +V EY G LA + + ++ Q+ L
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT----LALKE 126
Query: 616 LHEECKS--QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAP 673
H ++H D+KP N+ LDG N ++ DFGLA++L D + T + GT Y++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 674 EWFKNLPITAKVDVYSFGILLLELVCCRKNFE 705
E + K D++S G LL EL F
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
K +LG G +G+VY+GV + VAVK L K +EF E + + H NLVQL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYS-LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGLFYLHEECKS 622
LG C ++ E+++ G+L D+L R+ R + +A + + YL +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---K 130
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-TQTTTA---IRGTKGYVAPEWFKN 678
IH D+ +N L+ +++DFGL++L+ D T A I+ T APE
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 186
Query: 679 LPITAKVDVYSFGILLLELV 698
+ K DV++FG+LL E+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 68/279 (24%), Positives = 117/279 (41%), Gaps = 38/279 (13%)
Query: 505 FKEELGEGAFGK-VYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLV 562
K+ LG GA G VY+G+ + VAVK++ E+ + ++ H N++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDN---RDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
+ + + + + E + +L +++ +K + + + T GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---L 137
Query: 623 QIIHCDIKPQNILL-----DGTFNARISDFGLAKLLKTDQ--TQTTTAIRGTKGYVAPEW 675
I+H D+KP NIL+ G A ISDFGL K L + + + GT+G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 676 FK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMIL-ADWAYDCFRERKLGL 731
T VD++S G + ++ + + + IL + DC K
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK--- 254
Query: 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
D A + I++ I DP RP+ K V
Sbjct: 255 --HEDVIARELIEK----------MIAMDPQKRPSAKHV 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 31/216 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLVQ 563
+ LG+GA V++G + A+K + E + + NHKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 564 LLGF--CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTARGLFY 615
L H++L+ E+ GSL L S + + G+ +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV----VGGMNH 127
Query: 616 LHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
L E I+H +IKP NI+ DG +++DFG A+ L+ D+ + + GT+ Y+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182
Query: 672 APE--------WFKNLPITAKVDVYSFGILLLELVC 699
P+ A VD++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 15/223 (6%)
Query: 484 GMPEMNLQDFTYKEL--EVITGGFKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV 539
P + +F KEL I+ + +G G FG+V G L ++ E VA+K L
Sbjct: 29 EDPTQTVHEFA-KELDATNIS--IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 540 NEGEQ-EFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN 598
E ++ +F E S +G+ +H N+++L G + + ++V EY+ NGSL FL + +
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 599 WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658
+ + + G A G+ YL + +H D+ +NIL++ ++SDFGL ++L+ D
Sbjct: 146 VIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDP 201
Query: 659 QTTTAIRGTKGYV---APEWFKNLPITAKVDVYSFGILLLELV 698
+ RG K + +PE T+ DV+S+GI+L E++
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E LG G FG+V+ G VAVK L K + F AE + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYN--GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGLFYLHEECKS 622
+ E ++ EY+ NGSL DFL + + +A A G+ ++ E
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNL 679
IH D++ NIL+ T + +I+DFGLA+L++ ++ TA G K + APE
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYG 185
Query: 680 PITAKVDVYSFGILLLELV 698
T K DV+SFGILL E+V
Sbjct: 186 TFTIKSDVWSFGILLTEIV 204
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 46/229 (20%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
LG+GAFG+V K ++ A+KK+ + +E+ + NH+ +V+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRY-YAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRY 67
Query: 565 LGFCNEGEHRL-------------LVYEYVSNGSLADFLFRKSRRPN------WYKRMQI 605
E + + + EY NG+L D + ++ ++ QI
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QI 125
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD--------- 656
L Y+H + IIH D+KP NI +D + N +I DFGLAK +
Sbjct: 126 L----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 657 -----QTQTTTAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVC 699
T+AI GT YVA E K+D+YS GI+ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKN 560
+ LG G FG V+KGV E E PV +K + K+ + Q + AIG +H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+V+LLG C G LV +Y+ GSL D + + + A+G++YL E
Sbjct: 77 IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
++H ++ +N+LL +++DFG+A LL D Q K + A E
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIH 190
Query: 678 NLPITAKVDVYSFGILLLELV 698
T + DV+S+G+ + EL+
Sbjct: 191 FGKYTHQSDVWSYGVTVWELM 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 506 KEELGEGAFGKVYKGVLTTENEK-PVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNLVQ 563
ELG G FG V +GV ++ VA+K L + +E E + + ++ +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L+G C + E +LV E G L FL K ++ + G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNLP 680
+H D+ +N+LL A+ISDFGL+K L D + TA K + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 681 ITAKVDVYSFGILLLELV 698
+++ DV+S+G+ + E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 508 ELGEGAFGKVYKGVLTTENEK-PVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQL 564
ELG G FG V KG + VAVK L N+ + E AE + + + ++ +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+G C E E +LV E G L +L +++R +++ + G+ YL EE
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYL-EESN--F 138
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKNLPI 681
+H D+ +N+LL A+ISDFGL+K L+ D+ A K V APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYKF 197
Query: 682 TAKVDVYSFGILLLELV 698
++K DV+SFG+L+ E
Sbjct: 198 SSKSDVWSFGVLMWEAF 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLVQ 563
+ LG+GA V++G + A+K + E + + NHKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 564 LLGFCNEGEHRL--LVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTARGLFY 615
L E R L+ E+ GSL L S + + G+ +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV----VGGMNH 127
Query: 616 LHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
L E I+H +IKP NI+ DG +++DFG A+ L+ D+ + GT+ Y+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYL 182
Query: 672 APEWFKNLPI--------TAKVDVYSFGILLLELVC 699
P+ ++ + A VD++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
K ELGEGAFGKV+ +++ VAVK L +A Q+F+ E + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR----------------MQ 604
+V+ G C EG L+V+EY+ +G L FL +S P+ +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664
+A A G+ YL +H D+ +N L+ +I DFG+++ + +
Sbjct: 163 VASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---- 215
Query: 665 RGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
G + + PE T + DV+SFG++L E+
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 62/203 (30%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKN 560
+LGEG FGKV N+ VAVK L +K EI + H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 561 LVQLLGFCNEGEHR--LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
+++ G C + LV EYV GSL D+L + + A G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEW 675
+ IH D+ +N+LLD +I DFGLAK + + V APE
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAPEC 208
Query: 676 FKNLPITAKVDVYSFGILLLELV 698
K DV+SFG+ L EL+
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELL 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNL 561
LGEG FG+VY+GV T + VAVK K + +++F +E + +H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L+G E E ++ E G L +L R + + + + YL E
Sbjct: 76 VKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESIN 133
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFKN 678
+H DI +NIL+ ++ DFGL++ ++ + T+ + +PE
Sbjct: 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINF 188
Query: 679 LPITAKVDVYSFGILLLELV 698
T DV+ F + + E++
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 65/196 (33%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC 568
LG+G +G VY G + + +A+K++ + + Q EI+ HKN+VQ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVR-IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 569 NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA---RGLFYLHEECKSQII 625
+E + E V GSL+ L R P I F T GL YLH+ QI+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 626 HCDIKPQNILLDGTFN--ARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI-- 681
H DIK N+L++ T++ +ISDFG +K L T T GT Y+APE P
Sbjct: 145 HRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 682 TAKVDVYSFGILLLEL 697
D++S G ++E+
Sbjct: 203 GKAADIWSLGCTIIEM 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-36
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLVQ 563
KE LG G FG V + + E+ VA+K+ + ++ +E + EI + + NH N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ-VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 564 LL------GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTAR 611
+ LL EY G L +L + + I+
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS----S 132
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLAKLLKTDQTQTTTAIRGTK 668
L YLHE ++IIH D+KP+NI+L I D G AK L + T GT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTL 187
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
Y+APE + T VD +SFG L E +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQE--FKAEISAIGRTNHKNLVQLL 565
LG+G FG VY +++ +A+K L+KA + + E + E+ H N+++L
Sbjct: 17 LGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G+ ++ L+ EY G++ L + S+ A L Y H ++I
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRVI 131
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKV 685
H DIKP+N+LL +I+DFG + + + GT Y+ PE + KV
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKV 188
Query: 686 DVYSFGILLLELVC 699
D++S G+L E +
Sbjct: 189 DLWSLGVLCYEFLV 202
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG--EQEFKAEISAIGRTNHKNLV 562
+ +G+G FG V G VAVK + Q F AE S + + H NLV
Sbjct: 25 LLQTIGKGEFGDVMLGDY---RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 563 QLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKR--MQIAFGTARGLFYLHEE 619
QLLG E + L +V EY++ GSL D+L R R ++ + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL 679
+H D+ +N+L+ A++SDFGL K + Q ++ T APE +
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 189
Query: 680 PITAKVDVYSFGILLLELV 698
+ K DV+SFGILL E+
Sbjct: 190 KFSTKSDVWSFGILLWEIY 208
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
K ELGEGAFGKV+ T+++ VAVK L ++F+ E + H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-----------------M 603
+V+ G C +G+ ++V+EY+ +G L FL ++ P+ +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL-KTDQTQTTT 662
IA A G+ YL +H D+ +N L+ +I DFG+++ + TD +
Sbjct: 137 HIASQIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 663 A----IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
IR PE T + DV+SFG++L E+
Sbjct: 194 HTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKN 560
+ LG GAFG VYKG+ E EK PVA+K+L +A + +E E + ++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ +LLG C L+ + + G L D++ + A+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
++H D+ +N+L+ + +I+DFGLAKLL ++ + G K + A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 678 NLPITAKVDVYSFGILLLELV 698
+ T + DV+S+G+ + EL+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKL---YKAVNEGEQEFKAEISAIGRTNHK 559
E+LG+G+FG V +G + K VAVK L + E +F E++A+ +H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
NL++L G +V E GSL D L + + A A G+ YL +
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWF 676
+ IH D+ +N+LL +I DFGL + L + K APE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-EHRKVPFAWCAPESL 196
Query: 677 KNLPITAKVDVYSFGILLLELV 698
K + D + FG+ L E+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMF 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNL 561
F E +G G FG VY G L + K AVK L + + GE +F E + +H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 562 VQLLGFCNEGEH-RLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ LLG C E L+V Y+ +G L +F+ ++ P + A+G+ YL +
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
+ +H D+ +N +LD F +++DFGLA+ + + + G K V A E +
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 678 NLPITAKVDVYSFGILLLELV 698
T K DV+SFG+LL EL+
Sbjct: 206 TQKFTTKSDVWSFGVLLWELM 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-36
Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 51/296 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQ 563
++ LG G+ G V + +PVAVK++ + EI + + +H N+++
Sbjct: 19 SEKILGYGSSGTVVFQ--GSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIR 73
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTARGLFYLH 617
+ E N +L D + K+ K + A G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 618 EECKSQIIHCDIKPQNILLDGT-------------FNARISDFGLAKLLKTDQTQTTTAI 664
+IIH D+KPQNIL+ + ISDFGL K L + Q+ T +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 665 R---GTKGYVAPE-------WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM 714
GT G+ APE +T +D++S G + ++ K+ D
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
I+ + E K EA D I + I DP RP KV
Sbjct: 250 IIRG-IFS-LDEMKCLHDRSLIAEATDLISQ----------MIDHDPLKRPTAMKV 293
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 505 FKEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNL 561
+G+G FG VY G +N A+K L + + + F E + NH N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 562 VQLLGFCNEGE-HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ L+G E ++ Y+ +G L F+ R P + ARG+ YL E+
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ- 143
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
+ +H D+ +N +LD +F +++DFGLA+ + + + R + V A E +
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 678 NLPITAKVDVYSFGILLLELV 698
T K DV+SFG+LL EL+
Sbjct: 202 TYRFTTKSDVWSFGVLLWELL 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEI---SAIGRT 556
F + LG GAFGKV + + VAVK L + E + +E+ S +G+
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ- 108
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-------------M 603
H+N+V LLG C G L++ EY G L +FL RKSR +
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663
+ A+G+ +L K IH D+ +N+LL A+I DFGLA+ + D
Sbjct: 168 HFSSQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--- 221
Query: 664 IRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ APE + T + DV+S+GILL E+
Sbjct: 222 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQE--FKAEISAIGRTNHKNLVQLL 565
LG+G FG VY +N+ +A+K L+K+ + + E + EI H N++++
Sbjct: 22 LGKGKFGNVYL-AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM---QIAFGTARGLFYLHEECKS 622
+ ++ + L+ E+ G L L + R ++A L Y H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA----DALHYCH---ER 133
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
++IH DIKP+N+L+ +I+DFG + + + +T GT Y+ PE +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHD 190
Query: 683 AKVDVYSFGILLLELVC 699
KVD++ G+L E +
Sbjct: 191 EKVDLWCAGVLCYEFLV 207
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHK 559
ELG+G+FG VY+GV E E VA+K + +A + E EF E S + N
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-----------MQIAFG 608
++V+LLG ++G+ L++ E ++ G L +L +S RP +Q+A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
A G+ YL+ ++ +H D+ +N ++ F +I DFG+ + + +G K
Sbjct: 147 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGK 199
Query: 669 GYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
G + +PE K+ T DV+SFG++L E+
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEI---SAIGRT 556
F + LG GAFGKV + ++ VAVK L + + E + +E+ S +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-------------- 602
H N+V LLG C G L++ EY G L +FL R+ R +
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALD 143
Query: 603 ----MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658
+ ++ A+G+ +L + IH D+ +NILL +I DFGLA+ +K D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 659 QTTTAIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ APE N T + DV+S+GI L EL
Sbjct: 201 YV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 47/223 (21%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
+ LG G FG V++ ++ A+K++ E ++ E+ A+ + H +V+
Sbjct: 11 QCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 566 GF---------CNEGEHRLLVY---EYVSNGSLADFLFRKSRRPN------WYKRMQIAF 607
++ +Y + +L D++ + + +QIA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA- 128
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR-- 665
+ +LH + ++H D+KP NI ++ DFGL + D+ + T
Sbjct: 129 ---EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 666 ---------GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
GTK Y++PE + KVD++S G++L EL+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHK 559
LG GAFG+VY+G ++ + VAVK L + +E ++ +F E I + NH+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--------MQIAFGTAR 611
N+V+ +G + R ++ E ++ G L FL + RP + + +A A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLAKLLKTDQTQTTTAIRGTK 668
G YL E + IH DI +N LL R I DFG+A+ + +G
Sbjct: 152 GCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KGGC 204
Query: 669 GYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ PE F T+K D +SFG+LL E+
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 46/246 (18%), Positives = 84/246 (34%), Gaps = 31/246 (12%)
Query: 477 NTVESQKGMPEMNLQDFTYKELEVITGGF--KEELGEGAFGKVYKGVLTTENE----KPV 530
NT E Q +P + + E ++ + LGEGAF +VY+ N+ +
Sbjct: 43 NTFEWQCKLPAIKPK----TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 531 AVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFL 590
+K A + + + ++ +LV E S G+L + +
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 591 FRKSRRPNW-----YKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL--------- 636
+ + A + +H +IIH DIKP N +L
Sbjct: 159 -NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214
Query: 637 --DGTFNARISDFGLAKLLKT-DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGIL 693
D + + D G + +K + TA T G+ E N P ++D +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 694 LLELVC 699
+ ++
Sbjct: 275 VYCMLF 280
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNL 561
F E +G G FG VY G L + K AVK L + + GE +F E + +H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 562 VQLLGFCNEGEH-RLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ LLG C E L+V Y+ +G L +F+ ++ P + A+G+ +L +
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK- 211
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV---APEWFK 677
+ +H D+ +N +LD F +++DFGLA+ + + + G K V A E +
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 678 NLPITAKVDVYSFGILLLELV 698
T K DV+SFG+LL EL+
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 61/323 (18%), Positives = 126/323 (39%), Gaps = 57/323 (17%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
H + + M+++ Y L+ I G G KV++ E ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQI--------GSGGSSKVFQV--LNEKKQ 53
Query: 529 PVAVK--KLYKAVNEGEQEFKAEISAIGRTNHKNL--VQLLGFCNEGEHRLLVYEYVSNG 584
A+K L +A N+ ++ EI+ + + + ++L + ++ +V E N
Sbjct: 54 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 112
Query: 585 SLADFLFRKSRRPNWYKRM---QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641
L +L +K W ++ + + +H+ I+H D+KP N L+
Sbjct: 113 DLNSWLKKKKSIDPWERKSYWKNML----EAVHTIHQH---GIVHSDLKPANFLIVDG-M 164
Query: 642 ARISDFGLAKLLKTDQTQTT-TAIRGTKGYVAPEWFKNLP-----------ITAKVDVYS 689
++ DFG+A ++ D T + GT Y+ PE K++ I+ K DV+S
Sbjct: 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224
Query: 690 FGILLLELVCCRKNFEVDATEECQMILA--DWAYDCFRERKLGLLVENDEEAMDDIKRVE 747
G +L + + F+ + + A D ++ +++ D +K
Sbjct: 225 LGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLKC-- 275
Query: 748 KFVMIAIWCIQEDPSLRPAMKKV 770
C++ DP R ++ ++
Sbjct: 276 --------CLKRDPKQRISIPEL 290
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 45/201 (22%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYK-AVNEGEQEFKAEISAIGRTNHKNL 561
+GEG FG V++G+ + VA+K + ++F E + + +H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L+G ++ E + G L FL + + + A+ + L YL E +
Sbjct: 79 VKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR 136
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA----IRGTKGYVAPEWFK 677
+H DI +N+L+ ++ DFGL++ ++ + I+ APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190
Query: 678 NLPITAKVDVYSFGILLLELV 698
T+ DV+ FG+ + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 69/273 (25%), Positives = 105/273 (38%), Gaps = 56/273 (20%)
Query: 470 RRNQKKQNTVESQKGMPEMNLQDFTY----KELEV----ITGGFKEELGEGAFGKVYKGV 521
R + Q + E DF + E + F + LG GAFGKV
Sbjct: 8 RYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLE--FGKVLGSGAFGKVMNAT 65
Query: 522 LT----TENEKPVAVKKLYKAVNEGE-QEFKAEI---SAIGRTNHKNLVQLLGFCNEGEH 573
T VAVK L + + E + +E+ + +G H+N+V LLG C
Sbjct: 66 AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACTLSGP 123
Query: 574 RLLVYEYVSNGSLADFLFRKSRRPNWYKR-----------------------MQIAFGTA 610
L++EY G L ++L R R + A+ A
Sbjct: 124 IYLIFEYCCYGDLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGY 670
+G+ +L E K +H D+ +N+L+ +I DFGLA+ + +D
Sbjct: 183 KGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV----VRGNAR 235
Query: 671 V-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ APE T K DV+S+GILL E+
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 57/243 (23%), Positives = 90/243 (37%), Gaps = 16/243 (6%)
Query: 468 FHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFK-----EELGEGAFGKVYKGVL 522
+ + + Q S +G LQ Y + + LG G++G+V+K V
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFK-VR 77
Query: 523 TTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYE 579
+ E+ + AVK+ + AE+ + + H V+L EG L E
Sbjct: 78 SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137
Query: 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT 639
SL + T L +LH ++H D+KP NI L
Sbjct: 138 LCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPR 193
Query: 640 FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
++ DFGL L T G Y+APE + DV+S G+ +LE+ C
Sbjct: 194 GRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250
Query: 700 CRK 702
+
Sbjct: 251 NME 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQL 564
+ L EG F VY+ + + A+K+L E + E+ + + + H N+VQ
Sbjct: 33 RRVLAEGGFAFVYE-AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 565 LGFC-------NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTAR 611
+ G+ L+ + G L +FL + R + +I + T R
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR----GPLSCDTVLKIFYQTCR 147
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI------- 664
+ ++H K IIH D+K +N+LL ++ DFG A + + +A
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 665 ----RGTKGYVAPE---WFKNLPITAKVDVYSFGILLLELVCCRKNFE 705
T Y PE + N PI K D+++ G +L L + FE
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 8e-35
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 487 EMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK-PVAVKKLYK-AVNEGEQ 544
E+ + K ++ ELG G FG V +GV ++ VA+K L + +
Sbjct: 324 ELKDKKLFLKRDNLLIA--DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381
Query: 545 EFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ 604
E E + + ++ +V+L+G C + E +LV E G L FL K +
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664
+ + G+ YL EE +H ++ +N+LL A+ISDFGL+K L D + TA
Sbjct: 441 LLHQVSMGMKYL-EEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTAR 496
Query: 665 RGTKGYV---APEWFKNLPITAKVDVYSFGILLLELV 698
K + APE +++ DV+S+G+ + E +
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-35
Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNL 561
+GEG FG V++G+ + VA+K ++ ++F E + + +H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L+G ++ E + G L FL + + + A+ + L YL E +
Sbjct: 454 VKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR 511
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA----IRGTKGYVAPEWFK 677
+H DI +N+L+ ++ DFGL++ ++ + I+ APE
Sbjct: 512 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 678 NLPITAKVDVYSFGILLLELV 698
T+ DV+ FG+ + E++
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHK 559
LG GAFG+VY+G ++ + VAVK L + +E ++ +F E I + NH+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR--------MQIAFGTAR 611
N+V+ +G + R ++ E ++ G L FL + RP + + +A A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLAKLLKTDQTQTTTAIRGTK 668
G YL E + IH DI +N LL R I DFG+A+ + +G
Sbjct: 193 GCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGC 245
Query: 669 GYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ PE F T+K D +SFG+LL E+
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHK 559
F EELGE FGKVYKG L E + VA+K L +EF+ E R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR----------------- 602
N+V LLG + + +++ Y S+G L +FL R P+
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL--VMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
+ + A G+ YL ++H D+ +N+L+ N +ISD GL + +
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 663 A-----IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
IR APE + D++S+G++L E+
Sbjct: 188 GNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK-PVAVKKLYKAVNEGE-QEFKAEISAIGR-TNHKNL 561
F++ +GEG FG+V K + + + A+K++ + ++ + ++F E+ + + +H N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR----------------MQI 605
+ LLG C + L EY +G+L DFL RKSR +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA-- 663
A ARG+ YL K Q IH D+ +NIL+ + A+I+DFGL++ + T
Sbjct: 148 AADVARGMDYL--SQK-QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202
Query: 664 --IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+R A E T DV+S+G+LL E+V
Sbjct: 203 LPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 42/228 (18%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHK 559
+ LGEG FGKV K VAVK L + + E ++ +E + + + NH
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR----------------- 602
++++L G C++ LL+ EY GSL FL R+SR+
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 603 -------MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655
+ A+ ++G+ YL +++H D+ +NIL+ +ISDFGL++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 656 DQTQTTTAIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ + + ++G + A E + T + DV+SFG+LL E+V
Sbjct: 203 EDSYV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ---EFKAEISAIGRTNHKNLVQ 563
++LG G VY T N VA+K ++ E E+ F+ E+ + +H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
++ E + LV EY+ +L++++ + + G+ + H+ +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT-AIRGTKGYVAPEWFKNLPIT 682
I+H DIKPQNIL+D +I DFG+AK L ++ + T T + GT Y +PE K
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 683 AKVDVYSFGILLLELVCCRKNFEVD 707
D+YS GI+L E++ F +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 43/226 (19%)
Query: 505 FKEELGEGAFGKVYKGVLT------TENEKPVAVKKLYKAVNEGE-QEFKAEIS---AIG 554
+ LGEGAFG+V + VAVK L E + + +E+ IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 555 RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR------------ 602
+ HKN++ LLG C + ++ EY S G+L ++L ++RRP +
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQM 154
Query: 603 -----MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657
+ + ARG+ YL K IH D+ +N+L+ +I+DFGLA+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 658 TQTTTAIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ T G + APE + T + DV+SFG+L+ E+
Sbjct: 212 YYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 55/287 (19%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVK--KLYKAVNEGEQEFKAEISAIGRTNHKNL--V 562
+++G G KV++ E ++ A+K L +A N+ ++ EI+ + + + +
Sbjct: 15 KQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM---QIAFGTARGLFYLHEE 619
+L + ++ +V E N L +L +K W ++ + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIHQH 127
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-TAIRGTKGYVAPEWFKN 678
I+H D+KP N L+ ++ DFG+A ++ D T + GT Y+ PE K+
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 679 LP-----------ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER 727
+ I+ K DV+S G +L + + F+ + ++
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------HAII 234
Query: 728 KLGLLVEN----DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+E +++ D +K C++ DP R ++ ++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKC----------CLKRDPKQRISIPEL 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 36/218 (16%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-----------------VNEGEQEFKAEIS 551
L +G F K+ L ++ K A+KK K+ + +FK E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR 611
I ++ + G + ++YEY+ N S+ F + I +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIK 154
Query: 612 --------GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663
Y+H + I H D+KP NIL+D ++SDFG ++ + + + +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS-- 210
Query: 664 IRGTKGYVAPEWFKNLPIT--AKVDVYSFGILLLELVC 699
RGT ++ PE+F N AKVD++S GI L +
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-34
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 505 FKEELGEGAFGKVYKGVLT------TENEKPVAVKKLYKAVNEGE-QEFKAEIS---AIG 554
+ LGEGAFG+V VAVK L E + + +E+ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 555 RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR------------ 602
+ HKN++ LLG C + ++ EY S G+L ++L ++RRP +
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQL 188
Query: 603 -----MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657
+ A+ ARG+ YL K + IH D+ +N+L+ +I+DFGLA+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 658 TQTTTAIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ T G + APE + T + DV+SFG+LL E+
Sbjct: 246 YYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 43/226 (19%)
Query: 505 FKEELGEGAFGKVYKGVLT------TENEKPVAVKKLYKAVNEGE-QEFKAEI---SAIG 554
+ LGEG FG+V + VAVK L E + + +E+ IG
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 555 RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR------------ 602
+ HKN++ LLG C + ++ EY S G+L ++L ++RRP +
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQM 200
Query: 603 -----MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657
+ + ARG+ YL K IH D+ +N+L+ +I+DFGLA+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 658 --TQTTTA---IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+TT ++ APE + T + DV+SFG+L+ E+
Sbjct: 258 YYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 20/237 (8%)
Query: 472 NQKKQNTVESQKGMPEMNLQDFTYKELEVITGG-----FK--EELGEGAFGKVYKGVLTT 524
+ T + + F V+ G ++GEG+ G V
Sbjct: 9 SGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR-EK 67
Query: 525 ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584
+ + VAVK + + + E+ + H N+V++ GE ++ E++ G
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 585 SLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641
+L D + QIA + L YLH + +IH DIK +ILL
Sbjct: 128 ALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR 179
Query: 642 ARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
++SDFG + D + + + GT ++APE +VD++S GI+++E+V
Sbjct: 180 VKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 58/325 (17%), Positives = 127/325 (39%), Gaps = 56/325 (17%)
Query: 472 NQKKQNTVESQKGMPEMNLQDFTYKELEVITGG---FKEELGEGAFGKVYKGVLTTENEK 528
++Q+ G + + + E + G +++G G KV++ E ++
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV--LNEKKQ 81
Query: 529 PVAVK--KLYKAVNEGEQEFKAEISAIGRTNHKNL--VQLLGFCNEGEHRLLVYEYVSNG 584
A+K L +A N+ ++ EI+ + + + ++L + ++ +V E N
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 140
Query: 585 SLADFLFRKSRRPNWYKRM---QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641
L +L +K W ++ + + +H+ I+H D+KP N L+
Sbjct: 141 DLNSWLKKKKSIDPWERKSYWKNML----EAVHTIHQH---GIVHSDLKPANFLIVDG-M 192
Query: 642 ARISDFGLAKLLKTDQTQTT-TAIRGTKGYVAPEWFKNLP-----------ITAKVDVYS 689
++ DFG+A ++ D T + G Y+ PE K++ I+ K DV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 690 FGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN----DEEAMDDIKR 745
G +L + + F+ + ++ +E +++ D +K
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKL---------HAIIDPNHEIEFPDIPEKDLQDVLKC 303
Query: 746 VEKFVMIAIWCIQEDPSLRPAMKKV 770
C++ DP R ++ ++
Sbjct: 304 ----------CLKRDPKQRISIPEL 318
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E++G+GA G VY + + VA++++ ++ EI + + N+V L
Sbjct: 26 EKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
G+ +V EY++ GSL D + QIA + L +LH Q
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
+IH DIK NILL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 684 KVDVYSFGILLLELV 698
KVD++S GI+ +E++
Sbjct: 196 KVDIWSLGIMAIEMI 210
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 40/240 (16%)
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQE 545
M ++ E + E++G G FG V+K V + A+K+ A + EQ
Sbjct: 3 MGMKSRYTTEFHEL-----EKIGSGEFGSVFKCVKRLDGCI-YAIKRSKKPLAGSVDEQN 56
Query: 546 FKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ 604
E+ A H ++V+ E +H L+ EY + GSLAD + R +++K +
Sbjct: 57 ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116
Query: 605 IAFGT---ARGLFYLHEECKSQIIHCDIKPQNILLD-------------------GTFNA 642
+ RGL Y+H ++H DIKP NI +
Sbjct: 117 LKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITAKVDVYSFGILLLELVCCR 701
+I D G + + Q + G ++A E +N K D+++ + ++
Sbjct: 174 KIGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEIS---AIGRT 556
+ LG GAFG+V + T + VAVK L + E + +E+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 557 NHKNLVQLLGFC-NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR------------- 602
H N+V LLG C G +++ E+ G+L+ +L R R +
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 603 ---MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659
+ +F A+G+ +L + + IH D+ +NILL +I DFGLA+ + D
Sbjct: 148 EHLICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 660 TTTAIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
R + APE + T + DV+SFG+LL E+
Sbjct: 205 V----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGEQE---FKAEISAIGRTNHK 559
+ LGEG FG V +G L E+ VAVK + K N ++E F +E + + +H
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 560 NLVQLLGFCNEGE-----HRLLVYEYVSNGSLADFLFRKSRRPNWYKR------MQIAFG 608
N+++LLG C E +++ ++ G L +L SR K ++
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVD 155
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ--TQTTTA--- 663
A G+ YL +H D+ +N +L ++DFGL+K + + Q A
Sbjct: 156 IALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
++ A E + T+K DV++FG+ + E+
Sbjct: 213 VKWI----AIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEG-EQEFKAEISAIGRTNHKNLVQLL 565
LG+G F K ++ E A K + K+ + ++ EIS H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEV-FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR---MQIAFGTARGLFYLHEECKS 622
GF + + +V E SL + R+ R QI G YLH ++
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RN 134
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
++IH D+K N+ L+ +I DFGLA ++ D + + GT Y+APE +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEE 711
+VDV+S G ++ L+ + FE +E
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYK-AVNEGE-QEFKAEISAIGRTNHKN 560
LG+G FG V + L E+ VAVK L + + +EF E + + +H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 561 LVQLLGFCNEGEHR------LLVYEYVSNGSLADFLFRKSRRPNWYKR------MQIAFG 608
+ +L+G + +++ ++ +G L FL SR ++
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVD 145
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ--TQTTTA--- 663
A G+ YL IH D+ +N +L ++DFGL++ + + Q +
Sbjct: 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
++ A E + T DV++FG+ + E++
Sbjct: 203 VKWL----ALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEG-EQEFKAEISAIGRTNHKNLVQLL 565
LG+G F K ++ E A K + K+ + ++ EIS H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEV-FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR---MQIAFGTARGLFYLHEECKS 622
GF + + +V E SL + R+ R QI G YLH ++
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RN 160
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
++IH D+K N+ L+ +I DFGLA ++ D + + GT Y+APE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 683 AKVDVYSFGILLLELVC 699
+VDV+S G ++ L+
Sbjct: 220 FEVDVWSIGCIMYTLLV 236
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEG-EQEFKAEISAIGRTNHKNLVQLL 565
LG+G+F VY+ + VA+K + K G Q + E+ + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLE-VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 566 GFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPN----WYKRMQIAFGTARGLFYLHEEC 620
+ E + + LV E NG + +L + + + + QI G+ YLH
Sbjct: 78 NYF-EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSH- 131
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
I+H D+ N+LL N +I+DFGLA LK + T + GT Y++PE
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188
Query: 681 ITAKVDVYSFGILLLELVC 699
+ DV+S G + L+
Sbjct: 189 HGLESDVWSLGCMFYTLLI 207
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHK 559
+ ++GEGAFG+V++ E VAVK L + + +F+ E + + ++
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR----------------- 602
N+V+LLG C G+ L++EY++ G L +FL R
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 603 -------MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655
+ IA A G+ YL E + +H D+ +N L+ +I+DFGL++ + +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 656 DQTQTTTAIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
+ PE T + DV+++G++L E+
Sbjct: 227 ADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 67/339 (19%), Positives = 128/339 (37%), Gaps = 59/339 (17%)
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF-KAEI 550
+ + E I ELG G G V+K +A K ++ + + E+
Sbjct: 29 ELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGL-VMARKLIHLEIKPAIRNQIIREL 82
Query: 551 SAIGRTNHKNLVQLLG-FCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPNWYKRMQIA 606
+ N +V G F ++GE + E++ GSL L + R P +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILG-KVS 137
Query: 607 FGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666
+GL YL E+ K I+H D+KP NIL++ ++ DFG++ L + + + G
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-G 192
Query: 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE 726
T+ Y++PE + + + D++S G+ L+E+ R +E +++ E
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 727 RK--------------------------LGLLVENDEEAMDDIKRVEKFVMIAIWCIQED 760
L +V + +F C+ ++
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 761 PSLRPAMKK------VTQMIEGAVDVSIPPDPASFISSI 793
P+ R +K+ + + VD A ++ S
Sbjct: 313 PAERADLKQLMVHAFIKRSDAEEVDF------AGWLCST 345
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
E++G+G+FG+V+KG+ + VA+K + + + ++ + EI+ + + + + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKS 622
G + ++ EY+ GS D L P QIA +GL YLH E
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE--- 138
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+ IH DIK N+LL +++DFG+A L Q + T + GT ++APE K
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 197
Query: 683 AKVDVYSFGILLLEL 697
+K D++S GI +EL
Sbjct: 198 SKADIWSLGITAIEL 212
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 12/206 (5%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQE-FKAEISAIGRTNHKNLVQ 563
+G G G VY+ T + VA+K + + + + + + E GR ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-MQIAFGTARGLFYLHEECKS 622
+ F + ++ LA L R+ R + I L H +
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA--PPRAVAIVRQIGSALDAAHA---A 153
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT-AIRGTKGYVAPEWFKNLPI 681
H D+KP+NIL+ A + DFG+A TD+ T GT Y+APE F
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVD 707
T + D+Y+ +L E + ++ D
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGD 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQ---EFKAEISAIGRTNHKNLVQ 563
E LG G +V+ ++ + VAVK L + F+ E NH +V
Sbjct: 18 EILGFGGMSEVHLARDLRDH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 564 LL--GFCNEGEHRL--LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
+ G L +V EYV +L D + + +++ + L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQ- 134
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ---TQTTTAIRGTKGYVAPEWF 676
+ IIH D+KP NI++ T ++ DFG+A+ + TQT I GT Y++PE
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQA 191
Query: 677 KNLPITAKVDVYSFGILLLELVCCRKNFEVD 707
+ + A+ DVYS G +L E++ F D
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 34/298 (11%), Positives = 62/298 (20%), Gaps = 55/298 (18%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKAEISAIGRTNHKNL 561
E L G V+ E A+K E A R ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLE-DFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 562 VQLLGFCN--------------------------EGEHRLLVYEYVS-----NGSLADFL 590
+ + LL+ S S DF+
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 591 FRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650
+ + R L + ++H P N+ + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 651 KLLKTDQTQTTTAIRGTKGYVAPEWF--KNLPITAKVDVYSFGILLLELVCCRKNFEVDA 708
+ A Y E+ T ++ + G+ + + C F +
Sbjct: 242 WKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 709 TE-ECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
+ G + I R + D R
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR----------FLNFDRRRRL 345
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
ELG+GAFGKVYK E A K + E +++ EI + +H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAK-NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
++ E+ G++ + QI L +LH + +
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---R 137
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-----WFKN 678
IIH D+K N+L+ + R++DFG++ + + I GT ++APE K+
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 679 LPITAKVDVYSFGILLLEL 697
P K D++S GI L+E+
Sbjct: 197 TPYDYKADIWSLGITLIEM 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E+LGEG++G VYK + E + VA+K++ V QE EIS + + + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAI-HKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEECKSQ 623
+ +V EY GS++D + R +IA T +GL YLH +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM---R 145
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
IH DIK NILL+ +A+++DFG+A L + T I GT ++APE + +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 684 KVDVYSFGILLLELV 698
D++S GI +E+
Sbjct: 205 VADIWSLGITAIEMA 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 48/214 (22%), Positives = 78/214 (36%), Gaps = 25/214 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNLVQLL 565
+ G G +Y + N +PV +K L + + Q AE + H ++VQ+
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 566 GFCNEGEHRL--------LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
F EH +V EYV SL ++ + + L YLH
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH 199
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
+++ D+KP+NI+L ++ D G + GT G+ APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEIVR 250
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
P T D+Y+ G L L +
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 505 FKEELGEGAFGKVYKGV-LTTENE---KPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN 560
E +G+G F V + + T + K V V K + ++ K E S H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY------KRM-QIAFGTARGL 613
+V+LL + +V+E++ L + +++ Y M QI L
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI----LEAL 143
Query: 614 FYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGY 670
Y H+ + IIH D+KP +LL + + ++ FG+A L + GT +
Sbjct: 144 RYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 671 VAPEWFKNLPITAKVDVYSFGILLLELVC 699
+APE K P VDV+ G++L L+
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLS 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
EELG GAFG V++ V + K + + K EIS + + +H L+ L
Sbjct: 55 ILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR----GLFYLHEEC 620
+ +L+ E++S G L D + + + ++ R GL ++HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVI-NYMRQACEGLKHMHE-- 167
Query: 621 KSQIIHCDIKPQNILLDGTFNAR--ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
I+H DIKP+NI+ + + I DFGLA L D+ T T + APE
Sbjct: 168 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDR 224
Query: 679 LPITAKVDVYSFGILLLELVC 699
P+ D+++ G+L L+
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLS 245
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEI 550
DFT ++L+ + E+G GA+G V K ++ + + +AVK++ V+E EQ+ ++
Sbjct: 18 DFTAEDLKDL-----GEIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 551 SAIGRT-NHKNLVQLLG-FCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPNWYKRM-- 603
+ R+ + +VQ G EG+ + E + + S F K +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGD----CWICMELM-STSFDKFY--KYVYSVLDDVIPE 124
Query: 604 ----QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659
+I T + L +L E K IIH DIKP NILLD + N ++ DFG++ L +
Sbjct: 125 EILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 660 TTTAIRGTKGYVAPEWFKNLPI----TAKVDVYSFGILLLEL 697
T A G + Y+APE + DV+S GI L EL
Sbjct: 183 TRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEI 550
+ +LE I ELG GA+G V K + + + +AVK++ VN EQ+ ++
Sbjct: 3 EVKADDLEPI-----MELGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 551 SAIGRT-NHKNLVQLLG-FCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPNWYKRMQ- 604
RT + V G EG+ V+ E + + SL F + +
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGD----VWICMELM-DTSLDKFYKQVIDKGQTIPEDIL 111
Query: 605 --IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
IA + L +LH + +IH D+KP N+L++ ++ DFG++ L D +
Sbjct: 112 GKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169
Query: 663 AIRGTKGYVAPEWFKNLPI----TAKVDVYSFGILLLEL 697
A G K Y+APE + K D++S GI ++EL
Sbjct: 170 A--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQ 563
FK +LG GAFG V+ + +K + K ++ +AEI + +H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------Y 615
+ + + +V E G L + + R L Y
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY-----VAELMKQMMNALAY 139
Query: 616 LHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
H + ++H D+KP+NIL +I DFGLA+L K+D+ T A GT Y+A
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMA 194
Query: 673 PEWFKNLPITAKVDVYSFGILLLELVC 699
PE FK +T K D++S G+++ L+
Sbjct: 195 PEVFKR-DVTFKCDIWSAGVVMYFLLT 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLL 565
E +G G +G+VYKG + + A+K + + E+E K EI+ + + +H+N+
Sbjct: 30 ELVGNGTYGQVYKGR-HVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 566 G-----FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYL 616
G + +L LV E+ GS+ D + K+ + N K IA+ RGL +L
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-- 674
H+ ++IH DIK QN+LL ++ DFG++ L + T I GT ++APE
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 201
Query: 675 ---WFKNLPITAKVDVYSFGILLLEL 697
+ K D++S GI +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 91/375 (24%), Positives = 143/375 (38%), Gaps = 50/375 (13%)
Query: 356 FRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFCAVAIFREGECWKKRAPLSNGRIDPS 415
F+ T ED+ + A + +A L +D
Sbjct: 72 FQQFLRTHEQHGPALQLWKDIEDY--DTADDALRPQKAQALRAAYLEPQAQLFCSFLDAE 129
Query: 416 VGGKALVKVRKDYSDASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKK 475
+A L+ + A LG + F L + ++F R Q K
Sbjct: 130 TVARARAGAGDGLFQP-------------LLRAVLAHLGQAPFQEFLDS-LYFLRFLQWK 175
Query: 476 QNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKL 535
+E+Q M F V LG G FG+V+ K A KKL
Sbjct: 176 W--LEAQP----MGEDWFLD--FRV--------LGRGGFGEVF-ACQMKATGKLYACKKL 218
Query: 536 YKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLF 591
K +G Q E + + + + +V L + E + L LV ++ G + ++
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 592 RKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648
++ + F TA+ GL +LH+ II+ D+KP+N+LLD N RISD G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334
Query: 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR-----KN 703
LA LK QT+T GT G++APE VD ++ G+ L E++ R +
Sbjct: 335 LAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393
Query: 704 FEVDATEECQMILAD 718
+V+ E Q +L
Sbjct: 394 EKVENKELKQRVLEQ 408
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
E LG G FG+V+K T K +A K + + ++E K EIS + + +H NL+Q
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLK-LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-----WYKRMQIAFGTARGLFYLHE 618
L +LV EYV G L D + +S + + QI G+ ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QI----CEGIRHMH- 204
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARI--SDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
+ I+H D+KP+NIL +I DFGLA+ K + GT ++APE
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVV 260
Query: 677 KNLPITAKVDVYSFGILLLELVC 699
++ D++S G++ L+
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 52/303 (17%), Positives = 86/303 (28%), Gaps = 51/303 (16%)
Query: 507 EELGEGA--FGKVYKGVLTTENEKPVAVKK--LYKAVNEGEQEFKAEISAIGRTNHKNLV 562
+G+G V E V V++ L NE + E+ NH N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEY-VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEE 619
+V +++ GS D + + + + IA+ G + L Y+H
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV------AP 673
+H +K +IL+ +S + + + K V +P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 674 EWFKNLPI--TAKVDVYSFGILLLELV------------------------CCRKNFEVD 707
E + AK D+YS GI EL C +
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 708 ATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKF-----VMIAIWCIQEDPS 762
A E A + F + C+Q +P
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRNPD 323
Query: 763 LRP 765
RP
Sbjct: 324 ARP 326
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F E LG GAF +V+ + A+K + K+ + + EI+ + + H+N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKL-FALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKS----RRPNWYKRMQIAFGTARGLFYLHEEC 620
H LV + VS G L D + + + + + Q+ + YLHE
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLHEN- 125
Query: 621 KSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
I+H D+KP+N+L + I+DFGL+K+ + T GT GYVAPE
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC---GTPGYVAPEVLA 180
Query: 678 NLPITAKVDVYSFGILLLELVC 699
P + VD +S G++ L+C
Sbjct: 181 QKPYSKAVDCWSIGVITYILLC 202
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 507 EELGEGAFGKVYKG--VLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
+ +G+G F KV +LT VA+K + K Q+ E+ + NH N+V
Sbjct: 21 KTIGKGNFAKVKLARHILTGR---EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF-------- 614
+L + L+ EY S G + D+L RM+ AR F
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAH-------GRMKEK--EARSKFRQIVSAVQ 128
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
Y H++ I+H D+K +N+LLD N +I+DFG + G Y APE
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPE 183
Query: 675 WFKNLPIT-AKVDVYSFGILLLELVC 699
F+ +VDV+S G++L LV
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 71/219 (32%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
LGEGA+G+V V E VAVK + + + K EI NH+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------YLHEE 619
EG + L EY S G L D + P A+ F YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMAGVVYLH-- 122
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT---TTAIRGTKGYVAPEWF 676
I H DIKP+N+LLD N +ISDFGLA + + + + GT YVAPE
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELL 179
Query: 677 KNLPIT-AKVDVYSFGILLLELVCCRKNFEVDATEECQM 714
K VDV+S GI+L ++ ++ ++ CQ
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQE 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 27/206 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+ +G G++G+V V + A KK+ K E FK EI + +H N+++L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIR-RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------YL 616
+ LV E + G L + + K ++ A + Y
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRV----FRESD-----AARIMKDVLSAVAYC 122
Query: 617 HEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAP 673
H+ + H D+KP+N L ++ DFGLA K + T GT YV+P
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSP 177
Query: 674 EWFKNLPITAKVDVYSFGILLLELVC 699
+ + + D +S G+++ L+C
Sbjct: 178 QVLEG-LYGPECDEWSAGVMMYVLLC 202
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E+LG G FG V++ V T ++K K + + K EIS + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-----WYKRMQIAFGTARGLFYLHEE 619
E ++++E++S + + + + N Y Q+ L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLHS- 120
Query: 620 CKSQIIHCDIKPQNILLDGTFNA--RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
I H DI+P+NI+ ++ +I +FG A+ LK Y APE +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQ 176
Query: 678 NLPITAKVDVYSFGILLLELVC 699
+ ++ D++S G L+ L+
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLS 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---------VNEGEQEFKAEISAIGR 555
KE LG G V + + ++ AVK + V E + E+ + +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKE-YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 556 -TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF 614
+ H N++QL LV++ + G L D+L K + R +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKE-----TRKIM 130
Query: 615 --------YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666
LH+ I+H D+KP+NILLD N +++DFG + L + G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--G 185
Query: 667 TKGYVAPEWFKNLPITA------KVDVYSFGILLLELVC 699
T Y+APE + +VD++S G+++ L+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
KEELG+GAF V + V T + A K + Q+ + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLE-FAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY-----KRM--QIAFGTARGLFY 615
+L E LV++ V+ G L + + + Y QI + Y
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQI----LESIAY 120
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNA---RISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
H + I+H ++KP+N+LL +++DFGLA + + A GT GY++
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLS 175
Query: 673 PEWFKNLPITAKVDVYSFG----ILL 694
PE K P + VD+++ G ILL
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 505 FKEELGEGAFGKVYKGV-LTTENE---KPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHK 559
EELG G F V K +T E K + ++ + +E + E+S + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS----RRPNWYKRMQIAFGTARGLFY 615
N++ L +L+ E VS G L DFL +K + + QI G+ Y
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVNY 130
Query: 616 LHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
LH +I H D+KP+NI+L + ++ DFGLA ++ GT +V
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFV 185
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVC 699
APE P+ + D++S G++ L+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 69/339 (20%), Positives = 124/339 (36%), Gaps = 43/339 (12%)
Query: 370 EHFTSVDEDWCREACLSDCFCAVAIFREGE--CWKKRAPLSNGRIDPSVGGKALVKVRKD 427
E ++ W A + + R G+ ++ A +G+ P A V + D
Sbjct: 47 EKREAMGGSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPC-EPTAPVLIPGD 105
Query: 428 YSDASAGSGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPE 487
+ G + E ++ + ++ + + K + V
Sbjct: 106 --ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH----- 158
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK 547
Y EELG GAFG V++ A K + ++ +
Sbjct: 159 -------YD--------IHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVR 202
Query: 548 AEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS-----RRPNWYKR 602
EI + H LV L + +++YE++S G L + + + Y R
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARI--SDFGLAKLLKTDQTQT 660
Q+ +GL ++HE + +H D+KP+NI+ + + DFGL L Q+
Sbjct: 263 -QV----CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
T GT + APE + P+ D++S G+L L+
Sbjct: 315 VTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 30/239 (12%), Positives = 68/239 (28%), Gaps = 55/239 (23%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYK---AVNEGEQEFKAEISAIGR-------- 555
LG+ + E V Y + ++ K E+ +
Sbjct: 79 TVLGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 556 -----------------TNHKNLVQLLGFCNEGE--HRLLVYE--YVSNGSLADFLF--- 591
K ++++ + R +Y + + + L
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 592 RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+ + R+Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 652 LLKTDQTQTTTAIRGTKGYVAPEWFK-----------NLPITAKVDVYSFGILLLELVC 699
++G+ PE +T D ++ G+++ + C
Sbjct: 255 RDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
LG+G+FG+V K ++ AVK + KA N+ E+ + + +H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT---ARGLFYLHEE 619
+L + +V E + G L D + ++ R + A G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKH 140
Query: 620 CKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
I+H D+KP+NILL + + +I DFGL+ + + GT Y+APE
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL 195
Query: 677 KNLPITAKVDVYSFGILLLELVC 699
+ K DV+S G++L L+
Sbjct: 196 RG-TYDEKCDVWSAGVILYILLS 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 71/219 (32%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGF 567
LGEGA+G+V V E VAVK + + + K EI NH+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------YLHEE 619
EG + L EY S G L D + P A+ F YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMAGVVYLH-- 122
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT---TTAIRGTKGYVAPEWF 676
I H DIKP+N+LLD N +ISDFGLA + + + + GT YVAPE
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELL 179
Query: 677 KNLPIT-AKVDVYSFGILLLELVCCRKNFEVDATEECQM 714
K VDV+S GI+L ++ ++ ++ CQ
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQE 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQ 563
KE++G G++ + + N + AVK + K+ + +E I + R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNME-FAVKIIDKSKRDPTEE----IEILLRYGQHPNIIT 80
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM--QIAFGTARGLFYLHEECK 621
L ++G++ +V E + G L D + R+ + +R + F + + YLH +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLD---KILRQKFFSEREASAVLFTITKTVEYLHAQ-- 135
Query: 622 SQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
++H D+KP NIL + RI DFG AK L+ + T T +VAPE +
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLE 193
Query: 678 NLPITAKVDVYSFGILLLELVC 699
A D++S G+LL ++
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLT 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 35/212 (16%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYK------AVNEGEQEFKAEISAIGRTNHK- 559
LG G FG VY G+ ++N VA+K + K E+ + + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 560 -NLVQLLGFCNEGEHRLLVYEYVSN-GSLADFLFRKSRRPNWYKRMQIAFGTARGLF--- 614
+++LL + + +L+ E L DF+ + AR F
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE---------ELARSFFWQV 158
Query: 615 -----YLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
+ H ++H DIK +NIL+D ++ DFG LLK D T GT+
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD--GTR 212
Query: 669 GYVAPEWFKNLPITA-KVDVYSFGILLLELVC 699
Y PEW + V+S GILL ++VC
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+ ELG GA VY+ +KP A+K L K V++ + + EI + R +H N+++L
Sbjct: 57 VESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKL 113
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM-------QIAFGTARGLFYLH 617
LV E V+ G L D + K Y QI + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQIL----EAVAYLH 165
Query: 618 EECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
E + I+H D+KP+N+L +I+DFGL+K+++ T GT GY APE
Sbjct: 166 E---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPE 220
Query: 675 WFKNLPITAKVDVYSFGILLLELVC 699
+ +VD++S GI+ L+C
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLC 245
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA----VNEGEQEFKAEISAIGRTNHKNLVQL 564
LGEG++GKV + + + + AVK L K + GE K EI + R HKN++QL
Sbjct: 13 LGEGSYGKVKEVLDSETLCR-RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 565 LG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF-------- 614
+ NE + ++ +V EY G + KR + A G F
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE----KRFPVC--QAHGYFCQLIDGLE 123
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL---KTDQTQTTTAIRGTKGYV 671
YLH I+H DIKP N+LL +IS G+A+ L D T T+ G+ +
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQ 178
Query: 672 APEWFKNLPI--TAKVDVYSFGILLLELVC 699
PE L KVD++S G+ L +
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 505 FKEELGEGAFGKVYKGV-LTTENE---KPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHK 559
EELG G F V K +T E K + ++ + +E + E+S + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS----RRPNWYKRMQIAFGTARGLFY 615
N++ L +L+ E VS G L DFL +K + + QI G+ Y
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVNY 130
Query: 616 LHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
LH +I H D+KP+NI+L + ++ DFGLA ++ GT +V
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFV 185
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVC 699
APE P+ + D++S G++ L+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 29/211 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENE--KPVAVKKLYKAVNEGE------QEFKAEISAIGRT 556
EELG G F V K + K A K + K +E + E++ +
Sbjct: 9 MGEELGSGQFAIVRKC---RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS----RRPNWYKRMQIAFGTARG 612
H N++ L +L+ E VS G L DFL K + + QI G
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QIL----DG 120
Query: 613 LFYLHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
+ YLH +I H D+KP+NI+L ++ DFG+A ++ GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTP 175
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+VAPE P+ + D++S G++ L+
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 41/227 (18%)
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQE 545
+DF F + LGEG+F V + A+K L K + E +
Sbjct: 27 KRPEDFK----------FGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVP 75
Query: 546 F-KAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRM 603
+ E + R +H V+L F + + +L Y NG L ++ RK
Sbjct: 76 YVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGS------- 126
Query: 604 QIAFGTARGLFY----------LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653
F FY LH + IIH D+KP+NILL+ + +I+DFG AK+L
Sbjct: 127 ---FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 180
Query: 654 KTDQTQTTTA-IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+ Q GT YV+PE D+++ G ++ +LV
Sbjct: 181 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKA--EISAIGRTNHKNLVQLL 565
LG G FGKV G K VAVK L + + + K EI + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHK-VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------YLH 617
+ +V EYVS G L D++ + R++ AR LF Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKH-------GRVEEM--EARRLFQQILSAVDYCH 128
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
+ ++H D+KP+N+LLD NA+I+DFGL+ ++ + T+ G+ Y APE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVIS 183
Query: 678 NLPIT-AKVDVYSFGILLLELVC 699
+VD++S G++L L+C
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLC 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 67/311 (21%), Positives = 123/311 (39%), Gaps = 37/311 (11%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
H ++ + P M + E+ ++LG GA+G+V + +
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQ--RVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 529 PVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586
A+K + K + E++ + +H N+++L F + + LV E G L
Sbjct: 65 -RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 587 ADFLFRKSRRPNWYKRMQIAFGT---ARGLFYLHEECKSQIIHCDIKPQNILL---DGTF 640
D + + + + + A G+ YLH+ I+H D+KP+N+LL +
Sbjct: 124 FDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176
Query: 641 NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700
+I DFGL+ + + + GT Y+APE + K DV+S G++L L+
Sbjct: 177 LIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233
Query: 701 RKNFEVDATEE-CQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQE 759
F +E + + Y F + + E A D IK+ +Q
Sbjct: 234 YPPFGGQTDQEILRKVEKG-KYT-FDSPEWKNV---SEGAKDLIKQ----------MLQF 278
Query: 760 DPSLRPAMKKV 770
D R + ++
Sbjct: 279 DSQRRISAQQA 289
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL-YKAVNEGEQEFKAEISAIGRTNHKNLVQLL 565
E +G GA V + EK VA+K++ + E EI A+ + +H N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEK-VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFL----FRKSRRPNWYKRMQIAF---GTARGLFYLHE 618
+ LV + +S GS+ D + + + IA GL YLH+
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR----GTKGYVAPE 674
IH D+K NILL + +I+DFG++ L T T +R GT ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 675 WFKNL-PITAKVDVYSFGILLLEL 697
+ + K D++SFGI +EL
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIEL 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 492 DFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--- 548
+LE + E+G G G+V+K + +AVK++ + ++E K
Sbjct: 21 QAEINDLENL-----GEMGSGTCGQVWKMRFR-KTGHVIAVKQM--RRSGNKEENKRILM 72
Query: 549 EISAIGRT-NHKNLVQLLG-FCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPNWYKRM 603
++ + ++ + +VQ G F + V+ E + + + P
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILG- 127
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663
++ + L+YL E+ +IH D+KP NILLD ++ DFG++ L D+ + +A
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 664 IRGTKGYVAPEWFKNLPI-----TAKVDVYSFGILLLEL 697
G Y+APE + DV+S GI L+EL
Sbjct: 186 --GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 38/218 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--------VNEGEQEFKAEISAIGR- 555
K+ +G G V + V + AVK + + E + + E I R
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHE-FAVKIMEVTAERLSPEQLEEVREATRRET-HILRQ 155
Query: 556 -TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY-----KRM--QIAF 607
H +++ L+ LV++ + G L D+L K + + +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLL- 210
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGT 667
+ +LH I+H D+KP+NILLD R+SDFG + L+ + GT
Sbjct: 211 ---EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GT 262
Query: 668 KGYVAPEWFKNLPITA------KVDVYSFGILLLELVC 699
GY+APE K +VD+++ G++L L+
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 57/282 (20%), Positives = 93/282 (32%), Gaps = 64/282 (22%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
H + +G + LQ Y K +G+G++G V +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKK-YH--------LKGAIGQGSYGVVRVAIENQTRAI 53
Query: 529 PVAVK-----KLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583
A+K K+ + + + K E+ + + +H N+ +L + ++ LV E
Sbjct: 54 -RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 584 GSLADFLFRKSRRPNWYKRMQIAFGT-------------------------------ARG 612
G L D L M +
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 613 LF--------YLHEECKSQIIHCDIKPQNILL--DGTFNARISDFGLAKLL---KTDQTQ 659
+ YLH + I H DIKP+N L + +F ++ DFGL+K +
Sbjct: 173 IMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 660 TTTAIRGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVC 699
T GT +VAPE K D +S G+LL L+
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
KEELG+GAF V + V T + A K + Q+ + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLE-FAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM-------QIAFGTARGLFY 615
+L E LV++ V+ G L + + + Y QI + Y
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQIL----ESIAY 143
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNA---RISDFGLAKLLKTDQTQTTTAIRGTKGYVA 672
H + I+H ++KP+N+LL +++DFGLA + + A GT GY++
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLS 198
Query: 673 PEWFKNLPITAKVDVYSFG----ILL 694
PE K P + VD+++ G ILL
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILL 224
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--------NEGEQEFKAEISAIGRTNH 558
LG GAFG V+ V +N++ V VK + K + + EI+ + R H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKE-VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 559 KNLVQLLGFCNEGEHRLLVYE-YVSNGSLADFLFRKSRRPNWYKRM---QIAFGTARGLF 614
N++++L LV E + S L F+ R R Q+ +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVG 144
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YL IIH DIK +NI++ F ++ DFG A L+ + T GT Y APE
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPE 199
Query: 675 WFKNLP-ITAKVDVYSFGILLLELVC 699
P +++++S G+ L LV
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYK------AVNEGEQEFKAEIS----AIGRT 556
LG+G FG V+ G T+ + VA+K + + + E++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQ-VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGS-LADFLFRKSRRPNWYKRMQIAFGTARGLF- 614
H +++LL + E +LV E L D++ K + G +R F
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFG 146
Query: 615 -------YLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTAIRG 666
+ H ++H DIK +NIL+D A++ DFG LL D+ T G
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFD--G 200
Query: 667 TKGYVAPEWFKNLPIT-AKVDVYSFGILLLELVC 699
T+ Y PEW V+S GILL ++VC
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 505 FKEELGEGAFGKVYKGV-LTTENE---KPVAVKKLYKAVNEGEQE-FKAEISAIGRTNHK 559
EELG G F V K +T + K + ++ + +E + E+S + H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS----RRPNWYKRMQIAFGTARGLFY 615
N++ L +L+ E V+ G L DFL K + + QI G++Y
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QIL----NGVYY 129
Query: 616 LHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
LH QI H D+KP+NI+L +I DFGLA + GT +V
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFV 184
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVC 699
APE P+ + D++S G++ L+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 503 GGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNL 561
+ LGEG+F K V N+ AVK + K + Q+ EI+A+ H N+
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQA-FAVKIISKRMEANTQK---EITALKLCEGHPNI 68
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM--QIAFGTARGLFYLHEE 619
V+L ++ H LV E ++ G L + R ++ ++ + I + ++H+
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFE---RIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 620 CKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
++H D+KP+N+L + +I DFG A+L D T T Y APE
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 677 KNLPITAKVDVYSFGILLLELVC 699
D++S G++L ++
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLS 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 28/243 (11%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE- 527
H + + + ++++F ++T +ELG G F V +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENF--NNFYILTS---KELGRGKFAVVRQC---ISKST 53
Query: 528 -KPVAVKKLYKA--VNEGEQEFKAEISAIGRTNH-KNLVQLLGFCNEGEHRLLVYEYVSN 583
+ A K L K + E EI+ + ++ L +L+ EY +
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113
Query: 584 GSLADFLFRKSRRPNWYKRMQIAFGTAR----GLFYLHEECKSQIIHCDIKPQNILL--- 636
G + + + G++YLH+ + I+H D+KPQNILL
Sbjct: 114 GEIFSLCL--PELAEMVSENDVI-RLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSI 167
Query: 637 DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696
+ +I DFG+++ + GT Y+APE PIT D+++ GI+
Sbjct: 168 YPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNYDPITTATDMWNIGIIAYM 225
Query: 697 LVC 699
L+
Sbjct: 226 LLT 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNL 561
+ LG+G+FG+V ++ AVK + K ++ E+ + + +H N+
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQE-CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT---ARGLFYLHE 618
++L F + + LV E + G L D + + R + + A G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHK 144
Query: 619 ECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
+I+H D+KP+N+LL N RI DFGL+ + + GT Y+APE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEV 199
Query: 676 FKNLPITAKVDVYSFGILLLELVC 699
K DV+S G++L L+
Sbjct: 200 LHG-TYDEKCDVWSTGVILYILLS 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-27
Identities = 29/233 (12%), Positives = 61/233 (26%), Gaps = 44/233 (18%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYK---AVNEGEQEFKAEISAIGRTNH----- 558
LG+ + E + V Y + ++ K E+ +
Sbjct: 84 TVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 559 -----------KNLVQLLGFCN-----EGEHRLLVYEYV--------SNGSLADFLF--- 591
+LV+ E + V + + + L
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 592 RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+ + R+Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 652 LLKTDQTQTTTAIRGTKGYVAPEWFKNLP-----ITAKVDVYSFGILLLELVC 699
A +T D ++ G+ + + C
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
LG+G+FG+V K ++ AVK + KA N+ E+ + + +H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT---ARGLFYLHEE 619
+L + +V E + G L D + ++ R + A G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKH 140
Query: 620 CKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
I+H D+KP+NILL + + +I DFGL+ + + GT Y+APE
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL 195
Query: 677 KNLPITAKVDVYSFGILLLELVC 699
+ K DV+S G++L L+
Sbjct: 196 RG-TYDEKCDVWSAGVILYILLS 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-27
Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 32/250 (12%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
H + ++ + P M ++ K E +LG GA+G+V + +
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYF--KVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 529 PVAVKKLYKA-------------VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL 575
A+K + K+ + + +E EIS + +H N+++L + ++
Sbjct: 64 -KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT---ARGLFYLHEECKSQIIHCDIKPQ 632
LV E+ G L + + + + + A G+ YLH+ I+H DIKP+
Sbjct: 123 LVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHKH---NIVHRDIKPE 175
Query: 633 NILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYS 689
NILL + N +I DFGL+ D GT Y+APE K K DV+S
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPEVLKK-KYNEKCDVWS 232
Query: 690 FGILLLELVC 699
G+++ L+C
Sbjct: 233 CGVIMYILLC 242
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 63/200 (31%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL---YKAVNEGEQEFKAEISAIGRTNHKNLVQ 563
E+G G+FG VY N + VA+KK+ K NE Q+ E+ + + H N +Q
Sbjct: 60 REIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAF---GTARGLFYLHEEC 620
G LV EY GS +D L + ++IA G +GL YLH
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSH- 173
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE---WFK 677
+IH D+K NILL ++ DFG A ++ + + GT ++APE
Sbjct: 174 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMD 226
Query: 678 NLPITAKVDVYSFGILLLEL 697
KVDV+S GI +EL
Sbjct: 227 EGQYDGKVDVWSLGITCIEL 246
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 42/236 (17%)
Query: 491 QDFTYKELEVITGGFK------EELGEGAFGKVYKGVLTTENEKPVAVKKLYKA------ 538
D T + V + + LG GA G+V +K VA++ + K
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGS 177
Query: 539 --VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR 596
+ + EI + + NH ++++ F + ++ +V E + G L D + R
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR- 235
Query: 597 PNWY-----KRM--QIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISD 646
K Q+ + YLHE IIH D+KP+N+LL + +I+D
Sbjct: 236 ---LKEATCKLYFYQM----LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 647 FGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL---PITAKVDVYSFGILLLELVC 699
FG +K+L T GT Y+APE ++ VD +S G++L +
Sbjct: 286 FGHSKILGETSLMRTLC--GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
EELG+GAF V + V ++ A + Q+ + E H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQE-YAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWY------KRMQIAFGTARGLFYL 616
+L +E H L+++ V+ G L + + + Y +Q + +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILE---AVLHC 126
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNA---RISDFGLAKLLKTDQTQTTTAIRGTKGYVAP 673
H+ ++H ++KP+N+LL +++DFGLA ++ +Q GT GY++P
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
Query: 674 EWFKNLPITAKVDVYSFG----ILL 694
E + P VD+++ G ILL
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILL 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 44/219 (20%), Positives = 78/219 (35%), Gaps = 46/219 (21%)
Query: 567 FCNEGEHRLLVY---EYVSNGSLADFLFRKSRRPN------WYKRMQIAFGTARGLFYLH 617
++ +Y + +L D++ R+ + + +QIA + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA----EAVEFLH 181
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR-----------G 666
+ ++H D+KP NI ++ DFGL + D+ + T G
Sbjct: 182 SK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 667 TKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE 726
TK Y++PE + KVD++S G++L EL + E I+ D R
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFEL-LYSFS----TQMERVRIITD-----VRN 288
Query: 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
K + V + P+ RP
Sbjct: 289 LKF------PLLFTQKYPQEHMMVQ---DMLSPSPTERP 318
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKA--EISAIGRTNHKNLVQLL 565
LG G FGKV G K VAVK L + + + K EI + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHK-VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------YLH 617
+ +V EYVS G L D++ + R+ +R LF Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKN-------GRLDEK--ESRRLFQQILSGVDYCH 133
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
+ ++H D+KP+N+LLD NA+I+DFGL+ ++ + T+ G+ Y APE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVIS 188
Query: 678 NLP-ITAKVDVYSFGILLLELVCCRKNFE 705
+VD++S G++L L+C F+
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 38/217 (17%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--------VNEGEQEFKAEISAIGRT 556
+ LG GA G+V +K VA+K + K + + EI + +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF-- 614
NH ++++ F + ++ +V E + G L D + R K + F
Sbjct: 73 NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEAT-----CKLYFYQ 122
Query: 615 ------YLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIR 665
YLHE + IIH D+KP+N+LL + +I+DFG +K+L T
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-- 177
Query: 666 GTKGYVAPE---WFKNLPITAKVDVYSFGILLLELVC 699
GT Y+APE VD +S G++L +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 73/241 (30%), Positives = 105/241 (43%), Gaps = 32/241 (13%)
Query: 466 IFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTE 525
I+F+R Q K +E Q + F V LG+G FG+V
Sbjct: 165 IYFNRFLQWKW--LERQP----VTKNTFRQ--YRV--------LGKGGFGEVC-ACQVRA 207
Query: 526 NEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYV 581
K A KKL K +GE E + + N + +V L + E + L LV +
Sbjct: 208 TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLM 266
Query: 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILLDG 638
+ G L ++ + + + F A GL LH E +I++ D+KP+NILLD
Sbjct: 267 NGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDD 321
Query: 639 TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELV 698
+ RISD GLA + QT GT GY+APE KN T D ++ G LL E++
Sbjct: 322 HGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 699 C 699
Sbjct: 380 A 380
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 56/208 (26%), Positives = 76/208 (36%), Gaps = 27/208 (12%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC 568
+G G FG E VAVK + + E + EI H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 569 NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF--------YLHEEC 620
H ++ EY S G L + + R AR F Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNA-------GRFSED--EARFFFQQLLSGVSYCH--- 133
Query: 621 KSQIIHCDIKPQNILLDG--TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
QI H D+K +N LLDG +I DFG +K +T GT Y+APE
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLR 191
Query: 679 LPIT-AKVDVYSFGILLLELVCCRKNFE 705
DV+S G+ L ++ FE
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKA--EISAIGRTNHKNLVQLL 565
LGEG+FGKV +K VA+K + + + + + + EIS + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQK-VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM---QIAFGTARGLFYLHEECKS 622
++V EY G L D++ K R R QI Y H +
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH---RH 127
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+I+H D+KP+N+LLD N +I+DFGL+ ++ T+ G+ Y APE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPEVINGKLYA 185
Query: 683 -AKVDVYSFGILLLELVCCRKNFE 705
+VDV+S GI+L ++ R F+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 56/234 (23%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVK-----KLYKAVNEGEQEFKA------------ 548
K+E+G+G++G V +N A+K KL + +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTY-YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 549 ---------EISAIGRTNHKNLVQL---LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR 596
EI+ + + +H N+V+L L NE +H +V+E V+ G + + K
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLK--- 132
Query: 597 PNWYKRMQIAFGTARGLF--------YLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648
+ AR F YLH +IIH DIKP N+L+ + +I+DFG
Sbjct: 133 -----PLSED--QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT---AKVDVYSFGILLLELVC 699
++ K + + GT ++APE +DV++ G+ L V
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 37/267 (13%)
Query: 467 FFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTEN 526
F + ++ + + + DF+ + +G G FG+VY G +
Sbjct: 165 FIESDKFTRFCQWKNVELNIHLTMNDFSV--HRI--------IGRGGFGEVY-GCRKADT 213
Query: 527 EKPVAVKKLYKAV---NEGEQEFKAE---ISAIGRTNHKNLVQLLGFCNEGEHRL-LVYE 579
K A+K L K +GE E +S + + +V + + +L + +
Sbjct: 214 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILD 272
Query: 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILL 636
++ G L L + M+ F A GL ++H +++ D+KP NILL
Sbjct: 273 LMNGGDLHYHLSQHGVFSE--ADMR--FYAAEIILGLEHMHNR---FVVYRDLKPANILL 325
Query: 637 DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPITAKVDVYSFGILLL 695
D + RISD GLA + + GT GY+APE K + + D +S G +L
Sbjct: 326 DEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 696 ELVC----CRKNFEVDATEECQMILAD 718
+L+ R++ D E +M L
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTM 409
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-25
Identities = 73/253 (28%), Positives = 113/253 (44%), Gaps = 50/253 (19%)
Query: 470 RRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKP 529
++ K TV + G Q+ +Y + +VI G G+FG VY+ L E
Sbjct: 31 DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGEL- 81
Query: 530 VAVKKLYKAVNEGEQEFKA-EISAIGRTNHKNLVQLLG-FCNEGEHRL-----LVYEYVS 582
VA+KK+ + ++ FK E+ + + +H N+V+L F + GE + LV +YV
Sbjct: 82 VAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136
Query: 583 ---NGSLADFLFRKSRRPNWYKRM---QIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636
+ K P Y ++ Q+ R L Y+H I H DIKPQN+LL
Sbjct: 137 ETVYRVARHYSRAKQTLPVIYVKLYMYQLF----RSLAYIH---SFGICHRDIKPQNLLL 189
Query: 637 DG-TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV------APEW-FKNLPITAKVDVY 688
D T ++ DFG AK L + + Y+ APE F T+ +DV+
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELIFGATDYTSSIDVW 241
Query: 689 SFGILLLELVCCR 701
S G +L EL+ +
Sbjct: 242 SAGCVLAELLLGQ 254
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 506 KEELGEGAFGKVYKGV-LTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQ 563
++ LGEGA +V + L T E AVK + K E+ + + H+N+++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQE--YAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR------MQIAFGTARGLFYLH 617
L+ F E + LV+E + GS+ +R ++ + + A L +LH
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILS---HIHKRRHFNELEASVVVQDV----ASALDFLH 128
Query: 618 EECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIR------GTK 668
I H D+KP+NIL + +I DF L +K + + + G+
Sbjct: 129 N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 669 GYVAPEWFKNLPITAK-----VDVYSFGILLLELVC 699
Y+APE + A D++S G++L L+
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 478 TVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVY--KGVLTTENEKPVAVKKL 535
T ++G + + F L+V LG+G+FGKV+ K + ++ + A+K L
Sbjct: 11 THHVKEGHEKADPSQFEL--LKV--------LGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 536 YKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFR 592
KA K E + NH +V+L + + E +L L+ +++ G L
Sbjct: 61 KKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLF-TRLS 118
Query: 593 KSRRPNWYKRMQIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642
K F L +LH II+ D+KP+NILLD +
Sbjct: 119 KEVM----------FTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHI 165
Query: 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK 702
+++DFGL+K + + + GT Y+APE T D +SFG+L+ E++
Sbjct: 166 KLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 703 NFEVDATEE-CQMILAD 718
F+ +E MIL
Sbjct: 225 PFQGKDRKETMTMILKA 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 60/296 (20%)
Query: 486 PEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGE 543
++N F L I G+G+FGKV V + +K A+K + K V E
Sbjct: 10 EDVNFDHFEI--LRAI--------GKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNE 58
Query: 544 QEF-KAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYK 601
E+ + H LV L + + E + +V + + G L + +++
Sbjct: 59 VRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLR-YHLQQNVH----- 111
Query: 602 RMQIAF--GTAR--------GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
F T + L YL + +IIH D+KP NILLD + I+DF +A
Sbjct: 112 -----FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 652 LLKTDQTQTTTAIRGTKGYVAPEWFKNLPI---TAKVDVYSFGILLLELVCCRKNFEVDA 708
+L + TT A GTK Y+APE F + + VD +S G+ EL+ R+ + + +
Sbjct: 164 MLPRETQITTMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221
Query: 709 TEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLR 764
+ + I F + +E + +K+ ++ +P R
Sbjct: 222 STSSKEI-----VHTFETTVVTYPSAWSQEMVSLLKK----------LLEPNPDQR 262
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 31/208 (14%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQL 564
K+ LG G GKV + +K A+K LY + + + E+ + + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQK-CALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 565 LGFCNEGEHR----LLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTARGLF 614
L H L++ E + G L + + + + +R I +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIG----TAIQ 142
Query: 615 YLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
+LH I H D+KP+N+L + +++DFG AK + QT T YV
Sbjct: 143 FLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC---YTPYYV 196
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVC 699
APE D++S G+++ L+C
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLC 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 51/232 (21%)
Query: 491 QDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-E 549
++ Y +VI G G+FG V++ L +E VA+KK+ + ++ FK E
Sbjct: 38 REIAYTNCKVI--------GNGSFGVVFQAKLVESDE--VAIKKVLQ-----DKRFKNRE 82
Query: 550 ISAIGRTNHKNLVQLLGF-----CNEGEHRL-LVYEYVS---NGSLADFLFRKSRRPNWY 600
+ + H N+V L F + E L LV EYV + + K P
Sbjct: 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 601 KRM---QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTD 656
++ Q+ R L Y+H I H DIKPQN+LLD + ++ DFG AK+L
Sbjct: 143 IKLYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 657 QTQTTTAIRGTKGYV------APEW-FKNLPITAKVDVYSFGILLLELVCCR 701
+ Y+ APE F T +D++S G ++ EL+ +
Sbjct: 196 EPNV--------SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 58/245 (23%), Positives = 93/245 (37%), Gaps = 42/245 (17%)
Query: 468 FHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE 527
F + ++ L F + LG G+FG+V V E+
Sbjct: 18 FLAKAKEDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVML-VKHKESG 66
Query: 528 KPVAVKKLYKA--VNEGEQE-FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584
A+K L K V + E E + N LV+L + + +V EYV+ G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFY----------LHEECKSQIIHCDIKPQNI 634
+ R+ R F FY LH +I+ D+KP+N+
Sbjct: 127 EMF-SHLRRIGR----------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENL 172
Query: 635 LLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILL 694
L+D +++DFG AK +K T + GT +APE + VD ++ G+L+
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 695 LELVC 699
E+
Sbjct: 229 YEMAA 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 23/290 (7%)
Query: 435 SGSNRKENSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDFT 494
+ R+E +T I ++ L + + ++ V K + + +F
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE 151
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----NEGEQEFKAEI 550
Y L++ LG+G FGKV V + A+K L K V +E E
Sbjct: 152 Y--LKL--------LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHT-LTEN 199
Query: 551 SAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT 609
+ + H L L + + RL V EY + G L L R+ R A
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EI 257
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
L YLH E +++ D+K +N++LD + +I+DFGL K D T GT
Sbjct: 258 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 314
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE-CQMILAD 718
Y+APE ++ VD + G+++ E++C R F E+ ++IL +
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 29/240 (12%)
Query: 468 FHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE 527
F R + N + + M +D+ ++ +G GAFG+V V
Sbjct: 50 FLSRYKDTINKIRDLR----MKAEDYEVVKV----------IGRGAFGEVQL-VRHKSTR 94
Query: 528 KPVAVKKLYKA--VNEGEQE-FKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSN 583
K A+K L K + + F E + N +VQL + + + L +V EY+
Sbjct: 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPG 153
Query: 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643
G L L P + R A L +H IH D+KP N+LLD + + +
Sbjct: 154 GDLV-NLMSNYDVPEKWARFYTAEVVL-ALDAIH---SMGFIHRDVKPDNMLLDKSGHLK 208
Query: 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK----VDVYSFGILLLELVC 699
++DFG + + GT Y++PE K+ D +S G+ L E++
Sbjct: 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 44/259 (16%)
Query: 478 TVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVY--KGVLTTENEKPVAVKKL 535
+G ++ + F L V LG+G +GKV+ + V K A+K L
Sbjct: 4 ETSVNRGPEKIRPECFEL--LRV--------LGKGGYGKVFQVRKVTGANTGKIFAMKVL 53
Query: 536 YKAV---NEGEQEF-KAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFL 590
KA+ N + KAE + + H +V L+ + + +L L+ EY+S G L
Sbjct: 54 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF-MQ 111
Query: 591 FRKSRRPNWYKRMQIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNILLDGTF 640
+ F L +LH++ II+ D+KP+NI+L+
Sbjct: 112 LEREGI----------FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG 158
Query: 641 NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700
+ +++DFGL K D T T T GT Y+APE VD +S G L+ +++
Sbjct: 159 HVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 701 RKNFEVDATEE-CQMILAD 718
F + ++ IL
Sbjct: 218 APPFTGENRKKTIDKILKC 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 42/227 (18%)
Query: 486 PEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGE 543
P+ +LQDF LG G+FG+V+ + + N + A+K L K V +
Sbjct: 1 PKYSLQDFQILRT----------LGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQ 49
Query: 544 QE-FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR 602
E E + H ++++ G + + ++ +Y+ G L L RKS+R
Sbjct: 50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF-SLLRKSQR------ 102
Query: 603 MQIAFGTARGLFY----------LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKL 652
F FY LH + II+ D+KP+NILLD + +I+DFG AK
Sbjct: 103 ----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 155
Query: 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+ T + GT Y+APE P +D +SFGIL+ E++
Sbjct: 156 VPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 36/287 (12%)
Query: 473 QKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAV 532
Q + V K + + DF L+VI G GAF +V V + + A+
Sbjct: 44 QWAEPIVVRLKEVR-LQRDDFEI--LKVI--------GRGAFSEVAV-VKMKQTGQVYAM 91
Query: 533 KKLYKAV----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLA 587
K + K E F+ E + + + + QL F + E+ L LV EY G L
Sbjct: 92 KIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLL 149
Query: 588 DFLFRKSRR-PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646
L + R P R +A + +H + +H DIKP NILLD + R++D
Sbjct: 150 TLLSKFGERIPAEMARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 647 FGLAKLLKTDQTQTTTAIRGTKGYVAPE-------WFKNLPITAKVDVYSFGILLLELVC 699
FG L+ D T + GT Y++PE + D ++ G+ E+
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 700 CRKNFEVDATEE-CQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745
+ F D+T E I+ + G+ EEA D I+R
Sbjct: 266 GQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV----PEEARDFIQR 308
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 31/260 (11%)
Query: 468 FHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE 527
+ + + V+ + ++ +DF ++ +G GAFG+V V +
Sbjct: 55 YLEWAKPFTSKVKQMR----LHREDFEILKV----------IGRGAFGEVAV-VKLKNAD 99
Query: 528 KPVAVKKLYKA--VNEGEQE-FKAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSN 583
K A+K L K + E F+ E + + K + L + + ++ L LV +Y
Sbjct: 100 KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVG 158
Query: 584 GSLADFLFRKSRR-PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642
G L L + R P R +A + +H + +H DIKP NIL+D +
Sbjct: 159 GDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI 214
Query: 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK-----VDVYSFGILLLEL 697
R++DFG L D T ++ GT Y++PE + + D +S G+ + E+
Sbjct: 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274
Query: 698 VCCRKNFEVDATEE-CQMIL 716
+ F ++ E I+
Sbjct: 275 LYGETPFYAESLVETYGKIM 294
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 42/246 (17%)
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQE 545
+ + DF Y L++ LG+G FGKV V + A+K L K + + E
Sbjct: 2 VTMNDFDY--LKL--------LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVA 50
Query: 546 F-KAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRM 603
E + T H L L + + RL V EY + G L F + R
Sbjct: 51 HTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELF-FHLSRERV------- 101
Query: 604 QIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653
F R L YLH +++ DIK +N++LD + +I+DFGL K
Sbjct: 102 ---FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
Query: 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE-C 712
+D T GT Y+APE ++ VD + G+++ E++C R F E
Sbjct: 156 ISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
Query: 713 QMILAD 718
++IL +
Sbjct: 215 ELILME 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-22
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 34/211 (16%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQ 563
+ LG G GKV + EK A+K L + + E+ R + ++V+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEK-FALKMLQDC-----PKARREVELHWRASQCPHIVR 119
Query: 564 LLGFC----NEGEHRLLVYEYVSNGSLADFLFR-KSRRPNWY-----KRM--QIAFGTAR 611
++ + L+V E + G L R + R + + I
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFS---RIQDRGDQAFTEREASEIMKSI----GE 172
Query: 612 GLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
+ YLH I H D+KP+N+L +++DFG AK + + TT T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTP 227
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
YVAPE D++S G+++ L+C
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 41/226 (18%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVK----------------KLYKAVNEGEQEFKAEI 550
+LG G F V+ N VA+K KL + VN+ + +
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE--- 80
Query: 551 SAIGRTNHKNLVQLLG---FCNE-GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-I 605
++++LL G H ++V+E + +L + + R ++ I
Sbjct: 81 ---DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI 136
Query: 606 AFGTARGLFYLHEECKSQIIHCDIKPQNILLD------GTFNARISDFGLAKLLKTDQTQ 659
+ GL Y+H C IIH DIKP+N+L++ +I+D G A +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFE 705
T T+ Y +PE P D++S L+ EL+ FE
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 49/293 (16%)
Query: 473 QKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVY--KGVLTTENEKPV 530
+ + T ++ +++F L+V LG GA+GKV+ + + + K
Sbjct: 36 KHELRTANLTGHAEKVGIENFEL--LKV--------LGTGAYGKVFLVRKISGHDTGKLY 85
Query: 531 AVKKLYKA--VNEGEQEF--KAEISAIGRTNHKN-LVQLLGFCNEGEHRL-LVYEYVSNG 584
A+K L KA V + + + E + LV L + + E +L L+ +Y++ G
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGG 144
Query: 585 SLADFLFRKSRRPNWYKRMQIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNI 634
L + R F L +LH+ II+ DIK +NI
Sbjct: 145 ELF-THLSQRER----------FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENI 190
Query: 635 LLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE--WFKNLPITAKVDVYSFGI 692
LLD + ++DFGL+K D+T+ GT Y+AP+ + VD +S G+
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 693 LLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745
L+ EL+ F VD + Q + + + E A D I+R
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEI----SRRILKSEPPYPQEMSALAKDLIQR 299
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 52/229 (22%)
Query: 495 YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK----AEI 550
++ + G+G FG V G + VA+KK+ + + F+ +
Sbjct: 25 FQVERMA--------GQGTFGTVQLGKEKSTGMS-VAIKKVIQ-----DPRFRNRELQIM 70
Query: 551 SAIGRTNHKNLVQLL------GFCNEGEHRL-LVYEYVS---NGSLADFLFRKSRRPNWY 600
+ +H N+VQL G + + L +V EYV + ++ R+ P
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 601 KRM---QIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTD 656
++ Q+ R + LH + H DIKP N+L++ ++ DFG AK L
Sbjct: 131 IKVFLFQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 657 QTQTTTAIRGTKGYV------APEW-FKNLPITAKVDVYSFGILLLELV 698
+ Y+ APE F N T VD++S G + E++
Sbjct: 186 EPNV--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 26/211 (12%), Positives = 55/211 (26%), Gaps = 44/211 (20%)
Query: 507 EELGEGAFGKVYKG---VLTTENEKPVAVKKLYKAVNEGE---QEFKAEISAIGRTNHKN 560
G + ++ L ++ VA+ + + QE + + R +
Sbjct: 37 IFHGGVPPLQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ ++L + L+V E++ GSL + P+ ++ A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
+ P + +S G L +
Sbjct: 149 --GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA------ 179
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
+ D+ G L L+ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 31/256 (12%)
Query: 473 QKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAV 532
K+ + + +F + + V LG+G+FGKV E AV
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEF--IRV--------LGKGSFGKVML-ARVKETGDLYAV 53
Query: 533 KKLYKA--VNEGEQEF-KAE--ISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSL 586
K L K + + + E E I ++ NH L QL C + RL V E+V+ G L
Sbjct: 54 KVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL 111
Query: 587 ADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643
F +KSRR + + F A L +LH++ II+ D+K N+LLD + +
Sbjct: 112 M-FHIQKSRR---FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCK 164
Query: 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703
++DFG+ K + T T GT Y+APE + + VD ++ G+LL E++C
Sbjct: 165 LADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 704 FEVDATEE-CQMILAD 718
FE + ++ + IL D
Sbjct: 224 FEAENEDDLFEAILND 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 70/260 (26%), Positives = 105/260 (40%), Gaps = 43/260 (16%)
Query: 475 KQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKK 534
Q P DF + L+V +G+G+FGKV E AVK
Sbjct: 22 SQQINLGPSSNPHAKPSDFHF--LKV--------IGKGSFGKVLL-ARHKAEEVFYAVKV 70
Query: 535 LYKA--VNEGEQEF-KAEISAIGR-TNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADF 589
L K + + E++ +E + + + H LV L F + +L V +Y++ G L +
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELF-Y 128
Query: 590 LFRKSRRPNWYKRMQIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNILLDGT 639
++ R F R L YLH I++ D+KP+NILLD
Sbjct: 129 HLQRERC----------FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQ 175
Query: 640 FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+ ++DFGL K + T+T GT Y+APE P VD + G +L E++
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 700 CRKNFEVDATEE-CQMILAD 718
F T E IL
Sbjct: 235 GLPPFYSRNTAEMYDNILNK 254
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 45/260 (17%)
Query: 476 QNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKL 535
+ E ++ ++DF ++ LG+G+FGKV+ + + A+K L
Sbjct: 2 ELNKERPSLQIKLKIEDFIL--HKM--------LGKGSFGKVFL-AEFKKTNQFFAIKAL 50
Query: 536 YKA--VNEGEQE-FKAE--ISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADF 589
K + + + E E + ++ H L + + + L V EY++ G L +
Sbjct: 51 KKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLM-Y 107
Query: 590 LFRKSRRPNWYKRMQIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNILLDGT 639
+ + F +R GL +LH + I++ D+K NILLD
Sbjct: 108 HIQSCHK----------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD 154
Query: 640 FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+ +I+DFG+ K +T T GT Y+APE VD +SFG+LL E++
Sbjct: 155 GHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 700 CRKNFEVDATEE-CQMILAD 718
+ F EE I D
Sbjct: 214 GQSPFHGQDEEELFHSIRMD 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 18/242 (7%)
Query: 466 IFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFK--EELGEGAFGKVYKGVLT 523
++F + K+ G + N D+ K E ++ +G+G+FG+V K
Sbjct: 18 LYFQSMSSHKKERKVYNDGYDDDN-YDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK-AYD 75
Query: 524 TENEKPVAVK-----KLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578
++ VA+K K + + E ++ +V L H LV+
Sbjct: 76 RVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135
Query: 579 EYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTARGLFYLHEECKSQIIHCDIKPQNILL- 636
E +S +L D L + R + A L +L + IIHCD+KP+NILL
Sbjct: 136 EMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 637 -DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLL 695
+I DFG + Q ++ Y +PE +P +D++S G +L+
Sbjct: 194 NPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILV 249
Query: 696 EL 697
E+
Sbjct: 250 EM 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 73/259 (28%), Positives = 111/259 (42%), Gaps = 45/259 (17%)
Query: 477 NTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLY 536
+ ++ M L DF + L V LG+G+FGKV ++ AVK L
Sbjct: 6 SKFDNNGNRDRMKLTDFNF--LMV--------LGKGSFGKVML-SERKGTDELYAVKILK 54
Query: 537 KA--VNEGEQEF-KAE--ISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFL 590
K + + + E E + A+ L QL C + RL V EYV+ G L +
Sbjct: 55 KDVVIQDDDVECTMVEKRVLALP-GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM-YH 111
Query: 591 FRKSRRPNWYKRMQIAFGTAR----------GLFYLHEECKSQIIHCDIKPQNILLDGTF 640
++ R F GLF+L + II+ D+K N++LD
Sbjct: 112 IQQVGR----------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 158
Query: 641 NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700
+ +I+DFG+ K D T T GT Y+APE P VD ++FG+LL E++
Sbjct: 159 HIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
Query: 701 RKNFEVDATEE-CQMILAD 718
+ FE + +E Q I+
Sbjct: 218 QAPFEGEDEDELFQSIMEH 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 472 NQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVA 531
++ NT ES K + LQDF L V +G G++ KV V + ++ A
Sbjct: 33 EKEAMNTRESGKASSSLGLQDFDL--LRV--------IGRGSYAKVLL-VRLKKTDRIYA 81
Query: 532 VKKLYKA--VNEGEQEF-KAEISAIGR-TNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSL 586
++ + K ++ + ++ + E + +NH LV L C + E RL V EYV+ G L
Sbjct: 82 MRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL 140
Query: 587 ADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643
+R F +A L YLHE II+ D+K N+LLD + +
Sbjct: 141 ----MFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK 193
Query: 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703
++D+G+ K T+T GT Y+APE + VD ++ G+L+ E++ R
Sbjct: 194 LTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
Query: 704 FEVDATEE 711
F++ + +
Sbjct: 253 FDIVGSSD 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 8e-20
Identities = 74/259 (28%), Positives = 113/259 (43%), Gaps = 29/259 (11%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
+ + ++ M L DF + L V LG+G+FGKV ++
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNF--LMV--------LGKGSFGKVML-SERKGTDE 367
Query: 529 PVAVKKLYKA--VNEGEQEF-KAEISAIGRTN-HKNLVQLLGFCNEGEHRL-LVYEYVSN 583
AVK L K + + + E E + L QL C + RL V EYV+
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNG 426
Query: 584 GSLADFLFRKSRRPNWYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILLDGTF 640
G L + ++ R +K F A GLF+L + II+ D+K N++LD
Sbjct: 427 GDLM-YHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 479
Query: 641 NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC 700
+ +I+DFG+ K D T T GT Y+APE P VD ++FG+LL E++
Sbjct: 480 HIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
Query: 701 RKNFEVDATEE-CQMILAD 718
+ FE + +E Q I+
Sbjct: 539 QAPFEGEDEDELFQSIMEH 557
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.0 bits (219), Expect = 1e-19
Identities = 42/283 (14%), Positives = 89/283 (31%), Gaps = 34/283 (12%)
Query: 15 ISAAAQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGD---RGFLLAIWFNEIP 71
I +S + +L+A +S + F + G+ + +W
Sbjct: 7 IPFNGVGTSVLPAYQTLSAGQ-----YLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQ 61
Query: 72 ERTIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWREPPST-------GAAYAAML 124
+ R+ + + + L D S + +W ST + +
Sbjct: 62 QPFSSTIPLRN----KKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQ 117
Query: 125 DTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDG 184
D GN+VL + + + +++ G++++ + Y +G Q DG
Sbjct: 118 DDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV---YGAGASKLVFQGDG 174
Query: 185 NLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQ 244
NL+ Y AA W+ T + VF G + + ++L S+ T
Sbjct: 175 NLVAY------GPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWH--SH--TGG 224
Query: 245 DFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFLSFIPSN 287
+ +G I + + + + I +
Sbjct: 225 HASAVLRLQANGSIA--ILDEKPVWARFGFQPTYRHIRKINPD 265
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.6 bits (109), Expect = 2e-05
Identities = 23/156 (14%), Positives = 41/156 (26%), Gaps = 11/156 (7%)
Query: 136 SSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYP- 194
T T L Q +S G ++ + RF LQ DGNL++
Sbjct: 3 GRTRIPFNGVGTSVLPAYQTLSAGQYLL-------SPNQRFKLLLQGDGNLVIQDNGATV 55
Query: 195 ---FDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAV 251
+ + + + F+ +R L ++ Q V
Sbjct: 56 WVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLV 115
Query: 252 VDPDGVFRHYIYPKSSASTGGRWPKAWSFLSFIPSN 287
+ DG T + S + +
Sbjct: 116 LQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAP 151
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKA----EISAIGRTNHKNL 561
++GEG++G V+K + VA+KK + + K EI + + H NL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQI-VAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V LL LV+EY + ++ L R R + I + T + + + H K
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---K 120
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLA 650
IH D+KP+NIL+ ++ DFG A
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 28/236 (11%)
Query: 484 GMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNE 541
M + LQDF L VI G G++ KV V + ++ A+K + K ++
Sbjct: 2 AMDPLGLQDFDL--LRVI--------GRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDD 50
Query: 542 GEQEF-KAEISAIGR-TNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPN 598
+ ++ + E + +NH LV L C + E RL V EYV+ G L +R
Sbjct: 51 EDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQR 105
Query: 599 WYKRMQIAFGTAR---GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655
F +A L YLHE II+ D+K N+LLD + +++D+G+ K
Sbjct: 106 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162
Query: 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
T+T GT Y+APE + VD ++ G+L+ E++ R F++ + +
Sbjct: 163 PGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 55/254 (21%), Positives = 107/254 (42%), Gaps = 39/254 (15%)
Query: 465 FIFFHRRNQKKQNTVESQK---GMPEMNLQDFTYKELEVITGGFK--EELGEGAFGKVYK 519
I+F N KK+ + G + + + + ++ + +G+G+FG+V K
Sbjct: 57 EIYFLGLNAKKRQGMTGGPNNGGYDDDQ-GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVK 115
Query: 520 GVLTTENEKPVAVK------KLYKAVNEGEQEFK--AEISAIGRTNHKNLVQLLGFCNEG 571
+ + VA+K + ++ +E + + + N N++ +L
Sbjct: 116 -AYDHKVHQHVALKMVRNEKRFHRQ---AAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171
Query: 572 EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM------QIAFGTARGLFYLHEECKSQII 625
H + +E +S +L + + + N ++ + A + L LH K++II
Sbjct: 172 NHICMTFELLSM-NLYELI-----KKNKFQGFSLPLVRKFAHSILQCLDALH---KNRII 222
Query: 626 HCDIKPQNILL--DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
HCD+KP+NILL G ++ DFG + + Q ++ Y APE
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYRAPEVILGARYGM 278
Query: 684 KVDVYSFGILLLEL 697
+D++S G +L EL
Sbjct: 279 PIDMWSLGCILAEL 292
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
H + + M Y+ L ++ GEG++G V K
Sbjct: 5 HHHHSSGVDLGTENLYFQSME----KYENLGLV--------GEGSYGMVMKCRNKDTGRI 52
Query: 529 PVAVKKLYKAVNEGEQE-FKA----EISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583
VA+KK + + + K EI + + H+NLV LL C + + LV+E+V +
Sbjct: 53 -VAIKKF---LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643
++ D L ++ + F G+ + H IIH DIKP+NIL+ + +
Sbjct: 109 -TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVK 164
Query: 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
+ DFG A+ L + T+ Y APE
Sbjct: 165 LCDFGFARTL-AAPGEVYDDEVATRWYRAPE 194
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 72/256 (28%)
Query: 491 QDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA-E 549
Y + + G G+FG V + ++ A+KK+ + + +K E
Sbjct: 5 SSKKYSLGKTL--------GTGSFGIVCEVFDIESGKR-FALKKVLQ-----DPRYKNRE 50
Query: 550 ISAIGRTNHKNLVQLL-GFCNEGEHRL--------------------------------- 575
+ + +H N+++L+ F G+
Sbjct: 51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 576 ----LVYEYVSNGSLADFL--FRKSRR--PNWYKRM---QIAFGTARGLFYLHEECKSQI 624
++ EYV + +L L F +S R P + Q+ R + ++H I
Sbjct: 111 KYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGI 162
Query: 625 IHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE-WFKNLPIT 682
H DIKPQN+L++ ++ DFG AK L + ++ Y APE T
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYT 220
Query: 683 AKVDVYSFGILLLELV 698
+D++S G + EL+
Sbjct: 221 PSIDLWSIGCVFGELI 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 48/208 (23%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISAIGRTNHKNL 561
E++GEG +G V+K E + VA+K++ + + E A EI + HKN+
Sbjct: 8 EKIGEGTYGTVFKA-KNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L + + LV+E+ L + + + F +GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
++H D+KPQN+L++ ++++FGLA+ + +A T Y P+ +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPD------V 172
Query: 682 -------TAKVDVYSFGILLLELVCCRK 702
+ +D++S G + EL +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI---------GRTN 557
E+G GA+G VYK + VA+K + + N G IS +
Sbjct: 15 AEIGVGAYGTVYKA-RDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 558 HKNLVQLL----GFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGT 609
H N+V+L+ + E ++ LV+E+V L +L P I
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 129
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
RGL +LH + I+H D+KP+NIL+ +++DFGLA++ T + T
Sbjct: 130 LRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLW 184
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELV 698
Y APE VD++S G + E+
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 32/161 (19%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE----FKA--EISAIGRTNHKN 560
+ LGEG F VYK N+ VA+KK+ K + E + A EI + +H N
Sbjct: 16 DFLGEGQFATVYKARDKNTNQI-VAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA---------- 610
++ LL + LV++++ L + K + +
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMET-DLEVII----------KDNSLVLTPSHIKAYMLMTL 122
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+GL YLH+ I+H D+KP N+LLD +++DFGLAK
Sbjct: 123 QGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 36/213 (16%)
Query: 509 LGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT----------NH 558
+G GA G V VA+KKL + F+ + A R NH
Sbjct: 33 IGSGAQGIVCAAYDAILERN-VAIKKLSRP-------FQNQTHAK-RAYRELVLMKCVNH 83
Query: 559 KNLVQLL------GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTAR 611
KN++ LL E + +V E + A+ L + + ++RM + +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQVIQMELDHERMSYLLYQMLC 138
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
G+ +LH + IIH D+KP NI++ +I DFGLA+ + T T+ Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNF 704
APE + VD++S G ++ E++ F
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISA---IGRTNH 558
E+GEGA+GKV+K + VA+K++ + +E E++ + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 559 KNLVQLL----GFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGTA 610
N+V+L + E +L LV+E+V L +L I F
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLL 130
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGY 670
RGL +LH ++H D+KPQNIL+ + +++DFGLA++ T+ + T Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 185
Query: 671 VAPEWFKNLPITAKVDVYSFGILLLELV 698
APE VD++S G + E+
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISAIGRTNHKNL 561
E++GEG +G VYK + VA+KK+ + E E A EIS + NH N+
Sbjct: 9 EKIGEGTYGVVYKAR-NKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGTARGLFYLHE 618
V+LL + LV+E++ L F+ + I F +GL + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
+++H D+KPQN+L++ +++DFGLA+
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 48/247 (19%)
Query: 473 QKKQNTVESQKGMPEMNLQDFT----YKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
++ V++Q E+ FT Y+ L+ I G GA G V +
Sbjct: 38 NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI--------GSGAQGIVCAAYDAVLDRN 89
Query: 529 PVAVKKLYKAVNEGEQEFKAEISAIGRT----------NHKNLVQLL------GFCNEGE 572
VA+KKL + F+ + A R NHKN++ LL E +
Sbjct: 90 -VAIKKLSRP-------FQNQTHAK-RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 573 HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGTARGLFYLHEECKSQIIHCDIKP 631
LV E + A+ L + + ++RM + + G+ +LH + IIH D+KP
Sbjct: 141 DVYLVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 192
Query: 632 QNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFG 691
NI++ +I DFGLA+ + T T+ Y APE + VD++S G
Sbjct: 193 SNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
Query: 692 ILLLELV 698
++ E+V
Sbjct: 251 CIMGEMV 257
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA----EISAIGRTNHKNLV 562
E+LG G + VYKG L VA+K++ + E+ + EIS + H+N+V
Sbjct: 11 EKLGNGTYATVYKG-LNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIV 66
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFL--FRKSRRPNWYKRMQIA---FGTARGLFYLH 617
+L + LV+E++ N L ++ P + + + +GL + H
Sbjct: 67 RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650
+++I+H D+KPQN+L++ ++ DFGLA
Sbjct: 126 ---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 44/210 (20%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLL 565
+LG G + +V++ + T NEK V VK L +++ K EI + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEK-VVVKIL---KPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 566 G-FCNEGEHRL-LVYEYVSN-------GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL 616
+ LV+E+V+N +L D+ R + +I + L Y
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-------FYMYEIL----KALDYC 146
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNA-RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
H I+H D+KP N+++D R+ D+GLA+ Q VA +
Sbjct: 147 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--------VRVASRY 195
Query: 676 FK------NLPI-TAKVDVYSFGILLLELV 698
FK + + +D++S G +L ++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISAIGRTNHKNL 561
E++GEG +G VYK + A+KK+ E E E EIS + H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYG--ETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L + + +LV+E++ L L G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---D 118
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+++H D+KPQN+L++ +I+DFGLA+ + T T Y AP+ +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPD------V 171
Query: 682 -------TAKVDVYSFGILLLELV 698
+ +D++S G + E+V
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMV 195
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 48/214 (22%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISAIGRTNHKNL 561
E++GEG +G VYK + VA+K++ + E E A EIS + +H N+
Sbjct: 27 EKVGEGTYGVVYKAKDSQ-GRI-VALKRI---RLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA----------R 611
V L+ + LV+E++ L L + + R
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVL----------DENKTGLQDSQIKIYLYQLLR 130
Query: 612 GLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYV 671
G+ + H + +I+H D+KPQN+L++ +++DFGLA+ ++ T T Y
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYR 186
Query: 672 APEWFKNLPI-------TAKVDVYSFGILLLELV 698
AP+ + + VD++S G + E++
Sbjct: 187 APD------VLMGSKKYSTSVDIWSIGCIFAEMI 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 45/219 (20%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE--FKAEISAIGRT-------- 556
+ G++G V GV + VA+K+++ V++G R
Sbjct: 28 RFISSGSYGAVCAGVDSE-GIP-VAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLN 84
Query: 557 --NHKNLVQLLG-FCNEGEHRL----LVYEYVSNGSLADF--LFRKSRRPNWYKRMQ-IA 606
+H N++ L F + E + LV E + D + R + +Q
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFM 140
Query: 607 FGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666
+ GL LHE + ++H D+ P NILL + I DF LA+ D +T
Sbjct: 141 YHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT------ 191
Query: 667 TKGYVAPEWFKNLPI-------TAKVDVYSFGILLLELV 698
YV W++ + T VD++S G ++ E+
Sbjct: 192 --HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 37/170 (21%)
Query: 506 KEELGEGAFGKVYKGV-LTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT------NH 558
++G G +G VYK +++K A+K++ G +SA H
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGI-----SMSACREIALLRELKH 77
Query: 559 KNLVQLLG-FCNEGEHRL-LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA------ 610
N++ L F + + ++ L+++Y + L + K R + + +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII--KFHRASKANKKPVQLPRGMVKSLL 134
Query: 611 ----RGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR----ISDFGLAKL 652
G+ YLH + ++H D+KP NIL+ G R I+D G A+L
Sbjct: 135 YQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 41/236 (17%)
Query: 492 DFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVK------KLYKAVNEGE 543
+ + + ++ LGEG FGKV + + + VA+K K +A
Sbjct: 8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---AR 64
Query: 544 QEFK--AEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYK 601
E +I + N V + + N H + +E + + +FL + +P
Sbjct: 65 LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLP 123
Query: 602 RMQ-IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA------------------ 642
++ +A+ L +LH ++Q+ H D+KP+NIL +
Sbjct: 124 HVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 643 -RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
R++DFG A T + T I T+ Y PE L DV+S G +L E
Sbjct: 181 IRVADFGSA----TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKA--EISAIGRTNHKNLVQL 564
++LGEG + VYKG + + VA+K++ EG A E+S + H N+V L
Sbjct: 8 DKLGEGTYATVYKG-KSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTL 65
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQI---AFGTARGLFYLHEECK 621
+ + LV+EY+ L +L N + F RGL Y H
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHR--- 118
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+++H D+KPQN+L++ +++DFGLA+ K+ T+T T Y P+
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 682 -TAKVDVYSFGILLLELV 698
+ ++D++ G + E+
Sbjct: 178 YSTQIDMWGVGCIFYEMA 195
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 41/167 (24%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISAIGRTNHKNL 561
++G+G FG+V+K + + VA+KK+ E E+E A EI + H+N+
Sbjct: 23 AKIGQGTFGEVFKA-RHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENV 78
Query: 562 VQLLGFCNEGEHRL--------LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTA--- 610
V L+ C LV+++ + LA L + + F +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL----------SNVLVKFTLSEIK 127
Query: 611 -------RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650
GL+Y+H +++I+H D+K N+L+ +++DFGLA
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 21/156 (13%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE---FKA--EISAIGRTNHKNL 561
+LGEG +G+VYK + T + VA+K++ E E+E A E+S + H+N+
Sbjct: 40 TKLGEGTYGEVYKAI-DTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEEC 620
++L + L++EY N L ++ + K + G+ + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKS--FLYQLINGVNFCH--- 149
Query: 621 KSQIIHCDIKPQNILLDGTFNAR-----ISDFGLAK 651
+ +H D+KPQN+LL + + I DFGLA+
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 39/210 (18%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT---------- 556
+G GA+G V + EK VA+KKL + F++EI A R
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEK-VAIKKLSRP-------FQSEIFAK-RAYRELLLLKHM 80
Query: 557 NHKNLVQLL------GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAFGT 609
H+N++ LL LV ++ D L + +++Q + +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQYLVYQM 135
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
+GL Y+H + ++H D+KP N+ ++ +I DFGLA+ + T T+
Sbjct: 136 LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRW 188
Query: 670 YVAPEWFKNLPI-TAKVDVYSFGILLLELV 698
Y APE + VD++S G ++ E++
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 53/286 (18%), Positives = 97/286 (33%), Gaps = 90/286 (31%)
Query: 470 RRNQKKQNTVESQKGMPEMNLQDFT----YKELEVITGGFKEELGEGAFGKVYKGVLTTE 525
Q+KQ+ D+ Y+ +I G G++G V + E
Sbjct: 26 EGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI--------GTGSYGHVCEAYDKLE 77
Query: 526 NEKPVAVKKLYKAVNEGEQEFKAEISAIGRT----------NHKNLVQLLG-FCNEGEHR 574
VA+KK+ + F+ I R NH ++V++L + +
Sbjct: 78 KRV-VAIKKILRV-------FEDLIDCK-RILREIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 575 L----LVYEYV---------SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
+V E + L + + + G+ Y+H
Sbjct: 129 FDELYVVLEIADSDFKKLFRTPVYLTELHIK-------TLLYNLL----VGVKYVHS--- 174
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK------------- 668
+ I+H D+KP N L++ + ++ DFGLA+ + + + +
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 669 -------GYV------APE---WFKNLPITAKVDVYSFGILLLELV 698
G+V APE +N T +DV+S G + EL+
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIFAELL 278
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 48/282 (17%), Positives = 91/282 (32%), Gaps = 95/282 (33%)
Query: 473 QKKQNTVESQKGMPEMNLQDFT----YKELEVITGGFKEELGEGAFGKVYKGVLTTENEK 528
+ ++ + +++ Y +I G G++G VY +
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLI--------GRGSYGYVYLAYDKNTEKN 53
Query: 529 PVAVKKLYKAVNEGEQEFKAEISAIGRT----------NHKNLVQLLG-FCNEGEHRL-- 575
VA+KK+ + F+ I R +++L + +
Sbjct: 54 -VAIKKVNRM-------FEDLIDCK-RILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104
Query: 576 --LVYEYV---------SNGSLAD-----FLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
+V E + L + L+ + G ++HE
Sbjct: 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILY------------NLL----LGENFIHE- 147
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTK----------- 668
S IIH D+KP N LL+ + ++ DFGLA+ + +++
Sbjct: 148 --SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 669 ----GYV------APE---WFKNLPITAKVDVYSFGILLLEL 697
+V APE +N T +D++S G + EL
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAEL 245
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEIS-AIGRTNH 558
+ LG GAFG+V + T + VAVK L + E + +E+ I +H
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 559 KNLVQLLGFCN-EGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
N+V LLG C G +++ E+ G+L+ +L +S+R + +G Y+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651
I D+K + + + ++ S F K
Sbjct: 144 ------AIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
+ +F A+G+ +L + + IH D+ +NILL +I DFGLA+ + D
Sbjct: 196 ICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV-- 250
Query: 663 AIRGTKGYV-----APEWFKNLPITAKVDVYSFGILLLELV 698
R + APE + T + DV+SFG+LL E+
Sbjct: 251 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 41/229 (17%)
Query: 499 EVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVK------KLYKAVNEGEQEFK--A 548
+V++ ++ + LGEGAFGKV + + + VAVK + +A E +
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---ARSEIQVLE 66
Query: 549 EISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQ-IAF 607
++ + VQ+L + H +V+E + S DF+ P ++ +A+
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAY 125
Query: 608 GTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA-------------------RISDFG 648
+ + +LH +++ H D+KP+NIL + ++ DFG
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 649 LAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLEL 697
A T + + + T+ Y APE L + DV+S G +L+E
Sbjct: 183 SA----TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 62/222 (27%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT---------- 556
+ +G GA+G V V K VA+KKLY+ F++E+ A R
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAK-VAIKKLYRP-------FQSELFAK-RAYRELRLLKHM 81
Query: 557 NHKNLVQLL------GFCNEGEHRLLVYEY--------VSNGSLAD-----FLFRKSRRP 597
H+N++ LL ++ LV + + + L + ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY------ 135
Query: 598 NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657
Q+ +GL Y+H + IIH D+KP N+ ++ +I DFGLA+ ++
Sbjct: 136 ------QML----KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 658 TQTTTAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELV 698
T T+ Y APE N T VD++S G ++ E++
Sbjct: 183 TGYVV----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 43/212 (20%), Positives = 75/212 (35%), Gaps = 57/212 (26%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQ 563
+ LG G GKV + EK A+K L + + E+ R + ++V+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEK-FALKMLQDC-----PKARREVELHWRASQCPHIVR 75
Query: 564 LLGFC----NEGEHRLLVYEYVSNGSLADFLFR-KSRRPNWY-----KRM--QIAFGTAR 611
++ + L+V E + G L R + R + + I
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFS---RIQDRGDQAFTEREASEIMKSIG----E 128
Query: 612 GLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAK-LLKTDQTQTTTAIRGT 667
+ YLH I H D+KP+N+L +++DFG AK
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------- 172
Query: 668 KGYVAPEWFKNLPITAKVDVYSFGILLLELVC 699
+ Y D++S G+++ L+C
Sbjct: 173 EKY-----------DKSCDMWSLGVIMYILLC 193
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 55/245 (22%)
Query: 492 DFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVK------KLYKAVNEGE 543
F++K+ ++ F ++G+G FG+V +N+K AVK K ++
Sbjct: 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSA---- 78
Query: 544 QEFKAEISAIGR-----TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN 598
K E + + N+ N+V+ G +H L++E + SL + + R +
Sbjct: 79 ---KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGF 134
Query: 599 WYKRMQ-IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA--------------- 642
+ ++ + L YL K + H D+KP+NILLD +
Sbjct: 135 HIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 643 ----------RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGI 692
++ DFG A T ++ +I T+ Y APE NL D++SFG
Sbjct: 192 QIYRTKSTGIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247
Query: 693 LLLEL 697
+L EL
Sbjct: 248 VLAEL 252
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 54/240 (22%), Positives = 89/240 (37%), Gaps = 71/240 (29%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-------- 556
K LGEGA+G V E VA+KK+ + F + A+ RT
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEI-VAIKKI--------EPFDKPLFAL-RTLREIKILK 64
Query: 557 --NHKNLVQLLG-FCNEGEHRL----LVYEY--------VSNGSLAD-----FLFRKSRR 596
H+N++ + + ++ E +S L+D F++
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY----- 119
Query: 597 PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656
Q R + LH S +IH D+KP N+L++ + ++ DFGLA+++
Sbjct: 120 -------QTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 657 QTQTTTAIRGTK---GYV------APE---WFKNLPITAKVDVYSFGILLLELVCCRKNF 704
+ +V APE + +DV+S G +L EL R F
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRRPIF 223
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 59/282 (20%), Positives = 99/282 (35%), Gaps = 83/282 (29%)
Query: 499 EVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEI---SAI 553
++ G + +LG G F V+ + +K VA+K + K+ + EI ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWL-SWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSV 90
Query: 554 GRTN-----HKNLVQLLG-FC---NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM- 603
++ + +VQLL F G H +V+E V L ++ + + Y+ +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIK-----SNYQGLP 144
Query: 604 -----QIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---------------------- 636
+I +GL YLH +C +IIH DIKP+NILL
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 637 ---------------------------DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
+I+D G A + T+ T+
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQ 258
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE 711
Y + E D++S + EL FE + EE
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 60/217 (27%), Positives = 86/217 (39%), Gaps = 52/217 (23%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT---------- 556
+G GA+G V T + VAVKKL + F++ I A RT
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLR-VAVKKLSRP-------FQSIIHAK-RTYRELRLLKHM 85
Query: 557 NHKNLVQLL------GFCNEGEHRLLVYEY--------VSNGSLADFLFRKSRRPNWYKR 602
H+N++ LL E LV V L D + +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ-------FLI 138
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662
QI RGL Y+H + IIH D+KP N+ ++ +I DFGLA+ + T
Sbjct: 139 YQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191
Query: 663 AIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELV 698
T+ Y APE N VD++S G ++ EL+
Sbjct: 192 ----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 56/244 (22%), Positives = 96/244 (39%), Gaps = 75/244 (30%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-------- 556
++LG+GA+G V+K + E VAVKK++ A F+ A RT
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEV-VAVKKIFDA-------FQNSTDAQ-RTFREIMILT 63
Query: 557 ---NHKNLVQLLG-FCNEGEHRL-LVYEY--------VSNGSLAD-----FLFRKSRRPN 598
H+N+V LL + + + LV++Y + L ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY------- 116
Query: 599 WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658
Q+ + + YLH ++H D+KP NILL+ + +++DFGL++ +
Sbjct: 117 -----QLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 659 QTTTAIRGTK--------------GYV------APEWFKNLPI-TAKVDVYSFGILLLEL 697
T YV APE T +D++S G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 698 VCCR 701
+C +
Sbjct: 225 LCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 63/261 (24%), Positives = 100/261 (38%), Gaps = 73/261 (27%)
Query: 473 QKKQNTVESQKGMPEM-NLQDFT----YKELEVITGGFKEELGEGAFGKVYKGVLTTENE 527
+ + PEM Q F Y L I GEGA+G V
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYI--------GEGAYGMVCSAYDNLNKV 53
Query: 528 KPVAVKKLYKAVNEGEQEFKAEISAIGRT----------NHKNLVQLLG-FCNEGEHRL- 575
+ VA+KK+ F+ + RT H+N++ + ++
Sbjct: 54 R-VAIKKI--------SPFEHQTYCQ-RTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 576 ---LVYEY--------VSNGSLAD-----FLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
+V + + L++ FL+ QI RGL Y+H
Sbjct: 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------------QIL----RGLKYIHS- 146
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--TAIRGTKGYVAPEWFK 677
+ ++H D+KP N+LL+ T + +I DFGLA++ D T T T+ Y APE
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 678 NLPI-TAKVDVYSFGILLLEL 697
N T +D++S G +L E+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEM 225
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 51/259 (19%), Positives = 95/259 (36%), Gaps = 83/259 (32%)
Query: 488 MNLQDFT----YKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE 543
MN+ F Y +L+ + G G G V+ V +++ VA+KK+
Sbjct: 2 MNIHGFDLGSRYMDLKPL--------GCGGNGLVFSAVDNDCDKR-VAIKKI-------- 44
Query: 544 QEFKAEISAIGRT----------NHKNLVQLL--------------GFCNEGEHRLLVYE 579
S +H N+V++ G E +V E
Sbjct: 45 -VLTDPQSVK-HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQE 102
Query: 580 Y--------VSNGSLAD-----FLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626
Y + G L + F++ Q+ RGL Y+H + ++H
Sbjct: 103 YMETDLANVLEQGPLLEEHARLFMY------------QLL----RGLKYIH---SANVLH 143
Query: 627 CDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQTT--TAIRGTKGYVAPEWFKNLPI-T 682
D+KP N+ ++ +I DFGLA+++ + + TK Y +P + T
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203
Query: 683 AKVDVYSFGILLLELVCCR 701
+D+++ G + E++ +
Sbjct: 204 KAIDMWAAGCIFAEMLTGK 222
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 8e-13
Identities = 37/246 (15%), Positives = 69/246 (28%), Gaps = 51/246 (20%)
Query: 65 IWFNEIPERTIVWSANRDN-LVQRGSKVELTGDGQLILRDSSGKEIWREPPSTGAAYAAM 123
I F E + + + L + + D L+L DS + A +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 124 LDTGNLVLASQDSSTMWES-------------------------------------FDDP 146
G LV+ + ++ W S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVAN 122
Query: 147 TDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQ 206
+ + + ++TD NL+L+ + WST
Sbjct: 123 NGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-------DDRVWSTN 175
Query: 207 TS-IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPK 265
T+ G+G + V +G + + AV ++ + V+ PD IY
Sbjct: 176 TAGKGTGCRAVLQPNGRMDVLTNQN---IAVWTSGNSRSAGRYVFVLQPDRNLA--IYGG 230
Query: 266 SSASTG 271
+ +TG
Sbjct: 231 ALWTTG 236
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 13/159 (8%)
Query: 500 VITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN 557
++ F+ +++G G FG++ G NE VA+K L + Q +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEY-VAIK-LEPMKSRAPQLHLEYRFYKQLGS 63
Query: 558 HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
+ Q+ F G++ +V E + SL D R + + IA + Y+H
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 618 EECKSQIIHCDIKPQNILL--DGTFNAR---ISDFGLAK 651
+ +I+ D+KP+N L+ G + I DF LAK
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 5e-11
Identities = 31/195 (15%), Positives = 55/195 (28%), Gaps = 54/195 (27%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKL----YKAVNEGEQEFKAEI------------ 550
E++GEG FG+V++ + PVA+K + VN Q+ EI
Sbjct: 26 EKIGEGVFGEVFQT---IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82
Query: 551 -SAIGRTNHKNLVQLLGFC------------------------------NEGEHRLLVYE 579
S + + L + + +V E
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT 639
+ G D +++ + I L + H D+ N+LL T
Sbjct: 143 FEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKT 198
Query: 640 FNARISDFGLAKLLK 654
++ K
Sbjct: 199 SLKKLHYTLNGKSST 213
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 38/216 (17%), Positives = 76/216 (35%), Gaps = 33/216 (15%)
Query: 469 HRRNQKKQNTVESQKGMPEMNLQDFTYKELEVITGG-FK--EELGEGAFGKVYKG--VLT 523
H + + + ++ K L+ + G + +++G G FG +Y
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNK 61
Query: 524 TENEKPVAVK-------------KLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGF--- 567
E + VK K Y+ V + + K + ++ + G
Sbjct: 62 PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK--QLDYLGIPLFYGSGLT 119
Query: 568 -CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626
+R +V E + L + ++ +Q+ L Y+HE ++ +H
Sbjct: 120 EFKGRSYRFMVMERLGI-DLQK-ISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVH 174
Query: 627 CDIKPQNILLDGTFNAR---ISDFGLAKLLKTDQTQ 659
DIK N+LL G N ++D+GL+ +
Sbjct: 175 GDIKAANLLL-GYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 21/116 (18%)
Query: 147 TDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQ 206
+D L + G + G ++F +Q D NL+LY N A W++
Sbjct: 1 SDRLNSGHQLDTGGS---------LAEGGYLFIIQNDCNLVLYD-------NNRAVWASG 44
Query: 207 T-SIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261
T SG + G + + + + +I + T+ + ++ D Y
Sbjct: 45 TNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQ----NGNYYLILQRDRNVVIY 96
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 29/115 (25%), Positives = 53/115 (46%), Gaps = 16/115 (13%)
Query: 104 SSGKEIWR-EPPSTGAAYAAMLDTGNLVLASQDSSTMWESFDDP--TDTLLPTQ-----V 155
+SG ++ + G + + NLVL + +W S + + +L Q V
Sbjct: 5 NSGHQLDTGGSLAEGGYLFIIQNDCNLVLYDNNR-AVWASGTNGKASGCVLKMQNDGNLV 63
Query: 156 MSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIG 210
+ G++ I + TN +G + LQ D N+++Y D +N A W+T T++G
Sbjct: 64 IYSGSRAIWA-SNTNRQNGNYYLILQRDRNVVIY------DNSNNAIWATHTNVG 111
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-07
Identities = 16/100 (16%), Positives = 37/100 (37%), Gaps = 12/100 (12%)
Query: 45 QSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDS 104
G + F + + L ++ N W++ + G +++ DG L++
Sbjct: 17 AEGGYLFIIQNDCN----LVLYDNNRAV----WASGTNGKA-SGCVLKMQNDGNLVIYSG 67
Query: 105 SGKEIWREP--PSTGAAYAAMLDTGNLVLASQDSSTMWES 142
+ IW G Y + N+V+ ++ +W +
Sbjct: 68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 25/125 (20%), Positives = 41/125 (32%), Gaps = 22/125 (17%)
Query: 148 DTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+ LL Q + + +G + +Q NL+ Y W++ T
Sbjct: 3 NVLLSGQTLHADH---------SLQAGAYTLTIQNKCNLVKY-------QNGRQIWASNT 46
Query: 208 S-IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKS 266
GSG ++ G + + N N V + + V+ DG F IY
Sbjct: 47 DRRGSGCRLTLLSDGNLVIYDHNN---NDVWGSACWGDNGKYALVLQKDGRFV--IYGPV 101
Query: 267 SASTG 271
S G
Sbjct: 102 LWSLG 106
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 14/100 (14%)
Query: 45 QSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDS 104
Q+G + + + L + N +W++N D G ++ L DG L++ D
Sbjct: 18 QAGAYTLTIQNKCN----LVKYQN----GRQIWASNTDRR-GSGCRLTLLSDGNLVIYDH 68
Query: 105 SGKEIWRE--PPSTGAAYAAMLDTGNLVLASQDSSTMWES 142
+ ++W G + G V+ +W
Sbjct: 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIY---GPVLWSL 105
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-10
Identities = 23/129 (17%), Positives = 40/129 (31%), Gaps = 38/129 (29%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSSGKEIW---REPPSTGAAYAAMLDTGNLVLASQDSST 138
+L + D L+L D +W A + GN V+ + +
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRS 72
Query: 139 MWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGA 198
+W S + +G ++ LQ DGN+++Y
Sbjct: 73 LWAS-------------------------HSVRGNGNYVLVLQEDGNVVIY--------- 98
Query: 199 NAAYWSTQT 207
+ WST T
Sbjct: 99 GSDIWSTGT 107
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 8e-10
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 13/102 (12%)
Query: 45 QSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDS 104
+ F ++ + L ++ + T VW++N L ++G K L DG ++ D+
Sbjct: 17 DVEPYHFIMQEDCN----LVLYDH----STSVWASNTGILGKKGCKAVLQSDGNFVVYDA 68
Query: 105 SGKEIWRE--PPSTGAAYAAMLDTGNLVLASQDSSTMWESFD 144
G+ +W G + + GN+V+ S +W +
Sbjct: 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIY---GSDIWSTGT 107
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 6e-09
Identities = 20/116 (17%), Positives = 40/116 (34%), Gaps = 21/116 (18%)
Query: 148 DTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+ L + + G + + F +Q D NL+LY + + W++ T
Sbjct: 2 NLLTNGEGLYAGQSL---------DVEPYHFIMQEDCNLVLY-------DHSTSVWASNT 45
Query: 208 SI--GSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261
I G + V G + G ++ +++ + V+ DG Y
Sbjct: 46 GILGKKGCKAVLQSDGNFVVYDAEG---RSLWASHSVRGNGNYVLVLQEDGNVVIY 98
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 14/168 (8%)
Query: 498 LEVITGG-FK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIG 554
+E+ G ++ ++G G+FG +Y G E+ VA+K + V + E
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEE-VAIK--LECVKTKHPQLHIESKIYK 59
Query: 555 R-TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGL 613
+ + EG++ ++V E + SL D SR+ + + +A +
Sbjct: 60 MMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNA---RISDFGLAKLLKTDQT 658
Y+H IH D+KP N L+ I DFGLAK + +T
Sbjct: 119 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-09
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 11/95 (11%)
Query: 168 ETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT-SIGSGYQVVFNQSGFIYLT 226
E + + + F +QTD NL+LY N W+T T +G+G + V G + +
Sbjct: 24 EILFGTHVYRFIMQTDCNLVLYD-------NNNPIWATNTGGLGNGCRAVLQPDGVLVVI 76
Query: 227 ARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261
V + V + + V+ PD Y
Sbjct: 77 TNEN---VTVWQSPVAGKAGHYVLVLQPDRNVVIY 108
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-09
Identities = 25/137 (18%), Positives = 45/137 (32%), Gaps = 39/137 (28%)
Query: 75 IVWSANRDNLVQRGSKVELT--GDGQLILRDSSGKEIWR--EPPSTGAAYAAMLDTGNLV 130
I+ + ++ D L+L D+ IW A + G LV
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 131 LASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYT 190
+ + ++ T+W+S +G ++ LQ D N+++Y
Sbjct: 75 VITNENVTVWQS-------------------------PVAGKAGHYVLVLQPDRNVVIY- 108
Query: 191 TTYPFDGANAAYWSTQT 207
A W+TQT
Sbjct: 109 --------GDALWATQT 117
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 26/166 (15%), Positives = 61/166 (36%), Gaps = 29/166 (17%)
Query: 509 LGEGAFGKVYKG-------VLTTENEKPVAVK------KLYKAVNEGEQEFKAEISAIGR 555
G +Y+ + ++ ++K +L+ N ++ K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 556 TNHKNLV----QLLGF-CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM--QIAFG 608
+ + +GF ++ ++R LV + SL S + +R Q+A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQS-ALDVSPKHVLSERSVLQVACR 167
Query: 609 TARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLAK 651
L +LHE ++ +H ++ +NI + + ++ +G A
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFV-DPEDQSQVTLAGYGFAF 209
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 21/128 (16%), Positives = 41/128 (32%), Gaps = 38/128 (29%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSSGKEIWREPP--STGAAYAAMLDTGNLVLASQDSSTM 139
L + ++ + GD L+L K W+ + + + G L++ D T+
Sbjct: 19 GRLTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTI 76
Query: 140 WESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGAN 199
W S ++ G ++ LQ DG ++Y
Sbjct: 77 WSS-------------------------RSSSKQGEYVLILQDDGFGVIYGP-------- 103
Query: 200 AAYWSTQT 207
A + T +
Sbjct: 104 -AIFETSS 110
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 23/180 (12%)
Query: 488 MNLQDFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE 545
M+ Q+ V+ +K +GEG+FG +++G N + VA+K ++ +
Sbjct: 1 MSGQNN------VVGVHYKVGRRIGEGSFGVIFEGT-NLLNNQQVAIK--FEPRRSDAPQ 51
Query: 546 FKAEISAIG-RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKR-M 603
+ E + + F EG H +LV + + SL D L R K
Sbjct: 52 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLED-LLDLCGRKFSVKTVA 109
Query: 604 QIAFGTARGLFYLHEECKSQIIHCDIKPQNILL--DGTFNAR---ISDFGLAKLLKTDQT 658
A + +HE+ +++ DIKP N L+ + NA + DFG+ K + T
Sbjct: 110 MAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 498 LEVITGG-FK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIG 554
+E G F+ ++G G+FG++Y G NE+ VA+K + V + E
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIK--LENVKTKHPQLLYESKIYR 57
Query: 555 R-TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGL 613
+ + F EG++ +LV + + SL D SR+ + + +A +
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLAKLLKTDQT 658
++H + +H DIKP N L+ A I DFGLAK + T
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 21/129 (16%), Positives = 37/129 (28%), Gaps = 37/129 (28%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSS-GKEIWREPP--STGAAYAAMLDTGNLVLASQDSST 138
L R + + D L+L S +W + + +G L + +T
Sbjct: 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT 78
Query: 139 MWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGA 198
++ S T G ++ LQ +G ++Y
Sbjct: 79 VFVS-------------------------NTVGQEGDYVLILQINGQAVVYGP------- 106
Query: 199 NAAYWSTQT 207
A WST
Sbjct: 107 --AVWSTAA 113
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 23/127 (18%), Positives = 44/127 (34%), Gaps = 20/127 (15%)
Query: 146 PTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWST 205
+ L +QVM ++ ++ + ++ D NL+L W +
Sbjct: 5 VRNVLFSSQVMYDNAQL---------ATRDYSLVMRDDCNLVLTKG-----SKTNIVWES 50
Query: 206 QTS-IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYP 264
TS G + SG + +T N V +N Q+ ++ +G +Y
Sbjct: 51 GTSGRGQHCFMRLGHSGELDITDDRL---NTVFVSNTVGQEGDYVLILQINGQAV--VYG 105
Query: 265 KSSASTG 271
+ ST
Sbjct: 106 PAVWSTA 112
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 36/189 (19%), Positives = 68/189 (35%), Gaps = 30/189 (15%)
Query: 496 KELEVITGG-FK--EELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNEGEQEFK- 547
+ + + +K +G+G FG +Y + + ++ P VK E K
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF 86
Query: 548 ----AEISAIGRTNHKNLVQLLGFC----------NEGEHRLLVYEYVSNGSLADFLFRK 593
A+ I + ++ LG N +R ++ + + L
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN 145
Query: 594 SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR---ISDFGLA 650
++R + +Q++ L Y+HE +H DIK N+LL N + D+GLA
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL-NYKNPDQVYLVDYGLA 201
Query: 651 KLLKTDQTQ 659
+
Sbjct: 202 YRYCPEGVH 210
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-08
Identities = 24/125 (19%), Positives = 49/125 (39%), Gaps = 22/125 (17%)
Query: 148 DTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+ L + +S G + ++GR++F +Q D NL+LY + W+T T
Sbjct: 2 NILYSGETLSPGEFL---------NNGRYVFIMQEDCNLVLY-------DVDKPIWATNT 45
Query: 208 S-IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKS 266
+ + G + + + N + ++N ++ V+ D IY +
Sbjct: 46 GGLDRRCHLSMQSDGNLVVYSPRN---NPIWASNTGGENGNYVCVLQKDRNVV--IYGTA 100
Query: 267 SASTG 271
+TG
Sbjct: 101 RWATG 105
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-08
Identities = 28/130 (21%), Positives = 45/130 (34%), Gaps = 37/130 (28%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSSGKEIWRE--PPSTGAAYAAMLDTGNLVLASQDSSTM 139
+ L + D L+L D K IW + +M GNLV+ S ++ +
Sbjct: 14 EFLNNGRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPI 72
Query: 140 WESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGAN 199
W S T +G ++ LQ D N+++Y
Sbjct: 73 WAS-------------------------NTGGENGNYVCVLQKDRNVVIY---------G 98
Query: 200 AAYWSTQTSI 209
A W+T T+I
Sbjct: 99 TARWATGTNI 108
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-08
Identities = 21/102 (20%), Positives = 32/102 (31%), Gaps = 9/102 (8%)
Query: 172 SSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTS-IGSGYQVVFNQSGFIYLTARNG 230
S F +Q D NL+LY A + + T G + N G + + + N
Sbjct: 18 SYESAAFVMQGDCNLVLY--------NEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANS 69
Query: 231 SILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSSASTGG 272
+ V +V A + PD Y S
Sbjct: 70 NTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGPAIWSTPAAA 111
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-05
Identities = 19/132 (14%), Positives = 36/132 (27%), Gaps = 43/132 (32%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSSGKEIWREPPSTG------AAYAAMLDTGNLVLASQD 135
+ L + + GD L+L + + + + + G L + S +
Sbjct: 15 NQLSYESAAFVMQGDCNLVLYN--EAGGF----QSNTHGRGVDCTLRLNNRGQLEIHSAN 68
Query: 136 SSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPF 195
S+T + N G + L D ++ +Y
Sbjct: 69 SNTPVWVYP----------------------RSVNTVRGNYAATLGPDQHVTIYGP---- 102
Query: 196 DGANAAYWSTQT 207
A WST
Sbjct: 103 -----AIWSTPA 109
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-08
Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 37/125 (29%)
Query: 85 VQRGSKVELTGDGQLILRDSSGKEIWR--EPPSTGAAYAAMLDTGNLVLASQDSSTMWES 142
V ++ + GD +L DS GK +W + + GNLV+ Q + +W++
Sbjct: 18 VGPSYRLIMQGDCNFVLYDS-GKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT 76
Query: 143 FDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAY 202
+TN ++ LQ D N+++Y
Sbjct: 77 -------------------------KTNGKEDHYVLVLQQDRNVVIY---------GPVV 102
Query: 203 WSTQT 207
W+T +
Sbjct: 103 WATGS 107
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-08
Identities = 18/128 (14%), Positives = 44/128 (34%), Gaps = 23/128 (17%)
Query: 148 DTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
++L + G + + +Q D N +LY + W++ T
Sbjct: 2 NSLSSPNSLFTG--------HSLEVGPSYRLIMQGDCNFVLY-------DSGKPVWASNT 46
Query: 208 S-IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKS 266
+GSG ++ + +G + + ++ + ++ + V+ D IY
Sbjct: 47 GGLGSGCRLTLHNNGNLVIYDQSN---RVIWQTKTNGKEDHYVLVLQQDRNVV--IYGPV 101
Query: 267 --SASTGG 272
+ +G
Sbjct: 102 VWATGSGP 109
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 5e-08
Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 25/126 (19%)
Query: 147 TDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQ 206
T+ LL Q + +G F +Q D NL+LY W +
Sbjct: 3 TNYLLSGQTLDTEGH---------LKNGDFDLVMQDDCNLVLYN----------GNWQSN 43
Query: 207 TS-IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPK 265
T+ G ++ G + + +GS + S + + Y AVV PDG ++
Sbjct: 44 TANNGRDCKLTLTDYGELVIKNGDGSTVWK--SGAQSVKGNY-AAVVHPDGRLV--VFGP 98
Query: 266 SSASTG 271
S
Sbjct: 99 SVFKID 104
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 16/68 (23%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 77 WSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWRE--PPSTGAAYAAMLDTGNLVLASQ 134
W +N N R K+ LT G+L++++ G +W+ G A + G LV+
Sbjct: 40 WQSNTANN-GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV--- 95
Query: 135 DSSTMWES 142
++++
Sbjct: 96 FGPSVFKI 103
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 87/639 (13%), Positives = 184/639 (28%), Gaps = 171/639 (26%)
Query: 45 QSGDFAFGFR---QVGDRGFLLAIWFNEIPE--RTIVWSANRDNLVQRGSKVELTGDGQL 99
++G+ + ++ V + F+ ++ + ++I+ D+++ V T
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLF 68
Query: 100 ILRDSSGKEIWREPPSTGAA--YAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPT-QVM 156
S +E+ ++ Y ++ + + S M + + D L QV
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSP--IKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126
Query: 157 SQGT----KVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGSG 212
++ + +L + + EL+ N+L+ G +GSG
Sbjct: 127 AKYNVSRLQPYLKLRQA-------LLELRPAKNVLID-------GV----------LGSG 162
Query: 213 YQVV-------------FNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFR 259
V + F +L +N + V Q + +DP+ R
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEM---LQKLLYQ--IDPNWTSR 216
Query: 260 -----HYIYPKSSASTGGRWPKAWSFLSFIPSNICLRIRADTGSGAC--GFNSFC----- 307
+ S R L P CL + + + FN C
Sbjct: 217 SDHSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 308 --------SLGDDQRK---LCQCPPGYTFFDPDDVMK------GCKENFVP-QSCDRAVE 349
L L T PD+V C+ +P +
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLT---PDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 350 EMDLF--EFRDMPNT--DWPLNDYEHFTSVDEDWCREACLS--------DCFCAVAIFRE 397
+ + RD T +W + + T++ E+ L+ F +++F
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTI-----IESSLNVLEPAEYRKMFDRLSVFPP 383
Query: 398 GE---------CWKKRAPLSNGRIDPSVGGKALVKVRKD---------YSDASAGSGSNR 439
W + + +LV+ + Y + +
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 440 KENSTLI--Y----------ILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPE 487
+ +++ Y ++ L + H I H +N + E
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH-----IGHHLKNIEHP---ERMTLFRM 495
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFG-----KVYKGVLTTENEKPVAVKKLYKAVNEG 542
+ L DF + E ++ K YK + + K +
Sbjct: 496 VFL-DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL----- 549
Query: 543 EQEF--KAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579
+F K E + I + + +L++ + E E ++E
Sbjct: 550 --DFLPKIEENLI-CSKYTDLLR-IALMAEDEA---IFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 7e-07
Identities = 65/484 (13%), Positives = 132/484 (27%), Gaps = 157/484 (32%)
Query: 332 MKGCKENFVPQSCDRAVEEMDLFEFRDMPNTDWPLNDYEHFTSVDEDWCREACLSDCFC- 390
+ ++ + D V+ D + +DMP + + +H + L
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 391 ----AVAIFREGEC-----WKKRAPLSNGRIDPSVGGKALVKVRKDYSDASAGSGSNRKE 441
V F E + +P+ + PS+ + + Y + +R
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLM-SPIKTEQRQPSM-------MTRMYIEQR-----DRLY 120
Query: 442 NSTLIYILSATLGGSIFLHLLVTFIFFHRRNQKKQNTVESQKGMPEMNLQDFTYKELEVI 501
N +F V+ R Q + ++ + + L+ ++
Sbjct: 121 N-----------DNQVFAKYNVS------RLQPYL---KLRQAL--LELRPAKNVLID-- 156
Query: 502 TGGFKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHK 559
G GK + + V + + +I +
Sbjct: 157 --------GVLGSGK---TWVALDVCLSYKV------------QCKMDFKIFWLN----- 188
Query: 560 NLVQLLGFCNEGEHRL-----LVYEYVSNG-SLADFLFRKSRRPNWYKRMQIAFGTARGL 613
L CN E L L+Y+ N S +D R + + R L
Sbjct: 189 -----LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA------ELRRL 237
Query: 614 FYLHEECKSQIIHCDIKPQNILLDGTFNARISD-FGL-AKLLKTDQTQTTTAIRGTKGYV 671
++ L NA+ + F L K+L TT
Sbjct: 238 LKSKPYENCLLV----------LLNVQNAKAWNAFNLSCKIL------LTT--------- 272
Query: 672 APEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA---YDCFRE-- 726
+ +T + + + L+ D + +L +
Sbjct: 273 -----RFKQVTDFLSAATTTHISLDHH--SMTLTPDEVKS---LLLKYLDCRPQDLPREV 322
Query: 727 -----RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781
R+L ++ E+ + +A W D K+T +IE +++V
Sbjct: 323 LTTNPRRLSIIAESIRD------------GLATW----DNWKHVNCDKLTTIIESSLNVL 366
Query: 782 IPPD 785
P +
Sbjct: 367 EPAE 370
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 793 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.82 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.81 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.79 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.76 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.66 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.64 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.6 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.55 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.53 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.44 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.26 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.24 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.22 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.17 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.99 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.98 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.96 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.87 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.7 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.37 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.36 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.78 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.61 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 90.58 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 85.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.14 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 80.02 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=443.24 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=213.1
Q ss_pred HhcccccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceE
Q 003818 501 ITGGFKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 501 ~t~~f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 575 (793)
.+..|.++||+|+||+||+|.+. ..+++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34467889999999999999974 23568899999976433 34578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 576 LVYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
||||||++|+|.++|..+. ..+++..+++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996532 3578999999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCC-CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHH
Q 003818 641 NARISDFGLAKLLKTDQ-TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILAD 718 (793)
Q Consensus 641 ~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~ 718 (793)
.+||+|||+++.+.... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~----- 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----- 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH-----
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH-----
Confidence 99999999998664432 223344679999999999999999999999999999999998 89999877654422
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
..+..+...... ...+..+.+|+.+||+.||++||||+||++.|+....+
T Consensus 258 ---~~i~~~~~~~~p---------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 258 ---EMIRNRQVLPCP---------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp ---HHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred ---HHHHcCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 122222222111 12345678999999999999999999999999976543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=435.03 Aligned_cols=255 Identities=24% Similarity=0.441 Sum_probs=211.6
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.++||+|+||.||+|++.. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 46889999999999998643 35688999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecC
Q 003818 581 VSNGSLADFLFRK------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFG 648 (793)
Q Consensus 581 ~~~gsL~~~l~~~------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 648 (793)
|++|+|.++|+.. ...+++.+++.|+.|||+||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence 9999999999753 35689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhc
Q 003818 649 LAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRE 726 (793)
Q Consensus 649 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~ 726 (793)
+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||......+... .+..
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~--------~i~~ 245 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE--------CITQ 245 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--------HHHH
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHc
Confidence 998665433322 223468999999999999999999999999999999998 899998776554222 1222
Q ss_pred cccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
+...... ...++.+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 246 ~~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 GRVLQRP---------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221111 1234567899999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=437.04 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=206.4
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.++||+|+||.||+|++.. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46789999999999998642 35789999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 581 VSNGSLADFLFRKS--------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 581 ~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
|++|+|.++++... ..+++.+++.|+.|||+||+|||++ +||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 99999999997542 3588999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHh
Q 003818 647 FGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCF 724 (793)
Q Consensus 647 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~ 724 (793)
||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+.... +
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~--------i 273 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC--------I 273 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH--------H
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH--------H
Confidence 999987654332 23344679999999999999999999999999999999999 8999987765542211 1
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
..+...... ...+..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 274 ~~g~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRELERP---------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCCCCC---------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCCCc---------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222211111 12335678999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=427.45 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=201.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.++||+|+||+||+|++. ..||||+++... .+..+.|.+|+.++++++|||||+++|++.+ +..+||||||+
T Consensus 40 l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp EEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred EeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 5688999999999999864 249999986432 3345789999999999999999999999865 56899999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-Ccce
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-TQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 661 (793)
+|+|.++|......+++.++..|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+...... ....
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 9999999988778899999999999999999999998 99999999999999999999999999998765433 2334
Q ss_pred ecccCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TAIRGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....||+.|||||++.+ .+|+.++|||||||+||||+||+.||......+... ..+..+........
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~-------~~~~~~~~~p~~~~--- 261 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII-------FMVGRGYASPDLSK--- 261 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-------HHHHTTCCCCCSTT---
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH-------HHHhcCCCCCCccc---
Confidence 45679999999999964 368999999999999999999999998655433211 11112211111000
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....+..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 262 --~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 262 --LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11123456789999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=421.73 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=206.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.++||+|+||.||+|+.. .+++.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||++|+
T Consensus 79 ~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred eEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 467999999999999864 4678999999987666666789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.+ ..+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .....+
T Consensus 158 L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 231 (346)
T 4fih_A 158 LTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 231 (346)
T ss_dssp HHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCC
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccccc
Confidence 9999965 3589999999999999999999998 999999999999999999999999999987654332 234567
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ .......+ ......
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~~~-------~~~~~~ 296 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL-------KNLHKV 296 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSSCCCC-------SCGGGS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC-------CccccC
Confidence 999999999999999999999999999999999999999876654422211 11111000 111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.+|+.+||+.||++|||++|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 456789999999999999999999886
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=418.16 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=198.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|+.. .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|||||||+
T Consensus 28 ~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 28 RLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3478999999999999854 467899999996542 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|+|.++|..+ ...+++.....++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+.+.... ...
T Consensus 107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 182 (350)
T 4b9d_A 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELA 182 (350)
T ss_dssp TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHH
T ss_pred CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccc
Confidence 99999999765 34568889999999999999999998 99999999999999999999999999998764321 122
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|||||++.+..|+.++|||||||+||||++|+.||......+....+ ..+.....
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~~~~--------- 245 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--------ISGSFPPV--------- 245 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCCCC---------
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC---------
Confidence 3457999999999999999999999999999999999999999887655432221 11221111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112356789999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=406.12 Aligned_cols=246 Identities=27% Similarity=0.393 Sum_probs=196.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec----CCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE----GEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 578 (793)
|.++||+|+||.||+|... .+++.||+|++.... ....+.|.+|+.++++++|||||++++++.+ ++..+|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4567999999999999865 467889999996542 2334679999999999999999999999865 35689999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||++ .++|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999754 5688999999999999999999987 12399999999999997 4899999999999864332
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
......||+.|||||++.+ +++.++|||||||++|||+||+.||........ +...+..+......
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-------~~~~i~~~~~~~~~---- 251 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKPASF---- 251 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCCGGG----
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-------HHHHHHcCCCCCCC----
Confidence 3345679999999999875 699999999999999999999999976443321 11112222111100
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+......+.+|+.+||+.||++|||++|+++
T Consensus 252 ----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112245788999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=415.41 Aligned_cols=246 Identities=23% Similarity=0.251 Sum_probs=199.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.++||+|+||.||+|+.. .+++.||||+++... ...+|+.++++++|||||++++++.+++..+||||||++|+
T Consensus 63 ~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred CcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 467999999999999854 467899999996532 22579999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCCcc----
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQT---- 660 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~---- 660 (793)
|.++|.+. ..+++.....++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+..+....
T Consensus 137 L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 137 LGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 99999765 4689999999999999999999998 999999999999999987 69999999998775443221
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. . .... .. .
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-------~-~~~~-~~------~ 277 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-------S-EPPP-IR------E 277 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-------H-SCCG-GG------G
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-------c-CCCC-ch------h
Confidence 223579999999999999999999999999999999999999998765443222111 1 1100 00 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.+......+.+++.+||+.||++|||+.||++.|..
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111234567889999999999999999999988754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=422.59 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=206.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.++||+|+||.||+|... .+++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||++|+
T Consensus 156 ~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 478999999999999965 4678999999977666666789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .....+
T Consensus 235 L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 308 (423)
T 4fie_A 235 LTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 308 (423)
T ss_dssp HHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCE
T ss_pred HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccc
Confidence 99999653 588999999999999999999998 999999999999999999999999999987654332 234567
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ .......+ . .....
T Consensus 309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~~~-~------~~~~~ 373 (423)
T 4fie_A 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL-K------NLHKV 373 (423)
T ss_dssp ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCC-S------CTTSS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC-c------ccccC
Confidence 999999999999999999999999999999999999999876654422211 11111111 0 11122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.+|+.+||+.||++|||++|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 356789999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=408.81 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=205.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||+||+|+.. .+++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 36 i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~ 114 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 114 (311)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 4578999999999999854 467899999997542 334577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cc
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 660 (793)
++|+|.+++.+. ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 115 ~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 115 KNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999764 4688999999999999999999998 999999999999999999999999999997754432 33
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+ ..+.... . .
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~~-p---~--- 255 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI--------IKLEYDF-P---E--- 255 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCC-C---T---
T ss_pred ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCCC-C---c---
Confidence 45578999999999999999999999999999999999999999877655432222 1222111 0 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
.....+.+|+.+||+.||++|||++|++
T Consensus 256 ---~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 ---KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1234578899999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=410.41 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=198.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC----ceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----HRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey 580 (793)
+.++||+|+||+||+|++ .|+.||||++..... ....++.|+..+.+++|||||++++++.+++ ..+|||||
T Consensus 7 L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 457899999999999997 468899999965422 2233455677777899999999999997654 57999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE-----CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
|++|+|.++|... .+++..+.+++.|+++||+|||++ +.++|+||||||+||||++++.+||+|||+++....
T Consensus 83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 9999999999754 588999999999999999999976 245899999999999999999999999999987654
Q ss_pred CCCc---ceecccCcccccCcccccCC------CCCCccceehhHHHHHHHHhCCcCCCCCchhHHH--------HHHHH
Q 003818 656 DQTQ---TTTAIRGTKGYVAPEWFKNL------PITAKVDVYSFGILLLELVCCRKNFEVDATEECQ--------MILAD 718 (793)
Q Consensus 656 ~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~--------~~l~~ 718 (793)
.... ......||+.|||||++.+. .++.++|||||||+||||+||+.||......+.. .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3322 12235699999999999764 4678999999999999999998877543221100 00111
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....+.+..... ..+......+.+..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 241 -~~~~~~~~~~rp---~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 241 -MRKVVCEQKLRP---NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp -HHHHHTTSCCCC---CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHhcccCCC---CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111122221111 11112223355677899999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=413.74 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=208.1
Q ss_pred ccccccccccceeEEEeEeCC----CCceeEEEEEechhccc-chHHHHHHHHHHhcCCc-cccceeeeEEec-CCceEE
Q 003818 504 GFKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNH-KNLVQLLGFCNE-GEHRLL 576 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H-~niv~l~~~~~~-~~~~~l 576 (793)
.+.+.||+|+||.||+|.+.. ..++.||||++...... ..+.|.+|+.+|.+++| ||||+++|+|.+ ++..+|
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 345789999999999998653 23478999999765433 34679999999999965 899999999966 467899
Q ss_pred EEeecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRK---------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
|||||++|+|.++|+.. ...+++..+..++.|||+||+|||++ +||||||||+|||+++++.
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCC
Confidence 99999999999999753 23478999999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~------- 296 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------- 296 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-------
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 999999999976554433 3344678999999999999999999999999999999998 8999987653321
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
+...+.++......+ ....++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 297 ~~~~i~~g~~~~~p~---------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCc---------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 112222222111111 123567889999999999999999999999987543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=391.41 Aligned_cols=242 Identities=24% Similarity=0.388 Sum_probs=189.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||+||+|.. ..+++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 17 i~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 95 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 95 (275)
T ss_dssp EEEEEEC---CCEEEEEC-TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEecCcCeEEEEEEE-CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 457899999999999985 4567899999996532 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|+|.+++.++ ..+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 96 -~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~ 168 (275)
T 3hyh_A 96 -GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FL 168 (275)
T ss_dssp -CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred -CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--cc
Confidence 78999999765 4689999999999999999999998 99999999999999999999999999998654332 23
Q ss_pred ecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....||+.|||||++.+..+ +.++||||+||++|||++|+.||......+.... +..+.... . .
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~--------i~~~~~~~-p----~-- 233 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN--------ISNGVYTL-P----K-- 233 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHTCCCC-C----T--
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHcCCCCC-C----C--
Confidence 34679999999999998886 5799999999999999999999987654432211 12222111 0 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.....+.+++.+||+.||++|||++|+++
T Consensus 234 ---~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 234 ---FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 12345788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=399.72 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=195.0
Q ss_pred cccccccccceeEEEeEeC--CCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||+||+|+.. ..+++.||||++.+.. ......+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 4578999999999999853 3457899999997543 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
|++|+|.+++.+. ..+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 108 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 182 (304)
T 3ubd_A 108 LRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 182 (304)
T ss_dssp CTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-C
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-c
Confidence 9999999999764 4688999999999999999999998 999999999999999999999999999986543322 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ ..+.... +.
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~~~-----p~-- 247 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--------LKAKLGM-----PQ-- 247 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC-----CT--
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH--------HcCCCCC-----CC--
Confidence 33467999999999999999999999999999999999999999877655432221 1121111 00
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
..+..+.+|+.+||+.||++||| ++|+++
T Consensus 248 ---~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 ---FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12345788999999999999998 466664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=388.39 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=184.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCC-----------
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----------- 572 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----------- 572 (793)
+.+.||+|+||+||+|+.. .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 9 ~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 3478999999999999854 4678999999965433 23467899999999999999999999986544
Q ss_pred -ceEEEEeecCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 573 -HRLLVYEYVSNGSLADFLFRKSR--RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 573 -~~~lV~Ey~~~gsL~~~l~~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
..++|||||++|+|.+++..+.. ..++.....++.||++||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCcc
Confidence 36899999999999999976532 245566789999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc-----------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 650 AKLLKTDQTQ-----------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 650 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||...... ...+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~~-- 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRTL-- 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHH--
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHHH--
Confidence 9876543322 1223569999999999999999999999999999999996 77643211 1111
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......... .........+.+++.+||+.||++|||+.|+++
T Consensus 238 ---~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 ---TDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 011223345678999999999999999999987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=367.80 Aligned_cols=228 Identities=21% Similarity=0.353 Sum_probs=191.0
Q ss_pred cccCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCC-----CceEEE
Q 003818 19 AQSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQR-----GSKVEL 93 (793)
Q Consensus 19 ~~~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~-----~~~l~~ 93 (793)
+++.|+|++|++|++++ +|+|++|+|+||||+++ ++|+ |+ +.+ |||+|||++|+.+ +++|+|
T Consensus 11 ~~~~~~l~~g~~l~~~~-----~l~S~~g~F~lgf~~~~--~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l 77 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQ-----YLLSPNQRFKLLLQGDG--NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPL 77 (276)
T ss_dssp CTTSSEECTTEEBCTTC-----EEECTTSSEEEEECTTS--CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCS
T ss_pred cccCCEecCCCEecCCC-----EEEcCCCcEEEEEECCC--CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEE
Confidence 35679999999998765 89999999999999544 6888 76 777 9999999999975 678999
Q ss_pred ecCCcEEE--ECCCCCeeecCCCCC-------ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCcc----ccCCc
Q 003818 94 TGDGQLIL--RDSSGKEIWREPPST-------GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQV----MSQGT 160 (793)
Q Consensus 94 ~~~g~l~l--~~~~~~~~Wst~~~~-------~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~----l~~~~ 160 (793)
+.|||||| .|++|++||+|+++. .++.|+|+|+|||||++ +.+|||| |||||+||+|+ |..|+
T Consensus 78 ~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp EEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred eCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCc
Confidence 99999999 788899999997643 34689999999999998 7899999 99999999999 77888
Q ss_pred eEEEecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccccCCcceeEEecccceEEEEecCCeeEEEEeecc
Q 003818 161 KVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNN 240 (793)
Q Consensus 161 ~L~s~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (793)
+| ++..||++|.|+++||++|++++|... ..+||+++++.+....+.++.+|.++++..++..++.+...
T Consensus 154 ~L---~S~~dps~G~fsl~l~~dGnlvLy~~~------~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~- 223 (276)
T 3m7h_A 154 EL---VQGVVYGAGASKLVFQGDGNLVAYGPN------GAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG- 223 (276)
T ss_dssp EE---CTTCEEEETTEEEEECTTSCEEEECTT------SSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCT-
T ss_pred cc---ccCCCCCCceEEEeecCCceEEEEeCC------CeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCC-
Confidence 88 567899999999999999988776321 37899999987655677888899998888777666665432
Q ss_pred ccCcceEEEEEEcCCCcEEEEEecCCCCCCCCCCccccceeeccccc
Q 003818 241 VTAQDFYQRAVVDPDGVFRHYIYPKSSASTGGRWPKAWSFLSFIPSN 287 (793)
Q Consensus 241 ~~~~~~~~r~~l~~~G~l~~~~w~~~~~~~~~~w~~~w~~~~~~p~~ 287 (793)
....+|++|+.||++++|.|. ..|+.|+.+|+.
T Consensus 224 ---~~~~~rl~Ld~dGnLvly~~~-----------~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 224 ---GHASAVLRLQANGSIAILDEK-----------PVWARFGFQPTY 256 (276)
T ss_dssp ---TCTTCEEEECTTSCEEEEEEE-----------EEEESSSCCTTS
T ss_pred ---CCCCEEEEEcCCccEEEEcCC-----------CeEEccCccCCc
Confidence 122479999999999999982 468888787774
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=385.84 Aligned_cols=261 Identities=21% Similarity=0.268 Sum_probs=198.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEec------CCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNE------GEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~l 576 (793)
+.+.||+|+||+||+|... .+++.||||++..... ...+.+.+|+.+|+.++|||||++++++.. .+.+||
T Consensus 58 ~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 58 IIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 3478999999999999854 5678999999975432 234678899999999999999999998753 467899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|||||+ |+|.+++.++ ..+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 137 vmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 999995 7899999654 5789999999999999999999998 9999999999999999999999999999876432
Q ss_pred C---CcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc--
Q 003818 657 Q---TQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG-- 730 (793)
Q Consensus 657 ~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~-- 730 (793)
. ........||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+...... .......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~-p~~~~~~~~ 290 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT-PSPAVIQAV 290 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC-CCGGGTC--
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC-CChHHhhhh
Confidence 2 2233456799999999998875 5699999999999999999999999887665543333211100 0000000
Q ss_pred ----------eeecccch--hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 ----------LLVENDEE--AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ----------~~~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+...... ..........+.+|+.+||+.||++|||++|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0000012356789999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=377.48 Aligned_cols=196 Identities=24% Similarity=0.406 Sum_probs=167.1
Q ss_pred cccccccccceeEEEeEeC--CCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.++||+|+||+||+|+.+ ..+++.||+|++.... ....+.+|+++|..+ +|||||++++++.+.++.++||||+
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 3578999999999999753 3467899999986542 345788999999988 6999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCCCCC--
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQT-- 658 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~-- 658 (793)
++|+|.+++ ..+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 103 ~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 103 EHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp CCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred CcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 999999998 3588899999999999999999998 99999999999999876 7999999999986543221
Q ss_pred -------------------------cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCch
Q 003818 659 -------------------------QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDAT 709 (793)
Q Consensus 659 -------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~ 709 (793)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 112234699999999999876 489999999999999999999999965543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=401.33 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=208.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..+||||||++|
T Consensus 161 i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 4578999999999999864 567899999997765555678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC--CcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT--FNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.++|..+...+++..+..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+.... ...
T Consensus 240 ~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~ 314 (573)
T 3uto_A 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVK 314 (573)
T ss_dssp BHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEE
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--cee
Confidence 99999987777899999999999999999999998 99999999999999854 899999999998775433 334
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ .......... ..
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i--------~~~~~~~~~~------~~ 380 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDWNMDDS------AF 380 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCCCCSG------GG
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HhCCCCCCcc------cc
Confidence 457999999999999999999999999999999999999999887655432221 1111111000 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+|+.+||+.||++|||+.|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112356788999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=373.46 Aligned_cols=288 Identities=42% Similarity=0.737 Sum_probs=240.2
Q ss_pred cCCCCCHHHHHHHhcccc--cccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceee
Q 003818 489 NLQDFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLL 565 (793)
Q Consensus 489 ~~~~~~~~el~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~ 565 (793)
.+..+++.++...+++|. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 456788899998888875 68999999999999743 578899999976432 2334789999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcE
Q 003818 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKS---RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642 (793)
Q Consensus 566 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 642 (793)
+++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++.++|+||||||+|||+++++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997643 348899999999999999999999877799999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhH-HHHHHHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE-CQMILADWAY 721 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~-~~~~l~~~~~ 721 (793)
||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.++..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999998776555555555679999999999998899999999999999999999999996432211 1223345555
Q ss_pred HHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
............+..............+.+++.+||+.||++|||++||++.|++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 555566666666655555566778889999999999999999999999999998744
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=389.66 Aligned_cols=245 Identities=23% Similarity=0.270 Sum_probs=195.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHH---HHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKA---EISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|+.. .+++.||||++.+.. ......+.+ ++.+++.++|||||++++++.+.+.+||||
T Consensus 193 i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3578999999999999965 568899999997532 222333333 466777889999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
|||+||+|.++|.+. ..+++.....++.||+.||.|||++ +||||||||+||||+.+|++||+|||+|+.+....
T Consensus 272 Ey~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp CCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 999999999999765 4688999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
....+||+.|||||++.. ..|+.++|||||||++|||++|+.||......+... + ...........
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i----~~~i~~~~~~~------ 413 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I----DRMTLTMAVEL------ 413 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-H----HHHHHHCCCCC------
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-H----HHhhcCCCCCC------
Confidence 234679999999999964 579999999999999999999999997654322111 1 11111111110
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
+......+.+|+.+||+.||++|++ ++||++
T Consensus 414 ----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0112345789999999999999998 677764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=362.20 Aligned_cols=269 Identities=37% Similarity=0.652 Sum_probs=222.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 44 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp CCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred cceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 367999999999999853 577899999877655666789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-Ccce
Q 003818 586 LADFLFRKS---RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-TQTT 661 (793)
Q Consensus 586 L~~~l~~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 661 (793)
|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999996543 3588999999999999999999998 99999999999999999999999999998654322 2222
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .+..+.......+.+....+.......
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccccccHHHhcChhhcccc
Confidence 3345899999999999889999999999999999999999999765433221 122333334444445555554444444
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
.......+.+++.+||+.||++|||++||++.|+....+
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 567788899999999999999999999999999976544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=358.91 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=207.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 14 ~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred ccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 3578999999999999865 457889999987665666778999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc----
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT---- 660 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~---- 660 (793)
+|.+++......+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 93 TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp BHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 99999988778899999999999999999999998 99999999999999999999999999998764433221
Q ss_pred ---------eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH--HHHHHHHHHhhcccc
Q 003818 661 ---------TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM--ILADWAYDCFRERKL 729 (793)
Q Consensus 661 ---------~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~--~l~~~~~~~~~~~~~ 729 (793)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+.......... .........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~------ 243 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY------ 243 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT------
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc------
Confidence 113569999999999999999999999999999999999999986543221100 000000000
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
........+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 244 -----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 244 -----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112345788999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=361.33 Aligned_cols=257 Identities=24% Similarity=0.418 Sum_probs=208.9
Q ss_pred ccccccccceeEEEeEeCCC--CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|..... .+..||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 46799999999999987532 34569999997643 3345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc--
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-- 660 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 660 (793)
+++|.+++......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 134 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (325)
T 3kul_A 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210 (325)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEE
T ss_pred CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceee
Confidence 9999999987777899999999999999999999998 99999999999999999999999999998765443222
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ ..+....
T Consensus 211 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~~-------- 274 (325)
T 3kul_A 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRLP-------- 274 (325)
T ss_dssp CC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HTTCCCC--------
T ss_pred ccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------HcCCCCC--------
Confidence 222346778999999998899999999999999999999 99999876654422111 1111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSI 782 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 782 (793)
........+.+++..||+.||++|||+++|++.|+.+...+.
T Consensus 275 -~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 275 -APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 011233568899999999999999999999999998665543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=358.67 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=198.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|.. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 41 i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred eeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 357899999999999985 46789999986543 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 583 NGSLADFLFRKSR--RPNWYKRMQIAFGTARGLFYLHEECKSQ--IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 583 ~gsL~~~l~~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
+++|.+++..... .+++..++.++.|+++||+|||++ + |+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~- 193 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF- 193 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-
Confidence 9999999976532 388899999999999999999998 7 9999999999999999999999999997544322
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .........
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~------ 260 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-------GFKCKRLEI------ 260 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-------HHSCCCCCC------
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcCCCCCC------
Confidence 1223356899999999999999999999999999999999999999876654422111 001111111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCCc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPA 787 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~p~~p~ 787 (793)
.......+.+++.+||+.||++|||+++|++.|+.......||.++
T Consensus 261 ---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 261 ---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred ---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 0112345789999999999999999999999999977665555444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=350.96 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=205.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|.. ..+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||+++++
T Consensus 25 ~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CEEEEEETTEEEEEEEB-TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeccCCCeEEEEEEE-CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 46899999999999984 45678999999977666667789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......... .....
T Consensus 104 L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 177 (297)
T 3fxz_A 104 LTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 177 (297)
T ss_dssp HHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BCCCC
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-cCCcc
Confidence 99999654 588899999999999999999998 9999999999999999999999999999876544332 23456
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... .. ......
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~~~-~~-------~~~~~~ 242 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTP-EL-------QNPEKL 242 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHHCSC-CC-------SCGGGS
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCC-CC-------CCcccc
Confidence 999999999999999999999999999999999999999876554322211 111110 00 011123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3567899999999999999999999873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.29 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=213.7
Q ss_pred CCCCHHHHHHHhcc------------cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc
Q 003818 491 QDFTYKELEVITGG------------FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH 558 (793)
Q Consensus 491 ~~~~~~el~~~t~~------------f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H 558 (793)
..+++++++.++.. +.+.||+|+||.||+|... .+++.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 45788888877754 2357999999999999864 4578899999987666667789999999999999
Q ss_pred cccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC
Q 003818 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG 638 (793)
Q Consensus 559 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~ 638 (793)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999999854 4689999999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 639 TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 639 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~-- 253 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-- 253 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--
T ss_pred CCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 999999999999876543322 23456999999999999999999999999999999999999999876544322111
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........ .........+.+++.+||+.||++|||++||++.
T Consensus 254 ------~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 ------RDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ------HHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------hcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111110 0111223567889999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.04 Aligned_cols=280 Identities=38% Similarity=0.626 Sum_probs=222.6
Q ss_pred CcCCCCCHHHHHHHhcccc--------cccccccceeEEEeEeCCCCceeEEEEEechhc----ccchHHHHHHHHHHhc
Q 003818 488 MNLQDFTYKELEVITGGFK--------EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----NEGEQEFKAEISAIGR 555 (793)
Q Consensus 488 ~~~~~~~~~el~~~t~~f~--------~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~ 555 (793)
.....|++.++..++.+|. +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 3467899999999999986 4599999999999985 46789999986532 2335678999999999
Q ss_pred CCccccceeeeEEecCCceEEEEeecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003818 556 TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRK--SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQN 633 (793)
Q Consensus 556 l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 633 (793)
++||||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 99999999999999999999999999999999999643 45688999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH
Q 003818 634 ILLDGTFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC 712 (793)
Q Consensus 634 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~ 712 (793)
|++++++.+||+|||++.......... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 999999999999999998765433222 233468999999998875 588999999999999999999999987554332
Q ss_pred HHHHHHHHHHHhh-ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 713 QMILADWAYDCFR-ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 713 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
...+.. .... ...+...++... ........+.+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 243 ~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKE---EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHH---HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHH---Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111 1111 011111111111 1123456778999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=358.80 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=208.0
Q ss_pred cccccccccceeEEEeEeC------CCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLT------TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~------~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|... ...+..||+|+++.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 4578999999999999853 23467899999976532 3346789999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 241 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCC
Confidence 999999999999997643 3478899999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~----- 316 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----- 316 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Confidence 99999999986654322 22233457889999999999999999999999999999999 999998765443221
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.+..+..... +......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 317 ---~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 317 ---LLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ---HHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122211111 11233568899999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=363.73 Aligned_cols=254 Identities=24% Similarity=0.431 Sum_probs=197.1
Q ss_pred cccccccccceeEEEeEeCC--CCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|.... ..+..||||+++... ....+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 35789999999999998652 356789999997643 334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++......+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 129 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 205 (373)
T 2qol_A 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205 (373)
T ss_dssp TTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccce
Confidence 99999999988777899999999999999999999998 999999999999999999999999999987654332221
Q ss_pred --ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 --TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 --~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+... .
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~--------i~~~~~~---~---- 270 (373)
T 2qol_A 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA--------VDEGYRL---P---- 270 (373)
T ss_dssp --------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH--------HHTTEEC---C----
T ss_pred eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC---C----
Confidence 12235678999999999999999999999999999998 9999987654432211 1111110 0
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
........+.+++.+||+.||++||++++|+++|+.+.
T Consensus 271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 01123456889999999999999999999999997653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=343.57 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=208.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 14 FVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEECSSCEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred eeheecCCCccEEEEEEec--CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 3578999999999999865 45679999997643 34567999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++..............
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 91 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 99999988777899999999999999999999998 999999999999999999999999999986654333333334
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+..... +.
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~~ 230 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRLYK---------PR 230 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCCCCC---------CT
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------hcCccCCC---------CC
Confidence 56788999999999999999999999999999999 99999876654422211 11111000 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....+.+++..||+.||++|||++++++.|+++.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 12345788999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=342.33 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=210.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... ++..||+|++.... ...+++.+|+.++.+++||||+++++++.+++..++||||++++
T Consensus 12 ~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 12 LLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp EEEEEEEETTEEEEEEEET--TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred eeeeeccCCCceEEEEEec--CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 4578999999999999865 45679999997643 34567999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++..............
T Consensus 89 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 89 CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 99999987766789999999999999999999998 999999999999999999999999999987655544333444
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+..... + .
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~--~-------~ 228 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--------SQGHRLYR--P-------H 228 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCCCC--C-------T
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--------HcCCCCCC--C-------C
Confidence 56778999999999899999999999999999999 99999876654422111 11111100 0 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
.....+.+++.+||+.||++|||+++|++.|+.+.+.
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1234678999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.60 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=205.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... ..++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 15 i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 3478999999999999854 4578899999854322 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...........
T Consensus 94 ~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 94 EGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 999999999655 4688999999999999999999998 999999999999999999999999999987655444444
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ..+... .... ....
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------~~~~~~-~~~~-----~~~~ 236 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-------KHIQDS-VPNV-----TTDV 236 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-------HHHSSC-CCCH-----HHHS
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhhcc-CCCc-----chhc
Confidence 44569999999999999999999999999999999999999998776543211 111111 1110 0001
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcCCCC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-AMKKVTQMIEGAVDVSI 782 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~~~~~ 782 (793)
....+..+.+++.+||+.||++|| +++++.+.|+....-..
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 112345688999999999999998 99999999988665443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.68 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=204.8
Q ss_pred cccccccccceeEEEeEe---CCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVL---TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 579 (793)
+.+.||+|+||.||++.+ ...+++.||+|++........+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 457899999999999985 3456789999999876555667899999999999999999999998653 56899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170 (295)
T ss_dssp CCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--------
T ss_pred eCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcce
Confidence 9999999999988777789999999999999999999998 9999999999999999999999999999876543321
Q ss_pred --ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH--------HHHHHHHHHhhcccc
Q 003818 660 --TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM--------ILADWAYDCFRERKL 729 (793)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~--------~l~~~~~~~~~~~~~ 729 (793)
......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... .........+.....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T 3ugc_A 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250 (295)
T ss_dssp -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc
Confidence 2223346778999999999999999999999999999999999987653321100 000011111111111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.. .+......+.+++.+||+.||++|||++||++.|+.+.
T Consensus 251 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 251 LP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp CC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 01123456889999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=366.64 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=205.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.++||+|+||.||+|+.. .+++.||+|++.+.. ......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 478999999999999965 457899999997632 2223458999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++.+....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 158 gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 234 (437)
T 4aw2_A 158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234 (437)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECC
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccc
Confidence 9999999987667899999999999999999999998 9999999999999999999999999999876655544445
Q ss_pred cccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 663 AIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
...||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..... ... .....
T Consensus 235 ~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------~~~-~p~~~- 306 (437)
T 4aw2_A 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------RFQ-FPTQV- 306 (437)
T ss_dssp SCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------HCC-CCSSC-
T ss_pred cccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc------ccc-CCccc-
Confidence 567999999999987 55789999999999999999999999988765554333221100 000 00000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQM 773 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 773 (793)
......+.+++.+||+.+|++ ||+++||++.
T Consensus 307 -----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 307 -----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 012345778999999988888 9999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=354.75 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=199.6
Q ss_pred cccccccccceeEEEeEeCCCCc---eeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|.....+. ..||+|.+.... ....+.+.+|+.++++++||||+++++++.++. .++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEe
Confidence 34789999999999998654332 246888886533 345578999999999999999999999998754 7899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 174 (327)
T 3poz_A 98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp CTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccc
Confidence 999999999988878899999999999999999999998 99999999999999999999999999998765443222
Q ss_pred -eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 661 -TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~~~~~------ 240 (327)
T 3poz_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLPQ------ 240 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCCC------
T ss_pred cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH--------HcCCCCCC------
Confidence 223446889999999999999999999999999999999 99999876554422111 11111100
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.......+.+++.+||+.+|++|||+++|++.|+..
T Consensus 241 ---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 241 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111234678899999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=364.11 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=206.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|.... +++.||||+++.... ...+.|.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EeeEeccCCCCeEEEEEEec-CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 45789999999999999753 567899999875432 2335788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce-e
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT-T 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 662 (793)
|+|.+++......+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus 197 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~ 273 (377)
T 3cbl_A 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273 (377)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence 999999987766789999999999999999999998 999999999999999999999999999986443221111 1
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 274 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~~~--------- 336 (377)
T 3cbl_A 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF--------VEKGGRLPC--------- 336 (377)
T ss_dssp CCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH--------HHTTCCCCC---------
T ss_pred CCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------
Confidence 1235678999999998899999999999999999998 9999987665432211 111111111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
+...+..+.+++.+||+.||++|||+++|++.|+.+
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 011235678899999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.64 Aligned_cols=243 Identities=24% Similarity=0.359 Sum_probs=202.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 478999999999999854 467889999997643 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++... ..+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 99 ~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~ 172 (328)
T 3fe3_A 99 GEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDA 172 (328)
T ss_dssp CBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGT
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cccc
Confidence 9999999665 4588899999999999999999998 99999999999999999999999999998665432 2334
Q ss_pred ccCcccccCcccccCCCCC-CccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPIT-AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s-~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..||+.|+|||++.+..++ .++|||||||++|||++|+.||......+....+ ..+.....
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~~p---------- 234 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--------LRGKYRIP---------- 234 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCC----------
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCC----------
Confidence 5699999999999988775 7999999999999999999999877654432211 11211110
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1123457789999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.68 Aligned_cols=248 Identities=20% Similarity=0.266 Sum_probs=205.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 3578999999999999854 46788999998643 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--TFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++....... ...
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 161 (321)
T 1tki_A 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFR 161 (321)
T ss_dssp BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEE
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccc
Confidence 99999987777799999999999999999999998 9999999999999987 7899999999998765433 233
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ..+..... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~~------~~~~ 227 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--------MNAEYTFD------EEAF 227 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCCCC------HHHH
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HcCCCCCC------hhhh
Confidence 456899999999999988999999999999999999999999876654422211 11111100 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1234568899999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.58 Aligned_cols=264 Identities=28% Similarity=0.377 Sum_probs=202.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC----ceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----HRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey 580 (793)
+.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++||||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 3478999999999999863 6889999996542 23345677999999999999999999998754 46999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE-------CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
+++|+|.+++... .+++..+..++.|+++||.|||+. +..+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 104 HEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 9999999999654 488999999999999999999975 2348999999999999999999999999999876
Q ss_pred CCCCCc-ceecccCcccccCcccccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH---------HHHH
Q 003818 654 KTDQTQ-TTTAIRGTKGYVAPEWFKNL-----PITAKVDVYSFGILLLELVCCRKNFEVDATEECQM---------ILAD 718 (793)
Q Consensus 654 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~---------~l~~ 718 (793)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ....
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 544322 22335689999999999863 55678999999999999999999997643221100 0111
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......... ..... ...........+.+++.+||+.||++|||++||++.|+.+.
T Consensus 262 ~~~~~~~~~~-~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 262 MQEVVVHKKK-RPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHTTSCC-CCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhcccC-CCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 11111 11122345567899999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=341.43 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=205.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... ++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 28 ~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp EEEECC---CEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred hHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 3478999999999999865 45679999997643 34577999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..............
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp BHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 99999987667799999999999999999999998 999999999999999999999999999986654332223334
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+...... .
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~~~---------~ 244 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRLYRP---------H 244 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCCCCC---------T
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------hcccCCCCC---------C
Confidence 46788999999998899999999999999999998 99999876654422211 111111000 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
...+.+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11346789999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=372.19 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=209.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|.... .+..||||++.... ...++|.+|+.++++++|||||++++++.+.+..++||||+++|
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 45789999999999999753 46789999997643 34678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus 302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 378 (495)
T 1opk_A 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378 (495)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence 999999764 45688999999999999999999998 99999999999999999999999999998765443333333
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||++....++.++||||||+++|||++ |+.||......+.... +..+.... .+
T Consensus 379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~~---------~~ 441 (495)
T 1opk_A 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--------LEKDYRME---------RP 441 (495)
T ss_dssp CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--------HHTTCCCC---------CC
T ss_pred CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCC---------CC
Confidence 446788999999998899999999999999999999 9999987654432211 11111110 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1233567899999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.51 Aligned_cols=245 Identities=25% Similarity=0.306 Sum_probs=202.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh---cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||+|++++. .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 9 YLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 3478999999999999854 46788999999764 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 88 ~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~ 162 (337)
T 1o6l_A 88 NGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 162 (337)
T ss_dssp TTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCB
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Ccc
Confidence 999999999654 4678899999999999999999998 99999999999999999999999999998643322 223
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~---------- 224 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEIRF---------- 224 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC----------
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCCC----------
Confidence 3456999999999999999999999999999999999999999876544322111 1111110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 773 (793)
+......+.+++.+||+.||++|| +++||++.
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011235678899999999999999 89998763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=366.39 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=206.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+..||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+++|
T Consensus 192 ~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g 267 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKG 267 (454)
T ss_dssp EEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred EEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCC
Confidence 4578999999999999875 35679999997643 45678999999999999999999999987 66789999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus 268 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp BHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 999999754 23678889999999999999999998 99999999999999999999999999998764432222223
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||++....++.++||||||+++|||++ |+.||......+....+ ..+..... +
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--------~~~~~~~~---------~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMPR---------P 407 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------HHTCCCCC---------C
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCCC---------C
Confidence 346788999999998899999999999999999999 99999876654422211 11111000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
...+..+.+++.+||+.||++|||+++|++.|+.....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 12345688999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=348.28 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=208.9
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 34789999999999998754 4568999999976432 335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 580 YVSNGSLADFLFRKS-----------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 580 y~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
|+++++|.+++.... ..+++..++.++.||++||.|||++ +|+||||||+|||+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEE
Confidence 999999999997642 5688899999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQM 714 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~ 714 (793)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 287 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 287 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHH
Confidence 9999999999999986543322 22233457889999999998899999999999999999999 999998765543221
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
.+..+...... ......+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 288 --------~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 288 --------YVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --------HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --------HHhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 11222221111 11235678999999999999999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.50 Aligned_cols=247 Identities=26% Similarity=0.298 Sum_probs=199.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357999999999999854 4578899999977555556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE--cCCCcEEEeecCCccccCCCCCcceec
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL--DGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
|.+++......+++..+..++.||++||.|||+. +|+||||||+|||+ ++++.+||+|||+++.+..... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 9999987767789999999999999999999998 99999999999999 5678999999999987654332 223
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ........ ....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--------~~~~~~~~------~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--------ACRWDLED------EEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCCCSCS------GGGT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hccCCCCh------hhhc
Confidence 458999999999999899999999999999999999999998776544222111 11111000 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.....+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22456789999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.50 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=209.7
Q ss_pred cccccccccceeEEEeEeCC------CCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTT------ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|.... ..++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+++..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 45789999999999998532 3346899999976433 3346789999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||+++++.
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 229 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNV 229 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCc
Confidence 999999999999997653 3588999999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+...
T Consensus 230 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~----- 304 (382)
T 3tt0_A 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK----- 304 (382)
T ss_dssp EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-----
T ss_pred EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----
Confidence 99999999987654332 22233457889999999999999999999999999999999 999998765543221
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.+..+...... ......+.+++.+||+.||++|||++||++.|+.+....
T Consensus 305 ---~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 305 ---LLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ---HHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ---HHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11222111111 112356789999999999999999999999998865443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.44 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=206.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCC--ceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--HRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++||||+
T Consensus 13 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 3578999999999999865 457889999997643 334567889999999999999999999987655 779999999
Q ss_pred CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCcEEEeecCCccccCC
Q 003818 582 SNGSLADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 582 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~~~~~ 655 (793)
++++|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 9999999997643 3389999999999999999999998 99999999999999 7888899999999987654
Q ss_pred CCCcceecccCcccccCccccc--------CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHH-HHHHHHHHhhc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFK--------NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI-LADWAYDCFRE 726 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~-l~~~~~~~~~~ 726 (793)
... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........... +...... ...
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~p~ 245 (319)
T 4euu_A 169 DEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG-KPS 245 (319)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH-CCT
T ss_pred CCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC-CCc
Confidence 332 23345899999999986 56789999999999999999999999975433322111 1111111 111
Q ss_pred cccceee-----------cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 727 RKLGLLV-----------ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 727 ~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
....... ...............+.+++.+||+.||++|||++|+++...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1010000 00111122345567789999999999999999999999988753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=348.97 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=202.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc------chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence 4578999999999999864 46788999999764322 2467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----cEEEeecCCccccC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----NARISDFGLAKLLK 654 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~ 654 (793)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|||++....
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 95 ELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp ECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999999654 5688999999999999999999998 999999999999998877 79999999998765
Q ss_pred CCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+ .......
T Consensus 171 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~~~--- 237 (361)
T 2yab_A 171 DGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TAVSYDF--- 237 (361)
T ss_dssp TTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCCC---
T ss_pred CCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCCC---
Confidence 432 223456999999999999999999999999999999999999999877654422211 1111110
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. .........+.+++.+||+.||++|||+.|+++
T Consensus 238 -~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 -DE--EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Cc--hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 001122356789999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=340.72 Aligned_cols=253 Identities=20% Similarity=0.336 Sum_probs=195.0
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|..... .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence 457899999999999987542 356799999875432 33467899999999999999999999984 56789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (281)
T 1mp8_A 98 TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174 (281)
T ss_dssp TTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccccc
Confidence 99999999987777789999999999999999999998 999999999999999999999999999987654433333
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--------~~~~~~~~-------- 238 (281)
T 1mp8_A 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPM-------- 238 (281)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCCC--------
T ss_pred ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH--------HcCCCCCC--------
Confidence 33457789999999998899999999999999999996 99999876554322111 11111111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 239 -PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122356788999999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.97 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=204.0
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechh-cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.... ..++.||||++... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 45789999999999998642 35678999999654 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---cEEEeecCCc
Q 003818 580 YVSNGSLADFLFRKS------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---NARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~~------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla 650 (793)
|+++|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 999999999997543 4578899999999999999999998 999999999999999555 5999999999
Q ss_pred cccCCC-CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTD-QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+..... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~--------i~~~~ 303 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--------VTSGG 303 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--------HHTTC
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCC
Confidence 754322 2222334557899999999999999999999999999999998 9999987665442211 11111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.... .......+.+++.+||+.||++|||+++|++.|+..
T Consensus 304 ~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 111234578999999999999999999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.51 Aligned_cols=253 Identities=18% Similarity=0.188 Sum_probs=204.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++..++..++||||+ ++
T Consensus 14 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEECCC-CTTSEEEEEET-TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEeeccCCceEEEEEEC-CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 478999999999999853 467899999986542 235688999999999 9999999999999999999999999 99
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc-----EEEeecCCccccCCCCCc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN-----ARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~~~~~~~~ 659 (793)
+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++.+......
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 90 SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 99999987777899999999999999999999998 9999999999999998887 999999999876443322
Q ss_pred c------eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceee
Q 003818 660 T------TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLV 733 (793)
Q Consensus 660 ~------~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (793)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+...... ......
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----~~~~~~ 241 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-----KRATPI 241 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-----HHHSCH
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-----hccCCH
Confidence 1 23456999999999999999999999999999999999999999875433222111111111 000000
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
. .. ....+ .+.+++..|++.+|.+||++++|++.|+.
T Consensus 242 ~---~~--~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 242 E---VL--CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp H---HH--TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred H---HH--hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 0 00 00112 78899999999999999999999999965
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.08 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=202.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc------chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 93 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93 (326)
T ss_dssp EEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4578999999999999864 46788999998754321 3567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----cEEEeecCCccccC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----NARISDFGLAKLLK 654 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~ 654 (793)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 94 ELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp ECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999999654 5688999999999999999999998 999999999999999887 79999999998765
Q ss_pred CCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. ......
T Consensus 170 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--------~~~~~~--- 236 (326)
T 2y0a_A 170 FGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--------AVNYEF--- 236 (326)
T ss_dssp TTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------HTCCCC---
T ss_pred CCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--------hcCCCc---
Confidence 3322 233569999999999999999999999999999999999999998765544222111 111100
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...........+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 ---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00001122356789999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=352.31 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=205.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 55 i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 3478999999999999864 467889999987654445568899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--TFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++. .+.+||+|||+++....... ..
T Consensus 134 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~ 208 (387)
T 1kob_A 134 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VK 208 (387)
T ss_dssp BHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EE
T ss_pred cHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--ee
Confidence 99999987767789999999999999999999998 9999999999999974 57799999999987654432 23
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......... ..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i--------~~~~~~~~~~------~~ 274 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------KRCDWEFDED------AF 274 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HHCCCCCCSS------TT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCCcc------cc
Confidence 346899999999999999999999999999999999999999876544322111 1111110000 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1223567899999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.22 Aligned_cols=259 Identities=21% Similarity=0.271 Sum_probs=198.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 26 ~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 102 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME- 102 (311)
T ss_dssp EEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred hhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence 478999999999999864 478899999965432 224678899999999999999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 103 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 178 (311)
T 3niz_A 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTH 178 (311)
T ss_dssp EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----C
T ss_pred CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccC
Confidence 588888887777799999999999999999999998 999999999999999999999999999987643322 2233
Q ss_pred ccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHH-------------hhcccc
Q 003818 664 IRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDC-------------FRERKL 729 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~-------------~~~~~~ 729 (793)
..+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....... +.....
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 458999999999876 568999999999999999999999998765554322221111000 000000
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.................++.+++.+||+.||++|||++|+++
T Consensus 259 -~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 259 -QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp -CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000001122356789999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=362.28 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=201.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|.... +..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||+++|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g 263 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263 (452)
T ss_dssp EEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred eeeeecCCCCeEEEEEEECC--CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence 45789999999999999753 4579999997643 345789999999999999999999999876 7789999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 999999753 35688999999999999999999998 99999999999999999999999999998765443333333
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+..... +
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~~~---------~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRMPC---------P 403 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCC---------C
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------C
Confidence 457789999999998899999999999999999999 9999987655442211 111111100 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
...++.+.+++.+||+.||++|||+++|++.|+.....
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 12345678999999999999999999999999986544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.00 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=204.0
Q ss_pred ccccccccceeEEEeEe----CCCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCC-ceEEEE
Q 003818 506 KEELGEGAFGKVYKGVL----TTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGE-HRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~----~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV~ 578 (793)
.+.||+|+||.||+|.. ...+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+ ..++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 47899999999999984 334678999999976433 2346789999999999 8999999999998755 489999
Q ss_pred eecCCCCHHHHHhcCCC---------------------------------------------------------------
Q 003818 579 EYVSNGSLADFLFRKSR--------------------------------------------------------------- 595 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 595 (793)
||+++|+|.+++.....
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 99999999999976532
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cceecccCcccccC
Q 003818 596 --RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTTTAIRGTKGYVA 672 (793)
Q Consensus 596 --~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~a 672 (793)
.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 178889999999999999999998 999999999999999999999999999986644332 22334568899999
Q ss_pred cccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHH
Q 003818 673 PEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVM 751 (793)
Q Consensus 673 PE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 751 (793)
||++.+..++.++||||||+++|||++ |+.||......+... ..+..+...... ......+.+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~l~~ 327 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-------RRLKEGTRMRAP---------DYTTPEMYQ 327 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-------HHHHHTCCCCCC---------TTCCHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-------HHHHcCCCCCCC---------CCCCHHHHH
Confidence 999999999999999999999999998 999997765433211 111111111111 112346788
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 752 IAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 752 li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
++..||+.||++|||++||++.|+.+.
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.43 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=207.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 12 FVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeEecCCCceeEEEEEec--CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 3578999999999999864 456899999976433 4568999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|+++||.|||++ +|+|+||||+||+++.++.+||+|||++..............
T Consensus 89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 99999988777889999999999999999999998 999999999999999999999999999986543322222234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+..... +.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------i~~~~~~~~---------~~ 228 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------ISTGFRLYK---------PR 228 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------HHTTCCCCC---------CT
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH--------HhcCCcCCC---------Cc
Confidence 46788999999998899999999999999999999 8999987654432211 111111100 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....+.+++.+||+.||++|||++++++.|+++.
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12356788999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.21 Aligned_cols=257 Identities=18% Similarity=0.212 Sum_probs=206.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... .+++.||+|++... ...+.+.+|+.+++++ +|+|++++++++.++...++||||+ +
T Consensus 14 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEECSSCEEEEEEET-TTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 3478999999999999853 46789999998643 2345688999999999 8999999999999999999999999 9
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc-----EEEeecCCccccCCCCC
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN-----ARISDFGLAKLLKTDQT 658 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~~~~~~~ 658 (793)
++|.+++......+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||+++.......
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 90 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 999999988777799999999999999999999998 9999999999999987776 99999999987654332
Q ss_pred c------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 659 Q------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 659 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+......... ...
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--- 242 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPL--- 242 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCH---
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-ccH---
Confidence 1 223456999999999999999999999999999999999999999875432221111111111000 000
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..........+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 243 ------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 243 ------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp ------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 0001123457889999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.22 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=194.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc--CCccccceeeeEEec----CCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR--TNHKNLVQLLGFCNE----GEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~~lV~ 578 (793)
+.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 12 LLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp EEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 347899999999999986 4778999998653 23455556666655 899999999998654 35689999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH--------EECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
||+++|+|.+++.. ..+++..+..++.|+++||.||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred hhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999943 46889999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCcc---eecccCcccccCcccccCC------CCCCccceehhHHHHHHHHhC----------CcCCCCCchhH
Q 003818 651 KLLKTDQTQT---TTAIRGTKGYVAPEWFKNL------PITAKVDVYSFGILLLELVCC----------RKNFEVDATEE 711 (793)
Q Consensus 651 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~Dvws~Gvil~elltg----------~~pf~~~~~~~ 711 (793)
+......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 7654433322 2224689999999999876 455799999999999999999 78885543221
Q ss_pred HHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 712 CQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.... .............. .+...........+.+++.+||+.||++|||+++|++.|+++
T Consensus 241 ~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFE--DMRKVVCVDQQRPN----IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHH--HHHHHHTTSCCCCC----CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchh--hhhHHHhccCCCCC----CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1110 00111111111111 111112234567899999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.46 Aligned_cols=249 Identities=26% Similarity=0.458 Sum_probs=199.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccc-------hHHHHHHHHHHhcCCccccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG-------EQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||.||+|... .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.. ++|
T Consensus 23 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 23 YEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp EEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred ehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence 3578999999999999864 457889999986532221 267899999999999999999999987654 799
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEEcCCCc-----EEEeecCCc
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ--IIHCDIKPQNILLDGTFN-----ARISDFGLA 650 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~Dfgla 650 (793)
|||+++++|.+++......+++..+..++.|++.||+|||++ + |+||||||+|||++.++. +||+|||++
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred EEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 999999999999988878899999999999999999999998 7 999999999999988776 999999999
Q ss_pred cccCCCCCcceecccCcccccCcccc--cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQTTTAIRGTKGYVAPEWF--KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......+.... ......+.
T Consensus 177 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~ 247 (287)
T 4f0f_A 177 QQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-----NMIREEGL 247 (287)
T ss_dssp BCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-----HHHHHSCC
T ss_pred ccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-----HHHhccCC
Confidence 75432 23345689999999998 445678999999999999999999999986554332111 01111111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.... .......+.+++.+||+.||++|||++||++.|+++
T Consensus 248 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPTI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCC---------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 112235688999999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.67 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=200.2
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhc-----ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 27 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 27 ELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34578999999999999854 467889999986532 123578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecCCccc
Q 003818 579 EYVSNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKL 652 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~ 652 (793)
||+++++|.+++... ...+++..+..++.||++||.|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999888643 34578999999999999999999998 9999999999999986655 99999999987
Q ss_pred cCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ..+..+.....
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~-----~~i~~~~~~~~ 252 (351)
T 3c0i_A 183 LGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL----F-----EGIIKGKYKMN 252 (351)
T ss_dssp CCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH----H-----HHHHHTCCCCC
T ss_pred ecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH----H-----HHHHcCCCCCC
Confidence 654322 2233569999999999999999999999999999999999999998753221 1 11111111100
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .........+.+++.+||+.||++|||+.|+++
T Consensus 253 ----~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 ----P--RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ----H--HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----c--cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001122456789999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.15 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=205.9
Q ss_pred cccccccccceeEEEeEe----CCCCceeEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVL----TTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~----~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|.. ....++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 457899999999999986 23466789999997542 33457899999999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 579 EYVSNGSLADFLFRKSR----------------------RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
||+++|+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll 205 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 205 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEE
Confidence 99999999999976543 368889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQM 714 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~ 714 (793)
+.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 285 (344)
T 1rjb_A 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285 (344)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH
Confidence 999999999999998665443322 233457889999999999899999999999999999998 999997765433211
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
..+..+..... +......+.+++.+||+.||++|||+.+|++.|+.....
T Consensus 286 -------~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 286 -------KLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp -------HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------HHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111111100 111235678899999999999999999999999875543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.15 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=202.1
Q ss_pred cccccccccceeEEEeEeCCCC------ceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN------EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|...... ++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 4578999999999999865433 2579999998766666788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc--------EEEeecCCc
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN--------ARISDFGLA 650 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla 650 (793)
||+++++|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~ 168 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168 (289)
T ss_dssp ECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred ECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence 99999999999988766689999999999999999999998 9999999999999998887 999999998
Q ss_pred cccCCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcC-CCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKN-FEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~p-f~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..| +............ .....
T Consensus 169 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-------~~~~~ 236 (289)
T 4fvq_A 169 ITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-------EDRHQ 236 (289)
T ss_dssp TTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTTCC
T ss_pred ccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-------hccCC
Confidence 754321 22347889999999987 6789999999999999999996554 4443322211110 00111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.. .. ....+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 237 ~~---~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 237 LP---AP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CC---CC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CC---CC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11 00 1234678999999999999999999999999876643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=352.04 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=201.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 15 i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred EEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 4578999999999999854 467899999986543 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||++........
T Consensus 94 gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 94 GGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 99999999765 4588999999999999999999998 999999999999998 568899999999986654332
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.... +..+........
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~--------i~~~~~~~~~~~---- 236 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ--------IKAGAYDFPSPE---- 236 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------HHHTCCCCCTTT----
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHhCCCCCCccc----
Confidence 22345699999999999999999999999999999999999999987665442221 122221111100
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 237 --WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0112356789999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.55 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=205.0
Q ss_pred cccccccccceeEEEeEe---CCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVL---TTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 578 (793)
+.+.||+|+||.||+|.+ ...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 357899999999999985 34467899999997543 33457889999999999999999999999876 6789999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 105 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC
T ss_pred EeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCc
Confidence 99999999999977777799999999999999999999998 999999999999999999999999999987655433
Q ss_pred c--ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH--------HHHHHHHHHHhhccc
Q 003818 659 Q--TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ--------MILADWAYDCFRERK 728 (793)
Q Consensus 659 ~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~--------~~l~~~~~~~~~~~~ 728 (793)
. ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..... ....+..+.
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 260 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-LVNTLKEGK 260 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH-HHHHHHTTC
T ss_pred ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH-HHHHHhccC
Confidence 2 223345788899999999999999999999999999999999987543221100 00000 111111111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
... ........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 261 ~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 261 RLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 110 01123356889999999999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=349.35 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=209.1
Q ss_pred cccccccccceeEEEeEe---CCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEe--cCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVL---TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCN--EGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~E 579 (793)
+.+.||+|+||.||++.+ ....++.||+|++........+.+.+|+.++++++||||+++++++. +.+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 457899999999999985 34567899999998765556678999999999999999999999886 4566899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 183 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183 (327)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSE
T ss_pred ecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCcc
Confidence 9999999999987666789999999999999999999998 9999999999999999999999999999876544322
Q ss_pred c--eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHH-------HHHHHHHHhhccccc
Q 003818 660 T--TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI-------LADWAYDCFRERKLG 730 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~-------l~~~~~~~~~~~~~~ 730 (793)
. .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||........... ........+..+...
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lxl_A 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263 (327)
T ss_dssp EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCC
T ss_pred ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCC
Confidence 1 2224578889999999998999999999999999999999999876543321100 000011111111111
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.........+.+++.+||+.||++|||++||++.|+.+..
T Consensus 264 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 264 ---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111234568899999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=354.72 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=203.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+++.. .+++.||+|++.+.. ....+.+.+|+.+++.++|||||++++++.+++..++||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 478999999999999865 457889999997632 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 153 gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 153 GGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp TEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred CCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99999999653 578889999999999999999998 9999999999999999999999999999876654443444
Q ss_pred cccCcccccCcccccCCC----CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 663 AIRGTKGYVAPEWFKNLP----ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~----~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+..... .+. . ..
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------~~~-~-p~--- 296 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------SLT-F-PD--- 296 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------HCC-C-CT---
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc------ccc-C-CC---
Confidence 567999999999998765 78999999999999999999999987765543322211100 000 0 00
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSL--RPAMKKVTQM 773 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 773 (793)
.......+.+++.+||+.+|++ ||+++||++.
T Consensus 297 ---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 ---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0112356788999999999999 9999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.56 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=208.5
Q ss_pred cccccccccceeEEEeEe----CCCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVL----TTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~----~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|.. ...+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+++..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 457899999999999985 445678999999976433 3346789999999999 9999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 579 EYVSNGSLADFLFRKSR-----------------RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
||+++|+|.+++..... .+++..+..++.|+++||.|||++ +|+||||||+||+++.++.
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 183 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCC
Confidence 99999999999976543 478999999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---- 259 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 259 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH----
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH----
Confidence 9999999998765543322 223457789999999999999999999999999999999 9999977654332111
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.+...... .. .......+.+++.+||+.||++|||++||++.|++..
T Consensus 260 ---~~~~~~~~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 260 ---MIKEGFRM-LS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---HHHHTCCC-CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HhccCCCC-CC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11111110 00 0112356789999999999999999999999998744
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=354.61 Aligned_cols=250 Identities=22% Similarity=0.246 Sum_probs=203.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+++.. .+++.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+..++||||++
T Consensus 66 ~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 368999999999999864 467899999997532 2233568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++.+....+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...........
T Consensus 145 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 221 (412)
T 2vd5_A 145 GGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221 (412)
T ss_dssp SCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECS
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccc
Confidence 9999999987666789999999999999999999998 9999999999999999999999999999877655443344
Q ss_pred cccCcccccCccccc-------CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 663 AIRGTKGYVAPEWFK-------NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~-------~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
...||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... ......
T Consensus 222 ~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p~~--- 294 (412)
T 2vd5_A 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH----LSLPLV--- 294 (412)
T ss_dssp SCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCC-----
T ss_pred eeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----cCCCcc---
Confidence 467999999999997 457899999999999999999999999887655433222211000 000000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLR---PAMKKVTQM 773 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~~ 773 (793)
.......+.+++.+||+ +|++| |+++||++.
T Consensus 295 ------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 295 ------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 01123567889999999 99998 689888764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=358.92 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=201.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC-ceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE-HRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||+++
T Consensus 197 ~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred EEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 3578999999999999873 5789999997643 4578999999999999999999999987655 78999999999
Q ss_pred CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 344 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 344 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----c
Confidence 999999987544 468899999999999999999998 99999999999999999999999999998543221 1
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~~~--------- 407 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDA--------- 407 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH--------HHTTCCCCC---------
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------
Confidence 2246889999999999999999999999999999998 9999987654432111 112211111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1123456789999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.20 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=197.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 3478999999999999864 4578899999975432 234678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+ +|.+++......+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 159 (292)
T 3o0g_A 85 Q-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159 (292)
T ss_dssp E-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCC
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-ccc
Confidence 5 67777766667899999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred cccCcccccCcccccCCC-CCCccceehhHHHHHHHHhCCcCCCCCchh-HHHHHHHHHHHHHhhccccceee---c---
Q 003818 663 AIRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKNFEVDATE-ECQMILADWAYDCFRERKLGLLV---E--- 734 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~-~s~~~Dvws~Gvil~elltg~~pf~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~---~--- 734 (793)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... +....+...... .......... +
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT-PTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC-CCTTTCTTGGGSTTCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CChhhhhhhcccccccc
Confidence 345899999999998765 799999999999999999998886443332 221111110000 0000000000 0
Q ss_pred ------ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 ------NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..............+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000011123456789999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.81 Aligned_cols=252 Identities=26% Similarity=0.458 Sum_probs=199.7
Q ss_pred ccccccccceeEEEeEeCCCC---ceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTEN---EKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|.....+ +..||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 468999999999999875433 35699999976432 33457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc-
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT- 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 660 (793)
++++|.+++......+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 205 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccccc
Confidence 99999999988777899999999999999999999998 99999999999999999999999999998765432221
Q ss_pred -eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 661 -TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+... .+..+.....
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~--------~~~~~~~~~~------ 271 (333)
T 1mqb_A 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK--------AINDGFRLPT------ 271 (333)
T ss_dssp -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--------HHHTTCCCCC------
T ss_pred ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH--------HHHCCCcCCC------
Confidence 122346788999999999999999999999999999999 999997765443211 1111111100
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 272 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 272 ---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112235678999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.72 Aligned_cols=244 Identities=27% Similarity=0.380 Sum_probs=197.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|+.. .+++.||+|++.+.. ....+.+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus 27 ~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 105 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105 (353)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence 3578999999999999865 467889999997642 33446678899999987 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 106 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 180 (353)
T 3txo_A 106 VNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VT 180 (353)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-cc
Confidence 9999999999765 4588999999999999999999998 99999999999999999999999999998543222 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.....
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~~p-------- 244 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------LNDEVVYP-------- 244 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCC--------
T ss_pred ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCCCC--------
Confidence 33456999999999999989999999999999999999999999887655432222 11111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAM------KKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~ 772 (793)
......+.+++.+||+.||++||++ +||++
T Consensus 245 --~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 --TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1123457889999999999999998 66654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.57 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=191.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc----cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN----EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|.. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 11 ~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEETTEEEEEEEE---TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 357899999999999986 367899999865432 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--------CCcEEEeecCCccc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--------TFNARISDFGLAKL 652 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Dfgla~~ 652 (793)
+++++|.+++. ...+++..+..++.|+++||.|||++...+|+||||||+||+++. ++.+||+|||++..
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 88 ARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred CCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 99999999985 346889999999999999999999982222999999999999986 77899999999986
Q ss_pred cCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... .... .....
T Consensus 166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~-~~~~~ 234 (271)
T 3dtc_A 166 WHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-------VAMN-KLALP 234 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-------HHTS-CCCCC
T ss_pred cccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-------hhcC-CCCCC
Confidence 543322 234589999999999999999999999999999999999999987654432111 1111 11111
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
. .......+.+++.+||+.||++|||+.||++.|+.
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 235 I--------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C--------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 11123568899999999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.58 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=206.9
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|... ..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 3578999999999999853 23458899999976432 334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 580 YVSNGSLADFLFRKSR-----------------------RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~-----------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
|+++++|.+++..... .+++..+..++.|+++||.|||++ +|+||||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEE
Confidence 9999999999976432 378889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQM 714 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~ 714 (793)
++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 263 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999866543322 1223457788999999999899999999999999999999 999998765543221
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.+..+..... .......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 264 --------~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 264 --------LLKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp --------HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HhhcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 1123356889999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.27 Aligned_cols=263 Identities=15% Similarity=0.195 Sum_probs=199.9
Q ss_pred cccccccccceeEEEeEeCCC----CceeEEEEEechhcccc-----------hHHHHHHHHHHhcCCccccceeeeEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTE----NEKPVAVKKLYKAVNEG-----------EQEFKAEISAIGRTNHKNLVQLLGFCN 569 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~----~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~~~~ 569 (793)
+.+.||+|+||.||+|..... .++.||||++....... ...+..|+..+..++||||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 347899999999999987643 25789999986543211 123445666778889999999999987
Q ss_pred cC----CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCcEE
Q 003818 570 EG----EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD--GTFNAR 643 (793)
Q Consensus 570 ~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~k 643 (793)
.. ...+|||||+ +++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+|
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEE
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEE
Confidence 65 4589999999 9999999988777899999999999999999999998 999999999999999 899999
Q ss_pred EeecCCccccCCCCCc------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHH
Q 003818 644 ISDFGLAKLLKTDQTQ------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILA 717 (793)
Q Consensus 644 l~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~ 717 (793)
|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~- 273 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD- 273 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH-
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH-
Confidence 9999999876543221 112345999999999999999999999999999999999999999854332211111
Q ss_pred HHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 718 DWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....... .+..+.+... .....+..+.+++..|++.+|++||++++|++.|+...
T Consensus 274 --~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 274 --SKIRYRE-NIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp --HHHHHHH-CHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred --HHHHhhh-hHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1111100 0111110000 00112456889999999999999999999999997643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.06 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=201.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999854 467889999996543 2234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---cEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---NARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~ 659 (793)
+|+|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++.++ .+||+|||++.......
T Consensus 112 gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 112 GGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp SCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 99999998654 4688999999999999999999998 999999999999998654 59999999998765332
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +..+...... ..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------i~~~~~~~~~---~~- 253 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ--------IKAGAYDYPS---PE- 253 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHTCCCCCT---TG-
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHhCCCCCCc---cc-
Confidence 22335699999999999999999999999999999999999999987654432211 1122111110 00
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 254 --~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 --WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11123567899999999999999999998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.53 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=200.6
Q ss_pred ccccccccceeEEEeEeCCCCc---eeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|.....+. ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++|+||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 4789999999999998654322 237888775432 233467788999999999999999999986 56789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-c
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-T 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 660 (793)
++|+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 97 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 173 (325)
T 3kex_A 97 PLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173 (325)
T ss_dssp TTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC
T ss_pred CCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccccc
Confidence 99999999987767788999999999999999999998 9999999999999999999999999999877554332 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~----- 240 (325)
T 3kex_A 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--------EKGERLAQPQ----- 240 (325)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH--------HTTCBCCCCT-----
T ss_pred ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCCCCCCC-----
Confidence 233457889999999999999999999999999999999 99999876554422111 1111111111
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....+.+++.+||+.||++|||+++|++.|+...
T Consensus 241 ----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 241 ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01234678999999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=338.89 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=208.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 17 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred EEeecCCCCceeEEEeEec-CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 3578999999999999865 35788999998754 334578899999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++.............
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 95 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp EHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred cHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 999999764 45588999999999999999999999 99999999999999999999999999998776555444444
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ........ .
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~ 234 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDYRMER---------P 234 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTCCCCC---------C
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hccCCCCC---------C
Confidence 557889999999999899999999999999999999 99999876544322111 11111000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
......+.+++.+||+.||++|||+++|++.|+..
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=337.39 Aligned_cols=241 Identities=27% Similarity=0.348 Sum_probs=200.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+++.. .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 10 ILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 3478999999999999854 467899999997642 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 89 ~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~ 160 (318)
T 1fot_A 89 EGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 160 (318)
T ss_dssp CSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----c
Confidence 999999999764 4578889999999999999999998 9999999999999999999999999999865432 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~~----p----- 223 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--------LNAELRF----P----- 223 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHCCCCC----C-----
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCC----C-----
Confidence 3356999999999999999999999999999999999999999876544322211 1111110 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
......+.+++.+||+.||++|| ++++|++
T Consensus 224 -~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01234678899999999999999 8888874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.92 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=192.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--------------------------cchHHHHHHHHHHhcCCc
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--------------------------EGEQEFKAEISAIGRTNH 558 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~l~H 558 (793)
+.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++|
T Consensus 17 ~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 17 LKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 3578999999999999854 4678999999865321 113568899999999999
Q ss_pred cccceeeeEEec--CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 559 KNLVQLLGFCNE--GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 559 ~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
|||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|+++||.|||++ +|+||||||+|||+
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLV 170 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEE
Confidence 999999999986 568899999999999988653 34688999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCC---CCCccceehhHHHHHHHHhCCcCCCCCchhHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP---ITAKVDVYSFGILLLELVCCRKNFEVDATEECQ 713 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~ 713 (793)
+.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 9999999999999987654322 223456999999999998765 377899999999999999999999876543321
Q ss_pred HHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 714 MILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. +........ . .......+.+++.+||+.||++|||++||++
T Consensus 250 ~~--------~~~~~~~~~-~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 250 SK--------IKSQALEFP-D-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HH--------HHHCCCCCC-S-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HH--------HhcccCCCC-C-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11 111111110 0 0112356789999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.66 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=202.4
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|+.... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 347899999999999986433 34579999987643 2345778999999999999999999999875 4578999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++......+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 95 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 171 (281)
T 3cc6_A 95 PYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171 (281)
T ss_dssp TTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--------
T ss_pred CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccccc
Confidence 99999999987777789999999999999999999998 999999999999999999999999999987655443333
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------~~~~~~~~~------- 236 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------EKGDRLPKP------- 236 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH--------HHTCCCCCC-------
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH--------hcCCCCCCC-------
Confidence 44457889999999998899999999999999999998 99999765544322111 111111000
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 237 --~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 237 --DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 112356789999999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.34 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=197.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|.. ..++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred hhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 347899999999999986 357789999986532 2234678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+ +|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence 5 99999987777889999999999999999999998 999999999999999999999999999986543221 222
Q ss_pred cccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHH----hhcc-cccee----
Q 003818 663 AIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDC----FRER-KLGLL---- 732 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~----~~~~-~~~~~---- 732 (793)
...+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+....... +... .....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 34589999999998764 58999999999999999999999998766544322221110000 0000 00000
Q ss_pred --ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 --VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 --~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+.............+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000112456789999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.99 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=205.0
Q ss_pred cccccccceeEEEeEeC-CCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFGKVYKGVLT-TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.||+|+||.||+|+.. ...++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 37999999999999864 3457789999997643 23456789999999999999999999999 556789999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc--ee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT--TT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~ 662 (793)
+|.+++......+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......... ..
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 99999987777899999999999999999999998 99999999999999999999999999998765443222 22
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--------i~~~~~~~~--------- 234 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKRMEC--------- 234 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH--------HHTTCCCCC---------
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------HhcCCcCCC---------
Confidence 2346889999999998889999999999999999998 9999987655432211 112211111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
+......+.+++..||+.+|++||++.+|++.|+..
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112345688999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=344.81 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=194.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+++.. .+++.||+|++++... ...+.+.+|..++.++ +|||||++++++.+.+..++||||
T Consensus 56 ~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 3578999999999999865 4678999999976432 2335678899999876 899999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 135 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~ 209 (396)
T 4dc2_A 135 VNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 209 (396)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-Cc
Confidence 9999999999764 4688999999999999999999998 99999999999999999999999999998533222 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH-HHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ-MILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..........+........
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p------- 282 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP------- 282 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC-------
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC-------
Confidence 34467999999999999999999999999999999999999999754322110 0001112222222221111
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
......+.+++.+||+.||++||++
T Consensus 283 ---~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 283 ---RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1123457889999999999999995
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.79 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=192.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|+.. ..||+|++.... ....+.+.+|+.++++++||||+++++++ .....++||||++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 102 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 102 (289)
T ss_dssp EEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred eeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence 3578999999999999853 249999986543 23346789999999999999999999965 4567899999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC-Ccce
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ-TQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 661 (793)
+++|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 9999999987778899999999999999999999998 99999999999999999999999999997654322 2223
Q ss_pred ecccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TAIRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....||+.|+|||.+. +..++.++||||||+++|||++|+.||......+... .....+.........
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~-- 250 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-------EMVGRGSLSPDLSKV-- 250 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH-------HHHHHTSCCCCTTSS--
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH-------HHhcccccCcchhhc--
Confidence 3356899999999986 5678889999999999999999999998755443211 111122111111110
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....+..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 251 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 ---RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1123456889999999999999999999999999765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.00 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=192.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||++ +
T Consensus 10 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECS-SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEEC-CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 367999999999999854 4678999999865432 334678899999999999999999999999999999999997 6
Q ss_pred CHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 585 SLADFLFRK-----SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 585 sL~~~l~~~-----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+|.+++... ...+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 163 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN- 163 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-
Confidence 999988643 24578899999999999999999998 999999999999999999999999999987643322
Q ss_pred ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhcc-cccee-
Q 003818 660 TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRER-KLGLL- 732 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~-~~~~~- 732 (793)
......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.+.... .+... .....
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 22234589999999999764 6899999999999999999999999877665433322211100 00000 00000
Q ss_pred --e----cccc----hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 --V----ENDE----EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 --~----~~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .... ...........+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000 00000112356889999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.16 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=197.8
Q ss_pred ccccccccceeEEEeEeCCCCce---eEEEEEechh-cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||+|.....+.. .||+|.+... .....+.+.+|+.++++++||||+++++++..+. .++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 47899999999999986543322 3577777543 2345678999999999999999999999998754 88999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-c
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-T 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 660 (793)
++|+|.+++......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~ 175 (327)
T 3lzb_A 99 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175 (327)
T ss_dssp SSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccccc
Confidence 99999999988778899999999999999999999998 9999999999999999999999999999876443322 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------- 240 (327)
T 3lzb_A 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLPQ------- 240 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCCC-------
T ss_pred ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCCCC-------
Confidence 222346788999999999999999999999999999999 99999876655422211 11111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.......+.+++.+||+.||++|||+.||++.|+....
T Consensus 241 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 --PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11123457889999999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=335.10 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=197.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccc---hHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG---EQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++....... .+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 3478999999999999854 457889999997643322 367889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 117 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 117 NGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp CCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 999999999754 4588999999999999999999998 999999999999999999999999999987655443333
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+... ..... ..
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~~~~~-~~~~~------~~ 257 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG--------AHINQA-IPRPS------TV 257 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH--------HHHHSC-CCCGG------GT
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH--------HHhccC-CCCcc------cc
Confidence 4456899999999999999999999999999999999999999876543211 111111 11000 01
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-AMKKVTQMIEGAVDVSIPP 784 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~~~~~p~ 784 (793)
.......+.+++.+||+.||++|| +++++++.|+.......+.
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 112234678899999999999999 9999999999876655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=338.30 Aligned_cols=241 Identities=23% Similarity=0.283 Sum_probs=190.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.++||+|+||+||+|... .+++.||||++..... .....+..|+..+.+ .+||||+++++++.+++..++||||+
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~ 139 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139 (311)
T ss_dssp EEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence 4578999999999999865 4578899999865322 223344555555555 49999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+++|.+++......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 140 -~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 213 (311)
T 3p1a_A 140 -GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AG 213 (311)
T ss_dssp -CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CC
Confidence 7799999988777899999999999999999999998 99999999999999999999999999998664332 22
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+....... .+..+... ...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~--------~~~ 273 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-----------QLRQGYLP--------PEF 273 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-----------HHTTTCCC--------HHH
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------HHhccCCC--------ccc
Confidence 33458999999999886 78999999999999999999987765432211 11111111 011
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||++|+++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1123467889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=369.71 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=202.1
Q ss_pred ccccccceeEEEeEeCC-CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.||+|+||.||+|.+.. .++..||||+++.... ...+++.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 69999999999998653 3567899999976533 345789999999999999999999999976 56899999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc--eec
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT--TTA 663 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 663 (793)
|.+++..+...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 9999987777899999999999999999999998 99999999999999999999999999998765433221 122
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||......+... .+..+..... +
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~--------~i~~~~~~~~---------p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--------FIEQGKRMEC---------P 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH--------HHHTTCCCCC---------C
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--------HHHcCCCCCC---------C
Confidence 335689999999999999999999999999999998 999998766544221 1122221111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
......+.+++..||+.+|++||++++|++.|+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1234568899999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.29 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=203.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 3578999999999999854 456789999998776667788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCCCcce
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++........ .
T Consensus 92 ~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--~ 165 (277)
T 3f3z_A 92 ELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 165 (277)
T ss_dssp BHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC--B
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc--h
Confidence 999988654 4588999999999999999999998 99999999999999 7889999999999987654332 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+....+ ..+..... ...
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------~~~ 230 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------REGTFTFP------EKD 230 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCC------HHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCCC------chh
Confidence 334589999999998764 899999999999999999999999876654422211 11111110 000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123456889999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.40 Aligned_cols=249 Identities=30% Similarity=0.397 Sum_probs=197.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 11 i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 3478999999999999854 467889999986432 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-ccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~ 662 (793)
++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+..... ....
T Consensus 90 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 90 GELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp EEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 9999998544 4588999999999999999999998 999999999999999999999999999986543322 2233
Q ss_pred cccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......... .. +...... ...
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~-----~~~~~~~--~~~------ 230 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----WKEKKTY--LNP------ 230 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--HH-----HHTTCTT--STT------
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HH-----Hhccccc--CCc------
Confidence 4569999999999988775 779999999999999999999997654432111 01 1111100 000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11223556789999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.80 Aligned_cols=250 Identities=30% Similarity=0.444 Sum_probs=203.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 17 LVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENG 92 (279)
T ss_dssp EEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred heeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4578999999999999864 45679999987543 34578999999999999999999999987 45689999999999
Q ss_pred CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++.............
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9999996542 3688999999999999999999998 99999999999999999999999999998765543333333
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+..... .
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~---------~ 232 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--------LERGYRMVR---------P 232 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCC---------C
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH--------HhcccCCCC---------c
Confidence 456788999999998889999999999999999999 8999987654432111 111111100 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
......+.+++.+||+.||++|||+++|++.|+...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 122356889999999999999999999999998744
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.50 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=202.7
Q ss_pred ccccccccceeEEEeEeCCC--CceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCce-EEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHR-LLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV~Ey~ 581 (793)
.+.||+|+||.||+|..... .+..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 47899999999999986432 345799999876433 3346789999999999999999999999876665 9999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC---
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT--- 658 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~--- 658 (793)
.+++|.+++......+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999988778889999999999999999999998 999999999999999999999999999986543221
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCC-CCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF-EVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
.......+++.|+|||.+.+..++.++||||||+++|||++|..|+ ......+.... +........
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~~~----- 249 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF--------LAQGRRLPQ----- 249 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH--------HHTTCCCCC-----
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH--------hhcCCCCCC-----
Confidence 1222345788999999999999999999999999999999966554 43333221111 111111100
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.......+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 250 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 250 ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11123567899999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.79 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=180.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|+||.||++... .+++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++++
T Consensus 17 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK-KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEET-TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 57999999999999864 45788999998653 3467789999999997 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---cEEEeecCCccccCCCCCccee
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---NARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 99999765 5689999999999999999999998 999999999999997765 899999999986544322 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++||||||+++|||++|+.||.............+ ....+..+.... .....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~------~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF------EGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC------CSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC------Ccccc
Confidence 34589999999999999999999999999999999999999976543211111111 112222222111 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2234668899999999999999999999854
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.52 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=204.1
Q ss_pred cccccccccceeEEEeEeC---CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT---TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 578 (793)
+.+.||+|+||.||++.+. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+ ....++||
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 3478999999999888653 33678999999976532 335678999999999999999999999987 46789999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 115 e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp CCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred ecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 999999999999654 388999999999999999999998 999999999999999999999999999987654432
Q ss_pred c--ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH-------HHHHHHHHHhhcccc
Q 003818 659 Q--TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM-------ILADWAYDCFRERKL 729 (793)
Q Consensus 659 ~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~-------~l~~~~~~~~~~~~~ 729 (793)
. ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.......... .-.......+..+..
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 2 1223457888999999999899999999999999999999999997653321100 000001111111111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
.. ........+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 270 ~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 270 LP---------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 10 1112345688999999999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.53 Aligned_cols=254 Identities=21% Similarity=0.334 Sum_probs=191.7
Q ss_pred cccccccccceeEEEeEeCCCCc--eeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCce------
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE--KPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHR------ 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~--~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------ 574 (793)
+.+.||+|+||.||+|.....++ ..||+|++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 35789999999999998654332 37999998764 233457899999999999999999999999877655
Q ss_pred EEEEeecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 575 LLVYEYVSNGSLADFLFRK-----SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
++||||+++++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccc
Confidence 9999999999999999643 22588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcc
Q 003818 650 AKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRER 727 (793)
Q Consensus 650 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~ 727 (793)
++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~ 255 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--------IGG 255 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTT
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH--------hcC
Confidence 9866443322 2223446788999999999999999999999999999999 89999876654422111 111
Q ss_pred ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 728 KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..... .......+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 256 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 256 NRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 1122356789999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=340.27 Aligned_cols=244 Identities=28% Similarity=0.357 Sum_probs=200.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... .+++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus 24 ~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence 3478999999999999864 467899999997642 23456788999999987 899999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 103 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 177 (353)
T 2i0e_A 103 VNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT 177 (353)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cc
Confidence 9999999999754 4588899999999999999999998 99999999999999999999999999998543222 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~~p-------- 241 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNVAYP-------- 241 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCC--------
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhCCCCCC--------
Confidence 33456999999999999999999999999999999999999999876654422221 11111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
......+.+++.+||+.||++||+ +++|++
T Consensus 242 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112356788999999999999995 466654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=340.52 Aligned_cols=240 Identities=24% Similarity=0.254 Sum_probs=201.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 46 ~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 478999999999999864 467899999997642 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 125 gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~ 196 (350)
T 1rdq_E 125 GGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp TCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----cc
Confidence 99999999764 4588999999999999999999998 9999999999999999999999999999866432 22
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.....
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~p---------- 258 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------VSGKVRFP---------- 258 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCC----------
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH--------HcCCCCCC----------
Confidence 356899999999999999999999999999999999999999876554422211 12221110
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
......+.+++.+||+.||++||+ +++|++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112356789999999999999998 888765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.00 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=199.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|+.. .+++.||+|++++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus 21 ~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 21 LHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 3478999999999999965 467899999997642 33456678899999876 999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 100 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 174 (345)
T 1xjd_A 100 LNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-K 174 (345)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-C
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-c
Confidence 9999999999754 4588899999999999999999998 999999999999999999999999999985433222 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...... . +
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~-~----p--- 238 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------RMDNPF-Y----P--- 238 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC-C----C---
T ss_pred ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HhCCCC-C----C---
Confidence 33456999999999999999999999999999999999999999876654422211 111111 0 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMK-KVT 771 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 771 (793)
......+.+++.+||+.||++||++. +|+
T Consensus 239 --~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 --RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01235678899999999999999997 664
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.63 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=194.9
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|.....+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4578999999999999875333 4578999986533 2345689999999999999999999998754 5678999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+++|+|.+++......+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 173 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 999999999988777889999999999999999999998 9999999999999999999999999999865433221
Q ss_pred --ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 660 --TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.... +..+.....
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--------~~~~~~~~~---- 317 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------LLQGRRLLQ---- 317 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--------HHTTCCCCC----
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--------HHcCCCCCC----
Confidence 1223447789999999999999999999999999999999 6777765544332111 111111110
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+......+.+++.+||+.||++|||++||++.|+.+.
T Consensus 318 -----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 318 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112356789999999999999999999999998744
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.25 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=198.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 13 i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 13 IRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 3578999999999999864 467889999987542 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++........ .
T Consensus 92 -~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~--~ 164 (336)
T 3h4j_B 92 -GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--L 164 (336)
T ss_dssp -CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--T
T ss_pred -CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--c
Confidence 78999988654 4588999999999999999999999 999999999999999999999999999986654322 2
Q ss_pred ecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....||+.|+|||++.+..+ ++++||||||+++|||++|+.||......+... .+.......
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------~i~~~~~~~---- 227 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------KVNSCVYVM---- 227 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------------CCCSSCCCC----
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------------HHHcCCCCC----
Confidence 33569999999999988876 789999999999999999999997654332100 000000000
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+......+.+++.+||+.||++|||++|+++.
T Consensus 228 -p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 -PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11123567889999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=364.84 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=206.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.++||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++.+ +..+|||||+++|
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp EEEEEEECSSEEEEEEEETT--TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hheecccCCCeEEEEEEECC--CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 45789999999999999753 4579999997643 345789999999999999999999999876 7789999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 347 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 999999753 35688999999999999999999998 99999999999999999999999999998765332222223
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..++..|+|||.+.+..++.++||||||++||||++ |+.||......+.... +..+..... .
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~~~---------~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRMPC---------P 486 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH--------HHTTCCCCC---------C
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------C
Confidence 346788999999998899999999999999999999 8999987655442211 111111100 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
......+.+|+.+||+.||++|||+++|+++|+.....
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 12345678999999999999999999999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.80 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=201.0
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEE-ecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFC-NEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|.....+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++ ..++..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 4578999999999999865433 34689998875432 3346789999999999999999999986 456688999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+++++|.+++......+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (298)
T 3f66_A 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185 (298)
T ss_dssp CTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhc
Confidence 999999999988777889999999999999999999998 9999999999999999999999999999866443221
Q ss_pred --ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 660 --TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
......+|+.|+|||.+.+..++.++||||||+++|||++ +..||......+....+ ..+......
T Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--- 254 (298)
T 3f66_A 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRRLLQP--- 254 (298)
T ss_dssp C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--------HTTCCCCCC---
T ss_pred cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hcCCCCCCC---
Confidence 1223457789999999999999999999999999999999 55566554433321111 111111110
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
......+.+++.+||+.||++|||++||++.|+.+..
T Consensus 255 ------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 255 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1123468899999999999999999999999987553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=343.13 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=199.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||||+
T Consensus 19 i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 3478999999999999854 467889999997542 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 98 ~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~ 171 (384)
T 4fr4_A 98 LGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QI 171 (384)
T ss_dssp TTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CB
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--ce
Confidence 999999999654 5688999999999999999999998 99999999999999999999999999998765432 23
Q ss_pred ecccCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TAIRGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ..+.......
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-----~~~~~~~~~~------- 239 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-----HTFETTVVTY------- 239 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-----HHHHHCCCCC-------
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-----HHHhhcccCC-------
Confidence 44569999999999974 45899999999999999999999999755433221111 1111111110
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPA-MKKVTQ 772 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 772 (793)
+......+.+++.+||+.||++||+ +++|.+
T Consensus 240 ---p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ---PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1112356789999999999999998 777664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=329.20 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=200.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC--CceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG--EHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp EEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred HHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 3578999999999999963 6789999987543 23346799999999999999999999999887 788999999
Q ss_pred cCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 581 VSNGSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEECKSQ--IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
+++++|.+++..... .+++..+..++.|+++||.|||++ + |+||||||+||+++.++.++|.|||++......
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~- 166 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP- 166 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT-
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeeccc-
Confidence 999999999987543 589999999999999999999987 7 999999999999999999999999887543221
Q ss_pred CcceecccCcccccCcccccCCCCCC---ccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITA---KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~---~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
...+|+.|+|||.+.+..++. ++||||||+++|||++|+.||......+.... ....+......
T Consensus 167 -----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~- 233 (271)
T 3kmu_A 167 -----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------VALEGLRPTIP- 233 (271)
T ss_dssp -----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-------HHHSCCCCCCC-
T ss_pred -----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-------HHhcCCCCCCC-
Confidence 234789999999998765544 79999999999999999999987655442211 11111111111
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
......+.+++..||+.||++|||+++|++.|+.+.
T Consensus 234 --------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 234 --------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112346789999999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.75 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=201.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEe----cCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCN----EGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... .+++.||+|++........+.+.+|+.++++++||||+++++++. .....++|+||
T Consensus 33 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred EEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 3478999999999999854 467899999987655556678999999999999999999999986 34578999999
Q ss_pred cCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 581 VSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 581 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
+++++|.+++.. ....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 999999999975 456789999999999999999999998 99999999999999999999999999987553221
Q ss_pred Ccc--------eecccCcccccCcccccCCC---CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhc
Q 003818 658 TQT--------TTAIRGTKGYVAPEWFKNLP---ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE 726 (793)
Q Consensus 658 ~~~--------~~~~~gt~~y~aPE~~~~~~---~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~ 726 (793)
... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... +. .....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~----~~~~~ 262 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VA----LAVQN 262 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HH----HHHHC
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hh----HHhhc
Confidence 110 11234799999999987654 689999999999999999999999642211100 00 00111
Q ss_pred cccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.... . ........+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 263 -~~~~--~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 263 -QLSI--P------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -C--C--C------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -cCCC--C------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 0000 0 01122356889999999999999999999999999876443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=339.09 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=191.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCC-----------
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----------- 572 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----------- 572 (793)
+.+.||+|+||.||+|+.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred eeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 3578999999999999864 457889999997533 234578999999999999999999999986543
Q ss_pred ----------------------------------------------ceEEEEeecCCCCHHHHHhcCCC--CCCHHHHHH
Q 003818 573 ----------------------------------------------HRLLVYEYVSNGSLADFLFRKSR--RPNWYKRMQ 604 (793)
Q Consensus 573 ----------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~--~~~~~~~~~ 604 (793)
..++||||+++++|.+++..... ..++..+..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 27999999999999999976532 345566889
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-----------cceecccCcccccCc
Q 003818 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-----------QTTTAIRGTKGYVAP 673 (793)
Q Consensus 605 i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y~aP 673 (793)
++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 999999999999998 999999999999999999999999999987655432 112234689999999
Q ss_pred ccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHH
Q 003818 674 EWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIA 753 (793)
Q Consensus 674 E~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 753 (793)
|.+.+..++.++||||||+++|||++|..|+.... ..+ ......... .........+.+++
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~-----~~~~~~~~~---------~~~~~~~~~~~~li 306 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RII-----TDVRNLKFP---------LLFTQKYPQEHMMV 306 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHH-----HHHHTTCCC---------HHHHHHCHHHHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHH-----HHhhccCCC---------cccccCChhHHHHH
Confidence 99999999999999999999999999876642111 000 111111111 11223345678899
Q ss_pred HHccccCCCCCCCHHHHHH
Q 003818 754 IWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 754 ~~Cl~~dP~~RPt~~evl~ 772 (793)
.+||+.||++|||++|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=341.44 Aligned_cols=243 Identities=28% Similarity=0.352 Sum_probs=198.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 467999999999999854 4678999999865322 233578899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 138 -g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----~ 208 (348)
T 1u5q_A 138 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 208 (348)
T ss_dssp -EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----C
T ss_pred -CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----C
Confidence 688888876667789999999999999999999998 9999999999999999999999999999865432 2
Q ss_pred cccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 663 AIRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
...||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+ .... ......
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-------~~~~-~~~~~~----- 275 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNE-SPALQS----- 275 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSC-CCCCCC-----
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------HhcC-CCCCCC-----
Confidence 345899999999984 567899999999999999999999999876544321111 1111 111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
......+.+++.+||+.||++|||++++++..
T Consensus 276 ---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 ---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ---CCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11235578899999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.91 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=193.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCccccceeeeEEecCCce----EEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHR----LLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lV 577 (793)
+.+.||+|+||.||++... .+++.||+|++...... ....+.+|+.++++++||||+++++++...... ++|
T Consensus 16 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 16 LGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 3478999999999999854 46789999999764322 235788999999999999999999998766544 999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 9999999999999754 4688999999999999999999998 99999999999999999999999999998665432
Q ss_pred Cc--ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQ--TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... .........
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~----- 238 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------QHVREDPIP----- 238 (311)
T ss_dssp -----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHCCCCC-----
T ss_pred cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhcCCCCC-----
Confidence 22 2233568999999999999999999999999999999999999998766543221 111111110
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHhcC
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT-QMIEGA 777 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl-~~Le~~ 777 (793)
...........+.+++.+||+.||++||+..+++ ..|...
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 --PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0001112345678999999999999999665544 455443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.94 Aligned_cols=262 Identities=16% Similarity=0.225 Sum_probs=195.7
Q ss_pred cccccccccceeEEEeEeCC--CCceeEEEEEechhccc-----------chHHHHHHHHHHhcCCccccceeeeEEec-
Q 003818 505 FKEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAVNE-----------GEQEFKAEISAIGRTNHKNLVQLLGFCNE- 570 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~- 570 (793)
+.+.||+|+||.||+|.... ..+..||+|++...... ....+.+|+..+..++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 35789999999999999753 25678999998654321 12346678899999999999999999987
Q ss_pred ---CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC--cEEEe
Q 003818 571 ---GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF--NARIS 645 (793)
Q Consensus 571 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~ 645 (793)
....++||||+ +++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEE
Confidence 78899999999 999999997654 789999999999999999999998 999999999999999887 99999
Q ss_pred ecCCccccCCCCCc------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHH
Q 003818 646 DFGLAKLLKTDQTQ------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW 719 (793)
Q Consensus 646 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~ 719 (793)
|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... .
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~--~- 272 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ--T- 272 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH--H-
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH--H-
Confidence 99999876433211 11334689999999999999999999999999999999999999965322211110 0
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
........ +..... ........+..+.+++..||+.||++|||+++|++.|+...
T Consensus 273 ~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 273 AKTNLLDE-LPQSVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHT-TTHHHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHhhccc-ccHHHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00100000 000000 00000023457889999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=345.55 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=199.7
Q ss_pred cccccccc--cceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEG--AFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G--~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+| +||.||+|... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence 35789999 99999999965 467899999997643 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-
Q 003818 581 VSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT- 658 (793)
Q Consensus 581 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~- 658 (793)
+++++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||.+........
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 9999999999764 35688999999999999999999998 999999999999999999999999999865432211
Q ss_pred -----cceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhc-----
Q 003818 659 -----QTTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE----- 726 (793)
Q Consensus 659 -----~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~----- 726 (793)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+............+..
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence 11122358899999999987 579999999999999999999999997654433211110000000000
Q ss_pred -cc-------------cceee---------cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 727 -RK-------------LGLLV---------ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 727 -~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.. ..... ...............+.+|+.+||+.||++|||++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000 0000001112234568899999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.90 Aligned_cols=248 Identities=30% Similarity=0.485 Sum_probs=192.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||++++
T Consensus 12 ~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp EEEEEECCSSSEEEEEEET---TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred eeeEeecCCCceEEEEEEC---CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 3578999999999999863 578999998643 345678999999999999999999998874 589999999999
Q ss_pred CHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc-EEEeecCCccccCCCCCcce
Q 003818 585 SLADFLFRKSR--RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN-ARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 585 sL~~~l~~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|.+++..... .++...++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---- 160 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---- 160 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc----
Confidence 99999976543 4678889999999999999999943349999999999999998887 7999999997554321
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ... ...+.......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~-~~~~~~~~~~~------- 227 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-----MWA-VHNGTRPPLIK------- 227 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-----HHH-HHTTCCCCCBT-------
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-----HHH-HhcCCCCCccc-------
Confidence 22358999999999999999999999999999999999999997543322111 011 11111111111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 228 --~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 228 --NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred --ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 12345788999999999999999999999998744
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.17 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=206.2
Q ss_pred cccccccccceeEEEeEeCC------CCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTT------ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|.... .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 45789999999999998642 3467899999976432 3346789999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
||||+++++|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+||+++.++.
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 195 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCC
Confidence 999999999999997643 2478899999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---- 271 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL---- 271 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH----
Confidence 999999999876543322 1223346789999999998889999999999999999999 9999987654432211
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
+..+..... .......+.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 272 ----~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 272 ----LKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ----HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HhcCCCCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111 112235678999999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.46 Aligned_cols=273 Identities=25% Similarity=0.356 Sum_probs=206.0
Q ss_pred CCCCCHHHHHHHhccc--ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-----ccccc
Q 003818 490 LQDFTYKELEVITGGF--KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-----HKNLV 562 (793)
Q Consensus 490 ~~~~~~~el~~~t~~f--~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv 562 (793)
...+++++.....++| .++||+|+||.||+|... .+++.||||++... ....+.+..|+.+++.++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445555444444444 378999999999999864 45788999998643 233456788999999886 99999
Q ss_pred eeeeEEecCCceEEEEeecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---
Q 003818 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--- 638 (793)
Q Consensus 563 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--- 638 (793)
++++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 9999999999999999999 999999997653 4588999999999999999999998 9999999999999975
Q ss_pred ----------------------CCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHH
Q 003818 639 ----------------------TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLE 696 (793)
Q Consensus 639 ----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~e 696 (793)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998644322 23468999999999999999999999999999999
Q ss_pred HHhCCcCCCCCchhHHHHHHHHHH--------HHHhhccccceeec-----ccchhhh---------------hHHHHHH
Q 003818 697 LVCCRKNFEVDATEECQMILADWA--------YDCFRERKLGLLVE-----NDEEAMD---------------DIKRVEK 748 (793)
Q Consensus 697 lltg~~pf~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~~-----~~~~~~~---------------~~~~~~~ 748 (793)
|++|+.||......+....+.... .............. ..+.... .....+.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999998766554322221100 00000000000000 0000000 0011256
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 003818 749 FVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 749 l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+.+++.+||+.||++|||++|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 789999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.01 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=206.0
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|+... ..++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 35789999999999997542 3568899999975432 234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 580 YVSNGSLADFLFRKS---------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
|+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccc
Confidence 999999999996532 4568899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--------~~~~~ 257 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------VMEGG 257 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--------HHTTC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH--------HHcCC
Confidence 865433221 1222346889999999999899999999999999999999 8899987654432211 11221
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
..... ......+.+++.+||+.||++|||+.|+++.|++...
T Consensus 258 ~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 258 LLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111 1223567889999999999999999999999987544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=334.56 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=206.8
Q ss_pred cccccccccceeEEEeEe---CCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC--ceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVL---TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--HRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E 579 (793)
+.+.||+|+||.||++.+ ...+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 457899999999999985 34567899999998765556678999999999999999999999987644 7899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++......+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 125 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~ 201 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201 (326)
T ss_dssp CCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccc
Confidence 9999999999988777799999999999999999999998 9999999999999999999999999999876544322
Q ss_pred c--eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH--------HHHHHHHHHHhhcccc
Q 003818 660 T--TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ--------MILADWAYDCFRERKL 729 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~--------~~l~~~~~~~~~~~~~ 729 (793)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......-.. ..........+..+..
T Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (326)
T 2w1i_A 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281 (326)
T ss_dssp EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC
Confidence 1 12234677899999999888999999999999999999999998654221100 0000011111111111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
... .......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 282 ~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 282 LPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp CCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 100 112345688999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=344.63 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=189.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 24 ~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 24 FVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEESSSTTSSEEEEEET-TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 4578999999999999854 467889999996543 33467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc--EEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN--ARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++...... ...
T Consensus 102 ~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 175 (361)
T 3uc3_A 102 ELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPK 175 (361)
T ss_dssp BHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCC
Confidence 999999654 4588999999999999999999998 9999999999999987765 9999999997433222 223
Q ss_pred cccCcccccCcccccCCCCCCc-cceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAK-VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~-~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+ ...... ..... ..
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~~~~~-~~~~~--------~~ 243 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT---IQRILS-VKYSI--------PD 243 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH---HHHHHT-TCCCC--------CT
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH---HHHHhc-CCCCC--------CC
Confidence 3458999999999988887665 89999999999999999999865433221111 111111 11100 00
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11123567899999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.27 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=202.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc------chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE------GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94 (321)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 4578999999999999864 46788999998754321 3567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----cEEEeecCCccccC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----NARISDFGLAKLLK 654 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~ 654 (793)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 95 ELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp CCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999999654 4678899999999999999999998 999999999999999888 79999999998765
Q ss_pred CCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ......
T Consensus 171 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~---- 236 (321)
T 2a2a_A 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TSVSYD---- 236 (321)
T ss_dssp TTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCC----
T ss_pred cccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------Hhcccc----
Confidence 4322 23345899999999999999999999999999999999999999876554322111 111110
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 FDE--EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCH--HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cCh--hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 001122356789999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.52 Aligned_cols=260 Identities=23% Similarity=0.251 Sum_probs=197.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-----cchHHHHHHHHHHhcCC---ccccceeeeEEecCC----
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-----EGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGE---- 572 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~---- 572 (793)
+.+.||+|+||.||+|.. ..+++.||+|++..... .....+.+|+.++++++ ||||+++++++....
T Consensus 13 ~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~ 91 (308)
T 3g33_A 13 PVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE 91 (308)
T ss_dssp EEEEECCSSSCCEEEEEC-TTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSE
T ss_pred EEEEEecCCCeEEEEEEE-CCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCc
Confidence 347899999999999984 34678999999864321 12356777888877764 999999999997755
Q ss_pred -ceEEEEeecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 573 -HRLLVYEYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 573 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 92 IKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred eeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 5799999996 69999997654 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 651 KLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+...... .......
T Consensus 168 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDWP 244 (308)
T ss_dssp TTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSC
T ss_pred cccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhcc
Confidence 86643322 23456899999999999999999999999999999999999999887665433222211100 0000000
Q ss_pred eee----------cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLV----------ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .............+.+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000 000000011123466889999999999999999999886
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=329.13 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=180.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 478999999999999854 457889999996542 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++......+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++......... ..
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 170 (278)
T 3cok_A 95 NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HY 170 (278)
T ss_dssp TEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-ce
Confidence 9999999987777889999999999999999999998 9999999999999999999999999999866433221 22
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... . ...... .. +
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~-~~~~~~----~~------~ 232 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------K-VVLADY----EM------P 232 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCC----CC------C
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------H-Hhhccc----CC------c
Confidence 3458999999999999899999999999999999999999997654332110 0 000000 00 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+++.+||+.||++|||+++|++
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112346789999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.30 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=195.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred ecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence 4578999999999999854 4577899999876543 3457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCC
Q 003818 584 GSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 584 gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~ 657 (793)
++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 9999998643 46789999999999999999999998 99999999999999 456889999999998655432
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
. .....||+.|+|||.+. ..++.++||||||+++|||++|+.||......+..... ...........
T Consensus 182 ~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~--------~~~~~~~~~~~-- 248 (285)
T 3is5_A 182 H--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--------TYKEPNYAVEC-- 248 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCCC----
T ss_pred c--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh--------ccCCccccccc--
Confidence 2 23345899999999986 46899999999999999999999999876654422111 00111100000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+++.+||+.||++|||++||++
T Consensus 249 -----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 -----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012345778999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.06 Aligned_cols=250 Identities=23% Similarity=0.245 Sum_probs=195.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-----ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 108 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVME 108 (345)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEe
Confidence 4578999999999999854 567889999987542 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 003818 580 YVSNGSLADFLFRK---------------------------------------SRRPNWYKRMQIAFGTARGLFYLHEEC 620 (793)
Q Consensus 580 y~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~ia~gL~yLH~~~ 620 (793)
|+++|+|.+++... ...+++..+..++.|+++||.|||++
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~- 187 (345)
T 3hko_A 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187 (345)
T ss_dssp CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 99999999998521 11124566778999999999999998
Q ss_pred CCCeeecCCCCCCEEEcCCC--cEEEeecCCccccCCCCC---cceecccCcccccCcccccC--CCCCCccceehhHHH
Q 003818 621 KSQIIHCDIKPQNILLDGTF--NARISDFGLAKLLKTDQT---QTTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGIL 693 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvi 693 (793)
+|+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.+ ..++.++||||||++
T Consensus 188 --~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp --TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred --CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999998776 899999999986543221 12334568999999999875 678999999999999
Q ss_pred HHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 694 LLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 694 l~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+|||++|+.||......+....+ ... ..... ..........+.+++.+||+.||++|||+.++++
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~-------~~~-~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQV-------LNK-KLCFE------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHH-------HHC-CCCTT------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHH-------Hhc-ccccC------CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999877655432211 111 11100 0011112356789999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.47 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=197.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 478999999999999864 4578899999865432 2246688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 161 (311)
T 4agu_A 87 TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDD 161 (311)
T ss_dssp EHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred chHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCC
Confidence 9999887544 5688999999999999999999998 999999999999999999999999999987653322 2233
Q ss_pred ccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH-------Hhhcc------cc
Q 003818 664 IRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD-------CFRER------KL 729 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~-------~~~~~------~~ 729 (793)
..||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...... .+... .+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 458999999999876 57899999999999999999999999887665443322211100 00000 00
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...................+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000011234568899999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=335.21 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=195.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc-CCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.||+|+||.||+|.. ..+++.||||++........+.+.+|+.++.+ .+||||+++++++.+++..++||||+++++
T Consensus 19 ~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCIN-LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEEC-SSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEE-cCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 5799999999999984 34678899999977655566789999999988 479999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecCCccccCCCCC----
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKLLKTDQT---- 658 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~~~~---- 658 (793)
|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 98 ILSHIHKR-RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 99999764 4578899999999999999999998 9999999999999988776 99999999976543211
Q ss_pred --cceecccCcccccCcccccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH-------HHHHHHHHHHh
Q 003818 659 --QTTTAIRGTKGYVAPEWFKN-----LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ-------MILADWAYDCF 724 (793)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~-------~~l~~~~~~~~ 724 (793)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..........+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 11223458999999999875 46889999999999999999999999765322100 00000111122
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..+..... ..........+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 254 QEGKYEFP------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHCCCCCC------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccCcccC------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22211110 00001124568899999999999999999999873
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.97 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=195.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+++.. .+++.||+|++.+... ...+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 13 ~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 13 LLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 3478999999999999865 4678999999976432 2345678899999887 899999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 92 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~ 166 (345)
T 3a8x_A 92 VNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 166 (345)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence 9999999999754 4688999999999999999999998 99999999999999999999999999998543222 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH-HHHHHHHHHHhhccccceeecccchh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ-MILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..........+........
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p------- 239 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP------- 239 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-------
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-------
Confidence 33456999999999999999999999999999999999999999753221100 0000111222222221110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAM 767 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 767 (793)
......+.+++.+||+.||++||++
T Consensus 240 ---~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 ---RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1123457889999999999999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=368.19 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=200.1
Q ss_pred cccccccceeEEEeEeC-CCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLT-TENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||+|.+. ...++.||||+++.... ...+++.+|+.++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999654 34568899999976433 335789999999999999999999999964 568899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc--ce
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--TT 661 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~ 661 (793)
|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999654 5688999999999999999999998 9999999999999999999999999999876544321 22
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +..+......
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~--------i~~~~~~~~p------- 594 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------LEKGERMGCP------- 594 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCCC-------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCCCC-------
Confidence 23346788999999999999999999999999999998 9999987765542221 1222211111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
......+.+++..||+.||++|||+++|++.|+.
T Consensus 595 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 595 --AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp --TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1233568899999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.18 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=185.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|... .+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 58 ~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 478999999999999864 456789999997543 34678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCCCccee
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++...... ...
T Consensus 135 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 208 (349)
T 2w4o_A 135 LFDRIVEK-GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMK 208 (349)
T ss_dssp HHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccc
Confidence 99999654 4588999999999999999999998 9999999999999975 8899999999998654322 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...+........ .. ..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~i~~~~~~~~-~~-----~~ 275 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-------FRRILNCEYYFI-SP-----WW 275 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-------HHHHHTTCCCCC-TT-----TT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-------HHHHHhCCCccC-Cc-----hh
Confidence 356899999999999999999999999999999999999999765443211 111111111110 00 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||+.|+++.
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223567899999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=347.58 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=201.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 20 LGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 3478999999999999864 467889999997542 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 99 ~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~ 172 (476)
T 2y94_A 99 SGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL 172 (476)
T ss_dssp SSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CB
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--cc
Confidence 999999999654 5688999999999999999999998 99999999999999999999999999998765432 22
Q ss_pred ecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+.... +..+.... .
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~--------i~~~~~~~----p---- 236 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK--------ICDGIFYT----P---- 236 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH--------HHTTCCCC----C----
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH--------HhcCCcCC----C----
Confidence 34569999999999988765 6899999999999999999999987654432211 11221110 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+++.+||+.||++|||++||++
T Consensus 237 --~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 --QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011245788999999999999999999997
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.68 Aligned_cols=257 Identities=19% Similarity=0.256 Sum_probs=201.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEE-ecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC-NEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ..++..++||||+ +
T Consensus 13 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 3578999999999999854 467889999875432 234688999999999988877766655 6677889999999 9
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCCCc-
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
++|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 89 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 999999987777899999999999999999999998 99999999999999 78999999999999876544321
Q ss_pred -----ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 660 -----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 660 -----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.......... ..
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~- 239 (296)
T 4hgt_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----PI- 239 (296)
T ss_dssp BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----CH-
T ss_pred cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----hh-
Confidence 2234568999999999999999999999999999999999999998654332211111111111100 00
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+..+.+++..||+.||++|||+++|++.|+.+.
T Consensus 240 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 240 ----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ----hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0000112356889999999999999999999999998743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=337.92 Aligned_cols=261 Identities=22% Similarity=0.282 Sum_probs=195.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... .+++.||+|++...... ....+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 6 ~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 3478999999999999854 45788999998654322 22345679999999999999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 159 (324)
T 3mtl_A 84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDN 159 (324)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cccc
Confidence 599999988777899999999999999999999998 999999999999999999999999999976543222 2233
Q ss_pred ccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc-------
Q 003818 664 IRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN------- 735 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~------- 735 (793)
..+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+....... ...........
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHHHHTC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhhcccc
Confidence 458999999999876 568999999999999999999999998876655333222111000 00000000000
Q ss_pred ------cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 ------DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.............+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000001122456789999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.79 Aligned_cols=245 Identities=26% Similarity=0.292 Sum_probs=190.8
Q ss_pred cccccccccceeEEEeEeC--CCCceeEEEEEechhc----ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++... ..+++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 3578999999999999864 2467899999997642 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|.+++... ..++...+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 101 EYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred eCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence 999999999999654 4578889999999999999999998 999999999999999999999999999975433221
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ....... .
T Consensus 177 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------~~~~~~~----p-- 241 (327)
T 3a62_A 177 -VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--------LKCKLNL----P-- 241 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCCC----C--
T ss_pred -cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCC----C--
Confidence 223356899999999999999999999999999999999999999876554322111 1111110 0
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
......+.+++.+||+.||++|| ++.|+++
T Consensus 242 ----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 242 ----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11235678899999999999999 7778765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=338.65 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=200.0
Q ss_pred cccccccccceeEEEeEeCCCCce--eEEEEEechhc-ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAV-NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|..... +. .||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEET-TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ceeeeecCCCceEEEEEEccC-CcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 457899999999999986543 34 45999886532 33456789999999999 999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEe
Q 003818 581 VSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS 645 (793)
Q Consensus 581 ~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 645 (793)
+++++|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEc
Confidence 99999999997653 4688999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHh
Q 003818 646 DFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCF 724 (793)
Q Consensus 646 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~ 724 (793)
|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+
T Consensus 185 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~--------~~~ 254 (327)
T 1fvr_A 185 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--------EKL 254 (327)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------HHG
T ss_pred ccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH--------HHh
Confidence 999997433211 1222346889999999998889999999999999999998 99999876544321 111
Q ss_pred hccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..+.... . .......+.+++.+||+.||++|||++++++.|+.+.
T Consensus 255 ~~~~~~~---~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 255 PQGYRLE---K------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGTCCCC---C------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCC---C------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2211110 0 1122356789999999999999999999999997644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=352.55 Aligned_cols=244 Identities=25% Similarity=0.302 Sum_probs=192.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 152 ~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 3478999999999999854 467899999997642 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
++|+|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 231 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 305 (446)
T 4ejn_A 231 NGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 305 (446)
T ss_dssp SSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-cc
Confidence 999999999654 468899999999999999999997 7 99999999999999999999999999998543322 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~-p------- 369 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEIRF-P------- 369 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC-C-------
T ss_pred cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------HhCCCCC-C-------
Confidence 33467999999999999999999999999999999999999999876654422211 1111110 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
......+.+++.+||+.||++|| +++|+++
T Consensus 370 --~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 --RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01234678999999999999999 9999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.66 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=203.9
Q ss_pred cccccccccceeEEEeEeCCCC----ceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN----EKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|.....+ .+.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+++..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 3578999999999999865432 24799999976432 3346789999999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEe
Q 003818 579 EYVSNGSLADFLFRK-------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARIS 645 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 645 (793)
||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBC
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEEC
Confidence 999999999999653 24578899999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHH
Q 003818 646 DFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDC 723 (793)
Q Consensus 646 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~ 723 (793)
|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........... .
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-------~ 279 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-------L 279 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH-------H
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH-------H
Confidence 999998664433222 223456789999999999899999999999999999998 8999976544332111 1
Q ss_pred hhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 724 FRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
...+..... +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 280 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 VKDGYQMAQ---------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCC---------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111000 011235678899999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.73 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=192.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 577 (793)
.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 67 ~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 478999999999999854 467889999997542 23356788999999999999999999999654 456999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||++++ |.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 146 ~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 146 MELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred EeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 9999764 6666643 488899999999999999999998 99999999999999999999999999998654332
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH---------------HH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA---------------YD 722 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~---------------~~ 722 (793)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 219 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp --CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred --ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 2334568999999999999999999999999999999999999998876554332222110 00
Q ss_pred Hhhccc-cc-----eeecc---cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERK-LG-----LLVEN---DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~-~~-----~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+.... .. ..... .............+.+|+.+||+.||++|||++|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 00000 00011112235678999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.84 Aligned_cols=248 Identities=28% Similarity=0.409 Sum_probs=200.5
Q ss_pred ccccccceeEEEeEeC-CCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 508 ELGEGAFGKVYKGVLT-TENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.||+|+||.||+|... ...++.||+|++..... ...+.+.+|+.+++.++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 8999999999999643 34578999999976432 2246799999999999999999999999 567789999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce--e
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT--T 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--~ 662 (793)
+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++........... .
T Consensus 103 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 178 (291)
T 1xbb_A 103 PLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178 (291)
T ss_dssp EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccc
Confidence 999999764 4588999999999999999999998 999999999999999999999999999987654433221 2
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~--------- 241 (291)
T 1xbb_A 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------LEKGERMGC--------- 241 (291)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCC---------
T ss_pred cCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCCCC---------
Confidence 2346788999999998889999999999999999999 9999987655432211 112211111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112345688999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=332.07 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=197.0
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.+...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.++. .++|+|
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 3478999999999999865433 3479999987542 234568899999999999999999999998765 889999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++++|.+++......+++..+..++.|+++||.|||++ +|+|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred cccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 9999999999987666789999999999999999999998 9999999999999999999999999999876544322
Q ss_pred c--eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 660 T--TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... .........
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~----- 245 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------IDKEGERLP----- 245 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTSCCCCC-----
T ss_pred hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH-------HHccCCCCC-----
Confidence 1 222457788999999998889999999999999999999 9999987654432111 111111100
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
........+.+++.+||+.||++|||+.+|++.|++...
T Consensus 246 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 ----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 011234568899999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.23 Aligned_cols=267 Identities=20% Similarity=0.273 Sum_probs=206.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCC--ceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE--HRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++||||+
T Consensus 13 i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 3578999999999999864 457899999997643 334567889999999999999999999998755 779999999
Q ss_pred CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCcEEEeecCCccccCC
Q 003818 582 SNGSLADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 582 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~~~~~ 655 (793)
++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 9999999997643 3389999999999999999999998 99999999999999 7888899999999987644
Q ss_pred CCCcceecccCcccccCcccccC--------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKN--------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER 727 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~ 727 (793)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ........
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~~ 243 (396)
T 4eut_A 169 DE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV---MYKIITGK 243 (396)
T ss_dssp GG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH---HHHHHHSC
T ss_pred CC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH---HHHHhcCC
Confidence 32 2233568999999999865 56788999999999999999999999754332211111 11111111
Q ss_pred c---cceee-----------cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 728 K---LGLLV-----------ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 728 ~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
. +.... ...............+.+++..||+.||++||+++|+++.++.+.+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1 00000 00111112245567788999999999999999999999999876554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.62 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=198.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 478999999999999864 456789999986532 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 93 ~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 165 (279)
T 3fdn_A 93 LGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 165 (279)
T ss_dssp TEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---------
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc---cc
Confidence 99999999654 4578899999999999999999988 99999999999999999999999999986543322 23
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... . +
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~---------~ 227 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SRVEFT-F---------P 227 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC-C---------C
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH--------HhCCCC-C---------C
Confidence 346899999999999999999999999999999999999999876654432221 111111 0 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
......+.+++.+||+.||++|||++||++.-
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 01234577899999999999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.61 Aligned_cols=256 Identities=19% Similarity=0.255 Sum_probs=201.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEE-ecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC-NEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|++.... ..+.+.+|+.+++.++|++++..+.++ ..++..++||||+ ++
T Consensus 14 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEETTEEEEEEEET-TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 478999999999999854 467899999986543 235689999999999998877766655 6677889999999 99
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCCCc--
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQ-- 659 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~~-- 659 (793)
+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||++.........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence 99999987777899999999999999999999998 99999999999999 58899999999999876544321
Q ss_pred ----ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 660 ----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 660 ----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.......... ..
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~-- 239 (296)
T 3uzp_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----PI-- 239 (296)
T ss_dssp CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----CH--
T ss_pred cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----ch--
Confidence 1234568999999999999999999999999999999999999998643322111111111111100 00
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+..+.+++.+||+.||++|||+++|++.|+...
T Consensus 240 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 240 ---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0000112356889999999999999999999999998744
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.81 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=187.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCC-ccccceeeeEEecCC--ceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGE--HRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV~Ey 580 (793)
.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++..+. ||||+++++++...+ ..++||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 92 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92 (388)
T ss_dssp EEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred EEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence 478999999999999854 467889999986532 233467789999999997 999999999997544 78999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC---
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ--- 657 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~--- 657 (793)
++ ++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 93 ~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 93 ME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp CS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred cC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 97 689998865 4688899999999999999999998 99999999999999999999999999998653311
Q ss_pred -----------------CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHH
Q 003818 658 -----------------TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW 719 (793)
Q Consensus 658 -----------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~ 719 (793)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 112233569999999999976 67899999999999999999999999877655433222110
Q ss_pred HH-------------------HHhhccc-c-ceeeccc-chhh-------hhHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003818 720 AY-------------------DCFRERK-L-GLLVEND-EEAM-------DDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770 (793)
Q Consensus 720 ~~-------------------~~~~~~~-~-~~~~~~~-~~~~-------~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 770 (793)
.. ..+.... . ....... .... ........+.+|+.+||+.||++|||++|+
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 00 0000000 0 0000000 0000 000123568899999999999999999999
Q ss_pred HHH
Q 003818 771 TQM 773 (793)
Q Consensus 771 l~~ 773 (793)
++.
T Consensus 327 l~H 329 (388)
T 3oz6_A 327 LKH 329 (388)
T ss_dssp TTS
T ss_pred hCC
Confidence 876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=322.50 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=200.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 11 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 478999999999999854 457789999986543 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecCCccccCCCCCcc
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~~~~~~ 660 (793)
++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||++........
T Consensus 90 ~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~-- 163 (284)
T 3kk8_A 90 GELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163 (284)
T ss_dssp CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--
Confidence 9999988654 4588999999999999999999998 9999999999999986655 99999999976654322
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+........
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~~~~~~----- 230 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--------KAGAYDYPSPE----- 230 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCCCTTT-----
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH--------HhccccCCchh-----
Confidence 23356899999999999999999999999999999999999999876554422211 11111111000
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 -~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 -WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11123567899999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.77 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=204.4
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCC-ceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGE-HRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV 577 (793)
+.+.||+|+||.||+|... ..+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 3478999999999999752 35678999999976433 2346789999999999 7999999999987654 58999
Q ss_pred EeecCCCCHHHHHhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcE
Q 003818 578 YEYVSNGSLADFLFRKSRR---------------PNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 642 (793)
|||+++++|.+++...... +++..+..++.|+++||.|||++ +|+||||||+||+++.++.+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~ 187 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV 187 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCE
Confidence 9999999999999765432 78889999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWA 720 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~ 720 (793)
||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~------ 261 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------ 261 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH------
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH------
Confidence 99999999876544332 2233457889999999999999999999999999999998 999997654332111
Q ss_pred HHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..+..+...... ......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 262 -~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 262 -RRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp -HHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHhccCccCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111111 112346788999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.86 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=194.2
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC-----ceE
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE-----HRL 575 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 575 (793)
+.+.||+|+||.||+|..... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+ ..+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 357899999999999986543 45689999987542 233467899999999999999999999997755 359
Q ss_pred EEEeecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 576 LVYEYVSNGSLADFLFR-----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
+||||+++++|.+++.. ....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999853 345688999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~~~~ 266 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--------LHGH 266 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTC
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--------HcCC
Confidence 86644322 12223457889999999999999999999999999999999 88899876554322111 1111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.... .......+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 267 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 267 RLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1122356889999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.19 Aligned_cols=245 Identities=28% Similarity=0.307 Sum_probs=191.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHH-HhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISA-IGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+++.. .+++.||+|++.+... .....+.+|..+ ++.++||||+++++++.+.+..++||||
T Consensus 42 ~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 120 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120 (373)
T ss_dssp EEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeC
Confidence 4578999999999999864 4678899999976532 223456667766 5678999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++.+. ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 121 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~ 195 (373)
T 2r5t_A 121 INGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-ST 195 (373)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CC
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-Cc
Confidence 9999999999764 4577888899999999999999998 99999999999999999999999999998643222 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~~~-------- 259 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------LNKPLQLK-------- 259 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--------HHSCCCCC--------
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcccCCC--------
Confidence 34457999999999999999999999999999999999999999877655432222 11111110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++||++.+.++.
T Consensus 260 --~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 260 --PNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp --SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred --CCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 0122457889999999999999998544333
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.90 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=194.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 114 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 114 (310)
T ss_dssp EEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecC
Confidence 4578999999999999854 457889999987532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 582 SNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 582 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
++++|.+++.. ....+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999864 356688999999999999999999998 999999999999999999999999999986543322
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||......... + . ..+..........
T Consensus 192 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~---~-~~~~~~~~~~~~~---- 260 (310)
T 2wqm_A 192 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--L---C-KKIEQCDYPPLPS---- 260 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--H---H-HHHHTTCSCCCCT----
T ss_pred -cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--H---H-HHhhcccCCCCcc----
Confidence 122345899999999999999999999999999999999999999754322111 1 1 1111111111110
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
......+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 261 ----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 261 ----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11235678999999999999999999999999886543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=323.28 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=203.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 3578999999999999854 457789999986542 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++....... .
T Consensus 97 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 169 (284)
T 2vgo_A 97 PRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---R 169 (284)
T ss_dssp TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---B
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc---c
Confidence 999999999765 4578999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .......
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~~---------- 231 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--------VNVDLKF---------- 231 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCCC----------
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH--------hccccCC----------
Confidence 2345899999999999999999999999999999999999999876554322111 1111110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ--MIEGAV 778 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~Le~~~ 778 (793)
+......+.+++.+||+.||++|||++++++ .+....
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 0112346788999999999999999999987 444433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=330.88 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=195.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc--CCccccceeeeEEecC----CceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR--TNHKNLVQLLGFCNEG----EHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~lV~ 578 (793)
+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++... ...++||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp EEEEEEEETTEEEEEEEET---TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred EEeEeecCCCeEEEEEEEC---CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 4578999999999999863 788999998543 23344555556555 4999999999999877 7889999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC-----KSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
||+++|+|.+++... .+++..+..++.|++.||.|||++. ..+|+||||||+|||++.++.+||+|||+++.+
T Consensus 115 e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 115 DYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 999999999999654 5889999999999999999999752 348999999999999999999999999999766
Q ss_pred CCCCCcc---eecccCcccccCcccccCCCCCCc------cceehhHHHHHHHHhC----------CcCCCCCchhHHHH
Q 003818 654 KTDQTQT---TTAIRGTKGYVAPEWFKNLPITAK------VDVYSFGILLLELVCC----------RKNFEVDATEECQM 714 (793)
Q Consensus 654 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------~Dvws~Gvil~elltg----------~~pf~~~~~~~~~~ 714 (793)
....... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||..........
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 272 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence 4433221 123468999999999988766665 9999999999999999 56664432211110
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
. ............ ...+...........+.+++.+||+.||++|||+++|++.|+.+.+
T Consensus 273 ~---~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 273 E---DMREIVCIKKLR---PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp H---HHHHHHTTSCCC---CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h---hhHHHHhhhccC---ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 0 011111111111 1111112223567789999999999999999999999999987553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.58 Aligned_cols=237 Identities=27% Similarity=0.339 Sum_probs=196.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 577 (793)
.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 29 ~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999854 4678999999976431 1334678899999999999999999999999999999
Q ss_pred EeecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 578 YEYVSNG-SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 578 ~Ey~~~g-sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
|||+.+| +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 108 ~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 9999777 999998654 4688999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.. .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .. ....
T Consensus 184 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------~~----~~~~ 243 (335)
T 3dls_A 184 KL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------EA----AIHP 243 (335)
T ss_dssp CC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------TT----CCCC
T ss_pred Cc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------hh----ccCC
Confidence 32 233568999999999988877 789999999999999999999997532110 00 0000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.. .....+.+++.+||+.||++|||+++|++.
T Consensus 244 ~~------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 PY------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred Cc------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 123457899999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.41 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=198.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++... .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87 (283)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence 4578999999999999864 4578899999865321 13578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----cEEEeecCCccccC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----NARISDFGLAKLLK 654 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~ 654 (793)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .+||+|||++....
T Consensus 88 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 88 ELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999654 4688999999999999999999998 999999999999998877 89999999998664
Q ss_pred CCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .......
T Consensus 164 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~--- 230 (283)
T 3bhy_A 164 AGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--------SAVNYDF--- 230 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCCC---
T ss_pred CCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--------HhcccCC---
Confidence 4322 23345899999999999999999999999999999999999999876544322111 1111100
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...........+.+++.+||+.||++|||+.|+++
T Consensus 231 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 231 ---DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ---CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00011122456789999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.53 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=197.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 30 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 468999999999999854 45788999998654322 245678999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 109 ~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 183 (331)
T 4aaa_A 109 TILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDD 183 (331)
T ss_dssp EHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred chHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCC
Confidence 9998876543 4688999999999999999999998 999999999999999999999999999976543322 2223
Q ss_pred ccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhh------cccc
Q 003818 664 IRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFR------ERKL 729 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~------~~~~ 729 (793)
..||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.... ...+. ....
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 4589999999999875 78999999999999999999999998876554332221110 00000 0011
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.................+.+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111233567899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.48 Aligned_cols=247 Identities=27% Similarity=0.310 Sum_probs=201.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++.... ......+.+|+.+++.++|||||++++++.+.+..++||||++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 478999999999999864 467899999997642 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 583 NGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~~ 342 (576)
T 2acx_A 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TI 342 (576)
T ss_dssp SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CE
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc--cc
Confidence 999999997653 4588999999999999999999998 99999999999999999999999999998765433 22
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+.......
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----~~i~~~~~~~---------- 408 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----RLVKEVPEEY---------- 408 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH----HHHHHCCCCC----------
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH----HHhhcccccC----------
Confidence 33569999999999999999999999999999999999999998754321111111 1111111110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
.......+.+++.+||+.||++|| +++||++
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011235678899999999999999 7888875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.43 Aligned_cols=253 Identities=27% Similarity=0.376 Sum_probs=199.0
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|... ..+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 4578999999999999853 2356789999996532 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCc
Q 003818 580 YVSNGSLADFLFRKS------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~~------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 650 (793)
|+++++|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+|||++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 999999999997653 3478889999999999999999998 9999999999999984 456999999999
Q ss_pred cccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--------~~~~~ 262 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--------VTSGG 262 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--------HHTTC
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH--------HhcCC
Confidence 75433222 22233457889999999998899999999999999999998 9999987654432111 11111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
.... .......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 263 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111 011234678899999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=340.32 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=188.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHh-cCCccccceeeeEEec----CCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIG-RTNHKNLVQLLGFCNE----GEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~----~~~~~lV~Ey~ 581 (793)
+.||+|+||.||++... .+++.||||++.. ...+.+|+.++. ..+||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEEC-CCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 57999999999999854 4678899999853 245678888874 4689999999998865 66789999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCC
Q 003818 582 SNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 582 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~ 657 (793)
++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999997653 4689999999999999999999998 9999999999999987 7899999999998654322
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...+..+...... .
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~~~~~~~---~ 289 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEFPN---P 289 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHTCCCCCT---T
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcCcccCCC---c
Confidence 223456899999999999999999999999999999999999999765432211001 0111111111100 0
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.||++|||+.||++.
T Consensus 290 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001233567899999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=333.55 Aligned_cols=263 Identities=19% Similarity=0.264 Sum_probs=200.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEec--------CCce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNE--------GEHR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~~ 574 (793)
+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++++.. .+..
T Consensus 21 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp EEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred EEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence 3478999999999999864 4678899999865432 234578899999999999999999999877 4568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC
Q 003818 575 LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK 654 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 654 (793)
++||||+++ +|.+.+......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 100 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 100 YLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp EEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 999999974 88888877777799999999999999999999998 99999999999999999999999999998664
Q ss_pred CCC---CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 655 TDQ---TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 655 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...... .......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~ 254 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVWP 254 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTST
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CChhhcc
Confidence 322 222234568999999999876 46899999999999999999999999887655433332211100 0000000
Q ss_pred ee------------ecccchhhhh---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 731 LL------------VENDEEAMDD---IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 731 ~~------------~~~~~~~~~~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.. .......... ......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000000000 1113458899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.19 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=190.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 39 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence 478999999999999854 4678999999965432 224567899999999999999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-----CCCcEEEeecCCccccCCCCC
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-----GTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfgla~~~~~~~~ 658 (793)
++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||+++.......
T Consensus 117 ~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 117 NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence 5999999765 3588999999999999999999998 999999999999994 555699999999986643322
Q ss_pred cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc---------
Q 003818 659 QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK--------- 728 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~--------- 728 (793)
......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... ......
T Consensus 193 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 193 -QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPDDTTWPGVTALPD 270 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSTTGGGSTT
T ss_pred -ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-CCchhhhhhhhhhhh
Confidence 22334579999999999875 589999999999999999999999987765543322211100 000000
Q ss_pred ----cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 ----LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ----~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....................+.+++.+||+.||++|||++|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000001112356789999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.56 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=199.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEECC----CEEEEEEET-TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hheeeccCCCeEEEEEEEC-CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 3478999999999999864 45788999998653 24567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ .....
T Consensus 110 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 185 (314)
T 3com_A 110 SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTV 185 (314)
T ss_dssp EHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCC
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCcc
Confidence 99999976667889999999999999999999998 999999999999999999999999999976644322 22334
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ........ . ....
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-~------~~~~ 250 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--------PTNPPPTF-R------KPEL 250 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCC-S------SGGG
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------hcCCCccc-C------Cccc
Confidence 5899999999999999999999999999999999999999876543321111 11110000 0 0111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2356789999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.96 Aligned_cols=258 Identities=17% Similarity=0.184 Sum_probs=199.9
Q ss_pred cccccccccceeEEEeEeCCC-------CceeEEEEEechhcccchHHHHHHHHHHhcCCccccce--------------
Q 003818 505 FKEELGEGAFGKVYKGVLTTE-------NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQ-------------- 563 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-------------- 563 (793)
+.+.||+|+||.||+|..... .++.||+|++... +.+.+|+.++++++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 347899999999999997643 4789999998653 46889999999999999998
Q ss_pred -eeeEEec-CCceEEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC
Q 003818 564 -LLGFCNE-GEHRLLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF 640 (793)
Q Consensus 564 -l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~ 640 (793)
+++++.. ++..++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCC
Confidence 5667765 67889999999 99999999765 46789999999999999999999998 999999999999999998
Q ss_pred --cEEEeecCCccccCCCCCc------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH
Q 003818 641 --NARISDFGLAKLLKTDQTQ------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC 712 (793)
Q Consensus 641 --~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~ 712 (793)
.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 276 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE 276 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence 8999999999876543221 11334689999999999999999999999999999999999999986542211
Q ss_pred HHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 713 QMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
. +...... +.. ....+...... .......+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 277 ~--~~~~~~~-~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 277 D--IMKQKQK-FVD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp H--HHHHHHH-HHH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred H--HHHHHHh-ccC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 1 1111111 111 11111111100 0012356789999999999999999999999998744
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.96 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=194.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec----CCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE----GEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 578 (793)
+.+.||+|+||.||+|... .++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 3467999999999999854 467789999987543 2334678999999999999999999998865 45689999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEEc-CCCcEEEeecCCccccCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ--IIHCDIKPQNILLD-GTFNARISDFGLAKLLKT 655 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~ 655 (793)
||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++ +++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999654 4578899999999999999999998 7 99999999999997 889999999999975443
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.. .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......... ......+......
T Consensus 185 ~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~-- 251 (290)
T 1t4h_A 185 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVKPASF-- 251 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCCCGGG--
T ss_pred cc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-------HHHHhccCCcccc--
Confidence 32 233458999999998875 5899999999999999999999999765433211 1111111111000
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||++||++
T Consensus 252 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112245789999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.96 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=196.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 23 i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred ecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 3478999999999999864 457889999997766666788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... ......
T Consensus 102 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 177 (302)
T 2j7t_A 102 AVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSF 177 (302)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC----
T ss_pred cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccc
Confidence 99999987667799999999999999999999998 99999999999999999999999999875322111 111224
Q ss_pred cCcccccCcccc-----cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 665 RGTKGYVAPEWF-----KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 665 ~gt~~y~aPE~~-----~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.||+.|+|||++ ....++.++||||||+++|||++|+.||......+....+ .. ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~-~~~~~~------- 242 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-------AK-SDPPTL------- 242 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HH-SCCCCC-------
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-------hc-cCCccc-------
Confidence 589999999998 4667899999999999999999999999876544321111 11 111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.........+.+++.+||+.||++|||+.+|++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122356789999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=326.37 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=201.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||++... .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91 (304)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence 4578999999999999854 467889999997655445567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCCCcce
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++ ++++.+||+|||++...... ..
T Consensus 92 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~ 164 (304)
T 2jam_A 92 ELFDRILER-GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IM 164 (304)
T ss_dssp BHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TT
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---cc
Confidence 999998654 4578899999999999999999998 99999999999999 78899999999999754332 12
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... +..+..... . ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------i~~~~~~~~-~-----~~ 230 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK--------IKEGYYEFE-S-----PF 230 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------HHHCCCCCC-T-----TT
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHcCCCCCC-c-----cc
Confidence 234589999999999999999999999999999999999999987654432211 112211100 0 00
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ--MIEGAV 778 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~Le~~~ 778 (793)
.......+.+++.+||+.||++|||++|+++ .+++..
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1122356789999999999999999999987 445443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=337.10 Aligned_cols=246 Identities=19% Similarity=0.196 Sum_probs=199.1
Q ss_pred ccccccccceeEEEeEe----CCCCceeEEEEEechhcccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEEEE
Q 003818 506 KEELGEGAFGKVYKGVL----TTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 578 (793)
.+.||+|+||.||+|.. ....++.||+|++... ...++..|+.++.+++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 46899999999999952 3346789999998653 3457788888888886 999999999999999999999
Q ss_pred eecCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----------CCcEE
Q 003818 579 EYVSNGSLADFLFR----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-----------TFNAR 643 (793)
Q Consensus 579 Ey~~~gsL~~~l~~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----------~~~~k 643 (793)
||+++|+|.+++.. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEE
Confidence 99999999999975 356789999999999999999999998 9999999999999998 89999
Q ss_pred EeecCCccccCCC-CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH
Q 003818 644 ISDFGLAKLLKTD-QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD 722 (793)
Q Consensus 644 l~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~ 722 (793)
|+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------- 292 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----------- 292 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----------
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----------
Confidence 9999999765422 2233344679999999999999999999999999999999999999996543221
Q ss_pred HhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcCcC
Q 003818 723 CFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLR-PAMKKVTQMIEGAVD 779 (793)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~Le~~~~ 779 (793)
..+....... ...+.+.+++..|++.+|.+| |+++++.+.|+...+
T Consensus 293 ----~~~~~~~~~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ----CKPEGLFRRL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----EEECSCCTTC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----eeechhcccc-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0011111110 123456788999999999998 688888888876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.61 Aligned_cols=260 Identities=23% Similarity=0.243 Sum_probs=199.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc-----chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-----GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 92 (346)
T ss_dssp EEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred EEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEE
Confidence 3478999999999999854 45788999998653221 13468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++ +|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 93 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 167 (346)
T 1ua2_A 93 FMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 167 (346)
T ss_dssp CCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc-
Confidence 9976 89999987777788999999999999999999998 999999999999999999999999999987643322
Q ss_pred ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce------e
Q 003818 660 TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL------L 732 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~------~ 732 (793)
......+|+.|+|||.+.+. .++.++|||||||++|||++|..||......+....+.. ......... .
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE----TLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HHCCCCTTTSSSTTSS
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH----HcCCCChhhhhhhccC
Confidence 22335689999999998764 589999999999999999999999987765543222211 110000000 0
Q ss_pred ec-----c---cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003818 733 VE-----N---DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774 (793)
Q Consensus 733 ~~-----~---~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 774 (793)
.+ . .+...........+.+++.+||+.||++|||++|+++.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 0 000000112246788999999999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.50 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=182.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEe--------cCCceE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCN--------EGEHRL 575 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------~~~~~~ 575 (793)
+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++.++. ||||+++++++. .....+
T Consensus 32 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence 4578999999999999854 457889999986665555678899999999996 999999999983 344578
Q ss_pred EEEeecCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 576 LVYEYVSNGSLADFLFR--KSRRPNWYKRMQIAFGTARGLFYLHEECKSQ--IIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~--~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
+|+||+. |+|.+++.. ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++.
T Consensus 111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 9999995 799998865 455689999999999999999999988 7 9999999999999999999999999998
Q ss_pred ccCCCCCcc-----------eecccCcccccCcccc---cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHH
Q 003818 652 LLKTDQTQT-----------TTAIRGTKGYVAPEWF---KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILA 717 (793)
Q Consensus 652 ~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~ 717 (793)
......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----- 261 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI----- 261 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-----
Confidence 765432211 1134589999999998 566789999999999999999999999975432210
Q ss_pred HHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 718 DWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
. ......... ......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 262 --~-----~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 --V-----NGKYSIPPH--------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------CCCCTT--------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred --h-----cCcccCCcc--------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 011110000 011133678999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.92 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=190.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCC--ccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTN--HKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.++.+++ ||||+++++++..++..++|||
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred EEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 3478999999999999854 37789999986532 234467899999999996 5999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+.+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 137 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 137 CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 5688999999765 3678889999999999999999998 999999999999995 589999999999876544322
Q ss_pred ceecccCcccccCcccccC-----------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 660 TTTAIRGTKGYVAPEWFKN-----------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+ ...+....
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~----~~~~~~~~ 285 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KL----HAIIDPNH 285 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHHCTTS
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--HH----HHHhCccc
Confidence 2234569999999999875 3688999999999999999999999976432211 11 11111111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... .....+.+++.+||+.||++|||+.||++.
T Consensus 286 ~~~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 EIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCc---------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 100000 012457889999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.54 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=193.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecC-CceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-EHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++.. .++.||+|++... ...+.+.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 25 ~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp EEEEEEECSSCEEEEEEE---TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred EEeEEecCCCceEEEEEE---cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 357899999999999986 3678999998653 2456789999999999999999999987554 578999999999
Q ss_pred CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSR-RPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
++|.+++..... .+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++....... .
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~ 172 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 172 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----c
Confidence 999999975432 378888999999999999999998 99999999999999999999999999997544322 1
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +..+.....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--------~~~~~~~~~--------- 235 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDA--------- 235 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--------HTTTCCCCC---------
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HhcCCCCCC---------
Confidence 2347889999999999899999999999999999998 9999987654432111 111111111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1122356789999999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.62 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=195.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||++... .+++.||+|++..... ...+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 26 ~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 3578999999999999864 4678999999976432 345688888777 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC----CcEEEeecCCccccCCCCCc
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT----FNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||+++.......
T Consensus 101 g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~- 175 (342)
T 2qr7_A 101 GELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG- 175 (342)
T ss_dssp CBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence 9999999654 4688999999999999999999998 99999999999998543 3599999999987654332
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+..+.......
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-----~~i~~~~~~~~~~----- 245 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-----ARIGSGKFSLSGG----- 245 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-----HHHHHCCCCCCST-----
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-----HHHccCCcccCcc-----
Confidence 223456899999999999888999999999999999999999999764322111111 1122222211110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.||++|||+.++++.
T Consensus 246 -~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 246 -YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011223567899999999999999999998863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.73 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=199.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec--------------
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-------------- 570 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------------- 570 (793)
..+.||+|+||.||+|... .+++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp EEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred eeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 3578999999999999864 457889999986532 467889999999999999999998854
Q ss_pred --CCceEEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeec
Q 003818 571 --GEHRLLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDF 647 (793)
Q Consensus 571 --~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 647 (793)
....++||||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+||+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence 45589999999999999999754 45688999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcc
Q 003818 648 GLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER 727 (793)
Q Consensus 648 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~ 727 (793)
|++........ .....+|+.|+|||.+.+..++.++||||||+++|||++|..|+..... ....+..+
T Consensus 167 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~~~~ 234 (284)
T 2a19_B 167 GLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------FFTDLRDG 234 (284)
T ss_dssp TTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------HHHHHHTT
T ss_pred hhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----------HHHHhhcc
Confidence 99987654332 2234589999999999999999999999999999999999988742110 01111121
Q ss_pred ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 003818 728 KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781 (793)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 781 (793)
.+.. .....+.+++.+||+.||++|||+.|+++.|+......
T Consensus 235 ~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 235 IISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp CCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred cccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1110 12245678999999999999999999999998766544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.14 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=200.1
Q ss_pred cccccccccceeEEEeEeCC--CCceeEEEEEechhc----ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTT--ENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||.||++.... .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 35789999999999998642 467899999987532 23345678899999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++++|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 138 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 138 LDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 9999999999999754 4588999999999999999999998 99999999999999999999999999998765544
Q ss_pred CcceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+. ...... ... .
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~-~~~-~--- 285 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKS-EPP-Y--- 285 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHC-CCC-C---
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH---HHHhcc-CCC-C---
Confidence 444445679999999999985 357899999999999999999999997543322111111 111111 000 0
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQMI 774 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 774 (793)
.......+.+++.+||+.||++|| +++|+++..
T Consensus 286 ------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 ------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111234578899999999999999 999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.07 Aligned_cols=246 Identities=27% Similarity=0.352 Sum_probs=194.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCCH
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSL 586 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 586 (793)
..||+|+||.||+|... .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 47999999999999854 46788999999776555667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccCCCCCcceec
Q 003818 587 ADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 587 ~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
.+++.... ...++..+..++.|+++||.|||++ +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 99997653 3456888889999999999999998 9999999999999987 89999999999986543221 1233
Q ss_pred ccCcccccCcccccCCC--CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 664 IRGTKGYVAPEWFKNLP--ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~--~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
..|++.|+|||++.+.. ++.++||||||+++|||++|+.||........... ..... .....+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~-~~~~~~--------- 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-----KVGMF-KVHPEI--------- 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-----HHHHH-CCCCCC---------
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-----hhccc-cccccc---------
Confidence 45899999999997653 78999999999999999999999975433221110 00000 000000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||++++++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0112356788999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.02 Aligned_cols=246 Identities=20% Similarity=0.329 Sum_probs=189.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCc--cccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNH--KNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++| +||+++++++.+++..++|||
T Consensus 13 i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 3478999999999999853 57789999986532 2334678999999999976 999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+.+++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++ ++.+||+|||+++........
T Consensus 90 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 90 CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 5688999999765 5688899999999999999999998 999999999999997 578999999999876544332
Q ss_pred ceecccCcccccCcccccC-----------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 660 TTTAIRGTKGYVAPEWFKN-----------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~~ 238 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------LHAIIDPNH 238 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH------HHHHHCTTS
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH------HHHHhcCCc
Confidence 2234569999999999865 67889999999999999999999999764332111 111111111
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... .....+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~---------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 EIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCcc---------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111100 012457889999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=346.70 Aligned_cols=235 Identities=14% Similarity=0.165 Sum_probs=182.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechh---cccchHHHHHHH---HHHhcCCccccceee-------eEEecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEI---SAIGRTNHKNLVQLL-------GFCNEGE 572 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~~~~~ 572 (793)
.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+ .++++++|||||+++ +++.+.+
T Consensus 78 ~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred cceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 478999999999999854 45789999999743 233457789999 555666899999998 6665543
Q ss_pred -----------------ceEEEEeecCCCCHHHHHhcCCCCC------CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 003818 573 -----------------HRLLVYEYVSNGSLADFLFRKSRRP------NWYKRMQIAFGTARGLFYLHEECKSQIIHCDI 629 (793)
Q Consensus 573 -----------------~~~lV~Ey~~~gsL~~~l~~~~~~~------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 629 (793)
..++||||+ +|+|.+++....... ++..++.|+.||++||+|||++ +|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 378999999 689999997643222 2577888999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCC-----------CCCCccceehhHHHHHHHH
Q 003818 630 KPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL-----------PITAKVDVYSFGILLLELV 698 (793)
Q Consensus 630 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Dvws~Gvil~ell 698 (793)
||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||+
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999985322 2334557 999999999887 8999999999999999999
Q ss_pred hCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 699 CCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 699 tg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+|+.||......+... ...... ......+.+++.+||+.||++|||+.|+++
T Consensus 308 tg~~Pf~~~~~~~~~~----------------~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 308 CADLPITKDAALGGSE----------------WIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HSSCCC------CCSG----------------GGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HCCCCCcccccccchh----------------hhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999997544322110 000000 012356788999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.99 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=191.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHH--HhcCCccccceeeeEEe-----cCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISA--IGRTNHKNLVQLLGFCN-----EGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~-----~~~~~~lV 577 (793)
+.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+. .....++|
T Consensus 17 ~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 17 LLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp EEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred eeeecccCCCeEEEEEEE---CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 347899999999999986 56889999986532 2334444444 45589999999998553 23367899
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC------KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
|||+++|+|.+++.... .++..+..++.|+++||.|||+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp ECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 99999999999996543 478889999999999999999763 3389999999999999999999999999998
Q ss_pred ccCCCCC-------cceecccCcccccCcccccC-------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHH-HHH-
Q 003818 652 LLKTDQT-------QTTTAIRGTKGYVAPEWFKN-------LPITAKVDVYSFGILLLELVCCRKNFEVDATEEC-QMI- 715 (793)
Q Consensus 652 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~-~~~- 715 (793)
.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||........ ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 7654321 12223469999999999987 4567799999999999999999877644322110 000
Q ss_pred ---------HHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 716 ---------LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 716 ---------l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
................+.. ...........+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0000000111111111111 111223456678999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=321.22 Aligned_cols=248 Identities=30% Similarity=0.403 Sum_probs=199.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|+||+++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (276)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCC
Confidence 4578999999999999854 457789999986543 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-ccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~ 662 (793)
++|.+++... ..+++..+..++.|+++||.|||++ +|+|+||||+||+++.++.+||+|||++........ ....
T Consensus 90 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 90 GELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp EEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 9999988543 5688999999999999999999998 999999999999999999999999999986543322 1223
Q ss_pred cccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ... +...... .. .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~-----~~~~~~~--~~------~ 230 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD-----WKEKKTY--LN------P 230 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHH-----HHTTCTT--ST------T
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHH-----hhhcccc--cC------c
Confidence 3568999999999988765 77999999999999999999999875443211 111 1111100 00 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||++||++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1122346788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=324.11 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=201.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 478999999999999864 4577899999866432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 99 ~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (294)
T 2rku_A 99 RRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 173 (294)
T ss_dssp TCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccc
Confidence 99999988654 4688999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~~--------- 235 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEYS-IP--------- 235 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC-CC---------
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hhccCC-Cc---------
Confidence 345899999999999989999999999999999999999999876554322111 111111 00
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0122457889999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.76 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=199.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEe--cCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCN--EGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++||||
T Consensus 10 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 3478999999999999864 467889999986532 233467899999999999999999999874 46688999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 581 VSNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQ-----IIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 581 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
+++++|.+++... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999753 34589999999999999999999998 6 99999999999999999999999999986
Q ss_pred cCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+... .+..+....+
T Consensus 166 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~i~~~~~~~~ 236 (279)
T 2w5a_A 166 LNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG--------KIREGKFRRI 236 (279)
T ss_dssp C---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHTCCCCC
T ss_pred eccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH--------HHhhcccccC
Confidence 543322 1223458999999999999899999999999999999999999998765443221 1122222111
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
. ......+.+++.+||+.||++|||+.||++.+..
T Consensus 237 ~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 P---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 1233567899999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=329.36 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=198.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 78999999999999864 457899999987643 23357889999999998 569999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCCCc
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~~ 659 (793)
++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~- 189 (327)
T 3lm5_A 114 GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189 (327)
T ss_dssp EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc-
Confidence 9999998654 46689999999999999999999998 9999999999999987 78999999999987643322
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. .........
T Consensus 190 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--------~~~~~~~~~----- 255 (327)
T 3lm5_A 190 -LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS--------QVNVDYSEE----- 255 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCCCCCTT-----
T ss_pred -cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--------hcccccCch-----
Confidence 233568999999999999999999999999999999999999998766544322211 111111000
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.||++|||++++++.
T Consensus 256 -~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 256 -TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 011233567889999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=331.65 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=200.1
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc--CCccccceeeeEEecCC----ceEEE
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR--TNHKNLVQLLGFCNEGE----HRLLV 577 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV 577 (793)
.+.+.||+|+||.||+|+. .++.||+|++... ....+.+|.+++.. ++||||+++++++.... ..++|
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 45 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp EEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred EEEeeecCCCCcEEEEEEE---cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 3457899999999999986 4788999998643 34567788888877 79999999999998776 78999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCEEEcCCCcEEEeecCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH--------EECKSQIIHCDIKPQNILLDGTFNARISDFGL 649 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 649 (793)
|||+++|+|.+++.+. .+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 119 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999653 5889999999999999999999 66 999999999999999999999999999
Q ss_pred ccccCCCCCc---ceecccCcccccCcccccCC------CCCCccceehhHHHHHHHHhC----------CcCCCCCchh
Q 003818 650 AKLLKTDQTQ---TTTAIRGTKGYVAPEWFKNL------PITAKVDVYSFGILLLELVCC----------RKNFEVDATE 710 (793)
Q Consensus 650 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~Dvws~Gvil~elltg----------~~pf~~~~~~ 710 (793)
+......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9866543322 12334689999999999775 234689999999999999999 6787654321
Q ss_pred HHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 711 ECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+.. ... ....+........ .+......+....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 274 ~~~--~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 274 DPS--VEE-MRKVVCEQKLRPN---IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp SCC--HHH-HHHHHTTSCCCCC---CCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc--HHH-HHHHHHHHHhCCC---CcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 110 001 1111111111111 1111123356678899999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.97 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=181.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 3478999999999999843 456789999986543 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 584 GSLADFLFR-------KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 584 gsL~~~l~~-------~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 999999964 345688999999999999999999998 9999999999999999999999999999765432
Q ss_pred CC----cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 657 QT----QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 657 ~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
.. .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... ..... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~~~-~~~ 246 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-------TLQND-PPS 246 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-------HHTSS-CCC
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-------HhccC-CCc
Confidence 21 11223468999999999876 5689999999999999999999999987654432111 11111 000
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.................+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000001112356789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.95 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=201.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 478999999999999854 467889999987543 334578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ .....
T Consensus 106 ~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 179 (303)
T 3a7i_A 106 SALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 179 (303)
T ss_dssp EHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCC
T ss_pred cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCcc
Confidence 99999854 4688999999999999999999998 999999999999999999999999999987654332 22334
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (793)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ......... ..
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~---------~~ 242 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI--------PKNNPPTLE---------GN 242 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCC---------SS
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh--------hcCCCCCCc---------cc
Confidence 6899999999999999999999999999999999999999876544322111 111111110 11
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 745 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+.+++..||+.||++|||+.+|++.
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 23457899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=330.61 Aligned_cols=243 Identities=23% Similarity=0.371 Sum_probs=201.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 478999999999999864 4577899999875432 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 125 ~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (335)
T 2owb_A 125 RRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 199 (335)
T ss_dssp TCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-ccc
Confidence 99999988654 4688999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... +.
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~-~~--------- 261 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEYS-IP--------- 261 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC-CC---------
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--------hcCCCC-CC---------
Confidence 356899999999999999999999999999999999999999876544322111 111111 00
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012245778999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=334.34 Aligned_cols=269 Identities=21% Similarity=0.256 Sum_probs=196.9
Q ss_pred HHHHHHHhcccc--cccccccceeEEEeEeCCCCceeEEEEEechhccc-----------chHHHHHHHHHHhcCCcccc
Q 003818 495 YKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-----------GEQEFKAEISAIGRTNHKNL 561 (793)
Q Consensus 495 ~~el~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~ni 561 (793)
..++....++|. +.||+|+||.||+|... .++.||||++...... ..+.+.+|+.++++++||||
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 344555555554 78999999999999853 3788999998653221 12678999999999999999
Q ss_pred ceeeeEEec-----CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 562 VQLLGFCNE-----GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 562 v~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
+++++++.. ....++||||++ |+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 999999843 346799999997 689999887777899999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI 715 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~ 715 (793)
+.++.+||+|||++........ .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999975443322 233458899999999877 6789999999999999999999999988765543322
Q ss_pred HHHHHH----------------HHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 716 LADWAY----------------DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 716 l~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+..... ..+.. ........ ............+.+++.+||+.||++|||++|+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRN-SLSNVPAR-AWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTT-CCCCCCCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHh-hcccCChh-hHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 211100 00000 00000000 0000111224568899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=347.38 Aligned_cols=248 Identities=27% Similarity=0.331 Sum_probs=199.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||++... .+++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 367999999999999864 467899999997643 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999999764 34688999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+.......
T Consensus 346 -~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~----~~i~~~~~~~-------- 412 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRVLEQAVTY-------- 412 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH----HHHHHCCCCC--------
T ss_pred -cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH----HHHhhcccCC--------
Confidence 233469999999999999999999999999999999999999998653211111111 1111111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAM-----KKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 772 (793)
+......+.+++.+||+.||++||++ ++|++
T Consensus 413 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 --PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 01123567889999999999999975 56653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=342.95 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=200.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 26 ~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 104 (486)
T 3mwu_A 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (486)
T ss_dssp EEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCC
Confidence 4578999999999999854 467889999996542 3345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++......
T Consensus 105 ~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 105 GGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 99999988655 4688999999999999999999998 999999999999995 56679999999998664432
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+ ..+.......
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~~~~----- 244 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ETGKYAFDLP----- 244 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCSCSG-----
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCCCc-----
Confidence 2233569999999999976 5899999999999999999999999877654422211 1121111111
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.||++|||+.++++.
T Consensus 245 -~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111223567899999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=357.38 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=201.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh---cccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|... .+++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+|||||
T Consensus 345 ~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence 3478999999999999965 46788999999764 233456788899999987 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 424 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~ 498 (674)
T 3pfq_A 424 VNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT 498 (674)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CC
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-cc
Confidence 9999999999765 4588999999999999999999998 99999999999999999999999999998643322 22
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~~p-------- 562 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNVAYP-------- 562 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HSSCCCCC--------
T ss_pred cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhCCCCCC--------
Confidence 34467999999999999999999999999999999999999999887655432221 22221110
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAM-----KKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 772 (793)
......+.+|+..||+.||++||++ +||++
T Consensus 563 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1123567889999999999999997 66654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.25 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=193.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV 577 (793)
.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred eEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 468999999999999854 467889999986532 223467889999999999999999999997653 45999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+ +++|.+++.. ..++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp EECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 9999 8899999865 4588899999999999999999998 9999999999999999999999999999865432
Q ss_pred CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH-------HHhhcc--
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY-------DCFRER-- 727 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~-------~~~~~~-- 727 (793)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+..... ..+...
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 233468999999999887 6799999999999999999999999987765443222211100 000000
Q ss_pred -----ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 003818 728 -----KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAV 778 (793)
Q Consensus 728 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~ 778 (793)
.+........ ..........+.+++.+||+.||++|||++|+++. ++...
T Consensus 259 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 259 KNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0000000000 00011224567899999999999999999999883 44433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=358.45 Aligned_cols=253 Identities=20% Similarity=0.335 Sum_probs=202.8
Q ss_pred cccccccccceeEEEeEeCCC--CceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTE--NEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|..... .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 457899999999999987532 356899999865432 33467899999999999999999999985 46789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++......+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 473 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 549 (656)
T 2j0j_A 473 TLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549 (656)
T ss_dssp TTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceec
Confidence 99999999987777789999999999999999999998 999999999999999999999999999987654443333
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ..+.....
T Consensus 550 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i--------~~~~~~~~-------- 613 (656)
T 2j0j_A 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPM-------- 613 (656)
T ss_dssp ----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HHTCCCCC--------
T ss_pred cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HcCCCCCC--------
Confidence 34457789999999998899999999999999999997 99999876554422111 11111111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 614 -~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 614 -PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1122356789999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.22 Aligned_cols=249 Identities=11% Similarity=0.041 Sum_probs=178.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHH---HHHhcCCccccceee-------eEEecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEI---SAIGRTNHKNLVQLL-------GFCNEG 571 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~~~~ 571 (793)
+.+.||+|+||.||+|... .+++.||+|++..... ...+.+++|+ ..|+. +||||++++ +++...
T Consensus 66 ~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEET
T ss_pred eeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecC
Confidence 3578999999999999864 4578999999976432 2345677784 45555 799988754 444332
Q ss_pred -----------------CceEEEEeecCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeeecC
Q 003818 572 -----------------EHRLLVYEYVSNGSLADFLFRKSRRPNWYKR------MQIAFGTARGLFYLHEECKSQIIHCD 628 (793)
Q Consensus 572 -----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH~D 628 (793)
...++||||++ ++|.+++......+.+..+ ..++.||++||+|||++ +|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 34799999998 8999999875444555666 78889999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCCCC
Q 003818 629 IKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNFEV 706 (793)
Q Consensus 629 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf~~ 706 (793)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865321 113457799999999987 6899999999999999999999999987
Q ss_pred CchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 707 DATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 707 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....... .+........................+.+++.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTT---------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCccccc---------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6432110 00000000000001111111123456889999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.71 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=198.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 468999999999999864 457889999987543 233467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++... ..+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++...... .....
T Consensus 117 ~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~ 190 (360)
T 3eqc_A 117 SLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 190 (360)
T ss_dssp BHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C----
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccCC
Confidence 999999664 3578899999999999999999983 17999999999999999999999999998754322 12234
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhc---------cccce----
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRE---------RKLGL---- 731 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~---------~~~~~---- 731 (793)
.||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+.......... .....
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270 (360)
T ss_dssp CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence 68999999999999999999999999999999999999998766544322110000000000 00000
Q ss_pred -------------eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 -------------LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 -------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.................+.+++.+||+.||++|||++|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000112356889999999999999999999886
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=343.38 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=195.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.+++.++|||||++++++.+....++||||++
T Consensus 41 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 119 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119 (494)
T ss_dssp EEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999854 457789999987643 3345778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT---FNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 659 (793)
+|+|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++.. +.+||+|||++.......
T Consensus 120 ~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 120 GGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 99999988654 4588899999999999999999998 99999999999999764 559999999998765432
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+....+ ..+....... .
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~~~~---~- 260 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--------EKGKYTFDSP---E- 260 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCCCSG---G-
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCCch---h-
Confidence 223356999999999986 46999999999999999999999999877655432211 1121111100 0
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||+.|+++
T Consensus 261 --~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 --WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1122356789999999999999999999885
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.96 Aligned_cols=189 Identities=24% Similarity=0.386 Sum_probs=149.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec-----CCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-----GEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~~lV 577 (793)
+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.++|||||++++++.. ....++|
T Consensus 57 ~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp ECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 3578999999999999854 467899999996532 2234678899999999999999999999843 3578999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+ +++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 136 LEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp ECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred Eecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 9998 57899988654 5689999999999999999999998 99999999999999999999999999998764322
Q ss_pred C--------------------------cceecccCcccccCcccc-cCCCCCCccceehhHHHHHHHHh
Q 003818 658 T--------------------------QTTTAIRGTKGYVAPEWF-KNLPITAKVDVYSFGILLLELVC 699 (793)
Q Consensus 658 ~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dvws~Gvil~ellt 699 (793)
. .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 1 122335689999999986 56679999999999999999999
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=344.87 Aligned_cols=247 Identities=25% Similarity=0.331 Sum_probs=202.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 30 ~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 108 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108 (484)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 4578999999999999854 467889999986542 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCCC
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 109 ~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 109 TGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 999999998654 4688999999999999999999998 99999999999999 5678999999999987654332
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.... +..+.......
T Consensus 185 --~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------i~~~~~~~~~~---- 249 (484)
T 3nyv_A 185 --MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK--------VEKGKYTFELP---- 249 (484)
T ss_dssp --HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCCCCSG----
T ss_pred --cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHcCCCCCCCc----
Confidence 233469999999999876 699999999999999999999999987765442221 11222111111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
........+.+++.+||+.||++|||+.|+++.
T Consensus 250 --~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 --QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111234567899999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=340.23 Aligned_cols=256 Identities=19% Similarity=0.248 Sum_probs=202.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc-cccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH-KNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.++||+|+||.||+|... .+++.||||++..... ..++.+|+.+++.++| ++++.+..++.+.+..+|||||+ +
T Consensus 11 i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp CCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 3478999999999999854 4578899998765432 3468899999999987 55666666778888999999999 9
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE---cCCCcEEEeecCCccccCCCCCc-
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
++|.+++......+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++.+......
T Consensus 87 ~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 999999987777899999999999999999999998 99999999999999 68899999999999876544322
Q ss_pred -----ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 660 -----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 660 -----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+.......+. ....
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----~~~~ 238 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-----TSIE 238 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-----SCHH
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-----ccHH
Confidence 122456999999999999999999999999999999999999999875443222222111111111 0000
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
. ........+.+++..||+.+|++||++++|+++|+.+
T Consensus 239 ~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 A-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 0012245788999999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.71 Aligned_cols=244 Identities=26% Similarity=0.409 Sum_probs=192.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 15 i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 15 LGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3478999999999999864 357789999986542 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++++|.+++... ..+++..+..++.|+++||.|||++ +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 94 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 167 (276)
T 2h6d_A 94 SGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--L 167 (276)
T ss_dssp CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred CCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc--e
Confidence 999999999654 4578899999999999999999999 999999999999999999999999999987654322 2
Q ss_pred ecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||......+.... +..+... . +
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~-~----~--- 231 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK--------IRGGVFY-I----P--- 231 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCC-C----C---
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH--------hhcCccc-C----c---
Confidence 23458999999999988765 6899999999999999999999987654432111 1111110 0 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||++||++.
T Consensus 232 --~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 --EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0122457889999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.87 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=193.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 93 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC 93 (289)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEec
Confidence 3478999999999999864 457889999987532 23456788899999998 9999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------------------C
Q 003818 582 SNGSLADFLFRK---SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-------------------T 639 (793)
Q Consensus 582 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-------------------~ 639 (793)
++++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+|||++. .
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 94 NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp TTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------C
T ss_pred CCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999754 35688999999999999999999998 9999999999999984 4
Q ss_pred CcEEEeecCCccccCCCCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 640 FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 640 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
..+||+|||++........ ..||+.|+|||.+.+. .+++++||||||+++|||++|..++.......
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~------- 238 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH------- 238 (289)
T ss_dssp CCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH-------
T ss_pred eEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH-------
Confidence 4799999999987654322 3489999999999776 66789999999999999999998775443211
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+..+....... .....+.+++.+||+.||++|||+.|+++
T Consensus 239 ----~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 ----EIRQGRLPRIPQ---------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHHTTCCCCCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHcCCCCCCCc---------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111222211111 12356789999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=340.68 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=187.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--------ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--------NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++||||+++++++.. +..++
T Consensus 139 ~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l 216 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYI 216 (419)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEE
T ss_pred EEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEE
Confidence 3578999999999999854 467889999986532 1122358899999999999999999999864 55799
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CcEEEeecCCcccc
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT---FNARISDFGLAKLL 653 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 653 (793)
||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+ ..+||+|||+++..
T Consensus 217 v~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 217 VLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 99999999999988654 5688999999999999999999998 99999999999999754 45999999999876
Q ss_pred CCCCCcceecccCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+..+...
T Consensus 293 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-------~~~i~~~~~~ 363 (419)
T 3i6u_A 293 GETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------KDQITSGKYN 363 (419)
T ss_dssp C-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-------HHHHHTTCCC
T ss_pred CCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-------HHHHhcCCCC
Confidence 5322 2334569999999999863 56788999999999999999999999765332211 0111112111
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .........+.+++.+||+.||++|||++|+++
T Consensus 364 ~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 364 FIP------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCc------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 110 001123456889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.75 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=198.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--------cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--------EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++......++
T Consensus 99 ~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred ceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 478999999999999864 3578899999865431 1135678899999998 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 178 v~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999654 4688999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceecccCcccccCcccccC------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKN------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
.. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+ ..+...
T Consensus 254 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~ 323 (365)
T 2y7j_A 254 EK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------MEGQYQ 323 (365)
T ss_dssp CC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC
T ss_pred cc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCC
Confidence 22 234568999999999863 35889999999999999999999999876544321111 111111
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. ..........+.+++.+||+.||++|||++|+++
T Consensus 324 ~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 324 FS------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CC------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0000112356789999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.76 Aligned_cols=256 Identities=22% Similarity=0.275 Sum_probs=192.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec---------------
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--------------- 570 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------------- 570 (793)
.+.||+|+||.||+|... .+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 12 ~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEEECC-CEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 478999999999999854 467899999986542 233479999999999999999999843
Q ss_pred -----------------------CCceEEEEeecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003818 571 -----------------------GEHRLLVYEYVSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624 (793)
Q Consensus 571 -----------------------~~~~~lV~Ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~i 624 (793)
....++||||++ ++|.+.+.. ....+++..+..++.||++||.|||++ +|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi 162 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GI 162 (383)
T ss_dssp -----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TE
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cC
Confidence 334889999998 588777753 456789999999999999999999988 99
Q ss_pred eecCCCCCCEEEc-CCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCc
Q 003818 625 IHCDIKPQNILLD-GTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRK 702 (793)
Q Consensus 625 vH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~ 702 (793)
+||||||+|||++ +++.+||+|||+++.+..... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 9999999999998 689999999999987644332 2334589999999998775 58999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHH-------Hhh----ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 703 NFEVDATEECQMILADWAYD-------CFR----ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 703 pf~~~~~~~~~~~l~~~~~~-------~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
||......+....+...... ... +......................+.+++.+||+.||++|||+.|++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 99887655433322211000 000 0000000000000001112345688999999999999999999997
Q ss_pred H
Q 003818 772 Q 772 (793)
Q Consensus 772 ~ 772 (793)
+
T Consensus 321 ~ 321 (383)
T 3eb0_A 321 A 321 (383)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.78 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=189.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV 577 (793)
.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred eeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence 478999999999999854 467889999986532 233467889999999999999999999997654 78999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||++ ++|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 109 ~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 109 MELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred EEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 99997 57888875 3478899999999999999999998 99999999999999999999999999998654322
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHH---------------HHH
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW---------------AYD 722 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~---------------~~~ 722 (793)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...
T Consensus 182 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred --ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 223356899999999999999999999999999999999999999876654322211100 000
Q ss_pred Hhhccc-cc-----eeec---ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERK-LG-----LLVE---NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~-~~-----~~~~---~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... .. .... ..............+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 00 0000 000011122335678999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=323.75 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=194.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEec--CCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNE--GEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|... .+++.||+|++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||||+
T Consensus 40 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEecccCCeEEEEEEEC-CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 3478999999999999854 45788999998643 3567899999999997 9999999999987 67789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCCcc
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 660 (793)
++++|.+++. .++...+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 116 ~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 116 NNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp CCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred CchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--
Confidence 9999999984 378889999999999999999998 999999999999999776 899999999986654332
Q ss_pred eecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHH-HHHHHHH-----HHHHhhccccce--
Q 003818 661 TTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEEC-QMILADW-----AYDCFRERKLGL-- 731 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~-~~~l~~~-----~~~~~~~~~~~~-- 731 (793)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+... ....+.......
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 233458999999999877 6789999999999999999999999965433221 1111100 001111000000
Q ss_pred ------------eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 732 ------------LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 732 ------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.................+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000111113467889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=343.84 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=197.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-------------cchHHHHHHHHHHhcCCccccceeeeEEecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-------------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE 572 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 572 (793)
.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 41 ~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 478999999999999864 4678899999865321 23467899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC---cEEEeecCC
Q 003818 573 HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF---NARISDFGL 649 (793)
Q Consensus 573 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgl 649 (793)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 999999999999999998654 4588999999999999999999998 999999999999998775 699999999
Q ss_pred ccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc
Q 003818 650 AKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729 (793)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (793)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+ ..+..
T Consensus 196 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~ 264 (504)
T 3q5i_A 196 SSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--------EKGKY 264 (504)
T ss_dssp CEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCC
T ss_pred CEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCC
Confidence 98765432 2233569999999999874 6899999999999999999999999887655432221 11211
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.... .........+.+++.+||+.||++|||++|+++.
T Consensus 265 ~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1100 0011223568899999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=318.58 Aligned_cols=246 Identities=27% Similarity=0.347 Sum_probs=195.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc----ccchHHHHHHHHHHhcCCccccceeeeEE--ecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNHKNLVQLLGFC--NEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~--~~~~~~~lV~ 578 (793)
+.+.||+|+||.||++.. ..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ .+.+..++||
T Consensus 9 i~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLD-SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCEEEECSSCEEEEEEB-TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred EeeEEecCCCeEEEEEEE-CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 347899999999999985 4567889999997643 23457899999999999999999999998 4556889999
Q ss_pred eecCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFR-KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
||++++ |.+++.. ....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp ECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred hhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999877 7777654 356688999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CcceecccCcccccCcccccCCC--CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 658 -TQTTTAIRGTKGYVAPEWFKNLP--ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 658 -~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......+....+ ..+.... .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i--------~~~~~~~-~- 233 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--------GKGSYAI-P- 233 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHCCCCC-C-
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH--------hcCCCCC-C-
Confidence 22233456899999999997654 377999999999999999999999876544322111 1111110 0
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
......+.+++.+||+.||++|||++|+++.
T Consensus 234 --------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 234 --------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0123467789999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=330.19 Aligned_cols=262 Identities=25% Similarity=0.361 Sum_probs=197.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|.... .||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred EeeEeccCCceEEEEEEEcC----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 34789999999999998642 49999986532 2334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC----C
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ----T 658 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~----~ 658 (793)
+++|.+++......+++..+..++.|+++||.|||++ +|+||||||+||+++ ++.+||+|||++....... .
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 9999999987777789999999999999999999998 999999999999998 6799999999987553221 1
Q ss_pred cceecccCcccccCcccccC---------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKN---------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~---------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (793)
.......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ...+..
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~ 260 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ--------MGTGMK 260 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH--------HHTTCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------hccCCC
Confidence 12223458899999999874 3578899999999999999999999987665432211 111111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC-CCCCCchhh
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS-IPPDPASFI 790 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~-~p~~p~~~~ 790 (793)
...... .....+.+++.+||+.||++|||+++|+++|+.+.... ..+.|..+.
T Consensus 261 ~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 261 PNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp CCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred CCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 111110 12235778999999999999999999999999876543 334444443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=335.02 Aligned_cols=198 Identities=23% Similarity=0.320 Sum_probs=169.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC------CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT------NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+..++||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 3478999999999999854 45789999999653 22345677788888776 5779999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc--EEEeecCCccccCC
Q 003818 579 EYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN--ARISDFGLAKLLKT 655 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~ 655 (793)
||+. ++|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++. +||+|||++.....
T Consensus 179 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 179 ELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp CCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred eccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9995 68999887654 4589999999999999999999999 9999999999999999887 99999999975433
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC 712 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~ 712 (793)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 255 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 255 R----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp C----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred c----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2 2234689999999999999999999999999999999999999988765543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=336.63 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=189.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~E 579 (793)
.+.||+|+||.||+|+.. .+++.||||++.... ..+.+|+.++++++|||||++++++... ...++|||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred eeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 478999999999999965 457889999986532 2345799999999999999999988432 23679999
Q ss_pred ecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-CcEEEeecCCccccCC
Q 003818 580 YVSNGSLADFLF---RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKT 655 (793)
Q Consensus 580 y~~~gsL~~~l~---~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~ 655 (793)
|+++ +|.+.+. .....+++..+..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9975 5666554 3456789999999999999999999998 99999999999999955 6689999999987644
Q ss_pred CCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHhh---cc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCFR---ER 727 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~~---~~ 727 (793)
... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.... ...+. ..
T Consensus 210 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 210 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 332 2234689999999998765 78999999999999999999999998876544322221110 00000 00
Q ss_pred ----ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 728 ----KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 728 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....+................+.+|+.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000000000001112356889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=334.30 Aligned_cols=194 Identities=25% Similarity=0.378 Sum_probs=161.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV 577 (793)
+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++... +..++|
T Consensus 30 ~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 3578999999999999854 467899999997532 23346789999999999999999999999776 578999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 109 ~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 99986 6999998654 5689999999999999999999998 99999999999999999999999999998765432
Q ss_pred Cc---------------------ceecccCcccccCcccc-cCCCCCCccceehhHHHHHHHHhCCcCC
Q 003818 658 TQ---------------------TTTAIRGTKGYVAPEWF-KNLPITAKVDVYSFGILLLELVCCRKNF 704 (793)
Q Consensus 658 ~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~~~Dvws~Gvil~elltg~~pf 704 (793)
.. ......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 11 22445789999999986 5667999999999999999999855444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.14 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=200.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccch-----------------HHHHHHHHHHhcCCccccceeeeE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-----------------QEFKAEISAIGRTNHKNLVQLLGF 567 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~-----------------~~~~~E~~~l~~l~H~niv~l~~~ 567 (793)
+.+.||+|+||.||+|.. +++.||+|++........ +.+.+|+.++++++||||++++++
T Consensus 35 ~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred EEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 347899999999999986 678999999976432211 789999999999999999999999
Q ss_pred EecCCceEEEEeecCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCC
Q 003818 568 CNEGEHRLLVYEYVSNGSLADF------LFRK-SRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGT 639 (793)
Q Consensus 568 ~~~~~~~~lV~Ey~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~ 639 (793)
+.+.+..++||||+++++|.++ +... ...+++..+..++.|++.||.|||+ . +|+|+||||+||+++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence 9999999999999999999998 5443 5678999999999999999999998 7 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCCcceecccCcccccCcccccCC-CCCC-ccceehhHHHHHHHHhCCcCCCCCch-hHHHHHH
Q 003818 640 FNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL-PITA-KVDVYSFGILLLELVCCRKNFEVDAT-EECQMIL 716 (793)
Q Consensus 640 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~Dvws~Gvil~elltg~~pf~~~~~-~~~~~~l 716 (793)
+.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||..... .+..
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 262 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF--- 262 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH---
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---
Confidence 99999999999865433 23345689999999999887 6666 99999999999999999999987654 2211
Q ss_pred HHHHHHHhhccccceeeccc---------chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 717 ADWAYDCFRERKLGLLVEND---------EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..+..+......... ............+.+++.+||+.||++|||++|+++
T Consensus 263 -----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 -----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111222111110000 000001223456889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.12 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=198.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---------ccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---------NEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 575 (793)
.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++...+..+
T Consensus 22 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 478999999999999864 467889999986532 122356789999999995 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence 999999999999999754 4688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcceecccCcccccCccccc------CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFK------NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (793)
... .....+++.|+|||++. ...++.++||||||+++|||++|+.||......+....+ ..+..
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 246 (298)
T 1phk_A 177 GEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MSGNY 246 (298)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCC
T ss_pred Ccc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH--------hcCCc
Confidence 322 23345899999999985 456889999999999999999999999876544322111 11111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.... .........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 QFGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1100 011123456889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=323.22 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=200.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc------cceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN------LVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|.....+++.||+|++... ....+.+.+|+.+++.++|++ ++++++++.+.+..++||
T Consensus 18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 96 (339)
T 1z57_A 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96 (339)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence 3578999999999999865667889999998653 233467889999999987765 999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-------------------
Q 003818 579 EYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG------------------- 638 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~------------------- 638 (793)
||+ +++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 97 e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 97 ELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred cCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 999 899999997654 4678999999999999999999998 9999999999999987
Q ss_pred CCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 639 TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 639 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+..
T Consensus 173 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp CCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred CCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 678999999999864432 2234689999999999999999999999999999999999999987765543222211
Q ss_pred HHH----HHhhccccceee-------cc---------------cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 719 WAY----DCFRERKLGLLV-------EN---------------DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 719 ~~~----~~~~~~~~~~~~-------~~---------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... ..+......... .. ...........+.+.+++.+||+.||++|||++||++
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 100 000000000000 00 0000011234577899999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.29 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=198.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcC---CccccceeeeEEe-----cCCce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRT---NHKNLVQLLGFCN-----EGEHR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~~~~ 574 (793)
+.+.||+|+||.||+|.....+++.||+|++..... .....+.+|+.+++.+ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 347899999999999997556778999999865432 2234567788777766 8999999999987 56788
Q ss_pred EEEEeecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcccc
Q 003818 575 LLVYEYVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 653 (793)
++||||++ ++|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred EEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 99999997 69999997653 4588999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhccc-
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRERK- 728 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~~- 728 (793)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+...... .+....
T Consensus 171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 171 SFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 4322 223356899999999999999999999999999999999999999877654432222111000 000000
Q ss_pred cc--eee--cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 LG--LLV--ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ~~--~~~--~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. ... ...............+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000 000000011123456789999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.96 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=191.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEec------CCceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNE------GEHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~ 578 (793)
.+.||+|+||.||+|... .+++.||+|++... ....+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEeccCCCEEEEEEEEC-CCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 478999999999999864 45788999998653 33457889999999998 89999999999976 56789999
Q ss_pred eecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
||+++++|.+++... ...++...+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 999999999999764 35688899999999999999999998 99999999999999999999999999998654322
Q ss_pred CcceecccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 658 TQTTTAIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
. ......||+.|+|||++. +..++.++||||||+++|||++|+.||......+....+ ........
T Consensus 184 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~ 254 (326)
T 2x7f_A 184 G-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNPAPRL 254 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCC
T ss_pred c-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--------hcCccccC
Confidence 1 122345899999999987 567899999999999999999999999766544322111 11111111
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. .......+.+++.+||+.||++|||++++++
T Consensus 255 ~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 255 K--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp S--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred C--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 0112356789999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.91 Aligned_cols=247 Identities=26% Similarity=0.317 Sum_probs=182.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||++... .+++.||+|++...... ..+.+.++...++.++||||+++++++.+++..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 3478999999999999854 46789999999764222 22344556666888999999999999999999999999997
Q ss_pred CCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
++|.+++.. ....+++..+..++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 588887754 466789999999999999999999984 28999999999999999999999999999866543222
Q ss_pred ceecccCcccccCcccc----cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 660 TTTAIRGTKGYVAPEWF----KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~----~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... + .......... ..
T Consensus 167 --~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~~~~~-~~-- 235 (290)
T 3fme_A 167 --DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--L----KQVVEEPSPQ-LP-- 235 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--H----HHHHHSCCCC-CC--
T ss_pred --cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--H----HHHhccCCCC-cc--
Confidence 223589999999996 5567899999999999999999999999764332211 1 1111111111 10
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||+.|+++
T Consensus 236 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 ------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0112356789999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.89 Aligned_cols=258 Identities=24% Similarity=0.271 Sum_probs=195.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC--------ccccceeeeEEe----cCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN--------HKNLVQLLGFCN----EGE 572 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~----~~~ 572 (793)
+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++. .+.
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 118 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT 118 (397)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred EEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence 3478999999999999854 46789999999653 234567889999999885 888999999987 567
Q ss_pred ceEEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-----------
Q 003818 573 HRLLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----------- 640 (793)
Q Consensus 573 ~~~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----------- 640 (793)
..++||||+ +++|.+++... ...+++..+..++.||++||.|||+++ +|+||||||+|||++.++
T Consensus 119 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 119 HICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred eEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 899999999 56666666543 467899999999999999999999852 899999999999999775
Q ss_pred --------------------------------------cEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCC
Q 003818 641 --------------------------------------NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682 (793)
Q Consensus 641 --------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 682 (793)
.+||+|||++...... .....||+.|+|||++.+..++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 271 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYN 271 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCC
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCC
Confidence 7999999999866433 2234589999999999999999
Q ss_pred CccceehhHHHHHHHHhCCcCCCCCchhHHH---HHHHHHHHHHhhc--------cc-----------cceeecccc---
Q 003818 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQ---MILADWAYDCFRE--------RK-----------LGLLVENDE--- 737 (793)
Q Consensus 683 ~~~Dvws~Gvil~elltg~~pf~~~~~~~~~---~~l~~~~~~~~~~--------~~-----------~~~~~~~~~--- 737 (793)
.++|||||||++|||++|+.||......+.. ..+. ........ +. ...+.....
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA-LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHH-HHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHH-HHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999765432110 0110 01111000 00 000000000
Q ss_pred ------hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 ------EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...........+.+|+.+||+.||++|||++||++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00113455678999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.55 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=180.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecC------CceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG------EHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 577 (793)
.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 34 ~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEECC----CCEEEEEET-TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 468999999999999854 567899999986532 23346788999999999999999999998654 567999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
+||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 113 THLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp EECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred eccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 9999 7899998854 5688999999999999999999998 9999999999999999999999999999865432
Q ss_pred CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhh---cc--
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFR---ER-- 727 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~---~~-- 727 (793)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..... ..+. ..
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 233568999999999877 6789999999999999999999999987765443322211100 0000 00
Q ss_pred -----ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 728 -----KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 728 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+........ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 263 RNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHTSCCCCCCCH-HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCCCCCCCH-HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000 00001123567899999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=333.29 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=180.2
Q ss_pred cccccccceeEEEeEeCC-CCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEe--cCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCN--EGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey~~~ 583 (793)
++||+|+||.||+|.... ..++.||+|++... .....+.+|+.++++++||||+++++++. .....++||||+.
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 579999999999998653 35788999998653 23457889999999999999999999994 4678999999996
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE----cCCCcEEEeecCCcc
Q 003818 584 GSLADFLFRK--------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL----DGTFNARISDFGLAK 651 (793)
Q Consensus 584 gsL~~~l~~~--------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 651 (793)
++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 5788777521 23488899999999999999999998 99999999999999 778999999999998
Q ss_pred ccCCCCC--cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHH------HHHHHHHHHH
Q 003818 652 LLKTDQT--QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEEC------QMILADWAYD 722 (793)
Q Consensus 652 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~------~~~l~~~~~~ 722 (793)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+.. ...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~-i~~ 259 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR-IFN 259 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH-HHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH-HHH
Confidence 7654322 223345689999999999874 589999999999999999999999976543210 001111 111
Q ss_pred Hhhccc---cceeec-------------ccchhhhhH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 723 CFRERK---LGLLVE-------------NDEEAMDDI--------KRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 723 ~~~~~~---~~~~~~-------------~~~~~~~~~--------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+.... ...+.. ......... .....+.+|+.+||+.||++|||++|+++.
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 110000 000000 000000000 013467899999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=331.16 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=190.7
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 578 (793)
+.+.||+|+||.||+|.... ++ .||+|++..... ...+|+.+++.++||||+++++++.... ..++||
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~-~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVE-SD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEETTEEEEEEEETT-TE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECC-CC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 34789999999999998653 33 489998854322 2347999999999999999999985443 378999
Q ss_pred eecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccccCC
Q 003818 579 EYVSNGSLADFLF--RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKT 655 (793)
Q Consensus 579 Ey~~~gsL~~~l~--~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~ 655 (793)
||++++.+..... .....+++..+..++.||++||.|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9998754444332 2356788999999999999999999998 999999999999999 899999999999987644
Q ss_pred CCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhh--
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFR-- 725 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~-- 725 (793)
... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.... .....
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 332 2234589999999998765 58999999999999999999999998876554333222110 00000
Q ss_pred --ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 726 --ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 726 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+......................+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 011111111000011111234578899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.18 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=188.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec-------------C
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-------------G 571 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------------~ 571 (793)
+.+.||+|+||.||+|... .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 10 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 3478999999999999854 45788999998653 3345678999999999999999999998754 4
Q ss_pred CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 572 EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 572 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
+..++||||+++++|.+++......+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred CceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 578999999999999999987766778889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCC-------------CcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHH
Q 003818 652 LLKTDQ-------------TQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILA 717 (793)
Q Consensus 652 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~ 717 (793)
...... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||....... .+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~---~~- 237 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV---NI- 237 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH---HH-
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH---HH-
Confidence 654321 1122334589999999999865 68999999999999999998 554322211 11
Q ss_pred HHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 718 DWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+........ . .........+.+++.+||+.||++|||++++++
T Consensus 238 ---~~~~~~~~~~~~--~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 238 ---LKKLRSVSIEFP--P----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHSTTCCCC--T----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHhccccccccC--c----cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111100 0 011123355788999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=327.75 Aligned_cols=261 Identities=24% Similarity=0.256 Sum_probs=197.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 579 (793)
.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.++.+++||||+++++++... ...++|+|
T Consensus 32 ~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 478999999999999854 4678899999975332 2346788999999999999999999999654 46899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+. ++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 111 ~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp CCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred ccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 997 5999988653 588999999999999999999998 9999999999999999999999999999876543222
Q ss_pred c--eecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhc---cc-
Q 003818 660 T--TTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRE---RK- 728 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~---~~- 728 (793)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...... .+.. ..
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 1 233568999999998754 45899999999999999999999999877655433222110000 0000 00
Q ss_pred ---cceeec--ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 ---LGLLVE--NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ---~~~~~~--~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... ..............+.+++.+||+.||++|||++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000001123568899999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.54 Aligned_cols=199 Identities=26% Similarity=0.355 Sum_probs=167.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-cc-----ccceeeeEEecCCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HK-----NLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lV~E 579 (793)
.+.||+|+||.||+|... .+++.||||++... .....++..|+.+++.++ |+ +|+++++++...+..++|||
T Consensus 59 ~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEEEETTEEEEEEEET-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 478999999999999854 46788999999653 223456778888888774 33 59999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCcEEEeecCCccccCCC
Q 003818 580 YVSNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD--GTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 580 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~ 656 (793)
|++ ++|.+++.... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 137 ~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~ 214 (382)
T 2vx3_A 137 MLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214 (382)
T ss_dssp CCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred cCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence 996 59999997654 5689999999999999999999953 34899999999999994 5788999999999876432
Q ss_pred CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC 712 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~ 712 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 215 ----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 215 ----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp ----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2234689999999999999999999999999999999999999987765543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.53 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=189.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEe--------------cC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCN--------------EG 571 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--------------~~ 571 (793)
.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++||||+++++++. +.
T Consensus 16 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEECC-----CEEEEEET-TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 468999999999999864 457899999987655555678899999999999999999999873 44
Q ss_pred CceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCc
Q 003818 572 EHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLA 650 (793)
Q Consensus 572 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla 650 (793)
...++||||++ |+|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 67899999997 699999854 4578899999999999999999998 999999999999997 5679999999999
Q ss_pred cccCCCCCc--ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------
Q 003818 651 KLLKTDQTQ--TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA------- 720 (793)
Q Consensus 651 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~------- 720 (793)
+........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 876433221 1223457899999998865 678999999999999999999999998776544322211100
Q ss_pred HHHhhccccceeec-----c-cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 721 YDCFRERKLGLLVE-----N-DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 721 ~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.. .+..... . .............+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 249 RQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 0000000 0 0000001123467889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=322.12 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=191.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--------ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--------NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++..++ .++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~l 91 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYI 91 (322)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred EeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEE
Confidence 4578999999999999854 467889999986532 112346889999999999999999999987655 899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecCCcccc
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKLL 653 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~ 653 (793)
||||+++++|.+++... ..+++.....++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 92 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 92 VLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 99999999999998654 5688999999999999999999998 9999999999999987665 999999999876
Q ss_pred CCCCCcceecccCcccccCccccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccc
Q 003818 654 KTDQTQTTTAIRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLG 730 (793)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (793)
.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.......... ..+..+...
T Consensus 168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~ 238 (322)
T 2ycf_A 168 GETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-------DQITSGKYN 238 (322)
T ss_dssp CCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH-------HHHHHTCCC
T ss_pred cccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH-------HHHHhCccc
Confidence 4322 223345899999999974 5678999999999999999999999997654321110 111111111
Q ss_pred eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. +. ........+.+++.+||+.||++|||+.++++
T Consensus 239 ~~----~~--~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FI----PE--VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC----HH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC----ch--hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 10 00 01123456889999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.42 Aligned_cols=256 Identities=19% Similarity=0.270 Sum_probs=192.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCce------EEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHR------LLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------~lV 577 (793)
.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 47 ~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 468999999999999854 4678999999975422 2346788999999999999999999999877665 999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+. ++|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 126 MPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp EECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred Ecccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 99997 68888773 3488999999999999999999998 9999999999999999999999999999765432
Q ss_pred CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH-------HHhhccc-
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY-------DCFRERK- 728 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~-------~~~~~~~- 728 (793)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..... ..+....
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 233458999999999887 6889999999999999999999999987765443222211000 0000000
Q ss_pred ---cceeecccch--hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 ---LGLLVENDEE--AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 ---~~~~~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.......... ..........+.+++.+||+.||++|||++|+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000 00011224678899999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.72 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=198.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc------cceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN------LVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|.....+++.||+|++... ....+.+.+|+.++++++|++ ++.+++++...+..++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T 2eu9_A 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence 3478999999999999876655688999999653 234567888999999998776 899999999999999999
Q ss_pred eecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE-------------------cC
Q 003818 579 EYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL-------------------DG 638 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll-------------------~~ 638 (793)
||+ +++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.
T Consensus 102 e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 102 ELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred ecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccC
Confidence 999 66777776554 35689999999999999999999998 99999999999999 67
Q ss_pred CCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHH
Q 003818 639 TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILAD 718 (793)
Q Consensus 639 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~ 718 (793)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+..
T Consensus 178 ~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp CCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8899999999998644322 234689999999999999999999999999999999999999987665443222211
Q ss_pred HHH----HHhhccccce-ee------ccc---------------chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 719 WAY----DCFRERKLGL-LV------END---------------EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 719 ~~~----~~~~~~~~~~-~~------~~~---------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... ..+....... .. ... ............+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 100 0000000000 00 000 000111233557889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.36 Aligned_cols=260 Identities=21% Similarity=0.254 Sum_probs=195.2
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 579 (793)
.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++... ...++|||
T Consensus 16 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred eeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 478999999999999864 457899999996432 22345788999999999999999999988654 67899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+. ++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 95 ~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 95 LMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp CCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred ccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 997 689998865 4688999999999999999999998 9999999999999999999999999999876532211
Q ss_pred ---------ceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc-
Q 003818 660 ---------TTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK- 728 (793)
Q Consensus 660 ---------~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~- 728 (793)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+............
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 1122468999999998764 67899999999999999999999999877654332221110000000000
Q ss_pred --------------cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 729 --------------LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 729 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
+....... ...........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYPAAP-LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhHHhhcccCCCCcc-hhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000011234567899999999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.81 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=198.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 26 i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (287)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccC
Confidence 4578999999999999854 457789999986543 2345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC---CcEEEeecCCccccCCCCCc
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT---FNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 659 (793)
+++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.+ +.+||+|||++........
T Consensus 105 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~- 179 (287)
T 2wei_A 105 GGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179 (287)
T ss_dssp SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence 99999988654 3578999999999999999999998 99999999999999754 4699999999986644322
Q ss_pred ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 660 TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
.....+++.|+|||.+.+ .++.++||||||+++|||++|+.||......+.... +..+.......
T Consensus 180 -~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~----- 244 (287)
T 2wei_A 180 -MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR--------VETGKYAFDLP----- 244 (287)
T ss_dssp -CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCCCCSG-----
T ss_pred -cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCCCCch-----
Confidence 223347899999999876 489999999999999999999999987654432111 11222111110
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
........+.+++.+||+.||++|||+.|+++
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 01122356789999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.88 Aligned_cols=260 Identities=22% Similarity=0.235 Sum_probs=183.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCc-------eEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH-------RLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------~~lV~ 578 (793)
.+.||+|+||.||+|... .+++.||||++.... .....+.+|+..+..++||||+++++++..... .++||
T Consensus 28 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp C----------CEEEEET-TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 478999999999999864 457889999986542 233456778888899999999999999865433 78999
Q ss_pred eecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccc
Q 003818 579 EYVSNGSLADFLF---RKSRRPNWYKRMQIAFGTARGLFYLH--EECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKL 652 (793)
Q Consensus 579 Ey~~~gsL~~~l~---~~~~~~~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 652 (793)
||+++ +|.+.+. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 99976 5544443 34567888999999999999999999 66 9999999999999997 89999999999987
Q ss_pred cCCCCCcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHh
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCF 724 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~ 724 (793)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.... ...+
T Consensus 182 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 182 LSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 654332 2334589999999998665 48999999999999999999999998876554332222110 0000
Q ss_pred hccccc--eeecccch-----hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 725 RERKLG--LLVENDEE-----AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 725 ~~~~~~--~~~~~~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
...... ........ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 00000000 00011235678999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.79 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=169.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec----CCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE----GEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~ 582 (793)
+.||+|+||.||+|... .+++.||+|++... .....+....+..++||||+++++++.. +...++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHR-RTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEEC-CCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999865 45788999998653 1222333344567799999999999876 455899999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCCC
Q 003818 583 NGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 583 ~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~ 658 (793)
+|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++.......
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 999999998654 4689999999999999999999998 9999999999999976 4559999999998654322
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.....+|+.|+|||++.+..++.++||||||+++|||++|+.||............ ...+....... .
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~---~--- 253 (336)
T 3fhr_A 186 --LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----KRRIRLGQYGF---P--- 253 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC---C---
T ss_pred --cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----HHhhhcccccc---C---
Confidence 22345899999999998888999999999999999999999999765433211110 00011111000 0
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ--MIEGA 777 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~Le~~ 777 (793)
..........+.+++.+||+.||++|||++|+++ .+...
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0001123456789999999999999999999998 44443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=317.36 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=191.7
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCc------eEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH------RLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV 577 (793)
.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.+++.++||||+++++++..... .++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 468999999999999854 4678999999865322 234678899999999999999999999987654 4999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+. ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 108 ~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 108 MPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp EECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred ecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 99997 68887764 3488999999999999999999998 9999999999999999999999999999765432
Q ss_pred CcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH-------HHHhhcc--
Q 003818 658 TQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA-------YDCFRER-- 727 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~-------~~~~~~~-- 727 (793)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... ...+...
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 223458999999999877 678999999999999999999999998766543322211100 0000000
Q ss_pred -----ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 728 -----KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 728 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.+........ ..........+.+++.+||+.||++|||++++++.
T Consensus 257 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 257 KSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 00011234678899999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=327.66 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=182.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+.||+|+||+||.+.. .+++.||||++... ..+.+.+|+.++.++ +|||||++++++.+++..++||||+. |
T Consensus 20 ~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGS--FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 36799999999976432 35789999998653 235678899999876 89999999999999999999999995 6
Q ss_pred CHHHHHhcCCCCC------CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCC-------------CcEEEe
Q 003818 585 SLADFLFRKSRRP------NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGT-------------FNARIS 645 (793)
Q Consensus 585 sL~~~l~~~~~~~------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl~ 645 (793)
+|.+++....... .+..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 9999997653221 2334578999999999999998 99999999999999754 489999
Q ss_pred ecCCccccCCCCCc---ceecccCcccccCcccccC-------CCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHH
Q 003818 646 DFGLAKLLKTDQTQ---TTTAIRGTKGYVAPEWFKN-------LPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQM 714 (793)
Q Consensus 646 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~ 714 (793)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 99999876544322 1223569999999999975 578999999999999999999 8999976543321
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+ .. +.... ..............+.+++.+||+.||++|||+.+|++
T Consensus 249 ~i---~~-----~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NI---IR-----GIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH---HH-----TCCCC---CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH---hc-----CCCCc---ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 11 11100 00111123345677899999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=326.80 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=182.9
Q ss_pred ccccccccceeEE-EeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVY-KGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy-~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||+|+ ++. .+++.||||++..... ..+.+|+.+++++ +|||||++++++.+.+..++||||+.
T Consensus 29 ~~~LG~G~~G~V~~~~~---~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGM---FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEECGGGCEEEEEE---SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred CCeeecCcCEEEEEEEE---eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 4689999999954 443 2567899999865322 3457899999998 89999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----CCcEEEeecCCccccCCCCC
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-----TFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~~~~~ 658 (793)
|+|.+++..............++.||++||.|||++ +|+||||||+|||++. ...+||+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 699999987766666667789999999999999998 9999999999999943 34688999999987654322
Q ss_pred --cceecccCcccccCccccc---CCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 659 --QTTTAIRGTKGYVAPEWFK---NLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ..........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~~~~~~~~~~ 250 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LLGACSLDCL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------HTTCCCCTTS
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------HhccCCcccc
Confidence 2233456999999999997 4567889999999999999999 899996554332111 1111111100
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.........+.+++.+||+.||++|||++||++
T Consensus 251 -------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 -------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 011223445788999999999999999999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=320.83 Aligned_cols=258 Identities=25% Similarity=0.316 Sum_probs=192.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-----------ccccceeeeEEecCC-
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-----------HKNLVQLLGFCNEGE- 572 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~~- 572 (793)
+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.++++++ |+||+++++++...+
T Consensus 23 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 100 (373)
T 1q8y_A 23 LVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100 (373)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence 4578999999999999854 46789999998643 223467888999998876 899999999987654
Q ss_pred ---ceEEEEeecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc------CCCcE
Q 003818 573 ---HRLLVYEYVSNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD------GTFNA 642 (793)
Q Consensus 573 ---~~~lV~Ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~------~~~~~ 642 (793)
..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+++ +|+||||||+|||++ ..+.+
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~ 177 (373)
T 1q8y_A 101 NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQI 177 (373)
T ss_dssp TEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred CCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceE
Confidence 789999999 99999999764 455889999999999999999999842 899999999999994 44579
Q ss_pred EEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHH---HHHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC---QMILADW 719 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~---~~~l~~~ 719 (793)
||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+...
T Consensus 178 kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 178 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 999999998664322 234589999999999999999999999999999999999999986542211 0111111
Q ss_pred HHHHhhc--------cc-----------cceeecc---c------chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 720 AYDCFRE--------RK-----------LGLLVEN---D------EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 720 ~~~~~~~--------~~-----------~~~~~~~---~------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
. ..+.. ++ ....... . ............+.+++.+||+.||++|||++||+
T Consensus 254 ~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 254 I-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp H-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred H-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 0 10000 00 0000000 0 00011245667889999999999999999999998
Q ss_pred H
Q 003818 772 Q 772 (793)
Q Consensus 772 ~ 772 (793)
+
T Consensus 333 ~ 333 (373)
T 1q8y_A 333 N 333 (373)
T ss_dssp T
T ss_pred h
Confidence 7
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.97 Aligned_cols=245 Identities=20% Similarity=0.327 Sum_probs=188.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCC--ccccceeeeEEecCCceEEEEeec
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTN--HKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++ |+||+++++++.+.+..++||| +
T Consensus 33 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 109 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 109 (313)
T ss_dssp EEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence 478999999999999864 47789999986532 234467899999999997 4999999999999999999999 5
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-c
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-T 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 660 (793)
.+++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||+++ +.+||+|||++......... .
T Consensus 110 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~ 184 (313)
T 3cek_A 110 GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV 184 (313)
T ss_dssp CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---------
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccccc
Confidence 688999999765 4678889999999999999999998 9999999999999975 89999999999876543322 1
Q ss_pred eecccCcccccCcccccC-----------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccc
Q 003818 661 TTAIRGTKGYVAPEWFKN-----------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (793)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..........
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~~~ 258 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------LHAIIDPNHE 258 (313)
T ss_dssp -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH------HHHHHCTTSC
T ss_pred ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH------HHHHHhcccc
Confidence 223458999999999875 46888999999999999999999999765332111 1111111111
Q ss_pred ceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..... .....+.+++.+||+.||++|||++||++.
T Consensus 259 ~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCCCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcc---------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11100 012467889999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.33 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=176.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc--chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||||++...... ..+.+.++..+++.++||||+++++++.+++..++||||+ +
T Consensus 30 ~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred cceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 468999999999999864 45778999999764322 2234455566788899999999999999999999999999 5
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+.+..+.......+++..+..++.|+++||.|||+ . +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 108 ~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 182 (318)
T 2dyl_A 108 TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KD 182 (318)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--cc
Confidence 56666665556678999999999999999999998 5 899999999999999999999999999976544322 22
Q ss_pred cccCcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 663 AIRGTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
...+|+.|+|||.+. ...++.++||||||+++|||++|+.||......... + ...... .......
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~~~-~~~~~~~--- 252 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--L----TKVLQE-EPPLLPG--- 252 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HHHHHS-CCCCCCS---
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--H----HHHhcc-CCCCCCc---
Confidence 345899999999994 456889999999999999999999999864332211 1 111111 1111100
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||.+|||+++|++
T Consensus 253 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 ----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112346788999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.85 Aligned_cols=249 Identities=26% Similarity=0.344 Sum_probs=172.6
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHH-HHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEIS-AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||.||+|... .+++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp -CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred hheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 367999999999999864 4678999999976432 23345555655 77788999999999999999999999999975
Q ss_pred CCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 584 GSLADFLFR----KSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 584 gsL~~~l~~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
+|.+++.. ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 181 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA- 181 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc-
Confidence 88877753 356788999999999999999999984 2899999999999999999999999999986643322
Q ss_pred ceecccCcccccCcccc----cCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 660 TTTAIRGTKGYVAPEWF----KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 660 ~~~~~~gt~~y~aPE~~----~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
.....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... ... ...+....+..
T Consensus 182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~-~~~~~~~~~~~- 252 (327)
T 3aln_A 182 -KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQ-VVKGDPPQLSN- 252 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC-CCCSCCCCCCC-
T ss_pred -cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHH-HhcCCCCCCCC-
Confidence 2223589999999998 4567899999999999999999999999764322100 000 01111111100
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.........+.+++.+||+.||++|||+.+|++
T Consensus 253 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 ----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001123456889999999999999999999865
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.02 Aligned_cols=210 Identities=18% Similarity=0.284 Sum_probs=163.1
Q ss_pred ccCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcE
Q 003818 20 QSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQL 99 (793)
Q Consensus 20 ~~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l 99 (793)
++.|+|.+|++|.+++ +| ++|.|+|||+.+++. .+ |.. +|+||+|||+.| .++.|+|+.||||
T Consensus 6 ~~~~~i~~g~~L~~g~-----~l--~~g~f~l~f~~~gnl----~l-y~~---~~~vW~an~~~~--~~~~l~l~~dGnL 68 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ-----SL--ELSSFRFTMQSDCNL----VL-FDS---DVRVWASNTAGA--TGCRAVLQSDGLL 68 (236)
T ss_dssp CSSSSSCSCSCCCTTC-----EE--CSTTEEEEECTTSCE----EE-EES---SSEEECCCCCSC--SCCBCCBCSSSCB
T ss_pred eccceeCCCCEECCCC-----EE--EcCCEEEEECCCCcE----EE-EEC---CEEEEECCCCCC--CCeEEEEcCCCcE
Confidence 4569999999998866 77 599999999877652 23 433 799999999988 6789999999999
Q ss_pred EEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCCCcc----------cCCccccCC-ceEEEec
Q 003818 100 ILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTL----------LPTQVMSQG-TKVIARL 166 (793)
Q Consensus 100 ~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtl----------lp~~~l~~~-~~L~s~~ 166 (793)
||+|++|++||+|++.. ....|+|+|+|||||++. ++||||||||||+ +|||+++.+ ++|+
T Consensus 69 vl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~--- 142 (236)
T 1dlp_A 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLH--- 142 (236)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEEC---
T ss_pred EEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEE---
Confidence 99999999999997643 235799999999999954 8999999998665 666665543 3566
Q ss_pred CCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccccCCc-ceeEEecccceEEEEecCCeeEEEEeeccccCcc
Q 003818 167 TETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGS-GYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQD 245 (793)
Q Consensus 167 s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (793)
+..||++|.|+++++++|+++++.. . ..||+++++.+. .....++.+|.++++..++..+++++.. ...
T Consensus 143 s~~d~s~G~~~l~l~~dG~LvL~~~--~-----~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~--~~~- 212 (236)
T 1dlp_A 143 ATQSLQLSPYRLSMETDCNLVLFDR--D-----DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS--RSA- 212 (236)
T ss_dssp SSCCCBCSSCEEEEETTTEEEEEBT--T-----BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC--CSS-
T ss_pred cCcEeecCcEEEEECCCCcEEEEcC--C-----EeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCC--CCC-
Confidence 4788999999999999998777643 1 579999987532 2345667788877777667666665532 122
Q ss_pred eEEEEEEcCCCcEEEEE
Q 003818 246 FYQRAVVDPDGVFRHYI 262 (793)
Q Consensus 246 ~~~r~~l~~~G~l~~~~ 262 (793)
..+|++|++||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 35899999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.13 Aligned_cols=237 Identities=25% Similarity=0.425 Sum_probs=193.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc------chHHHHHHHHHHhcCC--ccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE------GEQEFKAEISAIGRTN--HKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|+.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+..++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l 125 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125 (320)
T ss_dssp EEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence 3578999999999999854 46789999999764322 2356778999999986 5999999999999999999
Q ss_pred EEeecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccccC
Q 003818 577 VYEYVSN-GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLK 654 (793)
Q Consensus 577 V~Ey~~~-gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~ 654 (793)
|+|++.+ ++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++ +++.+||+|||+++...
T Consensus 126 v~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 126 ILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 9999986 8999999764 4678899999999999999999998 999999999999999 78999999999998765
Q ss_pred CCCCcceecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceee
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLV 733 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (793)
... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ..... .
T Consensus 202 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~~~~--~ 262 (320)
T 3a99_A 202 DTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQVF--F 262 (320)
T ss_dssp SSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCCC--C
T ss_pred ccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------ccccc--c
Confidence 432 223458999999999987765 678999999999999999999997542110 01110 0
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
. ......+.+++.+||+.||++|||++||++.
T Consensus 263 ~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 R--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp S--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0123467889999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.60 Aligned_cols=237 Identities=26% Similarity=0.394 Sum_probs=187.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc------cchHHHHHHHHHHhcC----CccccceeeeEEecCCce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------EGEQEFKAEISAIGRT----NHKNLVQLLGFCNEGEHR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~~~~~~~~~ 574 (793)
+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++.++ +||||+++++++...+..
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~ 113 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGF 113 (312)
T ss_dssp EEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----C
T ss_pred EeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeE
Confidence 4578999999999999854 4678899999965432 1223456788888888 899999999999999999
Q ss_pred EEEEee-cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccc
Q 003818 575 LLVYEY-VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKL 652 (793)
Q Consensus 575 ~lV~Ey-~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~ 652 (793)
++|+|| +.+++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++ +++.+||+|||++..
T Consensus 114 ~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 114 MLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp EEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 999999 7899999999764 4588999999999999999999999 999999999999999 899999999999987
Q ss_pred cCCCCCcceecccCcccccCcccccCCCCC-CccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPIT-AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
..... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....... .....
T Consensus 190 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------~~~~~- 251 (312)
T 2iwi_A 190 LHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------------EAELH- 251 (312)
T ss_dssp CCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HTCCC-
T ss_pred cccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------------hhccC-
Confidence 65432 2334589999999999877664 58999999999999999999997532110 00000
Q ss_pred eecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 732 LVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 732 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
. .......+.+++.+||+.||++|||++|+++.
T Consensus 252 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 252 F---------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01123457889999999999999999999973
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=333.99 Aligned_cols=259 Identities=24% Similarity=0.269 Sum_probs=193.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh-cccchHHHHHHHHHHhcCCccccceeeeEEec------CCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE------GEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lV 577 (793)
+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 18 i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 4578999999999999854 46788999998654 23335678999999999999999999998765 6788999
Q ss_pred EeecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc---EEEeecCCccc
Q 003818 578 YEYVSNGSLADFLFRKS--RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKL 652 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~ 652 (793)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999997643 3588889999999999999999998 9999999999999997665 99999999987
Q ss_pred cCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHH-HHHHH-HHHHhh----c
Q 003818 653 LKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM-ILADW-AYDCFR----E 726 (793)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~-~l~~~-~~~~~~----~ 726 (793)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+... ...... .
T Consensus 174 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 174 LDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp TTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred cccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 654332 233568999999999999999999999999999999999999997653321100 00000 000000 0
Q ss_pred cccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003818 727 RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKK 769 (793)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 769 (793)
+.....................+.+++..||+.||++|||+++
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000000000111234567899999999999999999966
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=299.85 Aligned_cols=226 Identities=15% Similarity=0.076 Sum_probs=178.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhccc---chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|... .+++.||+|++...... ..+.+.+|+..+.+++||||+++++++.+++..++||||++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecC
Confidence 478999999999999854 45789999999765332 23678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+++|.+++... ....+..+++.|++.||.|||++ +|+||||||+|||+++++.+||++++
T Consensus 115 g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred CCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 99999999532 45667889999999999999998 99999999999999999999997443
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
|++ +++.++||||||+++|||++|+.||......+.... .......... ......
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------~~~~~~~~~~--~~~~~~ 229 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------AERDTAGQPI--EPADID 229 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------CCBCTTSCBC--CHHHHC
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------HHHHhccCCC--Chhhcc
Confidence 333 368899999999999999999999987543220000 0000000000 000111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
......+.+++.+||+.||++| |+.|+++.|+...
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 1234568899999999999999 9999999998744
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=337.36 Aligned_cols=235 Identities=23% Similarity=0.340 Sum_probs=188.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCc-----eEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEH-----RLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lV~ 578 (793)
+.+.||+|+||.||+|.....+++.||||++.... ......+.+|+.++++++||||+++++++...+. .+|||
T Consensus 84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 34789999999999998765467899999986532 2334678899999999999999999999987665 69999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++++ .+||+|||+++.....
T Consensus 164 E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp ECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred EeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence 99999999987744 689999999999999999999998 99999999999999986 9999999999866433
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....||+.|+|||++.+.. +.++|||||||++|||++|..||....... + ..
T Consensus 235 ---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~----~~ 286 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L----PE 286 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C----CT
T ss_pred ---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------c----cc
Confidence 3346899999999987654 889999999999999999988876432110 0 01
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPA-MKKVTQMIEG 776 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~Le~ 776 (793)
..........+.+++.+||+.||++||+ ++++.+.|.+
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 1112233456889999999999999995 5666665543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.54 Aligned_cols=230 Identities=19% Similarity=0.260 Sum_probs=177.7
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHH-hcCCccccceeeeEEec----CCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAI-GRTNHKNLVQLLGFCNE----GEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~Ey~ 581 (793)
+.||+|+||.||++... .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEc-CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 56999999999999854 4678999999854 24567888887 66799999999999876 67889999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCC
Q 003818 582 SNGSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 582 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~ 657 (793)
++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999998753 4689999999999999999999998 9999999999999998 7889999999986432
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
+..++.++||||||+++|||++|+.||......+... ...........
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~~~~~~~~~~~ 219 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMKTRIRMGQY 219 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------CSCCSSCTTCC
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------HHHHHHhhccc
Confidence 2346789999999999999999999997654332100 00000000000
Q ss_pred --hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCC
Q 003818 738 --EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAVDV 780 (793)
Q Consensus 738 --~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~ 780 (793)
...........+.+++.+||+.||++|||++|+++. +......
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 000111235678899999999999999999999973 4444333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.73 Aligned_cols=234 Identities=16% Similarity=0.150 Sum_probs=173.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCc-ccccee---------e-------
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNH-KNLVQL---------L------- 565 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l---------~------- 565 (793)
.+.||+|+||.||+|... .+++.||||++..... ...+.+++|+.+++.++| +|...+ .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 468999999999999954 4577999999874322 235789999999999977 221111 1
Q ss_pred -----eEEec-----CCceEEEEeecCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 003818 566 -----GFCNE-----GEHRLLVYEYVSNGSLADFLF------RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDI 629 (793)
Q Consensus 566 -----~~~~~-----~~~~~lV~Ey~~~gsL~~~l~------~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 629 (793)
.+... ....+++|+++ +++|.+++. .....+++..++.++.|+++||.|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 11111 12346666655 789999884 2234466778899999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccc----------cCCCCCCccceehhHHHHHHHHh
Q 003818 630 KPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF----------KNLPITAKVDVYSFGILLLELVC 699 (793)
Q Consensus 630 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~Dvws~Gvil~ellt 699 (793)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998765432 334457 999999999 55568899999999999999999
Q ss_pred CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003818 700 CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771 (793)
Q Consensus 700 g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 771 (793)
|+.||......+... ....... ..++.+.+++.+||+.||++|||+.+++
T Consensus 313 g~~Pf~~~~~~~~~~----------------~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGGSE----------------WIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSCSG----------------GGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhhHH----------------HHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999998654332111 0111000 1125688999999999999999976653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=303.21 Aligned_cols=237 Identities=15% Similarity=0.140 Sum_probs=177.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--------ccchHHHHHHHHHHhcCC---------cccccee---
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--------NEGEQEFKAEISAIGRTN---------HKNLVQL--- 564 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l--- 564 (793)
+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ |||||++
T Consensus 24 ~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp TCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred heeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 357899999999999986 46899999997642 122377889999988886 5555554
Q ss_pred --------------eeEEec-------------CCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003818 565 --------------LGFCNE-------------GEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617 (793)
Q Consensus 565 --------------~~~~~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH 617 (793)
++++.+ .+..++||||+++|++.+.+.+ ..+++..+..++.||+.||.|||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 444443 7889999999999977776643 56789999999999999999999
Q ss_pred -hcCCCCeeecCCCCCCEEEcCCC--------------------cEEEeecCCccccCCCCCcceecccCcccccCcccc
Q 003818 618 -EECKSQIIHCDIKPQNILLDGTF--------------------NARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676 (793)
Q Consensus 618 -~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 676 (793)
++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++
T Consensus 179 ~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 179 ASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred HhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence 88 999999999999999887 8999999999866432 23589999999999
Q ss_pred cCCCCCCccceehhHHH-HHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHH
Q 003818 677 KNLPITAKVDVYSFGIL-LLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIW 755 (793)
Q Consensus 677 ~~~~~s~~~Dvws~Gvi-l~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 755 (793)
.+.. +.++||||++++ .+++++|..||....... .+ ........... ..............+.+|+.+
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~---~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YL---TDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HH---HHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhh---HH---HHhhhhhhccC----cccchhhhhhcCHHHHHHHHH
Confidence 8776 889999998777 778899999884321100 01 11111111111 111112233566789999999
Q ss_pred ccccCCCCCCCHHHHH
Q 003818 756 CIQEDPSLRPAMKKVT 771 (793)
Q Consensus 756 Cl~~dP~~RPt~~evl 771 (793)
||+.| |++|++
T Consensus 319 ~L~~d-----sa~e~l 329 (336)
T 2vuw_A 319 MLNFS-----SATDLL 329 (336)
T ss_dssp GGGSS-----SHHHHH
T ss_pred HhccC-----CHHHHH
Confidence 99976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-28 Score=283.26 Aligned_cols=186 Identities=19% Similarity=0.123 Sum_probs=129.8
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhc----------ccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV----------NEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
.++.|++|.+.++. ....|+.+++|.+.+.. ....++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 241 ~~~~~~~~~h~~~r-r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSR-RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCE-EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccc-cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45667776665543 22346779999986531 22346799999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCC
Q 003818 577 VYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 656 (793)
||||++|++|.++|.+.+ .++. .+|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999997653 3443 35899999999999999 9999999999999999999999999999876544
Q ss_pred CCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcC
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~p 703 (793)
.. ......||+.|||||++.+ .+..++|+|++|++++++.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 33 2334679999999999976 467789999999999988765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.7e-25 Score=250.60 Aligned_cols=182 Identities=18% Similarity=0.235 Sum_probs=145.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 577 (793)
.+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 341 ~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 36899999999999964 356788887643211 1134589999999999999999777777788888999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||+++ .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999965 568999999999999998 9999999999999999 99999999999775432
Q ss_pred Ccc------eecccCcccccCcccccC--CCCCCccceehhHHHHHHHHhCCcCC
Q 003818 658 TQT------TTAIRGTKGYVAPEWFKN--LPITAKVDVYSFGILLLELVCCRKNF 704 (793)
Q Consensus 658 ~~~------~~~~~gt~~y~aPE~~~~--~~~s~~~Dvws~Gvil~elltg~~pf 704 (793)
... .....||+.|||||++.. ..|+..+|+|+..+-..+.+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 221 234579999999999987 56888899999998888887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=204.53 Aligned_cols=141 Identities=15% Similarity=0.080 Sum_probs=114.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc------------------cchHHHHHHHHHHhcCCccccceeeeE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------------------EGEQEFKAEISAIGRTNHKNLVQLLGF 567 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 567 (793)
.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.++++++ | +++.++
T Consensus 95 ~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred cCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 47899999999999996 5678999999864321 12456889999999999 5 677775
Q ss_pred EecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeec
Q 003818 568 CNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDF 647 (793)
Q Consensus 568 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 647 (793)
+.. +..++||||+++++|.+ +.. .....++.|+++||.|||+. +|+||||||+|||++ ++.+||+||
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred Eec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 543 66799999999999988 421 23457999999999999998 999999999999999 999999999
Q ss_pred CCccccCCCCCcceecccCcccccCcccccC
Q 003818 648 GLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678 (793)
Q Consensus 648 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 678 (793)
|+++. +..++|||++..
T Consensus 237 G~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHHH
Confidence 99963 345789998754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-20 Score=165.56 Aligned_cols=107 Identities=17% Similarity=0.378 Sum_probs=91.5
Q ss_pred ccCCccCCCCceeecCCCCCCeee--cCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCC
Q 003818 20 QSSSNISLGSSLTASNDNPAASWI--SQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDG 97 (793)
Q Consensus 20 ~~~~~~~~~~~l~~~~~~~~~~l~--S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g 97 (793)
++.++|.+|++|.+++ +|+ |++|.|+|+|+.+|+ + +||++ +++||+||++.| ..++.++|..||
T Consensus 6 ~~~~~l~~g~~L~~g~-----~l~~~S~~g~~~L~~~~dgn--l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dG 71 (119)
T 1b2p_A 6 SKQPDDNHPQILHATE-----SLEILFGTHVYRFIMQTDCN--L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDG 71 (119)
T ss_dssp CSCSSSCCCCEEETTC-----EEEEEETTEEEEEEECTTSC--E---EEEET---TEEEEECCCTTS-CSSCEEEECTTS
T ss_pred ecCcccCCCCEEcCCC-----EEEEeCCCCCEEEEEecCCC--E---EEEEC---CEEEEeCCCccC-CCceEEEEccCC
Confidence 3469999999999877 899 999999999998876 2 57875 799999999876 446789999999
Q ss_pred cEEEECCCCCeeecCCCC--CccceeeEecCcCEEEEecCCCceeeec
Q 003818 98 QLILRDSSGKEIWREPPS--TGAAYAAMLDTGNLVLASQDSSTMWESF 143 (793)
Q Consensus 98 ~l~l~~~~~~~~Wst~~~--~~~~~~~lld~GNlvl~~~~~~~~WqSF 143 (793)
||||+|.++.++|+|.+. .+...++|+|+|||||++ .++|||-
T Consensus 72 NLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg 116 (119)
T 1b2p_A 72 VLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQ 116 (119)
T ss_dssp CEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECC
T ss_pred EEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCCC
Confidence 999999999999999654 334579999999999998 3899983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.5e-20 Score=160.78 Aligned_cols=103 Identities=21% Similarity=0.433 Sum_probs=88.4
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
.|+|.+||.|.+++ +|+| |.|.|.|+.+|+ |.++. ..++||+|||++|....+.|.|+.||||||
T Consensus 1 kn~L~~g~~L~~g~-----~L~s--g~y~l~~q~DgN----Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL 65 (105)
T 4h3o_A 1 RNILDNNEGLYAGQ-----SLDV--EPYHFIMQDDCN----LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVV 65 (105)
T ss_dssp CCEECTTEEECTTC-----EEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEE
T ss_pred CCCcCCCCEEcCCC-----EEEE--CCEEEEECCCCe----EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEE
Confidence 37899999998876 8988 889999988875 55543 368999999999998889999999999999
Q ss_pred ECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeee
Q 003818 102 RDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWES 142 (793)
Q Consensus 102 ~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqS 142 (793)
+|+++++||+|+++. ....|+|+|+|||||++. .||||
T Consensus 66 ~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 66 YDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp ECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred ECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 999999999997643 345799999999999964 69998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=161.52 Aligned_cols=108 Identities=19% Similarity=0.415 Sum_probs=91.5
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
+|+|.+|+.|.+++ +|+ ++|.|+|+|+.+|+ . |+|. .+++||+||++.| ..++.+.|..||||||
T Consensus 1 ~d~l~~g~~L~~g~-----~l~-~~~~~~l~~~~dGn--l---vl~~---~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl 65 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH-----SLE-VGPSYRLIMQGDCN--F---VLYD---SGKPVWASNTGGL-GSGCRLTLHNNGNLVI 65 (110)
T ss_dssp CCEEETTCEECTTC-----EEE-ETTTEEEEECTTSC--E---EEEE---TTEEEEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECCCC-----EEE-ECCCEEEEEcCCCc--E---EEEE---CCEEEEECCCCCC-CCcEEEEEeCCCCEEE
Confidence 48899999998776 899 99999999988876 2 5676 3799999999876 3457899999999999
Q ss_pred ECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCC
Q 003818 102 RDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPT 147 (793)
Q Consensus 102 ~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Pt 147 (793)
+|.++.++|+|.+.. +...++|+|+|||||++. .+||||+||.
T Consensus 66 ~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 66 YDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred ECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 999999999997543 345799999999999975 7999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-19 Score=158.83 Aligned_cols=108 Identities=18% Similarity=0.423 Sum_probs=90.8
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
.|||.+||+|.+++ +|+ +|.|+|+|+.+|+ +. +|. .+++||+||++.| ..++.|.|+.+|||||
T Consensus 2 ~dtl~~gq~L~~g~-----~L~--~g~~~L~~~~dgn--lv---ly~---~~~~vW~sn~~~~-~~~~~l~l~~~GnLvl 65 (115)
T 2dpf_A 2 DNVLLSGQTLHADH-----SLQ--AGAYTLTIQNKCN--LV---KYQ---NGRQIWASNTDRR-GSGCRLTLLSDGNLVI 65 (115)
T ss_dssp CCEEETTCEEETTE-----EEE--ETTEEEEECTTSC--EE---EEE---TTEEEEECSCTTS-CSSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECCCC-----EEE--CCCEEEEEcCCCc--EE---EEe---CCEEEEeCCCCCC-CCceEEEECCCCcEEE
Confidence 48999999999876 788 7999999987765 33 354 4899999999988 3467899999999999
Q ss_pred ECCCCCeeecCCCC--CccceeeEecCcCEEEEecCCCceeeeccCCCC
Q 003818 102 RDSSGKEIWREPPS--TGAAYAAMLDTGNLVLASQDSSTMWESFDDPTD 148 (793)
Q Consensus 102 ~~~~~~~~Wst~~~--~~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptd 148 (793)
+|.++.++|+|... .+...++|+|+|||||++. ++||||.+++.
T Consensus 66 ~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 66 YDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred ECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 99999999999764 2345799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=154.84 Aligned_cols=108 Identities=18% Similarity=0.493 Sum_probs=90.3
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
+|||.+||+|.+++ +| ++|.|+|+|+.+|+ . +||.+ +++||+||++.+ ..++.+.|..+|||||
T Consensus 1 tdtl~~gq~L~~g~-----~L--~~~~~~L~~~~dgn--l---vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl 64 (112)
T 1xd5_A 1 SDRLNSGHQLDTGG-----SL--AEGGYLFIIQNDCN--L---VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTC-----EE--EETTEEEEECTTSC--E---EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEE
T ss_pred CCCCCCCCEECCCC-----EE--eCCCEEEEEcCCCc--E---EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEE
Confidence 48999999998776 78 57999999998886 2 35654 699999999763 3457899999999999
Q ss_pred ECCCCCeeecCCCC--CccceeeEecCcCEEEEecCCCceeeeccCC
Q 003818 102 RDSSGKEIWREPPS--TGAAYAAMLDTGNLVLASQDSSTMWESFDDP 146 (793)
Q Consensus 102 ~~~~~~~~Wst~~~--~~~~~~~lld~GNlvl~~~~~~~~WqSFd~P 146 (793)
+| ++.++|+|.+. .+...++|+++|||||++..+.++||||++.
T Consensus 65 ~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 65 YS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred Ec-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 99 88899998653 2345799999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=148.11 Aligned_cols=103 Identities=17% Similarity=0.403 Sum_probs=85.4
Q ss_pred CccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEEE
Q 003818 23 SNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILR 102 (793)
Q Consensus 23 ~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l~ 102 (793)
+||.+||.|.+++ +|+ +|.|+|+|+.+|+ ..| |.. .++||+||++.+ ..++.|.|..||||||+
T Consensus 2 ntL~~gq~L~~g~-----~L~--~g~~~L~~q~dGn--Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~ 65 (109)
T 3dzw_A 2 NILYSGETLSPGE-----FLN--NGRYVFIMQEDCN--LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVY 65 (109)
T ss_dssp CEEETTEEECTTC-----EEE--ETTEEEEECTTSC--EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEE
T ss_pred CCcCCCCEeCCCC-----EEE--CCCEEEEEcCCCc--EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEE
Confidence 6899999998766 786 7999999988875 444 654 699999999876 44578999999999999
Q ss_pred CCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeecc
Q 003818 103 DSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFD 144 (793)
Q Consensus 103 ~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd 144 (793)
|.++.++|+|++... ...|+|+|+|||||++. ++|||--
T Consensus 66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~t 106 (109)
T 3dzw_A 66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATGT 106 (109)
T ss_dssp CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCCC
Confidence 999999999976432 35799999999999984 8999843
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=171.21 Aligned_cols=135 Identities=19% Similarity=0.190 Sum_probs=103.7
Q ss_pred cccccccccceeEEEeEeCCCCcee--EEEEEechhccc------------------------chHHHHHHHHHHhcCCc
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKP--VAVKKLYKAVNE------------------------GEQEFKAEISAIGRTNH 558 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~H 558 (793)
+.+.||+|+||.||+|... .+|+. ||||+++..... ....+.+|+..+.+++|
T Consensus 51 i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3468999999999999862 24667 999986542111 11367899999999998
Q ss_pred ccc--ceeeeEEecCCceEEEEeecCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCC
Q 003818 559 KNL--VQLLGFCNEGEHRLLVYEYVSN-G----SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH-EECKSQIIHCDIK 630 (793)
Q Consensus 559 ~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlk 630 (793)
+++ +.++++ +..+|||||+.+ | +|.++... .++.....++.|++.||.||| +. +|+|||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 864 334432 467899999942 3 77776532 124467789999999999999 87 99999999
Q ss_pred CCCEEEcCCCcEEEeecCCcccc
Q 003818 631 PQNILLDGTFNARISDFGLAKLL 653 (793)
Q Consensus 631 p~NIll~~~~~~kl~Dfgla~~~ 653 (793)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-16 Score=139.32 Aligned_cols=103 Identities=18% Similarity=0.320 Sum_probs=83.3
Q ss_pred ccCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcE
Q 003818 20 QSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQL 99 (793)
Q Consensus 20 ~~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l 99 (793)
.+.|||.+||.|.+++ +|+| |.|.|-|...|+ |.+ |.. ++||++|++.. ..++.|.|..||||
T Consensus 4 ~~~dtL~~gq~L~~g~-----~L~s--g~~~L~~q~dGn----Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNL 66 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDG-----RLTA--KNHQLVMQGDCN----LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGEL 66 (110)
T ss_dssp CBTTEEETTCEEETTE-----EEEC--SSCEEEECTTSC----EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCE
T ss_pred cccCEECCCCEecCCC-----EEEe--CCEEEEEcCCCe----EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcE
Confidence 3579999999998776 8998 569998876664 333 544 48999999862 34578999999999
Q ss_pred EEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeee
Q 003818 100 ILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWES 142 (793)
Q Consensus 100 ~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqS 142 (793)
||+|.++.++|+|++.. +...|+|+|+|||||++ ..+|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 99999999999997643 33689999999999998 489987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-15 Score=135.10 Aligned_cols=105 Identities=13% Similarity=0.240 Sum_probs=85.6
Q ss_pred cCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEE
Q 003818 21 SSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLI 100 (793)
Q Consensus 21 ~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~ 100 (793)
+.|+|.+||.|..++ .|.+ |.|.|-|..+|+ |.++.. ...++||.+|+..+ ..+..|.|..|||||
T Consensus 5 ~~~tL~~gq~L~~g~-----~L~~--g~~~L~~q~dGN----LvL~~~--~~~~~vWssnt~~~-~~~~~l~l~~dGNLV 70 (113)
T 3mez_B 5 VRNVLFSSQVMYDNA-----QLAT--RDYSLVMRDDCN----LVLTKG--SKTNIVWESGTSGR-GQHCFMRLGHSGELD 70 (113)
T ss_dssp CSSEEETTCEEETTC-----EEEE--TTEEEEECTTSC----EEEEET--TTTEEEEECCCTTS-CSSCEEEECTTSCEE
T ss_pred cCCEeCCCCEECCCC-----EeEc--CCEEEEEcCCCE----EEEEEC--CCCEEEEECCcccC-CcCEEEEEeCCCcEE
Confidence 569999999998766 7864 899999987775 444332 14789999999865 345789999999999
Q ss_pred EECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeee
Q 003818 101 LRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWES 142 (793)
Q Consensus 101 l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqS 142 (793)
|+|.++.++|+|++.. +...|+|+|+|||||++ ..+|+|
T Consensus 71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 9999999999997643 33689999999999997 589997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=134.76 Aligned_cols=88 Identities=25% Similarity=0.531 Sum_probs=73.4
Q ss_pred CCCceEEEecCCcEEEECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEE
Q 003818 86 QRGSKVELTGDGQLILRDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVI 163 (793)
Q Consensus 86 ~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~ 163 (793)
+....|.|+.||||||++ .+++||++++... ...++|+|+|||||++.++.++||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t------------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT------------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC-------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC-------------------
Confidence 345789999999999998 5789999986432 358999999999999988899999993
Q ss_pred EecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCccccccccc
Q 003818 164 ARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTS 208 (793)
Q Consensus 164 s~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~ 208 (793)
++++|.|++.|+++|++++|.. .||++++.
T Consensus 79 ------~~~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~ 108 (110)
T 3a0c_A 79 ------NGKEDHYVLVLQQDRNVVIYGP---------VVWATGSG 108 (110)
T ss_dssp ------CCSSSCCEEEECTTSCEEEECS---------EEEECSCC
T ss_pred ------CCCCCCEEEEEeCCccEEEECC---------CEecCCCc
Confidence 4477999999999999887631 59998764
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.8e-15 Score=132.31 Aligned_cols=100 Identities=23% Similarity=0.515 Sum_probs=81.6
Q ss_pred cCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEE
Q 003818 21 SSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLI 100 (793)
Q Consensus 21 ~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~ 100 (793)
|.|||.+||.|..++ +| .+|.|.|.|+.+|+ .-+ |.. +|.+|+..+ ..+..|+|+.|||||
T Consensus 2 ~~dtL~~gq~L~~g~-----~L--~~g~~~L~~q~dGN--Lvl---~~~------~Wssnt~~~-~~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEG-----HL--KNGDFDLVMQDDCN--LVL---YNG------NWQSNTANN-GRDCKLTLTDYGELV 62 (109)
T ss_dssp CCSEEETTCEECTTC-----EE--EETTEEEEECTTSC--EEE---ETT------TEECCCTTS-CSSCEEEECTTSCEE
T ss_pred ccCCcCCCCCcCCCC-----Ee--ECCCEEEEEecCCe--EEE---EeC------eEEcCCCCC-CCcEEEEEcCCCeEE
Confidence 569999999998766 77 57999999987775 222 432 699998764 346789999999999
Q ss_pred EECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeee
Q 003818 101 LRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWES 142 (793)
Q Consensus 101 l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqS 142 (793)
|+|.++.++|++++.. ....|+|+|+|||||++ ..+|+|
T Consensus 63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s 103 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI 103 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence 9999999999997643 23579999999999997 689998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=129.57 Aligned_cols=91 Identities=30% Similarity=0.592 Sum_probs=75.4
Q ss_pred CCceEEEecCCcEEEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEE
Q 003818 87 RGSKVELTGDGQLILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIA 164 (793)
Q Consensus 87 ~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s 164 (793)
....|.|+.||||||++. +++||++++.. ....|+|+|+|||||++ ++.++||||++
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~------------------- 77 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTN------------------- 77 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCC-------------------
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCcc-------------------
Confidence 346899999999999987 78999998643 24689999999999999 77899999953
Q ss_pred ecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccccCC
Q 003818 165 RLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIG 210 (793)
Q Consensus 165 ~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~~~ 210 (793)
|++|.|++.|+++|++++|... ..+||+++++.|
T Consensus 78 ------~~~g~~~l~l~~dGnlvl~~~~------~~~~W~S~~~~g 111 (112)
T 1xd5_A 78 ------RQNGNYYLILQRDRNVVIYDNS------NNAIWATHTNVG 111 (112)
T ss_dssp ------CSCCCCEEEECTTSCEEEECTT------SCEEEECCCCCC
T ss_pred ------CCCCCEEEEEeCCCcEEEECCC------CceEEECCCccC
Confidence 4678999999999998887521 368999998765
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=128.61 Aligned_cols=84 Identities=29% Similarity=0.514 Sum_probs=71.4
Q ss_pred ceEEEecCCcEEEECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEec
Q 003818 89 SKVELTGDGQLILRDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARL 166 (793)
Q Consensus 89 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~ 166 (793)
..|.|..||||||++. +++||++++... ...++|+|+|||||++.++.++||||.
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~---------------------- 88 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV---------------------- 88 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCC----------------------
Confidence 5688899999999987 789999986432 368999999999999988999999993
Q ss_pred CCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 167 TETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 167 s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
+|++|.|++.|+++|+++++. ..||++++
T Consensus 89 ---~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~ 117 (119)
T 1b2p_A 89 ---AGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ---CCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ---CCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence 457899999999999987764 26998876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=7.5e-15 Score=158.19 Aligned_cols=135 Identities=13% Similarity=0.055 Sum_probs=93.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc--------------chHHH--------HHHHHHHhcCCccccc
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE--------------GEQEF--------KAEISAIGRTNHKNLV 562 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~--------------~~~~~--------~~E~~~l~~l~H~niv 562 (793)
+.+.||+|+||.||+|.. .+|+.||||+++..... ..... .+|...|.++.+.++.
T Consensus 99 I~~~IG~Gk~a~VY~a~d--~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVAD--EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp EEEEEEECSSEEEEEEEC--TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ecCEeeeCCceEEEEEEC--CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457899999999999985 35789999987542110 01112 2344555555433322
Q ss_pred eeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC--
Q 003818 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-- 640 (793)
Q Consensus 563 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 640 (793)
...-+ .....+|||||+++++|..+.. ......++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 177 vp~p~--~~~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPI--AQSRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEE--EEETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCeee--eccCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 11111 1123479999999988866432 123456889999999999998 999999999999998776
Q ss_pred --------cEEEeecCCcccc
Q 003818 641 --------NARISDFGLAKLL 653 (793)
Q Consensus 641 --------~~kl~Dfgla~~~ 653 (793)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=9.7e-14 Score=124.01 Aligned_cols=89 Identities=21% Similarity=0.476 Sum_probs=74.4
Q ss_pred CceEEEecCCcEEEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEe
Q 003818 88 GSKVELTGDGQLILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR 165 (793)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~ 165 (793)
...|.+..||||||++ .+++||++++.. ....++|+++|||||++.++.++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC-------------------
Confidence 4678889999999998 578999998643 235899999999999998888999999984
Q ss_pred cCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccccCCc
Q 003818 166 LTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSIGS 211 (793)
Q Consensus 166 ~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~~~~ 211 (793)
++|.|++.|+++|+++++.. .||++++|...
T Consensus 81 ------~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~~~~ 111 (115)
T 2dpf_A 81 ------DNGKYALVLQKDGRFVIYGP---------VLWSLGPNGCR 111 (115)
T ss_dssp ------SSSCCEEEECTTSCEEEECS---------EEECSSTTCBC
T ss_pred ------CCCCEEEEEeCCCeEEEECC---------CEEECCCCCCc
Confidence 56889999999999888631 69999988543
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-13 Score=120.57 Aligned_cols=101 Identities=18% Similarity=0.342 Sum_probs=79.9
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
.|+|.+||.|.+++ .| .+|.|.|.|..+|+ .-| |.. .. ||.+|+..+ .....+.|..||||||
T Consensus 2 ~~~l~~gq~L~~g~-----~L--~~g~~~L~~q~dGn--Lvl---~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl 64 (111)
T 3mez_A 2 NNVLLTGDVIHTDN-----QL--SYESAAFVMQGDCN--LVL---YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEI 64 (111)
T ss_dssp TTEEETTCEECTTC-----EE--EETTEEEEECTTSC--EEE---ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred cCEeCCCCEeCCCC-----EE--ecCCEEEEEccCCe--EEE---ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEE
Confidence 48899999998766 77 36999999987775 322 432 23 999999876 3457899999999999
Q ss_pred ECCCCC-eeecCCCC----CccceeeEecCcCEEEEecCCCceeee
Q 003818 102 RDSSGK-EIWREPPS----TGAAYAAMLDTGNLVLASQDSSTMWES 142 (793)
Q Consensus 102 ~~~~~~-~~Wst~~~----~~~~~~~lld~GNlvl~~~~~~~~WqS 142 (793)
+|.++. ++|+|++. .....++|+|+|||||++ ..+|+|
T Consensus 65 ~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 65 HSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp ECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 998876 59998742 134579999999999997 689988
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=109.50 Aligned_cols=87 Identities=22% Similarity=0.418 Sum_probs=69.4
Q ss_pred CCceEEEecCCcEEEECC-CCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEE
Q 003818 87 RGSKVELTGDGQLILRDS-SGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVI 163 (793)
Q Consensus 87 ~~~~l~~~~~g~l~l~~~-~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~ 163 (793)
....|.++.||||||++. .+.++|++++.. ....++|+++|||||++.++.++|||-.+-
T Consensus 24 g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~----------------- 86 (113)
T 3mez_B 24 RDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG----------------- 86 (113)
T ss_dssp TTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC-----------------
T ss_pred CCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC-----------------
Confidence 346899999999999998 588999998643 245899999999999998888999983210
Q ss_pred EecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 164 ARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 164 s~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
..|.|.+.|+.+|++++|. .+.|++++
T Consensus 87 --------~~~~~~~~L~~dGnlvly~---------~~~W~s~~ 113 (113)
T 3mez_B 87 --------QEGDYVLILQINGQAVVYG---------PAVWSTAA 113 (113)
T ss_dssp --------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred --------CCCCEEEEEcCCceEEEec---------CCEecCCC
Confidence 2356899999999999984 35787653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.8e-11 Score=106.92 Aligned_cols=86 Identities=22% Similarity=0.403 Sum_probs=68.9
Q ss_pred CceEEEecCCcEEEECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCC-ceeeeccCCCCcccCCccccCCceEEE
Q 003818 88 GSKVELTGDGQLILRDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSS-TMWESFDDPTDTLLPTQVMSQGTKVIA 164 (793)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~-~~WqSFd~Ptdtllp~~~l~~~~~L~s 164 (793)
...|.++.||||||++.++ +|++++... ...++|+++|||||++.++. ++|||..+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 4688999999999999877 999976432 36899999999999998766 59999621
Q ss_pred ecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 165 RLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 165 ~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
.....|.|.+.|+.+|++++|. .++|++++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1114478999999999999984 46898876
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.8e-11 Score=105.90 Aligned_cols=86 Identities=29% Similarity=0.489 Sum_probs=69.2
Q ss_pred CceEEEecCCcEEEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEe
Q 003818 88 GSKVELTGDGQLILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR 165 (793)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~ 165 (793)
...|.|+.||||||++. ++++|++++.. ....++|+++|||||++.++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 46789999999999987 68999998643 246889999999999998888999984321
Q ss_pred cCCCCCCcceEEEEEecCCceEEeeccCCCCCCCccccccccc
Q 003818 166 LTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTS 208 (793)
Q Consensus 166 ~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~ 208 (793)
..+.|.+.|+.+|++++|. .+.|++++.
T Consensus 80 ------~~~~~~~~L~ddGNlvly~---------~~~W~s~t~ 107 (109)
T 3dzw_A 80 ------ENGNYVCVLQKDRNVVIYG---------TARWATGTN 107 (109)
T ss_dssp ------SSSCEEEEECTTSCEEEEE---------SCCCCCCCC
T ss_pred ------CCCCEEEEEeCCCEEEEEC---------CCEEeCCCc
Confidence 2356889999999999985 257887763
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.6e-11 Score=103.64 Aligned_cols=84 Identities=24% Similarity=0.489 Sum_probs=66.8
Q ss_pred CceEEEecCCcEEEECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEe
Q 003818 88 GSKVELTGDGQLILRDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR 165 (793)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~ 165 (793)
+-.|.++.||||||++. +++|++++... ...++|+|+|||||++.++.++|||..+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 46788999999999987 58999986432 35889999999999998889999984321
Q ss_pred cCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 166 LTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 166 ~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
..|.|.+.|+.+|++++|. .+.|++++
T Consensus 84 ------~~~~~~~~L~~dGNlvly~---------~~~W~t~~ 110 (110)
T 3r0e_B 84 ------KQGEYVLILQDDGFGVIYG---------PAIFETSS 110 (110)
T ss_dssp ------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred ------CCCCEEEEEcCCccEEEec---------CCEecCCC
Confidence 2345889999999999985 35787653
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.2e-10 Score=120.29 Aligned_cols=111 Identities=14% Similarity=0.384 Sum_probs=84.0
Q ss_pred ccCCccCCCCc----eeecCCCCCCeeecCCCeEEeeeeec---CCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEE
Q 003818 20 QSSSNISLGSS----LTASNDNPAASWISQSGDFAFGFRQV---GDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVE 92 (793)
Q Consensus 20 ~~~~~~~~~~~----l~~~~~~~~~~l~S~~g~F~lgF~~~---~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~ 92 (793)
..+||+.||+. |..++ .|+|+ ..++.|+|.. .+++++| |.+ ..+++|.+++.++- ...+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~-----~L~S~-~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~--~~~l~ 200 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGS-----ELVQG-VVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKG--AVRAV 200 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSE-----EECTT-CEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTT--CCEEE
T ss_pred ccccccccccccccccccCc-----ccccC-CCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCc--cEEEE
Confidence 46799999999 65444 67553 5666665443 2334554 432 26899999998762 26889
Q ss_pred EecCCcEEEECCCCCeeecCCCCC-ccceeeEecCcCEEEEecCCCceeeeccC
Q 003818 93 LTGDGQLILRDSSGKEIWREPPST-GAAYAAMLDTGNLVLASQDSSTMWESFDD 145 (793)
Q Consensus 93 ~~~~g~l~l~~~~~~~~Wst~~~~-~~~~~~lld~GNlvl~~~~~~~~WqSFd~ 145 (793)
++.+|||+++|.++.++|++.+.. ....|+|+++|||||++. ..+||||||
T Consensus 201 l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 201 FQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp ECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred EcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 999999999999889999997543 346899999999999986 689999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.8e-10 Score=117.65 Aligned_cols=137 Identities=14% Similarity=0.035 Sum_probs=107.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
...++.|+.+.||+... .+..+++|+...........+.+|+.+++.+. |..+.+++++..+.+..++||||++|.
T Consensus 19 ~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 45678888899999763 25679999987543233456899999999884 677889999999888999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE--------------------------------------------- 619 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 619 (793)
+|.+.+. +......++.+++++|..||+.
T Consensus 96 ~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 96 LCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp EHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred ehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 9987631 1223457888999999999981
Q ss_pred -----------CCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 620 -----------CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 620 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876667799999874
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.99 E-value=1.4e-09 Score=110.43 Aligned_cols=76 Identities=24% Similarity=0.441 Sum_probs=62.0
Q ss_pred CceEEEecCCcEEEECCCCCeeecCCCCC-ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEec
Q 003818 88 GSKVELTGDGQLILRDSSGKEIWREPPST-GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARL 166 (793)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~-~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~ 166 (793)
.-.|.|..||||+|++. +++||.++... ....++|+++|||||+|.++.++|+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~-------------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG-------------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC--------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc--------------------
Confidence 35677778999999886 78999997643 356789999999999999899999998651
Q ss_pred CCCCCCcceEEEEEecCCceEEe
Q 003818 167 TETNYSSGRFMFELQTDGNLLLY 189 (793)
Q Consensus 167 s~~dps~G~~~~~~~~~g~~~l~ 189 (793)
++|.|.+.|+.+|+++++
T Consensus 86 -----~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 86 -----SIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp -----CSSCCEEEECSSSCEEEE
T ss_pred -----cCCcEEEEEeCCCCEEEe
Confidence 345678899999998887
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.3e-09 Score=95.85 Aligned_cols=83 Identities=20% Similarity=0.424 Sum_probs=66.2
Q ss_pred CceEEEecCCcEEEECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEe
Q 003818 88 GSKVELTGDGQLILRDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR 165 (793)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~ 165 (793)
...|.++.||||||+++ +|+|++... ...++|+++|||||++.++.++|+|-..
T Consensus 22 ~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~-------------------- 77 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ-------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC--------------------
T ss_pred CEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc--------------------
Confidence 45789999999999984 799986532 3578999999999999888899976210
Q ss_pred cCCCCCCcceEEEEEecCCceEEeeccCCCCCCCccccccccc
Q 003818 166 LTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTS 208 (793)
Q Consensus 166 ~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~ 208 (793)
...+.|.+.++.+|++++|. .+.|+++++
T Consensus 78 -----~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~ 106 (109)
T 3r0e_A 78 -----SVKGNYAAVVHPDGRLVVFG---------PSVFKIDPW 106 (109)
T ss_dssp -----CSSSCCEEEEETTTEEEEEC---------SEEEEECTT
T ss_pred -----CCCcCEEEEEcCCCeEEEEe---------cCEECCCCc
Confidence 02357889999999999984 457988876
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.96 E-value=2.1e-09 Score=93.73 Aligned_cols=76 Identities=25% Similarity=0.534 Sum_probs=61.5
Q ss_pred ceEEEecCCcEEEECCCCCeeecCCCCC---ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEe
Q 003818 89 SKVELTGDGQLILRDSSGKEIWREPPST---GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR 165 (793)
Q Consensus 89 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~---~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~ 165 (793)
-.|.+..||||||++. +++||++++.. .+..+.|+++|||||+|.++.++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 4688999999999985 57899997642 3457899999999999999999998721
Q ss_pred cCCCCCCcceEEEEEecCCceEEee
Q 003818 166 LTETNYSSGRFMFELQTDGNLLLYT 190 (793)
Q Consensus 166 ~s~~dps~G~~~~~~~~~g~~~l~~ 190 (793)
....|.|.+.|+.+|++++|.
T Consensus 79 ----~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 79 ----TRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp ----CCCSSCEEEEECTTSCEEEEE
T ss_pred ----CCCCCCEEEEEeCCCeEEEEC
Confidence 113467899999999999983
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.87 E-value=3.6e-09 Score=108.87 Aligned_cols=130 Identities=15% Similarity=0.076 Sum_probs=96.5
Q ss_pred ccc-cccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeeeEEecCCceEEEEeecCCC
Q 003818 508 ELG-EGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 508 ~LG-~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++ .|..+.||+... .+++.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.
T Consensus 26 ~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 100 (264)
T ss_dssp ECSCTTSSCEEEEEEC--TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred ecccCCCCceEEEEec--CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence 344 555699999764 34567999987543 2356788999998886544 556888888888899999999998
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC-------------------------------------------- 620 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 620 (793)
+|. .. . . ....++.++++.|..||+..
T Consensus 101 ~l~--~~-~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 101 DLL--SS-H---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp ETT--TS-C---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccC--cC-c---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 884 21 1 1 12367778888888888642
Q ss_pred -----------CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 621 -----------KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 621 -----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=9.8e-09 Score=111.30 Aligned_cols=140 Identities=17% Similarity=0.211 Sum_probs=104.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEec--hhc-ccchHHHHHHHHHHhcCC--ccccceeeeEEecC---CceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLY--KAV-NEGEQEFKAEISAIGRTN--HKNLVQLLGFCNEG---EHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~ 578 (793)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46899999999997743 3468888775 322 123457888999999886 45678899988776 4589999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC-------------------------------------- 620 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 620 (793)
||++|..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998775421 133567788899999999999999731
Q ss_pred -----------------CCCeeecCCCCCCEEEcCCCc--EEEeecCCccc
Q 003818 621 -----------------KSQIIHCDIKPQNILLDGTFN--ARISDFGLAKL 652 (793)
Q Consensus 621 -----------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 652 (793)
...++|+|+++.|||+++++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=8.5e-09 Score=109.03 Aligned_cols=185 Identities=20% Similarity=0.176 Sum_probs=120.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcC-Cccc--cceeeeEEecCC---ceEEEEee
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRT-NHKN--LVQLLGFCNEGE---HRLLVYEY 580 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lV~Ey 580 (793)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+ .+.. +.+++......+ ..++|||+
T Consensus 26 ~~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 458999999999853 34888886432 3346788999999887 3333 344555443333 35899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE----------------------------------------- 619 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 619 (793)
++|.+|.+... ..++..++..++.++++.|..||+.
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988875433 2356677788888888888888861
Q ss_pred --------------CCCCeeecCCCCCCEEEcC--CCcEEEeecCCccccCCCCCcceec-------------ccCcccc
Q 003818 620 --------------CKSQIIHCDIKPQNILLDG--TFNARISDFGLAKLLKTDQTQTTTA-------------IRGTKGY 670 (793)
Q Consensus 620 --------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~-------------~~gt~~y 670 (793)
....++|+|++|.||++++ ...+.|+||+.+........-.... .....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1135899999999999998 5668899999886532211000000 0000011
Q ss_pred cC-cccccCCCCCCccceehhHHHHHHHHhCCcCC
Q 003818 671 VA-PEWFKNLPITAKVDVYSFGILLLELVCCRKNF 704 (793)
Q Consensus 671 ~a-PE~~~~~~~s~~~Dvws~Gvil~elltg~~pf 704 (793)
.. |+..... ....+.|+++.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 2221111 12358999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.8e-05 Score=81.62 Aligned_cols=136 Identities=16% Similarity=0.084 Sum_probs=97.0
Q ss_pred cccccccce-eEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCC
Q 003818 507 EELGEGAFG-KVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 507 ~~LG~G~fg-~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+..|..+ .||+... ..++..+.+|+-... ....+.+|...|+.+. +--+.++++++.+++..++|||++++.
T Consensus 30 ~~~~~G~S~~~v~rl~~-~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYG-KPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEEECSSSSCEEEEEEC-CTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EEccCCCcCCeEEEEEe-cCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 345556555 5888653 334567888876443 3456788999888774 334678899999999999999999998
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC-------------------------------------------- 620 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 620 (793)
++.+..... ......+..++++.|.-||...
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765321 2234456667777777777520
Q ss_pred -----------CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 621 -----------KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 621 -----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
...++|+|+.+.|||+++.+.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999988777899999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.3e-05 Score=82.52 Aligned_cols=135 Identities=20% Similarity=0.162 Sum_probs=93.2
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcc---ccceeeeEEe-cCCceEEEEeecC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHK---NLVQLLGFCN-EGEHRLLVYEYVS 582 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~ 582 (793)
+.++.|....||+. +..+++|+-.. ......+.+|..+|..+.+. .+.+++.+.. ..+..++|||+++
T Consensus 25 ~~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 45788888899985 24588887532 22346788999999998653 3566677664 4556789999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE------------------------------------------- 619 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 619 (793)
|..|.+.... .++......++.++++.|..||+.
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9888763221 234444555555566555555542
Q ss_pred --------------CCCCeeecCCCCCCEEEcC---CCc-EEEeecCCccc
Q 003818 620 --------------CKSQIIHCDIKPQNILLDG---TFN-ARISDFGLAKL 652 (793)
Q Consensus 620 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgla~~ 652 (793)
....++|+|+++.||++++ ++. ..|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335699999999999987 455 48999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=1.7e-05 Score=85.45 Aligned_cols=81 Identities=7% Similarity=0.019 Sum_probs=55.0
Q ss_pred ccc-ccccceeEEEeEeC---CC--CceeEEEEEechhc---ccchHHHHHHHHHHhcCCc---cccceeeeEEecC---
Q 003818 507 EEL-GEGAFGKVYKGVLT---TE--NEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNH---KNLVQLLGFCNEG--- 571 (793)
Q Consensus 507 ~~L-G~G~fg~Vy~~~~~---~~--~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~--- 571 (793)
+.| +.|....+|+.... ++ +++.+++|+..... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999987642 00 15678888765432 1123567889998888853 3567788887665
Q ss_pred CceEEEEeecCCCCHH
Q 003818 572 EHRLLVYEYVSNGSLA 587 (793)
Q Consensus 572 ~~~~lV~Ey~~~gsL~ 587 (793)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00015 Score=79.36 Aligned_cols=75 Identities=17% Similarity=0.193 Sum_probs=48.3
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcc-------cchHHHHHHHHHHhcCCc--c-ccceeeeEEecCCceEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-------EGEQEFKAEISAIGRTNH--K-NLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~l 576 (793)
+.||.|..+.||++.... +++.+++|....... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999986432 356799997643211 123456778888887632 3 34456544 3456789
Q ss_pred EEeecCCC
Q 003818 577 VYEYVSNG 584 (793)
Q Consensus 577 V~Ey~~~g 584 (793)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00028 Score=75.19 Aligned_cols=137 Identities=16% Similarity=0.190 Sum_probs=78.0
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcc--ccceeee------EEecCCceEEEEe
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHK--NLVQLLG------FCNEGEHRLLVYE 579 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~------~~~~~~~~~lV~E 579 (793)
.|+.|..+.||+.... ++ .+++|+.... ...+..|..++..+... .+++++. +....+..++++|
T Consensus 39 ~l~gG~~n~~~~v~~~--~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--SG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET--TE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC--CC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4666778899997642 33 4888988652 23344555555554321 2334443 2234567889999
Q ss_pred ecCCCCHH-----------HH---Hhc--CCC-----------CCCHHHHH-----------------------------
Q 003818 580 YVSNGSLA-----------DF---LFR--KSR-----------RPNWYKRM----------------------------- 603 (793)
Q Consensus 580 y~~~gsL~-----------~~---l~~--~~~-----------~~~~~~~~----------------------------- 603 (793)
|++|..+. .. ++. ... ...|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11 111 100 11222110
Q ss_pred --HHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 604 --QIAFGTARGLFYLHE----------ECKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 604 --~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123446667763 124589999999999999888899999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00077 Score=70.76 Aligned_cols=135 Identities=17% Similarity=0.184 Sum_probs=88.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++++.+....+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 4689999999999763 3456888876542 3467888998888874 35688889988888889999999998
Q ss_pred CCHH--------HHH---hcCCC---------------------CCCHHHHH---HHHH----------------HHHH-
Q 003818 584 GSLA--------DFL---FRKSR---------------------RPNWYKRM---QIAF----------------GTAR- 611 (793)
Q Consensus 584 gsL~--------~~l---~~~~~---------------------~~~~~~~~---~i~~----------------~ia~- 611 (793)
..+. ..| +.... .-+|.... ++.. .+.+
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 111 22111 01343221 1111 1111
Q ss_pred HHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecC
Q 003818 612 GLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFG 648 (793)
Q Consensus 612 gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 648 (793)
....|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223321 2256799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0013 Score=72.46 Aligned_cols=79 Identities=9% Similarity=-0.049 Sum_probs=47.0
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecccCcccccCcccccCCC---CCCccceehhHHHHHHH
Q 003818 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP---ITAKVDVYSFGILLLEL 697 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dvws~Gvil~el 697 (793)
...++|+|+++.|||+++++ ++|+||+.+..-.....-......-...|.+|+...... -....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999998876 999999988643221110000000113456666543111 11234555777777877
Q ss_pred HhC
Q 003818 698 VCC 700 (793)
Q Consensus 698 ltg 700 (793)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 664
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0014 Score=67.91 Aligned_cols=74 Identities=23% Similarity=0.315 Sum_probs=52.8
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc---cccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH---KNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+|.|..+.||+..+. +|+.|.+|+...........|..|...|+.+.- -.+++++++ +..++||||+++
T Consensus 21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 46899999999998864 567899998765444444568899998887742 234455554 234789999987
Q ss_pred CCH
Q 003818 584 GSL 586 (793)
Q Consensus 584 gsL 586 (793)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0052 Score=64.08 Aligned_cols=70 Identities=14% Similarity=0.137 Sum_probs=43.4
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEeec-CCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYEYV-SNG 584 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~g 584 (793)
+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++. .+.-++++||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 56888999999986 34888877543221 1234567777777644333 3555543 34457899999 654
Q ss_pred CH
Q 003818 585 SL 586 (793)
Q Consensus 585 sL 586 (793)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0056 Score=64.43 Aligned_cols=139 Identities=14% Similarity=0.145 Sum_probs=77.6
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeeeE------EecCCceEEEEe
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLGF------CNEGEHRLLVYE 579 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~E 579 (793)
.|+.|....+|+.... ++ .+++|..... .....+..|+.++..+...+ +.+++.. ....+..+++++
T Consensus 29 ~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT--KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEES--SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeC--Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 4677888899987643 23 5888887652 12345666777777664322 2333321 123456789999
Q ss_pred ecCCCCHHH-----------H---HhcC--C---CC---C---CHHHHHH------------HHHHHHHHHHHHHhc---
Q 003818 580 YVSNGSLAD-----------F---LFRK--S---RR---P---NWYKRMQ------------IAFGTARGLFYLHEE--- 619 (793)
Q Consensus 580 y~~~gsL~~-----------~---l~~~--~---~~---~---~~~~~~~------------i~~~ia~gL~yLH~~--- 619 (793)
|++|..+.. . ++.. . .. . .|..... +...+.+.+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998865311 0 1110 0 00 0 1221110 111244556666543
Q ss_pred -CCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 620 -CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 620 -~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23478999999999999987666899999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0076 Score=66.29 Aligned_cols=73 Identities=16% Similarity=0.244 Sum_probs=48.1
Q ss_pred cccccccceeEEEeEeCCC------CceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEe
Q 003818 507 EELGEGAFGKVYKGVLTTE------NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E 579 (793)
+.|+.|....||+...... .++.+++|+.... .....+.+|..+++.+...++ +++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4578888899999876421 2456888877431 112455678888888754444 567776643 38999
Q ss_pred ecCCCC
Q 003818 580 YVSNGS 585 (793)
Q Consensus 580 y~~~gs 585 (793)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0085 Score=64.55 Aligned_cols=140 Identities=18% Similarity=0.208 Sum_probs=80.1
Q ss_pred cccccccceeEEEeEeCC------CCceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEe
Q 003818 507 EELGEGAFGKVYKGVLTT------ENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E 579 (793)
+.|..|-...+|+..... ..++.+++|+.... ......+.+|..+++.+...++ .++++++.++ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 346667788899877532 12357888876332 2334566789998887743333 5677766542 9999
Q ss_pred ecCCCCHHH--------------HH---hcC----CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 003818 580 YVSNGSLAD--------------FL---FRK----SRRPN--WYKRMQIAFGTA-------------------RGLFYLH 617 (793)
Q Consensus 580 y~~~gsL~~--------------~l---~~~----~~~~~--~~~~~~i~~~ia-------------------~gL~yLH 617 (793)
|++|..|.. .| +.. ..... +.++.++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765431 11 111 11122 233333333221 2233333
Q ss_pred hc-----CCCCeeecCCCCCCEEEcCC----CcEEEeecCCcc
Q 003818 618 EE-----CKSQIIHCDIKPQNILLDGT----FNARISDFGLAK 651 (793)
Q Consensus 618 ~~-----~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~ 651 (793)
+. ....++|+|+.+.|||++++ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 23468999999999999876 789999999885
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.022 Score=62.97 Aligned_cols=74 Identities=11% Similarity=0.040 Sum_probs=46.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEeecCCCC
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+.|+.|-...+|+..... .+..+++|+...... ......+|..++..+...++ .++++.+.. .+|+||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 458888889999987532 235688887644321 11223678888888865445 567777632 35999998754
Q ss_pred H
Q 003818 586 L 586 (793)
Q Consensus 586 L 586 (793)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.86 E-value=0.023 Score=55.21 Aligned_cols=104 Identities=13% Similarity=-0.007 Sum_probs=69.4
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
.-+|.+.|...+..+++.+.+.++.|.++.|.-+-... .-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 34799999988999999999999999999887763210 111333456899999999998764 1110
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcC
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKN 703 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~p 703 (793)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123467888764 3456788999999999998854433
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.046 Score=57.67 Aligned_cols=32 Identities=31% Similarity=0.352 Sum_probs=27.7
Q ss_pred CCCeeecCCCCCCEEEcCC----CcEEEeecCCccc
Q 003818 621 KSQIIHCDIKPQNILLDGT----FNARISDFGLAKL 652 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~ 652 (793)
...++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.77 E-value=0.034 Score=58.46 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=77.6
Q ss_pred ccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccc--cceeeeE-----EecCCceEEEEee
Q 003818 508 ELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKN--LVQLLGF-----CNEGEHRLLVYEY 580 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lV~Ey 580 (793)
.|+ |....||+... .+|+.+++|...... .....+..|..++..+.... +++++.. ...++..++++|+
T Consensus 33 ~l~-g~~n~~y~v~~--~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD--EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC--TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc--CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 366 77788998653 345579999875321 23456677888877764322 3444443 1224456789999
Q ss_pred cCCCCHH-----------HHH---hc--C------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 003818 581 VSNGSLA-----------DFL---FR--K------SRRPNWYKR----MQI---------------AFGTARGLFYLHEE 619 (793)
Q Consensus 581 ~~~gsL~-----------~~l---~~--~------~~~~~~~~~----~~i---------------~~~ia~gL~yLH~~ 619 (793)
++|..+. ..| +. . ....++... ..+ ...+.+.+..+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875431 111 11 0 011121110 000 11111223333322
Q ss_pred ----CCCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 620 ----CKSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 620 ----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234689999999999999 4 89999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.03 Score=60.14 Aligned_cols=74 Identities=16% Similarity=0.130 Sum_probs=42.6
Q ss_pred cccccccceeEEEeEeCCC-------CceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTE-------NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~ 578 (793)
+.|+.|....+|+...... .++.+++|+...... .......|..+++.+...++ .++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 3577788889998765321 125688887654322 11234678888887754443 46665442 37899
Q ss_pred eecCCCC
Q 003818 579 EYVSNGS 585 (793)
Q Consensus 579 Ey~~~gs 585 (793)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.85 E-value=0.45 Score=50.15 Aligned_cols=31 Identities=26% Similarity=0.337 Sum_probs=27.4
Q ss_pred CCeeecCCCCCCEEEcCCCcEEEeecCCccc
Q 003818 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKL 652 (793)
Q Consensus 622 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 652 (793)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.61 E-value=0.29 Score=53.27 Aligned_cols=75 Identities=12% Similarity=0.150 Sum_probs=46.1
Q ss_pred cccccccceeEEEeEeCCCC------ceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEe
Q 003818 507 EELGEGAFGKVYKGVLTTEN------EKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E 579 (793)
+.|..|-...+|+....... ++.+++|+..... .......+|..+++.+...++ .++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 35667778889987764211 4568888764432 222234678888877753333 45565432 378999
Q ss_pred ecCCCCH
Q 003818 580 YVSNGSL 586 (793)
Q Consensus 580 y~~~gsL 586 (793)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=90.58 E-value=15 Score=36.79 Aligned_cols=71 Identities=18% Similarity=0.310 Sum_probs=43.9
Q ss_pred eEEEEEeccCCCCeEEEeeCCCC---C----CCCCceEEEecCCcEEEECCCCCeeecCCCC--CccceeeEecCcCEEE
Q 003818 61 FLLAIWFNEIPERTIVWSANRDN---L----VQRGSKVELTGDGQLILRDSSGKEIWREPPS--TGAAYAAMLDTGNLVL 131 (793)
Q Consensus 61 ~~~giw~~~~~~~t~vW~anr~~---p----~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~--~~~~~~~lld~GNlvl 131 (793)
-.+.|| +.....++|...... + +..+..+-++.++.+...|.+|+.+|.-... .....+..+.+||+++
T Consensus 15 ~~v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv 92 (276)
T 3no2_A 15 NKIAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALV 92 (276)
T ss_dssp SEEEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEE
T ss_pred CEEEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEE
Confidence 355566 334678899987654 1 2233445455566666778889999986543 2233456677777776
Q ss_pred Ee
Q 003818 132 AS 133 (793)
Q Consensus 132 ~~ 133 (793)
.+
T Consensus 93 ~~ 94 (276)
T 3no2_A 93 AW 94 (276)
T ss_dssp EE
T ss_pred Ee
Confidence 54
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=85.18 E-value=8.5 Score=38.71 Aligned_cols=86 Identities=14% Similarity=0.448 Sum_probs=50.6
Q ss_pred cCCcEEEECC-CCCeeecCCCCC--ccceeeEecCcCEEEE--------ecCCCceeeeccCCCC-cccCCccccCCceE
Q 003818 95 GDGQLILRDS-SGKEIWREPPST--GAAYAAMLDTGNLVLA--------SQDSSTMWESFDDPTD-TLLPTQVMSQGTKV 162 (793)
Q Consensus 95 ~~g~l~l~~~-~~~~~Wst~~~~--~~~~~~lld~GNlvl~--------~~~~~~~WqSFd~Ptd-tllp~~~l~~~~~L 162 (793)
.++.+++.|. +|+.+|+..... ....+.+..+||+++. |.++..+|+ |+.|.+ .+..-+.+.-|..+
T Consensus 13 ~~~~v~~~d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~-~~~~~~~~~~~~~~~~dG~~l 91 (276)
T 3no2_A 13 GWNKIAIINKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWN-IAAPAGCEMQTARILPDGNAL 91 (276)
T ss_dssp TCSEEEEEETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEE-EECCTTCEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEE-EcCCCCccccccEECCCCCEE
Confidence 5688999997 999999975432 3345667778888773 234667886 555532 11122334445666
Q ss_pred EEecCCCCCCcceEEEEEecCCce
Q 003818 163 IARLTETNYSSGRFMFELQTDGNL 186 (793)
Q Consensus 163 ~s~~s~~dps~G~~~~~~~~~g~~ 186 (793)
++.... .+ -.+.++++|..
T Consensus 92 v~~~~~----~~-~v~~vd~~Gk~ 110 (276)
T 3no2_A 92 VAWCGH----PS-TILEVNMKGEV 110 (276)
T ss_dssp EEEEST----TE-EEEEECTTSCE
T ss_pred EEecCC----CC-EEEEEeCCCCE
Confidence 664320 12 23456777753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.14 E-value=0.63 Score=50.31 Aligned_cols=29 Identities=28% Similarity=0.366 Sum_probs=24.6
Q ss_pred eeecCCCCCCEEE------cCCCcEEEeecCCccc
Q 003818 624 IIHCDIKPQNILL------DGTFNARISDFGLAKL 652 (793)
Q Consensus 624 ivH~Dlkp~NIll------~~~~~~kl~Dfgla~~ 652 (793)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998853
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=80.02 E-value=1.2 Score=35.74 Aligned_cols=33 Identities=24% Similarity=0.576 Sum_probs=28.9
Q ss_pred cccChhhHHHHhhcCCCcceeeec--cCcceeecc
Q 003818 373 TSVDEDWCREACLSDCFCAVAIFR--EGECWKKRA 405 (793)
Q Consensus 373 ~~~~~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 405 (793)
..+++++|++.|+.+=.|.+|.|+ ...|++|.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 346899999999999999999997 467999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 793 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-18 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-17 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 5e-15 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-15 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 9e-06 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-11 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-05 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 9e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-69
Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLV 562
+ +G G+FG VYKG + VAVK L + Q FK E+ + +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 563 QLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKS 622
+G+ +V ++ SL L + K + IA TA+G+ YLH +
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 623 QIIHCDIKPQNILLDGTFNARISDFGLAKLL-KTDQTQTTTAIRGTKGYVAPEWFKNL-- 679
IIH D+K NI L +I DFGLA + + + + G+ ++APE +
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 680 -PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738
P + + DVY+FGI+L EL+ + + + + + L + N +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
AM + C+++ RP ++ IE
Sbjct: 241 AMKR---------LMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-67
Identities = 74/272 (27%), Positives = 119/272 (43%), Gaps = 24/272 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E LG G FG+V+ G + VAVK L + + F AE + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEECKSQ 623
+ E ++ EY+ NGSL DFL S K + +A A G+ ++ E
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
IH D++ NIL+ T + +I+DFGLA+L++ ++ + + APE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 684 KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743
K DV+SFGILL E+V + Y ++ +E +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP----------------YPGMTNPEVIQNLERGYRMVRPD 233
Query: 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
E+ + C +E P RP + ++E
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 9e-67
Identities = 62/271 (22%), Positives = 111/271 (40%), Gaps = 22/271 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F +ELG G FG V G + VA+K + + + E EF E + +H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
G C + ++ EY++NG L ++L R + +++ + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D+ +N L++ ++SDFGL++ + D+ ++ + + PE ++K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744
D+++FG+L+ E+ K Y+ F + +
Sbjct: 182 SDIWAFGVLMWEIYSLGK----------------MPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
EK I C E RP K + I
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 5e-66
Identities = 68/304 (22%), Positives = 133/304 (43%), Gaps = 37/304 (12%)
Query: 493 FTYKELEVITGGFKEE-----------LGEGAFGKVYKGVL--TTENEKPVAVKKLYKAV 539
FT+++ F +E +G G FG+V G L + E VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 540 NEGE-QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN 598
E + ++F +E S +G+ +H N++ L G + +++ E++ NGSL FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 599 WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658
+ + + G A G+ YL + +H D+ +NIL++ ++SDFGL++ L+ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 659 QTTT----AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQM 714
T + + APE + T+ DV+S+GI++ E++ +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMI 774
Y + + +E D + + + C Q+D + RP ++ +
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 775 EGAV 778
+ +
Sbjct: 288 DKMI 291
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-65
Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 22/271 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
F +E+G G FG V+ G +++ VA+K + + E++F E + + +H LVQL
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDK--VAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
G C E LV+E++ +G L+D+L + + + G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
IH D+ +N L+ ++SDFG+ + + DQ ++T + + +PE F ++K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744
DV+SFG+L+ E+ K + + + + ++ R
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS-------------- 228
Query: 745 RVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
I C +E P RPA ++ + +
Sbjct: 229 --THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 8e-64
Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 26/278 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNL 561
F E +G G FG VY G L + K AVK L + + GE +F E + +H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 562 VQLLGFCNEGE-HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ LLG C E L+V Y+ +G L +F+ ++ P + A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLL---KTDQTQTTTAIRGTKGYVAPEWFK 677
+ +H D+ +N +LD F +++DFGLA+ + + D T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737
T K DV+SFG+LL EL+ D D + R+L E
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL----LQPE 257
Query: 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
D + + + C +RP+ ++ I
Sbjct: 258 YCPDPLYE------VMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-63
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 28/293 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+E +G+G FG+V++G + VAVK + E +AEI H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGF 62
Query: 565 LGFCNEGE----HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ N+ LV +Y +GSL D+L +++A TA GL +LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 621 -----KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT---TTAIRGTKGYVA 672
K I H D+K +NIL+ I+D GLA + GTK Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 673 PEWF------KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEEC---QMILADWAYDC 723
PE K+ + D+Y+ G++ E+ + + ++ +D + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 724 FRERKL-GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
R+ L N + + I C + + R ++ + +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-63
Identities = 62/272 (22%), Positives = 112/272 (41%), Gaps = 24/272 (8%)
Query: 508 ELGEGAFGKVYKGVL-TTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHKNLVQLL 565
ELG G FG V +GV + + VA+K L + + + +E E + + ++ +V+L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 566 GFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQII 625
G C + E +LV E G L FL K ++ + G+ YL + +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 626 HCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--TTTAIRGTKGYVAPEWFKNLPITA 683
H D+ +N+LL A+ISDFGL+K L D + +A + + APE ++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 684 KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743
+ DV+S+G+ + E + + Y + ++ +E +
Sbjct: 192 RSDVWSYGVTMWEALSYGQ----------------KPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ + + C RP V Q +
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-62
Identities = 57/304 (18%), Positives = 114/304 (37%), Gaps = 36/304 (11%)
Query: 498 LEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEG-EQEFKAEISAIG 554
+E+ F+ ELG G G V+K + +A K ++ + + E+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 555 RTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF 614
N +V G + E++ GSL L + R P +++ +GL
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLT 118
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
YL E+ K I+H D+KP NIL++ ++ DFG++ L + GT+ Y++PE
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE 173
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734
+ + + D++S G+ L+E+ R +E +++ E
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 735 NDEEAMDDIKRVEKFVMIAI--------------------------WCIQEDPSLRPAMK 768
+ + + + C+ ++P+ R +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 769 KVTQ 772
++
Sbjct: 294 QLMV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 6e-62
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 24/281 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+ +LG+G FG+V+ G VA+K L + F E + + H+ LVQL
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-WYKRMQIAFGTARGLFYLHEECKSQ 623
E +V EY+S GSL DFL ++ + + + +A A G+ Y+
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
+H D++ NIL+ +++DFGLA+L++ ++ + + APE T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 684 KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743
K DV+SFGILL EL + + + + G + E + +
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNR----------EVLDQVERGYRMPCPPECPESL 243
Query: 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPP 784
+ C +++P RP + + +E + P
Sbjct: 244 HD------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 6e-61
Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 24/291 (8%)
Query: 488 MNLQDFTYKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE 545
M+ Y + E+ +LG G +G+VY+GV + VAVK L + E E E
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-E 59
Query: 546 FKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQ 604
F E + + H NLVQLLG C ++ E+++ G+L D+L +R+ + +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664
+A + + YL K IH D+ +N L+ +++DFGL++L+ D
Sbjct: 120 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCF 724
+ + APE + K DV++FG+LL E+ + Y
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----------------YPGI 220
Query: 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
++ L+E D EK + C Q +PS RP+ ++ Q E
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-61
Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 40/291 (13%)
Query: 487 EMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF 546
+N+++ + +G+G FG V G VAVK + + Q F
Sbjct: 3 ALNMKELK----------LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAF 47
Query: 547 KAEISAIGRTNHKNLVQLLGFCNEGEHRL-LVYEYVSNGSLADFLFRKSRRP-NWYKRMQ 604
AE S + + H NLVQLLG E + L +V EY++ GSL D+L + R ++
Sbjct: 48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107
Query: 605 IAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664
+ + YL +H D+ +N+L+ A++SDFGL K + Q
Sbjct: 108 FSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---- 160
Query: 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCF 724
+ + APE + + K DV+SFGILL E+ + + D
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------DVV 210
Query: 725 RERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ G ++ + + + C D ++RP+ ++ + +E
Sbjct: 211 PRVEKGYKMDAPDGCPPAVYE------VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-60
Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 42/301 (13%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEISAIGR-TNH 558
F + LG GAFGKV + ++ VAVK L + + E + +E+ + NH
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP-----------------NWYK 601
N+V LLG C G L++ EY G L +FL RK +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT- 660
+ ++ A+G+ +L + IH D+ +NILL +I DFGLA+ +K D
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720
R ++APE N T + DV+S+GI L EL + + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY----- 258
Query: 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780
+++ + + I C DP RP K++ Q+IE +
Sbjct: 259 ----------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
Query: 781 S 781
S
Sbjct: 309 S 309
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-60
Identities = 70/273 (25%), Positives = 113/273 (41%), Gaps = 26/273 (9%)
Query: 508 ELGEGAFGKVYKGVLT-TENEKPVAVKKLYKAVNEGE--QEFKAEISAIGRTNHKNLVQL 564
ELG G FG V KG + K VAVK L N+ E AE + + + ++ +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+G C E E +LV E G L +L + R +++ + G+ YL E
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---F 128
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--TTTAIRGTKGYVAPEWFKNLPIT 682
+H D+ +N+LL A+ISDFGL+K L+ D+ T + + APE +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742
+K DV+SFG+L+ E + Y + ++ ++E E
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ----------------KPYRGMKGSEVTAMLEKGERMGCP 232
Query: 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ + C D RP V +
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-59
Identities = 69/284 (24%), Positives = 135/284 (47%), Gaps = 27/284 (9%)
Query: 505 FKEE--LGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVNEGEQ-EFKAEISAIGRTNH 558
+ +G G FG+VYKG+L T + K PVA+K L E ++ +F E +G+ +H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
N+++L G ++ + +++ EY+ NG+L FL K + + + + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ--TQTTTAIRGTKGYVAPEWF 676
+H D+ +NIL++ ++SDFGL+++L+ D T TT+ + + APE
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 677 KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736
T+ DV+SFGI++ E++ + + + + + G +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------EVMKAINDGFRLPTP 235
Query: 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780
+ I + + + C Q++ + RP + +++ +
Sbjct: 236 MDCPSAIYQ------LMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 1e-58
Identities = 63/300 (21%), Positives = 124/300 (41%), Gaps = 48/300 (16%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGEQ-EFKAEISAIGRTNHK 559
+ ++GEGAFG+V++ E VAVK L + + Q +F+ E + + ++
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---------------------- 597
N+V+LLG C G+ L++EY++ G L +FL S
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 598 -NWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL-KT 655
+ +++ IA A G+ YL E +H D+ +N L+ +I+DFGL++ +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI 715
D + ++ PE T + DV+++G++L E+ E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249
Query: 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ + G ++ E ++ + C + P+ RP+ + ++++
Sbjct: 250 ------EVIYYVRDGNILACPENCPLELYN------LMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 66/292 (22%), Positives = 120/292 (41%), Gaps = 36/292 (12%)
Query: 487 EMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEF 546
++N +DF ++ ELG+GAFGKVYK E A K + E +++
Sbjct: 7 DLNPEDF-WE--------IIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDY 56
Query: 547 KAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIA 606
EI + +H N+V+LL + ++ E+ + G++ + R + +
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 607 FGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRG 666
T L YLH+ ++IIH D+K NIL + +++DFG++ + + G
Sbjct: 117 KQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIG 172
Query: 667 TKGYVAPEWF-----KNLPITAKVDVYSFGILLLELVCCRKNF-EVDATEECQMILADWA 720
T ++APE K+ P K DV+S GI L+E+ E++ I
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232
Query: 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+ + D +K+ C++++ R ++ Q
Sbjct: 233 PTLAQPSRW------SSNFKDFLKK----------CLEKNVDARWTTSQLLQ 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-58
Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 47/300 (15%)
Query: 505 FKEELGEGAFGKVYKGVLTTENE----KPVAVKKLYKAVNEGEQE-FKAEISAIGR-TNH 558
F + LG GAFGKV ++ VAVK L + + E+E +E+ + + +H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPN-------------------- 598
+N+V LLG C L++EY G L ++L K + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 599 --WYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTD 656
+ + A+ A+G+ +L + +H D+ +N+L+ +I DFGLA+ + +D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 657 QTQTT-TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMI 715
R ++APE T K DV+S+GILL E+ N +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 716 LADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
L++N + E+ +I C D RP+ +T +
Sbjct: 278 ---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 6e-58
Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 29/273 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISAIGRTNHKNLV 562
F E+G G+F VYKG+ TE VA +L Q FK E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLD-TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 563 QLLGFC----NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
+ + +LV E +++G+L +L ++ + +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 619 ECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFK 677
IIH D+K NI + G T + +I D GLA L + + + GT ++APE ++
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYE 186
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737
VDVY+FG+ +LE+ + + + + D+
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASF------DK 236
Query: 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
A+ ++K I CI+++ R ++K +
Sbjct: 237 VAIPEVKE------IIEGCIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 9e-58
Identities = 58/277 (20%), Positives = 111/277 (40%), Gaps = 28/277 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLV 562
+G G++G+ K + K + K+L +Q +E++ + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 563 QLLGFCNEGEHRLL--VYEYVSNGSLADFLFRKSRRP---NWYKRMQIAFGTARGLFYLH 617
+ + + L V EY G LA + + ++ + +++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 618 E--ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
+ ++H D+KP N+ LDG N ++ DFGLA++L D + GT Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQ 185
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735
+ K D++S G LL EL F + +E + + + R
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY------- 238
Query: 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+E + I R + RP+++++ +
Sbjct: 239 SDELNEIITR----------MLNLKDYHRPSVEEILE 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 61/279 (21%), Positives = 106/279 (37%), Gaps = 28/279 (10%)
Query: 505 FKEELGEGAFGKVYKGVL--TTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHK 559
E+LG+G+FG V +G + VAVK L V E +F E++A+ +H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
NL++L G ++ V E GSL D L + + A A G+ YL +
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--TTTAIRGTKGYVAPEWFK 677
IH D+ +N+LL +I DFGL + L + + + APE K
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 678 NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737
+ D + FG+ L E+ + + ++ ++ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQILHKIDKEG 231
Query: 738 EAMDDIKRV-EKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
E + + + + + C P RP + +
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 3e-57
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQ 563
E+G G+FG VY N + VA+KK+ + NE Q+ E+ + + H N +Q
Sbjct: 21 REIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
G LV EY + K + + + G +GL YLH
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL---P 680
+IH D+K NILL ++ DFG A ++ + GT ++APE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMDEGQ 190
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740
KVDV+S GI +EL + ++ L + +N+ A+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL----------------FNMNAMSALYHIAQNESPAL 234
Query: 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
E F C+Q+ P RP + +
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-57
Identities = 53/274 (19%), Positives = 105/274 (38%), Gaps = 23/274 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK--PVAVKKLYKAVNEGEQE-FKAEISAIGRTNHKNL 561
+GEG FG V++G+ + VA+K ++ +E F E + + +H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L+G E ++ E + G L FL + + + A+ + L YL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+H DI +N+L+ ++ DFGL++ ++ + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741
T+ DV+ FG+ + E++ D + G +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN----------DVIGRIENGERLPMPPNCPP 236
Query: 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
+ + C DPS RP ++ +
Sbjct: 237 TLYS------LMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-57
Identities = 76/269 (28%), Positives = 114/269 (42%), Gaps = 23/269 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQ 563
+ LGEGA+G+V V E+ VAVK + + + K EI NH+N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
G EG + L EY S G L D + P + G+ YLH
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAGVVYLHGIG--- 123
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLK-TDQTQTTTAIRGTKGYVAPEWFKNLPI- 681
I H DIKP+N+LLD N +ISDFGLA + + ++ + + GT YVAPE K
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741
VDV+S GI+L ++ + D + +DW + D +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI---DSAPLA 238
Query: 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ + + E+PS R + +
Sbjct: 239 LLHK----------ILVENPSARITIPDI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-57
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 29/271 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNL 561
LG+G FG VY +++ +A+K L+KA E + + E+ H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
++L G+ ++ L+ EY G++ L +K + + + A L Y H
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHS--- 124
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
++IH DIKP+N+LL +I+DFG + + + T + GT Y+ PE +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMH 181
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741
KVD++S G+L E + + FE + +E Y + E A D
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDFVTEGARD 233
Query: 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
I R ++ +PS RP +++V +
Sbjct: 234 LISR----------LLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-57
Identities = 62/267 (23%), Positives = 115/267 (43%), Gaps = 24/267 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLG 566
E++G+GA G VY + + VA++++ ++ EI + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIH 626
G+ +V EY++ GSL D + + + + + L +LH Q+IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 627 CDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVD 686
DIK NILL + +++DFG + +Q++ +T + GT ++APE KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198
Query: 687 VYSFGILLLELVCCRKNF-EVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745
++S GI+ +E++ + + +I + + KL D + R
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------SAIFRDFLNR 252
Query: 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
C+ D R + K++ Q
Sbjct: 253 ----------CLDMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 65/276 (23%), Positives = 119/276 (43%), Gaps = 25/276 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEK---PVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKN 560
+ LG GAFG VYKG+ E EK PVA+K+L +A + + +E E + ++ +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
+ +LLG C +L + + + G L D++ + A+G+ YL
Sbjct: 73 VCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNL 679
+++H D+ +N+L+ + +I+DFGLAKLL ++ + + ++A E +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 680 PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739
T + DV+S+G+ + EL+ YD ++ ++E E
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISSILEKGERL 232
Query: 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
MI + C D RP +++
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-56
Identities = 67/308 (21%), Positives = 127/308 (41%), Gaps = 49/308 (15%)
Query: 486 PEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEK-PVAVKKLYKAVN-EGE 543
P ++ D F++ +GEG FG+V K + + + A+K++ + + +
Sbjct: 5 PVLDWNDIK----------FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH 54
Query: 544 QEFKAEISAIGR-TNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRK--------- 593
++F E+ + + +H N++ LLG C + L EY +G+L DFL +
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 594 ------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDF 647
+ + + + A ARG+ YL + Q IH D+ +NIL+ + A+I+DF
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 171
Query: 648 GLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVD 707
GL++ + +T R ++A E T DV+S+G+LL E+V
Sbjct: 172 GLSRGQEVYVKKTMG--RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--- 226
Query: 708 ATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAM 767
Y +L + + ++ + C +E P RP+
Sbjct: 227 -------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 273
Query: 768 KKVTQMIE 775
++ +
Sbjct: 274 AQILVSLN 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (476), Expect = 1e-53
Identities = 59/268 (22%), Positives = 110/268 (41%), Gaps = 22/268 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
EELG GAFG V++ A K + ++ + EI + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNN-FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+ +++YE++S G L + + + + + + ++ +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 625 IHCDIKPQNILLDGTFNARI--SDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+H D+KP+NI+ + + DFGL L Q+ T GT + APE + P+
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVG 203
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742
D++S G+L L+ F + +E + ++ G+ E+ D
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI----SEDGKDF 259
Query: 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
I++ + DP+ R + +
Sbjct: 260 IRK----------LLLADPNTRMTIHQA 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-53
Identities = 73/302 (24%), Positives = 136/302 (45%), Gaps = 35/302 (11%)
Query: 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNHK 559
ELG+G+FG VY+GV E E VA+K + +A + E EF E S + N
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 560 NLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRR---------PNWYKRMQIAFGTA 610
++V+LLG ++G+ L++ E ++ G L +L P+ K +Q+A A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 611 RGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL-KTDQTQTTTAIRGTKG 669
G+ YL+ ++ +H D+ +N ++ F +I DFG+ + + +TD +
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
+++PE K+ T DV+SFG++L E+ + + E R
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----------QVLRFVME 250
Query: 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIPPDPASF 789
G L++ + D + + C Q +P +RP+ ++ I+ ++ + + +
Sbjct: 251 GGLLDKPDNCPDMLFE------LMRMCWQYNPKMRPSFLEIISSIKEEMEPG-FREVSFY 303
Query: 790 IS 791
S
Sbjct: 304 YS 305
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (460), Expect = 2e-51
Identities = 62/270 (22%), Positives = 109/270 (40%), Gaps = 22/270 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
EELG GAFG V++ V + K + + K EIS + + +H L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+ +L+ E++S G L D + + + + + + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 625 IHCDIKPQNILLDGTFNARI--SDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
+H DIKP+NI+ + + + DFGLA L D + T + APE P+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVG 206
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742
D+++ G+L L+ F + E + ++ + + EA D
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----SPEAKDF 262
Query: 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
IK +Q++P R + +
Sbjct: 263 IKN----------LLQKEPRKRLTVHDALE 282
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 43/301 (14%)
Query: 505 FKEELGEGAFGKVYKGVLTTENE------KPVAVKKLYKAVNEGE-QEFKAEISAIGR-T 556
+ LGEGAFG+V ++ VAVK L E + + +E+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRP---------------NWYK 601
HKN++ LLG C + ++ EY S G+L ++L + +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661
+ A+ ARG+ YL + + IH D+ +N+L+ +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 662 T-AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720
T R ++APE + T + DV+SFG+LL E+ +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---------------- 237
Query: 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780
Y +L L++ + M+ C PS RP K++ + ++ V +
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
Query: 781 S 781
+
Sbjct: 298 T 298
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 58/270 (21%), Positives = 108/270 (40%), Gaps = 23/270 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
E+LG G FG V++ V T ++K K + K + K EIS + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVET-SSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
E ++++E++S + + + + N + + L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 625 IHCDIKPQNILLD--GTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPIT 682
H DI+P+NI+ + +I +FG A+ LK Y APE ++ ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVS 181
Query: 683 AKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742
D++S G L+ L+ F + ++ + + Y E + EAMD
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----SIEAMDF 237
Query: 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+ R + ++ R + Q
Sbjct: 238 VDR----------LLVKERKSRMTASEALQ 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-50
Identities = 58/275 (21%), Positives = 100/275 (36%), Gaps = 27/275 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNL 561
F + LGEG+F V + + A+K L K E + R +H
Sbjct: 12 FGKILGEGSFSTVVLARELATSRE-YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
V+L + E Y NG L ++ + F TA + L
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHG 126
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLP 680
IIH D+KP+NILL+ + +I+DFG AK+L + Q + GT YV+PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740
D+++ G ++ +LV F + + + + +A
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKAR 238
Query: 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
D +++ + D + R +++
Sbjct: 239 DLVEK----------LLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (446), Expect = 5e-50
Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 27/284 (9%)
Query: 495 YKELEVITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-FKAEIS 551
+K+ E I + + LG GAF +V +K VA+K + K EG++ + EI+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIA 59
Query: 552 AIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTAR 611
+ + H N+V L G H L+ + VS G L D + K ++ F
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-ERDASRLIFQVLD 118
Query: 612 GLFYLHEECKSQIIHCDIKPQNILL---DGTFNARISDFGLAKLLKTDQTQTTTAIRGTK 668
+ YLH+ I+H D+KP+N+L D ISDFGL+K+ D + GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTP 173
Query: 669 GYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728
GYVAPE P + VD +S G++ L+C F + + + Y+
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
Query: 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772
+ + A D I+ +++DP R ++ Q
Sbjct: 234 DDI----SDSAKDFIRH----------LMEKDPEKRFTCEQALQ 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 41/300 (13%)
Query: 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTNH- 558
+ LG GAFG+V + T + VAVK L + E + +E+ + H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 559 KNLVQLLGFCNE-GEHRLLVYEYVSNGSLADFLFRKSRRP---------------NWYKR 602
N+V LLG C + G +++ E+ G+L+ +L K
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT-T 661
+ +F A+G+ +L + IH D+ +NILL +I DFGLA+ + D
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY 721
R ++APE + T + DV+SFG+LL E+ + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFC 247
Query: 722 DCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVS 781
+E + M + C +PS RP ++ + + + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (416), Expect = 3e-46
Identities = 59/271 (21%), Positives = 101/271 (37%), Gaps = 28/271 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE---QEFKAEISAIGRTNHKNL 561
E LG G +V+ + VAVK L + F+ E NH +
Sbjct: 11 LGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 562 VQLLGFC----NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH 617
V + G +V EYV +L D + + +++ + L + H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH 128
Query: 618 EECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--TTTAIRGTKGYVAPEW 675
+ + IIH D+KP NI++ T ++ DFG+A+ + T A+ GT Y++PE
Sbjct: 129 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 676 FKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735
+ + A+ DVYS G +L E++ F D+ R GL
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL---- 241
Query: 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPA 766
+ + + + ++P R
Sbjct: 242 SADLDAVVLK----------ALAKNPENRYQ 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 3e-46
Identities = 60/285 (21%), Positives = 104/285 (36%), Gaps = 40/285 (14%)
Query: 488 MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---VNEGEQ 544
+ + DF+ +G G FG+VY + K A+K L K + +GE
Sbjct: 1 LTMNDFS----------VHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGET 49
Query: 545 EFKAE---ISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYK 601
E +S + + +V + + + + + ++ G L L + +
Sbjct: 50 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAD 108
Query: 602 RMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661
A GL ++H +++ D+KP NILLD + RISD GLA + +
Sbjct: 109 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
Query: 662 TAIRGTKGYVAPEWF-KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA 720
GT GY+APE K + + D +S G +L +L+ F T++ I
Sbjct: 166 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
Query: 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRP 765
E ++ +Q D + R
Sbjct: 223 TMAVELPD-----SFSPELRSLLEG----------LLQRDVNRRL 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (414), Expect = 5e-46
Identities = 59/282 (20%), Positives = 104/282 (36%), Gaps = 37/282 (13%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA---------VNEGEQEFKAEISAIGR 555
KE LG G V + + K AVK + V E + E+ + +
Sbjct: 7 PKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 556 TN-HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLF 614
+ H N++QL LV++ + G L D+L + + + +I +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVIC 124
Query: 615 YLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
LH+ I+H D+KP+NILLD N +++DFG + L D + + GT Y+APE
Sbjct: 125 ALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPE 179
Query: 675 WF------KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728
+ +VD++S G+++ L+ F ++ Y
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ D + R + P R ++
Sbjct: 240 DDY----SDTVKDLVSR----------FLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 28/268 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRT-NHKN 560
+ LG+G+FGKV+ N+ A+K L K V ++ + E + H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQF-FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 561 LVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEEC 620
L + E+ V EY++ G L + + + + + A GL +L
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL---H 120
Query: 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLP 680
I++ D+K NILLD + +I+DFG+ K +T T GT Y+APE
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQK 179
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740
VD +SFG+LL E++ + F EE + R ++EA
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYPRWLEKEAK 231
Query: 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMK 768
D + + +P R ++
Sbjct: 232 DLLVK----------LFVREPEKRLGVR 249
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 1e-44
Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 35/282 (12%)
Query: 493 FTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAE 549
++ ++ +++ LG G+FG+V+ N + A+K L K + + + E
Sbjct: 1 YSLQDFQIL-----RTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 550 ISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGT 609
+ H ++++ G + + ++ +Y+ G L L + R PN F
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYA 110
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKG 669
A L II+ D+KP+NILLD + +I+DFG AK + T + GT
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPD 166
Query: 670 YVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKL 729
Y+APE P +D +SFGIL+ E++ F T + Y+ +L
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAEL 218
Query: 730 GLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771
+E+ D + R I D S R +
Sbjct: 219 RFPPFFNEDVKDLLSR----------LITRDLSQRLGNLQNG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 64/285 (22%), Positives = 108/285 (37%), Gaps = 24/285 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFK-----AEISAIGRTNHKNL 561
E+GEGA+GKV+K + VA+K++ E A + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 562 VQLLGFC-----NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL 616
V+L C + LV+E+V + F RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
H ++H D+KPQNIL+ + +++DFGLA++ T+ + T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPEVL 187
Query: 677 KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEE-----CQMILADWAYDCFRERKLGL 731
VD++S G + E+ + F + + +I D R+ L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 732 LVENDEEAMDDIKRVEKFVMIAI----WCIQEDPSLRPAMKKVTQ 772
+ + A K V + C+ +P+ R +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 2e-44
Identities = 52/281 (18%), Positives = 92/281 (32%), Gaps = 27/281 (9%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
++G G+FG +Y G E+ VA+K V + E +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEE-VAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 565 LGFC-NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
+ +C EG++ ++V E + SL D SR+ + + +A + Y+H
Sbjct: 68 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KN 123
Query: 624 IIHCDIKPQNIL---LDGTFNARISDFGLAKLLKTDQTQT------TTAIRGTKGYVAPE 674
IH D+KP N L I DFGLAK + +T + GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734
+ + + D+ S G +L+ ++ + + L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
E + C +P + Q+
Sbjct: 244 YPSEFATYLNF----------CRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-44
Identities = 56/274 (20%), Positives = 100/274 (36%), Gaps = 30/274 (10%)
Query: 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQL 564
+ LG G GKV + EK A+K L + + E+ R + ++V++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEK-FALKMLQDC-----PKARREVELHWRASQCPHIVRI 70
Query: 565 LGFC----NEGEHRLLVYEYVSNGSLADFLFRKSRRP-NWYKRMQIAFGTARGLFYLHEE 619
+ + L+V E + G L + + + + +I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 620 CKSQIIHCDIKPQNILLDGTFN---ARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF 676
I H D+KP+N+L +++DFG AK + + TT T YVAPE
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVL 185
Query: 677 KNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736
D++S G+++ L+C F + + E E
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
EE I+ ++ +P+ R + +
Sbjct: 246 EEVKMLIRN----------LLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 8e-44
Identities = 68/276 (24%), Positives = 106/276 (38%), Gaps = 31/276 (11%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE------QEFKAEISAIGRTNH 558
EELG G F V K A K + K + ++ + E+S + H
Sbjct: 14 TGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 559 KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
N++ L +L+ E V+ G L DFL K + + G++YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS 131
Query: 619 ECKSQIIHCDIKPQNILLD----GTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPE 674
I H D+KP+NI+L +I DFGLA + D I GT +VAPE
Sbjct: 132 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPE 186
Query: 675 WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734
P+ + D++S G++ L+ F D +E ++ Y+ E
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT--- 243
Query: 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
A D I+R + +DP R ++
Sbjct: 244 -SALAKDFIRR----------LLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 61/283 (21%), Positives = 106/283 (37%), Gaps = 22/283 (7%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE-----FKAEISAIGRTNHKNL 561
+ LGEG F VYK N+ VA+KK+ ++ EI + +H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
+ LL + LV++++ + S T +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNL-P 680
I+H D+KP N+LLD +++DFGLAK + T + T+ Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 681 ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740
VD+++ G +L EL+ D+ + + + E+ + D
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 741 DDIKRV----------EKFVMIAIWCIQEDPSLRPAMKKVTQM 773
+ + + + +P R + +M
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-42
Identities = 58/291 (19%), Positives = 112/291 (38%), Gaps = 25/291 (8%)
Query: 501 ITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE-QEFKAEISAIGRTN 557
+ + +GEGA+G V + VA+KK+ ++ Q EI + R
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 558 HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFR--KSRRPNWYKRMQIAFGTARGLFY 615
H+N++ + + Y+ + L++ K++ + + RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ--TTTAIRGTKGYVAP 673
+H ++H D+KP N+LL+ T + +I DFGLA++ D T T+ Y AP
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 674 EWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732
E N T +D++S G +L E++ R F + + +E ++
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 733 VENDEEAMDDIKRVEKFVMIAIW-------------CIQEDPSLRPAMKKV 770
+ + K ++ + +P R +++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-42
Identities = 60/277 (21%), Positives = 97/277 (35%), Gaps = 43/277 (15%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE------FKAEISAIGRTN- 557
LG G FG VY G+ ++N PVA+K + K E E+ + + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNL-PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 558 -HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL 616
+++LL + + +L+ E + + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 617 HEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
H ++H DIK +NIL+D ++ DFG LLK GT+ Y PEW
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPPEW 180
Query: 676 FKNLP-ITAKVDVYSFGILLLELVCCRKNFEVD-ATEECQMILADWAYDCFRERKLGLLV 733
+ V+S GILL ++VC FE D Q+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV------------- 227
Query: 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
E I+ C+ PS RP +++
Sbjct: 228 --SSECQHLIRW----------CLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-41
Identities = 74/319 (23%), Positives = 123/319 (38%), Gaps = 39/319 (12%)
Query: 475 KQNTVESQKGMPEMNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENEKPVAVKK 534
K TV + G Q+ +Y + +VI G G+FG VY+ L E VA+KK
Sbjct: 2 KVTTVVATPGQGPDRPQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGEL-VAIKK 52
Query: 535 LYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFC------NEGEHRLLVYEYVSNGSLAD 588
+ + ++ E+ + + +H N+V+L F + + LV +YV
Sbjct: 53 VLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 589 FLF--RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARIS 645
R + + R L Y+H I H DIKPQN+LLD T ++
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 165
Query: 646 DFGLAKLLKTDQTQTTTAIRGTKGYVAP-EWFKNLPITAKVDVYSFGILLLELVCCRKNF 704
DFG AK L + + + Y AP F T+ +DV+S G +L EL+ + F
Sbjct: 166 DFGSAKQLVRGEPNVSYICS--RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 705 EVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRV-----------EKFVMIA 753
D+ + + + RE+ + E IK + + +
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 754 IWCIQEDPSLRPAMKKVTQ 772
++ P+ R +
Sbjct: 284 SRLLEYTPTARLTPLEACA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 6e-41
Identities = 45/290 (15%), Positives = 92/290 (31%), Gaps = 31/290 (10%)
Query: 500 VITGGFK--EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN 557
V+ +K +GEG+FG +++G N + VA+K + + + E
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLA 58
Query: 558 H-KNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL 616
+ + F EG H +LV + + D L R+ + A + +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 617 HEECKSQIIHCDIKPQNILLD-----GTFNARISDFGLAKLLKTDQT------QTTTAIR 665
HE +++ DIKP N L+ + DFG+ K + T + +
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFR 725
GT Y++ + + D+ + G + + + ++ + +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--------YE 226
Query: 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775
E E+F + P + +
Sbjct: 227 RIGEKKQSTPLRELCAGFP--EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-41
Identities = 60/287 (20%), Positives = 101/287 (35%), Gaps = 37/287 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQL 564
E++GEG +G VYK E VA+KK+ EIS + NH N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
L + LV+E++ F +GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D+KPQN+L++ +++DFGLA+ T + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 685 VDVYSFGILLLELVCCRKNF--------------------EVDATEECQMILADWAYDCF 724
VD++S G + E+V R F EV M ++ +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 725 RERKLGLLVEN-DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKV 770
+ +V DE+ + + + DP+ R + K
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQ----------MLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (373), Expect = 2e-40
Identities = 51/277 (18%), Positives = 99/277 (35%), Gaps = 19/277 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQL 564
E++GEG +G VYK + A+KK+ EIS + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYG--ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+ + +LV+E++ + G+ Y H+ +
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE-SVTAKSFLLQLLNGIAYCHDRR---V 121
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D+KPQN+L++ +I+DFGLA+ + T I + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744
+D++S G + E+V F + + M + + + + +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 745 RV-----------EKFVMIAIWCIQEDPSLRPAMKKV 770
E + + ++ DP+ R K+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 60/270 (22%), Positives = 99/270 (36%), Gaps = 27/270 (10%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNL 561
+ + LG+G FGKV + A+K L K V + E + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 562 VQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECK 621
L + V EY + G L L R+ + F A + L
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGAEIVSALEYLHS 123
Query: 622 SQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPI 681
+++ DIK +N++LD + +I+DFGL K +D T GT Y+APE ++
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDY 182
Query: 682 TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741
VD + G+++ E++C R F E ++ ++ EA
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTLSPEAKS 234
Query: 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVT 771
+ +++DP R
Sbjct: 235 LLAG----------LLKKDPKQRLGGGPSD 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 45/278 (16%), Positives = 98/278 (35%), Gaps = 19/278 (6%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQL 564
E++GEG +G V+K +E VA+K++ + EI + HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 565 LGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQI 624
+ + LV+E+ F + + L L +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 625 IHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAK 684
+H D+KPQN+L++ ++++FGLA+ + + F +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 685 VDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIK 744
+D++S G + EL + + Q+ E + + + + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 745 RVEKFVMIAI------------WCIQEDPSLRPAMKKV 770
++ + ++ +P R + ++
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 69/310 (22%), Positives = 118/310 (38%), Gaps = 38/310 (12%)
Query: 472 NQKKQNTVESQKGMPE-MNLQDFTYKELEVITGGFKEELGEGAFGKVYKGVLTTENE--K 528
K + + G E + +++F + LG GA+GKV+ + ++ K
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFE----------LLKVLGTGAYGKVFLVRKISGHDTGK 53
Query: 529 PVAVKKLYKAV----NEGEQEFKAEISAIGRTNHK-NLVQLLGFCNEGEHRLLVYEYVSN 583
A+K L KA + + + E + LV L L+ +Y++
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNAR 643
G L L ++ R ++ + + L K II+ DIK +NILLD +
Sbjct: 114 GELFTHLSQRERFTEHEVQIYVG----EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 644 ISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWF--KNLPITAKVDVYSFGILLLELVCCR 701
++DFGL+K D+T+ GT Y+AP+ + VD +S G+L+ EL+
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 702 KNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDP 761
F VD + Q ++ + A D I+R + +DP
Sbjct: 230 SPFTVDGEKNSQAEISRRILKSEPPYPQEM----SALAKDLIQR----------LLMKDP 275
Query: 762 SLRPAMKKVT 771
R
Sbjct: 276 KKRLGCGPRD 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 51/292 (17%), Positives = 102/292 (34%), Gaps = 33/292 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYK--AVNEGEQEFKAEISAIGRTNHKNLVQL 564
++G+G FG+V+K +K VA+KK+ EI + H+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQK-VALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 565 LGFCNEGEHR--------LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYL 616
+ C LV+++ + + +I L L
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS----EIKRVMQMLLNGL 130
Query: 617 HEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLL---KTDQTQTTTAIRGTKGYVAP 673
+ +++I+H D+K N+L+ +++DFGLA+ K Q T T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 674 EWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732
E +D++ G ++ E+ + + + +++ E +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 733 VENDEEAMDDIKRVEKFVMIAIW--------------CIQEDPSLRPAMKKV 770
E ++ +K ++ V + + DP+ R
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-36
Identities = 65/329 (19%), Positives = 113/329 (34%), Gaps = 35/329 (10%)
Query: 492 DFTYKELEVITGGFK------EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGE 543
F +E+ + + +G GA+G V V K VA+KKLY+
Sbjct: 3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAK-VAIKKLYRPFQSELFA 61
Query: 544 QEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFL---FRKSRRPNWY 600
+ E+ + H+N++ LL E ++ K +
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 601 KRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660
+ + + +GL Y+H IIH D+KP N+ ++ +I DFGLA+
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD----SE 174
Query: 661 TTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADW 719
T T+ Y APE N + T VD++S G ++ E++ + F+ + +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIW-------------CIQEDPSLRPA 766
E L + + M + +EK +I + D R
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 767 MKKVTQM--IEGAVDVSIPPDPASFISSI 793
+ E D P + S
Sbjct: 295 AGEALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 1e-35
Identities = 60/268 (22%), Positives = 99/268 (36%), Gaps = 30/268 (11%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQ 563
+ LG G+FG+V E+ A+K L K + + E + N LV+
Sbjct: 47 KTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 564 LLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQ 623
L + + +V EYV+ G + L R R A YLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSL---D 161
Query: 624 IIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITA 683
+I+ D+KP+N+L+D +++DFG AK T + GT +APE +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 684 KVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743
VD ++ G+L+ E+ F D + Y+ K+ + D +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVT 771
+ +Q D + R K
Sbjct: 270 RN----------LLQVDLTKRFGNLKNG 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (331), Expect = 2e-34
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 43/310 (13%)
Query: 491 QDFTYKELEVITGG-----FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQE 545
+ + Y+ V G +LG G + +V++ + T NEK V VK L +++
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK-VVVKILKP---VKKKK 75
Query: 546 FKAEISAIGR-TNHKNLVQLLGFCNEGEHRL--LVYEYVSNGSLADFLFRKSRRPNWYKR 602
K EI + N++ L + R LV+E+V+N + Y
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDI 131
Query: 603 MQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLKTDQTQTT 661
+ + L Y H I+H D+KP N+++D R+ D+GLA+ Q
Sbjct: 132 RFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 662 TAIRGTKGYVAPE-WFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMIL---- 716
++ + PE +D++S G +L ++ ++ F Q++
Sbjct: 189 RV--ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 717 --ADWAYDCFRERKLGLLVE-NDEEAMDDIKRVEKFVMIAIW-------------CIQED 760
+ YD + + L ND KR E+FV ++ D
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 761 PSLRPAMKKV 770
R ++
Sbjct: 307 HQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 18/206 (8%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQL 564
+ +G GA G V + VA+KKL + + E+ + NHKN++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 565 LGFC------NEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE 618
L E + LV E + + + + + G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 619 ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN 678
IIH D+KP NI++ +I DFGLA+ + T T+ Y APE
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG 192
Query: 679 LPITAKVDVYSFGILLLELVCCRKNF 704
+ VD++S G ++ E+V + F
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 57/285 (20%), Positives = 104/285 (36%), Gaps = 31/285 (10%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGE--QEFKAEISAIGRTNHKNLVQL 564
+G GA+G V T + VAVKKL + + E+ + H+N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 565 LGFCNEGE-----HRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE 619
L + + + ++ L + K ++ + + RGL Y+H
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 620 CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKN- 678
IIH D+KP N+ ++ +I DFGLA+ T T+ Y APE N
Sbjct: 141 D---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNW 193
Query: 679 LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738
+ VD++S G ++ EL+ R F + ++ E + E+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 739 AMDDIKRVEKFVMIAIW-------------CIQEDPSLRPAMKKV 770
+ + ++ K ++ + D R +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 5e-28
Identities = 51/236 (21%), Positives = 78/236 (33%), Gaps = 21/236 (8%)
Query: 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQL 564
+LG G F V+ N VA+K + + + EI + R N + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTH-VAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 565 LGFCNEGEHRLLVY---------------EYVSNGSLADFLFRKSRRPNWYKRMQIAFGT 609
+LL + E + LA + R QI+
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 610 ARGLFYLHEECKSQIIHCDIKPQNILLDGT-FNARISDFGLAKLLKTDQTQTTTA-IRGT 667
GL Y+H C IIH DIKP+N+L++ + +A L T
Sbjct: 135 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 668 KGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDC 723
+ Y +PE P D++S L+ EL+ FE D A
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 4e-20
Identities = 29/201 (14%), Positives = 57/201 (28%), Gaps = 26/201 (12%)
Query: 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE----------GEQEFKAEISAIGRT 556
+ +GEG V+ +E VK G+ F R
Sbjct: 6 KLMGEGKESAVFNC--YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRM-QIAFGTARGLFY 615
+ L +L G Y + N L + + K + ++ +
Sbjct: 64 EFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 616 LHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEW 675
+ I+H D+ N+L+ I DF + + + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE---RDVRNIITY 171
Query: 676 FKNLPITAKVDVYSFGILLLE 696
F + D+ S +L+
Sbjct: 172 FSR-TYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 78.8 bits (194), Expect = 3e-18
Identities = 24/143 (16%), Positives = 46/143 (32%), Gaps = 36/143 (25%)
Query: 65 IWFNEIPERTIVWSANRDNLVQRGS-KVELTGDGQLILRDSSGKEIWREPPSTG-AAYAA 122
I ++ + + +Q ++ + D L+L D + G A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 123 MLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQT 182
+ G + + + + +W S + S+GR++F LQ
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQP 106
Query: 183 DGNLLLYTTTYPFDGANAAYWST 205
D NL +Y A W+T
Sbjct: 107 DRNLAIY---------GGALWTT 120
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 75.4 bits (185), Expect = 5e-17
Identities = 25/145 (17%), Positives = 44/145 (30%), Gaps = 35/145 (24%)
Query: 65 IWFNEIPERTIVWSANRDNLVQRGS-KVELTGDGQLILRDSSGKEIWREPPSTGAAYAAM 123
I F E + + + ++ S + + D L+L DS + A +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 124 LDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTD 183
G LV+ + ++ W S T S G ++ LQ D
Sbjct: 63 QSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQPD 97
Query: 184 GNLLLYTTTYPFDGANAAYWSTQTS 208
+ +Y W + TS
Sbjct: 98 RTVTIY---------GPGLWDSGTS 113
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 69.6 bits (170), Expect = 5e-15
Identities = 21/100 (21%), Positives = 43/100 (43%), Gaps = 13/100 (13%)
Query: 46 SGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSS 105
+ F ++ + L ++ + T VW++N L ++G K L DG ++ D+
Sbjct: 18 VEPYHFIMQEDCN----LVLYDH----STSVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69
Query: 106 GKEIW--REPPSTGAAYAAMLDTGNLVLASQDSSTMWESF 143
G+ +W G + + GN+V+ S +W +
Sbjct: 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIY---GSDIWSTG 106
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 48.4 bits (115), Expect = 1e-07
Identities = 23/129 (17%), Positives = 40/129 (31%), Gaps = 38/129 (29%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSSGKEIW---REPPSTGAAYAAMLDTGNLVLASQDSST 138
+L + D L+L D +W A + GN V+ + +
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRS 72
Query: 139 MWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGA 198
+W S + +G ++ LQ DGN+++Y
Sbjct: 73 LWASH-------------------------SVRGNGNYVLVLQEDGNVVIY--------- 98
Query: 199 NAAYWSTQT 207
+ WST T
Sbjct: 99 GSDIWSTGT 107
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 42.3 bits (99), Expect = 2e-05
Identities = 19/116 (16%), Positives = 38/116 (32%), Gaps = 21/116 (18%)
Query: 148 DTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+ L + + G + + F +Q D NL+LY + + W++ T
Sbjct: 2 NLLTNGEGLYAGQ---------SLDVEPYHFIMQEDCNLVLY-------DHSTSVWASNT 45
Query: 208 S--IGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261
G + V G + G + +++ + V+ DG Y
Sbjct: 46 GILGKKGCKAVLQSDGNFVVYDAEGRS---LWASHSVRGNGNYVLVLQEDGNVVIY 98
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 69.3 bits (169), Expect = 7e-15
Identities = 26/132 (19%), Positives = 48/132 (36%), Gaps = 22/132 (16%)
Query: 140 WESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGAN 199
+ D+ L T+ + E + + + F +QTD NL+LY D N
Sbjct: 7 KQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLY------DNNN 49
Query: 200 AAYWSTQTSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFR 259
+ + +G+G + V G + + V + V + + V+ PD
Sbjct: 50 PIWATNTGGLGNGCRAVLQPDGVLVVITNEN---VTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 260 HYIYPKSSASTG 271
IY + +T
Sbjct: 107 --IYGDALWATQ 116
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.5 bits (102), Expect = 9e-06
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 74 TIVWSANRDNLVQRGSKVELTGDGQLILRDSSGKEIWR--EPPSTGAAYAAMLDTGNLVL 131
+W+ N L G + L DG L++ + +W+ G + N+V+
Sbjct: 49 NPIWATNTGGLGN-GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 132 ASQDSSTMWES 142
+W +
Sbjct: 108 Y---GDALWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.7 bits (100), Expect = 1e-05
Identities = 20/100 (20%), Positives = 34/100 (34%), Gaps = 17/100 (17%)
Query: 115 STGAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR-------LT 167
T M NLVL + + +W + + G V+ +
Sbjct: 28 GTHVYRFIMQTDCNLVLYDNN-NPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQS 86
Query: 168 ETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+G ++ LQ D N+++Y A W+TQT
Sbjct: 87 PVAGKAGHYVLVLQPDRNVVIY---------GDALWATQT 117
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 57.5 bits (138), Expect = 9e-11
Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 19/115 (16%)
Query: 147 TDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQ 206
+D L + G + G ++F +Q D NL+LY D A + S
Sbjct: 1 SDRLNSGHQLDTGGS---------LAEGGYLFIIQNDCNLVLY------DNNRAVWASGT 45
Query: 207 TSIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261
SG + G + + + + A+ ++N Q+ ++ D Y
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGS----RAIWASNTNRQNGNYYLILQRDRNVVIY 96
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 54.4 bits (130), Expect = 1e-09
Identities = 15/104 (14%), Positives = 37/104 (35%), Gaps = 10/104 (9%)
Query: 46 SGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDSS 105
G + F + + ++ N VW++ + G +++ DG L++ S
Sbjct: 18 EGGYLFIIQNDCNL----VLYDNNRA----VWASGTNG-KASGCVLKMQNDGNLVIYSGS 68
Query: 106 GKEIWREPPSTGAAYAAML-DTGNLVLASQDSSTMWESFDDPTD 148
Y +L N+V+ ++ +W + + +
Sbjct: 69 RAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 40.6 bits (94), Expect = 9e-05
Identities = 28/133 (21%), Positives = 51/133 (38%), Gaps = 37/133 (27%)
Query: 82 DNLVQRGSKVELTGDGQLILRDSSGKEIW---REPPSTGAAYAAMLDTGNLVLASQDSST 138
+L + G + D L+L D+ + +W ++G M + GNLV+ S +
Sbjct: 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGC-VLKMQNDGNLVIYSGSRAI 71
Query: 139 MWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGA 198
+ N +G + LQ D N+++Y D +
Sbjct: 72 WASNT--------------------------NRQNGNYYLILQRDRNVVIY------DNS 99
Query: 199 NAAYWSTQTSIGS 211
N A W+T T++G+
Sbjct: 100 NNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 51.6 bits (123), Expect = 9e-09
Identities = 21/124 (16%), Positives = 42/124 (33%), Gaps = 20/124 (16%)
Query: 148 DTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207
+ L + +S G + G F+F +Q D NL+LY D + +
Sbjct: 2 NILYSGETLSTGE---------FLNYGSFVFIMQEDCNLVLY------DVDKPIWATNTG 46
Query: 208 SIGSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHYIYPKSS 267
+ + G + + + + ++N Q+ ++ D IY
Sbjct: 47 GLSRSCFLSMQTDGNLVVYNPSNKP---IWASNTGGQNGNYVCILQKDRNVV--IYGTDR 101
Query: 268 ASTG 271
+TG
Sbjct: 102 WATG 105
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 42.7 bits (100), Expect = 1e-05
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 14/102 (13%)
Query: 45 QSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILRDS 104
G F F ++ + L ++ + P W+ N + R + + DG L++ +
Sbjct: 17 NYGSFVFIMQEDCN----LVLYDVDKPI----WATNTGG-LSRSCFLSMQTDGNLVVYNP 67
Query: 105 SGKEIWREPPSTGA--AYAAMLDTGNLVLASQDSSTMWESFD 144
S K IW + N+V+ D W +
Sbjct: 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGT 106
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 793 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.77 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.72 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.59 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.54 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.08 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.06 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.02 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.98 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.57 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.01 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.25 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 80.1 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-49 Score=416.43 Aligned_cols=269 Identities=23% Similarity=0.414 Sum_probs=206.7
Q ss_pred CCCCHHHHHHHhccc-----------ccccccccceeEEEeEeCCCCc--eeEEEEEechhc-ccchHHHHHHHHHHhcC
Q 003818 491 QDFTYKELEVITGGF-----------KEELGEGAFGKVYKGVLTTENE--KPVAVKKLYKAV-NEGEQEFKAEISAIGRT 556 (793)
Q Consensus 491 ~~~~~~el~~~t~~f-----------~~~LG~G~fg~Vy~~~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l 556 (793)
..++|+++..++.+| .+.||+|+||+||+|.+...++ ..||||++.... ....+.|.+|+.+|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 344566666665544 3579999999999999764432 468999886543 33456799999999999
Q ss_pred CccccceeeeEEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 557 NHKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 557 ~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
+|||||+++|++.+++..++|||||++|+|.+++......+++.+++.++.|||+||.|||++ +|+||||||+||||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999999999988777899999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCcc----eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhH
Q 003818 637 DGTFNARISDFGLAKLLKTDQTQT----TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEE 711 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~ 711 (793)
+.++.+||+|||+++.+....... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998765443222 112357899999999999999999999999999999998 899998766544
Q ss_pred HHHHHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 712 CQMILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.... +..+.... . +...+..+.+++.+||+.||++||||+||++.|+.++.
T Consensus 242 ~~~~--------i~~~~~~~---~------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 242 VINA--------IEQDYRLP---P------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHH--------HHTTCCCC---C------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHH--------HHcCCCCC---C------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 2211 11111111 1 11234567899999999999999999999999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=407.75 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=198.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|++.+++..++||||+++|
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEECCSSCCEEEEEET--TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 4578999999999999975 4567999999764 345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..++.++.|||+||.|||++ +|+||||||+|||+++++.+||+|||+++.............
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 99999988878899999999999999999999998 999999999999999999999999999987765544444446
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.||+.|+|||++.+..++.++|||||||++|||+|+ +.|+......+....+ ..+..... +.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i--------~~~~~~~~---------p~ 225 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRLYK---------PR 225 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH--------HHTCCCCC---------CT
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HhcCCCCC---------cc
Confidence 689999999999999999999999999999999995 5555544433322111 11111111 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
....++.+++.+||+.||++||||+||++.|+++.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 12356789999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=403.36 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=200.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechh--cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKA--VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
+.+.||+|+||+||+|++. ..||||+++.. ..+..+.|.+|+.++++++|||||++++++.+ +..++|||||+
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 3578999999999999863 24999998653 23445789999999999999999999998764 56899999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cce
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTT 661 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~ 661 (793)
+|+|.+++......+++..+..|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....... ...
T Consensus 87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9999999988777899999999999999999999998 999999999999999999999999999987654332 233
Q ss_pred ecccCcccccCcccccCC---CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 662 TAIRGTKGYVAPEWFKNL---PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~---~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
....||+.|||||++.+. .++.++|||||||++|||+||+.||......+... ..+..+........
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~~p~~~~--- 233 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-------FMVGRGYLSPDLSK--- 233 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-------HHHHHTSCCCCGGG---
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH-------HHHhcCCCCCcchh---
Confidence 456799999999998643 58999999999999999999999998765433211 11111211111100
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.....++.+.+++.+||+.||++||||+||++.|+.+.
T Consensus 234 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 234 --VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp --SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11123456889999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=391.96 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=213.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
|.++||+|+||+||+|+++ +++.||||+++.. ....++|.+|+.++++++|||||+++|++.+++..++||||+++|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCEETTEEEEEEEET--TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred EeEEEecCCCeEEEEEEEC--CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 5688999999999999974 5678999999764 335678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceecc
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAI 664 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 664 (793)
+|.+++......+++..+.+++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.............
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 99999988878889999999999999999999998 999999999999999999999999999987766555445556
Q ss_pred cCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 665 RGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
.+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+....+ ..+...... .
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i--------~~~~~~~~p---------~ 224 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRLYRP---------H 224 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HTTCCCCCC---------T
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--------HhCCCCCCc---------c
Confidence 78999999999999999999999999999999998 79999887765532222 222111111 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
.....+.+++.+||+.||++|||+++|++.|..
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 123567899999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-48 Score=404.46 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=210.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||+||+|++. .+++.||||+++... ...++|.+|+.+|++++|||||++++++.+++..++||||+++|
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence 4578999999999999965 356889999997643 34578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..+..|+.||++||.|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 99 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 175 (287)
T d1opja_ 99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175 (287)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred chHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence 999999754 56789999999999999999999998 99999999999999999999999999999876655554555
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhH
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDI 743 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (793)
..|++.|+|||++.+..++.++|||||||++|||++|..|+......... ...+..+...... .
T Consensus 176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~-------~~~i~~~~~~~~~---------~ 239 (287)
T d1opja_ 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDYRMERP---------E 239 (287)
T ss_dssp EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHHTTCCCCCC---------T
T ss_pred ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH-------HHHHhcCCCCCCC---------c
Confidence 56899999999999999999999999999999999987776543332211 1112222111111 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 744 KRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 744 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..++.+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12356889999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=398.13 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=205.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||+||+|... .+++.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+++|+
T Consensus 25 ~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp CEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 478999999999999854 5678999999987666667789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.++ .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..... ......
T Consensus 104 L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~ 177 (293)
T d1yhwa1 104 LTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (293)
T ss_dssp HHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred HHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccccc
Confidence 99988653 588999999999999999999998 999999999999999999999999999987654332 233456
Q ss_pred CcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhhHHH
Q 003818 666 GTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDDIKR 745 (793)
Q Consensus 666 gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (793)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... + ..+...
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------~~~~~~~-~-------~~~~~~ 242 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPE-L-------QNPEKL 242 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHHCSCC-C-------SSGGGS
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH-------HhCCCCC-C-------CCcccC
Confidence 999999999999999999999999999999999999999876544322111 1111110 0 011122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 746 VEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 746 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...+.+++.+||+.||++|||++|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 356789999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=398.07 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=202.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|.++ +++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+++|
T Consensus 17 ~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 17 LVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp EEEEEEEETTEEEEEEEET--TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred EeEEEecCCCcEEEEEEEC--CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 4578999999999999975 4578999999764 3445789999999999999999999998865 5679999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++... ...+++..++.|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.+..........
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 999988654 33589999999999999999999998 99999999999999999999999999999876555444445
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCC-CCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNF-EVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..||+.|+|||++.+..++.++|||||||++|||+||..|+ ......+... .+..+......
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~--------~i~~~~~~~~p--------- 232 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ--------NLERGYRMVRP--------- 232 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------HHHTTCCCCCC---------
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHhcCCCCCc---------
Confidence 67899999999999999999999999999999999966554 4433332111 11222111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...++.+.+|+.+||+.||++||||+||+++|+.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1123467899999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=395.94 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=205.1
Q ss_pred ccccccceeEEEeEeCC-CCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 508 ELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 508 ~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
+||+|+||.||+|.+.. .++..||||+++.... ...++|.+|+++|++++|||||+++|++.+ +..+|||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 49999999999998753 3456799999976433 345789999999999999999999999865 56899999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc--eec
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT--TTA 663 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 663 (793)
|.+++......+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 9999987777899999999999999999999998 99999999999999999999999999998776543322 223
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
..||+.|+|||++.+..++.++|||||||++|||+| |+.||......+... .+..+.......
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~--------~i~~~~~~~~p~-------- 235 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--------FIEQGKRMECPP-------- 235 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH--------HHHTTCCCCCCT--------
T ss_pred cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcCCCCCCCC--------
Confidence 458899999999999999999999999999999998 899998766544221 222232221111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
..+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 236 -~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 236 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 123567899999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=401.00 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=205.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNGS 585 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 585 (793)
.+.||+|+||.||+|... .+++.||||++........+.+.+|++++++++|||||++++++.+++..++|||||++|+
T Consensus 17 ~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 478999999999999854 4678899999987666667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceeccc
Q 003818 586 LADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTAIR 665 (793)
Q Consensus 586 L~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 665 (793)
|.+++.+....+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+|+...... .......
T Consensus 96 L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~ 171 (288)
T d2jfla1 96 VDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI 171 (288)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccccc
Confidence 9999887777799999999999999999999998 99999999999999999999999999997543221 1223356
Q ss_pred CcccccCccccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 666 GTKGYVAPEWFK-----NLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 666 gt~~y~aPE~~~-----~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
||+.|+|||++. +..++.++|||||||++|||++|+.||......+....+ . .+....+ .
T Consensus 172 Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i-------~-~~~~~~~-------~ 236 (288)
T d2jfla1 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-------A-KSEPPTL-------A 236 (288)
T ss_dssp SCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-------H-HSCCCCC-------S
T ss_pred cccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH-------H-cCCCCCC-------C
Confidence 999999999984 456899999999999999999999999876654422211 1 1111111 1
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.+......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11123456789999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=391.87 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=203.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|+.. .+++.||+|++.+.. ....+.+.+|+.++++++|||||++++++.+++..++|||||
T Consensus 10 i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 4578999999999999964 467899999987532 334577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++.+. ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~ 161 (263)
T d2j4za1 89 PLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---R 161 (263)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---C
T ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---c
Confidence 999999999754 4588999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~~-p-------- 224 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SRVEFTF-P-------- 224 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCCC-C--------
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCCC-C--------
Confidence 3456999999999999999999999999999999999999999876654422211 1221110 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
....+.+.+++.+||+.||++|||++||++
T Consensus 225 -~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 -DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 012356788999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=397.35 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=201.1
Q ss_pred cccccccceeEEEeEeCC-CCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 507 EELGEGAFGKVYKGVLTT-ENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
++||+|+||.||+|.+.. ..++.||||+++.... ...++|.+|+.++++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 4568899999965432 234679999999999999999999999965 467899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc--e
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT--T 661 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~ 661 (793)
|+|.+++... ..+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998754 5688999999999999999999998 99999999999999999999999999998765543332 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+... .+..+......
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~--------~i~~~~~~~~p------- 232 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------MLEKGERMGCP------- 232 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------HHHTTCCCCCC-------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH--------HHHcCCCCCCC-------
Confidence 23568999999999999999999999999999999998 899998766544221 12222211111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 233 --~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 --AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1123567899999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=399.25 Aligned_cols=257 Identities=25% Similarity=0.438 Sum_probs=201.0
Q ss_pred cccccccccceeEEEeEeCCCCc---eeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|.+...++ ..||||++..... ....+|.+|+.++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 35789999999999999765433 5799999965433 3345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc-
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
+.+++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 999999999988888899999999999999999999998 9999999999999999999999999999876544322
Q ss_pred -ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 660 -TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
......||+.|+|||++.+..++.++|||||||++|||+++..|+........ + ...+..+.....
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---~----~~~i~~~~~~~~------ 234 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---V----MKAINDGFRLPT------ 234 (283)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHTTCCCCC------
T ss_pred eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---H----HHHHhccCCCCC------
Confidence 22234589999999999999999999999999999999997666544332221 1 112222221111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDV 780 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 780 (793)
+...+..+.+|+.+||+.||++||||+||+++|+.+...
T Consensus 235 ---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 ---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111335678999999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=394.90 Aligned_cols=248 Identities=30% Similarity=0.388 Sum_probs=199.0
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||+||+|+.. .+++.||||++.... .+..+.+.+|+.++++++|||||++++++.+++..+|||||+++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 3478999999999999864 457889999986543 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-ccee
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~ 662 (793)
|+|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+.+..... ....
T Consensus 88 g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 88 GELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp EEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 999999854 45688999999999999999999998 999999999999999999999999999987654432 2334
Q ss_pred cccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...||+.|||||++.+..+ +.++|||||||++|||++|+.||........... ........ ...
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-------~~~~~~~~--~~~------ 228 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-------DWKEKKTY--LNP------ 228 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-------HHHTTCTT--STT------
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-------HHhcCCCC--CCc------
Confidence 4679999999999988876 5789999999999999999999976543321111 01111110 000
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112345778999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=392.82 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=191.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec--CCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--GEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey 580 (793)
+.+.||+|+||.||+|+.. .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+ .+..++||||
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 3578999999999999854 467889999986543 2234678999999999999999999999864 4568999999
Q ss_pred cCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 581 VSNGSLADFLFR---KSRRPNWYKRMQIAFGTARGLFYLHEEC--KSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 581 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
|++|+|.+++.+ ....+++..++.++.|+++||.|||++. ..+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 999999999864 3567899999999999999999999862 12499999999999999999999999999987654
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+..+....+.
T Consensus 167 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~--------~i~~~~~~~~~-- 235 (269)
T d2java1 167 DTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG--------KIREGKFRRIP-- 235 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHTCCCCCC--
T ss_pred CCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH--------HHHcCCCCCCC--
Confidence 332 2334669999999999999999999999999999999999999998765544221 12222222111
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...++.+.+++.+||+.||++|||++||++
T Consensus 236 -------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 -------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112356789999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=387.50 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=195.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec----CCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE----GEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 578 (793)
|.++||+|+||+||+|... .+++.||+|++.... ....+.+.+|+++|++++|||||++++++.+ ....++||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4568999999999999864 467789999986543 2334678999999999999999999999865 35679999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc-CCCcEEEeecCCccccCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD-GTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~ 657 (793)
||+++|+|.+++.+. ..+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999654 4688899999999999999999987 22399999999999996 5889999999999864432
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
......||+.|||||++.+ +++.++|||||||++|||++|+.||......+.. ...+..+......
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-------~~~i~~~~~~~~~---- 234 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVKPASF---- 234 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCCCGGG----
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH-------HHHHHcCCCCccc----
Confidence 2334679999999999876 6999999999999999999999999765433211 1111221111100
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+.....++.+++.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112345788999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=400.08 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=203.2
Q ss_pred cccccccccceeEEEeEeCCCC----ceeEEEEEechh-cccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN----EKPVAVKKLYKA-VNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||+||+|+....+ ...||+|++... .......+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 5688999999999999865332 347999998654 333456789999999998 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 579 EYVSNGSLADFLFRKS----------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
|||++|+|.++|..+. ..+++..++.++.||++||+|||++ +|+||||||+|||+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill 197 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 197 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcccc
Confidence 9999999999997653 2478889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQM 714 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~ 714 (793)
+.++.+||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~ 277 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998765544332 334568999999999999999999999999999999998 899998755433211
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIE 775 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 775 (793)
..+..+..... +...++.+.+|+.+||+.||++|||++||++.|.
T Consensus 278 -------~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 278 -------KLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -------HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------HHHhcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11122211111 1112356889999999999999999999999995
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=390.50 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=200.0
Q ss_pred ccccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.+.||+|+||.||+|+++ +++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp EEEEEEEECSSCEEEEEEET--TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred EEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 45688999999999999875 3356999999754 3456789999999999999999999999854 568999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|..++... ...+++.+++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9999998754 45689999999999999999999998 9999999999999999999999999999877655544445
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++....++.++|||||||++|||++|..|+......... + ..+..+......
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~--~-----~~i~~~~~~~~~--------- 236 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--L-----DQVERGYRMPCP--------- 236 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H-----HHHHTTCCCCCC---------
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH--H-----HHHHhcCCCCCC---------
Confidence 566899999999999999999999999999999999976665443332211 1 111112111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVDVSIP 783 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~p 783 (793)
....+.+.+++.+||+.||++||||++|+++|+.......|
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 11235678999999999999999999999999986544333
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=391.45 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=200.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 90 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 90 (288)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEcc
Confidence 4578999999999999854 457889999997532 334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC-cc
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-QT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 660 (793)
++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..... ..
T Consensus 91 ~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 91 KNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999988654 4688999999999999999999998 999999999999999999999999999987754432 23
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ....... .
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~~-p------- 230 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------IKLEYDF-P------- 230 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCCC-C-------
T ss_pred cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH--------HcCCCCC-C-------
Confidence 34457999999999999999999999999999999999999999876554422211 1222110 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+|+.+||+.||++|||++|+++
T Consensus 231 --~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 --EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 012346789999999999999999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=398.59 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=199.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.++||+|+||+||+|... .+++.||+|+++.... ...+.+.+|+.+|++++|||||++++++.++++.++||||+++|
T Consensus 11 ~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 378999999999999854 5678999999975432 33467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+|.+++.+. ..+++..+..++.|+++||.|||+ + +|+||||||+|||+++++.+||+|||+|+.+... ....
T Consensus 90 ~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~ 162 (322)
T d1s9ja_ 90 SLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 162 (322)
T ss_dssp EHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC--
T ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---cccc
Confidence 999999765 458899999999999999999996 5 8999999999999999999999999999865432 2234
Q ss_pred ccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcc---------ccc-eee
Q 003818 664 IRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER---------KLG-LLV 733 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~---------~~~-~~~ 733 (793)
..||+.|+|||++.+.+++.++||||+||++|||++|+.||......+................ ... ...
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 5799999999999999999999999999999999999999987654432111000000000000 000 000
Q ss_pred cc--cchhhh--------------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 EN--DEEAMD--------------DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~~--~~~~~~--------------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
+. ...... .......+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000000 0012356889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.6e-46 Score=398.42 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=207.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|+.. .+++.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||++|
T Consensus 30 i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 4578999999999999854 467899999997765555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD--GTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++.+....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+..... ..
T Consensus 109 ~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~ 183 (350)
T d1koaa2 109 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VK 183 (350)
T ss_dssp BHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--EE
T ss_pred CHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc--cc
Confidence 99999987777899999999999999999999998 999999999999995 468899999999987654332 33
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ ......... ...
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~~~~------~~~ 249 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDWNMDD------SAF 249 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCSCC------GGG
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCCc------ccc
Confidence 456999999999999999999999999999999999999999877654432221 111111000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
....+.+.+|+.+||+.||++|||++|+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123567899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-45 Score=396.74 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=207.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||.||+|... .+++.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||++|
T Consensus 33 i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 4578999999999999854 467899999997665555678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc--CCCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD--GTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++......+++.++..|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.+..... ..
T Consensus 112 ~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~~ 186 (352)
T d1koba_ 112 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VK 186 (352)
T ss_dssp BHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EE
T ss_pred hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc--ee
Confidence 99999887777899999999999999999999998 999999999999997 678999999999987765432 34
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+....... ..
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~~~~~------~~ 252 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------KRCDWEFDED------AF 252 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HHCCCCCCSS------TT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCCcc------cc
Confidence 456999999999999999999999999999999999999999876654422111 1111111100 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+|+.+||+.||++|||++|+++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122356789999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=390.00 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=188.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..+||||||++
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~g 91 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG 91 (307)
T ss_dssp EEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 4578999999999999854 467889999997543 23345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCCCCCcc
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
|+|.+++..+ ..+++..+..++.||+.||.|||++ +|+||||||+|||+. +++.+||+|||+++...... .
T Consensus 92 g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~ 165 (307)
T d1a06a_ 92 GELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--V 165 (307)
T ss_dssp CBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred CcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--e
Confidence 9999999654 5689999999999999999999998 999999999999994 57899999999998654332 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.......
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~~~~~------ 231 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------LKAEYEFDSP------ 231 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HTTCCCCCTT------
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCCCCCc------
Confidence 23456999999999999999999999999999999999999999876654422211 1111111100
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122356789999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=383.52 Aligned_cols=252 Identities=20% Similarity=0.337 Sum_probs=196.6
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|++...+ +..||||+++..... ..+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 4578999999999999875433 457899988654333 3467999999999999999999999996 46789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++......+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||+++.+........
T Consensus 90 ~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~ 166 (273)
T d1mp8a_ 90 TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166 (273)
T ss_dssp TTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred cCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcceec
Confidence 99999999988878899999999999999999999998 999999999999999999999999999987765544444
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
....||+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +..+......
T Consensus 167 ~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~--------i~~~~~~~~~------- 231 (273)
T d1mp8a_ 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--------IENGERLPMP------- 231 (273)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--------HHTTCCCCCC-------
T ss_pred cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCCCCC-------
Confidence 55668999999999999999999999999999999998 8889987765542221 1222211111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
...++.+.+|+.+||+.||++|||++||++.|+.+
T Consensus 232 --~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12235688999999999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-45 Score=385.96 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=208.0
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhccc-chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVNE-GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||+||+|+... .+++.||||++...... ..++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 35789999999999998643 45688999999764333 35679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEE
Q 003818 580 YVSNGSLADFLFRKS-----------------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILL 636 (793)
Q Consensus 580 y~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll 636 (793)
|+++|+|.+++.... ..+++..++.|+.|++.||+|||++ +||||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEE
Confidence 999999999996432 2478889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCC-cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCC-cCCCCCchhHHHH
Q 003818 637 DGTFNARISDFGLAKLLKTDQT-QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR-KNFEVDATEECQM 714 (793)
Q Consensus 637 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~-~pf~~~~~~~~~~ 714 (793)
+.++.+||+|||+++.+..... .......+++.|+|||.+.+..++.++|||||||++|||++|. .||......+...
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~ 253 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH
Confidence 9999999999999986644332 2333456889999999999999999999999999999999996 5777665554322
Q ss_pred HHHHHHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 715 ILADWAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
.+..+....... ..+.++.+|+.+||+.+|++||||.||+++|+.+.+
T Consensus 254 --------~v~~~~~~~~p~---------~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 254 --------YVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp --------HHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --------HHHcCCCCCCCc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 122333222111 122467889999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-45 Score=387.64 Aligned_cols=241 Identities=27% Similarity=0.337 Sum_probs=197.9
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|+.. .+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|||||+
T Consensus 20 l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 467999999999999854 4678999999875432 233578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|..++..+ ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 99 ~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----~ 169 (309)
T d1u5ra_ 99 GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169 (309)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----C
T ss_pred CCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-----C
Confidence 99997666443 5689999999999999999999998 9999999999999999999999999999865432 2
Q ss_pred cccCcccccCcccccC---CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchh
Q 003818 663 AIRGTKGYVAPEWFKN---LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEA 739 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~---~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 739 (793)
...||+.|||||++.+ ..++.++|||||||++|||++|+.||......+....+ .. +.......
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i-------~~-~~~~~~~~----- 236 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQ-NESPALQS----- 236 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HH-SCCCCCSC-----
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------Hh-CCCCCCCC-----
Confidence 3469999999999864 45899999999999999999999999876544322111 11 11111111
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 740 MDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 740 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
...++.+.+++.+||+.||++|||++|+++
T Consensus 237 ---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 ---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112356889999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=389.46 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=205.9
Q ss_pred ccccccccccceeEEEeEeCCCCc--eeEEEEEechh-cccchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEe
Q 003818 504 GFKEELGEGAFGKVYKGVLTTENE--KPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYE 579 (793)
Q Consensus 504 ~f~~~LG~G~fg~Vy~~~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 579 (793)
+|.++||+|+||+||+|.+...++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 567889999999999999865443 46899999753 33345789999999999999999999999865 567899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
||++|+|.+++.......++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999999988888888999999999999999999998 9999999999999999999999999999876544322
Q ss_pred c---eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 660 T---TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 660 ~---~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ + . ..+..+......
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~---~-~~i~~g~~~~~p--- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I---T-VYLLQGRRLLQP--- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------C---H-HHHHTTCCCCCC---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---H---H-HHHHcCCCCCCc---
Confidence 2 2234689999999999999999999999999999999998888865432211 1 1 111222211111
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
....+.+.+++.+||+.||++||||.||++.|+.+..
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1123467899999999999999999999999987543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=382.48 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=198.0
Q ss_pred cccccccccceeEEEeEeCCCC--ceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLTTEN--EKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|++...+ ...||||++.... .+..++|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence 4578999999999999875443 3578999986542 2334689999999999999999999999976 46789999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCc
Q 003818 580 YVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQ 659 (793)
Q Consensus 580 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 659 (793)
|+++|+|.+++..+...+++..++.++.|||+||.|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 91 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred eecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 9999999999887777899999999999999999999998 9999999999999999999999999999977554433
Q ss_pred c--eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeeccc
Q 003818 660 T--TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVEND 736 (793)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 736 (793)
. .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+... .....+......
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~-------~i~~~~~~~~~~--- 237 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------KIDKEGERLPRP--- 237 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHTSCCCCCCC---
T ss_pred ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH-------HHHhCCCCCCCc---
Confidence 2 223457889999999999999999999999999999998 899998776554221 111222111111
Q ss_pred chhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 737 EEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 737 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
...+..+.+++.+||+.||++||||+||++.|++.
T Consensus 238 ------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 ------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11234678999999999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=381.48 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=202.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc------cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||+||+|... .+++.||||++.+... ...+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999864 4678999999865321 23467999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC----cEEEeecCCccccC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF----NARISDFGLAKLLK 654 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~ 654 (793)
|||++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 93 ELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999765 4689999999999999999999998 999999999999998776 49999999998765
Q ss_pred CCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 169 ~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~~~-- 236 (293)
T d1jksa_ 169 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAVNYEFE-- 236 (293)
T ss_dssp TSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCCCC--
T ss_pred CCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcCCCCC--
Confidence 432 223456899999999999999999999999999999999999999877655422211 11111100
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 237 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 237 ----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111123456789999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=375.19 Aligned_cols=244 Identities=27% Similarity=0.376 Sum_probs=194.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec-CCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE-GEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|.+ .++.||||+++.. ...+.|.+|++++++++|||||+++|++.+ .+..++||||+++
T Consensus 11 ~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEECSSCEEEEEEE---TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred EeEEEecCCCeEEEEEEE---CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 457899999999999997 3578999999653 345789999999999999999999999865 4568999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 584 GSLADFLFRKS-RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 584 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
|+|.+++..+. ..+++..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 158 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC----c
Confidence 99999997643 3588999999999999999999998 99999999999999999999999999998654322 2
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
...++..|+|||++.+..+++++||||||+++|||+| |+.||......+.... +..+.......
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~--------i~~~~~~~~~~------- 223 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDAPD------- 223 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--------HTTTCCCCCCT-------
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH--------HHcCCCCCCCc-------
Confidence 2357889999999999999999999999999999998 6778876655442221 22222222111
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
....++.+++.+||+.||++||||++|+++|+.+
T Consensus 224 --~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 224 --GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1235678999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=388.57 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=201.3
Q ss_pred cccccccccceeEEEeEeCCCCc---eeEEEEEechh-cccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE---KPVAVKKLYKA-VNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||+||+|.+...+. ..||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++++||
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEe
Confidence 34789999999999998754332 36899988653 334567899999999999999999999999864 56788999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+.+|+|.+++..+...+++..++.++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 92 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp CTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred ccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence 999999999988888899999999999999999999998 99999999999999999999999999998775544332
Q ss_pred -eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccch
Q 003818 661 -TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEE 738 (793)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 738 (793)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+ ..+.....
T Consensus 169 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i--------~~~~~~~~------ 234 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLPQ------ 234 (317)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH--------HHTCCCCC------
T ss_pred cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCCCC------
Confidence 233468999999999999999999999999999999998 78888876554422211 12211111
Q ss_pred hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 739 AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 739 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
+...+..+.+++.+||+.||++|||++||++.|+.
T Consensus 235 ---p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 235 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11123567899999999999999999999998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=380.89 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=203.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|+.. .+++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 9 ~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 4578999999999999854 467899999997642 334577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|.+++.+. ..+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 88 ~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~ 162 (337)
T d1o6la_ 88 NGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp TTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred CCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-cc
Confidence 999999998765 4578888999999999999999999 999999999999999999999999999986543322 23
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... ...+.+...
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~--------i~~~~~~~p--------- 225 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--------ILMEEIRFP--------- 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCCCC---------
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH--------HhcCCCCCC---------
Confidence 446799999999999999999999999999999999999999988765542211 122221110
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
......+.+|+.+||++||++||+ ++|+++
T Consensus 226 -~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112345788999999999999995 788876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-43 Score=376.93 Aligned_cols=241 Identities=27% Similarity=0.348 Sum_probs=201.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||+||+|+.. .+++.||||++++.. ....+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 8 i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 4578999999999999854 467899999997532 334578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
++|+|..++... ..++......++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 87 ~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~ 158 (316)
T d1fota_ 87 EGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 158 (316)
T ss_dssp CSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred CCcccccccccc-ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----c
Confidence 999999988655 4567788889999999999999998 9999999999999999999999999999876533 2
Q ss_pred ecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhh
Q 003818 662 TAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMD 741 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (793)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.... .
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--------~~~~~~~----p----- 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--------LNAELRF----P----- 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHCCCCC----C-----
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH--------HcCCCCC----C-----
Confidence 3457999999999999999999999999999999999999999877655432221 1111111 0
Q ss_pred hHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 742 DIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 742 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
......+.+++.+||+.||++|| |++++++
T Consensus 222 -~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01224578899999999999996 8999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=383.34 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=201.6
Q ss_pred cccccccccceeEEEeEeCCCCc-eeEEEEEechh-cccchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENE-KPVAVKKLYKA-VNEGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~-~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
+.+.||+|+||.||+|++...+. ..||||++... ..+..+.|.+|+++|.++ +|||||++++++.+++..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 45789999999999999765433 36888988643 333456899999999998 7999999999999999999999999
Q ss_pred CCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 582 SNGSLADFLFRK---------------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 582 ~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
++|+|.++|+.. ...+++..+.+++.|||+||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcc
Confidence 999999999654 36789999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCc-CCCCCchhHHHHHHHHHHHHHhh
Q 003818 647 FGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRK-NFEVDATEECQMILADWAYDCFR 725 (793)
Q Consensus 647 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~-pf~~~~~~~~~~~l~~~~~~~~~ 725 (793)
||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+.. ..+.
T Consensus 171 fG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~--------~~i~ 240 (309)
T d1fvra_ 171 FGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--------EKLP 240 (309)
T ss_dssp TTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------HHGG
T ss_pred ccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH--------HHHH
Confidence 9999865433222 23458999999999999999999999999999999999765 67665544321 1222
Q ss_pred ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 726 ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
.+..... +...++.+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 241 ~~~~~~~---------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 241 QGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2211111 1112356889999999999999999999999987754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=376.12 Aligned_cols=247 Identities=20% Similarity=0.263 Sum_probs=204.3
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
+.+.||+|+||+||+|... .+++.||||+++... .....+.+|+.+|++++|||||++++++.+++..+||||||++|
T Consensus 9 i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 4578999999999999854 467889999997643 33456889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC--CCcEEEeecCCccccCCCCCccee
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG--TFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|.+++......+++.++..++.||++||.|||++ +|+||||||+|||++. ...+||+|||+++...... ...
T Consensus 87 ~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~ 161 (321)
T d1tkia_ 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFR 161 (321)
T ss_dssp BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEE
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--ccc
Confidence 99999987777799999999999999999999998 9999999999999984 4589999999998764432 233
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+....+ ..+..... ....
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i--------~~~~~~~~------~~~~ 227 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--------MNAEYTFD------EEAF 227 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCCCC------HHHH
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCC------hhhc
Confidence 456899999999999999999999999999999999999999887655422221 11111100 0001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
......+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112456789999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=376.94 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=202.9
Q ss_pred cccccccccceeEEEeEeCCC------CceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTE------NEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|+.... .+..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..++
T Consensus 17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 357899999999999986432 235799999976543 3346788898888887 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 577 VYEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 577 V~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCC
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCC
Confidence 999999999999997543 4579999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHh-CCcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVC-CRKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~ellt-g~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~------ 247 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF------ 247 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH------
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH------
Confidence 9999999998765543332 334568999999999999999999999999999999998 68888766554321
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
..+..+....... ..+..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 248 --~~i~~~~~~~~p~---------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 248 --KLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp --HHHHTTCCCCCCS---------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHcCCCCCCCc---------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 2222222111111 12346889999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=377.85 Aligned_cols=254 Identities=30% Similarity=0.443 Sum_probs=206.1
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|++. ...++.||||+++.... .....|.+|+.+++++ +|||||++++++.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 4678999999999999863 35678999999976433 3345789999999998 7999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCc
Q 003818 579 EYVSNGSLADFLFRKS-----------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFN 641 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 641 (793)
|||++|+|.++++... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~ 183 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCc
Confidence 9999999999997543 2578899999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhC-CcCCCCCchhHHHHHHHHH
Q 003818 642 ARISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCC-RKNFEVDATEECQMILADW 719 (793)
Q Consensus 642 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg-~~pf~~~~~~~~~~~l~~~ 719 (793)
+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+++ .+||......+...
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~----- 258 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY----- 258 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH-----
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH-----
Confidence 999999999877654432 23345789999999999999999999999999999999995 55555544333211
Q ss_pred HHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 720 AYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
..+..+...... ...+..+.+|+.+||+.||++||||+||+++|++.
T Consensus 259 --~~i~~~~~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 --KMIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --HHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCCCCCc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111222111111 11235688999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=375.68 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=207.7
Q ss_pred cccccccccceeEEEeEeC----CCCceeEEEEEechhcc-cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEe
Q 003818 505 FKEELGEGAFGKVYKGVLT----TENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 579 (793)
+.+.||+|+||.||+|.+. ...++.||||+++.... +....|.+|+.++++++|||||++++++..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999864 23457899999975433 334568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCc
Q 003818 580 YVSNGSLADFLFRK---------SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLA 650 (793)
Q Consensus 580 y~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 650 (793)
|+++|+|.+++... ...+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccc
Confidence 99999999998642 23468889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcc-eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCC-cCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 651 KLLKTDQTQT-TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR-KNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 651 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~-~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
+.+....... .....+|+.|+|||.+.+..++.++||||||+++|||++|+ .||......+.... +..+.
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~--------i~~~~ 252 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------VMEGG 252 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--------HHTTC
T ss_pred eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHhCC
Confidence 8765433322 23345899999999999999999999999999999999985 67766655442221 12222
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAVD 779 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 779 (793)
...... ..+..+.+++.+||+.+|++||||++|+++|++..+
T Consensus 253 ~~~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 211111 123568899999999999999999999999988655
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=376.97 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=197.2
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEecCC----ceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----HRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey 580 (793)
+.++||+|+||.||+|++ +++.||||+++.... ....++.|+..+.+++|||||++++++.+.+ ..++||||
T Consensus 7 l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 457899999999999996 467899999865422 1223344566666789999999999997654 57899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEE-----CKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
|++|+|.++|.+. .+++..+++++.|+|.||+|||+. ..++|+||||||+||||++++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 9999999999764 588999999999999999999973 235999999999999999999999999999987654
Q ss_pred CCCc---ceecccCcccccCcccccCCC------CCCccceehhHHHHHHHHhCCcCCCCCchhHHH--------HHHHH
Q 003818 656 DQTQ---TTTAIRGTKGYVAPEWFKNLP------ITAKVDVYSFGILLLELVCCRKNFEVDATEECQ--------MILAD 718 (793)
Q Consensus 656 ~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~--------~~l~~ 718 (793)
.... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||......+.. ... .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-E 239 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-H
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH-H
Confidence 3322 223456999999999987643 577899999999999999999887543221100 001 1
Q ss_pred HHHHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 719 WAYDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
............. ..+......+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 240 ~~~~~~~~~~~~p---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 240 EMRKVVCEQKLRP---NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHTTSCCCC---CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccccCC---CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111222222111 11122223445677889999999999999999999999997643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=376.10 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=193.6
Q ss_pred cccccccccceeEEEeEeCC----CCceeEEEEEechhcc-cchHHHHHHHHHHhcC-CccccceeeeEEecC-CceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTT----ENEKPVAVKKLYKAVN-EGEQEFKAEISAIGRT-NHKNLVQLLGFCNEG-EHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV 577 (793)
+.++||+|+||.||+|.... .+++.||||+++.... ...+.+.+|...+.++ +|+|||++++++.+. ...++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 45789999999999998643 3457899999975433 3345677788877776 789999999988654 568999
Q ss_pred EeecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcE
Q 003818 578 YEYVSNGSLADFLFRKS---------------RRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNA 642 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 642 (793)
||||++|+|.+++..+. ..+++..+..++.||++||.|||++ +|+||||||+||||++++.+
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~ 173 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV 173 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcE
Confidence 99999999999997542 3478899999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCCc-ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCC-cCCCCCchhHHHHHHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQ-TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCR-KNFEVDATEECQMILADWA 720 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~-~pf~~~~~~~~~~~l~~~~ 720 (793)
||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+++. .||......+..
T Consensus 174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~------- 246 (299)
T d1ywna1 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------- 246 (299)
T ss_dssp EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH-------
T ss_pred EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 99999999876544332 233456999999999999999999999999999999999975 577655433211
Q ss_pred HHHhhccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 003818 721 YDCFRERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGAV 778 (793)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 778 (793)
...+..+......+ ..+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 CRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122222211111 12346789999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=373.43 Aligned_cols=260 Identities=22% Similarity=0.220 Sum_probs=196.6
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhccc-----chHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE-----GEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 581 (793)
++||+|+||+||+|... .+++.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 67999999999999854 46789999998654221 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcce
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTT 661 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 661 (793)
.++++..++ .....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 887766554 4556788899999999999999999998 9999999999999999999999999999876543322 2
Q ss_pred ecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhcc-ccce--ee
Q 003818 662 TAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRER-KLGL--LV 733 (793)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~-~~~~--~~ 733 (793)
....||+.|+|||++... .++.++|||||||++|||++|+.||......+....+.+.... .+... .... ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 334689999999998654 6799999999999999999999999877655533222211100 00000 0000 00
Q ss_pred c---ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 E---NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~---~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
. ............+.+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 00000001122456889999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-43 Score=369.00 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=197.8
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc---cchHHHHHHHHHHhcCCccccceeeeEEecCC----ceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN---EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----HRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 577 (793)
+.+.||+|+||.||+|... .+++.||||+++.... ...+.+.+|+.+++.++|||||++++++...+ ..++|
T Consensus 11 i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 11 LGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence 4578999999999999854 4678999999976433 23457899999999999999999999987654 37899
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+++++|.+++... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++..+|+|||.+.......
T Consensus 90 mE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 9999999999988655 4688999999999999999999998 99999999999999999999999999987654332
Q ss_pred C--cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 T--QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
. .......||+.|+|||++.+..+++++|||||||++|||++|+.||......+... ..+.......
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-------~~~~~~~~~~---- 234 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------QHVREDPIPP---- 234 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHCCCCCG----
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH-------HHHhcCCCCC----
Confidence 2 23344569999999999999999999999999999999999999998766544221 1222211110
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRP-AMKKVTQMIEGA 777 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~ 777 (793)
.......++.+.+++.+||++||++|| |++++++.|..+
T Consensus 235 ---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 235 ---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 001112235678999999999999999 899999888653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-43 Score=364.95 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=201.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc---------chHHHHHHHHHHhcCC-ccccceeeeEEecCCce
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE---------GEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHR 574 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 574 (793)
+.+.||+|+||+||+|+.. .+++.||||++...... ..+.+.+|+.++++++ |||||++++++.+++..
T Consensus 7 ~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 3578999999999999854 46789999998654211 1246889999999997 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccC
Q 003818 575 LLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLK 654 (793)
Q Consensus 575 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 654 (793)
+||||||++|+|.+++..+ ..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999764 4689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcceecccCcccccCcccccC------CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccc
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKN------LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERK 728 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 728 (793)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+ ..+.
T Consensus 162 ~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i--------~~~~ 231 (277)
T d1phka_ 162 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MSGN 231 (277)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTC
T ss_pred CCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH--------HhCC
Confidence 4332 234569999999999863 35788999999999999999999999887654432221 1221
Q ss_pred cceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 729 LGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..... ......++.+.+++.+||+.||++|||++||++
T Consensus 232 ~~~~~------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 YQFGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCC------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 111123456889999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=377.50 Aligned_cols=245 Identities=21% Similarity=0.269 Sum_probs=194.5
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhc-CCccccceeeeEEec----CCceEEEEeec
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGR-TNHKNLVQLLGFCNE----GEHRLLVYEYV 581 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~~lV~Ey~ 581 (793)
+.||+|+||.||+|... .+++.||||+++. ...+.+|+.++.+ .+|||||++++++.+ ....++|||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEEC-CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 46999999999999854 4578999999854 3567789988655 589999999999865 46789999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC---CCcEEEeecCCccccCCCC
Q 003818 582 SNGSLADFLFRK-SRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG---TFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 582 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~ 657 (793)
++|+|.+++.++ ...+++.++..++.||+.||.|||++ +|+||||||+|||+++ .+.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999765 35689999999999999999999998 9999999999999975 5679999999998765433
Q ss_pred CcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...+..+... .
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~~~------~ 236 (335)
T d2ozaa1 169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYE------F 236 (335)
T ss_dssp C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS------C
T ss_pred c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCCCC------C
Confidence 2 23456999999999999999999999999999999999999999765443311111 1111111110 0
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..........++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11112234567899999999999999999999988
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-42 Score=374.55 Aligned_cols=240 Identities=24% Similarity=0.253 Sum_probs=201.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVS 582 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 582 (793)
.+.||+|+||.||+|+.. .+++.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+..++||||+.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 478999999999999864 467899999996532 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCccee
Q 003818 583 NGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTT 662 (793)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 662 (793)
+|+|..++.+. ..+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.+.... .
T Consensus 125 ~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~----~ 196 (350)
T d1rdqe_ 125 GGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----W 196 (350)
T ss_dssp TCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----C
T ss_pred ccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc----c
Confidence 99999999765 4688999999999999999999998 99999999999999999999999999998765432 2
Q ss_pred cccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhhhh
Q 003818 663 AIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAMDD 742 (793)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (793)
...||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ ..+.... .
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--------~~~~~~~----p------ 258 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------VSGKVRF----P------ 258 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC----C------
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH--------hcCCCCC----C------
Confidence 356999999999999999999999999999999999999999876544322211 1111111 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 743 IKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 743 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
......+.+++.+||+.||++|+ |+++|++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11234678999999999999994 8999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=370.31 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=199.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHHHHHHHh-cCCccccceeeeEEecCCceEEEEee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKAEISAIG-RTNHKNLVQLLGFCNEGEHRLLVYEY 580 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV~Ey 580 (793)
+.+.||+|+||+||+|+.. .+++.||||++++.. ....+.+..|..++. .++|||||++++++.+++..++||||
T Consensus 6 i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy 84 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 84 (320)
T ss_dssp EEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEee
Confidence 4588999999999999965 467899999997532 333455667777665 68999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcc
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 660 (793)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~ 159 (320)
T d1xjda_ 85 LNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-K 159 (320)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-C
T ss_pred cCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc-c
Confidence 9999999999754 4578889999999999999999998 999999999999999999999999999986544332 2
Q ss_pred eecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccchhh
Q 003818 661 TTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDEEAM 740 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 740 (793)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~~~-p------- 223 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------RMDNPFY-P------- 223 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC-C-------
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCCC-C-------
Confidence 33456999999999999999999999999999999999999999877655422211 1111110 0
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003818 741 DDIKRVEKFVMIAIWCIQEDPSLRPAMK-KVTQ 772 (793)
Q Consensus 741 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 772 (793)
......+.+|+.+||+.||++|||+. +|++
T Consensus 224 --~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 --RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01234578999999999999999995 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-42 Score=375.46 Aligned_cols=245 Identities=24% Similarity=0.270 Sum_probs=194.4
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhc---ccchHHHHH---HHHHHhcCCccccceeeeEEecCCceEEEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV---NEGEQEFKA---EISAIGRTNHKNLVQLLGFCNEGEHRLLVY 578 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 578 (793)
+.+.||+|+||.||+|+.. .+++.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..++||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 3578999999999999854 467899999986532 222333444 467778889999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 87 DLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp CCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 999999999999765 4578889999999999999999998 99999999999999999999999999998765432
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecccc
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVENDE 737 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 737 (793)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.... ........ ....
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-----~~~~~~~~----~~~~- 229 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----DRMTLTMA----VELP- 229 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-----HHHSSSCC----CCCC-
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhcccCC----CCCC-
Confidence 234569999999999864 5689999999999999999999999987544322111 11111111 0000
Q ss_pred hhhhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003818 738 EAMDDIKRVEKFVMIAIWCIQEDPSLRPA-----MKKVTQ 772 (793)
Q Consensus 738 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 772 (793)
......+.+++.+||+.||++||| ++|+++
T Consensus 230 -----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 -----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 012345789999999999999999 688764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=366.14 Aligned_cols=262 Identities=24% Similarity=0.238 Sum_probs=198.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.+.||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+.++++++|||||++++++.++++.++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred ccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 378999999999999854 467889999996543 22357889999999999999999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+.+..........+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++....... ....
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~ 161 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTH 161 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTC
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-ccee
Confidence 555544455567799999999999999999999998 999999999999999999999999999987654332 2233
Q ss_pred ccCcccccCcccccCCC-CCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce---e---eccc
Q 003818 664 IRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL---L---VEND 736 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~-~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~---~---~~~~ 736 (793)
..||+.|+|||.+.... ++.++|||||||++|||++|+.||......+....+...... ..+..... . ....
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTCCTTS
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC-Cchhhcccccccccccccc
Confidence 46899999999987765 578999999999999999999999876554422211110000 00000000 0 0000
Q ss_pred ch------hhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 737 EE------AMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 737 ~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
.. ..........+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00011223567899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=366.80 Aligned_cols=262 Identities=23% Similarity=0.261 Sum_probs=198.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcC---CccccceeeeEEec-----CCceE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRT---NHKNLVQLLGFCNE-----GEHRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~~ 575 (793)
.++||+|+||+||+|+....+++.||||+++.... .....+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 47899999999999987656678899999865322 2234566787777665 89999999998853 35789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+++||+.++.+..........+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 92 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~ 168 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168 (305)
T ss_dssp EEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred EEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcc
Confidence 99999998888777666777889999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhccc-cc
Q 003818 656 DQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRERK-LG 730 (793)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~~-~~ 730 (793)
. .......||+.|+|||++.+.+++.++||||+||++|||++|+.||......+....+...... .+.... ..
T Consensus 169 ~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 169 Q--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp G--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred c--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 2 2334456999999999999999999999999999999999999999877655432222111100 000000 00
Q ss_pred ----eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 ----LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ----~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
................+.+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000001112356788999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=359.21 Aligned_cols=236 Identities=25% Similarity=0.428 Sum_probs=191.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhccc------chHHHHHHHHHHhcCC--ccccceeeeEEecCCceEE
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNE------GEQEFKAEISAIGRTN--HKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~l 576 (793)
+.+.||+|+||.||+|+.. .+++.||||++...... ....+.+|+.++++++ |||||++++++.+.+..++
T Consensus 8 i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l 86 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 86 (273)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence 3578999999999999854 46789999999754221 1244678999999986 8999999999999999999
Q ss_pred EEeecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-CCcEEEeecCCccccC
Q 003818 577 VYEYVSN-GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-TFNARISDFGLAKLLK 654 (793)
Q Consensus 577 V~Ey~~~-gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~ 654 (793)
||||+.+ +++.+++..+ ..+++..+..++.||++||.|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 87 v~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 87 ILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999976 5777777554 5688999999999999999999998 9999999999999985 5799999999998654
Q ss_pred CCCCcceecccCcccccCcccccCCCC-CCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceee
Q 003818 655 TDQTQTTTAIRGTKGYVAPEWFKNLPI-TAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLV 733 (793)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (793)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..+... .
T Consensus 163 ~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------------~~~~~~--~ 223 (273)
T d1xwsa_ 163 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------IRGQVF--F 223 (273)
T ss_dssp SS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------HHCCCC--C
T ss_pred cc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------------hhcccC--C
Confidence 32 2234569999999999987765 56799999999999999999999753211 011111 0
Q ss_pred cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 734 ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 734 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.. ..+.++.+++.+||+.||++|||++|+++
T Consensus 224 ~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 224 RQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 12356789999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-41 Score=353.60 Aligned_cols=260 Identities=22% Similarity=0.231 Sum_probs=195.5
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++..++..++++||+.+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred ccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 478999999999999864 56889999996542 33357899999999999999999999999999999999999977
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
+.+..+. .....++...+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++......... ...
T Consensus 85 ~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~ 159 (286)
T d1ob3a_ 85 DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTH 159 (286)
T ss_dssp EHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc-cce
Confidence 6665554 4557799999999999999999999998 9999999999999999999999999999876543222 223
Q ss_pred ccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhcc-cccee-----
Q 003818 664 IRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRER-KLGLL----- 732 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~~-~~~~~----- 732 (793)
..+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...... .+... .....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 3588999999998765 5699999999999999999999999876654432221110000 00000 00000
Q ss_pred -ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 733 -VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 733 -~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
................+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001112356789999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=356.15 Aligned_cols=257 Identities=24% Similarity=0.282 Sum_probs=191.4
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccceeeeEEec------CCceEEEEe
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQLLGFCNE------GEHRLLVYE 579 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lV~E 579 (793)
.++||+|+||+||+|+.. .+++.||||++.... ..+.+|+.+|++++|||||++++++.. ..+.+||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 367999999999999965 467899999996543 233579999999999999999998853 235789999
Q ss_pred ecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCC
Q 003818 580 YVSNGSLADFLF--RKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTD 656 (793)
Q Consensus 580 y~~~gsL~~~l~--~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~ 656 (793)
||+++.+..+.. .....+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||+++.+...
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 998765444432 3456789999999999999999999998 999999999999999775 8999999999876543
Q ss_pred CCcceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH----HHHh---h---
Q 003818 657 QTQTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA----YDCF---R--- 725 (793)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~----~~~~---~--- 725 (793)
.. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... ...+ .
T Consensus 177 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 177 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp SC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred cc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 32 233468999999998765 578999999999999999999999998776554322221100 0000 0
Q ss_pred -ccccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 726 -ERKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 726 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
.......................+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111000001111123456789999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-40 Score=345.56 Aligned_cols=255 Identities=19% Similarity=0.225 Sum_probs=196.1
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccce-eeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLVQ-LLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||.||+|+.. .+++.||||++.... ..+++..|+++++.++|+|++. +.++..+++..++||||+ +
T Consensus 11 l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 4578999999999999854 457899999886543 3356889999999998776555 455667788889999999 6
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEc---CCCcEEEeecCCccccCCCCCc-
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLD---GTFNARISDFGLAKLLKTDQTQ- 659 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~~~~~- 659 (793)
++|.+.+......+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 678787777778899999999999999999999998 999999999999985 4567999999999876543321
Q ss_pred -----ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeec
Q 003818 660 -----TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVE 734 (793)
Q Consensus 660 -----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 734 (793)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..........
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 235 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-------- 235 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--------
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--------
Confidence 2334579999999999999999999999999999999999999998765543322221111110000
Q ss_pred ccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003818 735 NDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEG 776 (793)
Q Consensus 735 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 776 (793)
+ . .......+.++.+++..|++.+|++||+++++.+.|+.
T Consensus 236 ~-~-~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 236 P-I-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp C-H-HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred C-h-hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0 0 00011233567899999999999999999999888875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-40 Score=348.89 Aligned_cols=262 Identities=18% Similarity=0.252 Sum_probs=193.0
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec--------CCceE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE--------GEHRL 575 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~~~ 575 (793)
.++||+|+||+||+|+.. .+++.||||++.... ....+.+.+|+.+|++++||||+++++++.. ....+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 478999999999999854 567899999986542 2345678899999999999999999998854 35689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCC
Q 003818 576 LVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKT 655 (793)
Q Consensus 576 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 655 (793)
+||||+.++.+..+ .......+...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 94 LVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp EEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred EEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 99999987766544 44556788889999999999999999998 999999999999999999999999999986654
Q ss_pred CCCc---ceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccce
Q 003818 656 DQTQ---TTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGL 731 (793)
Q Consensus 656 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (793)
.... ......||+.|+|||++.+. .+++++|||||||++|||++|+.||......+....+...... ........
T Consensus 170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 248 (318)
T d3blha1 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVWPN 248 (318)
T ss_dssp -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTT
T ss_pred ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CChhhccc
Confidence 3221 22234689999999998765 6899999999999999999999999876655433322221100 00000000
Q ss_pred --------eec----ccc---hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 732 --------LVE----NDE---EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 732 --------~~~----~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
... ... ...........+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 000 000111223467789999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-39 Score=341.75 Aligned_cols=256 Identities=18% Similarity=0.213 Sum_probs=202.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc-cccceeeeEEecCCceEEEEeecCC
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH-KNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
+.+.||+|+||+||+|+.. .+++.||||++.... ....+++|++.++.++| +|++.+++++.++...++||||+ +
T Consensus 9 i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 4578999999999999854 467899999885532 33567889999999865 89999999999999999999999 7
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcC-----CCcEEEeecCCccccCCCCC
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDG-----TFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~~~~~~ 658 (793)
++|.+++......++......++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.+.....
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 899999988878899999999999999999999998 9999999999999964 57899999999987654322
Q ss_pred c------ceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcccccee
Q 003818 659 Q------TTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLL 732 (793)
Q Consensus 659 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (793)
. ......||+.|||||.+.+..++.++||||||+++|||++|+.||.................... ......+
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l 240 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLREL 240 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCChHHh
Confidence 1 22345799999999999999999999999999999999999999976544322211111110000 0000000
Q ss_pred ecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 003818 733 VENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQMIEGA 777 (793)
Q Consensus 733 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 777 (793)
....++++.+++..|++.+|++||+++.+.+.|++.
T Consensus 241 ---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 241 ---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp ---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 011235678899999999999999999998888763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=350.90 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=191.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCC------ceEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE------HRLLV 577 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV 577 (793)
.++||+|+||+||+|... .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++...+ +.++|
T Consensus 23 i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 367999999999999854 4678999999975322 23467889999999999999999999997654 56999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+ +.+|..++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp EECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred Eecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCc-
Confidence 9999 6677777643 4689999999999999999999998 9999999999999999999999999999866433
Q ss_pred CcceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHH----HHhhcc-----
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAY----DCFRER----- 727 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~----~~~~~~----- 727 (793)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.......... ..+...
T Consensus 175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 2345689999999998764 568999999999999999999999987755443221111000 000000
Q ss_pred -----ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCC
Q 003818 728 -----KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM--IEGAVDV 780 (793)
Q Consensus 728 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~ 780 (793)
.......... ..........+.+|+.+||+.||++|||++|+++. ++...+.
T Consensus 252 ~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0000000000 00011123457889999999999999999999974 5554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=349.80 Aligned_cols=260 Identities=22% Similarity=0.246 Sum_probs=192.1
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhc-ccchHHHHHHHHHHhcCCccccceeeeEEecCC----ceEEEEee
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-NEGEQEFKAEISAIGRTNHKNLVQLLGFCNEGE----HRLLVYEY 580 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey 580 (793)
.++||+|+||+||+|+.. .+++.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+++++|
T Consensus 13 ~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEECC---CCCEEEEEET-TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 378999999999999854 567899999997543 233467889999999999999999999997653 23555667
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC--
Q 003818 581 VSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT-- 658 (793)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-- 658 (793)
+.+|+|.+++... .+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 92 ~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 92 LMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp CCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred ecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 7799999999654 588999999999999999999998 999999999999999999999999999986544322
Q ss_pred cceecccCcccccCcccccC-CCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhcc----------
Q 003818 659 QTTTAIRGTKGYVAPEWFKN-LPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRER---------- 727 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~---------- 727 (793)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+......... ......
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL-GSPSQEDLNCIINLKA 245 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CSCCHHHHHTCCCHHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc-cCCChhhhhhhhhhhh
Confidence 22334568999999999854 467899999999999999999999998765443221111000 000000
Q ss_pred -----ccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 728 -----KLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 728 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..... ..............++.+++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 246 RNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0000000001122467899999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=349.66 Aligned_cols=250 Identities=25% Similarity=0.293 Sum_probs=200.3
Q ss_pred cccccccccceeEEEeEeC--CCCceeEEEEEechhc----ccchHHHHHHHHHHhcCCc-cccceeeeEEecCCceEEE
Q 003818 505 FKEELGEGAFGKVYKGVLT--TENEKPVAVKKLYKAV----NEGEQEFKAEISAIGRTNH-KNLVQLLGFCNEGEHRLLV 577 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV 577 (793)
+.+.||+|+||+||+|... ..+++.||||++.... ....+.+.+|+.++++++| |||+++++++.+....+++
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 4578999999999999853 3457899999986532 2334678899999999976 8999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCC
Q 003818 578 YEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQ 657 (793)
Q Consensus 578 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 657 (793)
|||+.+|+|.+++.... .........++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 108 ~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp ECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 99999999999997654 456788888999999999999998 99999999999999999999999999998776555
Q ss_pred CcceecccCcccccCcccccCC--CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHHHhhccccceeecc
Q 003818 658 TQTTTAIRGTKGYVAPEWFKNL--PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYDCFRERKLGLLVEN 735 (793)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 735 (793)
........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+.. ... .....
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~---~~~-~~~~~----- 254 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RIL-KSEPP----- 254 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---HHH-HCCCC-----
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hcc-cCCCC-----
Confidence 5555556799999999999764 468899999999999999999999987654433222211 111 11110
Q ss_pred cchhhhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003818 736 DEEAMDDIKRVEKFVMIAIWCIQEDPSLRP-----AMKKVTQ 772 (793)
Q Consensus 736 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 772 (793)
.+.....++.+++.+||+.||++|| |++|+++
T Consensus 255 -----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 -----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0112346788999999999999999 4788876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=339.64 Aligned_cols=260 Identities=20% Similarity=0.218 Sum_probs=197.8
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecCCceEEEEeecCC
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEGEHRLLVYEYVSN 583 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 583 (793)
.++||+|+||+||+|+.. .+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.+....++|+|++.+
T Consensus 7 i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 378999999999999954 5678999999865432 3357889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCCcceec
Q 003818 584 GSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQTQTTTA 663 (793)
Q Consensus 584 gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 663 (793)
++|..++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++........ ...
T Consensus 86 ~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~~ 160 (292)
T d1unla_ 86 DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSA 160 (292)
T ss_dssp EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CCS
T ss_pred cccccccc-cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc-cee
Confidence 98887765 446678899999999999999999998 9999999999999999999999999999876543322 222
Q ss_pred ccCcccccCcccccCCC-CCCccceehhHHHHHHHHhCCcCCCCCchhHHH-HHHHHHHHHHhhccccc-----------
Q 003818 664 IRGTKGYVAPEWFKNLP-ITAKVDVYSFGILLLELVCCRKNFEVDATEECQ-MILADWAYDCFRERKLG----------- 730 (793)
Q Consensus 664 ~~gt~~y~aPE~~~~~~-~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~-~~l~~~~~~~~~~~~~~----------- 730 (793)
..+++.|+|||.+.... ++.++|||||||++|||++|+.||......... ..+...... ..+....
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT-PTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC-CCTTTCTTGGGSTTCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC-CChhhhhhhhhccccccc
Confidence 34778899999987665 689999999999999999999997554333221 111111000 0000000
Q ss_pred -eeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 -LLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 -~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
..................+.+|+.+||+.||++|||++||++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000111122356788999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-39 Score=344.30 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=192.5
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEec--CCceEEEEeec
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNE--GEHRLLVYEYV 581 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~Ey~ 581 (793)
+.++||+|+||+||+|+.. .+++.||||+++.. ..+.+.+|+.+|++++ ||||+++++++.. ....++||||+
T Consensus 39 i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 3478999999999999854 46789999998653 3467889999999985 9999999999874 45689999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCC-cEEEeecCCccccCCCCCcc
Q 003818 582 SNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTF-NARISDFGLAKLLKTDQTQT 660 (793)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 660 (793)
++++|..+. +.++...+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 115 ~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-- 185 (328)
T d3bqca1 115 NNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 185 (328)
T ss_dssp CSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--
T ss_pred CCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc--
Confidence 999987754 4688999999999999999999998 999999999999998655 689999999987654332
Q ss_pred eecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHH-HHHHHH-----HHHHhhccccc---
Q 003818 661 TTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQ-MILADW-----AYDCFRERKLG--- 730 (793)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~-~~l~~~-----~~~~~~~~~~~--- 730 (793)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+... ...........
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 2334689999999998765 4799999999999999999999999765443221 111110 00000000000
Q ss_pred ---eee--------cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 731 ---LLV--------ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 731 ---~~~--------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... ..............++.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000111122356789999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=345.66 Aligned_cols=257 Identities=22% Similarity=0.253 Sum_probs=187.0
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc--ccchHHHHHHHHHHhcCCccccceeeeEEec------CCceEEEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV--NEGEQEFKAEISAIGRTNHKNLVQLLGFCNE------GEHRLLVY 578 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lV~ 578 (793)
++||+|+||+||+|... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.. ..+.|+||
T Consensus 23 ~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 68999999999999854 467899999997543 2234578899999999999999999999853 46889999
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+.++.+. .+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++......
T Consensus 102 Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~- 173 (355)
T d2b1pa1 102 ELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_dssp ECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc-
Confidence 999765544 442 4578899999999999999999998 99999999999999999999999999988654432
Q ss_pred cceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHH---------------HHH
Q 003818 659 QTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWA---------------YDC 723 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~---------------~~~ 723 (793)
......+|+.|+|||++.+..+++++||||+||+++||++|+.||...........+.... ...
T Consensus 174 -~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 2233468999999999999999999999999999999999999998765443222111100 000
Q ss_pred hhccc-c-----ceee---cccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003818 724 FRERK-L-----GLLV---ENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQM 773 (793)
Q Consensus 724 ~~~~~-~-----~~~~---~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 773 (793)
..... . .... ...............+.+|+.+||+.||++|||++||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0 0000 0001111233456778999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-38 Score=339.76 Aligned_cols=264 Identities=22% Similarity=0.264 Sum_probs=194.3
Q ss_pred ccccccccceeEEEeEeCCCCceeEEEEEechhcc--cchHHHHHHHHHHhcCCccccceeeeEEecC-----CceEEEE
Q 003818 506 KEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN--EGEQEFKAEISAIGRTNHKNLVQLLGFCNEG-----EHRLLVY 578 (793)
Q Consensus 506 ~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~ 578 (793)
.++||+|+||+||+|... .+++.||||++..... ...+.+.+|+.+|++++|||||++++++... ...++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 378999999999999854 5688999999975432 2345788999999999999999999998643 3457778
Q ss_pred eecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEeecCCccccCCCCC
Q 003818 579 EYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISDFGLAKLLKTDQT 658 (793)
Q Consensus 579 Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 658 (793)
||+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.....
T Consensus 102 ~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 102 THLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp EECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred EeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc---
Confidence 88889999999854 4689999999999999999999998 999999999999999999999999999975432
Q ss_pred cceecccCcccccCcccccCC-CCCCccceehhHHHHHHHHhCCcCCCCCchhHHHHHHHHHHHH----Hhhc-------
Q 003818 659 QTTTAIRGTKGYVAPEWFKNL-PITAKVDVYSFGILLLELVCCRKNFEVDATEECQMILADWAYD----CFRE------- 726 (793)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~~~l~~~~~~----~~~~------- 726 (793)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+...... ....
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 22335588999999987765 4688999999999999999999999877654433222111000 0000
Q ss_pred ---cccceeecccchhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCC
Q 003818 727 ---RKLGLLVENDEEAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ--MIEGAVDV 780 (793)
Q Consensus 727 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~Le~~~~~ 780 (793)
........... ..........+.+|+.+||+.||++|||++|+++ .+.+..+.
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 253 NYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 00000000000 0000112356789999999999999999999997 45544433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-34 Score=312.94 Aligned_cols=260 Identities=23% Similarity=0.209 Sum_probs=183.9
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-----------ccccceeeeEEec--C
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-----------HKNLVQLLGFCNE--G 571 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~--~ 571 (793)
+.++||+|+||+||+|+.. .+++.||||+++... ...+.+.+|+.+++.++ |+||+++++++.. .
T Consensus 17 i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 4578999999999999854 467899999997542 23456788888888775 5789999988754 3
Q ss_pred CceEEEEeecCCCCHHHH--HhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEEcCCCc------E
Q 003818 572 EHRLLVYEYVSNGSLADF--LFRKSRRPNWYKRMQIAFGTARGLFYLHE-ECKSQIIHCDIKPQNILLDGTFN------A 642 (793)
Q Consensus 572 ~~~~lV~Ey~~~gsL~~~--l~~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIll~~~~~------~ 642 (793)
...+++++++..+..... ........+...+..++.||+.||+|||+ . +|+||||||+|||++.++. +
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccccee
Confidence 456677777655543332 23345677888999999999999999997 5 8999999999999986653 9
Q ss_pred EEeecCCccccCCCCCcceecccCcccccCcccccCCCCCCccceehhHHHHHHHHhCCcCCCCCchhHHH---HHHHHH
Q 003818 643 RISDFGLAKLLKTDQTQTTTAIRGTKGYVAPEWFKNLPITAKVDVYSFGILLLELVCCRKNFEVDATEECQ---MILADW 719 (793)
Q Consensus 643 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvws~Gvil~elltg~~pf~~~~~~~~~---~~l~~~ 719 (793)
|++|||.+....... ....||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+...
T Consensus 172 kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 999999997554322 3345899999999999999999999999999999999999999765432111 111111
Q ss_pred HHH-------Hhhc----------cc----cceeecccc------hhhhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003818 720 AYD-------CFRE----------RK----LGLLVENDE------EAMDDIKRVEKFVMIAIWCIQEDPSLRPAMKKVTQ 772 (793)
Q Consensus 720 ~~~-------~~~~----------~~----~~~~~~~~~------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 772 (793)
... .... .. +........ ...........+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 0000 00 000000000 01112345678899999999999999999999987
Q ss_pred H
Q 003818 773 M 773 (793)
Q Consensus 773 ~ 773 (793)
.
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=8.9e-21 Score=184.99 Aligned_cols=161 Identities=13% Similarity=0.098 Sum_probs=117.6
Q ss_pred cccccccccceeEEEeEeCCCCceeEEEEEechhcc------------------cchHHHHHHHHHHhcCCccccceeee
Q 003818 505 FKEELGEGAFGKVYKGVLTTENEKPVAVKKLYKAVN------------------EGEQEFKAEISAIGRTNHKNLVQLLG 566 (793)
Q Consensus 505 f~~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~ 566 (793)
+.++||+|+||+||+|+.. +|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999863 578899998753211 01133456888999999999998886
Q ss_pred EEecCCceEEEEeecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEEcCCCcEEEee
Q 003818 567 FCNEGEHRLLVYEYVSNGSLADFLFRKSRRPNWYKRMQIAFGTARGLFYLHEECKSQIIHCDIKPQNILLDGTFNARISD 646 (793)
Q Consensus 567 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 646 (793)
+. ..+++|||+++..+.+ ++......++.|++++|.|||++ +|+||||||+|||++++ .++|+|
T Consensus 82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 63 3479999998866543 33345668999999999999998 99999999999999975 489999
Q ss_pred cCCccccCCCCCcceecccCcccccCc------ccccCCCCCCccceehhHHH
Q 003818 647 FGLAKLLKTDQTQTTTAIRGTKGYVAP------EWFKNLPITAKVDVYSFGIL 693 (793)
Q Consensus 647 fgla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~~Dvws~Gvi 693 (793)
||+|.......... |... |.+ ...|+.++|+||..--
T Consensus 146 FG~a~~~~~~~~~~---------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWRE---------ILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHHH---------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcHH---------HHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99997654322111 1111 111 3467889999997543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=6.2e-20 Score=161.35 Aligned_cols=110 Identities=19% Similarity=0.474 Sum_probs=90.8
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
+|||.+||.|.+++ +|+| |.|+|+|+.+|+ |.|+. ..++||.||++.| ...+.+.|+.||+|||
T Consensus 1 tDtL~~gq~L~~g~-----~l~~--g~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~-~~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG-----SLAE--GGYLFIIQNDCN----LVLYD----NNRAVWASGTNGK-ASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTC-----EEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCTTS-CSSEEEEECTTSCEEE
T ss_pred CCEecCCCEecCCC-----EEEE--CCEEEEEcCCCC----EEEEc----CCcEEEEccCccC-CCCcEEEEeccccEEE
Confidence 48999999998877 7875 999999998886 44544 3689999999877 3457899999999999
Q ss_pred ECCCCCeeecCCCC-C-ccceeeEecCcCEEEEecCCCceeeeccCCCC
Q 003818 102 RDSSGKEIWREPPS-T-GAAYAAMLDTGNLVLASQDSSTMWESFDDPTD 148 (793)
Q Consensus 102 ~~~~~~~~Wst~~~-~-~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptd 148 (793)
+|.+ .++|++++. . +...|+|+|+|||||++.++.++|||+.+|++
T Consensus 65 ~~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSGS-RAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EETT-EEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EecC-CeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 9974 566666433 2 34589999999999999999999999999985
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.79 E-value=1.8e-19 Score=156.75 Aligned_cols=105 Identities=23% Similarity=0.454 Sum_probs=88.9
Q ss_pred CccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEEE
Q 003818 23 SNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLILR 102 (793)
Q Consensus 23 ~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l~ 102 (793)
|+|.+||.|.+++ +|.| |.|.|+|+.+|+ |.++. ..++||+||++.|....+.|.|+.||+|||+
T Consensus 2 ~~L~~g~~L~~g~-----~l~~--g~~~l~~q~dgn----Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~ 66 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQ-----SLDV--EPYHFIMQEDCN----LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVY 66 (109)
T ss_dssp CEEETTCEEETTC-----EEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEE
T ss_pred CCccCCCEEeCCC-----EEEe--CCEEEEecCCCe----EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEE
Confidence 7899999998776 7864 899999988775 44432 3689999999999988899999999999999
Q ss_pred CCCCCeeecCCCC--CccceeeEecCcCEEEEecCCCceeeeccC
Q 003818 103 DSSGKEIWREPPS--TGAAYAAMLDTGNLVLASQDSSTMWESFDD 145 (793)
Q Consensus 103 ~~~~~~~Wst~~~--~~~~~~~lld~GNlvl~~~~~~~~WqSFd~ 145 (793)
|++|++||+|+++ .+..+|+|+|+|||||+++ .+|||+-|
T Consensus 67 ~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp CSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred eCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9999999999764 3345799999999999964 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.77 E-value=5.6e-19 Score=153.59 Aligned_cols=105 Identities=19% Similarity=0.372 Sum_probs=87.2
Q ss_pred CCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEEE
Q 003818 22 SSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLIL 101 (793)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~l 101 (793)
.|+|.+||.|.+++ +|. +|.|+|+|+.+|+ |.|+. ..++||.||++.| ...+.+.++.+|||+|
T Consensus 1 ~~~L~~g~~L~~G~-----~l~--ng~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl 64 (108)
T d1jpca_ 1 DNILYSGETLSTGE-----FLN--YGSFVFIMQEDCN----LVLYD----VDKPIWATNTGGL-SRSCFLSMQTDGNLVV 64 (108)
T ss_dssp CCEEETTEEECTTC-----EEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred CCCccCCCEecCCC-----EEE--cCCEEEEECCCCe----EEEEe----CCceeeEeCCCCC-CCccEEEEeccceEEE
Confidence 37899999998766 775 5999999998886 55654 3589999999877 4456899999999999
Q ss_pred ECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeeccC
Q 003818 102 RDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFDD 145 (793)
Q Consensus 102 ~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd~ 145 (793)
.|++|.+||+|++... ..+|+|+|+|||||++. .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 9999999999975432 34789999999999964 58999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.72 E-value=7e-18 Score=148.99 Aligned_cols=99 Identities=21% Similarity=0.404 Sum_probs=84.8
Q ss_pred EEeccCCCCeEEEeeCCCCCCCCC-ceEEEecCCcEEEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceee
Q 003818 65 IWFNEIPERTIVWSANRDNLVQRG-SKVELTGDGQLILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWE 141 (793)
Q Consensus 65 iw~~~~~~~t~vW~anr~~p~~~~-~~l~~~~~g~l~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~Wq 141 (793)
|||.++++++.+|++|+++|+... -.|.++.||||||++. +.++|++++.. ....|+|+|+|||||++.++.++||
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 789999999999999999999755 4899999999999986 67899987643 3468999999999999999999999
Q ss_pred eccCCCCcccCCccccCCceEEEecCCCCCCcceEEEEEecCCceEEe
Q 003818 142 SFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLY 189 (793)
Q Consensus 142 SFd~Ptdtllp~~~l~~~~~L~s~~s~~dps~G~~~~~~~~~g~~~l~ 189 (793)
|+. +.++|.|.+.||+||++++|
T Consensus 91 S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 91 SGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred eCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 974 23678899999999999998
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.59 E-value=3.3e-16 Score=136.54 Aligned_cols=109 Identities=22% Similarity=0.376 Sum_probs=92.1
Q ss_pred EEeccCCCCeEEEeeCCCCCCCCC-ceEEEecCCcEEEECCCCCeeecCCCC-CccceeeEecCcCEEEEecCCCceeee
Q 003818 65 IWFNEIPERTIVWSANRDNLVQRG-SKVELTGDGQLILRDSSGKEIWREPPS-TGAAYAAMLDTGNLVLASQDSSTMWES 142 (793)
Q Consensus 65 iw~~~~~~~t~vW~anr~~p~~~~-~~l~~~~~g~l~l~~~~~~~~Wst~~~-~~~~~~~lld~GNlvl~~~~~~~~WqS 142 (793)
|||.-.++.+..|..+.++++.+. -.|.++.||||||++ .+.++|++++. ..+..+.|+|+|||||++.++.+||||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 678777788888999999998654 589999999999998 46889999764 456789999999999999999999998
Q ss_pred ccCCCCcccCCccccCCceEEEecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCccccccccc
Q 003818 143 FDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTS 208 (793)
Q Consensus 143 Fd~Ptdtllp~~~l~~~~~L~s~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~ 208 (793)
+. +.++|.|.+.|++||++++|. .++|++++.
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt~ 113 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIYG---------PGLWDSGTS 113 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEeC---------CCeecCCCC
Confidence 63 346899999999999999872 468998864
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=6.9e-15 Score=129.04 Aligned_cols=103 Identities=17% Similarity=0.405 Sum_probs=82.0
Q ss_pred cCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcEE
Q 003818 21 SSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQLI 100 (793)
Q Consensus 21 ~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l~ 100 (793)
..++|.+||+| ...+..|+|.|.|+.+|+ |.+ |. ..++||.||+..+ .....|.|..||+|+
T Consensus 13 ~~~~l~~~q~l---------~~~~~~~~y~l~mQ~DGN----LVL-y~---~~~~vWssnt~~~-~~~~~l~l~~dGnLv 74 (119)
T d1b2pa_ 13 HPQILHATESL---------EILFGTHVYRFIMQTDCN----LVL-YD---NNNPIWATNTGGL-GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CCCEEETTCEE---------EEEETTEEEEEEECTTSC----EEE-EE---TTEEEEECCCTTS-CSSCEEEECTTSCEE
T ss_pred CCCEEeCCCeE---------EEecCCceEEEEECCCCc----EEE-EE---CCeEEEEecCCCC-CcceEEEEEeCCCEE
Confidence 34677777777 357789999999999987 323 33 3689999999866 345789999999999
Q ss_pred EECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeecc
Q 003818 101 LRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFD 144 (793)
Q Consensus 101 l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd 144 (793)
|.|++|.+||++++.. ...+++|+|+|||||++ ..+|||..
T Consensus 75 L~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred EECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9999999999987643 23468999999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=5.6e-13 Score=115.83 Aligned_cols=99 Identities=17% Similarity=0.359 Sum_probs=76.9
Q ss_pred ccCCccCCCCceeecCCCCCCeeecCCCeEEeeeeecCCCCeEEEEEeccCCCCeEEEeeCCCCCCCCCceEEEecCCcE
Q 003818 20 QSSSNISLGSSLTASNDNPAASWISQSGDFAFGFRQVGDRGFLLAIWFNEIPERTIVWSANRDNLVQRGSKVELTGDGQL 99 (793)
Q Consensus 20 ~~~~~~~~~~~l~~~~~~~~~~l~S~~g~F~lgF~~~~~~~~~~giw~~~~~~~t~vW~anr~~p~~~~~~l~~~~~g~l 99 (793)
.+.+||.+|++|. +|.|.|.|+.+|+ |.++. ..++||.+|... ...+.+.|..+|||
T Consensus 12 ~~~~tl~~~~~l~-------------~g~~~l~~q~DGN----LvL~~----~~~~vW~s~t~~--~~~~~l~l~~dGNL 68 (115)
T d1dlpa1 12 SHPQTLHAAQSLE-------------LSSFRFTMQSDCN----LVLFD----SDVRVWASNTAG--ATGCRAVLQSDGLL 68 (115)
T ss_dssp CSCSCCCTTCEEC-------------STTEEEEECTTSC----EEEEE----SSSEEECCCCCS--CSCCBCCBCSSSCB
T ss_pred CCcceecCCCcEE-------------cCCEEEEECCCCe----EEEEc----CCeeEEEcccCC--CCceEEEEeccCCE
Confidence 3446777777773 3889999998886 44543 357899999754 34678999999999
Q ss_pred EEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeecc
Q 003818 100 ILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFD 144 (793)
Q Consensus 100 ~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd 144 (793)
||.|.++.+||++.+.. +...++|+++|||||++ ..+|+|-.
T Consensus 69 vl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred EEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 99999999999996543 34579999999999995 47999853
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.08 E-value=1.9e-10 Score=100.22 Aligned_cols=83 Identities=29% Similarity=0.546 Sum_probs=66.8
Q ss_pred eEEEecCCcEEEECCCCCeeecCCCCC--ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEecC
Q 003818 90 KVELTGDGQLILRDSSGKEIWREPPST--GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLT 167 (793)
Q Consensus 90 ~l~~~~~g~l~l~~~~~~~~Wst~~~~--~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~s 167 (793)
.|.+..||||||++. +.++|++++.. ....+.|.++|||||++.++.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 577889999999876 56899997643 2468999999999999999999998621
Q ss_pred CCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 168 ETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 168 ~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
.-+.|.|.+.|++||++++|. .+.|++++
T Consensus 89 --~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 89 --AGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp --CCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred --cCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 114578999999999999983 45888776
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.06 E-value=1.9e-10 Score=100.65 Aligned_cols=110 Identities=24% Similarity=0.363 Sum_probs=82.7
Q ss_pred eeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCc
Q 003818 121 AAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANA 200 (793)
Q Consensus 121 ~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~ 200 (793)
++++|+||+||.+. +|+|.|+++|.++|.+. .|.|+|.|+.+|+++++.. +.
T Consensus 3 ~v~~~~~n~il~~~------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~-------~~ 54 (120)
T d1dlpa2 3 VVVANNGNSILYST------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDR-------DD 54 (120)
T ss_dssp CCCSSCCCEECCCC--------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBT-------TB
T ss_pred EEEEeCCCeEEEcC------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecC-------Cc
Confidence 45677777777653 67899999999998874 4679999999999999853 25
Q ss_pred ccccccccC-CcceeEEecccceEEEEecCCeeEEEEeeccccCcceEEEEEEcCCCcEEEE
Q 003818 201 AYWSTQTSI-GSGYQVVFNQSGFIYLTARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261 (793)
Q Consensus 201 ~yw~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~ 261 (793)
++|.+.+.. +....+.++.+|.+.++..++..++.+... .....+|++|++||++++|
T Consensus 55 ~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~---~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 55 RVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS---RSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC---CSSSCCEEEECSSSCEEEE
T ss_pred EEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCC---CCCCcEEEEECCCCcEEEe
Confidence 688877654 345567888899999998888888776532 1122358999999999998
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.02 E-value=5.5e-10 Score=95.90 Aligned_cols=84 Identities=29% Similarity=0.516 Sum_probs=66.6
Q ss_pred ceEEEecCCcEEEECCCCCeeecCCCCCc--cceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEec
Q 003818 89 SKVELTGDGQLILRDSSGKEIWREPPSTG--AAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIARL 166 (793)
Q Consensus 89 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~--~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~~ 166 (793)
-.|.+..||||||++. +.+||++++... ...+.|+++|||||++.++.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 4678899999999874 578999976443 3579999999999999999999987
Q ss_pred CCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccc
Q 003818 167 TETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQT 207 (793)
Q Consensus 167 s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~ 207 (793)
.+....+.|.+.|+.+|++++|. .+.|++++
T Consensus 76 -~t~~~~~~~~l~L~ddGNlVly~---------~~~W~S~t 106 (108)
T d1jpca_ 76 -NTGGQNGNYVCILQKDRNVVIYG---------TDRWATGT 106 (108)
T ss_dssp -CCCCSCSCEEEEECTTSCEEEEE---------CCCCCCCC
T ss_pred -cccCCCCcEEEEEcCCCCEEEeC---------CCcccCCC
Confidence 11224578899999999999983 34677664
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.98 E-value=8.1e-10 Score=94.86 Aligned_cols=85 Identities=26% Similarity=0.546 Sum_probs=66.9
Q ss_pred ceEEEecCCcEEEECCCCCeeecCCCCC---ccceeeEecCcCEEEEecCCCceeeeccCCCCcccCCccccCCceEEEe
Q 003818 89 SKVELTGDGQLILRDSSGKEIWREPPST---GAAYAAMLDTGNLVLASQDSSTMWESFDDPTDTLLPTQVMSQGTKVIAR 165 (793)
Q Consensus 89 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~---~~~~~~lld~GNlvl~~~~~~~~WqSFd~Ptdtllp~~~l~~~~~L~s~ 165 (793)
-.|.+..||||||++ .+.+||++++.. .+..+.|.++|||||+++++.++|+|-
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~---------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH---------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC----------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe----------------------
Confidence 567888999999987 457899987642 345789999999999999999999871
Q ss_pred cCCCCCCcceEEEEEecCCceEEeeccCCCCCCCccccccccc
Q 003818 166 LTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTS 208 (793)
Q Consensus 166 ~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~ 208 (793)
+..+.|.|.+.|+++|++++|. ...|.+.+.
T Consensus 78 ---t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ---SVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY 108 (109)
T ss_dssp ---CCCCSSCCEEEECTTSCEEEEC---------CEEEECCCC
T ss_pred ---eECCCCCEEEEEeCCCcEEEEC---------CCEecCCCc
Confidence 1113577899999999999983 347877663
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.84 E-value=5e-09 Score=90.61 Aligned_cols=95 Identities=23% Similarity=0.376 Sum_probs=73.6
Q ss_pred CCcccCCccccCCceEEEecCCCCCCcceEEEEEecCCceEEeeccCCCCCCCcccccccccC-CcceeEEecccceEEE
Q 003818 147 TDTLLPTQVMSQGTKVIARLTETNYSSGRFMFELQTDGNLLLYTTTYPFDGANAAYWSTQTSI-GSGYQVVFNQSGFIYL 225 (793)
Q Consensus 147 tdtllp~~~l~~~~~L~s~~s~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~yw~~~~~~-~~~~~~~~~~~~~~~~ 225 (793)
||||+|||.|..|..|++ |.|+|.|+.||++++|.. ..++|.+.+.. +.+..+++..+|.+.+
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~-------~~~vW~s~~~~~~~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN-------NRAVWASGTNGKASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET-------TEEEEECCCTTSCSSEEEEECTTSCEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC-------CcEEEEccCccCCCCcEEEEeccccEEE
Confidence 799999999999999965 999999999999999853 26788877654 4455788999999988
Q ss_pred EecCCeeEEEEeeccccCcceEEEEEEcCCCcEEEE
Q 003818 226 TARNGSILNAVTSNNVTAQDFYQRAVVDPDGVFRHY 261 (793)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~ 261 (793)
+..+ ..++.+.. .......+++|+.||+|++|
T Consensus 65 ~~~~-~~~w~s~t---~~~~~~~~l~L~ddGNlvly 96 (112)
T d1xd5a_ 65 YSGS-RAIWASNT---NRQNGNYYLILQRDRNVVIY 96 (112)
T ss_dssp EETT-EEEEECCC---CCSCCCCEEEECTTSCEEEE
T ss_pred EecC-CeEEEEee---ccCCCceEEEEcCCCCEEEE
Confidence 8754 44443322 22233468999999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=1e-05 Score=80.52 Aligned_cols=130 Identities=15% Similarity=0.055 Sum_probs=92.1
Q ss_pred cceeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCC-ccccceeeeEEecCCceEEEEeecCCCCHHHHHh
Q 003818 513 AFGKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTN-HKNLVQLLGFCNEGEHRLLVYEYVSNGSLADFLF 591 (793)
Q Consensus 513 ~fg~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 591 (793)
+.+.||+..- +++.+.+|+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+...
T Consensus 26 s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 26 SPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp SSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 3468998652 44557888886655555566788888877663 4346778888888889999999999988866542
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------------
Q 003818 592 RKSRRPNWYKRMQIAFGTARGLFYLHEEC--------------------------------------------------- 620 (793)
Q Consensus 592 ~~~~~~~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------------- 620 (793)
.. .....++.++++.|..||+..
T Consensus 103 ~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 103 DE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp TC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred cc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 21 123345556666666666421
Q ss_pred -----CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 621 -----KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 621 -----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
...++|+|+.|.|||++++...-|+||+.+.
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987777799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.36 E-value=0.00032 Score=68.77 Aligned_cols=130 Identities=15% Similarity=0.102 Sum_probs=81.5
Q ss_pred ccccccc-eeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCc--cccceeeeEEecCCceEEEEeecCCC
Q 003818 508 ELGEGAF-GKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNH--KNLVQLLGFCNEGEHRLLVYEYVSNG 584 (793)
Q Consensus 508 ~LG~G~f-g~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g 584 (793)
.+..|.. +.||+... .++..+.+|.-... ....+..|...++.+.. -.+.+++.+..+++..++|||++++.
T Consensus 17 ~~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEEC--TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEe--CCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3444543 57898653 34556888875433 23356777777776633 34677888888888999999999886
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 003818 585 SLADFLFRKSRRPNWYKRMQIAFGTARGLFYLH----------------------------------------------- 617 (793)
Q Consensus 585 sL~~~l~~~~~~~~~~~~~~i~~~ia~gL~yLH----------------------------------------------- 617 (793)
++.+.. .. ...++.++++.|.-||
T Consensus 92 ~~~~~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 92 DLLSSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp ETTTSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccccc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 553210 00 0111222222333333
Q ss_pred ----hcC----CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 618 ----EEC----KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 618 ----~~~----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
... ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 221 1237999999999999987777899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.02 E-value=0.0012 Score=69.12 Aligned_cols=76 Identities=18% Similarity=0.198 Sum_probs=47.1
Q ss_pred cccccccceeEEEeEeCCCCceeEEEEEechhc-------ccchHHHHHHHHHHhcCC---ccccceeeeEEecCCceEE
Q 003818 507 EELGEGAFGKVYKGVLTTENEKPVAVKKLYKAV-------NEGEQEFKAEISAIGRTN---HKNLVQLLGFCNEGEHRLL 576 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 576 (793)
+.||.|....||+.... .+++.+++|.-.... .........|.+.|+.+. ...+++++.+ +++..++
T Consensus 32 ~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 46899999999998743 346678888653211 112234556777776552 2345556654 4556789
Q ss_pred EEeecCCCC
Q 003818 577 VYEYVSNGS 585 (793)
Q Consensus 577 V~Ey~~~gs 585 (793)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.34 E-value=0.023 Score=59.11 Aligned_cols=74 Identities=18% Similarity=0.253 Sum_probs=48.3
Q ss_pred cccccccceeEEEeEeCCC------CceeEEEEEechhcccchHHHHHHHHHHhcCCcccc-ceeeeEEecCCceEEEEe
Q 003818 507 EELGEGAFGKVYKGVLTTE------NEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNL-VQLLGFCNEGEHRLLVYE 579 (793)
Q Consensus 507 ~~LG~G~fg~Vy~~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E 579 (793)
+.|+-|---.+|+...... ..+.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577788889999876432 224466665542 2334556788888888754454 467887754 68999
Q ss_pred ecCCCCH
Q 003818 580 YVSNGSL 586 (793)
Q Consensus 580 y~~~gsL 586 (793)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.28 E-value=0.04 Score=55.42 Aligned_cols=132 Identities=14% Similarity=0.108 Sum_probs=74.7
Q ss_pred eeEEEeEeCCCCceeEEEEEechhcccchHHHHHHHHHHhcCCccccc-----eee--eEEecCCceEEEEeecCCCCHH
Q 003818 515 GKVYKGVLTTENEKPVAVKKLYKAVNEGEQEFKAEISAIGRTNHKNLV-----QLL--GFCNEGEHRLLVYEYVSNGSLA 587 (793)
Q Consensus 515 g~Vy~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-----~l~--~~~~~~~~~~lV~Ey~~~gsL~ 587 (793)
-.||+... ++|+.+++|..+.. ....+++..|...+..+....+. ..- .....+...+.++++++|..+.
T Consensus 36 N~vy~v~~--~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQD--EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECC--TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEc--CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 47998765 45677999987543 33456788888888776533321 111 1334456778899998764321
Q ss_pred -----------HHH---h----cC----CCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCC
Q 003818 588 -----------DFL---F----RK----SRRPNWY-------------------KRMQIAFGTARGLFYLHE----ECKS 622 (793)
Q Consensus 588 -----------~~l---~----~~----~~~~~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~ 622 (793)
..+ + .. ....+.. .+..+...+.+.+..+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 111 0 00 1111111 111122222333333332 2245
Q ss_pred CeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 623 QIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 623 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
++||+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999754 4589999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.57 E-value=0.18 Score=50.04 Aligned_cols=31 Identities=26% Similarity=0.378 Sum_probs=27.7
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEeecCCcc
Q 003818 621 KSQIIHCDIKPQNILLDGTFNARISDFGLAK 651 (793)
Q Consensus 621 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 651 (793)
+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999998878899999874
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.01 E-value=0.082 Score=32.68 Aligned_cols=32 Identities=25% Similarity=0.481 Sum_probs=23.8
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCcccccCCCCccc
Q 003818 287 NICLRIRADTGSGACGFNSFCSLGDDQRKLCQCPPGYTFF 326 (793)
Q Consensus 287 ~~C~~~~~~~~~g~CG~~~~C~~~~~~~~~C~C~~Gf~~~ 326 (793)
|+|.+ -..|| +|.|+.. ...-.|.|-.||+|.
T Consensus 2 dECsi------gnpCG-nGTCtNv-iGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNV-IGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEEC-SSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-Cceeeec-ccceEEeecCCcCCC
Confidence 56777 57888 6788753 345679999999984
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.25 E-value=0.21 Score=33.00 Aligned_cols=26 Identities=31% Similarity=0.574 Sum_probs=21.2
Q ss_pred CCCCCCCcccccCCCCCcccccCCCCc
Q 003818 298 SGACGFNSFCSLGDDQRKLCQCPPGYT 324 (793)
Q Consensus 298 ~g~CG~~~~C~~~~~~~~~C~C~~Gf~ 324 (793)
...|..+|.|.. ...+-.|.|++||+
T Consensus 10 ~~pC~n~g~C~n-~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCIN-TLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEE-CSSSEEEECCTTEE
T ss_pred CCCCCCCcEeEC-CCCCEEeECCCCCc
Confidence 467999999975 34567899999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.10 E-value=0.45 Score=30.75 Aligned_cols=25 Identities=24% Similarity=0.586 Sum_probs=19.9
Q ss_pred CCCCCCcccccCCCCCcccccCCCCc
Q 003818 299 GACGFNSFCSLGDDQRKLCQCPPGYT 324 (793)
Q Consensus 299 g~CG~~~~C~~~~~~~~~C~C~~Gf~ 324 (793)
.-|...|.|... ...-.|.|++||+
T Consensus 6 ~PC~ngg~C~~~-~~~y~C~C~~G~~ 30 (39)
T d1xkba1 6 SPCQNQGKCKDG-LGEYTCTCLEGFE 30 (39)
T ss_dssp CCCCSSCEECCC-SSSCCEECCTTEE
T ss_pred CCCCCCcEEECC-CCCEEEECCCCCC
Confidence 678888999753 4567899999996
|